|
5935 genotypes with 14417 annotations displayed
of selected term and subterms
|
|
Searched Term: abnormal mononuclear cell morphology
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93488
|
| decreased CD8-positive, alpha-beta T cell number
|
J:93488
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: C57BL/6 * FVB/N)
|
abnormal alveolar macrophage morphology
|
J:137452
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/Jdk)
|
decreased macrophage cell number
|
J:137009
|
| decreased NK T cell number
|
J:137009
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: FVB/N)
|
decreased gamma-delta T cell number
|
J:193548
|
| decreased T cell number
|
J:193548
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
increased monocyte cell number
|
J:194800
|
2310022B05Riktm1a(EUCOMM)Hmgu/2310022B05Riktm1a(EUCOMM)Hmgu
(C57BL/6N-2310022B05Riktm1a(EUCOMM)Hmgu/H)
|
increased B cell number
|
J:165965
|
2810408A11Riktm1a(EUCOMM)Wtsi/2810408A11Riktm1a(EUCOMM)Wtsi
(C57BL/6N-2810408A11Riktm1a(EUCOMM)Wtsi/H)
|
decreased NK cell number
|
J:165965
|
| increased CD4-positive, alpha-beta T cell number
|
J:165965
|
| increased NK cell number
|
J:165965
|
3425401B19Rikem2(IMPC)Ccpcz/3425401B19Rikem2(IMPC)Ccpcz
(C57BL/6NCrl-3425401B19Rikem2(IMPC)Ccpcz/Ph)
|
increased effector memory T-helper cell number
|
J:211773
|
9430015G10Riktm1Lex/9430015G10Riktm1Lex
(B6;129S5-9430015G10Riktm1Lex/Mmucd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:171883
|
| increased B cell number
|
J:171883
|
Ay/a
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
|
increased monocyte cell number
|
J:177084
|
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
|
decreased monocyte cell number
|
J:190966
|
| increased monocyte cell number
|
J:190966
|
Abcb1atm1Bor/Abcb1atm1Bor
(FVBTac.129P2-Abcb1atm1Bor)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:102640
|
| decreased gamma-delta intraepithelial T cell number
|
J:102640
|
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
(FVBTac.129P2-Abcb1btm1Bor Abcb1atm1Bor)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:102640
|
| decreased gamma-delta intraepithelial T cell number
|
J:102640
|
| increased double-positive T cell number
|
J:102640
|
Abcb4em1(IMPC)H/Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H)
|
increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Abcc1tm1Bor/Abcc1tm1Bor
Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0
(FVB.Cg-Abcc1tm1Bor Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr)
|
microgliosis
|
J:178230
|
Abcc2tm2b(KOMP)Wtsi/Abcc2tm2b(KOMP)Wtsi
(C57BL/6N-Abcc2tm2b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
Abcc5em1(IMPC)H/Abcc5em1(IMPC)H
(C57BL/6N-Abcc5em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Abcc9em1(IMPC)H/Abcc9+
(C57BL/6N-Abcc9em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Abcd1tm1Kds/Y
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal microglial cell morphology
|
J:94583
|
Abcd1tm1Kds/Y
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal microglial cell morphology
|
J:94583
|
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal microglial cell morphology
|
J:94583
|
Abce1tm1b(EUCOMM)Hmgu/Abce1+
(C57BL/6N-Abce1tm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
Abcg1tm1Dgen/Abcg1tm1Dgen
(B6.129P2-Abcg1tm1Dgen)
|
increased macrophage derived foam cell number
|
J:117028
|
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage morphology
|
J:132952
|
| abnormal monocyte differentiation
|
J:132952
|
| increased B cell number
|
J:132952
|
| increased CD4-positive, alpha-beta T cell number
|
J:132952
|
| increased CD8-positive, alpha-beta T cell number
|
J:132952
|
| increased monocyte cell number
|
J:132952
|
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz)
|
decreased B-2 B cell number
|
J:211773
|
| decreased CD4-negative NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
Abhd12tm1Crv/Abhd12tm1Crv
(involves: C57BL/6)
|
microgliosis
|
J:193716
|
Abl1m1/Abl1m1
(either: 129S/SvEv-Abl1m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))
|
abnormal B cell differentiation
|
J:14644
|
| abnormal T cell number
|
J:14644
|
| decreased immature B cell number
|
J:14644
|
| decreased pre-B cell number
|
J:14644
|
| decreased pro-B cell number
|
J:14644
|
| decreased single-positive T cell number
|
J:14644
|
| decreased thymocyte number
|
J:14644
|
| increased single-positive T cell number
|
J:14644
|
Abl1m1/Abl1m1
(involves: 129S/SvEv)
|
abnormal B cell differentiation
|
J:28795
|
| decreased mature B cell number
|
J:28795
|
| decreased pre-B cell number
|
J:28795
|
| decreased pro-B cell number
|
J:28795
|
Abl1m1/Abl1m1
(involves: 129S/SvEv * C57BL/6)
|
abnormal lymphopoiesis
|
J:148105
|
| decreased pro-B cell number
|
J:148105
|
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J)
|
decreased B cell number
|
J:72875
|
| decreased lymphocyte cell number
|
J:72875
|
| decreased T cell number
|
J:72875
|
| decreased thymocyte number
|
J:72875
|
Acacatm1Dejs/Acacatm1Dejs
Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
decreased memory T cell number
|
J:209886
|
| decreased T cell number
|
J:209886
|
Acbd5tm1a(EUCOMM)Wtsi/Acbd5tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Acbd5tm1a(EUCOMM)Wtsi/WtsiCnbc)
|
abnormal microglial cell morphology
|
J:299448
|
Acetm6Keb/Acetm6Keb
(involves: 129 * C57BL/6)
|
increased T cell number
|
J:122178
|
Ackr3tm1.1Fma/Ackr3tm1.1Fma
(involves: BALB/cJ * C57BL/6)
|
decreased marginal zone B cell number
|
J:124878
|
Ackr4tm1.1Rjbn/Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:166490
|
| abnormal T-helper 17 cell differentiation
|
J:166490
|
| increased T-helper 17 cell number
|
J:166490
|
Acoxlem1(IMPC)Mbp/Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Acp2tm1a(EUCOMM)Wtsi/Acp2tm1a(EUCOMM)Wtsi
(C57BL/6N-Acp2tm1a(EUCOMM)Wtsi/H)
|
decreased CD4-positive, alpha-beta T cell number
|
J:165965
|
| decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
| increased B cell number
|
J:165965
|
Acp2tm1Psa/Acp2tm1Psa
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
abnormal microglial cell morphology
|
J:41986
|
Acsl3Gt(OST148301)Lex/Acsl3Gt(OST148301)Lex
(B6;129S5-Acsl3Gt(OST148301)Lex/Orl)
|
decreased B cell number
|
J:82809
|
| increased CD4-positive, alpha-beta T cell number
|
J:82809
|
Actbtm4(cre/ERT2)Npa/Actb+
Sgpl1tm1.1Npa/Sgpl1tm1.1Npa
(involves: BALB/cJ * C57BL/6)
|
abnormal regulatory T cell number
|
J:199525
|
| decreased follicular B cell number
|
J:199525
|
| decreased marginal zone B cell number
|
J:199525
|
| decreased single-positive T cell number
|
J:199525
|
| increased thymocyte number
|
J:199525
|
Actl6atm1.1Grc/Actl6a+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA)
|
decreased macrophage cell number
|
J:192124
|
Actl6atm1.1Grc/Actl6atm1.1Grc
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA)
|
decreased B cell number
|
J:192124
|
| decreased lymphocyte cell number
|
J:192124
|
| decreased macrophage cell number
|
J:192124
|
| decreased monocyte cell number
|
J:192124
|
Adatm1Mw/Adatm1Mw
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased T cell number
|
J:25085
|
Adatm1Mw/Adatm1Mw
Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-positive T cell number
|
J:73418
|
| increased double-negative T cell number
|
J:73418
|
| increased macrophage cell number
|
J:73418
|
Adam8tm1.1Rood/Adam8tm1.1Rood
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal osteoclast differentiation
|
J:172936
|
Adam10tm1.1Dhc/Adam10tm1.1Dhc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
abnormal B cell differentiation
|
J:158127
|
| absent marginal zone B cells
|
J:158127
|
| decreased transitional stage T2 B cell number
|
J:158127
|
| increased follicular B cell number
|
J:158127
|
| increased transitional stage T1 B cell number
|
J:158127
|
Adam10tm1.1Khr/Adam10tm1.1Khr
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N)
|
abnormal T cell differentiation
|
J:179060
|
| decreased CD4-positive, alpha-beta T cell number
|
J:179060
|
| decreased CD8-positive, alpha-beta T cell number
|
J:179060
|
| decreased double-positive T cell number
|
J:179060
|
| decreased T cell number
|
J:179060
|
Adam10tm1Zhu/Adam10tm1.1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
abnormal T cell differentiation
|
J:139042
|
| decreased CD4-positive, alpha-beta T cell number
|
J:139042
|
| decreased double-positive T cell number
|
J:139042
|
Adam10tm1Zhu/Adam10tm1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL/J)
|
abnormal T cell differentiation
|
J:139042
|
| decreased CD4-positive, alpha-beta T cell number
|
J:139042
|
| decreased double-positive T cell number
|
J:139042
|
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Sox9tm3(cre)Crm/Sox9+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased B cell number
|
J:144795
|
| decreased lymphocyte cell number
|
J:144795
|
| decreased T cell number
|
J:144795
|
| increased macrophage cell number
|
J:144795
|
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Sox9tm3(cre)Crm/Sox9+
(B6.129(SJL)-Sox9tm3(cre)Crm Adam17tm1.2Bbl)
|
increased T-helper 1 cell number
|
J:229771
|
| increased T-helper 2 cell number
|
J:229771
|
| increased T-helper 17 cell number
|
J:229771
|
Adam28tm1.2Dica/Adam28tm1.2Dica
(B6JRj.129-Adam28tm1.2Dica)
|
abnormal alpha-beta T cell morphology
|
J:298188
|
| abnormal lymphocyte morphology
|
J:298188
|
| decreased CD8-positive, alpha-beta T cell number
|
J:298188
|
Adam28tm1.2Dica/Adam28tm1.2Dica
(CJRj.129-Adam28tm1.2Dica)
|
decreased CD8-positive, alpha-beta T cell number
|
J:298188
|
Adamts14Gt(511E11)Cmhd/Adamts14Gt(511E11)Cmhd
Adamts2tm1Prc/Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:271185
|
| decreased CD8-positive, alpha-beta T cell number
|
J:271185
|
| increased CD4-positive, alpha-beta T cell number
|
J:271185
|
Adap1tm1a(EUCOMM)Wtsi/Adap1tm1a(EUCOMM)Wtsi
(C57BL/6N-Adap1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased memory-marker NK cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
Adcyap1tm1Clw/Adcyap1tm1Clw
(B6.129S4-Adcyap1tm1Clw)
|
increased T-helper 17 cell number
|
J:194151
|
Adgre1m2Btlr/Adgre1m2Btlr
(C57BL/6J-Adgre1m2Btlr)
|
decreased macrophage cell number
|
J:195410
|
Adgre1m3Btlr/Adgre1m3Btlr
(C57BL/6J-Adgre1m3Btlr)
|
decreased macrophage cell number
|
J:234244
|
Adgre1M4Btlr/Adgre1+
(C57BL/6J-Adgre1M4Btlr)
|
decreased macrophage cell number
|
J:255001
|
Adgre1M4Btlr/Adgre1M4Btlr
(C57BL/6J-Adgre1M4Btlr)
|
decreased macrophage cell number
|
J:255001
|
Adgrf5tm1.2Bstc/Adgrf5tm1.2Bstc
(involves: 129S4/SvJae * C57BL/6J)
|
increased macrophage derived foam cell number
|
J:196943
|
Adgrf5tm1.2Jpbs/Adgrf5tm1.2Jpbs
(BALB/c-Adgrf5tm1.2Jpbs)
|
abnormal alveolar macrophage morphology
|
J:221769
|
Adgrf5tm1b(KOMP)Wtsi/Adgrf5tm1b(KOMP)Wtsi
(C57BL/6N-Adgrf5tm1b(KOMP)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
Adgrf5tm1Shiro/Adgrf5tm1Shiro
(B6.Cg-Adgrf5tm1Shiro)
|
abnormal alveolar macrophage morphology
|
J:204701
|
| increased macrophage cell number
|
J:204701
|
Adgrg3tm1Zgwg/Adgrg3tm1Zgwg
(involves: 129 * C57BL/6)
|
abnormal B cell morphology
|
J:222670
|
| decreased follicular B cell number
|
J:222670
|
| decreased mature B cell number
|
J:222670
|
| decreased transitional stage T1 B cell number
|
J:222670
|
| increased marginal zone B cell number
|
J:222670
|
| increased transitional stage T2 B cell number
|
J:222670
|
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal osteoclast morphology
|
J:199264
|
Adipor1tm1b(EUCOMM)Hmgu/Adipor1tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor1tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
Adipor2tm1b(EUCOMM)Hmgu/Adipor2tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor2tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
Adm2em1Zhan/Adm2em1Zhan
(Not Specified)
|
increased Ly6C high monocyte number
|
J:266495
|
Admtm1Kmca/Admtm1Kmca
(B6.129P2-Admtm1Kmca)
|
increased uterine NK cell number
|
J:201446
|
Admtm1Unc/Admtm1Unc
(involves: 129S6/SvEvTac)
|
decreased uterine NK cell number
|
J:201446
|
Adora2aem1(IMPC)H/Adora2aem1(IMPC)H
(C57BL/6N-Adora2aem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Adrb2tm1Bkk/Adrb2+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal osteoclast differentiation
|
J:97566
|
Adrb2tm1Bkk/Adrb2tm1Bkk
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal osteoclast differentiation
|
J:97566
|
| abnormal osteoclast morphology
|
J:97566
|
Adrm1Gt(OST128063)Lex/Adrm1Gt(OST128063)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal single-positive T cell number
|
J:166694
|
| increased CD4-positive, alpha-beta T cell number
|
J:166694
|
| increased CD8-positive, alpha-beta T cell number
|
J:166694
|
Afdnem1(IMPC)Mbp/Afdn+
(C57BL/6N-Afdnem1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Aff1Rob/Aff1+
(involves: BALB/cAnNCrl * C3H/HeN)
|
abnormal double-negative T cell morphology
|
J:82265
|
Aff1tm1Cim/Aff1tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal T cell differentiation
|
J:63253
|
| decreased B cell number
|
J:63253
|
| decreased double-positive T cell number
|
J:63253
|
| decreased mature B cell number
|
J:63253
|
| decreased pre-B cell number
|
J:63253
|
| decreased single-positive T cell number
|
J:63253
|
Afg3l1tm1.1Arte/Afg3l1tm1.1Arte
Afg3l2tm1Arte/Afg3l2tm1Arte
Tg(Plp1-cre/ERT)3Pop/0
(involves: C57BL/6J * C57BL/6N)
|
microgliosis
|
J:237410
|
Afg3l2tm1Arte/Afg3l2tm1Arte
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
microgliosis
|
J:193564
|
Agbl4em1(IMPC)Mbp/Agbl4em1(IMPC)Mbp
(C57BL/6NCrl-Agbl4em1(IMPC)Mbp/Mmucd)
|
increased monocyte cell number
|
J:211773
|
Agertm1.1Arnd/Agertm1.1Arnd
(B6.129P2-Agertm1.1Arnd)
|
decreased osteoclast cell number
|
J:104998
|
Agkem1Qiz/Agkem1Qiz
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:282052
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:282052
|
Agktm1.1Smoc/Agktm1.1Smoc
(Not Specified)
|
decreased effector memory CD8-positive, alpha-beta T cell number
|
J:282052
|
Aglna/?
(C57BL/6-Aglna/Anu)
|
increased activated T cell number
|
J:169366
|
Agpat5em1(IMPC)Ccpcz/Agpat5em1(IMPC)Ccpcz
(C57BL/6NCrl-Agpat5em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK cell number
|
J:211773
|
Agtpbp1atms/Agtpbp1atms
(MRL/Mp-Agtpbp1atms)
|
abnormal lymphocyte cell number
|
J:103944
|
| abnormal T cell differentiation
|
J:103944
|
| abnormal T cell subpopulation ratio
|
J:103944
|
| decreased B cell number
|
J:103944
|
| increased CD4-positive, alpha-beta T cell number
|
J:103944
|
| increased CD8-positive, alpha-beta T cell number
|
J:103944
|
Agtraptm1Tamk/Agtraptm1Tamk
(involves: C57BL/6N)
|
abnormal macrophage morphology
|
J:263253
|
Ahnaktm1b(KOMP)Mbp/Ahnak+
(C57BL/6N-Ahnaktm1b(KOMP)Mbp/H)
|
increased large unstained cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal Langerhans cell morphology
|
J:148870
|
Aicdaem1Jaych/Aicdaem1Jaych
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:305843
|
Aicdatm1.1Fwa/Aicdatm1.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:209271
|
| abnormal somatic hypermutation frequency
|
J:209271
|
Aicdatm1b(EUCOMM)Hmgu/Aicdatm1b(EUCOMM)Hmgu
(C57BL/6N-Aicdatm1b(EUCOMM)Hmgu/Wtsi)
|
decreased follicular B cell number
|
J:211773
|
| decreased late germinal center B cell number
|
J:211773
|
| increased early germinal center B cell number
|
J:211773
|
| increased germinal center B cell number
|
J:211773
|
Aicdatm1Hon/Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:136224,
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm1Hon/Aicdatm1.1Fwa
(involves: 129S/SvEv * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal class switch recombination
|
J:209271
|
Aicdatm1Hon/Aicdatm1Hon
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427,
J:73659,
J:120658
|
| abnormal somatic hypermutation frequency
|
J:136224,
J:141427
|
| increased germinal center B cell number
|
J:169227
|
Aicdatm1Hon/Aicdatm1Hon
Bcl6tm1.1Jwan/Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal somatic hypermutation frequency
|
J:190534
|
Aicdatm1Hon/Aicdatm1Hon
Exo1tm1Wed/Exo1tm1Wed
Ightm4.1Mnz/Igh+
(involves: C57BL/6 * CBA/JNCrlj * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
Aicdatm1Hon/Aicdatm1Hon
Exo1tm1Wed/Exo1tm1Wed
Ightm4.1Mnz/Igh+
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * CBA/JNCrlj * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
Aicdatm1Hon/Aicdatm1Hon
Ightm3Mnz/Ightm4.1Mnz
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:159173
|
Aicdatm1Hon/Aicdatm1Hon
Ightm4.1Mnz/Igh+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
Aicdatm1Hon/Aicdatm1Hon
Ightm4.1Mnz/Igh+
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
Aicdatm1Hon/Aicdatm3Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm1Hon/Aicdatm4Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm2.1Hon/Aicdatm2.1Hon
(C57BL/6-Aicdatm2.1Hon)
|
abnormal somatic hypermutation frequency
|
J:169227
|
| increased germinal center B cell number
|
J:169227
|
Aicdatm2.1Hon/Aicdatm2.1Hon
(involves: BALB/c * C57BL/6)
|
increased germinal center B cell number
|
J:169227
|
Aicdatm3.1Mnz/Aicdatm3.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
| abnormal somatic hypermutation frequency
|
J:147109
|
Aicdatm3Mnz/Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm4.1Mnz/Aicdatm4.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
| abnormal somatic hypermutation frequency
|
J:147109
|
Aicdatm4Mnz/Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aim2Gt(CSG445)Byg/Aim2Gt(CSG445)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased NK cell number
|
J:158969
|
Airetm1.1(cre)Ghr/Airetm1.1(cre)Ghr
(Not Specified)
|
decreased regulatory T cell number
|
J:176844
|
Airetm1.1(NCOM)Mfgc/Airetm1.1(NCOM)Mfgc
(C57BL/6N-Airetm1.1(NCOM)Mfgc/Tcp)
|
increased monocyte cell number
|
J:211773
|
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell number
|
J:83422
|
Airetm1.1Doi/Airetm1.1Doi
Tg(Ins2-TFRC/OVA)296Wehi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:135154
|
| decreased CD4-positive, alpha-beta T cell number
|
J:135154
|
Airetm1Mand/Aire+
Tg(Ins2-TFRC/OVA)296Wehi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:135154
|
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell morphology
|
J:77873
|
Airetm1Pltn/Airetm1Pltn
(B6.129S4-Airetm1Pltn)
|
abnormal metallophilic macrophage morphology
|
J:115076
|
| decreased follicular B cell number
|
J:115076
|
| increased B cell number
|
J:115076
|
| increased marginal zone B cell number
|
J:115076
|
| increased monocyte cell number
|
J:115076
|
Ajubaem1(IMPC)H/Ajubaem1(IMPC)H
(C57BL/6N-Ajubaem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
Akap9tm1a(KOMP)Wtsi/Akap9+
(involves: C57BL/6 * C57BL/6N)
|
decreased B cell number
|
J:213427
|
| decreased mature B cell number
|
J:213427
|
| increased CD4-positive, alpha-beta T cell number
|
J:213427
|
| increased CD8-positive, alpha-beta T cell number
|
J:213427
|
| increased T cell number
|
J:213427
|
Akap13tm1Segj/Akap13+
(involves: 129)
|
decreased B cell number
|
J:181088
|
| decreased transitional stage T2 B cell number
|
J:181088
|
| increased transitional stage T1 B cell number
|
J:181088
|
Akr1a1Gt(OST222400)Lex/Akr1a1Gt(OST222400)Lex
(B6.129S5-Akr1a1Gt(OST222400)Lex)
|
increased osteoclast cell number
|
J:164548
|
Akt1tm1Pnt/Akt1tm1Pnt
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Akt3tm1Mbb/Akt3tm1Mbb
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:135903
|
| decreased double-positive T cell number
|
J:135903
|
| increased double-negative T cell number
|
J:135903
|
Akt1tm1Pnt/Akt1tm1Pnt
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:135903
|
| decreased double-positive T cell number
|
J:135903
|
| increased double-negative T cell number
|
J:135903
|
Akt1tm1Pnt/Akt1tm1Pnt
Akt3tm1Mbb/Akt3tm1Mbb
Tg(Lck-cre)1Cwi/0
(Not Specified)
|
decreased double-positive T cell number
|
J:135903
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
(C57BL/6N-Aldh2tm1a(EUCOMM)Wtsi/Ieg)
|
decreased CD4-positive, alpha-beta T cell number
|
J:165965
|
| decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
abnormal lymphopoiesis
|
J:193232
|
| increased CD8-positive, alpha-beta T cell number
|
J:193232
|
| increased double-positive T cell number
|
J:193232
|
Alg1tm1b(KOMP)Wtsi/Alg1+
(C57BL/6N-Alg1tm1b(KOMP)Wtsi/Nju)
|
increased lymphocyte cell number
|
J:211773
|
Altretm1.1Hbgl/Altretm1.1Hbgl
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased regulatory T cell number
|
J:342907
|
| decreased T cell number
|
J:342907
|
| increased CD8-positive, alpha-beta T cell number
|
J:342907
|
| increased memory T cell number
|
J:342907
|
Amdhd1tm2b(EUCOMM)Hmgu/Amdhd1tm2b(EUCOMM)Hmgu
(C57BL/6N-Amdhd1tm2b(EUCOMM)Hmgu/BayMmucd)
|
increased lymphocyte cell number
|
J:211773
|
Amelxem1(IMPC)Ccpcz/Y
(C57BL/6N-Amelxem1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
Amelxem1(IMPC)Ccpcz/Amelx+
(C57BL/6N-Amelxem1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
Amhr2tm3(cre)Bhr/Amhr2+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
decreased uterine NK cell number
|
J:170203
|
Angtm1Dats/Angtm1Dats
(Not Specified)
|
increased lymphocyte cell number
|
J:236081
|
Ank1ity16/Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
increased lymphocyte cell number
|
J:199427
|
Anktm1.1Ejr/Ank+
(B6.129-Anktm1.1Ejr)
|
abnormal osteoclast differentiation
|
J:168526
|
Anktm1.1Ejr/Anktm1.1Ejr
(B6.129-Anktm1.1Ejr)
|
abnormal osteoclast differentiation
|
J:168526
|
Ankfy1tm1b(KOMP)Mbp/Ankfy1+
(C57BL/6N-Ankfy1tm1b(KOMP)Mbp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Ankrd11tm1c(EUCOMM)Wtsi/Ankrd11tm1c(EUCOMM)Wtsi
E2f1Tg(Wnt1-cre)2Sor/E2f1+
(involves: C3H * C57BL/6 * C57BL/6N)
|
decreased osteoclast cell number
|
J:306391
|
Ankrd11Yod/Ankrd11+
(involves: BALB/cAnNCrl * C3H/HeH)
|
decreased osteoclast cell number
|
J:136455
|
Ano5em2Huyi/Ano5em2Huyi
(C57BL/6-Ano5em2Huyi)
|
decreased osteoclast cell number
|
J:336715
|
Anpeptm1.1Lsha/Anpeptm1.1Lsha
(B6.Cg-Anpeptm1.1Lsha)
|
increased CD4-positive, alpha-beta T cell number
|
J:163945
|
Anxa5tm1Epo/Anxa5tm1Epo
Anxa6tm1Moss/Anxa6tm1Moss
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:193886
|
Anxa5tm1Epo/Anxa5tm1Epo
Anxa6tm1Moss/Anxa6tm1Moss
Col10a1tm1Ksec/Col10a1tm1Ksec
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
increased B cell number
|
J:193886
|
| increased T-helper cell number
|
J:193886
|
Ap1g1tm1Schu/Ap1g1+
(either: (involves: 129P2/OlaHsd * 129X1/SvJ) or (involves: 129P2/OlaHsd * C57BL/6J))
|
decreased CD4-positive, alpha-beta T cell number
|
J:53252
|
Ap3b1pe/Ap3b1pe
Hps1ep/Hps1ep
(involves: C3H/He * C3HeB/FeJ * C57BL/6J)
|
abnormal monocyte morphology
|
J:85431
|
Apbb1ipem1(IMPC)Ccpcz/Apbb1ipem1(IMPC)Ccpcz
(C57BL/6N-Apbb1ipem1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
ApcMin/Apc+
(C57BL/6J-ApcMin)
|
decreased macrophage cell number
|
J:85142
|
ApcMin/Apc+
(involves: 129 * C57BL/6)
|
decreased NK cell number
|
J:156864
|
| decreased T cell number
|
J:156864
|
ApcMin/Apc+
Tg(Rorc-EGFP)1Ebe/?
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
Apctm1Kk/Apctm1Kk
Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:100461
|
| arrested T cell differentiation
|
J:100461
|
| increased double-negative T cell number
|
J:100461
|
Apctm2.1Cip/Apc+
Atg7tm1Tchi/Atg7tm1Tchi
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:227287
|
| increased regulatory T cell number
|
J:227287
|
Apctm2.1Cip/Apctm2.1Cip
Lect2tm1Ymg/Lect2tm1Ymg
Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
|
increased NK T cell number
|
J:184496
|
Apctm2.1Cip/Apctm2.1Cip
Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
|
decreased NK T cell number
|
J:184496
|
Apctm2Rak/Apctm2Rak
Tg(KRT14-cre)8Brn/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL)
|
decreased thymocyte number
|
J:114152
|
Apex2em1(IMPC)H/Apex2em1(IMPC)H
(C57BL/6NTac-Apex2em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Apex2tm1Yun/Y
(B6.129S-Apex2tm1Yun)
|
decreased B cell number
|
J:95267
|
| decreased T cell number
|
J:95267
|
| decreased thymocyte number
|
J:95267
|
AplfGt(RRF189)Byg/AplfGt(RRF189)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:168260
|
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev)
|
decreased macrophage cell number
|
J:219838
|
| increased macrophage cell number
|
J:219838
|
Apoetm1Bres/Apoetm1Bres
Mapk9tm1Flv/Mapk9tm1Flv
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal macrophage morphology
|
J:94044
|
| increased macrophage derived foam cell number
|
J:94044
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:108154,
J:47027
|
| abnormal T cell number
|
J:47027
|
| decreased follicular B cell number
|
J:133606
|
| decreased marginal zone B cell number
|
J:133606
|
| increased B cell number
|
J:133606
|
| increased marginal zone B cell number
|
J:133606
|
| increased T-helper 2 cell number
|
J:47027
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc)
|
increased CD4-positive, alpha-beta T cell number
|
J:125366
|
Apoetm1Unc/Apoetm1Unc
Cbstm1Unc/Cbstm1Unc
Tg(Mt1-CBS)25Waku/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
increased Ly6C high monocyte number
|
J:168131
|
| increased monocyte cell number
|
J:168131
|
Apoetm1Unc/Apoetm1Unc
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.Cg-Apoetm1Unc Ccr2tm1Ifc)
|
decreased monocyte cell number
|
J:153310
|
Apoetm1Unc/Apoetm1Unc
Ccr2tm1Ifc/Ccr2tm1Ifc
Cx3cl1tm1Lira/Cx3cl1tm1Lira
(B6.Cg-Apoetm1Unc Cx3cl1tm1Lira Ccr2tm1Ifc)
|
decreased monocyte cell number
|
J:153310
|
Apoetm1Unc/Apoetm1Unc
Ccr5tm1Blck/Ccr5tm1Blck
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mononuclear phagocyte morphology
|
J:128063
|
| decreased T cell number
|
J:128063
|
Apoetm1Unc/Apoetm1Unc
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mononuclear phagocyte morphology
|
J:128063
|
| decreased T cell number
|
J:128063
|
Apoetm1Unc/Apoetm1Unc
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal macrophage derived foam cell morphology
|
J:61672
|
Apoetm1Unc/Apoetm1Unc
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs
(B6.129-Apoetm1Unc Cx3cl1tm1Sgs)
|
increased macrophage derived foam cell number
|
J:95279
|
Apoetm1Unc/Apoetm1Unc
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129-Cxcl10tm1Adl Apoetm1Unc)
|
decreased CD4-positive, alpha-beta T cell number
|
J:166204
|
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:121671
|
| decreased CD8-positive, alpha-beta T cell number
|
J:121671
|
Apoetm1Unc/Apoetm1Unc
Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc)
|
increased T cell number
|
J:91058
|
Apoetm1Unc/Apoetm1Unc
Glg1Gt(RST092)Byg/Glg1+
(B6J.129P2-Apoetm1Unc Glg1Gt(RST092)Byg)
|
decreased macrophage cell number
|
J:226586
|
Apoetm1Unc/Apoetm1Unc
Hsd11b1tm1Lex/Hsd11b1tm1Lex
(B6.129-Hsd11b1tm1Lex Apoetm1Unc)
|
abnormal macrophage derived foam cell morphology
|
J:199430
|
| decreased macrophage cell number
|
J:199430
|
Apoetm1Unc/Apoetm1Unc
Klf15tm2Jain/Klf15tm2Jain
Tg(Tagln-cre)1Jjl/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased macrophage cell number
|
J:203920
|
Apoetm1Unc/Apoetm1Unc
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased macrophage cell number
|
J:110044
|
Apoetm1Unc/Apoetm1Unc
Pla2g15tm1Ytan/Pla2g15tm1Ytan
(involves: 129S/SvEv * B6.129P2-Apoetm1Unc/J)
|
abnormal macrophage morphology
|
J:97471
|
Apoetm2(APOE*3)Mae/Apoetm2(APOE*3)Mae
Tg(Thy1-APPSwDutIowa)BWevn/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal microglial cell morphology
|
J:136318
|
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
Tg(Thy1-APPSwDutIowa)BWevn/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal microglial cell morphology
|
J:136318
|
Apptm1Ck/Apptm1Ck
Tg(PDGFB-PSEN1M146L)2Jhd/0
(involves: 129 * Black Swiss * C57BL/6 * DBA/2 * SW)
|
abnormal microglial cell morphology
|
J:102542
|
Apptm2.1Tcs/Apptm2.1Tcs
(involves: C57BL/6)
|
microgliosis
|
J:212758
|
Apptm2.1Tcs/Apptm2.1Tcs
Casttm1Tcs/Casttm1Tcs
(involves: 129P2/OlaHsd * C57BL/6)
|
microgliosis
|
J:212758
|
Apptm3.1Tcs/Apptm3.1Tcs
(involves: C57BL/6)
|
microgliosis
|
J:212758
|
Aptxtm1Pmc/Aptxtm1Pmc
Atmtm2.1Mfgc/Atmtm2.1Mfgc
(involves: 129 * C57BL/6)
|
abnormal CD4-positive helper T cell morphology
|
J:316365
|
| abnormal T cell differentiation
|
J:316365
|
| decreased T cell number
|
J:316365
|
| increased CD8-positive, alpha-beta T cell number
|
J:316365
|
ArTfm/Y
(involves: STOCK EdaTa Atp7aMo-blo)
|
increased immature B cell number
|
J:110923
|
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
increased osteoclast cell number
|
J:81789
|
Arb2aem2(IMPC)Ccpcz/Arb2aem2(IMPC)Ccpcz
(C57BL/6NCrl-Arb2aem2(IMPC)Ccpcz/Ph)
|
decreased Ly6C-positive NK T cell number
|
J:211773
|
Arg1tm1.1Lky/Arg1+
Tg(Sftpc-Chia)#Lky/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2)
|
decreased macrophage cell number
|
J:122735
|
Arhgap15tm1Ehi/Arhgap15tm1Ehi
(B6.129-Arhgap15tm1Ehi)
|
abnormal macrophage morphology
|
J:174896
|
| decreased lymphocyte cell number
|
J:174896
|
| decreased macrophage cell number
|
J:174896
|
| decreased monocyte cell number
|
J:174896
|
Arhgap17tm1b(EUCOMM)Wtsi/Arhgap17tm1b(EUCOMM)Wtsi
(C57BL/6N-Arhgap17tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased B-1a cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| increased transitional stage T1 B cell number
|
J:211773
|
Arhgap45em1Ciphe/Arhgap45em1Ciphe
(C57BL/6-Arhgap45em1Ciphe)
|
decreased B cell number
|
J:309971
|
| decreased CD4-positive, alpha-beta T cell number
|
J:309971
|
| decreased CD8-positive, alpha-beta T cell number
|
J:309971
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:309971
|
| decreased DN1 thymic pro-T cell number
|
J:309971
|
| decreased naive B cell number
|
J:309971
|
| decreased T cell number
|
J:309971
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk
(involves: 129S/SvEv * C57BL/6 * DBA)
|
decreased T cell number
|
J:140671
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk
Arhgdibtm1Miyo/Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
decreased double-positive T cell number
|
J:140671
|
| decreased follicular B cell number
|
J:140671
|
| decreased immature B cell number
|
J:140671
|
| decreased marginal zone B cell number
|
J:140671
|
| decreased mature B cell number
|
J:140671
|
| decreased pre-B cell number
|
J:140671
|
| decreased T cell number
|
J:140671
|
| decreased transitional stage B cell number
|
J:140671
|
| increased single-positive T cell number
|
J:140671
|
Arhgdibtm1Miyo/Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
decreased B cell number
|
J:140671
|
| decreased T cell number
|
J:140671
|
Arhgef1tm1.1Rmt/Arhgef1tm1.1Rmt
(C57BL/6-Arhgef1tm1.1Rmt)
|
decreased B cell number
|
J:113295
|
| decreased B-1 B cell number
|
J:113295
|
| decreased follicular B cell number
|
J:113295
|
| decreased marginal zone B cell number
|
J:113295
|
Arhgef1tm1a(EUCOMM)Wtsi/Arhgef1tm1a(EUCOMM)Wtsi
(C57BL/6N-Arhgef1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased immature NK cell number
|
J:211773
|
| decreased Ly6C-positive immature NK cell number
|
J:211773
|
| decreased marginal zone B cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased memory-marker gamma-delta T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased Ly6C low monocyte number
|
J:211773
|
| increased Ly6C-positive NK T cell number
|
J:211773
|
| increased mature NK cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Arhgef1tm1Djle/Arhgef1tm1Djle
(involves: 129S4/SvJae)
|
increased germinal center B cell number
|
J:174313
|
Arhgef1tm1Kdf/Arhgef1tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphocyte cell number
|
J:99463
|
| decreased B cell number
|
J:99463
|
| decreased marginal zone B cell number
|
J:99463
|
Arhgef4tm1a(KOMP)Wtsi/Arhgef4tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef4tm1a(KOMP)Wtsi/Wtsi)
|
decreased T cell number
|
J:165965
|
| increased mature B cell number
|
J:165965
|
Arhgef6tm1Kdf/Arhgef6tm1Kdf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:137269
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137269
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137269
|
| decreased lymphocyte cell number
|
J:137269
|
| decreased mature B cell number
|
J:137269
|
Arhgef6tm2e.1(EUCOMM)Wtsi/Arhgef6tm2e.1(EUCOMM)Wtsi
(C57BL/6N-Arhgef6tm2e.1(EUCOMM)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Arid3atm1Pwt/Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:169178
|
| abnormal class switch recombination
|
J:169178
|
| decreased B cell number
|
J:169178
|
| decreased B-1 B cell number
|
J:169178
|
| decreased B-1a cell number
|
J:169178
|
| decreased B-2 B cell number
|
J:169178
|
| decreased marginal zone B cell number
|
J:169178
|
| decreased pre-B cell number
|
J:169178
|
| decreased pro-B cell number
|
J:169178
|
| decreased transitional stage B cell number
|
J:169178
|
| decreased transitional stage T1 B cell number
|
J:169178
|
| decreased transitional stage T2 B cell number
|
J:169178
|
Arid3btm1c(KOMP)Wtsi/Arid3btm1c(KOMP)Wtsi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6N * SJL)
|
abnormal B cell differentiation
|
J:236980
|
| decreased B cell number
|
J:236980
|
| decreased B-1b cell number
|
J:236980
|
| decreased CD4-positive, alpha-beta T cell number
|
J:236980
|
| decreased immature B cell number
|
J:236980
|
| decreased pre-B cell number
|
J:236980
|
| decreased pre-pro B cell number
|
J:236980
|
| decreased pro-B cell number
|
J:236980
|
| decreased transitional stage B cell number
|
J:236980
|
| increased B-1a cell number
|
J:236980
|
| increased follicular B cell number
|
J:236980
|
Arid4atm1Alb/Arid4atm1Alb
(involves: 129S7/SvEvBrd)
|
decreased B cell number
|
J:141004
|
| decreased lymphocyte cell number
|
J:141004
|
| decreased monocyte cell number
|
J:141004
|
| decreased T cell number
|
J:141004
|
| increased T cell number
|
J:141004
|
Arid4atm1Alb/Arid4atm1Alb
Arid4btm1Alb/Arid4b+
(involves: 129S7/SvEvBrd)
|
decreased B cell number
|
J:141004
|
| decreased lymphocyte cell number
|
J:141004
|
| decreased T cell number
|
J:141004
|
| increased monocyte cell number
|
J:141004
|
| increased T cell number
|
J:141004
|
Arid5atm1Rnis/Arid5atm1Rnis
(B6.Cg-Arid5atm1Rnis)
|
decreased T-helper 17 cell number
|
J:197418
|
| increased T cell number
|
J:197418
|
Arid5btm1Pjh/Arid5btm1Pjh
(involves: 129S4/SvJae * BALB/c)
|
abnormal lymphopoiesis
|
J:70658
|
| decreased double-positive T cell number
|
J:70658
|
| decreased pro-B cell number
|
J:70658
|
| increased single-positive T cell number
|
J:70658
|
Armc2tm1b(EUCOMM)Hmgu/Armc2+
(C57BL/6N-Armc2tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
Arpc1btm1a(EUCOMM)Wtsi/Arpc1btm1a(EUCOMM)Wtsi
(C57BL/6N-Arpc1btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased macrophage cell number
|
J:211773
|
| decreased marginal zone precursor B cell number
|
J:211773
|
| decreased mature NK cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased transitional stage T2 B cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased immature NK cell number
|
J:211773
|
| increased KLRG1+ CD4 alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive T-helper cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased plasma cell number
|
J:211773
|
Arrdc4em1(IMPC)Tcp/Arrdc4em1(IMPC)Tcp
(C57BL/6N-Arrdc4em1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Arsatm1Gie/Arsatm1Gie
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal microglial cell morphology
|
J:37978
|
Arsgtm1Tdi/Arsgtm1Tdi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal macrophage morphology
|
J:185592
|
| abnormal microglial cell morphology
|
J:185592
|
| abnormal perivascular macrophage morphology
|
J:185592
|
| microgliosis
|
J:185592,
J:254592
|
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6)
|
decreased B cell number
|
J:285931
|
| decreased CD4-positive, alpha-beta T cell number
|
J:285931
|
| decreased CD8-positive, alpha-beta T cell number
|
J:285931
|
| decreased double-positive T cell number
|
J:285931
|
| decreased lymphocyte cell number
|
J:285931
|
| decreased T cell number
|
J:285931
|
| increased macrophage cell number
|
J:285931
|
| increased macrophage derived foam cell number
|
J:285931
|
| increased monocyte cell number
|
J:285931
|
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1)
|
increased macrophage derived foam cell number
|
J:232306
|
| increased monocyte cell number
|
J:232306
|
Asb2tm2b(KOMP)Wtsi/Asb2+
(C57BL/6N-Asb2tm2b(KOMP)Wtsi/Kmpc)
|
decreased effector memory T-helper cell number
|
J:211773
|
| decreased Ly6C-positive immature NK cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased Ly6C-positive immature NK cell number
|
J:211773
|
| increased Ly6C-positive mature NK cell number
|
J:211773
|
| increased Ly6C-positive NK T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
Asb7em1(IMPC)Ccpcz/Asb7em1(IMPC)Ccpcz
(C57BL/6N-Asb7em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
Asltm1Brle/Asltm1Brle
(involves: 129S7/SvEvBrd)
|
decreased lymphocyte cell number
|
J:180208
|
| increased macrophage cell number
|
J:180208
|
Aspscr1em1(IMPC)Tcp/Aspscr1em1(IMPC)Tcp
(C57BL/6NCrl-Aspscr1em1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Asxl1tm1.1Iaai/Asxl1tm1.1Iaai
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
decreased mature B cell number
|
J:208092
|
| decreased monocyte cell number
|
J:208092
|
Asxl1tm1.1Iaai/Asxl1tm1.1Iaai
Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
decreased mature B cell number
|
J:208092
|
| decreased monocyte cell number
|
J:208092
|
Asxl1tm1.1Mjxu/Asxl1+
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:208085
|
| increased monocyte cell number
|
J:208085
|
Asxl1tm1.1Mjxu/Asxl1tm1.1Mjxu
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:208085
|
| decreased lymphocyte cell number
|
J:208085
|
| increased monocyte cell number
|
J:208085
|
| increased single-positive T cell number
|
J:208085
|
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(C57BL/6N-Asxl1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased B cell number
|
J:165965
|
Asxl1tm1Bc/Asxl1tm1Bc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal lymphopoiesis
|
J:155898
|
| decreased B cell number
|
J:155898
|
| decreased CD4-positive, alpha-beta T cell number
|
J:155898
|
| decreased pre-B cell number
|
J:155898
|
| decreased T cell number
|
J:155898
|
| increased double-negative T cell number
|
J:155898
|
Atad2btm1b(EUCOMM)Hmgu/Atad2btm1b(EUCOMM)Hmgu
(C57BL/6N-Atad2btm1b(EUCOMM)Hmgu/Ics)
|
decreased NK T cell number
|
J:211773
|
Atf2Tg(Gzma-Klra1)7Wum/Atf2+
(involves: C57BL/6)
|
decreased NK cell number
|
J:61178
|
| decreased NK T cell number
|
J:61178
|
Atf4tm1(KOMP)Mbp/Atf4+
(C57BL/6NCrl-Atf4tm1(KOMP)Mbp/MbpMmucd)
|
decreased monocyte cell number
|
J:211773
|
Atg3tm1.1Ywh/Atg3tm1.1Ywh
Fnip1m1Btlr/Fnip1m1Btlr
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
absent B cells
|
J:234285
|
Atg3tm1.1Ywh/Atg3tm1.1Ywh
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
abnormal T cell morphology
|
J:172749
|
Atg3tm1.1Ywh/Atg3tm1.1Ywh
Tg(Lck-cre)548Jxm/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal T cell morphology
|
J:172749
|
| decreased CD4-positive, alpha-beta T cell number
|
J:172749
|
| decreased CD8-positive, alpha-beta T cell number
|
J:172749
|
Atg5tm1Myok/Atg5tm1Myok
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
increased lymphocyte cell number
|
J:235399
|
| increased monocyte cell number
|
J:235399
|
Atg5tm1Nmz/Atg5tm1Nmz
Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell morphology
|
J:211733
|
| abnormal T cell subpopulation ratio
|
J:211733
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211733
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211733
|
| decreased T cell number
|
J:211733
|
Atg7tm1Tchi/Atg7tm1Tchi
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)
|
decreased B cell number
|
J:176843
|
| decreased NK cell number
|
J:176843
|
| decreased T cell number
|
J:176843
|
Atg7tm1Tchi/Atg7tm1Tchi
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
increased lymphocyte cell number
|
J:235399
|
| increased monocyte cell number
|
J:235399
|
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi
Tg(Vil1-cre)997Gum/?
(involves: C57BL/6J * C57BL/6N * SJL)
|
increased macrophage cell number
|
J:221019
|
Atg16l2m1Anu/Atg16l2m1Anu
(C57BL/6NCrlAnu-Atg16l2m1Anu)
|
decreased lymphocyte cell number
|
J:104190
|
Atl2tm2b(EUCOMM)Hmgu/Atl2+
(C57BL/6N-Atl2tm2b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
Atmm1Btlr/Atmm1Btlr
(C57BL/6J-Atmm1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265252
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265252
|
| decreased single-positive T cell number
|
J:265252
|
| decreased T cell number
|
J:265252
|
Atmm2Btlr/Atmm2Btlr
(C57BL/6J-Atmm2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265253
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265253
|
| decreased single-positive T cell number
|
J:265253
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265253
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265253
|
Atmm3Btlr/Atmm3Btlr
(C57BL/6J-Atmm3Btlr)
|
increased B-1a cell number
|
J:272820
|
| increased macrophage cell number
|
J:272820
|
AtmM4Btlr/AtmM4Btlr
(C57BL/6J-AtmM4Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272821
|
Atmm5Btlr/Atmm5Btlr
(C57BL/6J-Atmm5Btlr)
|
abnormal lymphocyte morphology
|
J:272824
|
| increased B-1 B cell number
|
J:272824
|
Atmm6Btlr/Atmm6Btlr
(C57BL/6J-Atmm6Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274964
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274964
|
| abnormal T cell differentiation
|
J:274964
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274964
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274964
|
| decreased T cell number
|
J:274964
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:274964
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274964
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274964
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274964
|
Atmtm1.1Mmpl/Atmtm1.1Mmpl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J)
|
decreased T cell number
|
J:226414
|
| increased B cell number
|
J:226414
|
Atmtm1Awb/Atm+
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
decreased macrophage cell number
|
J:103922
|
Atmtm1Awb/Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
decreased activated T cell number
|
J:34193
|
| decreased double-positive T cell number
|
J:34193
|
| decreased T cell number
|
J:34193
|
| increased double-positive T cell number
|
J:34193
|
Atmtm1Awb/Atmtm1Awb
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150435
|
| decreased CD4-positive, alpha-beta T cell number
|
J:90941
|
| decreased CD8-positive, alpha-beta T cell number
|
J:90941
|
Atmtm1Awb/Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb/J)
|
decreased single-positive T cell number
|
J:226414
|
| decreased T cell number
|
J:226414
|
| increased B cell number
|
J:226414
|
| increased double-positive T cell number
|
J:226414
|
Atmtm1Awb/Atmtm1Awb
Paxxem1Spj/Paxxem1Spj
(involves: A/J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:236776
|
| decreased B cell number
|
J:236776
|
| decreased T cell number
|
J:236776
|
Atmtm1Awb/Atmtm1Awb
Rad52tm1Aps/Rad52tm1Aps
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:90941
|
| decreased CD8-positive, alpha-beta T cell number
|
J:90941
|
Atmtm1Bal/Atmtm1Bal
(involves: 129S4/SvJae)
|
decreased pre-B cell number
|
J:35914
|
| decreased thymocyte number
|
J:35914
|
Atmtm1Fwa/Atmtm1Fwa
(involves: 129S4/SvJae * C57BL/6)
|
decreased immature B cell number
|
J:61201
|
| decreased lymphocyte cell number
|
J:61201
|
| decreased pre-B cell number
|
J:61201
|
| decreased T cell number
|
J:61201
|
| decreased thymocyte number
|
J:61201
|
Atmtm1Fwa/Atmtm1Fwa
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:191288
|
Atmtm1Led/Atmtm1Led
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal T cell differentiation
|
J:36561
|
| decreased CD4-positive, alpha-beta T cell number
|
J:36561
|
| increased double-positive T cell number
|
J:36561
|
Atmtm1Mfl/Atmtm1Mfl
(involves: 129T2/SvEms * C57BL/6J)
|
abnormal T cell differentiation
|
J:69726
|
| decreased thymocyte number
|
J:69726
|
| increased double-negative T cell number
|
J:69726
|
| increased single-positive T cell number
|
J:69726
|
Atmtm1Shzh/Atmtm2.1Fwa
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:191288
|
Atmtm2.1Fwa/Atmtm2.1Fwa
Tg(VAV1-cre)1Graf/0
(involves: 129S6/SvEvTac)
|
decreased B cell number
|
J:277750
|
| decreased T cell number
|
J:277750
|
| decreased thymocyte number
|
J:277750
|
Atmtm2.1Mfgc/Atmtm2.1Mfgc
(C57BL/6-Atmtm2.1Mfgc)
|
abnormal T cell differentiation
|
J:316365
|
| decreased T cell number
|
J:316365
|
Atmintm1.1Jhh/Atmintm1.1Jhh
Cd79atm1(cre)Reth/Cd79a+
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh)
|
decreased B cell number
|
J:230105
|
| decreased immature B cell number
|
J:230105
|
Atmintm1.1Jhh/Atmintm1.1Jhh
Cd79atm1(cre)Reth/Cd79a+
Tg(IghMyc)22Bri/0
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh Tg(IghMyc)22Bri)
|
decreased B cell number
|
J:230105
|
| decreased immature B cell number
|
J:230105
|
Atmintm1.2Jhh/Atmintm1.2Jhh
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S1/Sv * BALB/c * C57BL/6)
|
increased B cell number
|
J:191832
|
| increased immature B cell number
|
J:191832
|
| increased pre-B cell number
|
J:191832
|
Atmintm1.2Jhh/Atmintm1.2Jhh
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:191832
|
| decreased immature B cell number
|
J:191832
|
| decreased mature B cell number
|
J:191832
|
| decreased pre-B cell number
|
J:191832
|
Atmintm1.2Jhh/Atmintm1.2Jhh
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:191832
|
| decreased lymphocyte cell number
|
J:191832
|
| decreased mature B cell number
|
J:191832
|
| decreased pre-B cell number
|
J:191832
|
Atmintm1.2Jhh/Atmintm1.2Jhh
Trp53tm1Brn/Trp53tm1Brn
Cd79atm1(cre)Reth/Cd79a+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased B cell number
|
J:191832
|
| decreased immature B cell number
|
J:191832
|
Atn1tm1b(EUCOMM)Wtsi/Atn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Atn1tm1b(EUCOMM)Wtsi/Cnrm)
|
decreased lymphocyte cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
Atp1a3Myk/Atp1a3+
(involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr * FVB/NCr)
|
microgliosis
|
J:151948
|
Atp2a2tm1Ges/Atp2a2+
(involves: 129X1/SvJ)
|
abnormal osteoclast differentiation
|
J:198051
|
Atp5mktm1b(EUCOMM)Wtsi/Atp5mktm1b(EUCOMM)Wtsi
(C57BL/6N-Atp5mktm1b(EUCOMM)Wtsi/H)
|
increased monocyte cell number
|
J:211773
|
Atp6v0a2tm1Kdb/Atp6v0a2tm1Kdb
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:274048
|
| decreased alpha-beta T cell number
|
J:274048
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274048
|
| decreased T cell number
|
J:274048
|
Atp6v0d1tm1b(EUCOMM)Hmgu/Atp6v0d1+
(C57BL/6N-Atp6v0d1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Atp6v0d2tm1Ywc/Atp6v0d2tm1Ywc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:117744
|
| abnormal osteoclast morphology
|
J:117744
|
Atp6v1hem1Xhd/Atp6v1h+
(involves: C57BL/6)
|
abnormal osteoclast differentiation
|
J:239439
|
Atp11cambr/Y
(C57BL/6-Atp11cambr)
|
abnormal B cell differentiation
|
J:171924
|
| decreased B cell number
|
J:171924
|
| decreased B-1 B cell number
|
J:171924
|
| decreased B-1a cell number
|
J:171924
|
| decreased B-1b cell number
|
J:171924
|
| decreased B-2 B cell number
|
J:171924
|
| decreased follicular B cell number
|
J:171924
|
| decreased immature B cell number
|
J:171924
|
| decreased lymphocyte cell number
|
J:171924
|
| decreased mature B cell number
|
J:171924
|
| decreased pre-B cell number
|
J:171924
|
| decreased pro-B cell number
|
J:171924
|
| decreased T cell number
|
J:171924
|
Atp11cambr/Y
Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6 * C57BL/6JApb * DBA/2)
|
decreased B cell number
|
J:171924
|
Atp11cambr/Y
Tg(IghelMD4)4Ccg/0
(involves: C57BL/6 * C57BL/6JApb)
|
decreased immature B cell number
|
J:171924
|
| decreased pro-B cell number
|
J:171924
|
Atp11cambr/Y
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6 * C57BL/6J * C57BL/6JApb)
|
decreased B cell number
|
J:171924
|
| decreased immature B cell number
|
J:171924
|
| decreased pre-B cell number
|
J:171924
|
Atp11cm1Btlr/Y
(involves: C57BL/6J)
|
absent follicular B cells
|
J:171925
|
| arrested B cell differentiation
|
J:171925
|
| decreased B cell number
|
J:185495,
J:171925
|
| decreased B-1 B cell number
|
J:171925
|
| decreased B-2 B cell number
|
J:171925
|
| decreased immature B cell number
|
J:171925
|
| decreased transitional stage B cell number
|
J:171925
|
| decreased transitional stage T1 B cell number
|
J:171925
|
| decreased transitional stage T2 B cell number
|
J:171925
|
| decreased transitional stage T3 B cell number
|
J:171925
|
Atp11cm1Btlr/Y
Tg(BCL2)22Wehi/0
(involves: C57BL/6J * C57BL/6JWehi * SJL/Wehi)
|
decreased B cell number
|
J:171925
|
| decreased follicular B cell number
|
J:171925
|
| decreased mature B cell number
|
J:171925
|
| increased marginal zone B cell number
|
J:171925
|
Atp11cm1Btlr/Y
Tg(IghmHyHEL10,IgkHyHEL10)4Ccg/0
(involves: C57BL/6 * C57BL/6J * C57BL/6JSfdAnu)
|
decreased B cell number
|
J:171925
|
Atp11cm1Btlr/Atp11cm1Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:185495
|
Atp11cm1Btlr/Atp11cm2Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:171925
|
Atp11cm2Anu/Y
(C57BL/6JAnu-Atp11cm2Anu/AnuApb)
|
decreased B cell number
|
J:171924
|
Atp11cm2Btlr/Y
(involves: C57BL/6J)
|
decreased B cell number
|
J:185495,
J:171925
|
Atp11cm2Btlr/Atp11cm2Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:185495
|
Atp13a5tm1Lex/Atp13a5tm1Lex
(B6;129S5-Atp13a5tm1Lex/Mmucd)
|
decreased NK cell number
|
J:171883
|
Atrtm1Bal/Atrtm2Bal
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
decreased thymocyte number
|
J:123200
|
Avptm1b(EUCOMM)Wtsi/Avp+
(C57BL/6N-Avptm1b(EUCOMM)Wtsi/H)
|
decreased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Avpr1atm1Sbhu/Avpr1atm1Sbhu
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:105892
|
| increased B-1a cell number
|
J:105892
|
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased lymphocyte cell number
|
J:70420
|
B2mtm1Jae/B2mtm1Jae
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:80910
|
| decreased CD8-positive, alpha-beta T cell number
|
J:80910,
J:744
|
| increased gamma-delta intraepithelial T cell number
|
J:744
|
| increased gamma-delta T cell number
|
J:744
|
B2mtm1Jae/B2mtm1Jae
(involves: 129S2/SvPas)
|
decreased CD8-positive, alpha-beta T cell number
|
J:166104
|
B2mtm1Jae/B2mtm1Jae
Cd4tm1Jrp/Cd4tm1Jrp
(involves: 129S2/SvPas * C57BL/6)
|
increased CD8-positive, alpha-beta T cell number
|
J:45168
|
B2mtm1Jae/B2mtm1Jae
Foxp3sfOtcspf/Y
(involves: 129/Rl * 129S2/SvPas)
|
increased CD4-positive, alpha-beta T cell number
|
J:20865
|
| increased plasma cell number
|
J:20865
|
B2mtm1Jae/B2mtm1Jae
Rr94tm3.2Litt/Rr94tm3.2Litt
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
B2mtm1Jae/B2mtm1Jae
Rr96tm1.1Yzo/Rr96tm1.1Yzo
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal T cell differentiation
|
J:130559
|
B2mtm1Jae/B2mtm1Jae
Tg(H2-K-Cd86)27All/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
absent B cells
|
J:112475
|
B2mtm1Jae/B2mtm1Jae
Tg(LckNotch1)9Erob/?
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
increased CD8-positive, alpha-beta T cell number
|
J:93005
|
B2mtm1Jae/B2mtm1Jae
Themistm1Lov/Themistm1Lov
(involves: 129)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:151075
|
B2mtm1Jae/B2mtm1Jae
Toxtm1.1Kay/Toxtm1.1Kay
(involves: 129S6/SvEvTac * 129S2/SvPas)
|
abnormal CD8-positive, alpha-beta T cell number
|
J:131287
|
B2mtm1Jae/B2mtm1Jae
Zbtb7btm1Litt/Zbtb7btm1.2Litt
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141144
|
| abnormal double-positive T cell morphology
|
J:141144
|
B2mtm1Unc/B2m+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:64451
|
B2mtm1Unc/B2mtm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell number
|
J:113083
|
| absent CD8-positive, alpha-beta T cells
|
J:64451
|
B2mtm1Unc/B2mtm1Unc
(NOD.129P2-B2mtm1Unc)
|
absent CD8-positive, alpha-beta T cells
|
J:121685
|
B2mtm1Unc/B2mtm1Unc
(B6.129P2-B2mtm1Unc/DcrJ)
|
decreased CD8-positive, alpha-beta T cell number
|
J:123934
|
| increased T-helper 1 cell number
|
J:123934
|
B2mtm1Unc/B2mtm1Unc
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.Cg-B2mtm1Unc Ciitatm1Ccum)
|
decreased single-positive T cell number
|
J:107051
|
B2mtm1Unc/B2mtm1Unc
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
Lattm1.1Mal/Lattm1.1Mal
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
absent CD4-positive, alpha-beta T cells
|
J:77098
|
| absent CD8-positive, alpha-beta T cells
|
J:77098
|
B2mtm1Unc/B2mtm1Unc
H2-D1b-tm1Bpe/H2-D1b-tm1Bpe
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:41077
|
B2mtm1Unc/B2mtm1Unc
Il2tm1Hor/Il2tm1Hor
(involves: 129 * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:39981
|
| abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:39981
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:51450
|
| abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:39981
|
B2mtm1Unc/B2mtm1Unc
Il2rgtm1.1Asin/Il2rgtm1Wjl
Tg(Cd8a*-cre)B8Asin/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
B2mtm1Unc/B2mtm1Unc
Il7rtm1.1Asin/Il7rtm1Imx
Tg(Cd8a*-cre)B8Asin/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
B2mtm1Unc/B2mtm1Unc
Prkdcscid/Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid)
|
absent lymphocyte
|
J:102141
|
| arrested B cell differentiation
|
J:102141
|
| arrested T cell differentiation
|
J:102141
|
| increased macrophage cell number
|
J:102141
|
B2mtm1Unc/B2mtm1Unc
Rr381em2Kap/Rr381em2Kap
(involves: 129P2/OlaHsd * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
B2mtm1Unc/B2mtm1Unc
Tespa1tm1Smoc/Tespa1tm1Smoc
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:186446
|
B2mtm1Unc/B2mtm1Unc
Tg(GFAP-B2m)9Mdos/?
(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)
|
absent CD8-positive, alpha-beta T cells
|
J:135214
|
B2mtm1Unc/B2mtm1Unc
Tg(GFAP-B2m)#Mdos/?
(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)
|
absent CD8-positive, alpha-beta T cells
|
J:135214
|
B2mtm1Unc/B2mtm1Unc
Tg(HLA-A/H2-D/B2M)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(HLA-A/H2-D/B2M)1Dvs)
|
decreased CD8-positive, alpha-beta T cell number
|
J:121685
|
B2mtm1Unc/B2mtm1Unc
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:93553
|
B2mtm1Unc/B2mtm1Unc
Zbtb7btm4.1Itan/Zbtb7btm4.1Itan
(involves: 129P2/OlaHsd)
|
increased CD8-positive, alpha-beta T cell number
|
J:193321
|
B3galt2tm1.1(KOMP)Vlcg/B3galt2+
(C57BL/6N-B3galt2tm1.1(KOMP)Vlcg/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
B3gnt5tm1Big/B3gnt5tm1Big
(C57BL/6-B3gnt5tm1Big)
|
decreased B cell number
|
J:166763
|
B3gnt5tm1Nari/B3gnt5tm1Nari
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:161366
|
B3gnt5tm2.1Big/B3gnt5tm2.1Big
(involves: 129/Sv * C57BL/6 * FVB/N)
|
decreased B cell number
|
J:166763
|
B3gnt6tm1Lx/B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J)
|
increased macrophage cell number
|
J:123826
|
| increased monocyte cell number
|
J:123826
|
| increased T cell number
|
J:123826
|
B4galnt1tm1Rlp/B4galnt1tm1Rlp
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage morphology
|
J:53080
|
B4galnt2tm1Jbl/B4galnt2tm1Jbl
(involves: 129S1/Sv)
|
abnormal B cell number
|
J:217719
|
B4galnt3tm1a(EUCOMM)Wtsi/B4galnt3tm1a(EUCOMM)Wtsi
(C57BL/6N-B4galnt3tm1a(EUCOMM)Wtsi/Ics)
|
increased CD8-positive, alpha-beta T cell number
|
J:165965
|
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased lymphocyte cell number
|
J:106669
|
B9d2/Tgfb1tm1Flv/B9d2/Tgfb1tm1Flv
Tg(CD207-cre)1Dhka/?
(involves: 129S6/SvEvTac * C57BL/6J * SJL/J)
|
decreased Langerhans cell number
|
J:126147
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
increased regulatory T cell number
|
J:169839
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:123547
|
| abnormal T-helper 17 cell differentiation
|
J:169839
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:169839
|
| decreased T-helper 17 cell number
|
J:169839
|
| increased regulatory T cell number
|
J:169839
|
| increased T-helper 1 cell number
|
J:169839
|
B9d2/Tgfb1tm1Flv/B9d2/Tgfb1tm1Flv
Tg(CD207-cre)1Dhka/?
(involves: 129S6/SvEvTac * C57BL/6J * SJL/J)
|
decreased Langerhans cell number
|
J:126147
|
B9d2/Tgfb1tm1Flv/B9d2+
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
increased regulatory T cell number
|
J:169839
|
B9d2/Tgfb1tm1Flv/B9d2+
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:169839
|
B9d2/Tgfb1tm1Flv/B9d2+
Tg(CD207-cre)1Dhka/?
(involves: 129S6/SvEvTac * C57BL/6J * SJL/J)
|
decreased Langerhans cell number
|
J:126147
|
B9d2/Tgfb1tm1Flv/B9d2+
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:169839
|
| decreased T-helper 17 cell number
|
J:169839
|
| increased regulatory T cell number
|
J:169839
|
| increased T-helper 1 cell number
|
J:169839
|
Babam1em1(IMPC)Ccpcz/Babam1em1(IMPC)Ccpcz
(C57BL/6NCrl-Babam1em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
Bach2M1Btlr/Bach2M1Btlr
(C57BL/6J-Bach2M1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:272023
|
| increased B-1 B cell number
|
J:272023
|
Bach2m1Ccg/Bach2m1Ccg
(C57BL/6-Bach2m1Ccg)
|
decreased B cell number
|
J:94077
|
| decreased marginal zone B cell number
|
J:94077
|
Bach2m2Anu/Bach2m2Anu
(C57BL/6NCrlAnu-Bach2m2Anu)
|
decreased mature B cell number
|
J:104190
|
| increased immature B cell number
|
J:104190
|
Bach2tm1a(EUCOMM)Wtsi/Bach2tm1a(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased B cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased memory-marker NK cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased immature B cell number
|
J:211773
|
| increased KLRG1+ CD4 alpha-beta T cell number
|
J:211773
|
| increased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-negative NK T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive gamma-delta T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased Ly6C high monocyte number
|
J:211773
|
| increased Ly6C low monocyte number
|
J:211773
|
| increased macrophage cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
Bach2tm1b(EUCOMM)Wtsi/Bach2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased B cell number
|
J:211773
|
| decreased B-1a cell number
|
J:211773
|
| decreased B-2 B cell number
|
J:211773
|
| decreased CD4-negative NK T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
| decreased Ly6C-positive immature NK cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased marginal zone B cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased transitional stage B cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
Bach2tm1Igar/Bach2tm1Igar
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:91110
|
| abnormal class switch recombination
|
J:91110
|
| abnormal somatic hypermutation frequency
|
J:91110
|
| absent germinal center B cells
|
J:91110
|
| decreased B cell number
|
J:91110
|
| decreased mature B cell number
|
J:91110
|
Badtm1Meg/Badtm1Meg
(involves: 129S4/SvJae)
|
abnormal B cell differentiation
|
J:88139
|
| abnormal T cell differentiation
|
J:88139
|
| decreased mature B cell number
|
J:88139
|
| decreased pro-B cell number
|
J:88139
|
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
|
decreased lymphocyte cell number
|
J:144416
|
Bahd1tm2b(KOMP)Wtsi/Bahd1+
(C57BL/6N-Bahd1tm2b(KOMP)Wtsi/Ics)
|
decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
| increased CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm1Sjk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6)
|
abnormal B cell morphology
|
J:66872
|
| abnormal T cell morphology
|
J:66872
|
| increased lymphocyte cell number
|
J:66872
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal B cell number
|
J:100463
|
| decreased marginal zone B cell number
|
J:100463
|
| increased B cell number
|
J:100463
|
| increased B-2 B cell number
|
J:100463
|
| increased follicular B cell number
|
J:100463
|
| increased pre-B cell number
|
J:100463
|
| increased pro-B cell number
|
J:100463
|
| increased transitional stage B cell number
|
J:100463
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:100463
|
| increased B cell number
|
J:100463
|
| increased lymphocyte cell number
|
J:100463
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm2Sjk/Baxtm2Sjk
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased regulatory T cell number
|
J:208318
|
Bank1tm1Kuro/Bank1tm1Kuro
(Not Specified)
|
increased B-1a cell number
|
J:113321
|
| increased mature B cell number
|
J:113321
|
Bap1tm1.1Geno/Bap1tm1.1Geno
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
increased monocyte cell number
|
J:187380
|
Batf3tm1Kmm/Batf3tm1Kmm
(involves: 129S6/SvEvTac * BALB/cJ)
|
decreased memory T cell number
|
J:141064
|
| decreased myeloid dendritic cell number
|
J:141064
|
Batftm1.1Ejt/Batftm1.1Ejt
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:160935
|
| abnormal T-helper 2 cell differentiation
|
J:160935
|
| absent germinal center B cells
|
J:160935
|
| decreased CD4-positive, alpha-beta T cell number
|
J:160935
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:160935
|
| decreased T follicular helper cell number
|
J:160935
|
| decreased T-helper 17 cell number
|
J:160935
|
Batftm1.1Kmm/Batftm1.1Kmm
(129S6/SvEvTac-Batftm1.1Kmm)
|
abnormal CD4-positive T cell differentiation
|
J:150643
|
Baxtm1Sjk/Baxtm1Sjk
(involves: 129X1/SvJ)
|
increased B cell number
|
J:29253
|
| increased thymocyte number
|
J:29253
|
Bbc3tm1Ast/Bbc3tm1Ast
(involves: C57BL/6 * NZB)
|
increased CD8-positive, alpha-beta T cell number
|
J:132819
|
Bbc3tm1Gpz/Bbc3tm1Gpz
Trp53tm1Brd/Trp53tm8Xu
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:170216
|
Bblntm1(KOMP)Wtsi/Bbln+
(involves: C57BL/6N)
|
abnormal osteoclast differentiation
|
J:296689
|
Bblntm1(KOMP)Wtsi/Bblntm1(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal osteoclast differentiation
|
J:296689
|
| increased osteoclast cell number
|
J:296689
|
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:274469
|
| decreased single-positive T cell number
|
J:274469
|
| decreased thymocyte number
|
J:274469
|
| increased effector memory T-helper cell number
|
J:274469
|
Bckdhaem1(IMPC)Tcp/Bckdha+
(C57BL/6NCrl-Bckdhaem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Bcl2tm1Dlo/Bcl2tm1Dlo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:73660
|
| decreased CD8-positive, alpha-beta T cell number
|
J:73660
|
| decreased lymphocyte cell number
|
J:73660
|
| decreased mature B cell number
|
J:73660
|
| decreased pre-B cell number
|
J:73660
|
| decreased thymocyte number
|
J:73660
|
Bcl2tm1Lbox/Bcl2tm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal B cell differentiation
|
J:114637
|
| decreased B cell number
|
J:114637
|
| decreased immature B cell number
|
J:114637
|
| decreased mature B cell number
|
J:114637
|
| decreased pre-B cell number
|
J:114637
|
Bcl2tm1Sjk/Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:15224
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:15224
|
| decreased B cell number
|
J:15224
|
| decreased double-positive T cell number
|
J:15224
|
| decreased lymphocyte cell number
|
J:15224
|
| decreased T cell number
|
J:15224
|
| increased double-negative T cell number
|
J:15224
|
Bcl2tm1Tsu/Bcl2tm1Tsu
(involves: 129P2/OlaHsd * ICR)
|
abnormal lymphocyte morphology
|
J:22391
|
Bcl2tm2.1Lbox/Bcl2+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased B cell number
|
J:175730
|
| increased immature B cell number
|
J:175730
|
| increased mature B cell number
|
J:175730
|
| increased pre-B cell number
|
J:175730
|
Bcl2tm2.1Lbox/Bcl2tm2.1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased B cell number
|
J:175730
|
| increased immature B cell number
|
J:175730
|
| increased mature B cell number
|
J:175730
|
| increased pre-B cell number
|
J:175730
|
Bcl2a1atm1.1Tac/Bcl2a1atm1.1Tac
Bcl2a1btm1.1Tac/Bcl2a1btm1.1Tac
Bcl2a1dtm1.1Tac/Bcl2a1dtm1.1Tac
(involves: BALB/cJ * C57BL/6NTac)
|
decreased CD4-positive, alpha-beta memory T cell number
|
J:258915
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:258915
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:258915
|
| decreased gamma-delta T cell number
|
J:258915
|
| decreased regulatory T cell number
|
J:258915
|
Bcl2l1tm1Cant/Bcl2l1tm1Cant
(involves: 129S6/SvEvTac)
|
decreased memory T cell number
|
J:77507
|
Bcl2l1tm1Ywh/Bcl2l1tm1Ywh
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
absent CD4-positive, alpha-beta T cells
|
J:137400
|
| absent CD8-positive, alpha-beta T cells
|
J:137400
|
| decreased double-positive T cell number
|
J:137400
|
Bcl2l1tm1Ywh/Bcl2l1tm1Ywh
Tg(Lck-cre)548Jxm/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:99012
|
| decreased thymocyte number
|
J:99012
|
Bcl2l11em1(IMPC)H/Bcl2l11em1(IMPC)H
(C57BL/6NTac-Bcl2l11em1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Bcl2l11em1Flv/Bcl2l11+
Morrbid+/Morrbidem1Flv
(C57BL/6N-Bcl2l11em1Flv +/+ Morrbidem1Flv)
|
decreased Ly6C high monocyte number
|
J:236609
|
Bcl2l11tm1.1Ast/Bcl2l11+
Ptentm1Hwu/Pten+
Tg(CD2-icre)4Kio/0
(involves: 129S1/Sv * 129S4/SvJae * C57BL/10 * CBA/Ca)
|
abnormal T cell number
|
J:133215
|
| increased germinal center B cell number
|
J:133215
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
|
abnormal plasma cell morphology
|
J:58641
|
| decreased double-positive T cell number
|
J:58641
|
| increased B cell number
|
J:58641
|
| increased CD4-positive, alpha-beta T cell number
|
J:58641
|
| increased CD8-positive, alpha-beta T cell number
|
J:58641
|
| increased double-negative T cell number
|
J:58641
|
| increased follicular B cell number
|
J:132217
|
| increased immature B cell number
|
J:132217
|
| increased marginal zone B cell number
|
J:132217
|
| increased monocyte cell number
|
J:58641
|
| increased T cell number
|
J:58641
|
| increased transitional stage B cell number
|
J:132217
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast)
|
abnormal B cell morphology
|
J:133084
|
| abnormal NK cell morphology
|
J:123409
|
| increased immature B cell number
|
J:133084
|
| increased mature B cell number
|
J:133084
|
| increased NK cell number
|
J:123409
|
| increased regulatory T cell number
|
J:208318
|
| increased transitional stage B cell number
|
J:133084
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129-Bcl2l11tm1.1Ast/J)
|
decreased lymphocyte cell number
|
J:137609
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:132819
|
| increased B cell number
|
J:132819
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast/J)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Biktm1Ast/Biktm1Ast
(B6.Cg-Bcl2l11tm1.1Ast Biktm1Ast)
|
abnormal B cell differentiation
|
J:103605
|
| abnormal T cell differentiation
|
J:103605
|
| decreased immature B cell number
|
J:103605
|
| decreased pre-B cell number
|
J:103605
|
| decreased pro-B cell number
|
J:103605
|
| increased B cell number
|
J:103605
|
| increased mature B cell number
|
J:103605
|
| increased monocyte cell number
|
J:103605
|
| increased T cell number
|
J:103605
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Bmftm1Rjd/Bmftm1Rjd
(B6.129S-Bcl2l11tm1.1Ast Bmftm1Rjd)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
| increased thymocyte number
|
J:153652
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Bmftm2.1Rjd/Bmftm2.1Rjd
(B6.129S-Bcl2l11tm1.1Ast Bmftm2.1Rjd)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Bnip3lGt(XT0573)Wtsi/Bnip3lGt(XT0573)Wtsi
(involves: 129S1/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:137609
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Dicer1tm1Mmk/Dicer1tm1Mmk
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S1/Sv * BALB/c)
|
decreased B cell number
|
J:135783
|
| decreased mature B cell number
|
J:135783
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Faslpr/Faslpr
(B6.Cg-Bcl2l11tm1.1Ast Faslpr)
|
abnormal effector T cell morphology
|
J:132217
|
| abnormal T cell number
|
J:132217
|
| abnormal T cell subpopulation ratio
|
J:132217
|
| decreased B cell number
|
J:132217
|
| increased follicular B cell number
|
J:132217
|
| increased immature B cell number
|
J:132217
|
| increased macrophage cell number
|
J:132217
|
| increased marginal zone B cell number
|
J:132217
|
| increased memory T cell number
|
J:132217
|
| increased transitional stage B cell number
|
J:132217
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Mirc14tm1.2Flv/Mirc14tm1.2Flv
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased NK T cell number
|
J:203157
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Pmaip1tm1Ast/Pmaip1tm1Ast
(involves: 129S1/Sv * C57BL/6)
|
abnormal NK cell morphology
|
J:123409
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Zbtb1m1Btlr/Zbtb1m1Btlr
(involves: 129S1/Sv * C3H/HeN * C57BL/6 * C57BL/6J)
|
absent T cells
|
J:178820
|
Bcl2l11tm1Ast/Bcl2l11tm1Ast
Dicer1tm1Bdh/Dicer1tm1Bdh
Aicdatm1(cre)Njen/Aicda+
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:181782
|
| decreased germinal center B cell number
|
J:181782
|
| decreased plasma cell number
|
J:181782
|
Bcl2l11tm1Sjk/Bcl2l11tm1Sjk
(involves: 129X1/SvJ)
|
increased B cell number
|
J:100463
|
| increased B-2 B cell number
|
J:100463
|
| increased follicular B cell number
|
J:100463
|
| increased transitional stage B cell number
|
J:100463
|
Bcl2l11tm3Rjd/Bcl2l11tm3Rjd
(B6.129S6-Bcl2l11tm3Rjd)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
Bcl2l11tm3Rjd/Bcl2l11tm3Rjd
Bmftm3.1Rjd/Bmftm3.1Rjd
(B6.129S6-Bcl2l11tm3Rjd Bmftm3.1Rjd)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
Bcl2l11tm6.1Boui/Bcl2l11tm6.1Boui
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased regulatory T cell number
|
J:208318
|
Bcl3m1Btlr/Bcl3+
(C57BL/6J-Bcl3m1Btlr)
|
decreased B cell number
|
J:255184
|
| decreased B-1b cell number
|
J:255184
|
| increased CD8-positive, alpha-beta T cell number
|
J:255184
|
| increased macrophage cell number
|
J:255184
|
Bcl3m1Btlr/Bcl3m1Btlr
(C57BL/6J-Bcl3m1Btlr)
|
decreased B cell number
|
J:255184
|
| decreased B-1b cell number
|
J:255184
|
| increased B-1 B cell number
|
J:255184
|
| increased CD8-positive, alpha-beta T cell number
|
J:255184
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:255184
|
| increased macrophage cell number
|
J:255184
|
Bcl3m2Btlr/Bcl3m2Btlr
(C57BL/6J-Bcl3m2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:264818
|
| increased B-1 B cell number
|
J:264818
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:264818
|
Bcl3m3Btlr/Bcl3m3Btlr
(C57BL/6J-Bcl3m3Btlr)
|
decreased central memory CD8 positive, alpha-beta T cell number
|
J:274858
|
Bcl3tm1Rie/Bcl3tm1Rie
(involves: 129)
|
abnormal myeloid dendritic cell morphology
|
J:77049
|
| decreased B cell number
|
J:77049
|
Bcl3tm1Sbn/Bcl3tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:39747
|
| abnormal class switch recombination
|
J:39747
|
| abnormal lymphocyte morphology
|
J:39747
|
| abnormal metallophilic macrophage morphology
|
J:39747
|
| abnormal spleen marginal zone macrophage morphology
|
J:39747
|
| decreased B cell number
|
J:39747
|
| decreased macrophage cell number
|
J:39747
|
Bcl3tm1Sbn/Bcl3tm1Sbn
(involves: 129S4/SvJae)
|
decreased follicular B cell number
|
J:207111
|
| decreased transitional stage T1 B cell number
|
J:207111
|
| decreased transitional stage T2 B cell number
|
J:207111
|
| increased marginal zone B cell number
|
J:207111
|
Bcl6tm1.1Dent/Bcl6tm1.1Dent
Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2 * FVB/N)
|
abnormal T follicular helper cell differentiation
|
J:202372
|
| decreased germinal center B cell number
|
J:202372
|
| decreased T follicular helper cell number
|
J:202372
|
Bcl6tm1.1Jwan/Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac)
|
abnormal somatic hypermutation frequency
|
J:190534
|
Bcl6tm1.1Meln/Bcl6tm1.1Meln
(involves: 129 * C57BL/6 * FVB/N)
|
decreased T follicular helper cell number
|
J:194821
|
Bcl6tm1.1Mtto/Bcl6tm1.1Mtto
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6 * C57BL/6JJcl)
|
abnormal memory B cell morphology
|
J:190943
|
| abnormal somatic hypermutation frequency
|
J:190943
|
| decreased germinal center B cell number
|
J:190943
|
Bcl6tm1.1Mtto/Bcl6tm1.1Mtto
Cd79atm1(cre)Reth/Cd79a+
Tg(Cd4-cre)1Cwi/0
(involves: BALB/c * C57BL/6 * C57BL/6JJcl * DBA/2)
|
decreased germinal center B cell number
|
J:190943
|
Bcl6tm1.1Mtto/Bcl6tm1.1Mtto
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JJcl)
|
decreased germinal center B cell number
|
J:190943
|
Bcl6tm1.1Mtto/Bcl6tm1.1Mtto
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2)
|
abnormal somatic hypermutation frequency
|
J:190943
|
| absent germinal center B cells
|
J:190943
|
| decreased germinal center B cell number
|
J:190943
|
| decreased T follicular helper cell number
|
J:190943
|
Bcl6tm1.1Toka/Bcl6tm1.1Toka
(involves: C57BL/6 * NZB)
|
decreased germinal center B cell number
|
J:174014
|
| decreased T follicular helper cell number
|
J:174014
|
Bcl6btm1Dtf/Bcl6btm1Dtf
(involves: 129P2/OlaHsd)
|
decreased memory T cell number
|
J:99818
|
Bcl6btm1Tto/Bcl6btm1Tto
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93656
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:93656
|
Bcl6btm2Dent/Bcl6btm2Dent
(involves: 129/Sv * C57BL/6)
|
increased monocyte cell number
|
J:123621
|
Bcl6btm2Dent/Bcl6btm2Dent
Rag1tm1Mom/Rag1tm1Mom
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)
|
decreased lymphocyte cell number
|
J:123621
|
Bcl10m1Btlr/Bcl10m1Btlr
(C57BL/6J-Bcl10m1Btlr)
|
decreased B-1 B cell number
|
J:265122
|
| increased CD4-positive, alpha-beta T cell number
|
J:265122
|
| increased single-positive T cell number
|
J:265122
|
| increased T cell number
|
J:265122
|
Bcl10tm1Mak/Bcl10tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:67297
|
| decreased activated T cell number
|
J:67297
|
| decreased double-positive T cell number
|
J:67297
|
| decreased thymocyte number
|
J:67297
|
| increased double-negative T cell number
|
J:67297
|
Bcl10tm1Swm/Bcl10tm1Swm
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:85147
|
| decreased B cell number
|
J:85147
|
| decreased B-1 B cell number
|
J:85147
|
| decreased follicular B cell number
|
J:85147
|
| decreased marginal zone B cell number
|
J:85147
|
| decreased mature B cell number
|
J:85147
|
Bcl11atm1Ngc/Bcl11a+
(involves: 129S1/Sv)
|
abnormal T cell differentiation
|
J:194616
|
| decreased DN2 thymocyte number
|
J:194616
|
| decreased lymphocyte cell number
|
J:207383
|
Bcl11atm1Ngc/Bcl11atm1Ngc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:83646
|
| absent B cells
|
J:207383,
J:83646
|
| absent CD4-positive, alpha-beta T cells
|
J:83646
|
| absent lymphocyte
|
J:207383
|
| decreased T cell number
|
J:83646
|
| increased CD8-positive, alpha-beta T cell number
|
J:83646
|
| increased double-negative T cell number
|
J:83646
|
| increased gamma-delta T cell number
|
J:83646
|
Bcl11atm1Pwt/Bcl11atm1Pwt
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:207383
|
Bcl11atm1Pwt/Bcl11atm1Pwt
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased B cell number
|
J:207383
|
Bcl11atm2.1Peli/Bcl11atm2.1Peli
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
abnormal T cell differentiation
|
J:194616
|
| decreased B cell number
|
J:194616
|
| decreased DN2 thymocyte number
|
J:194616
|
| decreased immature B cell number
|
J:194616
|
| decreased pre-B cell number
|
J:194616
|
| decreased pro-B cell number
|
J:194616
|
Bcl11btm1.2Leid/Bcl11btm1.2Leid
(involves: C57BL/6 * SJL)
|
absent T cells
|
J:147182
|
Bcl11btm1Avram/Bcl11btm1Avram
Tcratm1Mom/Tcratm1Mom
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
| decreased double-positive T cell number
|
J:128515
|
Bcl11btm1Avram/Bcl11btm1Avram
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
| decreased CD4-positive, alpha-beta T cell number
|
J:128515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:128515
|
| decreased double-negative T cell number
|
J:128515
|
| decreased double-positive T cell number
|
J:128515
|
| increased B cell number
|
J:128515
|
| increased gamma-delta T cell number
|
J:128515
|
| increased NK cell number
|
J:128515
|
Bcl11btm1Avram/Bcl11btm1Avram
Tg(Cd4-cre)1Cwi/?
Tg(LCKprBCL2)36Sjk/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
| decreased CD4-positive, alpha-beta T cell number
|
J:128515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:128515
|
| decreased double-positive T cell number
|
J:128515
|
Bcl11btm1Jpk/Bcl11btm1Jpk
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:83651
|
| abnormal T cell morphology
|
J:83651
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:83651
|
| decreased double-positive T cell number
|
J:83651
|
| increased CD8-positive, alpha-beta T cell number
|
J:83651
|
| increased double-negative T cell number
|
J:83651
|
Bcl11btm1Peli/Bcl11btm1Peli
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J)
|
abnormal NK cell differentiation
|
J:161373
|
Bcl11btm2.1Jpk/Bcl11b+
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
abnormal T cell number
|
J:210122
|
| decreased CD4-positive, alpha-beta T cell number
|
J:210122
|
| decreased CD8-positive, alpha-beta T cell number
|
J:210122
|
| decreased double-positive T cell number
|
J:210122
|
| decreased thymocyte number
|
J:210122
|
| increased double-negative T cell number
|
J:210122
|
Bclaf1tm1Raz/Bclaf1tm1Raz
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:158087
|
| increased B cell number
|
J:158087
|
Bcrtm1(BCR/ABL)Tsr/Bcr+
Runx1tm3Dow/Runx1+
Tg(Vav1-cre)#Cgp/0
(involves: C57BL/6)
|
decreased lymphocyte cell number
|
J:203111
|
| increased monocyte cell number
|
J:203111
|
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp)
|
abnormal macrophage morphology
|
J:273501
|
| increased macrophage cell number
|
J:273501
|
Bdkrb1em1(IMPC)H/Bdkrb1em1(IMPC)H
(B6N;B6NTac-Bdkrb1em1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Bdp1em1(IMPC)Tcp/Bdp1+
(C57BL/6NCrl-Bdp1em1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Bean1em1(IMPC)H/Bean1em1(IMPC)H
(C57BL/6N-Bean1em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Becn1tm1.1Bflu/Becn1tm1.1Bflu
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:203090
|
| decreased CD8-positive, alpha-beta T cell number
|
J:203090
|
Becn1tm1Ebr/Becn1tm1Ebr
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased lymphocyte cell number
|
J:235399
|
| increased monocyte cell number
|
J:235399
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased osteoclast cell number
|
J:34440
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased osteoclast cell number
|
J:34440
|
Bhlhe40tm1Tan/Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal CD4-positive T cell differentiation
|
J:72651
|
| decreased double-positive T cell number
|
J:72651
|
| increased CD4-positive, alpha-beta T cell number
|
J:72651
|
| increased CD8-positive, alpha-beta T cell number
|
J:72651
|
| increased double-negative T cell number
|
J:72651
|
Bhlhe41tm1.1Cdon/Bhlhe41tm1.1Cdon
(B6.129S6-Bhlhe41tm1.1Cdon)
|
abnormal lymphocyte cell number
|
J:157740
|
| abnormal T-helper 2 cell differentiation
|
J:157740
|
| decreased macrophage cell number
|
J:157740
|
Birc2tm1Jda/Birc2tm1Jda
(B6.129P2-Birc2tm1Jda)
|
decreased lymphocyte cell number
|
J:97656
|
Birc2tm1Rbr/Birc2tm1Rbr
Birc3tm1.1Rbr/Birc3tm1.1Rbr
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
decreased germinal center B cell number
|
J:172843
|
| increased B cell number
|
J:172843
|
| increased follicular B cell number
|
J:172843
|
| increased marginal zone B cell number
|
J:172843
|
Birc3tm1Jda/Birc3tm1Jda
(B6.Cg-Birc3tm1Jda)
|
abnormal lymphocyte cell number
|
J:166899
|
| decreased follicular B cell number
|
J:166899
|
| decreased immature B cell number
|
J:166899
|
| increased B cell number
|
J:166899
|
| increased marginal zone B cell number
|
J:166899
|
| increased T cell number
|
J:166899
|
Birc3tm1Rgk/Birc3tm1Rgk
(B6.129X1-Birc3tm1Rgk)
|
decreased macrophage cell number
|
J:144012
|
Birc5tm1Mak/Birc5tm1Mak
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd)
|
abnormal T cell morphology
|
J:90892
|
| decreased double-negative T cell number
|
J:90892
|
| decreased thymocyte number
|
J:90892
|
Birc5tm1Wnt/Birc5tm1Emc
Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:87435
|
Birc5tm1Wnt/Birc5tm1Emc
Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:87435
|
| decreased T cell number
|
J:87435
|
| increased double-negative T cell number
|
J:87435
|
Blktm1Tara/Blktm1Tara
Fyntm1Sor/Fyntm1Sor
Lyntm1Ard/Lyntm1Ard
(either: B6.129-Lyntm1Ard Fyntm1Sor Blktm1Tara or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6))
|
abnormal B cell differentiation
|
J:115080
|
| abnormal pro-B cell differentiation
|
J:115080
|
| arrested B cell differentiation
|
J:115080
|
| decreased B cell number
|
J:115080
|
| decreased immature B cell number
|
J:115080
|
| decreased pre-B cell number
|
J:115080
|
Blmtm4Ches/Blmtm4Ches
Cd19tm1(cre)Cgn/Cd19+
Nsmce2tm2.1Ofc/Nsmce2tm2.1Ofc
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal B cell morphology
|
J:227197
|
| decreased B cell number
|
J:227197
|
Blmtm4Ches/Blmtm4Ches
Trp53bp1tm1Jc/Trp53bp1tm1Jc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:194603
|
Blnkem1(IMPC)H/Blnkem1(IMPC)H
(C57BL/6N-Blnkem1(IMPC)H/H)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
Blnkm1Btlr/Blnkm1Btlr
(C57BL/6J-Blnkm1Btlr)
|
arrested B cell differentiation
|
J:159439
|
| decreased mature B cell number
|
J:159439
|
| increased CD4-positive, alpha-beta T cell number
|
J:159439
|
| increased CD8-positive, alpha-beta T cell number
|
J:159439
|
Blnkm1Btlr/Blnkm1Btlr
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:185495
|
Blnktm1Achn/Blnktm1Achn
(involves: 129X1/SvJ)
|
abnormal B cell differentiation
|
J:58805
|
| abnormal mature B cell morphology
|
J:58805
|
| absent B-1b cells
|
J:58805
|
| arrested B cell differentiation
|
J:58805
|
| decreased B-1a cell number
|
J:58805
|
| decreased mature B cell number
|
J:58805
|
| increased pro-B cell number
|
J:58805
|
Blnktm1Dkit/Blnktm1Dkit
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:84040
|
| abnormal immature B cell morphology
|
J:94297
|
| abnormal plasma cell differentiation
|
J:143854
|
| abnormal pre-B cell morphology
|
J:84040
|
| arrested B cell differentiation
|
J:143854
|
| decreased follicular B cell number
|
J:143854
|
| decreased immature B cell number
|
J:84040
|
| decreased marginal zone B cell number
|
J:143854
|
| decreased mature B cell number
|
J:84040
|
| decreased transitional stage B cell number
|
J:143854
|
Blnktm1Dkit/Blnktm1Dkit
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
abnormal pre-B cell morphology
|
J:84040
|
| absent immature B cells
|
J:84040
|
| absent mature B cells
|
J:84040
|
| arrested B cell differentiation
|
J:84040
|
| decreased pre-B cell number
|
J:84040
|
Blnktm1Dkit/Blnktm1Dkit
Igh-Jtm1(3H9-VDJ)Mwg/Igh-J+
(involves: C57BL/6 * NZB)
|
abnormal immature B cell morphology
|
J:94297
|
Blnktm1Dkit/Blnktm1Dkit
Igh-Jtm1(3H9-VDJ)Mwg/Igh-J+
Igk-Jtm1Mwg/Igk-J+
(involves: C57BL/6 * NZB)
|
abnormal immature B cell morphology
|
J:94297
|
Blnktm1Dkit/Blnktm1Dkit
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
abnormal plasma cell differentiation
|
J:143854
|
| arrested B cell differentiation
|
J:143854
|
| decreased B-1 B cell number
|
J:143854
|
| decreased B-2 B cell number
|
J:143854
|
| decreased follicular B cell number
|
J:143854
|
| decreased marginal zone B cell number
|
J:143854
|
Blnktm1Kplm/Blnktm1Kplm
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:61130,
J:131161
|
| absent B-1a cells
|
J:61130
|
| decreased B cell number
|
J:61130,
J:131161
|
| decreased immature B cell number
|
J:61130
|
| decreased mature B cell number
|
J:61130
|
| decreased pre-B cell number
|
J:61130,
J:120460
|
| increased pro-B cell number
|
J:61130,
J:131161
|
Blnktm1Kplm/Blnktm1Kplm
Ightm4Cgn/Igh+
Igktm1Rsky/Igk+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:120460
|
| decreased B cell number
|
J:120460
|
| increased pre-B cell number
|
J:120460
|
| increased transitional stage B cell number
|
J:120460
|
Blnktm1Kplm/Blnktm1Kplm
Plcg2tm1.1Kuro/Plcg2+
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:131161
|
Blnktm1Kplm/Blnktm1Kplm
Plcg2tm1.1Kuro/Plcg2tm1.1Kuro
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:131161
|
Blnktm1Pjln/Blnktm1Pjln
(involves: BALB/c)
|
abnormal pre-B cell morphology
|
J:58740
|
| arrested B cell differentiation
|
J:58740
|
| decreased mature B cell number
|
J:58740
|
| increased mature B cell number
|
J:157575
|
| increased pre-B cell number
|
J:58740,
J:80332
|
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:94768
|
| decreased immature B cell number
|
J:94768
|
| decreased mature B cell number
|
J:94768
|
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
Tg(CD19-BTK*K430R)XK24Rwhe/?
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB)
|
abnormal B cell differentiation
|
J:94768
|
Blnktm1Pjln/Blnktm1Pjln
Btktm1Wk/Btktm1Wk
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
arrested B cell differentiation
|
J:70406
|
Bloc1s5em1(IMPC)Tcp/Bloc1s5+
(C57BL/6NCrl-Bloc1s5em1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
decreased lymphocyte cell number
|
J:110697
|
| increased lymphocyte cell number
|
J:191844
|
| increased monocyte cell number
|
J:110697
|
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:118522
|
| abnormal T cell subpopulation ratio
|
J:118522
|
| decreased B cell number
|
J:135933,
J:118522
|
| decreased follicular B cell number
|
J:118522
|
| decreased lymphocyte cell number
|
J:135933,
J:118522
|
| decreased transitional stage B cell number
|
J:118522
|
Bmftm1.1Ast/Bmftm1.1Ast
(B6.Cg-Bmftm1.1Anst)
|
abnormal B cell morphology
|
J:133084
|
| increased follicular B cell number
|
J:133084
|
| increased immature B cell number
|
J:133084
|
| increased mature B cell number
|
J:133084
|
| increased pre-B cell number
|
J:133084
|
| increased transitional stage B cell number
|
J:133084
|
Bmftm1Rjd/Bmftm1Rjd
(B6.129S6-Bmftm1Rjd)
|
increased B cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
Bmftm3.1Rjd/Bmftm3.1Rjd
(B6.129S6-Bmftm3.1Rjd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:153652
|
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
abnormal double-negative T cell morphology
|
J:17712
|
| decreased immature B cell number
|
J:17712
|
| decreased mature B cell number
|
J:17712
|
| decreased thymocyte number
|
J:17712
|
Bmi1tm1Brn/Bmi1tm1Brn
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:134271
|
Bmi1tm1Brn/Bmi1tm1Brn
E2f6tm1Lees/E2f6tm1Lees
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:134271
|
Bmi1tm1Sgon/Bmi1tm1Sgon
Commd10Tg(Vav1-icre)A2Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:221849
|
| decreased T cell number
|
J:221849
|
Bmi1tm1Sgon/Bmi1tm1Sgon
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased lymphocyte cell number
|
J:221849
|
Bmp1tm1.1Dgr/Bmp1tm1.1Dgr
Tll1tm2.1Dgr/Tll1tm2.1Dgr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * SJL)
|
increased osteoclast cell number
|
J:210366
|
Bmp2tm1.1Mis/Bmp2tm1.2Mis
Tg(Col1a1-cre)1Bek/0
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * CD-1)
|
decreased osteoclast cell number
|
J:210409
|
Bmp7tm1a(EUCOMM)Hmgu/Bmp7+
(C57BL/6N-Bmp7tm1a(EUCOMM)Hmgu/H)
|
increased monocyte cell number
|
J:165965
|
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr
Tg(Col1a1-cre/Esr1*)1Mis/0
(involves: 129S7/SvEvBrd)
|
abnormal osteoclast differentiation
|
J:143588
|
| decreased osteoclast cell number
|
J:143588
|
Bod1lem1Bltn/Bod1lem1Bltn
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:337726
|
Bomb1NSF/N/Bomb1NSF/N
(involves: NFS/N * SL/Kh)
|
increased pre-B cell number
|
J:55364
|
Bomb1SL/Kh/Bomb1SL/Kh
(involves: NFS/N * SL/Kh)
|
increased pre-B cell number
|
J:55364
|
Bptftm1.1Cwu/Bptftm1.1Cwu
Emx1tm1(cre)Krj/Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
microgliosis
|
J:334252
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased thymocyte number
|
J:170095
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
decreased thymocyte number
|
J:170095
|
Braftm1Bbd/Braf+
(B6.129-Braftm1Bbd)
|
decreased thymocyte number
|
J:170095
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Shld1em1Nus/Shld1em1Nus
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:307190
|
Brca1tm2Mak/Brca1tm2Mak
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:63282
|
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell number
|
J:63282
|
| decreased double-positive T cell number
|
J:63282
|
| decreased single-positive T cell number
|
J:63282
|
| decreased thymocyte number
|
J:63282
|
| increased double-negative T cell number
|
J:63282
|
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell number
|
J:63282
|
| decreased double-positive T cell number
|
J:63282
|
| decreased thymocyte number
|
J:63282
|
| increased double-negative T cell number
|
J:63282
|
Brca2tm1Mak/Brca2tm2Mak
Trp53tm1Brd/Trp53tm1Brd
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA)
|
increased activated T cell number
|
J:79697
|
Brd2em1(IMPC)Wtsi/Brd2+
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
Brpf1tm1a(EUCOMM)Wtsi/Brpf1+
(Not Specified)
|
decreased T cell number
|
J:165965
|
| increased monocyte cell number
|
J:165965
|
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics)
|
increased large unstained cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Bsgtm1.1Znc/Bsgtm1.1Znc
Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased double-positive T cell number
|
J:207886
|
| decreased single-positive T cell number
|
J:207886
|
| decreased thymocyte number
|
J:207886
|
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas)
|
increased T-helper 17 cell number
|
J:287636
|
Bst1tm1Thir/Bst1tm1Thir
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:111424
|
| decreased immature B cell number
|
J:111424
|
| increased B cell number
|
J:111424
|
Btbd3tm1b(EUCOMM)Hmgu/Btbd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Btbd3tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased CD8-positive, CD25-positive alpha-beta T cell number
|
J:211773
|
Btf3em1(IMPC)Tcp/Btf3+
(C57BL/6NCrl-Btf3em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Btg1em1(IMPC)Mbp/Btg1em1(IMPC)Mbp
(C57BL/6NCrl-Btg1em1(IMPC)Mbp/Mmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Btkm1Anu/Btkm1Anu
(involves: BXSB/MpJ * C57BL/6JAnu * SB/Le)
|
decreased B cell number
|
J:104190
|
Btkm1Anu/Btkm1Anu
X/Yaa
(involves: BXSB/MpJ * C57BL/6JAnu * SB/Le)
|
decreased B cell number
|
J:104190
|
Btkm2Anu/Btkm2Anu
(C57BL/6NCrlAnu-Btkm2Anu)
|
increased immature B cell number
|
J:104190
|
Btktm1a(EUCOMM)Hmgu/Y
(C57BL/6N-Btktm1a(EUCOMM)Hmgu/Ics)
|
increased CD4-positive, alpha-beta T cell number
|
J:165965
|
Btktm1Gsv/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:35769
|
| absent B-1a cells
|
J:35769
|
| absent mature B cells
|
J:35769
|
| decreased B cell number
|
J:35769
|
| decreased immature B cell number
|
J:35769
|
Btktm1Gsv/Y
Tg(CD19-BTK*K430R)XK24Rwhe/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal lymphocyte cell number
|
J:120989
|
| abnormal pre-B cell morphology
|
J:120989
|
| absent B-1a cells
|
J:120989
|
| decreased B cell number
|
J:120989
|
Btktm1Gsv/Btk+
(involves: 129P2/OlaHsd * C57BL/6)
|
absent B-1a cells
|
J:35769
|
| decreased B cell number
|
J:35769
|
| decreased mature B cell number
|
J:35769
|
Btktm1Wk/Btktm1Wk
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:28968
|
| decreased mature B cell number
|
J:28968,
J:82298
|
| increased pro-B cell number
|
J:28968
|
Btktm1Wk/Btktm1Wk
Cd40tm1Geha/Cd40tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:82298
|
| decreased mature B cell number
|
J:82298
|
Btktm1Wk/Btktm1Wk
Tectm1Welm/Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:66080
|
| decreased B cell number
|
J:66080
|
| increased pre-B cell number
|
J:66080
|
Btkvila/Btkvila
(C57BL/6JAnu-Btkvila/AnuApb)
|
decreased B cell number
|
J:104190
|
Btkxid/Y
(CBA/HN-Btkxid)
|
decreased B cell number
|
J:81429
|
Btkxid/Y
(involves: CBA/HN * DBA/2N)
|
decreased B cell number
|
J:81429
|
Btkxid/?
(involves: BALB/c * CBA/N)
|
decreased B-1 B cell number
|
J:108696
|
| decreased mature B cell number
|
J:108696
|
Btkxid/Y
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * CBA/CaHN)
|
decreased follicular B cell number
|
J:69477
|
Btkxid/?
Tg(IGH-Btk)1Witt/0
(involves: BALB/c * C3H * C57BL/6 * CBA/N)
|
decreased B-1 B cell number
|
J:108696
|
Btkxid/?
Tg(IGH-Btk)1Witt/Tg(IGH-Btk)1Witt
(involves: BALB/c * C3H * C57BL/6 * CBA/N)
|
decreased B-1 B cell number
|
J:108696
|
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J)
|
decreased follicular B cell number
|
J:69477
|
Btkxid/Btkxid
(involves: CBA/HN * DBA/2N)
|
decreased B cell number
|
J:81429
|
Btkxid/Btkxid
(CBA/HN-Btkxid)
|
abnormal lymphopoiesis
|
J:7981
|
| abnormal pre-B cell morphology
|
J:7981
|
| decreased B cell number
|
J:81429
|
Btkxid/Btkxid
(B6.CBA-Btkxid)
|
decreased transitional stage B cell number
|
J:145687
|
Btkxid/Btkxid
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * CBA/CaHN)
|
decreased follicular B cell number
|
J:69477
|
Btnl1em1Ahay/Btnl1em1Ahay
(Not Specified)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:236526
|
| decreased gamma-delta intraepithelial T cell number
|
J:236526
|
Btnl1tm1(KOMP)Mbp/Btnl1tm1(KOMP)Mbp
(C57BL/6N-Btnl1tm1(KOMP)Mbp)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:236526
|
| decreased gamma-delta intraepithelial T cell number
|
J:236526
|
Btnl1tm1(KOMP)Mbp/Btnl1tm1(KOMP)Mbp
Foxn1nu/Foxn1nu
(involves: albino stock * C57BL/6N)
|
decreased gamma-delta intraepithelial T cell number
|
J:236526
|
Btnl1tm1(KOMP)Mbp/Btnl1tm1(KOMP)Mbp
Gt(ROSA)26Sortm1(rtTA*M2)Jae/0
Tg(tetO-Btnl1)#Ahay/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N)
|
decreased gamma-delta intraepithelial T cell number
|
J:236526
|
Btnl1tm1(KOMP)Mbp/Btnl1tm1(KOMP)Mbp
Tg(tetO-Btnl1)#Ahay/0
Tg(Vil-rtTA2*M2)1Rsmi/0
(involves: C57BL/6N * FVB/N)
|
decreased gamma-delta intraepithelial T cell number
|
J:236526
|
Btnl2em1Wche/Btnl2em1Wche
(C57BL/6-Btnl2em1Wche)
|
abnormal gamma-delta T cell morphology
|
J:321348
|
Btnl6em1.1Ahay/Btnl6em1.1Ahay
(Not Specified)
|
decreased CD4-positive, gamma-delta intraepithelial T cell number
|
J:291989
|
Btnl6em1Ahay/Btnl6em1Ahay
Tg(Vil1-cre)20Syr/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, gamma-delta intraepithelial T cell number
|
J:291989
|
Btrctm1b(KOMP)Wtsi/Btrctm1b(KOMP)Wtsi
(C57BL/6N-Btrctm1b(KOMP)Wtsi/H)
|
increased monocyte cell number
|
J:211773
|
Btrctm1Kin/Btrctm1Kin
(involves: C57BL/6)
|
abnormal lymphocyte morphology
|
J:84639
|
C1ql3em1(IMPC)H/C1ql3em1(IMPC)H
(C57BL/6NTac-C1ql3em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
C1ql4tm1Lex/C1ql4tm1Lex
(B6.129S5-C1ql4tm1Lex)
|
decreased lymphocyte cell number
|
J:344722
|
C1qtnf4em1Smoc/C1qtnf4em1Smoc
(C57BL/6J-C1qtnf4em1Smoc/Smoc)
|
abnormal macrophage differentiation
|
J:302282
|
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw)
|
increased B cell number
|
J:227217
|
C1qtnf7tm1(KOMP)Vlcg/C1qtnf7tm1(KOMP)Vlcg
(C57BL/6N-C1qtnf7tm1(KOMP)Vlcg)
|
increased macrophage cell number
|
J:244352
|
C2cd3em1(IMPC)Tcp/C2cd3+
(C57BL/6N-C2cd3em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
decreased osteoclast cell number
|
J:166640
|
C3ar1tm1Cge/C3ar1tm1Cge
(involves: 129S4/SvJae * C57BL/6)
|
decreased osteoclast cell number
|
J:166640
|
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
|
abnormal T-helper 2 cell differentiation
|
J:80071
|
| decreased lymphocyte cell number
|
J:80071
|
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6J)
|
increased macrophage cell number
|
J:111811
|
C5ar1tm1Cge/C5ar1tm1Cge
(involves: 129S4/SvJae * C57BL/6)
|
decreased osteoclast cell number
|
J:166640
|
C8atm1b(EUCOMM)Hmgu/C8atm1b(EUCOMM)Hmgu
(C57BL/6N-C8atm1b(EUCOMM)Hmgu/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
|
abnormal lymphocyte morphology
|
J:240357
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:240357
|
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N)
|
abnormal lymphocyte morphology
|
J:240357
|
C9orf72tm1Lagi/C9orf72tm1Lagi
(involves: C57BL/6 * C57BL/6N)
|
decreased lymphocyte cell number
|
J:232242
|
Cabp1tm1b(EUCOMM)Wtsi/Cabp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cabp1tm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Cacna2d1em1(IMPC)Mbp/Cacna2d1em1(IMPC)Mbp
(C57BL/6N-Cacna2d1em1(IMPC)Mbp/MbpMmucd)
|
increased monocyte cell number
|
J:211773
|
Cacnb4lh/Cacnb4lh
(B6EiC3Sn a/A-Cacnb4lh/J)
|
decreased double-positive T cell number
|
J:115345
|
| decreased lymphocyte cell number
|
J:5281
|
CacybpGT(OST39970)Lex/CacybpGT(OST39970)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell morphology
|
J:110899
|
| decreased thymocyte number
|
J:110899
|
Cadm1Gt(Ayu21-W34)Imeg/Cadm1Gt(Ayu21-W34)Imeg
(involves: C57BL/6 * CBA/JNCrlj)
|
abnormal T cell differentiation
|
J:178612
|
| abnormal T cell receptor V(D)J recombination
|
J:178612
|
| decreased CD4-positive, alpha-beta T cell number
|
J:178612
|
| decreased CD8-positive, alpha-beta T cell number
|
J:178612
|
| increased double-positive T cell number
|
J:178612
|
Calcrtm1Dgal/Calcr+
Iapptm1Sgm/Iapp+
(involves: 129P2/OlaHsd)
|
increased osteoclast cell number
|
J:88964
|
Calcrltm1Kmca/Calcrltm1Kmca
(involves: 129S6/SvEvTac)
|
decreased uterine NK cell number
|
J:201446
|
Camk4tm1Tch/Camk4tm1Tch
(B6.129X1-Camk4tm1Tch)
|
abnormal osteoclast differentiation
|
J:129599
|
| decreased osteoclast cell number
|
J:129599
|
Camltm1Rjb/Camltm2Rjb
Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased single-positive T cell number
|
J:100536
|
| decreased thymocyte number
|
J:100536
|
Camltm1Rjb/Camltm2Rjb
Tg(Lck-cre)1Cwi/0
Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:100536
|
| abnormal positive T cell selection
|
J:100536
|
| decreased thymocyte number
|
J:100536
|
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased gamma-delta T cell number
|
J:211773
|
Capza1em1(IMPC)Tcp/Capza1em1(IMPC)Tcp
(C57BL/6NCrl-Capza1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Car6em1(IMPC)Ccpcz/Car6em1(IMPC)Ccpcz
(C57BL/6NCrl-Car6em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK cell number
|
J:211773
|
Car9tm1Lex/Car9tm1Lex
(B6;129S5-Car9tm1Lex/Mmucd)
|
increased mature B cell number
|
J:171883
|
Card11em1(IMPC)Ccpcz/Card11em1(IMPC)Ccpcz
(C57BL/6NCrl-Card11em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
Card11em1Welu/Card11+
(involves: C57BL/6)
|
decreased marginal zone B cell number
|
J:292926
|
| decreased transitional stage T1 B cell number
|
J:292926
|
| decreased transitional stage T3 B cell number
|
J:292926
|
| increased transitional stage T2 B cell number
|
J:292926
|
Card11em1Welu/Card11em1Welu
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:292926
|
| abnormal germinal center B cell morphology
|
J:292926
|
| abnormal plasma cell differentiation
|
J:292926
|
| decreased B-1 B cell number
|
J:292926
|
| decreased B-1a cell number
|
J:292926
|
| decreased germinal center B cell number
|
J:292926
|
| decreased marginal zone B cell number
|
J:292926
|
| decreased pre-B cell number
|
J:292926
|
| decreased transitional stage T1 B cell number
|
J:292926
|
| decreased transitional stage T3 B cell number
|
J:292926
|
| increased follicular B cell number
|
J:292926
|
| increased transitional stage T2 B cell number
|
J:292926
|
Card11em2Welu/Card11+
(involves: C57BL/6)
|
increased B-1 B cell number
|
J:292926
|
| increased marginal zone B cell number
|
J:292926
|
Card11em2Welu/Card11em2Welu
(involves: C57BL/6)
|
abnormal plasma cell differentiation
|
J:292926
|
| decreased mature B cell number
|
J:292926
|
| increased B-1a cell number
|
J:292926
|
| increased B-1b cell number
|
J:292926
|
| increased germinal center B cell number
|
J:292926
|
| increased marginal zone B cell number
|
J:292926
|
| increased pre-B cell number
|
J:292926
|
| increased transitional stage T2 B cell number
|
J:292926
|
Card11em3Welu/Card11em3Welu
(Not Specified)
|
decreased B-1 B cell number
|
J:292926
|
| decreased marginal zone B cell number
|
J:292926
|
Card11m1Btlr/Card11m1Btlr
(C57BL/6J-Card11m1Btlr)
|
abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:149767
|
| abnormal double-negative T cell morphology
|
J:149767,
J:139069
|
| decreased B-1 B cell number
|
J:149767,
J:139069
|
| decreased gamma-delta T cell number
|
J:149767,
J:139069
|
| decreased mature B cell number
|
J:149767,
J:139069
|
| decreased memory T cell number
|
J:149767,
J:139069
|
| decreased NK cell number
|
J:149767,
J:139069
|
| decreased NK T cell number
|
J:149767,
J:139069
|
| decreased regulatory T cell number
|
J:149767
|
Card11m3Btlr/Card11m3Btlr
(C57BL/6J-Card11m3Btlr)
|
increased B-1a cell number
|
J:221487
|
Card11M4Btlr/Card11+
(C57BL/6J-Card11M4Btlr)
|
decreased B-1a cell number
|
J:254856
|
| increased B-1b cell number
|
J:254856
|
Card11M4Btlr/Card11M4Btlr
(C57BL/6J-Card11M4Btlr)
|
decreased B-1a cell number
|
J:254856
|
| increased B-1b cell number
|
J:254856
|
Card11M5Btlr/Card11+
(C57BL/6J-Card11M5Btlr)
|
increased B-1 B cell number
|
J:254879
|
| increased B-1a cell number
|
J:254879
|
Card11M5Btlr/Card11M5Btlr
(C57BL/6J-Card11M5Btlr)
|
increased B-1 B cell number
|
J:254879
|
| increased B-1a cell number
|
J:254879
|
Card11M6Btlr/Card11M6Btlr
(C57BL/6J-Card11M6Btlr)
|
increased alpha-beta T cell number
|
J:272116
|
Card11M7Btlr/Card11M7Btlr
(C57BL/6J-Card11M7Btlr)
|
abnormal T cell differentiation
|
J:274762
|
| decreased B cell number
|
J:274762
|
| decreased B-1 B cell number
|
J:274762
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:274762
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:274762
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:274762
|
| increased CD4-positive, alpha-beta T cell number
|
J:274762
|
| increased CD8-positive, alpha-beta T cell number
|
J:274762
|
| increased T cell number
|
J:274762
|
Card11m8Btlr/Card11m8Btlr
(C57BL/6J-Card11m8Btlr)
|
abnormal B cell differentiation
|
J:274940
|
| decreased B cell number
|
J:274940
|
| decreased B-1a cell number
|
J:274940
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:274940
|
| increased B-1b cell number
|
J:274940
|
| increased CD4-positive, alpha-beta T cell number
|
J:274940
|
| increased CD8-positive, alpha-beta T cell number
|
J:274940
|
| increased NK T cell number
|
J:274940
|
| increased T cell number
|
J:274940
|
Card11tm1Litt/Card11tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal double-negative T cell morphology
|
J:89322
|
| abnormal T cell differentiation
|
J:89322
|
| absent B-1a cells
|
J:89322
|
Card11tm1Pngr/Card11tm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:84036
|
| abnormal lymphocyte morphology
|
J:84036
|
| absent B-1a cells
|
J:84036
|
| decreased NK cell number
|
J:84036
|
Card11tm1Vmd/Card11tm1Vmd
(involves: 129S6/SvEvTac * C57BL/6N)
|
absent immature B cells
|
J:95800
|
Card11tm1Xav/Card11tm1Xav
(involves: 129 * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:132226
|
| increased CD4-positive, alpha-beta T cell number
|
J:132226
|
| increased CD8-positive, alpha-beta T cell number
|
J:132226
|
Card11unm/Card11unm
(C57BL/6JSfdAnu-Card11unm/Anu)
|
abnormal B cell differentiation
|
J:84042
|
| decreased B-1 B cell number
|
J:84042
|
Card14em2Tshu/Card14+
(involves: C57BL/6)
|
abnormal gamma-delta T cell number
|
J:289239
|
| increased alpha-beta T cell number
|
J:289239
|
Card19tm1Rwen/Card19tm1Rwen
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JSfd)
|
decreased B cell number
|
J:336763
|
| increased B cell number
|
J:336763
|
Carm1tm1b(EUCOMM)Hmgu/Carm1+
(C57BL/6N-Carm1tm1b(EUCOMM)Hmgu/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
Carm1tm1Mtb/Carm1tm1Mtb
(involves: 129S6/SvEvTac)
|
arrested T cell differentiation
|
J:159958
|
Carm1tm2.1Mtb/Carm1tm2.1Mtb
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss)
|
arrested T cell differentiation
|
J:159958
|
Carmil2bas/Carmil2bas
(involves: C3HeB/FeJ * C57BL/6)
|
decreased regulatory T cell number
|
J:205441
|
Carmil2bas/Carmil2tm1a(KOMP)Mbp
(involves: C3HeB/FeJ * C57BL/6 * C57BL/6N)
|
decreased regulatory T cell number
|
J:205441
|
Cartpttm1Hmh/Cartpttm1Hmh
(Not Specified)
|
abnormal osteoclast morphology
|
J:97566
|
| increased osteoclast cell number
|
J:97566
|
Casp3tm1Flv/Casp3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
decreased thymocyte number
|
J:36821
|
Casp3tm1Flv/Casp3tm1Flv
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased lymphocyte cell number
|
J:100854
|
| increased macrophage cell number
|
J:100854
|
Casp3tm1Mak/Casp3tm1Mak
Tg(TcrLCMV)327Sdz/0
(B6.Cg-Casp3tm1Mak Tg(TcrLCMV)327Sdz)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:97650
|
Casp8em1Hbz/Casp8em1Hbz
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:342732
|
Casp8em1Hbz/Casp8em1Hbz
Mlklem1Hbz/Mlklem1Hbz
(involves: C57BL/6)
|
decreased B cell number
|
J:342732
|
| decreased lymphocyte cell number
|
J:342732
|
| decreased mature B cell number
|
J:342732
|
| decreased T cell number
|
J:342732
|
| increased macrophage cell number
|
J:342732
|
Casp8em1Hbz/Casp8em1Hbz
Ripk1em1Hbz/Ripk1em1Hbz
Ripk3tm1Xidw/Ripk3tm1Xidw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased lymphocyte cell number
|
J:342732
|
| decreased mature B cell number
|
J:342732
|
| decreased T cell number
|
J:342732
|
Casp8em1Hbz/Casp8em1Hbz
Ripk3tm1Xidw/Ripk3tm1Xidw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:342732
|
| decreased lymphocyte cell number
|
J:342732
|
| decreased mature B cell number
|
J:342732
|
| decreased T cell number
|
J:342732
|
| increased macrophage cell number
|
J:342732
|
Casp8m1Btlr/Casp8m1Btlr
(C57BL/6J-Casp8m1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:255007
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:255007
|
| decreased T cell number
|
J:255007
|
| increased CD8-positive, alpha-beta T cell number
|
J:255007
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:255007
|
Casp8M2Btlr/Casp8M2Btlr
(C57BL/6J-Casp8M2Btlr)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:272851
|
Casp8tm1.1Raz/Casp8tm1.1Raz
Ripk3tm1Vmd/Ripk3tm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased B cell number
|
J:170815
|
| increased T cell number
|
J:170815,
J:170814
|
Casp8tm1.1Vmd/Casp8tm1.1Vmd
Ripk3tm2Vmd/Ripk3tm2Vmd
(involves: C57BL/6N)
|
increased T cell number
|
J:209137
|
Casp8tm1Hed/Casp8tm1Hed
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:116713
|
| decreased B-1 B cell number
|
J:116713
|
| decreased marginal zone B cell number
|
J:116713
|
Casp8tm1Raz/Casp8tm1Raz
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal lymphocyte morphology
|
J:107455
|
| abnormal T cell morphology
|
J:82759
|
| abnormal T cell subpopulation ratio
|
J:107455,
J:82759
|
| decreased CD4-positive, alpha-beta T cell number
|
J:82759
|
| decreased CD8-positive, alpha-beta T cell number
|
J:82759
|
| decreased T cell number
|
J:82759
|
| increased B cell number
|
J:107455
|
| increased lymphocyte cell number
|
J:107455
|
| increased T cell number
|
J:107455
|
Casp8tm1Wll/Casp8tm1.1Yuan
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129S1/Sv * 129X1/SvJ * MF1)
|
abnormal macrophage differentiation
|
J:92722
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal osteoclast morphology
|
J:141361
|
Cbfa2t3tm1.1Swh/Cbfa2t3tm1.1Swh
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased immature B cell number
|
J:140967
|
Cbfbtm1Itan/Cbfbtm1Itan
Rr94tm3.1Litt/Rr94tm3.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal double-positive T cell morphology
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| decreased double-positive T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
| increased double-positive T cell number
|
J:158962
|
Cbfbtm1Itan/Cbfbtm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:158962,
J:125953
|
| abnormal CD8-positive, alpha-beta T cell number
|
J:125953
|
| abnormal T cell differentiation
|
J:125953
|
| abnormal T-helper 1 cell differentiation
|
J:125953
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158962
|
| increased double-positive T cell number
|
J:158962
|
Cbfbtm1Itan/Cbfbtm1Itan
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
abnormal CD4-positive T cell differentiation
|
J:125953
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125953
|
| abnormal double-positive T cell morphology
|
J:125953
|
| abnormal T-helper 1 cell differentiation
|
J:125953
|
| decreased thymocyte number
|
J:125953
|
Cbfbtm1Itan/Cbfbtm1Itan
Zbtb7btm2Litt/Zbtb7b+
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
Cbfbtm1Itan/Cbfbtm1Itan
Zbtb7btm2Litt/Zbtb7btm1.2Litt
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)1Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1))
|
increased CD4-positive, alpha-beta T cell number
|
J:80670
|
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)2Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster))
|
increased CD4-positive, alpha-beta T cell number
|
J:80670
|
Cbfbtm1Spe/Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:124224
|
| decreased double-positive T cell number
|
J:124224
|
| increased CD4-positive, alpha-beta T cell number
|
J:124224
|
Cbfbtm1Tok/Cbfbtm1Tok
Tg(Gata1-Cbfb)1Tok/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent T cells
|
J:80668
|
| decreased lymphocyte cell number
|
J:80668
|
Cbfbtm2.1Spe/Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:124224
|
| decreased double-positive T cell number
|
J:124224
|
| increased CD4-positive, alpha-beta T cell number
|
J:124224
|
Cbfbtm6Ppl/Cbfb+
(involves: 129S/SvEv * C57BL/6)
|
decreased B cell number
|
J:252447
|
Cbltm1.1Hua/Cbltm1.1Hua
Lattm1Les/Lattm1Les
(involves: 129P2/OlaHsd)
|
increased CD4-positive, alpha-beta T cell number
|
J:91369
|
Cbltm1.1Hua/Cbltm1.1Hua
Lcp2tm1Gak/Lcp2tm1Gak
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:91369
|
| increased CD4-positive, alpha-beta T cell number
|
J:91369
|
Cbltm1.1Hua/Cbltm1.1Hua
Lcp2tm1Gak/Lcp2tm1Gak
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv * 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:91369
|
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:103366
|
| abnormal T cell differentiation
|
J:103366
|
| decreased single-positive T cell number
|
J:103366
|
Cbltm2Hua/Cbltm2Hua
Cblbtm1Hua/Cblbtm1Hua
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
abnormal T cell morphology
|
J:80427
|
Cblbtm1Pngr/Cblbtm1Pngr
Itktm1Litt/Itktm1Litt
(B6.129-Itktm1Litt Cblbtm1Pngr)
|
abnormal T cell morphology
|
J:141390
|
| abnormal T-helper 2 cell differentiation
|
J:141390
|
| decreased T cell number
|
J:141390
|
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi)
|
increased CD4-positive, alpha-beta T cell number
|
J:236022
|
| increased T cell number
|
J:236022
|
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent uterine NK cells
|
J:190486
|
| decreased uterine NK cell number
|
J:190486
|
Cbstm1Unc/Cbstm1Unc
Tg(Mt1-CBS*S466L)EB86Waku/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
increased Ly6C high monocyte number
|
J:168131
|
| increased monocyte cell number
|
J:168131
|
Cbx2tm1Cim/Cbx2tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
arrested T cell differentiation
|
J:38487
|
Cbx4tm1.1Gxu/Cbx4tm1.2Gxu
Tg(Foxn1-cre)1Tbo/0
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal lymphopoiesis
|
J:194053
|
| decreased double-positive T cell number
|
J:194053
|
| decreased T cell number
|
J:194053
|
Ccbe1tm1Mlkn/Ccbe1tm1Mlkn
(either: B6.129-Ccbe1tm1Mlkn or (involves: 129 * C57BL/6))
|
decreased macrophage cell number
|
J:196696
|
Ccdc86tm1Hfuj/Ccdc86+
(involves: C57BL/6NTac)
|
abnormal T cell morphology
|
J:151722
|
Ccdc88bem1(IMPC)Tcp/Ccdc88bem1(IMPC)Tcp
(C57BL/6NCrl-Ccdc88bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Ccdc88bm1Pgrs/Ccdc88bm1Pgrs
(involves: C57BL/6J * C57BL/10J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:230618
|
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp)
|
decreased macrophage cell number
|
J:332421
|
Ccdc171m1Anu/Ccdc171+
(C57BL/NCrlAnu-Ccdc171m1Anu/Anu)
|
decreased mature B cell number
|
J:104190
|
Ccdc171m1Anu/Ccdc171m1Anu
(C57BL/NCrlAnu-Ccdc171m1Anu/Anu)
|
decreased mature B cell number
|
J:104190
|
Ccl2tm1Rol/Ccl2+
Mpztm1Msch/Mpz+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal macrophage derived foam cell morphology
|
J:133028
|
| decreased macrophage cell number
|
J:133028
|
Ccl2tm1Rol/Ccl2+
Tg(PMP22)C61Clh/0
(involves: 129S4/SvJae * C57BL/6J * CBA/Ca)
|
increased macrophage cell number
|
J:158350
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal monocyte morphology
|
J:45920
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
|
abnormal monocyte morphology
|
J:121281
|
| decreased lymphocyte cell number
|
J:147697
|
| decreased macrophage cell number
|
J:147697
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
decreased macrophage cell number
|
J:147328
|
| increased CD4-positive, alpha-beta T cell number
|
J:68145
|
| increased osteoclast cell number
|
J:109290
|
Ccl2tm1Rol/Ccl2tm1Rol
((129S4/SvJae x C57BL/6)F1)
|
decreased macrophage cell number
|
J:119615
|
Ccl2tm1Rol/Ccl2tm1Rol
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
abnormal microglial cell morphology
|
J:200877
|
Ccl2tm1Rol/Ccl2tm1Rol
Mpztm1Msch/Mpz+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
decreased macrophage cell number
|
J:133028
|
| increased macrophage cell number
|
J:133028
|
Ccl2tm1Rol/Ccl2tm1Rol
Tg(PMP22)C61Clh/0
(involves: 129S4/SvJae * C57BL/6J * CBA/Ca)
|
increased macrophage cell number
|
J:158350
|
Ccl5tm1Hso/Ccl5tm1Hso
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:75842
|
Ccl7tm1Ifc/Ccl7tm1Ifc
(involves: 129S4/SvJae)
|
abnormal monocyte morphology
|
J:121281
|
Ccl19tm1Cys/Ccl19tm1Cys
(B6.129X1-Ccl19tm1Cys)
|
decreased T cell number
|
J:126345
|
Ccl21atm1Yout/Ccl21atm1Yout
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal negative T cell selection
|
J:244640
|
| decreased alpha-beta T cell number
|
J:244640
|
| decreased B cell number
|
J:244640
|
| decreased thymocyte number
|
J:244640
|
Ccl25tm1.1Mal/Ccl25tm1.1Mal
(B6.129S2-Ccl25tm1.1Mal)
|
abnormal gamma-delta T cell number
|
J:136944
|
| abnormal T cell subpopulation ratio
|
J:136944
|
| decreased gamma-delta intraepithelial T cell number
|
J:136944
|
Ccl25tm1.1Mal/Ccl25tm1.1Mal
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:136667
|
| abnormal T cell subpopulation ratio
|
J:136667
|
| decreased gamma-delta intraepithelial T cell number
|
J:136667
|
Ccm2tm2.1Sbn/Ccm2tm2.1Sbn
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
microgliosis
|
J:174085
|
Ccn3tm1.1Ecan/Ccn3tm1.1Ecan
(B6.Cg-Ccn3tm1.1Ecan)
|
abnormal osteoclast differentiation
|
J:158478
|
Ccnb2tm1Thnt/Ccnb2tm1Thnt
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:47430
|
Ccnd1tm1Dsn/Ccnd1tm1Dsn
Ccnd2tm1Wbg/Ccnd2tm1Wbg
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal lymphopoiesis
|
J:92563
|
Ccnd3tm1.1(Ccnd2)Iaai/Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac)
|
decreased double-positive T cell number
|
J:192031
|
| decreased pre-B cell number
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(Not Specified)
|
decreased double-positive T cell number
|
J:88120,
J:192031
|
| decreased lymphocyte cell number
|
J:88120
|
| decreased pre-B cell number
|
J:192031
|
| increased double-negative T cell number
|
J:88120
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
decreased double-positive T cell number
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Rb1tm2Brn/Rb1tm2Brn
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:192031
|
Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:192032
|
Ccr1tm1Cge/Ccr1tm1Cge
(C.129S4-Ccr1tm1Cge)
|
decreased CD4-positive, alpha-beta T cell number
|
J:95242
|
| decreased CD8-positive, alpha-beta T cell number
|
J:95242
|
Ccr1tm1Gao/Ccr1tm1Gao
(involves: 129S4/SvJae)
|
abnormal Kupffer cell morphology
|
J:152548
|
Ccr2em1(IMPC)H/Ccr2em1(IMPC)H
(C57BL/6N-Ccr2em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
Ccr2tm1.1(CCR2)Rodb/Ccr2tm1.1(CCR2)Rodb
(involves: C57BL/6)
|
abnormal macrophage morphology
|
J:203000
|
Ccr2tm1.1Mpa/Ccr2tm1.1Mpa
(involves: BALB/cJ * C57BL/6)
|
decreased macrophage cell number
|
J:189044
|
| decreased monocyte cell number
|
J:189044
|
Ccr2tm1Blck/Ccr2tm1Blck
Faslpr/Faslpr
(MRL.Cg-Ccr2tm1Blck Faslpr)
|
abnormal lymphocyte cell number
|
J:113343
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc/J)
|
abnormal osteoclast cell number
|
J:149360
|
| abnormal osteoclast differentiation
|
J:149360
|
| decreased osteoclast cell number
|
J:149360
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae)
|
abnormal monocyte morphology
|
J:121281
|
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:110814
|
| increased B cell number
|
J:110814
|
| increased CD8-positive, alpha-beta T cell number
|
J:110814
|
Ccr2tm1Mae/Ccr2tm1Mae
(B6.129P2-Ccr2tm1Mae)
|
decreased macrophage cell number
|
J:147328
|
Ccr2tm1Mpa/Ccr2tm1Mpa
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased macrophage cell number
|
J:189044
|
Ccr3tm1Cge/Ccr3tm1Cge
(involves: 129S4/SvJae * BALB/c)
|
decreased monocyte cell number
|
J:115273
|
Ccr4tm1Pwr/Ccr4tm1Pwr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased lymphocyte cell number
|
J:70088
|
| decreased macrophage cell number
|
J:70088
|
| increased macrophage cell number
|
J:120221
|
Ccr4tm1Pwr/Ccr4tm1Pwr
(B6.129P2-Ccr4tm1Pwr)
|
increased CD8-positive, alpha-beta T cell number
|
J:95239
|
| increased NK T cell number
|
J:95239
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:110814
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:110814
|
| abnormal Kupffer cell morphology
|
J:152548
|
| decreased NK cell number
|
J:135308
|
| increased NK T cell number
|
J:110814
|
Ccr6tm1(EGFP)Irw/Ccr6tm1(EGFP)Irw
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:85086
|
| abnormal CD4-positive, alpha-beta intraepithelial T cell morphology
|
J:85086
|
| abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:85086
|
| decreased B cell number
|
J:120122
|
Ccr6tm1Gma/Ccr6tm1Gma
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myeloid dendritic cell morphology
|
J:68191
|
Ccr6tm1Gma/Ccr6tm1Gma
Tg(Rorc-EGFP)1Ebe/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:148286
|
| abnormal intraepithelial T cell number
|
J:76461
|
| abnormal lymphocyte morphology
|
J:148286
|
| abnormal myeloid dendritic cell morphology
|
J:124358
|
| abnormal peritoneal macrophage morphology
|
J:124358
|
| decreased B cell number
|
J:148286
|
| decreased CD4-positive, alpha-beta T cell number
|
J:148286
|
| decreased CD8-positive, alpha-beta T cell number
|
J:148286
|
| increased activated T cell number
|
J:76461
|
| increased B-1 B cell number
|
J:124358
|
| increased double-positive T cell number
|
J:76461
|
| increased T cell number
|
J:76461
|
Ccr7m1Btlr/Ccr7+
(C57BL/6J-Ccr7m1Btlr)
|
decreased macrophage cell number
|
J:221477
|
Ccr7m1Btlr/Ccr7m1Btlr
(C57BL/6J-Ccr7m1Btlr)
|
decreased macrophage cell number
|
J:221477
|
| increased single-positive T cell number
|
J:221477
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal class switch recombination
|
J:57976
|
| decreased CD4-positive, alpha-beta T cell number
|
J:57976
|
| decreased T cell number
|
J:57976
|
| increased CD4-positive, alpha-beta T cell number
|
J:57976
|
| increased T cell number
|
J:57976
|
Ccr9tm1.1Mal/Ccr9tm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:72386
|
| decreased double-positive T cell number
|
J:72386
|
| decreased pro-B cell number
|
J:72386
|
| decreased T cell number
|
J:72386
|
| increased T cell number
|
J:72386
|
Ccr9tm1.1Mal/Ccr9tm1.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell number
|
J:136944
|
| abnormal T cell subpopulation ratio
|
J:136944
|
| decreased gamma-delta intraepithelial T cell number
|
J:136944
|
Ccr9tm1.1Mal/Ccr9tm1.1Mal
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:136667
|
| abnormal T cell subpopulation ratio
|
J:136667
|
| decreased gamma-delta intraepithelial T cell number
|
J:136667
|
Ccr9tm1Ccb/Ccr9tm1Ccb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:94596
|
| decreased thymocyte number
|
J:94596
|
Ccr9tm1Lov/Ccr9tm1Lov
(involves: 129)
|
abnormal gamma-delta intraepithelial T cell morphology
|
J:110846
|
| decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:110846
|
| decreased lymphocyte cell number
|
J:110846
|
| increased gamma-delta T cell number
|
J:110846
|
Ccr10tm1.1Nax/Ccr10tm1.1Nax
(B6.129S4(Cg)-Ccr10tm1.1Nax)
|
decreased gamma-delta intraepithelial T cell number
|
J:165323
|
Ccr10tm1Cge/Ccr10tm1Cge
(C.129S4-Ccr10tm1Cge)
|
abnormal plasma cell morphology
|
J:140728
|
Cd1tm1Gru/Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
absent NK T cells
|
J:47769
|
| decreased CD4-positive, alpha-beta T cell number
|
J:126220
|
Cd1d1tm1.1Aben/Cd1d1tm1.1Aben
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Cd1d1tm1.1Aben Tg(Cd4-cre)1Cwi)
|
decreased NK T cell number
|
J:183087
|
Cd1d1tm1.1Boes/Cd1d1tm1.1Boes
(involves: C57BL/6)
|
abnormal NK T cell morphology
|
J:151699
|
| decreased NK T cell number
|
J:151699
|
Cd1d1tm1.2Aben/Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J)
|
abnormal CD4-positive T cell differentiation
|
J:177038
|
Cd1d1tm1Crw/Cd1d1tm1Crw
(involves: 129S4/SvJae * C57BL/6)
|
decreased NK T cell number
|
J:76976
|
Cd1d1tm1Luc/Cd1d1tm1Luc
(B6.129S6-Cd1d1tm1Luc)
|
decreased regulatory T cell number
|
J:122245
|
Cd1d1tm1Luc/Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested T cell differentiation
|
J:125679
|
| decreased NK T cell number
|
J:39748
|
Cd1d1tm1Luc/Cd1d1tm1Luc
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129-Cd1d1tm1Luc Cx3cr1tm1Litt)
|
decreased NK cell number
|
J:129712
|
Cd1d1tm2Aben/Cd1d1tm2Aben
(B6.129P2-Cd1d1tm2Aben)
|
decreased NK T cell number
|
J:174337
|
Cd1d1tm2Aben/Cd1d1tm2Aben
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased NK T cell number
|
J:174337
|
Cd3dtm1Kap/Cd3dtm1Kap
(C57BL/6-Cd3dtm1Kap)
|
arrested T cell differentiation
|
J:39925
|
| decreased CD4-positive, alpha-beta T cell number
|
J:39925
|
| decreased CD8-positive, alpha-beta T cell number
|
J:39925
|
Cd3em1Btlr/Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr)
|
absent T cells
|
J:132486
|
| arrested T cell differentiation
|
J:132486
|
Cd3em1Btlr/Cd3em1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Cd3em2Btlr/Cd3em2Btlr
(C57BL/6J-Cd3em2Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274934
|
| abnormal T cell differentiation
|
J:274934
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274934
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274934
|
| increased CD8-positive, alpha-beta T cell number
|
J:274934
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274934
|
Cd3etm1.1Geno/Cd3etm1.1Geno
(involves: C57BL/6)
|
abnormal double-positive T cell morphology
|
J:192604
|
| abnormal T cell differentiation
|
J:192604
|
| abnormal T cell number
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Geno/Cd3etm1.1Geno
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:192604
|
| abnormal positive T cell selection
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Geno/Cd3etm1.1Geno
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
abnormal CD4-positive T cell differentiation
|
J:192604
|
| abnormal positive T cell selection
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Geno/Cd3etm1.1Geno
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:192604
|
| abnormal T cell differentiation
|
J:192604
|
| decreased double-positive T cell number
|
J:192604
|
| decreased T cell number
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Lov/Cd3etm1.1Lov
(Not Specified)
|
abnormal T cell morphology
|
J:72144
|
| arrested T cell differentiation
|
J:72144
|
| decreased double-positive T cell number
|
J:72144
|
| increased double-negative T cell number
|
J:72144
|
Cd3etm1.1Lov/Cd3etm1.1Lov
Trdctm1Mal/Trdctm1Mal
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112658
|
Cd3etm1Cpt/Cd3etm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
absent T cells
|
J:54756
|
| decreased double-positive T cell number
|
J:54756
|
Cd3etm1Cpt/Cd3etm1Cpt
Tg(CD3E)26Cpt/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:54756
|
| decreased T cell number
|
J:54756
|
Cd3etm1Lov/Cd3etm1Lov
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell morphology
|
J:72144
|
| arrested T cell differentiation
|
J:72144
|
| decreased double-positive T cell number
|
J:72144
|
| increased double-negative T cell number
|
J:72144
|
Cd3etm1Mal/Cd3etm1Mal
(involves: C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:77098
|
| absent CD8-positive, alpha-beta T cells
|
J:77098
|
| arrested T cell differentiation
|
J:77098
|
Cd3etm1Mal/Cd3etm1Mal
(C57BL/6-Cd3etm1Mal)
|
abnormal B cell morphology
|
J:81133
|
| abnormal double-negative T cell morphology
|
J:81133
|
| absent T cells
|
J:131351
|
| arrested T cell differentiation
|
J:81133
|
Cd3etm1Mal/Cd3etm1Mal
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:77098
|
| absent CD8-positive, alpha-beta T cells
|
J:77098
|
| arrested T cell differentiation
|
J:77098
|
Cd3gtm1.1Cage/Cd3gtm1.1Cage
(B6.129P2-Cd3gtm1.1Cage)
|
decreased CD8-positive, alpha-beta T cell number
|
J:153813
|
| decreased thymocyte number
|
J:153813
|
Cd3gtm1Amk/Cd3gtm1Amk
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:77504
|
| decreased thymocyte number
|
J:114561
|
Cd3gtm1Amk/Cd3gtm1Amk
Tg(Igh-Pim1)1Brn/0
(involves: 129P2/OlaHsd * C57BL/6LiA * CBA)
|
decreased thymocyte number
|
J:114561
|
Cd4del/Cd4del
(C57BR/cdJ-Cd4del)
|
absent CD4-positive, alpha-beta T cells
|
J:46692
|
| increased CD8-positive, alpha-beta T cell number
|
J:46692
|
Cd4em1Litt/Cd4em1Litt
Rr386em1Pdi/Rr386em1Pdi
(involves: C57BL/6J)
|
decreased T helper 1 cell number
|
J:333574
|
Cd4m1Btlr/Cd4m1Btlr
(C57BL/6J-Cd4m1Btlr)
|
absent CD4-positive, alpha-beta T cells
|
J:212900
|
Cd4maat/Cd4maat
(C57BL/6JAnu-Cd4maat/Apb)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal double-positive T cell morphology
|
J:104190
|
| decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
| increased CD8-positive, alpha-beta T cell number
|
J:104190
|
Cd4sesh/Cd4sesh
(C57BL/6JAnu-Cd4sesh/AnuApb)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal double-positive T cell morphology
|
J:104190
|
| decreased T cell number
|
J:104190
|
Cd4thth/Cd4thth
(C57BL/6JSfdAnu-Cd4thth)
|
absent CD4-positive, alpha-beta T cells
|
J:104190
|
Cd4tm1(cre/ERT2)Thbu/Cd4+
Gfm1tm1c(EUCOMM)Wtsi/Gfm1tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal T-helper 17 cell differentiation
|
J:302272
|
| increased CD8-positive, alpha-beta T cell number
|
J:302272
|
| increased single-positive T cell number
|
J:302272
|
Cd4tm1(cre/ERT2)Thbu/Cd4+
Tgfbr2tm1Karl/Tgfbr2tm1Karl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased memory T cell number
|
J:204579
|
| increased regulatory T cell number
|
J:204579
|
Cd4tm1Doi/Cd4tm1Doi
Lag3tm1Doi/Lag3tm1Doi
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:33272
|
Cd4tm1Doi/Cd4tm1Litt
Lag3tm1Doi/Lag3+
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:33272
|
Cd4tm1Jrp/Cd4tm1Jrp
(either: B6.129S2-Cd4tm1Jrp or B10.Cg-Cd4tm1Jrp)
|
abnormal T cell differentiation
|
J:45168
|
| decreased CD4-positive, alpha-beta T cell number
|
J:45168
|
| decreased double-positive T cell number
|
J:45168
|
| increased CD8-positive, alpha-beta T cell number
|
J:45168
|
Cd4tm1Jrp/Cd4tm1Jrp
Tg(TcrAND)53Hed/0
(either: (involves: 129S2/SvPas * C57BL/6 * SJL) or (involves: 129S2/SvPas * C57BL/6 * C57BL/10 * SJL))
|
abnormal T cell number
|
J:45168
|
Cd4tm1Knw/Cd4tm1Knw
(B6.129S-Cd4tm1Knw/J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:87828
|
| increased CD8-positive, alpha-beta T cell number
|
J:87828
|
Cd4tm1Litt/Cd4tm1Litt
(involves: 129S2/SvPas)
|
absent CD4-positive, alpha-beta T cells
|
J:50435
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962,
J:50435
|
Cd4tm1Litt/Cd4tm1Litt
Foxp3sfOtcspf/Y
(involves: 129/Rl * 129S2/SvPas)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:20865
|
Cd4tm1Litt/Cd4tm1Nik
Tg(Lck-cre)3785Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:73479
|
| increased CD8-positive, alpha-beta T cell number
|
J:73479
|
Cd4tm1Mak/Cd4tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:68957
|
Cd4tm1Mak/Cd4tm1Mak
(B6.129S2-Cd4tm1Mak/J)
|
absent plasma cells
|
J:133047
|
Cd4tm1Mak/Cd4tm1Mak
Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal double-negative T cell morphology
|
J:12572
|
| abnormal gamma-delta T cell number
|
J:12572
|
| abnormal T cell differentiation
|
J:12572
|
| abnormal T cell number
|
J:12572
|
| decreased double-positive T cell number
|
J:12572
|
Cd4ts1BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Cd4ts2DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Cd4ts3BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Cd4ts4C3H/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Cd4ts5BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Cd4ts5C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
Cd4ts6DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Cd4vts1DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Cd5tm1.1Chra/Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N)
|
decreased B cell number
|
J:189919
|
| decreased CD4-positive, alpha-beta T cell number
|
J:189919
|
| decreased double-positive T cell number
|
J:189919
|
| decreased follicular B cell number
|
J:189919
|
| decreased T-helper 17 cell number
|
J:189919
|
| increased double-negative T cell number
|
J:189919
|
Cd5tm1.1Chra/Cd5tm1.1Chra
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6 * FVB/N)
|
decreased T helper 1 cell number
|
J:189919
|
Cd5tm1Cgn/Cd5tm1Cgn
(B6.129P2-Cd5tm1Cgn)
|
increased regulatory T cell number
|
J:189919
|
Cd5ltm1Nto/Cd5ltm1Nto
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:52195
|
| decreased thymocyte number
|
J:52195
|
Cd6tm1Linf/Cd6tm1Linf
(D1.Cg-Cd6tm1Linf)
|
decreased B-1 B cell number
|
J:238478
|
| decreased B-1a cell number
|
J:238478
|
| increased B-1a cell number
|
J:238478
|
| increased B-1b cell number
|
J:238478
|
Cd7tm1Bfh/Cd7tm1Bfh
(involves: 129 * C57BL/6)
|
increased double-positive T cell number
|
J:48758
|
| increased thymocyte number
|
J:48758
|
Cd7tm1Bfh/Cd7tm1Bfh
(B6.129-Cd7tm1Bfh)
|
increased double-positive T cell number
|
J:48758
|
| increased thymocyte number
|
J:48758
|
Cd8am1Btlr/Cd8am1Btlr
(C57BL/6J-Cd8am1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:221492
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221492
|
Cd8atm1.1(cre)Koni/Cd8atm1.1(cre)Koni
(involves: C57BL/6J * C57BL/6NHsd * SJL)
|
decreased CD8-positive, alpha-beta T cell number
|
J:177182
|
Cd8atm1.1Kio/Cd8atm1.1Kio
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
abnormal CD4-positive T cell differentiation
|
J:76799
|
Cd8atm1.1Litt/Cd8atm1.1Litt
(either: (involves: 129P2/OlaHsd * AKR) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:50624
|
Cd8atm1Asin/Cd8atm1Asin
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal double-positive T cell morphology
|
J:126026
|
Cd8atm1Asin/Cd8atm1Asin
Cd8b1tm1Litt/Cd8b1tm1Litt
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(involves: 129 * FVB/N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:126026
|
| increased CD8-positive, alpha-beta T cell number
|
J:126026
|
Cd8atm1Asin/Cd8atm1Asin
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
Cd8atm1Asin/Cd8atm1Asin
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
| decreased CD4-positive, alpha-beta T cell number
|
J:126026
|
| increased CD8-positive, alpha-beta T cell number
|
J:126026
|
Cd8atm1Asin/Cd8atm1Mak
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
| abnormal T cell subpopulation ratio
|
J:126026
|
| increased CD8-positive, alpha-beta T cell number
|
J:126026
|
Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
absent CD8-positive, alpha-beta T cells
|
J:68956
|
Cd8atm1Mak/Cd8atm1Mak
Il15tm1Imx/Il15tm1Imx
X/Yaa
(BXSB.Cg-Cd8atm1Mak Il15tm1Imx/Dcr)
|
increased monocyte cell number
|
J:179430
|
Cd8atm1Mak/Cd8atm1Mak
Zbtb7bhd/Zbtb7bhd
(involves: B6.129S2-Cd8atm1Mak * B6.Cg-Thpokhd)
|
absent CD4-positive, alpha-beta T cells
|
J:95867
|
Cd8b1M1Btlr/Cd8b1+
(C57BL/6J-Cd8b1M1Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:255009
|
| increased CD4-positive, alpha-beta T cell number
|
J:255009
|
Cd8b1M1Btlr/Cd8b1M1Btlr
(C57BL/6J-Cd8b1M1Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:255009
|
| increased CD4-positive, alpha-beta T cell number
|
J:255009
|
Cd8b1m2Btlr/Cd8b1m2Btlr
(C57BL/6J-Cd8b1m2Btlr)
|
abnormal B cell differentiation
|
J:274761
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274761
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274761
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274761
|
| decreased T cell number
|
J:274761
|
| increased CD4-positive, alpha-beta T cell number
|
J:274761
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274761
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274761
|
Cd8b1tm1Litt/Cd8b1+
Tg(Cd8b1)46Erob/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal T cell subpopulation ratio
|
J:110916
|
| decreased T cell number
|
J:110916
|
| decreased thymocyte number
|
J:110916
|
Cd8b1tm1Litt/Cd8b1+
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
decreased double-positive T cell number
|
J:112551
|
Cd8b1tm1Litt/Cd8b1tm1Litt
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal T cell subpopulation ratio
|
J:110916
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112551,
J:110916
|
| decreased thymocyte number
|
J:110916
|
Cd8b1tm1Litt/Cd8b1tm1Litt
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
abnormal negative T cell selection
|
J:112551
|
| abnormal positive T cell selection
|
J:112551
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112551
|
| increased CD4-positive, alpha-beta T cell number
|
J:112551
|
Cd8b1tm1Wpfl/Cd8b1tm1Wpfl
(involves: 129S2/SvPas)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:19928
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:19928
|
| abnormal T cell subpopulation ratio
|
J:19928
|
| decreased CD8-positive, alpha-beta T cell number
|
J:19928
|
| decreased thymocyte number
|
J:19928
|
Cd8mts1DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
Cd8mts2BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
Cd8mts3C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
Cd8mts4DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
Cd8mts5BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Cd8mts5C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
Cd8mts6C3H/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
Cd8ts1DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
Cd8ts2C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
Cd8ts3C3H/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
Cd8ts3DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Cd19em2(IMPC)Ics/Cd19em2(IMPC)Ics
(C57BL/6N-Cd19em2(IMPC)Ics/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Cd19tm1(cre)Cgn/?
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sortm1(HBEGF)Awai
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:131076
|
| abnormal lymphocyte cell number
|
J:131076
|
| abnormal lymphocyte morphology
|
J:131076
|
| absent immature B cells
|
J:131076
|
| absent mature B cells
|
J:131076
|
Cd19tm1(cre)Cgn/Cd19+
Cxcr4tm1Tng/Cxcr4tm2Tng
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased plasma cell number
|
J:109147
|
Cd19tm1(cre)Cgn/Cd19+
Ell2tm1.1Cmil/Ell2tm1.1Cmil
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased mature B cell number
|
J:234692
|
| decreased plasma cell number
|
J:234692
|
| decreased transitional stage T1 B cell number
|
J:234692
|
| decreased transitional stage T2 B cell number
|
J:234692
|
| decreased transitional stage T3 B cell number
|
J:234692
|
| increased follicular B cell number
|
J:234692
|
| increased immature B cell number
|
J:234692
|
| increased pre-B cell number
|
J:234692
|
| increased pro-B cell number
|
J:234692
|
Cd19tm1(cre)Cgn/Cd19+
Ell2tm2.1Cmil/Ell2tm2.1Cmil
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased mature B cell number
|
J:234692
|
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:147840
|
| abnormal spleen marginal zone macrophage morphology
|
J:147840
|
| abnormal transitional stage B cell morphology
|
J:147840
|
| decreased marginal zone B cell number
|
J:147840
|
| increased activated T cell number
|
J:147840
|
| increased B cell number
|
J:147840
|
Cd19tm1(cre)Cgn/Cd19+
Faslpr/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * MRL)
|
increased double-negative T cell number
|
J:114948
|
Cd19tm1(cre)Cgn/Cd19+
Fastm1Ach/Fastm1Ach
(involves: 129P2/OlaHsd * BALB/c)
|
increased lymphocyte cell number
|
J:123556
|
Cd19tm1(cre)Cgn/Cd19+
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6N)
|
decreased marginal zone B cell number
|
J:117663
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm1(DTA)Riet/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:92789
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(CARD11*L225LI)Jrld/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
abnormal plasmablast number
|
J:228288
|
| increased B cell number
|
J:228288
|
| increased plasma cell number
|
J:228288
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:113365
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm5(Map3k14)Rsky/Gt(ROSA)26Sortm5(Map3k14)Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
increased marginal zone B cell number
|
J:139293
|
| increased mature B cell number
|
J:139293
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm5(Map3k14)Rsky/Gt(ROSA)26Sortm5(Map3k14)Rsky
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased lymphocyte cell number
|
J:139293
|
| decreased mature B cell number
|
J:139293
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm6(Map3k14*)Rsky/Gt(ROSA)26Sortm6(Map3k14*)Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:139293
|
| increased mature B cell number
|
J:139293
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm6(Map3k14*)Rsky/Gt(ROSA)26Sortm6(Map3k14*)Rsky
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:139293
|
| increased mature B cell number
|
J:139293
|
Cd19tm1(cre)Cgn/Cd19+
Igbp1tm1Imku/Y
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:74619
|
| decreased B cell number
|
J:74619
|
| decreased follicular B cell number
|
J:74619
|
| decreased pre-B cell number
|
J:74619
|
Cd19tm1(cre)Cgn/Cd19+
Ikbkbtm1Cgn/Ikbkbtm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:79132
|
| decreased follicular B cell number
|
J:79132
|
| decreased immature B cell number
|
J:79132
|
| decreased marginal zone B cell number
|
J:79132
|
| decreased mature B cell number
|
J:79132
|
Cd19tm1(cre)Cgn/Cd19+
Ikbkbtm2Cgn/Ikbkbtm2.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:79132
|
| decreased follicular B cell number
|
J:79132
|
| decreased marginal zone B cell number
|
J:79132
|
| decreased mature B cell number
|
J:79132
|
Cd19tm1(cre)Cgn/Cd19+
Ikbkbtm2Mka/Ikbkbtm2Mka
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:82995
|
| decreased B-1 B cell number
|
J:82995
|
| decreased marginal zone B cell number
|
J:82995
|
Cd19tm1(cre)Cgn/Cd19+
Ikbkgtm1.1Mpa/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:79132
|
| decreased follicular B cell number
|
J:79132
|
| decreased immature B cell number
|
J:79132
|
| decreased marginal zone B cell number
|
J:79132
|
| decreased mature B cell number
|
J:79132
|
Cd19tm1(cre)Cgn/Cd19+
Il10tm1Roer/Il10tm1Roer
(involves: 129P2/OlaHsd)
|
increased B cell number
|
J:151551
|
| increased CD4-positive, alpha-beta T cell number
|
J:151551
|
| increased plasma cell number
|
J:151551
|
Cd19tm1(cre)Cgn/Cd19+
Inpp5dtm1Rav/Inpp5dtm1Rav
Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal B cell morphology
|
J:166155
|
| decreased B cell number
|
J:166155
|
| increased B cell number
|
J:166155
|
Cd19tm1(cre)Cgn/Cd19+
Irf8tm1.1Hm/Irf8tm1.1Hm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased follicular B cell number
|
J:168923
|
| increased B cell number
|
J:168923
|
| increased B-2 B cell number
|
J:168923
|
| increased follicular B cell number
|
J:168923
|
| increased marginal zone B cell number
|
J:168923
|
| increased transitional stage B cell number
|
J:168923
|
Cd19tm1(cre)Cgn/Cd19+
Klhl6tm2Sato/Klhl6tm2Sato
(either: (involves: 129P2/OlaHsd * 129T2/SvEms) or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal B cell differentiation
|
J:101363
|
| decreased B cell number
|
J:101363
|
Cd19tm1(cre)Cgn/Cd19+
Ltbtm1Avt/Ltbtm1Avt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased marginal zone B cell number
|
J:79129
|
Cd19tm1(cre)Cgn/Cd19+
Map3k7tm1Aki/Map3k7tm1.1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:112597
|
Cd19tm1(cre)Cgn/Cd19+
Mcl1tm2Sjk/Mcl1tm3Sjk
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:86906
|
| absent early pro-B cells
|
J:86906
|
| absent late pro-B cells
|
J:86906
|
| absent pre-B cells
|
J:86906
|
| arrested B cell differentiation
|
J:86906
|
| decreased B cell number
|
J:86906
|
Cd19tm1(cre)Cgn/Cd19+
Mirc30tm1.1Rdf/Mirc30tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased B cell number
|
J:156946
|
| increased B-1a cell number
|
J:156946
|
Cd19tm1(cre)Cgn/Cd19+
Myd88em1.1Rsky/Myd88+
(involves: C57BL/6NTac)
|
increased germinal center B cell number
|
J:308792
|
| increased plasma cell number
|
J:308792
|
Cd19tm1(cre)Cgn/Cd19+
Notch2tm1.1Hhi/Notch2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased marginal zone B cell number
|
J:83476
|
Cd19tm1(cre)Cgn/Cd19+
Notch2tm2Hhi/Notch2tm1.1Hhi
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent marginal zone B cells
|
J:83476
|
| decreased transitional stage B cell number
|
J:83476
|
Cd19tm1(cre)Cgn/Cd19+
Pax5tm1Mbu/Pax5tm3Mbu
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal B cell differentiation
|
J:75504
|
| abnormal class switch recombination
|
J:75504
|
| decreased immature B cell number
|
J:75504
|
| decreased mature B cell number
|
J:75504
|
| decreased pre-B cell number
|
J:75504
|
Cd19tm1(cre)Cgn/Cd19+
Prdm1tm1Clme/Prdm1tm1Clme
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:101890
|
| abnormal memory B cell number
|
J:101890
|
| abnormal plasma cell differentiation
|
J:101890
|
| abnormal plasma cell morphology
|
J:101890,
J:114881
|
| decreased plasma cell number
|
J:101890
|
Cd19tm1(cre)Cgn/Cd19+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal B cell negative selection
|
J:155314
|
| abnormal class switch recombination
|
J:114881
|
| abnormal plasma cell morphology
|
J:114881
|
| increased B cell number
|
J:83213
|
| increased B-1 B cell number
|
J:83213
|
| increased marginal zone B cell number
|
J:83213
|
Cd19tm1(cre)Cgn/Cd19+
Ptpn6tm1Rsky/Ptpn6tm1Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased follicular B cell number
|
J:123568
|
| decreased marginal zone B cell number
|
J:123568
|
| increased B cell number
|
J:123568
|
| increased B-1a cell number
|
J:123568
|
| increased macrophage cell number
|
J:123568
|
| increased plasma cell number
|
J:123568
|
| increased T cell number
|
J:123568
|
Cd19tm1(cre)Cgn/Cd19+
Rac1tm1Tyb/Rac1tm1Tyb
Rac2tm1Mddw/Rac2tm1Mddw
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:86765
|
| decreased B cell number
|
J:86765
|
| decreased B-1 B cell number
|
J:86765
|
| decreased follicular B cell number
|
J:86765
|
| decreased marginal zone B cell number
|
J:86765
|
| decreased transitional stage B cell number
|
J:86765
|
Cd19tm1(cre)Cgn/Cd19+
Rbpjtm1Hon/Rbpjtm1Hon
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:76240
|
| decreased marginal zone B cell number
|
J:121523,
J:76240
|
| increased follicular B cell number
|
J:121523,
J:76240
|
Cd19tm1(cre)Cgn/Cd19+
Rbpjtm1Hon/Rbpjtm1Hon
Spentm2.1Hon/Spentm2.1Hon
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased marginal zone B cell number
|
J:121523
|
| increased follicular B cell number
|
J:121523
|
Cd19tm1(cre)Cgn/Cd19+
Slc3a2tm1.1Mgin/Slc3a2tm1.1Mgin
(involves: 129 * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:148000
|
| abnormal plasma cell differentiation
|
J:148000
|
| decreased germinal center B cell number
|
J:148000
|
Cd19tm1(cre)Cgn/Cd19+
Spentm2.1Hon/Spentm2.1Hon
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased follicular B cell number
|
J:121523
|
| increased marginal zone B cell number
|
J:121523
|
Cd19tm1(cre)Cgn/Cd19+
Srsf3tm1Pjln/Srsf3tm1Pjln
(involves: 129P2/OlaHsd * BALB/c)
|
decreased B cell number
|
J:113645
|
Cd19tm1(cre)Cgn/Cd19+
Tbl1xr1tm1c(EUCOMM)Hmgu/Tbl1xr1tm1c(EUCOMM)Hmgu
Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
abnormal B cell differentiation
|
J:292118
|
| abnormal lymphocyte morphology
|
J:292118
|
Cd19tm1(cre)Cgn/Cd19+
Tcf3tm1Mbu/Tcf3tm1.2Mbu
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased B cell number
|
J:137719
|
| decreased immature B cell number
|
J:137719
|
| decreased mature B cell number
|
J:137719
|
| decreased pre-B cell number
|
J:137719
|
| decreased pro-B cell number
|
J:137719
|
| decreased transitional stage B cell number
|
J:137719
|
Cd19tm1(cre)Cgn/Cd19+
Tcf3tm1Mbu/Tcf3tm1.2Mbu
Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
decreased pre-B cell number
|
J:137719
|
Cd19tm1(cre)Cgn/Cd19+
Tgfbr2tm1Roes/Tgfbr2tm1Roes
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B-1 B cell morphology
|
J:90558
|
| abnormal B-1 B cell number
|
J:90558
|
| absent plasma cells
|
J:90558
|
Cd19tm1(cre)Cgn/Cd19+
Tnfaip3tm1.1Awai/Tnfaip3tm1.1Awai
(involves: 129P2/OlaHsd)
|
decreased B-1a cell number
|
J:175422
|
| decreased B-1b cell number
|
J:175422
|
| decreased marginal zone B cell number
|
J:175422
|
| decreased mature B cell number
|
J:175422
|
| increased B cell number
|
J:175422
|
| increased follicular B cell number
|
J:175422
|
| increased germinal center B cell number
|
J:175422
|
| increased T cell number
|
J:175422
|
Cd19tm1(cre)Cgn/Cd19+
Tnfaip3tm2Ama/Tnfaip3+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased germinal center B cell number
|
J:163917
|
| increased plasma cell number
|
J:163917
|
Cd19tm1(cre)Cgn/Cd19+
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:172843
|
Cd19tm1(cre)Cgn/Cd19+
Tnfsf13btm1Msc/Tnfsf13btm1Msc
Traf2tm1Rbr/Traf2tm1Rbr
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased follicular B cell number
|
J:132877
|
| increased marginal zone B cell number
|
J:132877
|
Cd19tm1(cre)Cgn/Cd19+
Traf2tm1Rbr/Traf2tm1Rbr
(involves: 129P2/OlaHsd * C57BL/6)
|
increased follicular B cell number
|
J:132877
|
| increased marginal zone B cell number
|
J:132877
|
Cd19tm1(cre)Cgn/Cd19+
Traf2tm1Rbr/Traf2tm1Rbr
Traf3tm1Rbr/Traf3tm1Rbr
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased marginal zone B cell number
|
J:132877
|
Cd19tm1(cre)Cgn/Cd19+
Traf3tm1Rbr/Traf3tm1Rbr
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased follicular B cell number
|
J:132877
|
| increased marginal zone B cell number
|
J:132877
|
Cd19tm1(cre)Cgn/Cd19+
Ube2ntm1Aki/Ube2ntm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:112287
|
| decreased marginal zone B cell number
|
J:112287
|
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:27463
|
| decreased B-1 B cell number
|
J:83213,
J:27463
|
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:155314
|
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:155314
|
Cd19tm1(cre/ERT2)Rsky/Cd19+
Myd88em1.1Rsky/Myd88+
(involves: 129P2/OlaHsd * C57BL/6NTac)
|
increased plasma cell number
|
J:308792
|
Cd19tm1Tft/Cd19tm1Tft
(Not Specified)
|
decreased B cell number
|
J:27236
|
| decreased B-1 B cell number
|
J:27236
|
Cd19tm1Tft/Cd19tm1Tft
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:71174
|
| decreased B-1 B cell number
|
J:71174
|
Cd19tm1Tft/Cd19tm1Tft
(B6.Cg-Cd19tm1Tft)
|
increased CD8-positive, alpha-beta T cell number
|
J:106487
|
Cd19tm1Tft/Cd19tm1Tft
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased B cell number
|
J:71174
|
| decreased B-1 B cell number
|
J:71174
|
| decreased mature B cell number
|
J:71174
|
Cd22m1Anu/Cd22m1Anu
(C57BL/6JAnu-Cd22m1Anu/AnuApb)
|
arrested B cell differentiation
|
J:104190
|
| decreased B cell number
|
J:104190
|
Cd22m1Btlr/Cd22m1Btlr
(C57BL/6J-Cd22m1Btlr)
|
abnormal B cell differentiation
|
J:173079
|
Cd22m1Btlr/Cd22m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
Cd22m2Btlr/Cd22m2Btlr
(C57BL/6J-Cd22m2Btlr)
|
abnormal B cell differentiation
|
J:215821
|
Cd22m3Btlr/Cd22m3Btlr
(C57BL/6J-Cd22m3Btlr)
|
decreased B cell number
|
J:220066
|
| increased B-1a cell number
|
J:220066
|
Cd22m4Btlr/Cd22m4Btlr
(C57BL/6J-Cd22m4Btlr)
|
decreased B cell number
|
J:224660
|
| decreased B-2 B cell number
|
J:224660
|
| decreased memory B cell number
|
J:224660
|
| increased B-1a cell number
|
J:224660
|
Cd22m5Btlr/Cd22m5Btlr
(C57BL/6J-Cd22m5Btlr)
|
decreased B cell number
|
J:254827
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254827
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254827
|
Cd22tm1.1(CD22)Lnit/Cd22tm1.1(CD22)Lnit
(involves: 129S4/SvJae)
|
decreased B cell number
|
J:189017
|
| decreased marginal zone B cell number
|
J:189017
|
| decreased transitional stage T1 B cell number
|
J:189017
|
| decreased transitional stage T2 B cell number
|
J:189017
|
Cd22tm1b(EUCOMM)Wtsi/Cd22tm1b(EUCOMM)Wtsi
(C57BL/6N-Cd22tm1b(EUCOMM)Wtsi/Tcp)
|
increased monocyte cell number
|
J:211773
|
Cd22tm1Eac/Cd22+
Lyntm1Ard/Lyn+
Ptpn6me-v/Ptpn6+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
| abnormal mature B cell morphology
|
J:110531
|
Cd22tm1Eac/Cd22+
Lyntm1Ard/Lyn+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
| abnormal mature B cell morphology
|
J:110531
|
Cd22tm1Eac/Cd22+
Ptpn6me-v/Ptpn6+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
| abnormal mature B cell morphology
|
J:110531
|
Cd22tm1Eac/Cd22+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:110531
|
Cd22tm1Eac/Cd22tm1Eac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:37451
|
| abnormal transitional stage B cell morphology
|
J:132991
|
| decreased marginal zone B cell number
|
J:132991
|
| decreased mature B cell number
|
J:37451,
J:132991
|
| decreased memory B cell number
|
J:37451
|
Cd22tm1Lam/Cd22tm1Lam
(involves: 129 * C57BL/6)
|
decreased marginal zone B cell number
|
J:125719
|
| decreased mature B cell number
|
J:125719
|
Cd22tm1Lam/Cd22tm1Lam
Ightm1.2Rsky/Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd22tm1Lam/Cd22tm1Lam
Ightm1.2Rsky/Ightm1.2Rsky
(involves: 129 * BALB/c * C57BL/6)
|
decreased B-1a cell number
|
J:125719
|
Cd22tm1Lnit/Cd22tm1Lnit
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased marginal zone B cell number
|
J:198790
|
Cd22tm1Msn/Cd22tm1Msn
(either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J))
|
abnormal mature B cell morphology
|
J:76974
|
| increased B-1 B cell number
|
J:76974
|
Cd22tm1Tft/Cd22tm1Tft
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:92736
|
| decreased marginal zone B cell number
|
J:92736
|
| decreased mature B cell number
|
J:92736
|
Cd22tm2Lnit/Cd22tm2Lnit
(involves: 129P2/OlaHsd * C57BL/6)
|
absent mature B cells
|
J:198790
|
| decreased marginal zone B cell number
|
J:198790
|
Cd22tm2Tft/Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased B cell number
|
J:92736
|
Cd22tm2Tft/Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:208364
|
Cd22tm3Lnit/Cd22tm3Lnit
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
absent mature B cells
|
J:198790
|
| decreased B cell number
|
J:198790
|
| decreased marginal zone B cell number
|
J:198790
|
| decreased transitional stage B cell number
|
J:198790
|
Cd22tm3Tft/Cd22tm3Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased B cell number
|
J:92736
|
Cd24atm1Pjln/Cd24atm1Pjln
(C57BL/6-Cd24atm1Pjln)
|
abnormal B cell differentiation
|
J:76695
|
| decreased immature B cell number
|
J:76695
|
| decreased pre-B cell number
|
J:76695
|
Cd27em1(IMPC)Ccpcz/Cd27em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd27em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
Cd27tm1Jbo/Cd27tm1Jbo
(B6.129P2-Cd27tm1Jbo)
|
decreased regulatory T cell number
|
J:198200
|
Cd28tm1.1Huen/Cd28tm1.1Huen
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
decreased regulatory T cell number
|
J:191101
|
Cd28tm1a(EUCOMM)Hmgu/Cd28tm1a(EUCOMM)Hmgu
(C57BL/6N-Cd28tm1a(EUCOMM)Hmgu/H)
|
decreased T cell number
|
J:165965
|
| increased CD4-positive, alpha-beta T cell number
|
J:165965
|
Cd28tm1Jmg/Cd28tm1Jmg
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:124570
|
Cd28tm1Jmg/Cd28tm1Mak
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:124570
|
Cd28tm1Ltu/Cd28tm1Ltu
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased regulatory T cell number
|
J:194503
|
| increased activated T cell number
|
J:194503
|
| increased B cell number
|
J:194503
|
Cd28tm1Mak/Cd28+
Cd5tm1Cgn/Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal class switch recombination
|
J:14194
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:123989
|
| decreased regulatory T cell number
|
J:191101,
J:205441
|
Cd28tm1Mak/Cd28tm1Mak
Cd5tm1Cgn/Cd5+
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
Cd28tm1Mak/Cd28tm1Mak
Cd5tm1Cgn/Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
| increased CD4-positive, alpha-beta T cell number
|
J:110925
|
| increased CD8-positive, alpha-beta T cell number
|
J:110925
|
Cd28tm1Mak/Cd28tm1Mak
Cd40lgtm1Flv/Cd40lgtm1Flv
(NOD.Cg-Cd40lgtm1Flv Cd28tm1Mak)
|
decreased regulatory T cell number
|
J:93421
|
Cd28tm1Mak/Cd28tm1Mak
Tg(Cd4-cre)1Cwi/?
Traf6tm2Ywc/Traf6tm2Ywc
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:130882
|
| increased memory T cell number
|
J:130882
|
Cd28tm1Mak/Cd28tm1Mak
Tg(H2-K-Cd86)7All/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:112266
|
Cd28tm1Pjl/Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:83722
|
Cd28tm1Pjl/Cd28tm1Pjl
Tg(H2-K-Cd86)27All/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased B cell number
|
J:112475
|
Cd28tm1Pjl/Cd28tm1Pjl
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk)
|
abnormal class switch recombination
|
J:83722
|
Cd28tm1Shr/Cd28tm1Shr
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:68642
|
Cd28tm1Shr/Cd28tm1Shr
Ctla4tm1Shr/Ctla4+
(C.129S4-Cd28tm1Shr Ctla4tm1Shr)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
Cd28tm1Shr/Cd28tm1Shr
Ctla4tm1Shr/Ctla4tm1Shr
(C.129S4-Cd28tm1Shr Ctla4tm1Shr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:68642
|
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe)
|
abnormal B cell morphology
|
J:130897
|
| abnormal plasma cell differentiation
|
J:130897
|
| increased transitional stage B cell number
|
J:130897
|
Cd37tm1Hor/Cd37tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:63315
|
Cd38em1(IMPC)Ccpcz/Cd38em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd38em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
Cd40tm1Kik/Cd40+
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T follicular helper cell number
|
J:266124
|
Cd40tm1Kik/Cd40tm1Kik
(involves: 129P2/OlaHsd)
|
absent germinal center B cells
|
J:190943
|
| decreased B cell number
|
J:190943
|
Cd40tm1Kik/Cd40tm1Kik
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
| increased marginal zone B cell number
|
J:113556
|
Cd40tm1Kik/Cd40tm1Kik
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(involves: 129 * 129P2/OlaHsd * BALB/c)
|
increased follicular B cell number
|
J:138560
|
| increased marginal zone B cell number
|
J:138560
|
| increased transitional stage B cell number
|
J:138560
|
Cd40lgm1Btlr/Y
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Cd40lgm1Btlr/Cd40lgm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Cd40lgtm1Flv/Cd40lgtm1Flv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:25010
|
| abnormal osteoclast differentiation
|
J:120087
|
| abnormal T cell differentiation
|
J:25010
|
| decreased double-positive T cell number
|
J:25010
|
| increased CD4-positive, alpha-beta T cell number
|
J:25010
|
Cd40lgtm1Flv/Cd40lgtm1Flv
(NOD.129S2-Cd40lgtm1Flv)
|
decreased regulatory T cell number
|
J:93421
|
Cd40lgtm1Imx/Y
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:21137
|
Cd40lgtm1Imx/Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6J * BALB/c)
|
abnormal T cell clonal deletion
|
J:110925
|
Cd40lgtm1Imx/Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6)
|
microgliosis
|
J:115487
|
Cd44M1Btlr/Cd44M1Btlr
(C57BL/6J-Cd44M1Btlr)
|
decreased alpha-beta T cell number
|
J:267483
|
| decreased CD4-positive, alpha-beta T cell number
|
J:267483
|
| decreased CD8-positive, alpha-beta T cell number
|
J:267483
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:267483
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:267483
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:267483
|
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:68069
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:68069
|
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal osteoclast differentiation
|
J:101563
|
Cd44tm1Hbg/Cd44tm1Hbg
Tg(TNF)197Gkl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal osteoclast differentiation
|
J:97992
|
| abnormal osteoclast morphology
|
J:97992
|
| increased osteoclast cell number
|
J:97992
|
Cd47tm1Fpl/Cd47tm1Fpl
(involves: 129S7/SvEvBrd)
|
decreased T cell number
|
J:36489
|
Cd47tm1Fpl/Cd47tm1Fpl
(B6.129S7-Cd47tm1Fpl)
|
decreased osteoclast cell number
|
J:116609
|
Cd47tm1Fpl/Cd47tm1Fpl
(C.129S7-Cd47tm1Fpl)
|
decreased osteoclast cell number
|
J:116609
|
Cd47tm1Fpl/Cd47tm1Fpl
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:147367
|
Cd48tm1Rsr/Cd48tm1Rsr
(B6.129S4-Cd48tm1Rsr)
|
increased CD4-positive, alpha-beta T cell number
|
J:53718
|
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129)
|
increased macrophage cell number
|
J:148367
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
decreased plasma cell number
|
J:119703
|
| increased CD4-positive, alpha-beta T cell number
|
J:123582
|
| increased double-positive T cell number
|
J:123582
|
Cd68tm1Xfen/Cd68tm1Xfen
(C57BL/6J-Cd68tm1Xfen)
|
abnormal osteoclast morphology
|
J:178120
|
Cd69tm1Fsm/Cd69tm1Fsm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:61329
|
| increased immature B cell number
|
J:61329
|
| increased pre-B cell number
|
J:61329
|
Cd69tm1Naka/Cd69tm1Naka
(B6.129P2-Cd69tm1Naka)
|
decreased CD4-positive, alpha-beta T cell number
|
J:184704
|
Cd70tm1(cre)Jbo/Cd70tm1(cre)Jbo
(B6.129P2-Cd70tm1(cre)Jbo)
|
decreased regulatory T cell number
|
J:198200
|
Cd70tm1.1Jda/Cd70tm1.1Jda
(B6.Cg-Cd70tm1.1Jda)
|
decreased CD8-positive, alpha-beta T cell number
|
J:193042
|
Cd72b/Cd72b
Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
|
abnormal B cell number
|
J:204782
|
| abnormal T cell number
|
J:204782
|
Cd72c/Cd72c
Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
|
abnormal B cell number
|
J:204782
|
| abnormal T cell number
|
J:204782
|
Cd72tm1Jrp/Cd72tm1Jrp
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal B cell differentiation
|
J:76990
|
| decreased B cell number
|
J:76990
|
| decreased B-2 B cell number
|
J:76990
|
| decreased follicular B cell number
|
J:76990
|
| decreased mature B cell number
|
J:76990
|
| increased B-1 B cell number
|
J:76990
|
| increased B-1a cell number
|
J:76990
|
| increased immature B cell number
|
J:76990
|
| increased marginal zone B cell number
|
J:76990
|
| increased pre-B cell number
|
J:76990
|
| increased pro-B cell number
|
J:76990
|
Cd72tm1Jrp/Cd72tm1Jrp
Tg(BCL2)22Wehi/0
(either: (involves: 129P2/OlaHsd * C57BL/6JWehi * SJL/JWehi) or (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JWehi * SJL/JWehi))
|
decreased mature B cell number
|
J:76990
|
| increased immature B cell number
|
J:76990
|
Cd72tm1Tsub/Cd72tm1Tsub
Faslpr/Faslpr
(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp)
|
abnormal B cell number
|
J:204782
|
| abnormal T cell number
|
J:204782
|
Cd74em1(IMPC)H/Cd74em1(IMPC)H
(C57BL/6N-Cd74em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Cd74tm1Doi/Cd74tm1Doi
(either: (involves: 129/Sv * B10.BR) or (involves: 129/Sv * C57BL/6))
|
decreased CD4-positive, alpha-beta T cell number
|
J:4119,
J:45185
|
| increased CD8-positive, alpha-beta T cell number
|
J:4119
|
Cd74tm1Doi/Cd74tm1Doi
H2-DMatm1Doi/H2-DMatm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:42482
|
| increased CD8-positive, alpha-beta T cell number
|
J:42482
|
Cd74tm1Doi/Cd74tm1Doi
Tap1tm1Arp/Tap1tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell number
|
J:113083
|
Cd74tm1Eae/Cd74tm1Eae
(involves: 129S2/SvPas)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113050
|
Cd74tm1Eae/Cd74tm1Eae
(B6.129S2-Cd74tm1Eae)
|
arrested B cell differentiation
|
J:112084
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:65918
|
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:28966
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * BALB/cAn)
|
abnormal B cell differentiation
|
J:110927
|
| decreased CD4-positive, alpha-beta T cell number
|
J:110927,
J:113714
|
| increased immature B cell number
|
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * BALB/c * C57BL)
|
abnormal B cell differentiation
|
J:110927
|
| increased immature B cell number
|
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL * C57BL/10 * C57BR)
|
abnormal B cell differentiation
|
J:110927
|
| increased immature B cell number
|
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv)
|
abnormal positive T cell selection
|
J:125548
|
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz/J)
|
decreased B cell number
|
J:194664
|
Cd74tm1Liz/Cd74tm1Liz
H2-DMatm1Liz/H2-DMatm1Liz
(involves: 129S/SvEv * BALB/c)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113714
|
Cd74tm1Liz/Cd74tm1Liz
H2-DMatm1Luc/H2-DMatm1Luc
Tg(CD74)AR194Ayr/?
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6J * DBA/2J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:88717
|
Cd74tm1Liz/Cd74tm1Liz
H2-DMatm1Luc/H2-DMatm1Luc
Tg(CD74*)1Ayr/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6J * DBA/2J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:88717
|
Cd74tm1Liz/Cd74tm1Liz
Sppl2atm1Basc/Sppl2atm1Basc
(B6.129-Sppl2atm1Basc Cd74tm1Liz)
|
decreased B cell number
|
J:194664
|
Cd74tm1Liz/Cd74tm1Liz
Sppl2atm1Dgen/Sppl2atm1Dgen
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
decreased follicular B cell number
|
J:194595
|
Cd79am1Anu/Cd79am1Anu
(involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd)
|
absent pre-B cells
|
J:104190
|
Cd79am1Anu/Cd79am1Anu
(C57BL/6-Cd79am1Anu)
|
absent pre-B cells
|
J:171924
|
Cd79am1Btlr/Cd79am1Btlr
(involves: C57BL/6J * C57BL/10J)
|
decreased B cell number
|
J:174338
|
Cd79am1Btlr/Cd79am1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
Cd79am2Btlr/Cd79am2Btlr
(C57BL/6J-Cd79am2Btlr)
|
decreased B-1 B cell number
|
J:254836
|
Cd79atm1(cre)Reth/Cd79a+
Commd3tm1.1Ksuz/Commd3tm1.1Ksuz
(involves: BALB/c * C57BL/6NSlc * SJL)
|
abnormal plasmablast number
|
J:278399
|
| decreased follicular B cell number
|
J:278399
|
| decreased mature B cell number
|
J:278399
|
Cd79atm1(cre)Reth/Cd79a+
Commd8tm1.1Ksuz/Commd8tm1.1Ksuz
(involves: BALB/c * C57BL/6NSlc * SJL)
|
abnormal plasmablast number
|
J:278399
|
| decreased follicular B cell number
|
J:278399
|
| decreased mature B cell number
|
J:278399
|
Cd79atm1(cre)Reth/Cd79a+
Ctnnbl1tm1.1Crad/Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:232010
|
Cd79atm1(cre)Reth/Cd79a+
Dicer1tm1Mmk/Dicer1tm1Mmk
Tg(BCL2)22Wehi/0
(involves: BALB/c * C57BL/6JWehi * SJL/JWehi)
|
decreased B cell number
|
J:135783
|
| decreased mature B cell number
|
J:135783
|
Cd79atm1(cre)Reth/Cd79a+
Dynll1tm1.1Jhh/Dynll1tm1.1Jhh
(B6.Cg-Dynll1tm1.1Jhh Cd79atm1(Cre)Reth)
|
abnormal B cell morphology
|
J:230105
|
| decreased immature B cell number
|
J:230105
|
| decreased mature B cell number
|
J:230105
|
| decreased pre-B cell number
|
J:230105
|
Cd79atm1(cre)Reth/Cd79a+
Dynll1tm1.1Jhh/Dynll1tm1.1Jhh
Tg(IghMyc)22Bri/0
(B6.Cg-Dynll1tm1.1Jhh Cd79atm1(Cre)Reth Tg(IghMyc)22Bri)
|
decreased immature B cell number
|
J:230105
|
Cd79atm1(cre)Reth/Cd79a+
Huwe1tm1.1Mak/Y
(B6.Cg-Cd79atm1(cre)Reth Huwe1tm1.1Mak)
|
abnormal B cell differentiation
|
J:181705
|
| abnormal class switch recombination
|
J:181705
|
| absent B-1a cells
|
J:181705
|
| decreased follicular B cell number
|
J:181705
|
| decreased marginal zone B cell number
|
J:181705
|
| decreased mature B cell number
|
J:181705
|
| decreased pre-B cell number
|
J:181705
|
| decreased transitional stage B cell number
|
J:181705
|
Cd79atm1(cre)Reth/Cd79a+
Huwe1tm1.1Mak/Y
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:181705
|
| absent B-1a cells
|
J:181705
|
Cd79atm1(cre)Reth/Cd79a+
Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:209928
|
| abnormal B cell number
|
J:209928
|
| decreased pre-B cell number
|
J:209928
|
| increased pro-B cell number
|
J:209928
|
Cd79atm1(cre)Reth/Cd79a+
Phf5atm1.1Oux/Phf5atm1.1Oux
(involves: BALB/c * C57BL/6J)
|
abnormal B cell receptor editing
|
J:345807
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:345807
|
| decreased B cell number
|
J:345807
|
| decreased early pro-B cell number
|
J:345807
|
| decreased immature B cell number
|
J:345807
|
| decreased late pro-B cell number
|
J:345807
|
| decreased mature B cell number
|
J:345807
|
| decreased pre-B cell number
|
J:345807
|
| increased pre-pro B cell number
|
J:345807
|
Cd79atm1(cre)Reth/Cd79a+
Phf5atm1.1Oux/Phf5atm1.1Oux
Tg(IghelMD4)4Ccg/0
(involves: BALB/c * C57BL/6 * C57BL/6J)
|
abnormal B cell number
|
J:345807
|
Cd79atm1(cre)Reth/Cd79a+
Slc39a10tm1.1Tfk/Slc39a10tm1.1Tfk
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)
|
decreased B cell number
|
J:213935
|
| decreased pro-B cell number
|
J:213935
|
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Y
(involves: BALB/c * C57BL/6)
|
decreased B cell number
|
J:182528
|
| decreased follicular B cell number
|
J:182528
|
| decreased marginal zone B cell number
|
J:182528
|
| decreased mature B cell number
|
J:182528
|
| increased germinal center B cell number
|
J:182528
|
| increased plasma cell number
|
J:182528
|
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Was+
(involves: BALB/c * C57BL/6)
|
abnormal B cell number
|
J:182528
|
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Wastm1.1Ldn
(involves: BALB/c * C57BL/6)
|
decreased B cell number
|
J:182528
|
| decreased follicular B cell number
|
J:182528
|
| decreased marginal zone B cell number
|
J:182528
|
| decreased mature B cell number
|
J:182528
|
| increased germinal center B cell number
|
J:182528
|
| increased plasma cell number
|
J:182528
|
Cd79atm1(cre)Reth/Cd79atm1(cre)Reth
Mzb1tm1.1Rug/Mzb1tm1.1Rug
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
abnormal B cell number
|
J:211639
|
| decreased pre-B cell number
|
J:211639
|
| increased late pro-B cell number
|
J:211639
|
| increased pro-B cell number
|
J:211639
|
Cd79atm1.1Cgn/Cd79a+
Cd79btm1Gzmn/Cd79btm1Gzmn
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:179254
|
| decreased pre-B cell number
|
J:179254
|
| increased pro-B cell number
|
J:179254
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
(involves: 129P2/OlaHsd)
|
decreased B-1a cell number
|
J:124400
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:71100
|
| decreased marginal zone B cell number
|
J:71100
|
| decreased mature B cell number
|
J:71100
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
Cd79btm1Gzmn/Cd79b+
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:179254
|
| decreased pre-B cell number
|
J:179254
|
| increased pro-B cell number
|
J:179254
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
Cd79btm1Gzmn/Cd79btm1Gzmn
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:124400
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
Cd79btm1Gzmn/Cd79btm1Gzmn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:179254
|
| absent pre-B cells
|
J:179254
|
| decreased B cell number
|
J:179254
|
| increased pro-B cell number
|
J:179254
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
Cd79btm2.1Mnz/Cd79btm2.1Mnz
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
absent mature B cells
|
J:71100
|
| arrested B cell differentiation
|
J:71100
|
Cd79atm1.1Rsky/Cd79atm1.1Rsky
(involves: C57BL/6)
|
decreased marginal zone B cell number
|
J:179254
|
| decreased mature B cell number
|
J:179254
|
| increased immature B cell number
|
J:179254
|
| increased pre-B cell number
|
J:179254
|
| increased transitional stage B cell number
|
J:179254
|
| increased transitional stage T1 B cell number
|
J:179254
|
| increased transitional stage T2 B cell number
|
J:179254
|
| increased transitional stage T3 B cell number
|
J:179254
|
Cd79atm2(cre/Esr1*)Reth/Cd79a+
Rag1tm1.1Sadu/Rag1tm1.1Sadu
(involves: BALB/c)
|
arrested B cell differentiation
|
J:155473
|
Cd79atm2Cgn/Cd79atm2Cgn
(involves: C57BL/6 * C.B-20)
|
decreased B cell number
|
J:80885
|
| decreased mature B cell number
|
J:80885
|
Cd79atm2Cgn/Cd79atm2Cgn
(involves: C57BL/6)
|
decreased mature B cell number
|
J:71100,
J:66840
|
| decreased pre-B cell number
|
J:71100,
J:66840
|
| increased pro-B cell number
|
J:66840
|
Cd79atm2Cgn/Cd79atm2Cgn
Cd79btm2.1Mnz/Cd79btm2.1Mnz
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:66840
|
| decreased transitional stage B cell number
|
J:66840
|
Cd79atm2Pld/Cd79atm2Pld
(BALB/c-Cd79atm2Pld)
|
abnormal B cell differentiation
|
J:87492
|
| abnormal T cell differentiation
|
J:87492
|
| absent mature B cells
|
J:87492
|
| decreased double-positive T cell number
|
J:87492
|
Cd79atm2Pld/Cd79atm2Pld
Cd79btm1Mnz/Cd79btm1Mnz
(involves: 129S1/Sv * BALB/c)
|
absent pre-B cells
|
J:87492
|
Cd79atm3Cgn/Cd79atm3Cgn
Tg(Mx1-cre)1Cgn/?
(involves: C57BL/6 * CBA)
|
abnormal metallophilic macrophage morphology
|
J:88620
|
| abnormal spleen marginal zone macrophage morphology
|
J:88620
|
| decreased B cell number
|
J:88620
|
Cd79atm4.1Cgn/Cd79atm4.1Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:91091
|
Cd79atm4.1Cgn/Cd79atm4.1Cgn
Ightm1.2Rsky/Igh+
(involves: BALB/c * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:125719
|
Cd79atm4Cgn/Cd79atm4.1Cgn
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:91091
|
Cd79atm4Cgn/Cd79atm4.1Cgn
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent immature B cells
|
J:91091
|
| arrested B cell differentiation
|
J:91091
|
| decreased B cell number
|
J:91091
|
| decreased follicular B cell number
|
J:91091
|
| decreased marginal zone B cell number
|
J:91091
|
Cd79atm5.1Cgn/Cd79a+
Ightm1.2Rsky/Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:91091
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
(involves: 129 * C57BL/6)
|
abnormal B cell morphology
|
J:125719
|
| decreased B-1a cell number
|
J:125719
|
| decreased immature B cell number
|
J:125719
|
| decreased mature B cell number
|
J:125719
|
| decreased pre-B cell number
|
J:125719
|
| decreased T cell number
|
J:125719
|
| increased pro-B cell number
|
J:125719
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
Ightm1.2Rsky/Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
Ightm1.2Rsky/Ightm1.2Rsky
(involves: 129 * BALB/c * C57BL/6)
|
abnormal B cell morphology
|
J:125719
|
| abnormal class switch recombination
|
J:125719
|
| decreased immature B cell number
|
J:125719
|
| decreased mature B cell number
|
J:125719
|
| decreased pre-B cell number
|
J:125719
|
| decreased T cell number
|
J:125719
|
| increased B-1b cell number
|
J:125719
|
| increased pro-B cell number
|
J:125719
|
Cd79atm5Cgn/Cd79atm5.1Cgn
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:91091
|
Cd79atm5Cgn/Cd79atm5.1Cgn
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent immature B cells
|
J:91091
|
| arrested B cell differentiation
|
J:91091
|
| decreased B cell number
|
J:91091
|
Cd79atm6Cgn/Cd79atm6Cgn
(involves: C57BL/6)
|
abnormal B cell number
|
J:113407
|
| decreased B-1a cell number
|
J:113407
|
| increased transitional stage B cell number
|
J:113407
|
Cd79bm1Btlr/Cd79bm1Btlr
(C57BL/6J-Cd79bm1Btlr)
|
decreased B cell number
|
J:267537
|
| decreased B-1 B cell number
|
J:267537
|
| decreased NK cell number
|
J:267537
|
| increased alpha-beta T cell number
|
J:267537
|
| increased CD4-positive, alpha-beta T cell number
|
J:267537
|
| increased CD8-positive, alpha-beta T cell number
|
J:267537
|
Cd79bm1Ghost/Cd79bm1Ghost
(B10.Cg-Ptprca Cd79bm1Ghost H2a)
|
abnormal B cell differentiation
|
J:157450
|
| absent B cells
|
J:157450
|
| arrested B cell differentiation
|
J:157450
|
Cd79bM2Btlr/Cd79bM2Btlr
(C57BL/6J-Cd79bM2Btlr)
|
abnormal lymphocyte morphology
|
J:272863
|
| decreased B cell number
|
J:272863
|
| decreased B-1 B cell number
|
J:272863
|
Cd79btm1Gzmn/Cd79btm1Gzmn
(involves: 129/Sv * C57BL/6)
|
decreased B-1a cell number
|
J:124400
|
Cd79btm1Mnz/Cd79btm1Mnz
(involves: 129S1/Sv)
|
abnormal pro-B cell differentiation
|
J:78601
|
| abnormal pro-B cell morphology
|
J:78601
|
| arrested B cell differentiation
|
J:78601
|
Cd79btm1Mnz/Cd79btm1Mnz
Tg(BCL2)22Wehi/0
Tg(IghelMD4)4Ccg/0
Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6JWehi * SJL/JWehi)
|
arrested B cell differentiation
|
J:78601
|
Cd79btm1Mnz/Cd79btm1Mnz
Tg(BCL2)22Wehi/0
Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6JWehi * SJL/JWehi)
|
arrested B cell differentiation
|
J:78601
|
Cd79btm1Mnz/Cd79btm1Mnz
Tg(IghelMD4)4Ccg/0
Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6)
|
abnormal immature B cell morphology
|
J:78601
|
| arrested B cell differentiation
|
J:78601
|
Cd79btm1Mnz/Cd79btm1Mnz
Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv)
|
abnormal pre-B cell morphology
|
J:78601
|
| arrested B cell differentiation
|
J:78601
|
Cd79btm2.1Mnz/Cd79btm2.1Mnz
(involves: 129 * C57BL/6)
|
decreased mature B cell number
|
J:71100
|
Cd79btm2.1Mnz/Cd79btm2.1Mnz
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:66840
|
| decreased mature B cell number
|
J:66840
|
| decreased pre-B cell number
|
J:66840
|
| decreased transitional stage B cell number
|
J:66840
|
| increased pro-B cell number
|
J:66840
|
Cd79btm3Mnz/Cd79btm3Mnz
(involves: 129/Sv * C57BL/6)
|
abnormal immature B cell morphology
|
J:128768
|
| decreased B cell number
|
J:128768
|
| decreased B-1a cell number
|
J:128768
|
| decreased immature B cell number
|
J:128768
|
| decreased mature B cell number
|
J:128768
|
| increased marginal zone B cell number
|
J:128768
|
| increased pro-B cell number
|
J:128768
|
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae)
|
decreased regulatory T cell number
|
J:205441,
J:113109
|
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell number
|
J:112266
|
| decreased double-positive T cell number
|
J:112266
|
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0
(involves: 129S4/SvJae * FVB/N * NOD)
|
decreased regulatory T cell number
|
J:113109
|
Cd81tm1Geha/Cd81tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell morphology
|
J:43975
|
| decreased B-1 B cell number
|
J:43975
|
| decreased B-1a cell number
|
J:43975
|
Cd81tm1Lvy/Cd81tm1Lvy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell morphology
|
J:40394
|
Cd81tm1Lvy/Cd81tm1Lvy
(either: (B6ByJ.129-Cd81tm1Lvy x CByJ.129-Cd81tm1Lvy)F1 or (CByJ.129-Cd81tm1Lvy x B6ByJ.129-Cd81tm1Lvy)F1)
|
abnormal microglial cell morphology
|
J:79426
|
Cd81tm1Tmiy/Cd81tm1Tmiy
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:41830
|
| decreased B-1 B cell number
|
J:41830
|
Cd81tm1Tmiy/Cd81tm1Tmiy
Cd9tm1Mek/Cd9tm1Mek
(involves: 129/Sv * C57BL/6)
|
increased osteoclast cell number
|
J:83795
|
Cd82tm1Kjbr/Cd82tm1Kjbr
(Not Specified)
|
abnormal macrophage differentiation
|
J:326451
|
| increased macrophage cell number
|
J:326451
|
Cd83anu/Cd83anu
(involves: C57BL/6JAnu * CBA/CaJAnu)
|
abnormal B cell morphology
|
J:104190
|
| decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
Cd83lcd4/Cd83lcd4
(involves: C57BL/6J)
|
abnormal CD4-positive T cell differentiation
|
J:92721
|
Cd83tm1.1Lnjt/Cd83tm1.1Lnjt
(involves: C57BL/6 * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:236611
|
Cd83tm1.1Lnjt/Cd83tm1.1Lnjt
Marchf1tm1.1Sish/Marchf1tm1.1Sish
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:236611
|
Cd83tm1Tft/Cd83tm1Tft
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:75700
|
| arrested T cell differentiation
|
J:75700
|
| decreased CD4-positive, alpha-beta T cell number
|
J:75700
|
Cd84tm1Pls/Cd84tm1Pls
(C57BL/6J-Cd84tm1Pls)
|
abnormal long lived plasma cell morphology
|
J:157915
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157915
|
| decreased germinal center B cell number
|
J:157915
|
Cd86tm1Shr/Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr)
|
decreased regulatory T cell number
|
J:93421
|
Cd177tm1(KOMP)Vlcg/Cd177tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased monocyte cell number
|
J:225335
|
Cd180tm1Kmiy/Cd180tm1Kmiy
Faslpr/Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr)
|
decreased B cell number
|
J:137066
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137066
|
| increased double-negative T cell number
|
J:137066
|
Cd200tm1Jods/Cd200tm1Jods
(C57BL/6-Cd200tm1Jods)
|
abnormal microglial cell morphology
|
J:65982
|
| increased macrophage cell number
|
J:79906,
J:65982
|
Cd207tm1(Hbegf/EGFP)Bjec/Cd207+
(involves: C57BL/6 * SJL)
|
absent Langerhans cell
|
J:137517
|
Cd207tm1Mal/Cd207tm1Mal
(B6.129S2-Cd207tm1Mal)
|
abnormal Langerhans cell morphology
|
J:95147
|
Cd207tm2.1Mal/Cd207tm3.1(HBEGF/EGFP)Mal
(involves: 129S2/SvPas)
|
abnormal Langerhans cell morphology
|
J:99114
|
| absent Langerhans cell
|
J:99114
|
| decreased Langerhans cell number
|
J:99114
|
Cd209atm1.1Cfg/Cd209atm1.1Cfg
(involves: C57BL/6)
|
increased lymphocyte cell number
|
J:217719
|
| increased mature B cell number
|
J:217719
|
| increased monocyte cell number
|
J:217719
|
| increased plasma cell number
|
J:217719
|
Cd209btm1.1Cfg/Cd209btm1.1Cfg
(involves: C57BL/6)
|
decreased mature B cell number
|
J:217719
|
| increased macrophage cell number
|
J:217719
|
Cd209dtm1.1Cfg/Cd209dtm1.1Cfg
(involves: C57BL/6)
|
increased B cell number
|
J:217719
|
Cd247tm1Lov/Cd247tm1Lov
(involves: 129S4/SvJae)
|
abnormal single-positive T cell number
|
J:14170
|
| abnormal T-helper 1 cell morphology
|
J:14170
|
| absent gamma-delta intraepithelial T cell
|
J:46914
|
| decreased CD4-positive, alpha-beta T cell number
|
J:14170
|
| decreased double-positive T cell number
|
J:14170
|
| decreased thymocyte number
|
J:14170
|
Cd247tm1Lov/Cd247tm1Lov
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal effector T cell morphology
|
J:46914
|
| absent gamma-delta intraepithelial T cell
|
J:46914
|
| decreased thymocyte number
|
J:46914
|
Cd247tm1Mal/Cd247tm1Mal
(either: C57BL/6-Cd247tm1Mal or (involves: BALB/c * C57BL/6))
|
abnormal intraepithelial T cell morphology
|
J:15272
|
| abnormal T cell differentiation
|
J:15272
|
| decreased CD4-positive, alpha-beta T cell number
|
J:15272
|
| decreased CD8-positive, alpha-beta T cell number
|
J:15272
|
| decreased double-positive T cell number
|
J:15272
|
| decreased single-positive T cell number
|
J:15272
|
| decreased thymocyte number
|
J:15272
|
| increased double-negative T cell number
|
J:15272
|
Cd247tm1Mal/Cd247tm1Mal
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112990,
J:110847
|
| abnormal T cell differentiation
|
J:112990
|
| abnormal T cell morphology
|
J:110847
|
| decreased double-positive T cell number
|
J:110847
|
Cd247tm1Mal/Cd247tm1Mal
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:110847
|
| abnormal T cell differentiation
|
J:110847
|
| abnormal T cell morphology
|
J:110847
|
| decreased double-positive T cell number
|
J:110847
|
Cd247tm1Mhu/Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:15579
|
| decreased CD4-positive, alpha-beta T cell number
|
J:15579
|
| decreased CD8-positive, alpha-beta T cell number
|
J:15579
|
| decreased double-positive T cell number
|
J:15579
|
| decreased thymocyte number
|
J:15579
|
| increased double-negative T cell number
|
J:15579
|
Cd247tm1Mhu/Cd247tm1Mhu
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased uterine NK cell number
|
J:100668
|
Cd247tm1Tks/Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:15271
|
| decreased CD4-positive, alpha-beta T cell number
|
J:15271
|
| decreased CD8-positive, alpha-beta T cell number
|
J:15271
|
| decreased double-positive T cell number
|
J:15271
|
| decreased single-positive T cell number
|
J:15271
|
| decreased thymocyte number
|
J:15271
|
Cd247tm1Tks/Cd247tm1Tks
(B6.129P2-Cd247tm1Tks)
|
abnormal NK cell morphology
|
J:66403
|
| decreased NK T cell number
|
J:28282
|
Cd247tm2.1Lov/Cd247tm2.1Lov
(Not Specified)
|
abnormal gamma-delta T cell differentiation
|
J:192915
|
| abnormal NK T cell morphology
|
J:192915
|
| abnormal T cell differentiation
|
J:192915
|
| abnormal T-helper 1 cell differentiation
|
J:192915
|
| decreased CD4-positive, alpha-beta T cell number
|
J:192915
|
| decreased CD8-positive, alpha-beta T cell number
|
J:192915
|
| decreased thymocyte number
|
J:192915
|
| increased regulatory T cell number
|
J:192915
|
Cd247tm2.1Lov/Cd247tm2.1Lov
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:192915
|
Cd274tm1.1Lex/Cd274tm1.1Lex
(involves: 129S5/SvEvBrd)
|
decreased CD8-positive, alpha-beta T cell number
|
J:126829
|
Cd274tm1Lpc/Cd274tm1Lpc
(B6.129S-Cd274tm1Lpc)
|
increased activated T cell number
|
J:89781
|
| increased CD8-positive, alpha-beta T cell number
|
J:89781
|
Cd274tm1Lpc/Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell morphology
|
J:136330
|
| abnormal T-helper 1 cell differentiation
|
J:162539
|
| decreased T helper 1 cell number
|
J:162539
|
| increased CD8-positive, alpha-beta T cell number
|
J:152305
|
| increased T cell number
|
J:142815
|
Cd274tm1Lpc/Cd274tm1Lpc
(C.129S-Cd274tm1Lpc)
|
decreased germinal center B cell number
|
J:165841
|
| decreased plasma cell number
|
J:165841
|
| decreased T-helper 17 cell number
|
J:165841
|
Cd274tm1Shr/Cd274tm1Shr
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:91480
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:91480
|
Cdc7tm1.1(KOMP)Vlcg/Cdc7+
(C57BL/6N-Cdc7tm1.1(KOMP)Vlcg/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Cdh10tm2b(KOMP)Wtsi/Cdh10tm2b(KOMP)Wtsi
(C57BL/6N-Cdh10tm2b(KOMP)Wtsi/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Cdh17tm1Ohn/Cdh17tm1Ohn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:96738
|
| decreased B-1a cell number
|
J:96738
|
| decreased germinal center B cell number
|
J:96738
|
| decreased marginal zone B cell number
|
J:96738
|
| decreased mature B cell number
|
J:96738
|
| increased pre-B cell number
|
J:96738
|
| increased pro-B cell number
|
J:96738
|
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased single-positive T cell number
|
J:92529
|
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae)
|
abnormal lymphopoiesis
|
J:144975
|
| abnormal T cell differentiation
|
J:144975
|
| decreased CD8-positive, alpha-beta T cell number
|
J:144975
|
| decreased double-negative T cell number
|
J:144975
|
| decreased double-positive T cell number
|
J:144975
|
| decreased thymocyte number
|
J:144975
|
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae * C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:174697
|
| decreased DN2 thymocyte number
|
J:174697
|
| decreased double-positive T cell number
|
J:174697
|
| increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased CD8-positive, alpha-beta T cell number
|
J:174697
|
| increased DN3 thymocyte number
|
J:174697
|
Cdk6tm1Phin/Cdk6tm1Phin
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:144975
|
Cdk6tm2.1Phin/Cdk6tm2.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
| decreased DN1 thymic pro-T cell number
|
J:174697
|
| decreased DN2 thymocyte number
|
J:174697
|
| decreased DN4 thymocyte number
|
J:174697
|
| decreased double-positive T cell number
|
J:174697
|
| decreased thymocyte number
|
J:174697
|
| increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased CD8-positive, alpha-beta T cell number
|
J:174697
|
| increased DN3 thymocyte number
|
J:174697
|
| increased double-negative T cell number
|
J:174697
|
Cdk6tm2.1Phin/Cdk6tm2.1Phin
Il2ratm1Dw/Il2ratm1Dw
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased CD8-positive, alpha-beta T cell number
|
J:174697
|
Cdk6tm3.1Phin/Cdk6tm3.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
| increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased DN1 thymic pro-T cell number
|
J:174697
|
| increased thymocyte number
|
J:174697
|
Cdk6tm4.1Phin/Cdk6tm4.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
| decreased DN1 thymic pro-T cell number
|
J:174697
|
| decreased DN2 thymocyte number
|
J:174697
|
| decreased DN4 thymocyte number
|
J:174697
|
| decreased double-positive T cell number
|
J:174697
|
| decreased thymocyte number
|
J:174697
|
| increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased CD8-positive, alpha-beta T cell number
|
J:174697
|
| increased DN3 thymocyte number
|
J:174697
|
Cdkn1atm1Led/Cdkn1atm1Led
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))
|
abnormal lymphopoiesis
|
J:76041
|
| decreased lymphocyte cell number
|
J:76041
|
Cdkn1atm1Led/Cdkn1atm1Led
Zbtb17tm1Cksn/Zbtb17tm1Cksn
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Zbtb17tm1Cksn Cdkn1atm1Led Commd10Tg(Vav1-icre)A2Kio)
|
arrested T cell differentiation
|
J:170508
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6;129S2-Cdkn1atm1Tyj/J)
|
decreased monocyte cell number
|
J:108569
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:60292
|
| increased B cell number
|
J:60292
|
| increased memory T cell number
|
J:60292
|
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL/6)
|
increased thymocyte number
|
J:33401
|
Cdkn1btm1Kin/Cdkn1btm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell number
|
J:33402
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Nop53tm2.1Asuz/Nop53tm2.1Asuz
Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:241062
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:71394
|
| increased CD8-positive, alpha-beta T cell number
|
J:71394
|
| increased double-positive T cell number
|
J:71394
|
Cdkn2btm1Bbd/Cdkn2btm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
abnormal lymphocyte morphology
|
J:63299
|
| increased mature B cell number
|
J:63299
|
Cdkn2btm1Bbd/Cdkn2btm1Bbd
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
abnormal Langerhans cell morphology
|
J:63299
|
| abnormal lymphocyte morphology
|
J:63299
|
Cdkn2btm1Wff/Cdkn2btm1Wff
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
increased monocyte cell number
|
J:163498
|
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(involves: 129/Sv * C57BL/6 * DBA/2)
|
increased B cell number
|
J:50053
|
| increased T cell number
|
J:50053
|
Cds2Gt(OST184358)Lex/Cds2+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:103485
|
| increased T cell number
|
J:103485
|
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased monocyte cell number
|
J:136134
|
Cebpbtm1.1Acle/Cebpbtm1.1Acle
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal osteoclast differentiation
|
J:150006
|
| abnormal osteoclast morphology
|
J:150006
|
Cebpbtm1Pfj/Cebpbtm1Pfj
(involves: 129S1/Sv * C57BL/6)
|
abnormal osteoclast differentiation
|
J:150006
|
| abnormal osteoclast morphology
|
J:150006
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
abnormal plasma cell morphology
|
J:25215
|
Cebpbtm2.1Acle/Cebpbtm2.1Acle
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal osteoclast morphology
|
J:155795
|
| decreased osteoclast cell number
|
J:155795
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
increased plasma cell number
|
J:76024
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac)
|
increased plasma cell number
|
J:76024
|
Cemiptm1.1Okda/Cemiptm1.1Okda
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased osteoclast cell number
|
J:241936
|
Cenpjtm1a(EUCOMM)Wtsi/Cenpjtm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cenpjtm1a(EUCOMM)Wtsi/Wtsi)
|
increased CD8-positive, alpha-beta T cell number
|
J:194085
|
| increased T cell number
|
J:194085
|
Cers6tm1.1Kwi/Cers6tm1.1Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
microgliosis
|
J:201327
|
Cflartm1.1Pope/Cflartm1.2Pope
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
abnormal B cell number
|
J:167430
|
| abnormal CD4-positive, alpha-beta T cell number
|
J:167430
|
| abnormal CD8-positive, alpha-beta T cell number
|
J:167430
|
| abnormal lymphocyte cell number
|
J:167430
|
| decreased macrophage cell number
|
J:167430
|
| increased CD8-positive, alpha-beta T cell number
|
J:167430
|
| increased monocyte cell number
|
J:167430
|
Cflartm1Ywh/Cflartm1Ywh
Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased single-positive T cell number
|
J:100558
|
Cftrtm2Mrc/Cftrtm2Mrc
(B6.129S6-Cftrtm2Mrc)
|
abnormal alveolar macrophage morphology
|
J:112450
|
Cgrrf1tm1b(KOMP)Wtsi/Cgrrf1tm1b(KOMP)Wtsi
(C57BL/6N-Cgrrf1tm1b(KOMP)Wtsi/Wtsi)
|
increased CD5-positive gamma-delta T cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased lymphocyte cell number
|
J:146176
|
| increased CD4-positive, alpha-beta T cell number
|
J:146176
|
Chd4tm1.1Kge/Chd4tm1.1Kge
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:109547
|
| arrested T cell differentiation
|
J:109547
|
| decreased double-positive T cell number
|
J:109547
|
| increased CD8-positive, alpha-beta T cell number
|
J:109547
|
Chd4tm1.2Kge/Chd4tm1.2Kge
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal T cell differentiation
|
J:109547
|
| decreased double-positive T cell number
|
J:109547
|
| increased CD8-positive, alpha-beta T cell number
|
J:109547
|
| increased double-negative T cell number
|
J:109547
|
Chd7tm2a(EUCOMM)Wtsi/Chd7+
(involves: 129S5/SvEvBrd * C57BL/6N)
|
decreased monocyte cell number
|
J:330596
|
| increased NK T cell number
|
J:330596
|
Chd7Whi/Chd7+
(C3HeB/FeJ-Chd7Whi)
|
decreased monocyte cell number
|
J:330596
|
| increased NK T cell number
|
J:330596
|
Chd9tm1a(EUCOMM)Wtsi/Chd9tm1a(EUCOMM)Wtsi
(C57BL/6N-Chd9tm1a(EUCOMM)Wtsi/Wtsi)
|
increased Langerhans cell number
|
J:211773
|
Chek2tm1Mak/Chek2+
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:103922
|
| decreased double-negative T cell number
|
J:103922
|
| decreased macrophage cell number
|
J:103922
|
Chi3l1tm1Eli/Chi3l1tm1Eli
(B6.Cg-Chi3l1tm1Eli)
|
abnormal macrophage morphology
|
J:148490
|
| decreased T-helper 2 cell number
|
J:148490
|
Chi3l1tm1Eli/Chi3l1tm1Eli
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
(involves: C57BL/6 * CBA)
|
abnormal T-helper 2 cell number
|
J:148490
|
Chia1tm1.1Lof/Chia1tm1.1Lof
(C57BL/6-Chia1tm1.1Lof)
|
increased lymphocyte cell number
|
J:257728
|
Chordc1em1(IMPC)Mbp/Chordc1+
(C57BL/6N-Chordc1em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Chrna5em1(IMPC)H/Chrna5em1(IMPC)H
(C57BL/6N-Chrna5em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Chrna7tm1Bay/Chrna7tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased lymphocyte cell number
|
J:140280
|
Chrna10em1(IMPC)Mbp/Chrna10em1(IMPC)Mbp
(C57BL/6NCrl-Chrna10em1(IMPC)Mbp/MbpMmucd)
|
increased monocyte cell number
|
J:211773
|
Chrnb2tm1Jpc/Chrnb2tm1Jpc
(B6.129P2-Chrnb2tm1Jpc)
|
decreased B cell number
|
J:112766
|
Chrnb2tm1Jpc/Chrnb2tm1Jpc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:103908
|
Chst1tm1(KOMP)Vlcg/Chst1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased B cell number
|
J:204813
|
| increased T cell number
|
J:204813
|
Chst3tm1Tmu/Chst3tm1Tmu
(involves: 129S2/SvPas * 129X1/SvJ)
|
decreased T cell number
|
J:73698
|
Chsy1skt/Chsy1skt
Pde6b+/Pde6b+
(mixed)
|
decreased macrophage cell number
|
J:286529
|
| microgliosis
|
J:286529
|
Chsy1skt/Chsy1tm1Lex
(mixed)
|
microgliosis
|
J:286529
|
Chsy1tm1Lex/Chsy1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
microgliosis
|
J:286529
|
Chuktm2Mka/Chuktm2Mka
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Chuktm2Mka Tg(Tnfsf13b)1Fma)
|
decreased marginal zone B cell number
|
J:113556
|
| increased transitional stage B cell number
|
J:113556
|
Chuktm2Yhu/Chuktm2Yhu
Tg(Lor-CHUK)8Yhu/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:197037
|
| increased CD8-positive, alpha-beta T cell number
|
J:197037
|
| increased macrophage cell number
|
J:197037
|
Churc1tm1b(EUCOMM)Wtsi/Churc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Churc1tm1b(EUCOMM)Wtsi/Wtsi)
|
increased effector memory T-helper cell number
|
J:211773
|
Cib1tm1b(EUCOMM)Hmgu/Cib1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cib1tm1b(EUCOMM)Hmgu/Bay)
|
increased large unstained cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Cigs2tm1.1Anse/Cigs2tm1.1Anse
(involves: BALB/cJ * C57BL/6)
|
abnormal class switch recombination
|
J:181313
|
Ciitam1Btlr/Ciitam1Btlr
(C57BL/6J-Ciitam1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:221483
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221483
|
Ciitatm1.1Dim/Ciitatm1.1Dim
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:51885
|
Ciitatm1Ccum/Ciitatm1Ccum
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal T cell differentiation
|
J:64283
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31601
|
| increased CD4-positive, alpha-beta T cell number
|
J:64283
|
| increased CD8-positive, alpha-beta T cell number
|
J:64283
|
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum)
|
abnormal T cell differentiation
|
J:106081
|
| decreased CD4-positive, alpha-beta T cell number
|
J:106081
|
| increased CD8-positive, alpha-beta T cell number
|
J:106081
|
Ciitatm1Jpyt/Ciitatm1Jpyt
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal T cell subpopulation ratio
|
J:57100
|
| decreased CD4-positive, alpha-beta T cell number
|
J:57100
|
| increased CD8-positive, alpha-beta T cell number
|
J:57100
|
| increased double-positive T cell number
|
J:57100
|
Ciitatm1Wrth/Ciitatm1Wrth
(involves: 129P2/OlaHsd * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:233241
|
| increased osteoclast cell number
|
J:233241
|
Ciitatm2Wrth/Ciitatm2Wrth
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92170
|
Cimap1bem1(IMPC)Ccpcz/Cimap1bem1(IMPC)Ccpcz
(C57BL/6NCrl-Cimap1bem1(IMPC)Ccpcz/Ccpcz)
|
decreased NK T cell number
|
J:211773
|
Cimap2Retro/Cimap2+
(involves: C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:223336
|
Cimap2Retro/Cimap2Retro
(involves: C57BL/6J)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:223336
|
| increased activated T cell number
|
J:223336
|
| increased CD8-positive, alpha-beta T cell number
|
J:223336
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:223336
|
Cimap2tm1a(KOMP)Wtsi/Cimap2+
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:223336
|
Cishtm1.1Cdon/Cishtm1.1Cdon
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T-helper 2 cell differentiation
|
J:204829
|
Cishtm1.2Cdon/Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
| abnormal T-helper 2 cell differentiation
|
J:204829
|
| increased lymphocyte cell number
|
J:204829
|
Ciz1Gt(IST13830B6)Tigm/Ciz1Gt(IST13830B6)Tigm
(B6J.B6N-Ciz1Gt(IST13830B6)Tigm)
|
increased monocyte cell number
|
J:231433
|
Ckbtm1.1(KOMP)Wtsi/Ckbtm1.1(KOMP)Wtsi
(C57BL/6N-Ckbtm1.1(KOMP)Wtsi/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
Cks1btm1Sir/Cks1btm1Sir
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL)
|
decreased lymphocyte cell number
|
J:121564
|
Clcn1em1(IMPC)Mbp/Clcn1em1(IMPC)Mbp
(C57BL/6NCrl-Clcn1em1(IMPC)Mbp/MbpMmucd)
|
decreased monocyte cell number
|
J:211773
|
Clcn7tm1.1Lex/Clcn7tm1.1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
microgliosis
|
J:186049
|
Clcn7tm1.1Mawa/Clcn7+
(involves: C57BL/6J * C57BL/6N * CD-1)
|
increased osteoclast cell number
|
J:254787
|
Clcn7tm1.1Teti/Clcn7+
(involves: 129S2/SvPas * C57BL/6)
|
increased osteoclast cell number
|
J:203761
|
Clcn7tm1Tjj/Clcn7tm1Tjj
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast morphology
|
J:67273
|
Clcn7tm2Tjj/Clcn7tm2Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast morphology
|
J:67273,
J:217031
|
Clcn7tm2Tjj/Clcn7tm2Tjj
(involves: 129S1/Sv * 129X1/SvJ)
|
microgliosis
|
J:155176
|
Clcn7tm3.1Tjj/Clcn7tm3.1Tjj
Emx1tm1.1(cre)Ito/Emx1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
microgliosis
|
J:155176
|
Clcn7tm4.1Tjj/Clcn7tm4.1Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast morphology
|
J:160702,
J:217031
|
Clcn7tm5.1Tjj/Clcn7tm5.1Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast morphology
|
J:217031
|
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Cldn18tm1Lex/Cldn18tm1Lex
(involves: 129S5/SvEvBrd)
|
abnormal osteoclast differentiation
|
J:195931
|
| increased osteoclast cell number
|
J:195931
|
Clec1btm1Lex/Clec1btm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal mononuclear cell morphology
|
J:161922
|
Clec2dtm1.1Mgil/Clec2dtm1.1Mgil
(C57BL/6-Clec2dtm1.1Mgil)
|
abnormal osteoclast differentiation
|
J:143122
|
| increased osteoclast cell number
|
J:143122
|
Clec4a2tm1Yiw/Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased single-positive T cell number
|
J:217720
|
Clec4dtm1.1Cfg/Clec4dtm1.1Cfg
(involves: C57BL/6)
|
increased B cell number
|
J:217719
|
| increased mature B cell number
|
J:217719
|
Clec4etm1.1Cfg/Clec4etm1.1Cfg
(B6.Cg-Clec4etm1.1Cfg)
|
decreased lymphocyte cell number
|
J:136334
|
| decreased monocyte cell number
|
J:136334
|
Clec4gtm1.1Cfg/Clec4gtm1.1Cfg
(involves: C57BL/6)
|
increased lymphocyte cell number
|
J:217719
|
| increased monocyte cell number
|
J:217719
|
Clec4gtm1.1Fhe/Clec4gtm1.1Fhe
(B6.129-Clec4gtm1.1Fhe)
|
increased activated T cell number
|
J:200968
|
| increased CD4-positive, alpha-beta T cell number
|
J:200968
|
| increased CD8-positive, alpha-beta T cell number
|
J:200968,
J:194891
|
Clec4ntm1Yiw/Clec4ntm1Yiw
(B6.129P2-Clec4ntm1Yiw)
|
abnormal CD4-positive T cell differentiation
|
J:160680
|
Clec10atm1Hed/Clec10a+
St3gal1tm1Jxm/St3gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:78035
|
Clec10atm1Hed/Clec10atm1Hed
St3gal1tm1Jxm/St3gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:78035
|
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6)
|
decreased monocyte cell number
|
J:160186
|
Clnktm1Rygo/Clnktm1Rygo
Lcp2tm1Geha/Lcp2tm1Geha
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c)
|
increased NK cell number
|
J:131621
|
Clockem1(IMPC)Ccpcz/Clockem1(IMPC)Ccpcz
(C57BL/6NCrl-Clockem1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
Clp1tm1.1Pngr/Clp1tm1.1Pngr
(CBA.Cg-Clp1tm1.1Pngr)
|
abnormal microglial cell morphology
|
J:209564
|
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased gamma-delta T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| increased B cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased Ly6C high monocyte number
|
J:211773
|
| increased Ly6C low monocyte number
|
J:211773
|
| increased mature B cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Clptm1em1(IMPC)Tcp/Clptm1+
(C57BL/6NCrl-Clptm1em1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Clptm1ltm1d(EUCOMM)Wtsi/Clptm1l+
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)
|
abnormal class switch recombination
|
J:265892
|
Clptq1NZB/BlNJ/Clptq1NZB/BlNJ
(B6.NZB-(D4Mit193-D4Mit33))
|
increased B-1a cell number
|
J:143646
|
| increased NK T cell number
|
J:143646
|
Clspntm1(KOMP)Vlcg/Clspn+
(C57BL/6N-Clspntm1(KOMP)Vlcg)
|
increased B cell number
|
J:332163
|
Cltatm1.2Fmb/Cltatm1.2Fmb
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:235591
|
| decreased germinal center B cell number
|
J:235591
|
Cluhem1(IMPC)Ccpcz/Cluh+
(C57BL/6N-Cluhem1(IMPC)Ccpcz/Ccpcz)
|
increased Ly6C-positive mature NK cell number
|
J:211773
|
Cmahtm1Avrk/Cmahtm1Avrk
Dmdmdx/Dmdmdx
(involves: 129X1/SvJ * C57BL/10ScSn)
|
increased macrophage cell number
|
J:164594
|
| increased monocyte cell number
|
J:164594
|
Cmahtm1Avrk/Cmahtm1Avrk
Dock2m1Hsd/Dock2m1Hsd
(B6NHsd.Cg-Dock2m1Hsd Cmahtm1Avrk)
|
decreased follicular B cell number
|
J:144035
|
| decreased marginal zone B cell number
|
J:144035
|
Cmahtm1Avrk/Cmahtm1Avrk
Dock2m1Hsd/Dock2m1Hsd
Siaetm1.2Avrk/Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd Cmahtm1Avrk)
|
decreased follicular B cell number
|
J:144035
|
| decreased marginal zone B cell number
|
J:144035
|
Cmklr1tm1Dgen/Cmklr1tm1Dgen
(B6.Cg-Cmklr1tm1Dgen)
|
abnormal alveolar macrophage morphology
|
J:157190
|
Cmtm4tm1d(EUCOMM)Wtsi/Cmtm4tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:333836
|
| increased B cell number
|
J:333836
|
Cmtm5tm1c(KOMP)Wtsi/Cmtm5tm1c(KOMP)Wtsi
Cnptm1(cre)Kan/Cnp+
(B6.Cg-Cnptm1(cre)Kan Cmtm5tm1c(KOMP)Wtsi)
|
microgliosis
|
J:327261
|
Cmtm7tm2a(EUCOMM)Hmgu/Cmtm7+
Rag1tm1Fwa/Rag1tm1Fwa
(chimera involves: C57BL/6 * C57BL/6N)
|
abnormal B-1a B cell morphology
|
J:207033
|
| decreased B-1a cell number
|
J:207033
|
| decreased plasma cell number
|
J:207033
|
Cnn2tm1.2Jin/Cnn2tm1.2Jin
(B6.129X1-Cnn2tm1.2Jin)
|
decreased monocyte cell number
|
J:141867
|
| increased macrophage cell number
|
J:141867
|
Cnn2tm1Jin/Cnn2tm1Jin
(B6.129X1-Cnn2tm1Jin)
|
decreased monocyte cell number
|
J:141867
|
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya)
|
abnormal osteoclast differentiation
|
J:206802
|
| increased osteoclast cell number
|
J:206802
|
Cnot4tm1b(EUCOMM)Wtsi/Cnot4+
(C57BL/6N-Cnot4tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased KLRG1-positive NK cell number
|
J:211773
|
Cnpy2em1(IMPC)Wtsi/Cnpy2+
(C57BL/6N-Cnpy2em1(IMPC)Wtsi/Wtsi)
|
increased effector memory T-helper cell number
|
J:211773
|
Cntftm1Mpin/Cntftm1Mpin
(involves: 129S2/SvPas)
|
abnormal microglial cell morphology
|
J:15313
|
Cog6tm1a(EUCOMM)Wtsi/Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased Ly6C-positive immature NK cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased marginal zone B cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased memory-marker gamma-delta T cell number
|
J:211773
|
| decreased memory-marker NK cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| decreased transitional stage T2 B cell number
|
J:211773
|
| increased B-2 B cell number
|
J:211773
|
| increased CD4-negative NK T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD5-positive gamma-delta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased follicular B cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased KLRG1+ CD4 alpha-beta T cell number
|
J:211773
|
| increased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased KLRG1-positive T-helper cell number
|
J:211773
|
| increased Ly6C high monocyte number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
| increased plasma cell number
|
J:211773
|
Col1a1tm1(CAG-Ezh2*)Meln/Col1a1+
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased germinal center B cell number
|
J:199122
|
Col1a1tm1(CAG-Mir22)Ppp/Col1a1tm1(CAG-Mir22)Ppp
Tg(Mx1-cre)1Cgn/0
(Not Specified)
|
increased myeloid dendritic cell number
|
J:199366
|
Col1a1tm1(tetO-Fos)Wag/Col1a1+
Tg(KRT5-rtTA)T2D6Sgkd/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:201145
|
Col1a1tm1(tetO-GFP/RNAi:Rad21)Iaai/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:229031
|
Col1a1tm1(tetO-Irf4)Sing/Col1a1tm1(tetO-Irf4)Sing
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
Irf4tm1Mak/Irf4+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
| abnormal plasma cell differentiation
|
J:203903
|
Col1a1tm1(tetO-Irf4)Sing/Col1a1tm1(tetO-Irf4)Sing
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
| abnormal plasma cell differentiation
|
J:203903
|
Col1a1tm1(tetO-RNAi:Rps19)Karl/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:179085
|
Col1a1tm1(tetO-RNAi:Rps19)Karl/Col1a1tm1(tetO-RNAi:Rps19)Karl
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:179085
|
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
abnormal osteoclast morphology
|
J:211215
|
Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:229031
|
Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai/Col1a1tm3(tetO-GFP/RNAi:Stag2)Iaai
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:229031
|
Col1a1tm2(tetO-RNAi:Rps19)Karl/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:179085
|
Col1a1tm2(tetO-RNAi:Rps19)Karl/Col1a1tm2(tetO-RNAi:Rps19)Karl
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:179085
|
Col1a1tm3(tetO-GFP/RNAi:Stag2)Iaai/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:229031
|
Col1a1tm6(tetO-MSI2)Jae/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:163322
|
Col1a2tm1b(EUCOMM)Wtsi/Col1a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col1a2tm1b(EUCOMM)Wtsi/BayMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
Col3a1m1Btlr/Col3a1m1Btlr
(C57BL/6J-Col3a1m1Btlr)
|
increased alpha-beta T cell number
|
J:271973
|
| increased CD4-positive, alpha-beta T cell number
|
J:271973
|
| increased CD8-positive, alpha-beta T cell number
|
J:271973
|
Col4a3tm1b(EUCOMM)Wtsi/Col4a3tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a3tm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
|
increased large unstained cell number
|
J:211773
|
Col7a1em#Jtol/Col7a1em#Jtol
(involves: 129S4/SvJae * BALB/c * C57BL/Ka * NOD)
|
absent B cells
|
J:280214
|
| absent NK T cells
|
J:280214
|
| absent T cells
|
J:280214
|
Col10a1tm1.1Rpbh/Col10a1tm1.1Rpbh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased osteoclast cell number
|
J:154052
|
Col10a1tm1Bhr/Col10a1tm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased B cell number
|
J:62230
|
| decreased double-positive T cell number
|
J:62230
|
| decreased thymocyte number
|
J:62230
|
| increased CD4-positive, alpha-beta T cell number
|
J:62230
|
| increased double-negative T cell number
|
J:62230
|
| increased single-positive T cell number
|
J:62230
|
Col10a1tm1Ksec/Col10a1tm1Ksec
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:193886
|
| increased B cell number
|
J:193886
|
| increased T-helper cell number
|
J:193886
|
Col17a1tm1Tiin/Col17a1tm1Tiin
(involves: C57BL/6)
|
increased monocyte cell number
|
J:220622
|
Colgalt2tm1.1Hwei/Colgalt2tm1.1Hwei
(involves: C57BL/6J)
|
abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:310468
|
| abnormal regulatory T cell morphology
|
J:310468
|
Commd9tm1b(KOMP)Wtsi/Commd9+
(C57BL/6N-Commd9tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
Commd10Tg(Vav1-icre)A2Kio/0
Map3k7tm1.1Arte/Map3k7tm1.1Arte
(involves: C57BL/10 * C57BL/6J * C57BL/6NTac * CBA/Ca)
|
decreased macrophage cell number
|
J:332172
|
| increased B cell number
|
J:332172
|
| increased lymphocyte cell number
|
J:332172
|
Comttm1Kara/Comttm1Kara
(involves: 129S4/SvJaeSor)
|
increased uterine NK cell number
|
J:137276
|
Copatm1.1Shum/Copa+
(B6(CBA)-Copatm1.1Shum)
|
abnormal B cell morphology
|
J:288425
|
| decreased double-positive T cell number
|
J:288425
|
| increased effector memory T-helper cell number
|
J:288425
|
| increased single-positive T cell number
|
J:288425
|
Cops5tm1Rpar/Cops5tm1Rpar
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased double-positive T cell number
|
J:132114
|
| decreased single-positive T cell number
|
J:132114
|
| decreased thymocyte number
|
J:132114
|
Cops5tm1Rpar/Cops5tm1Rpar
Tg(Lck-cre)548Jxm/0
Tg(TcraTcrb)425Cbn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased thymocyte number
|
J:132114
|
Cops5tm1Rpar/Cops5tm1Rpar
Tg(Lck-cre)548Jxm/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129 * C57BL/6 * CBA * SJL)
|
decreased thymocyte number
|
J:132114
|
Cops7atm1b(KOMP)Mbp/Cops7atm1b(KOMP)Mbp
(C57BL/6N-Cops7atm1b(KOMP)Mbp/Ucd)
|
increased monocyte cell number
|
J:211773
|
Cops8tm1Nwe/Cops8tm1.1Nwe
Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * C57BL/6 * DBA/2)
|
decreased T cell number
|
J:126339
|
Coro1akoy/Coro1akoy
(C57BL/6-Coro1akoy)
|
decreased CD4-positive, alpha-beta T cell number
|
J:141431
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141431
|
| decreased thymocyte number
|
J:141431
|
Coro1aptcd/Coro1aptcd
(B6.CTS-Coro1aptcd)
|
abnormal effector T cell morphology
|
J:141431
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141431
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141431
|
| increased thymocyte number
|
J:141431
|
Coro1aptcd/Coro1atm1Achn
(B6.Cg-Coro1aptcd Coro1atm1Achn)
|
abnormal effector T cell morphology
|
J:141431
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141431
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141431
|
| increased thymocyte number
|
J:141431
|
Coro1atm1Achn/Coro1atm1Achn
(involves: 129X1/SvJ * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:111593
|
| decreased CD8-positive, alpha-beta T cell number
|
J:111593
|
| decreased memory T cell number
|
J:111593
|
| decreased T cell number
|
J:111593
|
Coro1atm1Achn/Coro1atm1Achn
(B6.129X1-Coro1atm1Achn)
|
decreased thymocyte number
|
J:141431
|
Coro1atm1Jpie/Coro1atm1Jpie
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:133258
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133258
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133258
|
| decreased monocyte cell number
|
J:133258
|
Cox10tm1Ctm/Cox10tm1Ctm
Slc6a3tm1.1(cre)Bkmn/?
(B6.Cg-Cox10tm1Ctm Slc6a3tm1.1(cre)Bkmn)
|
microgliosis
|
J:231810
|
Cptm1Yos/Cptm1Yos
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal Kupffer cell morphology
|
J:79916
|
Cpa3tm3(icre)Hrr/Cpa3+
Gt(ROSA)26Sortm1Hjf/?
Notch1tm1Agt/Notch1tm1Agt
(involves: 129 * C57BL/6)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143731
|
Cpa3tm3(icre)Hrr/Cpa3+
Notch1tm1Agt/Notch1tm1Agt
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:143731
|
| abnormal B cell morphology
|
J:143731
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:143731
|
| decreased double-negative T cell number
|
J:143731
|
| decreased double-positive T cell number
|
J:143731
|
| increased single-positive T cell number
|
J:143731
|
Cpgi5563tm1.1(NCC)Wcs/Cpgi5563tm1.1(NCC)Wcs
(C57BL/6N-Cpgi5563tm1.1(NCC)Wcs/Wtsi)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:277622
|
| decreased CD8-positive, alpha-beta T cell number
|
J:277622
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:277622
|
| decreased gamma-delta T cell number
|
J:277622
|
Cpmem1(IMPC)Ccpcz/Cpmem1(IMPC)Ccpcz
(C57BL/6NCrl-Cpmem1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
Cps1em1(IMPC)H/Cps1+
(C57BL/6NTac-Cps1em1(IMPC)H/H)
|
increased lymphocyte cell number
|
J:211773
|
Cpxm1em1(IMPC)Tcp/Cpxm1em1(IMPC)Tcp
(C57BL/6N-Cpxm1em1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Cr1ltm1.1Song/Cr1ltm1.1Song
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:146538
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146538
|
| decreased lymphocyte cell number
|
J:146538
|
| increased B cell number
|
J:146538
|
Cr1ltm1.1Song/Cr1ltm1.1Song
Tg(Lck-cre)548Jxm/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:146538
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146538
|
| decreased lymphocyte cell number
|
J:146538
|
| increased B cell number
|
J:146538
|
Cr1ltm1.1Song/Cr1ltm1.1Song
Vsig4tm1Gne/Vsig4tm1Gne
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6N * DBA/2 * SJL)
|
decreased lymphocyte cell number
|
J:146538
|
Cr2tm1.1Jhws/Cr2tm1.1Jhws
(Not Specified)
|
decreased B-1a cell number
|
J:205353
|
Cr2tm1Crr/Cr2tm1Crr
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B-1 B cell morphology
|
J:31942
|
| decreased B cell number
|
J:31942
|
| decreased B-1a cell number
|
J:69452
|
Cr2tm1Crr/Cr2tm1Crr
(involves: 129S7/SvEvBrd)
|
decreased follicular B cell number
|
J:69477
|
| increased marginal zone B cell number
|
J:69477
|
Cr2tm1Hmo/Cr2tm1Hmo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:151991
|
| abnormal memory B cell differentiation
|
J:151991
|
Cr2tm2.1(HLA-A)Crr/Cr2tm2.1(HLA-A)Crr
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:151991
|
| abnormal memory B cell differentiation
|
J:151991
|
Crabp1tm1b(EUCOMM)Wtsi/Crabp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Crabp1tm1b(EUCOMM)Wtsi/Tcp)
|
increased monocyte cell number
|
J:211773
|
Crbntm1.1Ble/Crbntm1.1Ble
(involves: C57BL/6)
|
decreased B cell number
|
J:267091
|
| decreased T cell number
|
J:267091
|
Crebbptm1Dli/Crebbp+
(involves: 129S6/SvEvTac * C57BL/6)
|
absent pre-B cells
|
J:60630
|
| decreased B cell number
|
J:60630
|
| decreased lymphocyte cell number
|
J:191503
|
Crebbptm1Jvd/Crebbptm1Jvd
Ep300tm2Pkb/Ep300tm2Pkb
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell number
|
J:105505
|
| decreased double-positive T cell number
|
J:105505
|
| increased double-negative T cell number
|
J:105505
|
Crebbptm1Jvd/Crebbptm1Jvd
Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:105505
|
| decreased T cell number
|
J:105505
|
| decreased thymocyte number
|
J:105505
|
| increased double-positive T cell number
|
J:105505
|
Crebbptm1Jvd/Crebbptm1Jvd
Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * FVB)
|
decreased double-positive T cell number
|
J:88323
|
| increased CD8-positive, alpha-beta T cell number
|
J:88323
|
Crebbptm1Pkb/Crebbptm1Pkb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:98329
|
Crip3tm1Mjb/Crip3tm1Mjb
(either: (involves: 129S/Sv) or (involves: 129S/Sv * C57BL/6))
|
decreased thymocyte number
|
J:72942
|
Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: 129 * C57BL/6)
|
abnormal lymphopoiesis
|
J:108209
|
| decreased B cell number
|
J:108209
|
| decreased single-positive T cell number
|
J:108209
|
Crppaem1(IMPC)H/Crppa+
(C57BL/6NTac-Crppaem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Crtamtm1Achn/Crtamtm1Achn
(involves: 129 * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:145314
|
| increased CD8-positive, alpha-beta T cell number
|
J:145314
|
Crxem1(IMPC)Ccpcz/Crxem1(IMPC)Ccpcz
(C57BL/6N-Crxem1(IMPC)Ccpcz/Ccpcz)
|
increased NK cell number
|
J:211773
|
Csf1op/Csf1op
(C57BL/6J-Csf1op)
|
abnormal osteoclast morphology
|
J:5634
|
| decreased macrophage cell number
|
J:110981
|
| decreased osteoclast cell number
|
J:5634
|
Csf1op/Csf1op
(B6C3Fe a/a-Csf1op/J)
|
abnormal Kupffer cell morphology
|
J:26978
|
| abnormal Langerhans cell morphology
|
J:112594
|
| abnormal microglial cell morphology
|
J:49613
|
| abnormal osteoclast differentiation
|
J:19549,
J:4732
|
| abnormal osteoclast morphology
|
J:26978
|
| abnormal perivascular macrophage morphology
|
J:49613
|
| absent Langerhans cell
|
J:112594
|
| decreased macrophage cell number
|
J:26978,
J:104139
|
| decreased monocyte cell number
|
J:104139
|
| decreased osteoclast cell number
|
J:73663
|
Csf1op/Csf1op
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal osteoclast cell number
|
J:33189
|
| abnormal osteoclast differentiation
|
J:38039
|
| decreased osteoclast cell number
|
J:33189
|
Csf1op/Csf1op
(B6;C3Fe a/a-Csf1op/J)
|
abnormal microglial cell morphology
|
J:170081
|
| decreased macrophage cell number
|
J:30863,
J:147697
|
Csf1tm1.2Sabw/Csf1tm1.2Sabw
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal Kupffer cell morphology
|
J:180199
|
| decreased B cell number
|
J:180199
|
| decreased lymphocyte cell number
|
J:180199
|
| decreased macrophage cell number
|
J:180199
|
| decreased monocyte cell number
|
J:180199
|
| decreased osteoclast cell number
|
J:180199
|
| increased T cell number
|
J:180199
|
Csf1rtm1Ers/Csf1r+
(B6.129X1-Csf1rtm1Ers)
|
microgliosis
|
J:219294
|
Csf1rtm1Ers/Csf1rtm1Ers
(involves: 129X1/SvJ * C3Heb/FeJ * C57BL/6J)
|
abnormal osteoclast differentiation
|
J:73663
|
| decreased Langerhans cell number
|
J:73663
|
| decreased lymphocyte cell number
|
J:73663
|
| decreased macrophage cell number
|
J:73663
|
| decreased monocyte cell number
|
J:73663
|
Csf1rtm1Ers/Csf1rtm1Ers
(FVB.129X1-Csf1rtm1Ers)
|
abnormal macrophage differentiation
|
J:112594
|
| abnormal osteoclast morphology
|
J:111489
|
| absent Langerhans cell
|
J:112594
|
Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal alveolar macrophage morphology
|
J:18747
|
Csf2tm1Mlg/Csf2tm1Mlg
(involves: 129S2/SvPas)
|
abnormal alveolar macrophage morphology
|
J:17978
|
Csf2raem1Szut/Csf2raem1Szut
(C57BL/6-Csf2raem1Szut)
|
abnormal alveolar macrophage morphology
|
J:322934
|
| increased lymphocyte cell number
|
J:322934
|
Csf3em1(IMPC)H/Csf3em1(IMPC)H
(C57BL/6NTac-Csf3em1(IMPC)H/H)
|
increased lymphocyte cell number
|
J:211773
|
Csf3tm1Ard/Csf3tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased monocyte cell number
|
J:20400
|
Csf3rtm1Link/Csf3rtm1Link
(involves: 129X1/SvJ * NIH Black Swiss)
|
abnormal monocyte morphology
|
J:37618
|
| decreased monocyte cell number
|
J:37618
|
Csktm1Sor/Csk+
Ptprcltng/Ptprctm1Mak
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
Csktm1Tara/Csktm1Tara
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CB20 * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:49654
|
| absent CD8-positive, alpha-beta T cells
|
J:49654
|
CsptC57BL/6/CsptC57BL/6
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
increased CD8-positive, alpha-beta T cell number
|
J:97046
|
CsptC57BL/6/CsptNOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
increased CD8-positive, alpha-beta T cell number
|
J:97046
|
Cstbtm1b(EUCOMM)Wtsi/Cstbtm1b(EUCOMM)Wtsi
(C57BL/6N-Cstbtm1b(EUCOMM)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Ctbstm1Tbec/Ctbstm1Tbec
(involves: 129S2/SvPas * C57BL/6N)
|
abnormal Kupffer cell morphology
|
J:185162
|
Ctcftm2Gal/Ctcf+
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:143271
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143271
|
Ctcftm2Gal/Ctcftm2Gal
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * C57BL/10)
|
decreased double-positive T cell number
|
J:143271
|
Ctcftm2Gal/Ctcftm2Gal
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:143271
|
| abnormal T cell morphology
|
J:143271
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143271
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143271
|
| decreased double-positive T cell number
|
J:143271
|
| decreased single-positive T cell number
|
J:143271
|
| increased double-negative T cell number
|
J:143271
|
| increased single-positive T cell number
|
J:143271
|
Ctcftm2Gal/Ctcftm2Gal
Tg(Lck-cre)1Cwi/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * DBA/2J)
|
abnormal T cell differentiation
|
J:143271
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143271
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143271
|
| decreased double-positive T cell number
|
J:143271
|
Ctcftm2Gal/Ctcftm2Gal
Tg(Lck-cre)1Cwi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:143271
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143271
|
| decreased double-positive T cell number
|
J:143271
|
| decreased T cell number
|
J:143271
|
| increased double-negative T cell number
|
J:143271
|
| increased single-positive T cell number
|
J:143271
|
Ctla4m1Btlr/Ctla4m1Btlr
(C57BL/6J-Ctla4m1Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:265263
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265263
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265263
|
Ctla4tm1All/Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased double-positive T cell number
|
J:42481
|
| decreased T cell number
|
J:42481
|
| increased double-negative T cell number
|
J:42481
|
Ctla4tm1All/Ctla4tm1All
Tg(TcrAND)53Hed/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:119845
|
| abnormal T cell subpopulation ratio
|
J:119845
|
| increased CD4-positive, alpha-beta T cell number
|
J:119845
|
| increased CD8-positive, alpha-beta T cell number
|
J:119845
|
Ctla4tm1All/Ctla4tm1All
Tg(TcraTcrb)8Rest/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:140448
|
| increased CD4-positive, alpha-beta T cell number
|
J:140448
|
Ctla4tm1Saka/Ctla4tm1Saka
Foxp3tm1(cre)Saka/Y
(involves: BALB/c)
|
increased regulatory T cell number
|
J:140085
|
Ctla4tm1Shr/Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal T cell differentiation
|
J:30393
|
| abnormal T cell morphology
|
J:30393
|
| decreased double-positive T cell number
|
J:30393
|
| increased double-negative T cell number
|
J:30393
|
| increased T cell number
|
J:30393
|
Ctnnb1tm1Mmt/Ctnnb1+
Ctsktm1(cre)Ska/Ctsk+
(involves: 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal osteoclast differentiation
|
J:178340
|
Ctnnb1tm1Mmt/Ctnnb1+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal osteoclast differentiation
|
J:178340
|
Ctnnb1tm1Mmt/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast differentiation
|
J:178340
|
| decreased osteoclast cell number
|
J:178340
|
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Col1a1-cre)1Kry/0
(involves: 129X1/SvJ * FVB)
|
decreased osteoclast cell number
|
J:98430
|
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129X1/SvJ * CD-1)
|
abnormal osteoclast differentiation
|
J:114494
|
Ctnnb1tm2Kem/Ctnnb1+
Ctsktm1(cre)Ska/Ctsk+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)
|
increased osteoclast cell number
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased osteoclast cell number
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased osteoclast cell number
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1+
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased osteoclast cell number
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ctsktm1(cre)Ska/Ctsk+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)
|
increased osteoclast cell number
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased osteoclast cell number
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased osteoclast cell number
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
Tg(tetO-HIST1H2BJ/GFP)47Efu/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
abnormal osteoclast differentiation
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Tg(Col1a1-cre)1Kry/0
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
increased osteoclast cell number
|
J:98430
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased osteoclast cell number
|
J:178340
|
Ctnnb1tm4Wbm/Ctnnb1tm4Wbm
Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd)
|
decreased gamma-delta T cell number
|
J:202499
|
Ctsatm2b(EUCOMM)Hmgu/Ctsatm2b(EUCOMM)Hmgu
(C57BL/6N-Ctsatm2b(EUCOMM)Hmgu/H)
|
increased monocyte cell number
|
J:211773
|
Ctsdtm1.1Thre/Ctsdtm1.1Thre
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * C57BL/6N * CBA * SJL)
|
decreased double-positive T cell number
|
J:227618
|
| microgliosis
|
J:227618
|
Ctsdtm1.1Thre/Ctsdtm1.1Thre
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased double-positive T cell number
|
J:227618
|
| microgliosis
|
J:227618
|
Ctsdtm1Cptr/Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))
|
abnormal microglial cell morphology
|
J:71688
|
| decreased double-positive T cell number
|
J:28201
|
| decreased lymphocyte cell number
|
J:28201
|
Ctsetm1Kjy/Ctsetm1Kjy
(involves: C57BL/6)
|
increased double-positive T cell number
|
J:108745
|
Ctsktm1(cre)Ska/Ctsk+
Esr1tm1Mma/Esr1tm1Mma
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
increased osteoclast cell number
|
J:127179
|
Ctsktm1(cre)Ska/Ctsk+
Plekhm1tm1.1Hzhao/Plekhm1tm1.1Hzhao
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal osteoclast morphology
|
J:236517
|
Ctsktm1.1Rbar/Ctsktm1.1Rbar
Tg(Itgam-cre)AJva/0
(involves: C57BL/6)
|
increased osteoclast cell number
|
J:194492
|
Ctsktm1.1Rbar/Ctsktm1.1Rbar
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal osteoclast differentiation
|
J:194492
|
| increased osteoclast cell number
|
J:194492
|
Ctsktm1Mbs/Ctsktm1Mbs
(B6.129-Ctsktm1Mbs)
|
increased osteoclast cell number
|
J:128098
|
Ctsktm1Vuo/Ctsktm1Vuo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal osteoclast morphology
|
J:95525
|
| increased osteoclast cell number
|
J:95525
|
Ctsktm1Ypl/Ctsktm1Ypl
(B6.129S4-Ctsktm1Ypl)
|
increased osteoclast cell number
|
J:117870
|
Ctsktm1Ypl/Ctsktm1Ypl
(129S4/SvJae-Ctsktm1Ypl)
|
increased osteoclast cell number
|
J:117870
|
Ctslm1Btlr/Ctslm1Btlr
(C57BL/6J-Ctslm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272869
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:272869
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272869
|
| abnormal T cell differentiation
|
J:272869
|
| decreased alpha-beta T cell number
|
J:272869
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272869
|
| increased alpha-beta T cell number
|
J:272869
|
| increased CD8-positive, alpha-beta T cell number
|
J:272869
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272869
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272869
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272869
|
Ctslnkt/Ctslnkt
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2))
|
decreased CD4-positive, alpha-beta T cell number
|
J:54856
|
Ctslnkt/Ctslnkt
(C.Cg-Ctslnkt)
|
decreased CD4-positive, alpha-beta T cell number
|
J:99009
|
| increased CD8-positive, alpha-beta T cell number
|
J:99009
|
Ctsltm1.2Thre/Ctsltm1.2Thre
(involves: C57BL/6 * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:216506
|
Ctsltm1Alpk/Ctsltm1Alpk
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased osteoclast cell number
|
J:99755
|
Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased regulatory T cell number
|
J:153355
|
Ctsltm1Cptr/Ctsltm1Cptr
(NOD.129P2-Ctsltm1Cptr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:153355
|
| increased regulatory T cell number
|
J:153355
|
Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:216506
|
Ctsmtm1(KOMP)Wtsi/Ctsmtm1(KOMP)Wtsi
(C57BL/6N-Ctsmtm1(KOMP)Wtsi/Nju)
|
increased monocyte cell number
|
J:211773
|
Ctsstm1Hap/Ctsstm1Hap
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
increased lymphocyte cell number
|
J:100854
|
| increased macrophage cell number
|
J:100854
|
Cttnbp2tm1b(KOMP)Wtsi/Cttnbp2tm1b(KOMP)Wtsi
(C57BL/6N-Cttnbp2tm1b(KOMP)Wtsi/Wtsi)
|
decreased transitional stage T1 B cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased plasma cell number
|
J:211773
|
Cul4a/Pcid2tm2Ktc/Cul4a/Pcid2tm2Ktc
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)
|
decreased lymphocyte cell number
|
J:138468
|
| decreased monocyte cell number
|
J:138468
|
Cul4a/Pcid2tm2Ktc/Cul4a/Pcid2tm2Ktc
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)
|
decreased lymphocyte cell number
|
J:138468
|
| decreased monocyte cell number
|
J:138468
|
Cux1tm1Rhsc/Cux1tm1Rhsc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal T cell differentiation
|
J:100055
|
| decreased B cell number
|
J:100055
|
| decreased double-positive T cell number
|
J:100055
|
| decreased thymocyte number
|
J:100055
|
Cx3cl1tm1Lira/Cx3cl1tm1Lira
(involves: C57BL/6)
|
decreased monocyte cell number
|
J:145036
|
Cx3cr1tm1Litt/Cx3cr1+
(B6.129P2-Cx3cr1tm1Litt)
|
microgliosis
|
J:110266
|
Cx3cr1tm1Litt/Cx3cr1+
Psen1tm1Mpm/Psen1tm1Mpm
Tg(APPSwe,tauP301L)1Lfa/0
Tg(Thy1-YFP)HJrs/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal microglial cell morphology
|
J:159680
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased monocyte cell number
|
J:145036
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
abnormal microglial cell morphology
|
J:265696
|
| decreased NK cell number
|
J:129712
|
| microgliosis
|
J:110266
|
Cx3cr1tm2.1(cre/ERT2)Litt/Cx3cr1+
Vps35Gt(RRK261)Byg/Vps35Gt(RRK261)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased macrophage cell number
|
J:292365
|
| microgliosis
|
J:292365
|
Cxadrtm1.1Ics/Cxadrtm1.1Ics
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)
|
increased thymocyte number
|
J:174138
|
Cxcl1em1(IMPC)Mbp/Cxcl1em1(IMPC)Mbp
(C57BL/6N-Cxcl1em1(IMPC)Mbp/MbpMmucd)
|
increased monocyte cell number
|
J:211773
|
Cxcl9tm1b(EUCOMM)Wtsi/Cxcl9tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl9tm1b(EUCOMM)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:75584
|
Cxcl11em1Groj/Cxcl11em1Groj
(C57BL/6J-Cxcl11em1Groj)
|
abnormal B cell morphology
|
J:345391
|
| increased CD8-positive, alpha-beta T cell number
|
J:345391
|
Cxcl12tm1.1Sjm/Cxcl12tm1.1Sjm
Ndor1Tg(UBC-cre/ERT2)1Ejb/?
(involves: 129S/SvEv * C57BL/6)
|
decreased lymphocyte cell number
|
J:194748
|
Cxcl12tm1.1Sjm/Cxcl12tm1.1Sjm
Tg(Prrx1-cre)1Cjt/?
(involves: C57BL/6 * SJL/J)
|
abnormal B cell differentiation
|
J:194748
|
Cxcl12tm1.1Ystz/Cxcl12tm1.2Ystz
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
decreased pro-B cell number
|
J:168434
|
Cxcl12tm1Tng/Cxcl12tm1.1Link
Tg(BGLAP-cre)1Clem/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac * FVB/N)
|
decreased B cell number
|
J:193594
|
Cxcl12tm1Tng/Cxcl12tm1.1Link
Tg(Prrx1-cre)1Cjt/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL/J)
|
decreased B cell number
|
J:193594
|
| decreased pre-pro B cell number
|
J:193594
|
Cxcl12tm1Tng/Cxcl12tm1.1Link
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * FVB/N)
|
decreased B cell number
|
J:193594
|
| decreased pre-pro B cell number
|
J:193594
|
Cxcl12tm1Tng/Cxcl12tm1Tng
(involves: 129P2/OlaHsd)
|
decreased pre-B cell number
|
J:34750
|
| decreased pro-B cell number
|
J:34750
|
Cxcl12tm3.1(HBEGF/EGFP)Tng/Cxcl12+
(B6.Cg-Cxcl12tm3.1(HBEGF/EGFP)Tng)
|
decreased pro-B cell number
|
J:164657
|
Cxcl13em2(IMPC)H/Cxcl13em2(IMPC)H
(C57BL/6NTac-Cxcl13em2(IMPC)H/H)
|
increased lymphocyte cell number
|
J:211773
|
Cxcl13m1Btlr/Cxcl13m1Btlr
(C57BL/6J-Cxcl13m1Btlr)
|
increased B-1 B cell number
|
J:221480
|
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA)
|
decreased macrophage cell number
|
J:126841
|
Cxcl16tm1Syon/Cxcl16tm1Syon
(B6.129P2-Cxcl16tm1Syon)
|
decreased NK T cell number
|
J:155199
|
Cxcr2tm1a(EUCOMM)Wtsi/Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased B cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased immature B cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased pre-B cell number
|
J:211773
|
| decreased pre-pro B cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased KLRG1+ CD4 alpha-beta T cell number
|
J:211773
|
| increased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| increased Ly6C high monocyte number
|
J:211773
|
| increased Ly6C low monocyte number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(involves: 129S2/SvPas * C57BL/6J)
|
increased B cell number
|
J:19570
|
Cxcr4em1(IMPC)Mbp/Cxcr4+
(C57BL/6NCrl-Cxcr4em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Cxcr4tm1.1Bala/Cxcr4+
(B6.129S2-Cxcr4tm1.1Bala)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:186735
|
| decreased B cell number
|
J:186735
|
| decreased immature B cell number
|
J:186735
|
| decreased NK cell number
|
J:178789
|
| decreased T cell number
|
J:186735
|
| increased mature B cell number
|
J:186735
|
| increased NK cell number
|
J:178789
|
Cxcr4tm1Qma/Cxcr4tm1Qma
(involves: 129X1/SvJ)
|
decreased pro-B cell number
|
J:49070
|
Cxcr4tm1Tng/Cxcr4tm1Tng
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:69256
|
Cxcr4tm1Tng/Cxcr4tm1Tng
(B6.Cg-Cxcr4tm1Tng)
|
abnormal T cell differentiation
|
J:82996
|
| decreased double-positive T cell number
|
J:82996
|
Cxcr4tm1Yiw/Cxcr4tm1Yiw
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:164872
|
Cxcr4tm1Yzo/Cxcr4tm1Yzo
(Not Specified)
|
abnormal B cell differentiation
|
J:167314
|
| abnormal lymphopoiesis
|
J:69255
|
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:94911
|
| decreased B-1 B cell number
|
J:94911
|
| decreased B-2 B cell number
|
J:94911
|
| decreased mature B cell number
|
J:94911
|
| decreased plasma cell number
|
J:94911
|
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:217569
|
| increased monocyte cell number
|
J:217569
|
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage cell number
|
J:217569
|
| decreased B cell number
|
J:217569
|
| decreased CD4-positive, alpha-beta T cell number
|
J:217569
|
| increased CD8-positive, alpha-beta T cell number
|
J:217569
|
Cxcr4tm2Yzo/Cxcr4tm3.1Yzo
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:167314
|
Cxcr4tm3.1Yzo/Cxcr4tm3.1Yzo
(Not Specified)
|
decreased pro-B cell number
|
J:167314
|
Cxcr5tm1Lipp/Cxcr5tm1Lipp
(involves: 129S2/SvPas * CD-1)
|
increased B cell number
|
J:37126
|
Cyb5r3tm1c(KOMP)Wtsi/Cyb5r3tm1c(KOMP)Wtsi
Tg(Myh11-icre/ERT2)1Soff/0
(B6.Cg-Cyb5r3tm1c(KOMP)Wtsi Tg(Myh11-icre/ERT2)1Soff)
|
decreased monocyte cell number
|
J:280543
|
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J)
|
increased lymphocyte cell number
|
J:235399
|
| increased monocyte cell number
|
J:235399
|
Cycstm1Mak/Cycstm1Mak
(involves: C57BL/6)
|
absent pre-B cells
|
J:98949
|
| decreased B cell number
|
J:98949
|
| decreased T cell number
|
J:98949
|
Cyldtm1.1Awai/Cyldtm1.1Awai
(Not Specified)
|
abnormal B cell differentiation
|
J:126113
|
| abnormal B cell morphology
|
J:126113
|
| abnormal class switch recombination
|
J:126113
|
| decreased B-1 B cell number
|
J:126113
|
| decreased immature B cell number
|
J:126113
|
| increased B cell number
|
J:126113
|
| increased follicular B cell number
|
J:126113
|
| increased marginal zone B cell number
|
J:126113
|
| increased pro-B cell number
|
J:126113
|
Cyldtm1Awai/Cyldtm1Awai
Tg(CD19-cre/ERT2)1Cgn/?
(Not Specified)
|
abnormal mature B cell morphology
|
J:126113
|
| decreased B-1 B cell number
|
J:126113
|
| decreased immature B cell number
|
J:126113
|
| increased B cell number
|
J:126113
|
Cyldtm1Scs/Cyldtm1Scs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:112392
|
| abnormal T cell number
|
J:112392
|
| decreased CD4-positive, alpha-beta T cell number
|
J:112392
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112392
|
| increased double-positive T cell number
|
J:112392
|
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn)
|
decreased lymphocyte cell number
|
J:163973
|
Cyp1a1tm4.1Dwn/Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn)
|
decreased lymphocyte cell number
|
J:163973
|
Cyp2g1tm1(rtTA)Lane/Cyp2g1+
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: 129 * C57BL/6 * SJL)
|
increased macrophage cell number
|
J:157842
|
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
increased B cell number
|
J:92438
|
| increased lymphocyte cell number
|
J:92438
|
| increased mature B cell number
|
J:92438
|
Cyp19a1tm1Sih/Cyp19a1tm1Sih
(involves: 129S/SvEv)
|
increased macrophage cell number
|
J:216958
|
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased osteoclast cell number
|
J:114305
|
Cyp27b1tm1b(EUCOMM)Hmgu/Cyp27b1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp27b1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Cyp27b1tm1Dgo/Cyp27b1tm1Dgo
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
decreased osteoclast cell number
|
J:70030
|
| decreased T cell number
|
J:70030
|
Cyrenem1Vokh/Cyrenem1Vokh
(C57BL/6-Cyrenem1Vokh)
|
abnormal class switch recombination
|
J:306598
|
Cyrentm1.1(KOMP)Vlcg/Cyrentm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal class switch recombination
|
J:265834
|
Cytiptm1Tes/Cytiptm1Tes
(involves: 129S1/Sv * FVB/N)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:110320
|
| decreased lymphocyte cell number
|
J:110320
|
D6Wsu163etm1b(EUCOMM)Wtsi/D6Wsu163etm1b(EUCOMM)Wtsi
(C57BL/6N-D6Wsu163etm1b(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased memory-marker NK cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
Daam2tm1b(KOMP)Wtsi/Daam2tm1b(KOMP)Wtsi
(C57BL/6N-Daam2tm1b(KOMP)Wtsi/Wtsi)
|
increased large unstained cell number
|
J:211773
|
Dapp1tm1Mnz/Dapp1tm1Mnz
(B6.129P2-Dapp1tm1Mnz)
|
decreased B-1a cell number
|
J:86182
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Wtsi)
|
increased CD8-positive, alpha-beta T cell number
|
J:211773
|
Dbr1Gt(YTA280)Byg/Dbr1+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:223318
|
Dcaf12em1(IMPC)Ccpcz/Dcaf12em1(IMPC)Ccpcz
(C57BL/6N-Dcaf12em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
Dckm1Btlr/Dck+
(C57BL/6J-Dckm1Btlr)
|
decreased B cell number
|
J:236696
|
Dckm1Btlr/Dckm1Btlr
(C57BL/6J-Dckm1Btlr)
|
decreased B cell number
|
J:236696
|
| decreased CD4-positive, alpha-beta T cell number
|
J:236696
|
| increased CD8-positive, alpha-beta T cell number
|
J:236696
|
| increased macrophage cell number
|
J:236696
|
Dckmemi/Dckmemi
(C57BL/6J-Dckmemi)
|
abnormal T cell differentiation
|
J:184080
|
| decreased B cell number
|
J:184080
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184080
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:184080
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:184080
|
Dcktm1.1Radu/Dcktm1.1Radu
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * C57BL/6J)
|
abnormal double-negative T cell morphology
|
J:158373
|
| abnormal T cell differentiation
|
J:158373
|
| decreased B cell number
|
J:158373
|
| decreased double-positive T cell number
|
J:158373
|
| decreased pre-B cell number
|
J:158373
|
| decreased T cell number
|
J:158373
|
| increased double-negative T cell number
|
J:158373
|
| increased pro-B cell number
|
J:158373
|
Dclre1cm1Brck/Dclre1cm1Brck
(involves: C3H * C57BL/6)
|
absent B cells
|
J:207533
|
| absent T cells
|
J:207533
|
Dclre1cm1Brck/Dclre1cm1Brck
(involves: C57BL/6)
|
absent B cells
|
J:207533
|
| absent CD4-positive, alpha-beta T cells
|
J:207533
|
| absent CD8-positive, alpha-beta T cells
|
J:207533
|
| decreased DN1 thymic pro-T cell number
|
J:207533
|
| decreased DN4 thymocyte number
|
J:207533
|
| decreased double-positive T cell number
|
J:207533
|
| decreased pre-B cell number
|
J:207533
|
Dclre1cm1Btlr/Dclre1cm1Btlr
(C57BL/6J-Dclre1cm1Btlr)
|
decreased B cell number
|
J:217790
|
| decreased single-positive T cell number
|
J:217790
|
| decreased T cell number
|
J:217790
|
| increased macrophage cell number
|
J:217790
|
| increased NK cell number
|
J:217790
|
Dclre1cM2Btlr/Dclre1cM2Btlr
(C57BL/6J-Dclre1cM2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265131
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265131
|
| decreased single-positive T cell number
|
J:265131
|
| decreased T cell number
|
J:265131
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265131
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265131
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265131
|
Dclre1cm3Btlr/Dclre1cm3Btlr
(C57BL/6J-Dclre1cm3Btlr)
|
decreased B cell number
|
J:265132
|
| decreased B-1 B cell number
|
J:265132
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265132
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265132
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265132
|
| decreased NK T cell number
|
J:265132
|
| decreased single-positive T cell number
|
J:265132
|
| decreased T cell number
|
J:265132
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265132
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265132
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265132
|
Dclre1ctm1.1Fwa/Dclre1ctm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:80995
|
| arrested T cell differentiation
|
J:80995
|
Dclre1ctm1.1Jpdv/Dclre1ctm1.1Jpdv
(involves: 129P1/ReJ)
|
abnormal B cell differentiation
|
J:137743
|
| abnormal T cell receptor V(D)J recombination
|
J:194422
|
| arrested T cell differentiation
|
J:137712
|
Dclre1ctm1Fwa/Dclre1ctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
absent immature B cells
|
J:80995
|
| arrested B cell differentiation
|
J:80995
|
| arrested T cell differentiation
|
J:80995
|
| decreased thymocyte number
|
J:80995
|
Dclre1ctm1Fwa/Dclre1ctm1Fwa
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:147864
|
| absent B cells
|
J:147864
|
| arrested B cell differentiation
|
J:147864
|
| decreased CD4-positive, alpha-beta T cell number
|
J:147864
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147864
|
| decreased double-positive T cell number
|
J:147864
|
| decreased thymocyte number
|
J:147864
|
Dclre1ctm1Jsek/Dclre1ctm1Jsek
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:147864
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:147864
|
| decreased B cell number
|
J:147864
|
| decreased CD4-positive, alpha-beta T cell number
|
J:147864
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147864
|
| decreased double-positive T cell number
|
J:147864
|
| decreased pre-B cell number
|
J:147864
|
| decreased thymocyte number
|
J:147864
|
| increased pro-B cell number
|
J:147864
|
Dclre1ctm2.1Jpdv/Dclre1ctm2.2Jpdv
Tg(Cr2-cre)3Cgn/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:153841
|
Dclre1ctm2.2Jpdv/Dclre1ctm2.2Jpdv
(B6.129S2-Dclre1ctm2.2Jpdv)
|
abnormal mononuclear cell morphology
|
J:153841
|
| absent immature B cells
|
J:153841
|
| arrested B cell differentiation
|
J:153841
|
| arrested T cell differentiation
|
J:153841
|
| decreased CD4-positive, alpha-beta T cell number
|
J:153841
|
| decreased CD8-positive, alpha-beta T cell number
|
J:153841
|
| decreased double-positive T cell number
|
J:153841
|
| decreased mature B cell number
|
J:153841
|
| decreased thymocyte number
|
J:153841
|
Dclre1ctm2Mcow/Dclre1ctm2Mcow
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:96535
|
| arrested T cell differentiation
|
J:96535
|
| decreased lymphocyte cell number
|
J:96535
|
| decreased thymocyte number
|
J:96535
|
Dcstamptm1Suda/Dcstamptm1Suda
(Not Specified)
|
abnormal osteoclast differentiation
|
J:100555
|
Dctn1tm2.1Cai/Dctn1tm2.1Cai
Tg(Thy1-cre)1Vln/?
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/N)
|
microgliosis
|
J:264431
|
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J)
|
abnormal T cell morphology
|
J:214136
|
Ddr1tm1Wfv/Ddr1tm1Wfv
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)
|
decreased macrophage cell number
|
J:149015
|
Ddrgk1tm1c(EUCOMM)Hmgu/Ddrgk1tm1c(EUCOMM)Hmgu
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)
|
decreased lymphocyte cell number
|
J:231701
|
| decreased monocyte cell number
|
J:231701
|
Ddx52tm1a(EUCOMM)Wtsi/Ddx52+
(C57BL/6N-Ddx52tm1a(EUCOMM)Wtsi/Ics)
|
decreased NK cell number
|
J:165965
|
Def6Gt(OST307148)Lex/Def6Gt(OST307148)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased immature B cell number
|
J:106469
|
| increased memory T cell number
|
J:106469
|
| increased T cell number
|
J:106469
|
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw
(involves: 129S4/SvJae * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:174337
|
| decreased NK T cell number
|
J:112657,
J:174337,
J:39749,
J:76976
|
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw
TcraLn1Ogu/Tcra+
(involves: 129/Sv * C57BL/6)
|
abnormal NK T cell morphology
|
J:152041
|
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw
Tg(TcraAV19AJ33)1Shima/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal NK T cell morphology
|
J:112657
|
Del(3Cd1d2-Cd1d1)1Sbp/Del(3Cd1d2-Cd1d1)1Sbp
(involves: 129S6/SvEvTac)
|
decreased NK T cell number
|
J:151699
|
Del(6Gimap5-Gimap3)1Yout/Del(6Gimap5-Gimap3)1Yout
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased B cell number
|
J:209926
|
| decreased NK cell number
|
J:209926
|
| decreased T cell number
|
J:209926
|
Del(6Snca)1Slab/Del(6Snca)1Slab
Tg(Th-SNCA*)1Mgsp/0
(involves: C57BL/6J * C57BL/6JOlaHsd * CBA/Ca)
|
abnormal microglial cell morphology
|
J:108310
|
Del(9Apoa1-Apoa4)1Hmez/Del(9Apoa1-Apoa4)1Hmez
(involves: 129P2/OlaHsd * C57BL/6)
|
increased macrophage derived foam cell number
|
J:109005
|
Del(9Cd3g-Cd3d)1Cpt/Del(9Cd3g-Cd3d)1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
absent gamma-delta T cells
|
J:76991
|
| arrested T cell differentiation
|
J:76991
|
| decreased alpha-beta T cell number
|
J:76991
|
Del(11Stat5a-Stat5b)1Mam/Del(11Stat5a-Stat5b)1Mam
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
absent gamma-delta T cells
|
J:122463
|
| arrested B cell differentiation
|
J:122463
|
| decreased B cell number
|
J:122463
|
| decreased CD8-positive, alpha-beta T cell number
|
J:122463
|
Del(14Trim13-Dleu2)4Rdf/Del(14Trim13-Dleu2)4Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased B cell number
|
J:156946
|
| increased B-1a cell number
|
J:156946
|
Del(14Trim13-Rnaseh2b)6Rdf/+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
| increased B cell number
|
J:179879
|
Del(15Rr316124-Rr313939)2Fsp/+
Myctm1Atp/Myc+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:257739
|
Del(15Rr316124-Rr313939)2Fsp/+
Rr331em1Fsp/Rr331+
(involves: C57BL/6)
|
decreased B cell number
|
J:257739
|
| increased pre-B cell number
|
J:257739
|
Del(15Rr316124-Rr313939)2Fsp/+
Rr307328em1Fsp/Rr307328+
(involves: C57BL/6)
|
decreased B cell number
|
J:257739
|
| increased pre-B cell number
|
J:257739
|
Del(15Rr316124-Rr313939)2Fsp/Del(15Rr316124-Rr313939)2Fsp
(Not Specified)
|
decreased B cell number
|
J:257739
|
Del(17Btnl1-Btnl6)1Ahay/Del(17Btnl1-Btnl6)1Ahay
(involves: BALB/c * C57BL/6J)
|
decreased CD4-positive, gamma-delta intraepithelial T cell number
|
J:291989
|
Del(18Pcdhg)1Xzw/Del(18Pcdhg)1Xzw
(Not Specified)
|
microgliosis
|
J:188341
|
Dennd1btm1.2Achn/Dennd1btm1.2Achn
(involves: C57BL/6)
|
abnormal T cell number
|
J:229307
|
Dennd5bem1(IMPC)Tcp/Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Dffbtm1Osa/Dffbtm1Osa
Dnase2atm1Osa/Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:81474
|
| decreased double-positive T cell number
|
J:81474
|
| increased double-negative T cell number
|
J:81474
|
Dgkatm1Xpz/Dgkatm1Xpz
(involves: 129 * C57BL/6)
|
increased T cell number
|
J:113564
|
Dgkatm1Xpz/Dgkatm1Xpz
Dgkztm1Gak/Dgkztm1Gak
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:113564
|
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85149
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85149
|
| increased B cell number
|
J:85149
|
Dgkztm1Gak/Dgkztm1Gak
(B6.129X1-Dgkztm1Gak)
|
increased T cell number
|
J:113564
|
Dh/Dh+
(Not Specified)
|
increased lymphocyte cell number
|
J:30753
|
Dh/Dh+
(B6.CBA-Dh)
|
abnormal T cell differentiation
|
J:5834
|
Dhx9Tn(pb-Act-RFP)1.071225026-HRAZhu/Dhx9+
Igs12tm1Zhu/Igs12tm1Zhu
Ptprca/Ptprcb
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/NJ * SJL/J)
|
abnormal T cell differentiation
|
J:207361
|
Dhx15tm1c(EUCOMM)Wtsi/Dhx15tm1c(EUCOMM)Wtsi
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C3H * C57BL/6N)
|
abnormal B cell differentiation
|
J:284624
|
| decreased B cell number
|
J:284624
|
| decreased pre-B cell number
|
J:284624
|
Dhx15tm1c(EUCOMM)Wtsi/Dhx15tm1c(EUCOMM)Wtsi
Tg(Cd4-cre)1Cwi/0
(involves: C3H * C57BL/6N * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:284624
|
| decreased CD8-positive, alpha-beta T cell number
|
J:284624
|
Diaph1M1Btlr/Diaph1+
(C57BL/6J-Diaph1M1Btlr)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:254820
|
| abnormal CD8-positive, alpha-beta T cell number
|
J:254820
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254820
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254820
|
Diaph1M1Btlr/Diaph1M1Btlr
(C57BL/6J-Diaph1M1Btlr)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:254820
|
| abnormal CD8-positive, alpha-beta T cell number
|
J:254820
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:254820
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254820
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254820
|
Diaph1M2Btlr/Diaph1+
(C57BL/6J-Diaph1M2Btlr)
|
decreased B-1 B cell number
|
J:254819
|
Diaph1M2Btlr/Diaph1M2Btlr
(C57BL/6J-Diaph1M2Btlr)
|
decreased B-1 B cell number
|
J:254819
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:254819
|
Diaph1m3Btlr/Diaph1m3Btlr
(C57BL/6J-Diaph1m3Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254818
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254818
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254818
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254818
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254818
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254818
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254818
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:254818
|
Diaph1tm1.1Sna/Diaph1tm1.1Sna
(B6.Cg-Diaph1tm1.1Sna)
|
decreased CD4-positive, alpha-beta T cell number
|
J:126090
|
| decreased CD8-positive, alpha-beta T cell number
|
J:126090
|
| decreased T cell number
|
J:126090
|
| increased single-positive T cell number
|
J:126090
|
Diaph1tm1Asal/Diaph1tm1Asal
(involves: 129S1/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:124319
|
| increased monocyte cell number
|
J:124319
|
Dicer1m1Btlr/Dicer1m1Btlr
(C57BL/6J-Dicer1m1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265172
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265172
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265172
|
| decreased single-positive T cell number
|
J:265172
|
| decreased T cell number
|
J:265172
|
| increased B-1 B cell number
|
J:265172
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265172
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265172
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265172
|
Dicer1tm1Bdh/Dicer1tm1Bdh
Aicdatm1(cre)Njen/Aicda+
(involves: 129 * C57BL/6)
|
absent memory B cells
|
J:181782
|
| absent plasma cells
|
J:181782
|
| decreased germinal center B cell number
|
J:181782
|
Dicer1tm1Bdh/Dicer1tm1Bdh
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased regulatory T cell number
|
J:138683
|
Dicer1tm1Bdh/Dicer1tm1Bdh
Tg(Foxp3-EGFP/icre)1aJbs/0
(involves: 129 * NOD/ShiLt)
|
abnormal effector T cell morphology
|
J:138808
|
| abnormal regulatory T cell morphology
|
J:138808
|
| decreased regulatory T cell number
|
J:138808
|
Dicer1tm1Dli/Dicer1tm1Dli
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
decreased T cell number
|
J:100546
|
Dicer1tm1Mmk/Dicer1tm1.1Mmk
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
abnormal immunoglobulin V(D)J recombination
|
J:135783
|
| decreased B cell number
|
J:135783
|
Dicer1tm1Mmk/Dicer1tm1Mmk
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
arrested B cell differentiation
|
J:135783
|
| decreased immature B cell number
|
J:135783
|
| decreased mature B cell number
|
J:135783
|
| decreased pre-B cell number
|
J:135783
|
| increased pro-B cell number
|
J:135783
|
Dicer1tm1Mmk/Dicer1tm1Mmk
Tg(IghelMD4)4Ccg/0
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
decreased B cell number
|
J:135783
|
| decreased mature B cell number
|
J:135783
|
Dicer1tm1Mmk/Dicer1tm1Mmk
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell number
|
J:98192
|
| decreased thymocyte number
|
J:98192
|
| increased gamma-delta T cell number
|
J:98192
|
Dicer1tm1Mmk/Dicer1tm1Mmk
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1)
|
decreased B cell number
|
J:158901
|
Dicer1tm1Tara/Dicer1tm1Tara
Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd)
|
abnormal positive T cell selection
|
J:180783
|
| decreased CD4-positive, alpha-beta T cell number
|
J:180783
|
| decreased CD8-positive, alpha-beta T cell number
|
J:180783
|
Dido1tm1Cmar/Dido1+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased monocyte cell number
|
J:101201
|
Dido1tm1Cmar/Dido1tm1Cmar
(involves: 129S1/Sv * 129X1/SvJ)
|
increased monocyte cell number
|
J:101201
|
Dip2cem1(IMPC)Tcp/Dip2c+
(C57BL/6N-Dip2cem1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Dis3tm1.1Uba/Dis3tm1.1Uba
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal B cell morphology
|
J:302856
|
| abnormal class switch recombination
|
J:302856
|
Dkc1tm1.1Pjma/Y
(B6.129X1(FVB)-Dkc1tm1.1Pjma)
|
decreased B cell number
|
J:217050
|
| decreased T cell number
|
J:217050
|
Dkc1tm1Ppp/Y
(involves: 129S1/Sv)
|
decreased B cell number
|
J:81054
|
| decreased lymphocyte cell number
|
J:81054
|
| decreased pre-B cell number
|
J:81054
|
Dkk2tm1Dwu/Dkk2tm1Dwu
(involves: 129)
|
abnormal osteoclast differentiation
|
J:100858
|
| increased osteoclast cell number
|
J:100858
|
Dkk3tm1Cni/Dkk3tm1Cni
(involves: 129X1/SvJ * C57BL/6)
|
decreased NK cell number
|
J:106922
|
Dlgap2em1(IMPC)Mhzh/Dlgap2em1(IMPC)Mhzh
(C57BL/6N-Dlgap2em1(IMPC)Mhzh/Mhzh)
|
decreased lymphocyte cell number
|
J:211773
|
Dlk1tm1Srba/Dlk1tm1Srba
(involves: 129X1/SvJ * C57BL/6)
|
abnormal B cell number
|
J:145076
|
| decreased immature B cell number
|
J:145076
|
| decreased mature B cell number
|
J:145076
|
| increased immature B cell number
|
J:145076
|
| increased marginal zone B cell number
|
J:145076
|
| increased transitional stage B cell number
|
J:145076
|
Dll1tm1Gos/Dll1+
(C3Fe.129-Dll1tm1Gos)
|
decreased B-1 B cell number
|
J:150183
|
| decreased CD4-positive, alpha-beta T cell number
|
J:150183
|
| decreased CD8-positive, alpha-beta T cell number
|
J:150183
|
| increased B cell number
|
J:150183
|
| increased CD8-positive, alpha-beta T cell number
|
J:150183
|
Dll1tm1Gos/Dll1+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased CD4-positive, alpha-beta T cell number
|
J:150183
|
| increased B cell number
|
J:150183
|
Dll1tm1Mjo/Dll1tm1Mjo
Tg(Mx1-cre)1Cgn/?
(involves: 129 * C57BL/6 * CBA)
|
absent marginal zone B cells
|
J:90630
|
Dll4tm1Frad/Dll4tm1Frad
Foxn1tm3(cre)Nrm/Foxn1+
(B6.Cg-Dll4tm1Frad Foxn1tm3(cre)Nrm)
|
abnormal T cell differentiation
|
J:143472
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143472
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143472
|
| decreased double-positive T cell number
|
J:143472
|
| decreased thymocyte number
|
J:143472
|
| increased immature B cell number
|
J:143472
|
Dll4tm1Kaho/Dll4tm1Kaho
Tg(Foxn1-cre)8Ghr/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymphopoiesis
|
J:143473
|
| absent CD4-positive, alpha-beta T cells
|
J:143473
|
| absent CD8-positive, alpha-beta T cells
|
J:143473
|
| decreased double-positive T cell number
|
J:143473
|
Dmdmdx/Y
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
decreased T cell number
|
J:150572
|
| increased regulatory T cell number
|
J:150572
|
| increased T cell number
|
J:150572
|
Dmdmdx/Dmdmdx
Mmp9tm1Tvu/Mmp9+
(B10.Cg-Mmp9tm1Tvu Dmdmdx)
|
decreased macrophage cell number
|
J:150030
|
Dmdmdx/Dmdmdx
Mmp9tm1Tvu/Mmp9tm1Tvu
(B10.Cg-Mmp9tm1Tvu Dmdmdx)
|
decreased macrophage cell number
|
J:150030
|
Dmdmdx/Dmdmdx
Prkdcscid/Prkdcscid
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
absent CD4-positive, alpha-beta T cells
|
J:125527
|
| absent CD8-positive, alpha-beta T cells
|
J:125527
|
| decreased B cell number
|
J:125527
|
Dmdmdx/Dmdmdx
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
decreased T cell number
|
J:150572
|
| increased regulatory T cell number
|
J:150572
|
| increased T cell number
|
J:150572
|
Dmp1tm1Mis/Dmp1tm1Mis
(involves: 129S7/SvEvBrd * CD-1)
|
decreased osteoclast cell number
|
J:184352
|
Dmtf1tm1Cjs/Dmtf1tm1Cjs
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:63444
|
Dnajc3m1Btlr/Dnajc3m1Btlr
(C57BL/6J-Dnajc3m1Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:265248
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265248
|
| increased single-positive T cell number
|
J:265248
|
| increased T cell number
|
J:265248
|
Dnajc11spc/Dnajc11spc
(B6.Cg-Dnajc11spc)
|
decreased B cell number
|
J:221543
|
| decreased double-positive T cell number
|
J:221543
|
| increased CD4-positive, alpha-beta T cell number
|
J:221543
|
| increased CD8-positive, alpha-beta T cell number
|
J:221543
|
| increased DN1 thymic pro-T cell number
|
J:221543
|
| increased double-negative T cell number
|
J:221543
|
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:204025
|
Dnase2atm1Osa/Dnase2atm1Osa
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal macrophage morphology
|
J:114982
|
Dnase2atm1Osa/Dnase2atm2Osa
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal macrophage morphology
|
J:114982
|
Dnm2tm2.1Ics/Dnm2+
(involves: C57BL/6J)
|
increased macrophage cell number
|
J:288372
|
Dnmt1tm2Jae/Dnmt1tm2Jae
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:113645
|
| decreased pro-B cell number
|
J:113645
|
Dnmt3btm1Enl/Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
Dnmt3btm1Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:106540
|
| decreased thymocyte number
|
J:106540
|
| increased double-negative T cell number
|
J:106540
|
Dnmt3btm6Enl/Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
Dnmt3btm6Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
Dnmt3btm7Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
Dntttm1Gfn/Dntttm1Gfn
Polmtm1Crey/Polmtm1Crey
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
Dntttm1Tok/Dntttm1Tok
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte cell number
|
J:61801
|
| abnormal T cell morphology
|
J:61801
|
| decreased gamma-delta T cell number
|
J:61801
|
Dock2m1Anu/Dock2m1Anu
(C57BL/6JAnu-Dock2m1Anu)
|
decreased B cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
Dock2m1Btlr/Dock2m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:173592
|
| abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
| decreased T cell number
|
J:185495
|
Dock2m1Hsd/Dock2m1Hsd
Irf5tm1Ttg/Irf5tm1Ttg
(B6NHsd.Cg-Irf5tm1Ttg Dock2m1Hsd)
|
abnormal B cell differentiation
|
J:182658
|
| absent marginal zone B cells
|
J:182658
|
| decreased follicular B cell number
|
J:182658
|
| increased B cell number
|
J:182658
|
| increased immature B cell number
|
J:182658
|
Dock2m1Hsd/Dock2m1Hsd
Siaetm1.2Avrk/Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd)
|
decreased B-1a cell number
|
J:144035
|
| decreased follicular B cell number
|
J:144035
|
| decreased marginal zone B cell number
|
J:231437,
J:144035
|
| decreased T cell number
|
J:144035
|
| increased B-1b cell number
|
J:144035
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:231437
|
Dock2m2Anu/Dock2m2Anu
(C57BL/6JAnu-Dock2m2Anu)
|
abnormal T cell morphology
|
J:104190
|
| decreased mature B cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
Dock2m2Btlr/Dock2m2Btlr
(C57BL/6J-Dock2m2Btlr)
|
decreased B cell number
|
J:173670
|
| decreased CD4-positive, alpha-beta T cell number
|
J:173670
|
| decreased CD8-positive, alpha-beta T cell number
|
J:173670
|
Dock2m2Btlr/Dock2m2Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
| abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
| decreased T cell number
|
J:185495
|
Dock2m3Anu/Dock2m3Anu
(C57BL/6NCrlAnu-Dock2m3Anu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:104190
|
| decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
Dock2m3Btlr/Dock2m3Btlr
(C57BL/6J-Dock2m3Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:191187
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:191187
|
| decreased CD4-positive, alpha-beta T cell number
|
J:191187
|
| decreased CD8-positive, alpha-beta T cell number
|
J:191187
|
Dock2m4Btlr/Dock2m4Btlr
(C57BL/6J-Dock2m4Btlr)
|
abnormal B cell differentiation
|
J:221486
|
| abnormal CD4-positive T cell differentiation
|
J:221486
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221486
|
Dock2m5Btlr/Dock2+
(C57BL/6J-Dock2m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:225938
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225938
|
| decreased CD4-positive, alpha-beta T cell number
|
J:225938
|
| decreased single-positive T cell number
|
J:225938
|
| increased CD8-positive, alpha-beta T cell number
|
J:225938
|
| increased single-positive T cell number
|
J:225938
|
Dock2m5Btlr/Dock2m5Btlr
(C57BL/6J-Dock2m5Btlr)
|
abnormal B cell differentiation
|
J:225938
|
| abnormal CD4-positive T cell differentiation
|
J:225938
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225938
|
| decreased CD4-positive, alpha-beta T cell number
|
J:225938
|
| decreased single-positive T cell number
|
J:225938
|
| increased B cell number
|
J:225938
|
| increased CD8-positive, alpha-beta T cell number
|
J:225938
|
| increased single-positive T cell number
|
J:225938
|
Dock2m7Btlr/Dock2+
(C57BL/6J-Dock2m7Btlr)
|
decreased B cell number
|
J:255181
|
| increased macrophage cell number
|
J:255181
|
Dock2m7Btlr/Dock2m7Btlr
(C57BL/6J-Dock2m7Btlr)
|
decreased B cell number
|
J:255181
|
| increased macrophage cell number
|
J:255181
|
| increased NK cell number
|
J:255181
|
Dock2m8Btlr/Dock2m8Btlr
(C57BL/6J-Dock2m8Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:272402
|
| increased CD8-positive, alpha-beta T cell number
|
J:272402
|
Dock2M9Btlr/Dock2M9Btlr
(C57BL/6J-Dock2M9Btlr)
|
increased CD8-positive, alpha-beta T cell number
|
J:272403
|
Dock2m10Btlr/Dock2m10Btlr
(C57BL/6J-Dock2m10Btlr)
|
decreased B-1b cell number
|
J:272404
|
| increased NK cell number
|
J:272404
|
Dock2m11Btlr/Dock2m11Btlr
(C57BL/6J-Dock2m11Btlr)
|
abnormal B cell differentiation
|
J:272405
|
| abnormal CD4-positive T cell differentiation
|
J:272405
|
| abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:272405
|
| decreased B cell number
|
J:272405
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272405
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272405
|
| decreased NK cell number
|
J:272405
|
| increased B-1 B cell number
|
J:272405
|
| increased CD8-positive, alpha-beta T cell number
|
J:272405
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272405
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272405
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272405
|
Dock2M12Btlr/Dock2M12Btlr
(C57BL/6J-Dock2M12Btlr)
|
decreased B-1a cell number
|
J:272406
|
Dock2m13Btlr/Dock2m13Btlr
(C57BL/6J-Dock2m13Btlr)
|
increased alpha-beta T cell number
|
J:272437
|
| increased CD8-positive, alpha-beta T cell number
|
J:272437
|
Dock2M14Btlr/Dock2M14Btlr
(C57BL/6J-Dock2M14Btlr)
|
abnormal lymphocyte morphology
|
J:272438
|
| increased CD8-positive, alpha-beta T cell number
|
J:272438
|
Dock2m15Btlr/Dock2m15Btlr
(C57BL/6J-Dock2m15Btlr)
|
decreased B cell number
|
J:274942
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274942
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274942
|
| decreased T cell number
|
J:274942
|
| increased B-1 B cell number
|
J:274942
|
| increased CD8-positive, alpha-beta T cell number
|
J:274942
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274942
|
| increased NK cell number
|
J:274942
|
Dock2M16Btlr/Dock2M16Btlr
(C57BL/6J-Dock2M16Btlr)
|
abnormal CD8-positive, alpha-beta T cell number
|
J:274971
|
Dock2tm1Tsas/Dock2tm1Tsas
(involves: C57BL/6)
|
decreased marginal zone B cell number
|
J:71005
|
Dock2tm1Tsas/Dock2tm1Tsas
(B6.Cg-Dock2tm1Tsas)
|
decreased lymphocyte cell number
|
J:130919
|
| decreased mature B cell number
|
J:130919
|
| decreased T cell number
|
J:130919
|
Dock2tm1Tsas/Dock2tm1Tsas
Tg(Tcra2B4)1Mmd/?
Tg(Tcrb2B4)1Mmd/?
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:84581
|
| decreased double-positive T cell number
|
J:84581
|
Dock8cpm/Dock8cpm
(C57BL/6JSfdAnu-Dock8cpm)
|
decreased marginal zone B cell number
|
J:155516
|
| decreased T cell number
|
J:155516
|
Dock8cpm/Dock8pri
(C57BL/6J-Dock8cpm/Dock8pri)
|
decreased marginal zone B cell number
|
J:155516
|
| decreased T cell number
|
J:155516
|
Dock8m1Anu/Dock8m1Anu
(C57BL/6NCrlAnu-Dock8m1Anu)
|
decreased activated T cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
Dock8m2Anu/Dock8m2Anu
(C57BL/6NCrlAnu-Dock8m2Anu)
|
absent marginal zone B cells
|
J:104190
|
| decreased activated T cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
Dock8M2Btlr/Dock8M2Btlr
(C57BL/6J-Dock8M2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272530
|
Dock8m4Btlr/Dock8m4Btlr
(C57BL/6J-Dock8m4Btlr)
|
abnormal B cell differentiation
|
J:274856
|
| abnormal CD4-positive T cell differentiation
|
J:274856
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274856
|
| abnormal T cell differentiation
|
J:274856
|
| decreased B-1 B cell number
|
J:274856
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274856
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274856
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274856
|
| decreased T cell number
|
J:274856
|
| increased CD4-positive, alpha-beta T cell number
|
J:274856
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274856
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274856
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274856
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274856
|
Dock8pri/Dock8pri
(C57BL/6JAnu-Dock8pri)
|
decreased B-1 B cell number
|
J:155516
|
| decreased germinal center B cell number
|
J:155516
|
| decreased marginal zone B cell number
|
J:155516
|
| decreased T cell number
|
J:155516
|
Dock8tm1Ysfk/Dock8tm1Ysfk
(B6.Cg-Dock8tm1Ysfk)
|
decreased CD4-positive, alpha-beta T cell number
|
J:185165
|
| decreased CD8-positive, alpha-beta T cell number
|
J:185165
|
| decreased marginal zone B cell number
|
J:185165
|
Dock10tm1a(EUCOMM)Hmgu/Dock10tm1a(EUCOMM)Hmgu
(C57BL/6N-Dock10tm1a(EUCOMM)Hmgu/Ieg)
|
arrested B cell differentiation
|
J:236911
|
| decreased B cell number
|
J:236911
|
| decreased follicular B cell number
|
J:236911
|
| decreased marginal zone B cell number
|
J:236911
|
| increased single-positive T cell number
|
J:236911
|
| increased T cell number
|
J:236911
|
Dock10tm1Thar/Dock10tm1Thar
(involves: C57BL/6)
|
decreased B cell number
|
J:300632
|
Dock11tm1.1Mmar/Dock11tm1.1Mmar
(Not Specified)
|
abnormal metallophilic macrophage morphology
|
J:238172
|
| decreased marginal zone B cell number
|
J:238172
|
Dok1tm1Ppp/Dok1tm1Ppp
Dok2tm1Ppp/Dok2tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok2tm1Ppp)
|
increased monocyte cell number
|
J:95334
|
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
(B6.129-Dok1tm1Yyam Dok2tm1Yyam)
|
increased monocyte cell number
|
J:95335
|
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Dok3tm1Brs/Dok3tm1Brs
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased macrophage cell number
|
J:163407
|
Dok3tm1Brs/Dok3tm1Brs
(involves: C57BL/6)
|
increased macrophage cell number
|
J:163407
|
Dok7tm1.1(KOMP)Vlcg/Dok7+
(C57BL/6N-Dok7tm1.1(KOMP)Vlcg/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
Dot1ltm1.1Saam/Dot1ltm1.1Saam
Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:193161
|
Dp(16Cbr1-Fam3b)1Rhr/0
Gata1tm8.2Sho/Y
(involves: 129S1/Sv * 129S6/SvEvTac)
|
increased monocyte cell number
|
J:184564
|
Dph6tm1a(KOMP)Wtsi/Dph6tm1a(KOMP)Wtsi
(C57BL/6N-Dph6tm1a(KOMP)Wtsi/Wtsi)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD5-positive gamma-delta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive T-helper cell number
|
J:211773
|
| increased marginal zone B cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
| increased plasma cell number
|
J:211773
|
Dpp3tm1d(EUCOMM)Hmgu/Dpp3tm1d(EUCOMM)Hmgu
(involves: BALB/c * C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
increased osteoclast cell number
|
J:294242
|
Dpp4em1Rba/Dpp4em1Rba
(C57BL/6J-Dpp4em1Rba)
|
decreased lymphocyte cell number
|
J:279723
|
| increased monocyte cell number
|
J:279723
|
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased CD4-positive, alpha-beta T cell number
|
J:238079
|
| increased CD8-positive, alpha-beta T cell number
|
J:238079
|
| increased macrophage cell number
|
J:238079
|
Dpp4tm1b(EUCOMM)Wtsi/Dpp4tm1b(EUCOMM)Wtsi
(C57BL/6N-Dpp4tm1b(EUCOMM)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low/J)
|
microgliosis
|
J:194407
|
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased CD8-positive, alpha-beta T cell number
|
J:138683
|
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal regulatory T cell morphology
|
J:138683
|
| increased CD8-positive, alpha-beta T cell number
|
J:138683
|
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:138683
|
| decreased double-positive T cell number
|
J:138683
|
| decreased lymphocyte cell number
|
J:138683
|
| decreased regulatory T cell number
|
J:138683
|
| decreased thymocyte number
|
J:138683
|
| increased activated T cell number
|
J:138683
|
| increased gamma-delta T cell number
|
J:138683
|
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk)
|
decreased B cell number
|
J:219200
|
| decreased double-positive T cell number
|
J:219200
|
| decreased immature B cell number
|
J:219200
|
| decreased lymphocyte cell number
|
J:219200
|
| decreased pre-B cell number
|
J:219200
|
| decreased single-positive T cell number
|
J:219200
|
| decreased transitional stage B cell number
|
J:219200
|
Dsg4hage/Dsg4hage
Faslpr/Faslpr
X/Yaa
(EOD-Dsg4hage)
|
abnormal effector T cell morphology
|
J:140028
|
Dtnbp1tm1b(EUCOMM)Hmgu/Dtnbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Dtnbp1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl)
|
abnormal lymphocyte morphology
|
J:151605
|
| decreased marginal zone B cell number
|
J:151605
|
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi)
|
decreased B cell number
|
J:211773
|
| decreased B-2 B cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
| decreased immature B cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased Ly6C low monocyte number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased memory-marker gamma-delta T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased transitional stage T1 B cell number
|
J:211773
|
| increased alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
Dusp4Gt(XG164)Byg/Dusp4Gt(XG164)Byg
(B6.129P2-Dusp4Gt(XG164)Byg)
|
increased CD4-positive, alpha-beta T cell number
|
J:180366
|
Dusp5tm1.1Achn/Dusp5tm1.1Achn
(involves: C57BL/6NCrl)
|
increased thymocyte number
|
J:218203
|
Dusp5tm1a(KOMP)Wtsi/Dusp5tm1a(KOMP)Wtsi
(C57BL/6-Dusp5tm1a(KOMP)Wtsi)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:240637
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:240637
|
Dusp10tm1Flv/Dusp10tm1Flv
(involves: 129S6/SvEvTac)
|
increased activated T cell number
|
J:92104
|
Dusp14Gt(OST210117)Lex/Dusp14Gt(OST210117)Lex
(B6.129S5-Dusp14Gt(OST210117)Lex)
|
increased T-helper 1 cell number
|
J:209403
|
| increased T-helper 17 cell number
|
J:209403
|
Dyrk1atm1Jdc/Dyrk1atm1Jdc
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J)
|
decreased B cell number
|
J:223138
|
| decreased double-positive T cell number
|
J:223138
|
| decreased immature B cell number
|
J:223138
|
| decreased mature B cell number
|
J:223138
|
| decreased pre-B cell number
|
J:223138
|
| decreased thymocyte number
|
J:223138
|
Dyrk1btm1b(EUCOMM)Wtsi/Dyrk1b+
(C57BL/6N-Dyrk1btm1b(EUCOMM)Wtsi/Ics)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
Dyrk2em1(IMPC)Ics/Dyrk2+
(C57BL/6N-Dyrk2em1(IMPC)Ics/Ics)
|
decreased large unstained cell number
|
J:211773
|
E2f1tm1Meg/E2f1tm1Meg
(either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
|
abnormal double-positive T cell morphology
|
J:33100
|
| increased CD4-positive, alpha-beta T cell number
|
J:33100
|
| increased CD8-positive, alpha-beta T cell number
|
J:33100
|
| increased thymocyte number
|
J:33100
|
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93708
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:93708
|
| abnormal double-positive T cell morphology
|
J:93708
|
| decreased double-positive T cell number
|
J:93708
|
| decreased regulatory T cell number
|
J:93708
|
| increased T cell number
|
J:93708
|
| increased thymocyte number
|
J:93708
|
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:76318
|
| abnormal T cell subpopulation ratio
|
J:76318
|
| increased memory T cell number
|
J:76318
|
E2f2tm1Zubi/E2f2tm1Zubi
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)
|
increased CD8-positive, alpha-beta T cell number
|
J:76318
|
E2f4tm1Jrn/E2f4tm1Jrn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased double-positive T cell number
|
J:64192
|
| decreased thymocyte number
|
J:64192
|
| increased double-negative T cell number
|
J:64192
|
| increased NK cell number
|
J:64192
|
Ebag9tm1Rehm/Ebag9tm1Rehm
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:152534
|
Ebf1m1Btlr/Ebf1m1Btlr
(C57BL/6J-Ebf1m1Btlr)
|
decreased B cell number
|
J:265157
|
| increased CD4-positive, alpha-beta T cell number
|
J:265157
|
| increased single-positive T cell number
|
J:265157
|
| increased T cell number
|
J:265157
|
Ebf1m2Btlr/Ebf1m2Btlr
(C57BL/6J-Ebf1m2Btlr)
|
decreased B cell number
|
J:265158
|
| decreased B-1 B cell number
|
J:265158
|
| decreased B-2 B cell number
|
J:265158
|
| increased B-1a cell number
|
J:265158
|
| increased B-1b cell number
|
J:265158
|
| increased CD4-positive, alpha-beta T cell number
|
J:265158
|
| increased single-positive T cell number
|
J:265158
|
| increased T cell number
|
J:265158
|
Ebf1M3Btlr/Ebf1M3Btlr
(C57BL/6J-Ebf1M3Btlr)
|
decreased B-1 B cell number
|
J:265160
|
| increased CD4-positive, alpha-beta T cell number
|
J:265160
|
| increased single-positive T cell number
|
J:265160
|
| increased T cell number
|
J:265160
|
Ebf1M4Btlr/Ebf1M4Btlr
(C57BL/6J-Ebf1M4Btlr)
|
decreased B cell number
|
J:267560
|
| decreased NK cell number
|
J:267560
|
| increased alpha-beta T cell number
|
J:267560
|
| increased CD4-positive, alpha-beta T cell number
|
J:267560
|
| increased CD8-positive, alpha-beta T cell number
|
J:267560
|
Ebf1M5Btlr/Ebf1M5Btlr
(C57BL/6J-Ebf1M5Btlr)
|
abnormal lymphocyte morphology
|
J:272841
|
| decreased B cell number
|
J:272841
|
| decreased B-1 B cell number
|
J:272841
|
Ebf1m6Btlr/Ebf1m6Btlr
(C57BL/6J-Ebf1m6Btlr)
|
abnormal lymphocyte morphology
|
J:272842
|
| decreased B cell number
|
J:272842
|
| decreased B-1 B cell number
|
J:272842
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:272842
|
| increased alpha-beta T cell number
|
J:272842
|
| increased CD4-positive, alpha-beta T cell number
|
J:272842
|
| increased CD8-positive, alpha-beta T cell number
|
J:272842
|
Ebf1Serv/Ebf1+
(C57BL/6JAnu-Ebf1Serv)
|
decreased B cell number
|
J:104190
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased B-1 B cell number
|
J:182210
|
| decreased marginal zone B cell number
|
J:182210
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6 * SJL)
|
arrested B cell differentiation
|
J:182210
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased germinal center B cell number
|
J:182210
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: C57BL/6 * SJL)
|
arrested B cell differentiation
|
J:182210
|
| decreased germinal center B cell number
|
J:182210
|
| decreased immature B cell number
|
J:182210
|
| decreased marginal zone B cell number
|
J:182210
|
| decreased pre-B cell number
|
J:182210
|
| decreased transitional stage B cell number
|
J:182210
|
| increased B cell number
|
J:182210
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Polr2atm1(cre/ERT2)Bbd/Polr2a+
Tg(BCL2)#Wehi/0
(involves: C57BL/6 * C57BL/6JWehi * SJL * SJL/JWehi)
|
decreased immature B cell number
|
J:182210
|
| decreased pre-B cell number
|
J:182210
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6 * SJL)
|
decreased B-1 B cell number
|
J:182210
|
| decreased marginal zone B cell number
|
J:182210
|
Ebf1tm1Rug/Ebf1tm1Rug
(involves: 129S2/SvPas)
|
abnormal B cell morphology
|
J:52607
|
| absent B-1 B cells
|
J:52607
|
| absent mature B cells
|
J:52607
|
| arrested B cell differentiation
|
J:52607
|
| decreased pro-B cell number
|
J:52607
|
Ebf1tm1Rug/Ebf1tm1Rug
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
increased osteoclast cell number
|
J:147179
|
Ebi3Gt716Lex/Ebi3Gt716Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:286951
|
| increased CD8-positive, alpha-beta T cell number
|
J:286951
|
| increased macrophage cell number
|
J:286951
|
Ebi3Gt716Lex/Ebi3Gt716Lex
Tg(DO11.10)10Dlo/0
(involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:134148
|
Ebi3tm1Rsb/Ebi3tm1Rsb
(involves: 129X1/SvJ * C57BL/6)
|
abnormal T-helper 1 cell morphology
|
J:97822
|
| abnormal T-helper 2 cell morphology
|
J:97822
|
| decreased NK cell number
|
J:81014
|
| decreased T-helper 2 cell number
|
J:81014
|
Ecrg4tm1b(EUCOMM)Hmgu/Ecrg4tm1b(EUCOMM)Hmgu
(C57BL/6N-Ecrg4tm1b(EUCOMM)Hmgu/Orl)
|
decreased large unstained cell number
|
J:211773
|
Ednrbtm1Nrd/Ednrbtm1Nrd
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA/J)
|
abnormal mature B cell number
|
J:233811
|
| decreased B cell number
|
J:233811
|
| decreased germinal center B cell number
|
J:233811
|
| decreased marginal zone B cell number
|
J:233811
|
Eef1a1tm2Arge/Eef1a1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal double-positive T cell morphology
|
J:197167
|
Eef1a2wst/Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J)
|
decreased plasma cell number
|
J:7903
|
Efhd2tm1(KOMP)Vlcg/Efhd2tm1(KOMP)Vlcg
(C57BL/6-Efhd2tm1(KOMP)Vlcg)
|
increased germinal center B cell number
|
J:228565
|
| increased plasma cell number
|
J:228565
|
Efnb1tm1.1Jwu/Efnb1tm1.1Jwu
Efnb2tm1.1Jwu/Efnb2tm1.1Jwu
Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm)
|
abnormal T cell differentiation
|
J:178148
|
| abnormal T-helper 1 cell differentiation
|
J:178148
|
| abnormal T-helper 17 cell differentiation
|
J:178148
|
| decreased CD4-positive, alpha-beta T cell number
|
J:178148
|
| decreased CD8-positive, alpha-beta T cell number
|
J:178148
|
| decreased DN4 thymocyte number
|
J:178148
|
| decreased double-positive T cell number
|
J:178148
|
| decreased T cell number
|
J:178148
|
| increased DN3 thymocyte number
|
J:178148
|
| increased double-negative T cell number
|
J:178148
|
Eftud2tm1b(KOMP)Wtsi/Eftud2+
(C57BL/6N-Eftud2tm1b(KOMP)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Egfrtm1Dwt/Egfrtm1Dwt
Sox9tm3(cre)Crm/Sox9+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
increased T-helper 1 cell number
|
J:229771
|
| increased T-helper 2 cell number
|
J:229771
|
| increased T-helper 17 cell number
|
J:229771
|
Egln1tm1.1Brei/Egln1tm1.1Brei
Tg(CD68-icre)1Bwlx/0
(involves: C57BL/6)
|
abnormal lymphocyte cell number
|
J:194598
|
Egr1tm1b(NCOM)Mfgc/Egr1+
(C57BL/6N-Egr1tm1b(NCOM)Mfgc/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Egr1tm1Jmi/Egr1tm1Jmi
(B6.129-Egr1tm1Jmi)
|
increased osteoclast cell number
|
J:51107
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
increased lymphocyte cell number
|
J:123870
|
Eif1adtm1b(EUCOMM)Hmgu/Eif1ad+
(C57BL/6N-Eif1adtm1b(EUCOMM)Hmgu/Bay)
|
increased large unstained cell number
|
J:211773
|
Eif4btm1.1Smoc/Eif4btm1.1Smoc
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * C57BL/6)
|
decreased lymphocyte cell number
|
J:311140
|
| decreased NK cell number
|
J:311140
|
| increased macrophage cell number
|
J:311140
|
Elapor1tm1b(EUCOMM)Hmgu/Elapor1+
(C57BL/6N-Elapor1tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Elavl1tm1.1Atas/Elavl1tm1.1Atas
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6)
|
decreased T-helper 17 cell number
|
J:207013
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo)
|
increased macrophage cell number
|
J:184388
|
| increased monocyte cell number
|
J:184388
|
Elavl1tm1Dkon/Elavl1tm1Dkon
Tg(Lck-cre)I57Jxm/0
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm)
|
abnormal positive T cell selection
|
J:148866
|
| decreased CD4-positive, alpha-beta T cell number
|
J:148866
|
| decreased CD8-positive, alpha-beta T cell number
|
J:148866
|
| increased double-negative T cell number
|
J:148866
|
| increased double-positive T cell number
|
J:148866
|
| increased single-positive T cell number
|
J:148866
|
Elavl1tm1Dkon/Elavl1tm1Dkon
Tg(Lck-cre)I57Jxm/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm Tg(TcraH-Y,TcrbH-Y)71Vbo)
|
abnormal negative T cell selection
|
J:148866
|
| increased thymocyte number
|
J:148866
|
Elavl1tm1Thla/Elavl1tm1Thla
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129)
|
decreased double-positive T cell number
|
J:155109
|
Elf1tm1Jml/Elf1tm1Jml
(Not Specified)
|
abnormal B cell differentiation
|
J:100734
|
Elf4em1Hdu/Elf4em1Hdu
(C57BL/6-Elf4em1Hdu)
|
abnormal CD4-positive T cell differentiation
|
J:328935
|
Elf4tm1Nim/Elf4tm1Nim
(B6.129S1-Elf4tm1Nim)
|
abnormal lymphocyte morphology
|
J:79568
|
| abnormal T cell differentiation
|
J:79568
|
| decreased NK cell number
|
J:79568
|
| decreased NK T cell number
|
J:79568
|
| increased B cell number
|
J:79568
|
Elk4tm1a(EUCOMM)Wtsi/Elk4tm1a(EUCOMM)Wtsi
(C57BL/6N-Elk4tm1a(EUCOMM)Wtsi/H)
|
decreased CD4-positive, alpha-beta T cell number
|
J:165965
|
| decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased mature B cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
| increased B cell number
|
J:165965
|
| increased T cell number
|
J:165965
|
Elk4tm1Rtr/Elk4tm1Rtr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
abnormal positive T cell selection
|
J:88515
|
| abnormal T cell selection
|
J:88515
|
| decreased CD4-positive, alpha-beta T cell number
|
J:88515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:88515
|
| decreased single-positive T cell number
|
J:88515
|
| decreased T cell number
|
J:88515
|
| decreased thymocyte number
|
J:88515
|
Elk4tm1Rtr/Elk4tm1Rtr
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129/Sv * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:88515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:88515
|
Elk4tm1Rtr/Elk4tm1Rtr
Tg(TcraTcrb)425Cbn/?
(involves: 129/Sv * C57BL/6)
|
abnormal positive T cell selection
|
J:88515
|
| decreased CD4-positive, alpha-beta T cell number
|
J:88515
|
Elk4tm1Rtr/Elk4tm1Rtr
Tg(TcrLCMV)327Sdz/?
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:88515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:88515
|
Elmo1M1Btlr/Elmo1M1Btlr
(C57BL/6J-Elmo1M1Btlr)
|
decreased B cell number
|
J:265231
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:265231
|
| increased B-1 B cell number
|
J:265231
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265231
|
Elmo1m2Btlr/Elmo1m2Btlr
(C57BL/6J-Elmo1m2Btlr)
|
decreased B cell number
|
J:265232
|
Elmo1m3Btlr/Elmo1m3Btlr
(C57BL/6J-Elmo1m3Btlr)
|
decreased central memory CD8 positive, alpha-beta T cell number
|
J:271894
|
| decreased NK cell number
|
J:271894
|
| increased CD8-positive, alpha-beta T cell number
|
J:271894
|
Elmo1M4Btlr/Elmo1M4Btlr
(C57BL/6J-Elmo1M4Btlr)
|
abnormal B cell morphology
|
J:271969
|
| abnormal T cell morphology
|
J:271969
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271969
|
| increased B-1 B cell number
|
J:271969
|
| increased CD8-positive, alpha-beta T cell number
|
J:271969
|
Elmod1tm1a(EUCOMM)Hmgu/Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H)
|
decreased B cell number
|
J:165965
|
Elmod1tm1b(EUCOMM)Hmgu/Elmod1tm1b(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1b(EUCOMM)Hmgu/H)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
Emp2tm1.1Tac/Emp2tm1.1Tac
Tg(Zp3-cre)93Knw/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
increased uterine NK cell number
|
J:243365
|
Emsyem1(IMPC)Ccpcz/Emsy+
(C57BL/6NCrl-Emsyem1(IMPC)Ccpcz/Ccpcz)
|
increased NK cell number
|
J:211773
|
Emv72b/Emv72b
(CAnNCr.B6NCr-Emv72b)
|
abnormal T cell morphology
|
J:194735
|
En1tm1(Tnf)Fpit/En1tm1(Tnf)Fpit
(involves: C57BL/6)
|
increased monocyte cell number
|
J:170743
|
| microgliosis
|
J:170743
|
Entpd1tm1a(EUCOMM)Wtsi/Entpd1tm1a(EUCOMM)Wtsi
(C57BL/6N-Entpd1tm1a(EUCOMM)Wtsi/Ieg)
|
increased T cell number
|
J:165965
|
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal Kupffer cell morphology
|
J:163795
|
Entpd7tm1Ktak/Entpd7tm1Ktak
(B6.Cg-Entpd7tm1Ktak)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:191188
|
| increased T-helper 17 cell number
|
J:191188
|
Eomestm1.1Bflu/Eomestm1.1Bflu
Tbx21tm1Glm/Tbx21tm1Glm
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:163822
|
| decreased CD8-positive, alpha-beta T cell number
|
J:163822
|
| decreased memory T cell number
|
J:163822
|
Eomestm1.1Bflu/Eomestm1.1Bflu
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased memory T cell number
|
J:163822
|
Eomestm1.1Twa/?
Il15tm1Imx/Il15tm1Imx
(involves: C57BL/6 * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
Eomestm1.1Twa/?
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
Eomestm1.1Twa/?
Tg(CD2-Tbx21)#Staka/?
(involves: C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
Eomestm1.1Twa/?
Tg(Itgax-TGFBR2)1Flv/?
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
Eomestm1Apr/Eomes+
(involves: C57BL/6)
|
decreased memory T cell number
|
J:112679
|
| decreased NK cell number
|
J:112679
|
Eomestm1Apr/Eomes+
Tbx21tm1Srnr/Tbx21tm1Srnr
(involves: C57BL/6)
|
decreased memory T cell number
|
J:112679
|
| decreased NK cell number
|
J:112679
|
| decreased NK T cell number
|
J:112679
|
Eomestm1Srnr/Eomestm1Srnr
Tbx21tm1Srnr/Tbx21tm1Srnr
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:137655
|
| abnormal T cell morphology
|
J:137655
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137655
|
| decreased memory T cell number
|
J:137655
|
Eomestm1Srnr/Eomestm1Srnr
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased memory T cell number
|
J:137655
|
Ep300Plt6/Ep300Plt6
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell number
|
J:140200
|
| decreased lymphocyte cell number
|
J:140200
|
Ep300tm1Pkb/Ep300+
Mybtm1Ssp/Myb+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased thymocyte number
|
J:98329
|
Ep300tm1Pkb/Ep300tm1Pkb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:98329
|
Ep300tm2Pkb/Ep300tm2Pkb
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased single-positive T cell number
|
J:105505
|
| decreased thymocyte number
|
J:105505
|
| increased double-positive T cell number
|
J:105505
|
Epas1tm1.1Fsl/Epas1+
(involves: C57BL/6 * C57BL/6NTac)
|
increased lymphocyte cell number
|
J:199595
|
| increased monocyte cell number
|
J:199595
|
Epas1tm1.1Fsl/Epas1tm1.1Fsl
(involves: C57BL/6 * C57BL/6NTac)
|
increased monocyte cell number
|
J:199595
|
Epcamtm1.1Mcu/Epcamtm1.1Mcu
Tg(CD207-cre)1Dhka/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL/J)
|
abnormal Langerhans cell morphology
|
J:182665
|
Epdr1tm1b(NCOM)Mfgc/Epdr1tm1b(NCOM)Mfgc
(C57BL/6N-Epdr1tm1b(NCOM)Mfgc/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Epg5em1(IMPC)H/Epg5em1(IMPC)H
(C57BL/6NTac-Epg5em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Epg5tm1Ygz/Epg5tm1Ygz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
microgliosis
|
J:196603
|
epi/?
(involves: CBA/J)
|
decreased lymphocyte cell number
|
J:27487
|
Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+
(involves: C57BL/6J * CBA/J)
|
increased CD8-positive, alpha-beta T cell number
|
J:107545
|
Eps15tm1Noff/Eps15tm1Noff
(B6.129-Eps15tm1Noff)
|
decreased B cell number
|
J:195689
|
| decreased lymphocyte cell number
|
J:195689
|
| increased marginal zone B cell number
|
J:195689
|
Eps15tm1Noff/Eps15tm1Noff
(involves: 129 * C57BL/6)
|
abnormal marginal zone B cell morphology
|
J:195689
|
| increased marginal zone B cell number
|
J:195689
|
| increased transitional stage T1 B cell number
|
J:195689
|
Epsti1em1Mjnh/Epsti1em1Mjnh
(Not Specified)
|
abnormal macrophage differentiation
|
J:272013
|
| decreased macrophage cell number
|
J:272013
|
Epxtm1b(EUCOMM)Wtsi/Epxtm1b(EUCOMM)Wtsi
(C57BL/6N-Epxtm1b(EUCOMM)Wtsi/Orl)
|
increased monocyte cell number
|
J:211773
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:92471
|
Ercc2tm3Jhjh/Ercc2tm3Jhjh
(involves: 129 * C57BL/6J)
|
microgliosis
|
J:179808
|
Ercc6tm1Gvh/Ercc6tm1Gvh
(involves: 129P2/OlaHsd * C57BL/6J)
|
microgliosis
|
J:179808
|
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Gvh/Xpatm1Hvs
Tg(Camk2a-cre)1Szi/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA)
|
microgliosis
|
J:179808
|
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Gvh/Xpatm1Hvs
Tg(Pcp2-cre)2Mpin/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
microgliosis
|
J:179808
|
Ercc6l2em1Mengf/Ercc6l2em1Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
| decreased T cell number
|
J:311900
|
Ercc6l2em1Mengf/Ercc6l2em1Mengf
Nhej1em1Mengf/Nhej1em1Mengf
(Not Specified)
|
abnormal T cell receptor V(D)J recombination
|
J:311900
|
Ercc6l2em2Mengf/Ercc6l2em2Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
Ercc8tm1Jhjh/Ercc8tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6J)
|
microgliosis
|
J:179808
|
Ergmld2/Erg+
(involves: 129S1/Sv * C57BL/6)
|
decreased transitional stage B cell number
|
J:137835
|
Ern1tm1Rjk/Ern1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal pro-B cell morphology
|
J:106975
|
Esr1tm1.1Scma/Esr1tm1.1Scma
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
increased osteoclast cell number
|
J:156947
|
Esr1tm1Arnal/Esr1tm1Arnal
(involves: C57BL/6)
|
increased osteoclast cell number
|
J:171276
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell number
|
J:82423
|
| abnormal class switch recombination
|
J:82423
|
| decreased CD4-positive, alpha-beta T cell number
|
J:110416
|
| decreased CD8-positive, alpha-beta T cell number
|
J:110416
|
| increased double-positive T cell number
|
J:110416
|
| increased plasma cell number
|
J:88156
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:110923
|
| decreased mature B cell number
|
J:110923
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal B cell differentiation
|
J:63462
|
| decreased B cell number
|
J:63462
|
| decreased immature B cell number
|
J:63462
|
| decreased mature B cell number
|
J:63462
|
| decreased thymocyte number
|
J:111590
|
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell number
|
J:82423
|
| abnormal class switch recombination
|
J:82423
|
| decreased CD4-positive, alpha-beta T cell number
|
J:110416
|
| decreased CD8-positive, alpha-beta T cell number
|
J:110416
|
| increased double-positive T cell number
|
J:110416
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell number
|
J:82423
|
| abnormal lymphopoiesis
|
J:83617
|
| increased monocyte cell number
|
J:83617
|
| increased pre-B cell number
|
J:83617
|
| increased pro-B cell number
|
J:83617
|
Esrratm1Vgi/Esrratm1Vgi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal osteoclast differentiation
|
J:160910
|
| decreased osteoclast cell number
|
J:160910
|
Ess2tm1.1Nbioc/Ess2tm1.1Nbioc
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6N * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:339504
|
| decreased CD8-positive, alpha-beta T cell number
|
J:339504
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:339504
|
| decreased memory T cell number
|
J:339504
|
| increased gamma-delta T cell number
|
J:339504
|
| increased NK T cell number
|
J:339504
|
Ets1tm1.1Dds/Ets1+
(129S6/SvEvTac-Ets1tm1.1Dds)
|
decreased memory T cell number
|
J:121460
|
Ets1tm1.1Dds/Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:121460
|
| abnormal lymphopoiesis
|
J:121460
|
| decreased B cell number
|
J:121460
|
| decreased CD4-positive, alpha-beta T cell number
|
J:121460
|
| decreased memory T cell number
|
J:121460
|
| increased double-positive T cell number
|
J:121460
|
Ets1tm1Fwa/Ets1tm1Fwa
(B6.129S4-Ets1tm1Fwa)
|
abnormal B cell differentiation
|
J:93845
|
| absent B-1a cells
|
J:93845
|
| decreased B cell number
|
J:93845
|
| decreased mature B cell number
|
J:93845
|
| decreased pro-B cell number
|
J:93845
|
| increased pro-B cell number
|
J:93845
|
Ets1tm1Jml/Ets1tm1Jml
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125056
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125056
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125056
|
| increased double-negative T cell number
|
J:125056
|
Ets1tm1Jml/Ets1tm1Jml
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * DBA/2J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:125056
|
| increased double-negative T cell number
|
J:125056
|
Ets1tm2Jml/Ets1tm2Jml
(involves: 129X1/SvJ * C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:50627
|
| decreased NK cell number
|
J:50627
|
| decreased T cell number
|
J:50627
|
| decreased thymocyte number
|
J:50627
|
| increased plasma cell number
|
J:50627
|
Etv6em1(IMPC)Rbrc/Etv6+
(C57BL/6NJcl-Etv6em1(IMPC)Rbrc/Rbrc)
|
increased large unstained cell number
|
J:211773
|
Etv6em3Knic/Etv6+
(involves: C57BL/6J)
|
abnormal B cell number
|
J:342774
|
Etv6tm1(RUNX1)Haho/Etv6+
Tg(Gata1-cre)1Sho/0
(involves: 129S1/Sv * C57BL/6 * CD-1 * Swiss Webster)
|
abnormal B cell differentiation
|
J:151639
|
Etv6tm1(RUNX1)Haho/Etv6+
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:151639
|
| decreased B cell number
|
J:151639
|
| decreased lymphocyte cell number
|
J:151639
|
Etv6tm1(RUNX1)Haho/Etv6+
Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:151639
|
| decreased B cell number
|
J:151639
|
| decreased pre-B cell number
|
J:151639
|
| decreased pro-B cell number
|
J:151639
|
Ewsr1tm1(ERG)Thr/Ewsr1+
Rag1tm1(cre)Thr/Rag1+
(involves: 129S/SvEv)
|
increased lymphocyte cell number
|
J:98679
|
Ewsr1tm1b(EUCOMM)Wtsi/Ewsr1+
(C57BL/6N-Ewsr1tm1b(EUCOMM)Wtsi/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Ewsr1tm1Sblee/Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased double-positive T cell number
|
J:122058
|
| decreased immature B cell number
|
J:122058
|
| decreased mature B cell number
|
J:122058
|
| decreased pre-B cell number
|
J:122058
|
Exo1tm2Wed/Exo1tm2Wed
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:198719
|
| abnormal somatic hypermutation frequency
|
J:198719
|
Ezh1tm1Sgon/Ezh1tm1Sgon
Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:193722
|
| decreased immature B cell number
|
J:193722
|
| decreased pro-B cell number
|
J:193722
|
Ezh2tm1Tara/Ezh2tm1Tara
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd)
|
decreased germinal center B cell number
|
J:199122
|
Ezh2tm1Tara/Ezh2tm1Tara
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:83216
|
| abnormal immunoglobulin V(D)J recombination
|
J:83216
|
| abnormal pro-B cell morphology
|
J:83216
|
| decreased immature B cell number
|
J:83216
|
| decreased pre-B cell number
|
J:83216
|
Ezh2tm2Sho/Ezh2tm2.1Sho
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:182211
|
| decreased thymocyte number
|
J:182211
|
| increased double-negative T cell number
|
J:182211
|
Ezh2tm2Sho/Ezh2tm2Sho
Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased uterine NK cell number
|
J:290765
|
Ezh2tm2Sho/Ezh2tm2Sho
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:182211
|
| decreased thymocyte number
|
J:182211
|
| increased double-negative T cell number
|
J:182211
|
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
decreased B cell number
|
J:91165
|
Fabp1tm1b(EUCOMM)Hmgu/Fabp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fabp1tm1b(EUCOMM)Hmgu/Cnrm)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
Faddtm1Wnt/Faddtm1Wnt
Tg(Fadd)33Wnt/0
Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA * ICR)
|
abnormal T cell differentiation
|
J:69617
|
| decreased CD4-positive, alpha-beta T cell number
|
J:69617
|
| decreased CD8-positive, alpha-beta T cell number
|
J:69617
|
| decreased double-positive T cell number
|
J:69617
|
| increased B cell number
|
J:69617
|
| increased double-negative T cell number
|
J:69617
|
Faddtm1Wnt/Faddtm1Wnt
Tg(Fadd)33Wnt/0
Tg(Lck-cre)I57Jxm/0
Tg(Tcra2C,Tcrb2C)1Dlo/0
(involves: 129S4/SvJae * C57BL/6 * C57L * CBA * ICR * SJL)
|
increased double-negative T cell number
|
J:69617
|
Faddtm1Wnt/Faddtm1Wnt
Tg(Fadd/EGFP)#Jizh/?
Tg(Cd4-cre)1Cwi/?
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased activated T cell number
|
J:113207
|
| decreased single-positive T cell number
|
J:113207
|
| increased B cell number
|
J:113207
|
Faddtm1Wnt/Faddtm1Wnt
Tg(Fadd/EGFP)#Jizh/?
Tg(Lck-cre)1Cwi/?
(involves: 129S4/SvJae)
|
decreased activated T cell number
|
J:113207
|
| decreased single-positive T cell number
|
J:113207
|
| increased B cell number
|
J:113207
|
Faddtm2.1Wnt/Faddtm2.1Wnt
Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Faddtm2.1Wnt)
|
abnormal T cell subpopulation ratio
|
J:162312
|
| increased B cell number
|
J:162312
|
Fads1Gt(IST11525H2)Tigm/Fads1Gt(IST11525H2)Tigm
(C57BL/6-Fads1Gt(IST11525H2)Tigm)
|
abnormal mononuclear cell morphology
|
J:186265
|
| decreased regulatory T cell number
|
J:186265
|
Fam3aem1Cya/Fam3aem1Cya
(involves: C57BL/6)
|
increased macrophage cell number
|
J:295206
|
| increased NK T cell number
|
J:295206
|
| increased T cell number
|
J:295206
|
Fam3dem1Wko/Fam3dem1Wko
(C57BL/6-Fam3dem1Wko)
|
decreased Ly6C high monocyte number
|
J:304594
|
| decreased macrophage cell number
|
J:304594
|
Fam72atm1.1(KOMP)Vlcg/Fam72atm1.1(KOMP)Vlcg
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
| increased germinal center B cell number
|
J:326431
|
Fam72atm1.1(KOMP)Vlcg/Fam72atm1.1(KOMP)Vlcg
Msh2tm1Mak/Msh2tm1Mak
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
Fam83hem1(IMPC)Ccpcz/Fam83hem1(IMPC)Ccpcz
(C57BL/6N-Fam83hem1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
Fam110btm1a(EUCOMM)Wtsi/Fam110b+
(C57BL/6N-Fam110btm1a(EUCOMM)Wtsi/Cnrm)
|
decreased mature B cell number
|
J:165965
|
Fam161aGt(462E7)Cmhd/Fam161aGt(462E7)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
microgliosis
|
J:214319
|
Fam210atm1b(EUCOMM)Wtsi/Fam210a+
(involves: BALB/cJ * C57BL/6N)
|
increased osteoclast cell number
|
J:261817
|
Fam210atm1c(EUCOMM)Wtsi/Fam210atm1c(EUCOMM)Wtsi
Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: C3H * C57BL/6N * SJL)
|
increased osteoclast cell number
|
J:261817
|
Fam210atm1c(EUCOMM)Wtsi/Fam210atm1c(EUCOMM)Wtsi
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6N * CBA * SJL)
|
increased osteoclast cell number
|
J:261817
|
Fam210btm1b(KOMP)Mbp/Fam210btm1b(KOMP)Mbp
(C57BL/6N-Fam210btm1b(KOMP)Mbp/Ucd)
|
increased monocyte cell number
|
J:211773
|
Fam221aem1(IMPC)Ccpcz/Fam221aem1(IMPC)Ccpcz
(C57BL/6N-Fam221aem1(IMPC)Ccpcz/Ccpcz)
|
increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
Fam234btm1a(EUCOMM)Wtsi/Fam234btm1a(EUCOMM)Wtsi
(C57BL/6N-Fam234btm1a(EUCOMM)Wtsi/Cnrm)
|
decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
Fancctm1Mab/Fancctm1Mab
Sod1tm1Cep/Sod1tm1Cep
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphocyte morphology
|
J:71134
|
| decreased lymphocyte cell number
|
J:71134
|
Farp2tm1Akum/Farp2tm1Akum
(B6.Cg-Farp2tm1Akum)
|
decreased osteoclast cell number
|
J:166376
|
| increased osteoclast cell number
|
J:166376
|
Faslpr-cg/Faslpr-cg
(CBA/KlJms-Faslpr-cg/J)
|
abnormal T cell differentiation
|
J:24805
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
abnormal B cell morphology
|
J:108760
|
| abnormal B cell receptor editing
|
J:131138
|
| abnormal marginal zone B cell morphology
|
J:131138
|
| abnormal T cell morphology
|
J:108760,
J:8267
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J)
|
decreased immature B cell number
|
J:122315
|
| decreased marginal zone B cell number
|
J:122315
|
| decreased mature B cell number
|
J:122315
|
| decreased transitional stage B cell number
|
J:122315
|
| increased plasma cell number
|
J:122315
|
Faslpr/Faslpr
(B6.MRL-Faslpr/J)
|
increased follicular B cell number
|
J:132217
|
| increased immature B cell number
|
J:132217
|
| increased marginal zone B cell number
|
J:132217
|
| increased transitional stage B cell number
|
J:132217
|
Faslpr/Faslpr
(C3.MRL-Faslpr/J)
|
abnormal T cell morphology
|
J:7454
|
Faslpr/Faslpr
(B6.MRL-Faslpr)
|
increased double-negative T cell number
|
J:135036
|
Faslpr/Faslpr
(C3.MRL-Faslpr)
|
abnormal T cell morphology
|
J:8267
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr)
|
decreased activated T cell number
|
J:137066
|
| decreased B cell number
|
J:137066
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137066
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137066
|
| increased double-negative T cell number
|
J:137066
|
Faslpr/Faslpr
(involves: 129P2/OlaHsd * MRL)
|
increased double-negative T cell number
|
J:26250
|
| increased gamma-delta T cell number
|
J:26250
|
Faslpr/Faslpr
Fcer1gtm1Tks/Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr)
|
increased double-negative T cell number
|
J:106188
|
Faslpr/Faslpr
Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch Faslpr)
|
increased activated T cell number
|
J:186484
|
| increased B cell number
|
J:186484
|
| increased CD4-positive, alpha-beta T cell number
|
J:186484
|
| increased CD8-positive, alpha-beta T cell number
|
J:186484
|
| increased double-negative T cell number
|
J:186484
|
| increased T cell number
|
J:186484
|
Faslpr/Faslpr
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)
|
decreased double-negative T cell number
|
J:39600
|
Faslpr/Faslpr
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(MRL.Cg-Faslpr Igh-Jtm2(3H9-VDJ*)Mwg)
|
abnormal B cell receptor editing
|
J:131138
|
| abnormal marginal zone B cell morphology
|
J:131138
|
Faslpr/Faslpr
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6 * MRL/Mp)
|
arrested B cell differentiation
|
J:119584
|
| decreased mature B cell number
|
J:119584
|
| increased T cell number
|
J:119584
|
Faslpr/Faslpr
Irf1tm1Mak/Irf1+
(MRL.Cg-Irf1tm1Mak Faslpr)
|
increased CD4-positive, alpha-beta T cell number
|
J:114771
|
Faslpr/Faslpr
Irf1tm1Mak/Irf1tm1Mak
(MRL.Cg-Irf1tm1Mak Faslpr)
|
increased CD4-positive, alpha-beta T cell number
|
J:114771
|
Faslpr/Faslpr
Itfg2Gt(OST215121)Lex/Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)
|
decreased B cell number
|
J:205951
|
| increased double-negative T cell number
|
J:205951
|
Faslpr/Faslpr
Pou2af1tm1Pmt/Pou2af1tm1Pmt
(involves: 129P2/OlaHsd * C57BL/6 * MRL)
|
abnormal T cell number
|
J:125114
|
| decreased plasma cell number
|
J:125114
|
| increased B cell number
|
J:125114
|
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * MRL)
|
increased gamma-delta intraepithelial T cell number
|
J:26250
|
| increased gamma-delta T cell number
|
J:26250
|
| increased T cell number
|
J:26250
|
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp)
|
decreased CD4-positive, alpha-beta T cell number
|
J:122222
|
| increased double-negative T cell number
|
J:122222
|
Faslpr/Faslpr
Tg(H2-K-Cd86)27All/0
(involves: C57BL/6 * CBA * MRL/MpJ)
|
decreased B cell number
|
J:112475
|
Faslpr/Faslpr
Tlr7tm1Flv/Y
(involves: 129S1/Sv * C57BL/6 * MRL/Mp)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:113557
|
| decreased double-negative T cell number
|
J:113557
|
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(B6.Cg-Tlr9tm1Aki Faslpr)
|
increased double-negative T cell number
|
J:135036
|
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr)
|
increased CD4-positive, alpha-beta T cell number
|
J:113557
|
| increased double-negative T cell number
|
J:113557
|
Faslpr/Faslpr
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr)
|
increased B-1 B cell number
|
J:127197
|
| increased B-2 B cell number
|
J:127197
|
| increased CD4-positive, alpha-beta T cell number
|
J:127197,
J:126929
|
| increased double-negative T cell number
|
J:127197,
J:126929
|
Faslpr/Faslpr
Tnfrsf13cBcmd1/Tnfrsf13c+
(MRL.Cg-Tnfrsf13cBcmd1 Faslpr)
|
decreased B cell number
|
J:122315
|
| decreased marginal zone B cell number
|
J:122315
|
Faslpr/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * MRL)
|
increased double-negative T cell number
|
J:114948
|
Fasm1Btlr/Fasm1Btlr
(C57BL/6J-Fasm1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:216052
|
| decreased CD8-positive, alpha-beta T cell number
|
J:216052
|
| increased NK cell number
|
J:216052
|
Fasm2Btlr/Fasm2Btlr
(C57BL/6J-Fasm2Btlr)
|
increased central memory CD4-positive, alpha-beta T cell number
|
J:271891
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:271891
|
Fastm1Ach/Fastm1Ach
Tg(GZMB-cre)1Jcb/?
(involves: C57BL/6 * FVB/N)
|
increased double-positive T cell number
|
J:123556
|
Fastm1Ach/Fastm1Ach
Tg(Lck-cre)548Jxm/?
(involves: C57BL/6 * CBA)
|
increased double-positive T cell number
|
J:123556
|
Fastm1Cgn/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn)
|
decreased B cell number
|
J:114948
|
| decreased T cell number
|
J:114948
|
| increased activated T cell number
|
J:114948
|
| increased double-negative T cell number
|
J:114948
|
| increased memory T cell number
|
J:114948
|
Fastm1Osa/Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell clonal deletion
|
J:32125
|
| increased B cell number
|
J:32125
|
| increased lymphocyte cell number
|
J:64296,
J:32125
|
Faslgld/Faslgld
(C3H/HeJ-Faslgld/J)
|
abnormal T cell differentiation
|
J:12002,
J:8267
|
| decreased B cell number
|
J:29572
|
| increased lymphocyte cell number
|
J:7306,
J:29572
|
| increased T cell number
|
J:29572
|
Faslgld/Faslgld
(C3H/HeJ-Faslgld)
|
abnormal T cell morphology
|
J:8267
|
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6)
|
increased T cell number
|
J:153501
|
Fasltm1.1Cgm/Fasltm1.1Cgm
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N)
|
increased germinal center B cell number
|
J:168406
|
| increased plasma cell number
|
J:168406
|
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:87990
|
Fblim1tm1.1Chen/Fblim1tm1.1Chen
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal osteoclast differentiation
|
J:186501
|
| increased osteoclast cell number
|
J:186501
|
Fbn1em1(IMPC)H/Fbn1+
(C57BL/6NTac-Fbn1em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Fbn1tm2.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal T-helper 1 cell morphology
|
J:206074
|
| increased B cell number
|
J:206074
|
| increased plasma cell number
|
J:206074
|
Fbn1tm3.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal T-helper 1 cell morphology
|
J:206074
|
| increased B cell number
|
J:206074
|
| increased plasma cell number
|
J:206074
|
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk)
|
abnormal uterine NK cell morphology
|
J:1377
|
Fbxl19tm1b(EUCOMM)Wtsi/Fbxl19+
(C57BL/6N-Fbxl19tm1b(EUCOMM)Wtsi/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Fbxo7tm1a(EUCOMM)Hmgu/Fbxo7tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
increased pro-B cell number
|
J:183053
|
Fbxo7tm1a(EUCOMM)Wtsi/Fbxo7tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal effector T cell number
|
J:272313
|
| abnormal T cell differentiation
|
J:272313
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272313
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272313
|
| decreased T cell number
|
J:272313
|
| increased activated T cell number
|
J:272313
|
| increased double-negative T cell number
|
J:272313
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272313
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272313
|
| increased memory T cell number
|
J:272313
|
Fbxo7tm1c(EUCOMM)Wtsi/Fbxo7tm1c(EUCOMM)Wtsi
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6J * C57BL/6N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272313
|
| decreased T cell number
|
J:272313
|
Fbxo21em1Smbk/Fbxo21em1Smbk
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Fbxo21em1Smbk Commd10Tg(Vav1-icre)A2Kio)
|
increased T cell number
|
J:333469
|
Fbxo36tm1b(KOMP)Wtsi/Fbxo36tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo36tm1b(KOMP)Wtsi/Nju)
|
decreased monocyte cell number
|
J:211773
|
Fbxw7tm1Iaai/Fbxw7tm1Iaai
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:137138
|
| decreased double-negative T cell number
|
J:137138
|
Fbxw7tm1Iaai/Fbxw7tm1Iaai
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:200006
|
Fbxw7tm1Kei/Fbxw7tm1Kei
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased double-positive T cell number
|
J:128523
|
Fbxw7tm1Kei/Fbxw7tm1Kei
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-positive T cell number
|
J:128523
|
Fbxw7tm1Kei/Fbxw7tm1Kei
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested T cell differentiation
|
J:128523
|
| decreased single-positive T cell number
|
J:128523
|
| increased double-positive T cell number
|
J:128523
|
Fbxw8tm1b(EUCOMM)Hmgu/Fbxw8+
(C57BL/6N-Fbxw8tm1b(EUCOMM)Hmgu/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
Fbxw16em1(IMPC)Ccpcz/Fbxw16+
(C57BL/6N-Fbxw16em1(IMPC)Ccpcz/Ccpcz)
|
increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
Fbxw26tm1b(KOMP)Wtsi/Fbxw26tm1b(KOMP)Wtsi
(C57BL/6N-Fbxw26tm1b(KOMP)Wtsi/Wtsi)
|
decreased memory-marker NK cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
Fcamrtm1Shib/Fcamrtm1Shib
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal memory B cell differentiation
|
J:150824
|
| abnormal somatic hypermutation frequency
|
J:150824
|
Fcer1gtm1Rav/Fcer1gtm1Rav
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased uterine NK cell number
|
J:100668
|
Fcer1gtm1Rav/Fcer1gtm1Rav
Tyrobptm1Lll/Tyrobptm1Lll
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:89583
|
Fcgr2btm1.2Jsv/Fcgr2b+
X/Yaa
(involves: C57BL/6 * FVB/N * SB/Le)
|
increased monocyte cell number
|
J:179175
|
Fcgr2btm1Kgcs/Fcgr2b+
(involves: C57BL/6)
|
increased germinal center B cell number
|
J:190890
|
Fcgr2btm1Ttk/Fcgr2b+
X/Yaa
(involves: 129S4/SvJae * C57BL/6 * SB/Le)
|
increased monocyte cell number
|
J:129409
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Il17atm1Yiw/Il17a+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased plasma cell number
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased double-negative T cell number
|
J:191090
|
| increased plasma cell number
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell morphology
|
J:191090
|
| increased double-negative T cell number
|
J:191090
|
| increased memory T cell number
|
J:191090
|
| increased monocyte cell number
|
J:191090
|
| increased myeloid dendritic cell number
|
J:191090
|
| increased plasma cell number
|
J:191090
|
| increased single-positive T cell number
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell morphology
|
J:191090
|
| increased double-negative T cell number
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm2Sbn/Traf3ip2+
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased germinal center B cell number
|
J:191090
|
| increased plasma cell number
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm2Sbn/Traf3ip2tm2Sbn
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased germinal center B cell number
|
J:191090
|
| increased plasma cell number
|
J:191090
|
Fcgr3tm1Jsv/Fcgr3tm1Jsv
Sle21129P2/Ola/Sle21129P2/Ola
(B6.129P2-Fcgr3tm1Jsv)
|
increased activated T cell number
|
J:179175
|
| increased B cell number
|
J:179175
|
Fcgr4tm1Rav/Fcgr4tm1Rav
Tg(Ctsk-cre)1Rda/0
(involves: C57BL/6)
|
decreased osteoclast cell number
|
J:197378
|
Fcmrtm1.2Khl/Fcmrtm1.2Khl
(involves: C57BL/6)
|
decreased B cell number
|
J:174871
|
Fcmrtm1Ohno/Fcmrtm1Ohno
(B6.129-Fcmrtm1Ohno)
|
abnormal B cell morphology
|
J:190117
|
| decreased marginal zone B cell number
|
J:190117
|
| increased B-1 B cell number
|
J:190117
|
| increased T cell number
|
J:190117
|
Fcrl2tm1Lex/Fcrl2tm1Lex
(B6;129S5-Fcrl2tm1Lex/Mmucd)
|
decreased CD8-positive, alpha-beta T cell number
|
J:171883
|
Fen1tm3.1Bhsh/Fen1+
(Not Specified)
|
increased plasma cell number
|
J:231218
|
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified)
|
increased plasma cell number
|
J:231218
|
Fermt3tm2.1Ref/Fermt3tm2.1Ref
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal effector T cell morphology
|
J:203436
|
Festm1Mcs/Festm1Mcs
(involves: 129X1/SvJ)
|
decreased B cell number
|
J:64748
|
| increased monocyte cell number
|
J:64748
|
Festm2Pag/Festm2Pag
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased B cell number
|
J:98590
|
| increased pre-B cell number
|
J:98590
|
| increased pro-B cell number
|
J:98590
|
Ffar2tm1Dgen/Ffar2tm1Dgen
(involves: C57BL/6)
|
increased T cell number
|
J:153951
|
Fgd3em1(IMPC)Ccpcz/Fgd3em1(IMPC)Ccpcz
(C57BL/6N-Fgd3em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
Fgf23tm1Tyam/Fgf23tm1Tyam
(involves: C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:88172
|
Fgfbp3tm1.1(KOMP)Wtsi/Fgfbp3tm1.1(KOMP)Wtsi
(C57BL/6N-Fgfbp3tm1.1(KOMP)Wtsi/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
Fgfr2tm1Dor/Fgfr2tm1.1Dor
Twist2tm1(cre)Dor/Twist2+
(involves: 129X1/SvJ)
|
abnormal osteoclast differentiation
|
J:90391
|
Fgfr2tm1Dsn/Fgfr2tm1Dsn
Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
increased gamma-delta T cell number
|
J:119723
|
Fgfr2tm1Ewj/Fgfr2+
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased osteoclast cell number
|
J:101174
|
Fgfr3tm1.1(FGFR3*)Ytc/Fgfr3+
(involves: 129)
|
decreased osteoclast cell number
|
J:287271
|
Fgfr3tm1.1(FGFR3*)Ytc/Fgfr3tm1.1(FGFR3*)Ytc
(involves: 129)
|
decreased osteoclast cell number
|
J:287271
|
Fgfr3tm1Led/Fgfr3tm1Led
(involves: 129S6/SvEvTac)
|
increased osteoclast cell number
|
J:32105
|
Fgfr3tm2Llm/Fgfr3+
Tg(CMV-cre)1Ipc/?
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
increased osteoclast cell number
|
J:183772
|
Fgfr3tm2Llm/Fgfr3+
Tg(Col2a1-cre)1Bhr/?
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
increased osteoclast cell number
|
J:183772
|
Fgfr4M1Btlr/Fgfr4M1Btlr
(C57BL/6J-Fgfr4M1Btlr)
|
decreased B-1a cell number
|
J:265097
|
Fgl1tm1b(EUCOMM)Hmgu/Fgl1tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N)
|
decreased B cell number
|
J:269578
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:269578
|
Fgl2tm1Pam/Fgl2tm1Pam
(B6.129X1-Fgl2tm1Pam)
|
increased regulatory T cell number
|
J:130895
|
Fgrtm1Hev/Fgrtm1Hev
Hcktm1Hev/Hcktm1Hev
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal macrophage morphology
|
J:59037
|
Fhip1bem1(IMPC)Tcp/Fhip1bem1(IMPC)Tcp
(C57BL/6NCrl-Fhip1bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Flcntm1Baba/Flcntm1.1Lss
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested B cell differentiation
|
J:189078
|
| decreased B cell number
|
J:189078
|
Fli1tm1.1Dkw/Fli1+
(B6.129S6-Fli1tm1.1Dkw)
|
decreased B cell number
|
J:137876
|
Fli1tm1.1Dkw/Fli1tm1.1Dkw
(B6.129S6-Fli1tm1.1Dkw)
|
abnormal B cell differentiation
|
J:137876
|
| abnormal class switch recombination
|
J:137876
|
| decreased B cell number
|
J:137876
|
| decreased follicular B cell number
|
J:137876
|
| increased marginal zone B cell number
|
J:137876
|
| increased transitional stage B cell number
|
J:137876
|
Fli1tm1Ber/Fli1tm1Ber
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1))
|
decreased thymocyte number
|
J:33052
|
Fli1tm1Morl/Fli1tm1Morl
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
increased monocyte cell number
|
J:167426
|
| increased NK cell number
|
J:167426
|
Flt1tm1.1Fong/Flt1tm1.1Fong
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6NCr * CD-1)
|
increased macrophage cell number
|
J:202202
|
Flt3em1(IMPC)Ccpcz/Flt3em1(IMPC)Ccpcz
(C57BL/6NCrl-Flt3em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
Flt3m1Btlr/Flt3m1Btlr
(C57BL/6J-Flt3m1Btlr)
|
decreased NK cell number
|
J:159599
|
Flt3tm1.1Dosm/Flt3+
(B6.129(C)-Flt3tm1.1Dosm)
|
arrested B cell differentiation
|
J:205200
|
Flt3tm1Dgg/Flt3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:126003
|
| decreased B cell number
|
J:126003
|
| decreased mature B cell number
|
J:126003
|
| decreased T cell number
|
J:126003
|
| increased monocyte cell number
|
J:126003
|
Flt3tm1Dgg/Flt3tm1Dgg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:126003
|
| decreased B cell number
|
J:126003
|
| decreased mature B cell number
|
J:126003
|
| decreased T cell number
|
J:126003
|
| increased monocyte cell number
|
J:126003
|
Flt3tm1Dosm/Flt3+
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Flt3tm1Dosm Tg(Mx1-cre)1Cgn)
|
arrested B cell differentiation
|
J:133528
|
| decreased B cell number
|
J:133528
|
| decreased lymphocyte cell number
|
J:133528
|
| decreased pre-B cell number
|
J:133528
|
| increased monocyte cell number
|
J:133528
|
| increased pro-B cell number
|
J:133528
|
Flt3tm1Irl/Flt3tm1Irl
(either: 129S/SvEv-Flt3tm1Irl or (involves: 129S/SvEv * C57BL/6J))
|
abnormal B cell differentiation
|
J:27238,
J:99149
|
| decreased pre-B cell number
|
J:27238
|
| decreased pro-B cell number
|
J:27238
|
Flt3tm1Irl/Flt3tm1Irl
KitW/KitW-v
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell number
|
J:27238
|
| decreased B cell number
|
J:27238
|
| decreased double-negative T cell number
|
J:27238
|
| decreased double-positive T cell number
|
J:27238
|
| decreased lymphocyte cell number
|
J:27238
|
| decreased pre-B cell number
|
J:27238
|
| decreased pro-B cell number
|
J:27238
|
Flt3tm2.1Dosm/Flt3+
(B6.129(C)-Flt3tm2.1Dosm)
|
abnormal B cell morphology
|
J:205200
|
| increased pre-pro B cell number
|
J:205200
|
| increased pro-B cell number
|
J:205200
|
Flt3ltm1Imx/Flt3ltm1Imx
(C57BL/6-Flt3ltm1Imx)
|
abnormal immature B cell morphology
|
J:62536
|
| decreased B cell number
|
J:79569
|
| decreased double-negative T cell number
|
J:79569
|
| decreased lymphocyte cell number
|
J:62536
|
| decreased myeloid dendritic cell number
|
J:62536,
J:89868
|
| decreased NK cell number
|
J:62536
|
| decreased pre-B cell number
|
J:79569
|
| decreased pro-B cell number
|
J:79569,
J:62536
|
Flt3ltm1Imx/Flt3ltm1Imx
(involves: C57BL/6)
|
decreased macrophage cell number
|
J:189122
|
| decreased monocyte cell number
|
J:189122
|
| decreased NK cell number
|
J:189122
|
Fmnl1tm1.2Sdb/Fmnl1tm1.2Sdb
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo
(involves: C3H * C57BL/6 * FVB/N)
|
abnormal Kupffer cell morphology
|
J:250144
|
| abnormal macrophage morphology
|
J:250144
|
| decreased macrophage cell number
|
J:250144
|
Fndc3aem1(IMPC)Tcp/Fndc3aem1(IMPC)Tcp
(C57BL/6N-Fndc3aem1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Fndc9tm1.1(KOMP)Vlcg/Fndc9tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc9tm1.1(KOMP)Vlcg/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
Fnip1Gt(RRM154)Byg/Fnip1Gt(RRM154)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| arrested B cell differentiation
|
J:189078
|
| decreased B cell number
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
| decreased mature B cell number
|
J:189078
|
| decreased pre-B cell number
|
J:189078
|
| decreased transitional stage B cell number
|
J:189078
|
| increased pro-B cell number
|
J:189078
|
Fnip1Gt(RRM154)Byg/Fnip1Gt(RRM154)Byg
Ightm2Cgn/Ightm2Cgn
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
Fnip1Gt(RRM154)Byg/Fnip1Gt(RRM154)Byg
Tg(BCL2)22Wehi/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
increased B cell number
|
J:189078
|
Fnip1Gt(RRM154)Byg/Fnip1Gt(RRM154)Byg
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
| increased immature B cell number
|
J:189078
|
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
|
absent B cells
|
J:187318
|
| arrested B cell differentiation
|
J:187318
|
| decreased B-1 B cell number
|
J:187318
|
Fnip1m1Btlr/Fnip1m1Btlr
(C57BL/6J-Fnip1m1Btlr)
|
absent B cells
|
J:234285
|
| decreased marginal zone B cell number
|
J:234285
|
Fnip1m2Btlr/Fnip1m2Btlr
(C57BL/6J-Fnip1m2Btlr)
|
decreased B cell number
|
J:265134
|
| increased B-1 B cell number
|
J:265134
|
| increased CD4-positive, alpha-beta T cell number
|
J:265134
|
| increased single-positive T cell number
|
J:265134
|
| increased T cell number
|
J:265134
|
Fnip1M3Btlr/Fnip1M3Btlr
(C57BL/6J-Fnip1M3Btlr)
|
abnormal B cell differentiation
|
J:272802
|
Fnip1tm1.2Baba/Fnip1tm1.2Baba
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| arrested B cell differentiation
|
J:189078
|
| decreased B cell number
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
| decreased mature B cell number
|
J:189078
|
| decreased pre-B cell number
|
J:189078
|
| decreased transitional stage B cell number
|
J:189078
|
| increased pro-B cell number
|
J:189078
|
Fnip1tm1.2Baba/Fnip1tm1.2Baba
Ightm2Cgn/Ightm2Cgn
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
Fnip1tm1.2Baba/Fnip1tm1.2Baba
Tg(BCL2)22Wehi/0
(involves: C57BL/6 * FVB/N * SJL)
|
increased B cell number
|
J:189078
|
Fnip1tm1.2Baba/Fnip1tm1.2Baba
Tg(IghelMD4)4Ccg/0
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
| increased immature B cell number
|
J:189078
|
Fostm1Pa/Fostm1Pa
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal lymphopoiesis
|
J:3233
|
Fostm1Wag/Fostm1Wag
(involves: 129S2/SvPas)
|
decreased osteoclast cell number
|
J:65766
|
Fostm1Wag/Fostm1Wag
(involves: 129S2/SvPas * C57BL/6)
|
decreased B cell number
|
J:3493
|
| decreased double-positive T cell number
|
J:3493
|
| decreased thymocyte number
|
J:3493
|
| increased T cell number
|
J:3493
|
Fostm1Wag/Fostm2(Fosl1)Wag
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased osteoclast cell number
|
J:65766
|
Fostm5.1Wag/Fostm5.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal osteoclast differentiation
|
J:175064
|
| decreased osteoclast cell number
|
J:175064
|
Fostm6.1Wag/Fostm6.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal osteoclast differentiation
|
J:175064
|
Fostm7Wag/Fostm7Wag
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:190150
|
Fosl2tm2.1Wag/Fosl2tm2.1Wag
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:137646
|
| abnormal osteoclast morphology
|
J:137646
|
| increased osteoclast cell number
|
J:137646
|
Fosl2tm2Wag/Fosl2tm2Wag
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:137646
|
Fosl2tm2Wag/Fosl2tm2Wag
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
abnormal osteoclast morphology
|
J:211215
|
Foxa2tm1Khk/Foxa2tm1Khk
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased macrophage cell number
|
J:88601
|
Foxn1nu-StL/Foxn1nu-StL
(involves: C57BL/6)
|
absent T cells
|
J:63313
|
Foxn1nu-str/Foxn1nu-str
(AKR/J-Foxn1nu-str/J)
|
decreased lymphocyte cell number
|
J:30715
|
| decreased T cell number
|
J:30715
|
Foxn1nu-Y/Foxn1nu-Y
(101/HY-Foxn1nu-Y)
|
absent T cells
|
J:4060
|
Foxn1nu/Foxn1nu
(involves: CBA)
|
decreased lymphocyte cell number
|
J:202299
|
| decreased T cell number
|
J:202808
|
Foxn1nu/Foxn1nu
Map3k14aly/Map3k14aly
(involves: BALB/cAJcl * C57BL/6J)
|
absent B cells
|
J:96579
|
| decreased gamma-delta intraepithelial T cell number
|
J:96579
|
| decreased T cell number
|
J:96579
|
Foxn1nu/Foxn1tm1.1Dmsu
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
decreased thymocyte number
|
J:159773
|
Foxn1tm1.1Cbln/Foxn1tm1.1Cbln
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte cell number
|
J:177992
|
| decreased single-positive T cell number
|
J:177992
|
| increased DN1 thymic pro-T cell number
|
J:177992
|
| increased double-positive T cell number
|
J:177992
|
Foxn1tm1.1Cbln/Foxn1tm1Tbo
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
absent T cells
|
J:177992
|
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
decreased double-positive T cell number
|
J:159773
|
| decreased thymocyte number
|
J:159773
|
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(KRT5-cre/ERT2)2Ipc/0
(involves: 129/Sv * C57BL/6 * SJL)
|
decreased thymocyte number
|
J:159773
|
Foxn1tm1Nrm/Foxn1tm1Nrm
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:86255
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:86255
|
| abnormal T cell differentiation
|
J:86255
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86255
|
| decreased double-negative T cell number
|
J:86255
|
| decreased double-positive T cell number
|
J:86255
|
| decreased T cell number
|
J:86255
|
| decreased thymocyte number
|
J:86255
|
Foxn1tm1Tbo/Foxn1tm1Tbo
(involves: 129S1/Sv)
|
absent T cells
|
J:33796
|
| increased B cell number
|
J:33796
|
Foxn1tm2Tbo/Foxn1tm2Tbo
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased T cell number
|
J:110046
|
Foxn1tm3(cre)Nrm/Foxn1+
Gt(ROSA)26Sortm1(Tbx1)Rche/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NHsd)
|
decreased thymocyte number
|
J:214094
|
Foxn1tm3(cre)Nrm/Foxn1+
Mir205hgtm1Oers/Mir205hgtm1Oers
(B6(Cg)-Mir205hgtm1Oers Foxn1tm3(cre)Nrm)
|
decreased thymocyte number
|
J:278363
|
Foxo1tm1.1Rdp/Foxo1+
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv)
|
increased B cell number
|
J:157297
|
Foxo1tm1.1Stlp/Foxo1tm1.1Stlp
Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae)
|
abnormal single-positive T cell number
|
J:154205
|
| decreased CD8-positive, alpha-beta T cell number
|
J:154205
|
| decreased double-positive T cell number
|
J:154205
|
| decreased T cell number
|
J:154205
|
| increased CD4-positive, alpha-beta T cell number
|
J:154205
|
| increased CD8-positive, alpha-beta T cell number
|
J:154205
|
Foxo1tm1Flv/Foxo1tm1Flv
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
increased CD4-positive, alpha-beta T cell number
|
J:189962
|
| increased CD8-positive, alpha-beta T cell number
|
J:189962
|
| increased regulatory T cell number
|
J:189962
|
| increased T cell number
|
J:189962
|
Foxo1tm1Flv/Foxo1tm1Flv
Ifngtm1Ts/Ifngtm1Ts
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129S7/SvEvBrd * 129X1/SvJ)
|
increased CD4-positive, alpha-beta T cell number
|
J:189962
|
| increased CD8-positive, alpha-beta T cell number
|
J:189962
|
Foxo1tm1Flv/Foxo1tm1Flv
Rag1tm1Mom/Rag1tm1Mom
Tg(CD2-Il7r)1Asin/?
Tg(Cd4-cre)1Cwi/?
Tg(TcraTcrb)425Cbn/?
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
decreased T cell number
|
J:147057
|
Foxo1tm1Flv/Foxo1tm1Flv
Rag1tm1Mom/Rag1tm1Mom
Tg(Cd4-cre)1Cwi/?
Tg(TcraTcrb)425Cbn/?
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
decreased T cell number
|
J:147057
|
Foxo1tm1Flv/Foxo1tm1Flv
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased single-positive T cell number
|
J:147057
|
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv)
|
absent marginal zone B cells
|
J:157297
|
| increased B cell number
|
J:157297
|
Foxo3tm1Nmt/Foxo3tm1Nmt
(B6.Cg-Foxo3tm1Nmt)
|
abnormal NK cell morphology
|
J:123409
|
| increased NK cell number
|
J:123409
|
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg)
|
abnormal Kupffer cell morphology
|
J:236585
|
Foxp1tm1.1Pwt/Foxp1tm1.1Pwt
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:156832
|
| decreased CD8-positive, alpha-beta T cell number
|
J:156832
|
Foxp1tm1Rao/Foxp1tm1Rao
(B6.129-Foxp1tm1Rao)
|
abnormal B cell differentiation
|
J:112644
|
| arrested B cell differentiation
|
J:112644
|
| decreased mature B cell number
|
J:112644
|
Foxp2tm2.2Woen/Foxp2+
(involves: C57BL/6 * C57BL/6J)
|
increased CD4-positive, alpha-beta T cell number
|
J:150425
|
| increased CD8-positive, alpha-beta T cell number
|
J:150425
|
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))
|
abnormal lymphocyte morphology
|
J:11262
|
| abnormal macrophage morphology
|
J:11262
|
Foxp3sf/Y
(B6.Cg-Foxp3sf)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:82560
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:82560
|
Foxp3sfOtcspf/Y
(involves: 129/Rl)
|
increased CD4-positive, alpha-beta T cell number
|
J:20865
|
Foxp3sf/Foxp3sf
Tg(Rorc-EGFP)1Ebe/?
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
Foxp3tm1(CD2/CD52)Shori/Foxp3tm1(CD2/CD52)Shori
(involves: C57BL/6)
|
decreased regulatory T cell number
|
J:171378
|
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:82560
|
| abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:82560
|
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:125405
|
| decreased double-positive T cell number
|
J:125405
|
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased regulatory T cell number
|
J:167922
|
Foxp3tm1.1Mal/Foxp3tm1.1Mal
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
decreased regulatory T cell number
|
J:131351
|
Foxp3tm1Ayr/Foxp3tm1Ayr
Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:125405
|
| decreased double-positive T cell number
|
J:125405
|
Foxp3tm1Flv/Foxp3+
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased regulatory T cell number
|
J:123547
|
Foxp3tm1Kuch/?
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:123352
|
| increased regulatory T cell number
|
J:123352
|
Foxp3tm1Tch/Y
(C.129X1-Foxp3tm1Tch)
|
absent regulatory T cells
|
J:117165
|
| increased activated T cell number
|
J:117165
|
| increased CD4-positive, alpha-beta T cell number
|
J:117165
|
| increased CD8-positive, alpha-beta T cell number
|
J:117165
|
| increased lymphocyte cell number
|
J:117165
|
| increased monocyte cell number
|
J:117165
|
Foxp3tm1Tch/Y
(B6.129X1-Foxp3tm1Tch)
|
increased lymphocyte cell number
|
J:117165
|
| increased monocyte cell number
|
J:117165
|
Foxp3tm2.1(EGFP/cre)Shori/Y
(involves: 129 * C57BL/6)
|
decreased regulatory T cell number
|
J:234397
|
Foxp3tm2.1(EGFP/cre)Shori/Y
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129 * 129S2/SvPas * C57BL/6)
|
increased effector memory T-helper cell number
|
J:234397
|
Foxp3tm2Ayr/?
Zap70rps/Zap70rps
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:211510
|
| abnormal double-positive T cell morphology
|
J:211510
|
| abnormal regulatory T cell number
|
J:211510
|
| abnormal T cell differentiation
|
J:211510
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211510
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211510
|
Foxp3tm3(HBEGF/GFP)Ayr/Foxp3tm3(HBEGF/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell number
|
J:117743
|
Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:120636
|
| abnormal T cell subpopulation ratio
|
J:120636
|
Foxp3tm3Tch/Foxp3+
(C.129X1-Foxp3tm3Tch)
|
decreased T cell number
|
J:120636
|
| decreased thymocyte number
|
J:120636
|
Foxp3tm4(YFP/icre)Ayr/Foxp3+
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal regulatory T cell morphology
|
J:205658
|
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
Ikzf4tm1Djr/Ikzf4tm1Djr
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased regulatory T cell number
|
J:294549
|
| increased germinal center B cell number
|
J:294549
|
| increased T cell number
|
J:294549
|
| increased T follicular helper cell number
|
J:294549
|
Foxp3tm5.2Ayr/Foxp3tm5.2Ayr
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal intraepithelial T cell morphology
|
J:156942
|
| abnormal T cell differentiation
|
J:156942
|
| decreased regulatory T cell number
|
J:156942
|
| increased T cell number
|
J:156942
|
Foxp3tm6.2Ayr/Foxp3tm6.2Ayr
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
decreased regulatory T cell number
|
J:156942
|
Foxp3tm7.2Ayr/Foxp3+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
decreased regulatory T cell number
|
J:156942
|
Foxp3tm7.2Ayr/Foxp3tm7.2Ayr
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal regulatory T cell morphology
|
J:156942
|
| decreased regulatory T cell number
|
J:156942
|
Foxq1sa-e1/Foxq1sa-e1
(involves: 101/Rl * C3H/Rl)
|
abnormal lymphocyte cell number
|
J:75422
|
Fshrtm1Saco/Fshrtm1Saco
(involves: 129)
|
increased pre-B cell number
|
J:65577
|
Fstl1tm1b(EUCOMM)Hmgu/Fstl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
Ftl1tm1.1Ruvi/Ftl1tm1.1Ruvi
(involves: 129 * C57BL/6)
|
abnormal mononuclear phagocyte morphology
|
J:244236
|
Fts/Fts+
(B6.Cg-Fts)
|
abnormal CD4-positive T cell differentiation
|
J:108193
|
| abnormal T cell morphology
|
J:108193
|
| increased thymocyte number
|
J:108193
|
Fubp1tm1.1Dlev/Fubp1tm1.1Dlev
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:229985
|
FusGt(U3NeoSV1)HO14Ggh/FusGt(U3NeoSV1)HO14Ggh
(B6.129S2-FusGt(U3NeoSV1)HO14Ggh)
|
decreased B cell number
|
J:60213
|
| decreased lymphocyte cell number
|
J:60213
|
Fut4tm1Jbl/Fut4tm1Jbl
(B6.129S2-Fut4tm1Jbl)
|
increased monocyte cell number
|
J:79397
|
Fyb1tm1Gak/Fyb1tm1Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte number
|
J:111368
|
Fyntm1Rmp/Fyntm1Rmp
(involves: 129S2/SvPas)
|
decreased gamma-delta T cell number
|
J:37062
|
| decreased T cell number
|
J:37062
|
Fyntm1Rmp/Fyntm1Rmp
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:112977
|
| abnormal NK T cell number
|
J:37940
|
| absent CD4-positive, alpha-beta T cells
|
J:37940
|
| absent CD8-positive, alpha-beta T cells
|
J:37940
|
| absent T cells
|
J:37062
|
| arrested T cell differentiation
|
J:37062,
J:37940
|
| decreased double-positive T cell number
|
J:37940
|
| decreased gamma-delta intraepithelial T cell number
|
J:112977,
J:37940
|
Fyntm1Sor/Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal T cell clonal deletion
|
J:2242
|
Fyntm1Sor/Fyntm1Sor
Lcktm1Litt/Lcktm1.1Litt
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S7/SvEvBrd * 129X1/SvJ)
|
decreased regulatory T cell number
|
J:152472
|
| increased regulatory T cell number
|
J:152472
|
| increased T cell number
|
J:152472
|
Fyntm1Yik/Fyntm1Yik
Ptk2tm1Lfr/Ptk2+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:110771
|
| decreased double-positive T cell number
|
J:110771
|
| decreased thymocyte number
|
J:110771
|
Fzd1em1(IMPC)Mbp/Fzd1em1(IMPC)Mbp
(C57BL/6N-Fzd1em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Fzd9tm1Uta/Fzd9tm1Uta
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
decreased B cell number
|
J:98133
|
| decreased pre-B cell number
|
J:98133
|
| decreased pro-B cell number
|
J:98133
|
| increased monocyte cell number
|
J:98133
|
G6pc2tm1.1Pesa/G6pc2tm1.1Pesa
(NOD.129S2-G6pc2tm1.1Pesa)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:160286
|
Gab2tm1Pngr/Gab2tm1Pngr
(B6.Cg-Gab2tm1Pngr)
|
abnormal osteoclast differentiation
|
J:97515
|
| abnormal osteoclast morphology
|
J:97515
|
| decreased osteoclast cell number
|
J:97515
|
Gab3em1Khoe/Gab3em1Khoe
(C57BL/6-Gab3em1Khoe)
|
abnormal mature NK cell morphology
|
J:291290
|
| abnormal uterine NK cell morphology
|
J:291290
|
| decreased NK cell number
|
J:291290
|
Gab3m1Khoe/Gab3m1Khoe
(C57BL/6-Gab3m1Khoe)
|
abnormal mature NK cell morphology
|
J:291290
|
| abnormal uterine NK cell morphology
|
J:291290
|
| decreased NK cell number
|
J:291290
|
Gabarapl2tm1b(EUCOMM)Hmgu/Gabarapl2+
(C57BL/6N-Gabarapl2tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
GabpaGt(XH074)Byg/GabpaGt(XH074)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:92671
|
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
|
abnormal lymphopoiesis
|
J:76041
|
| decreased lymphocyte cell number
|
J:76041
|
| increased T cell number
|
J:76041
|
| increased thymocyte number
|
J:57882
|
Gadd45btm1Flv/Gadd45btm1Flv
(involves: 129S6/SvEvTac)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
Gadd45btm1Flv/Gadd45btm1Flv
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
Gadd45btm1Flv/Gadd45btm1Flv
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
increased mature B cell number
|
J:118837
|
| increased memory T cell number
|
J:118837
|
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
Galctwi/Galctwi
(B6.CE-Galctwi/J)
|
abnormal microglial cell morphology
|
J:108359
|
Galctwi/Galctwi
(involves: C57BL/6J * CE/J)
|
abnormal macrophage morphology
|
J:6390
|
Galnt1tm1.1Jxm/Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm)
|
decreased B cell number
|
J:128982
|
| decreased germinal center B cell number
|
J:128982
|
| decreased plasma cell number
|
J:128982
|
| decreased T cell number
|
J:128982
|
| increased lymphocyte cell number
|
J:128982
|
Galnt3tm1.1Cfg/Galnt3tm1.1Cfg
(involves: C57BL/6)
|
decreased monocyte cell number
|
J:217719
|
Galnt18tm1b(KOMP)Wtsi/Galnt18tm1b(KOMP)Wtsi
(C57BL/6N-Galnt18tm1b(KOMP)Wtsi/Wtsi)
|
increased NK cell number
|
J:211773
|
Galr1em1(IMPC)H/Galr1em1(IMPC)H
(C57BL/6N-Galr1em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Galr2Gt(OST105469)Lex/Galr2Gt(OST105469)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:103485
|
| increased T cell number
|
J:103485
|
Gapttm1.1Wz/Gapttm1.1Wz
(Not Specified)
|
increased marginal zone B cell number
|
J:138146
|
Gata1tm1Mym/Y
Tg(Gata1*V205G)1Mym/0
(involves: C57BL/6 * DBA/2)
|
abnormal mononuclear cell morphology
|
J:89054
|
Gata1tm2Sho/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
decreased lymphocyte cell number
|
J:78348
|
Gata1tm2Sho/Gata1tm2Sho
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
decreased lymphocyte cell number
|
J:78348
|
Gata1tm2Sho/Gata1tm2Sho
(involves: 129S4/SvJae)
|
increased osteoclast cell number
|
J:111270
|
Gata1tm6Sho/Gata1tm6Sho
(involves: 129S1/Sv * BALB/c)
|
decreased lymphocyte cell number
|
J:115273
|
Gata3tm1Iho/Gata3tm1Iho
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:86996
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86996
|
Gata3tm1Iho/Gata3tm1Iho
Tg(Cd4-cre)1Cwi/0
Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:86996
|
Gata3tm1Iho/Gata3tm1Iho
Tg(DO11.10)10Dlo/0
Tg(Lck-cre)1Cwi/0
(involves: BALB/c * C3H * C57BL/6)
|
arrested T cell differentiation
|
J:86996
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86996
|
| decreased CD8-positive, alpha-beta T cell number
|
J:86996
|
| decreased double-positive T cell number
|
J:86996
|
Gata3tm1Iho/Gata3tm1Iho
Tg(Lck-cre)1Cwi/0
(involves: BALB/c)
|
abnormal CD8-positive, alpha-beta T cell number
|
J:86996
|
| abnormal T cell subpopulation ratio
|
J:86996
|
| arrested T cell differentiation
|
J:86996
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86996
|
| decreased double-positive T cell number
|
J:86996
|
| decreased thymocyte number
|
J:86996
|
Gata3tm1Jfz/Gata3tm1Jfz
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Cd4-cre)1Cwi/0
Tg(Tcra5CC7,Tcrb5CC7)IWep/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:141145
|
Gata3tm1Jfz/Gata3tm1Jfz
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93538
|
| abnormal T cell differentiation
|
J:141145
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141145
|
Gata3tm1Jfz/Gata3tm1Jfz
Tg(Tnfrsf4-cre)1Nik/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93538
|
| decreased T-helper 2 cell number
|
J:93538
|
| increased T-helper 1 cell number
|
J:93538
|
Gata3tm2Jeng/Gata3tm2Jeng
(Not Specified)
|
abnormal double-positive T cell morphology
|
J:155686
|
| abnormal T cell differentiation
|
J:155686
|
| abnormal T cell number
|
J:155686
|
| decreased double-negative T cell number
|
J:155686
|
| decreased gamma-delta T cell number
|
J:155686
|
| decreased thymocyte number
|
J:155686
|
Gata3tm3Gsv/Gata3tm3Gsv
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased T cell number
|
J:117058
|
Gatad2btm1b(EUCOMM)Hmgu/Gatad2b+
(C57BL/6N-Gatad2btm1b(EUCOMM)Hmgu/Ics)
|
increased monocyte cell number
|
J:211773
|
Gba1tm1.1Pmis/Gba1tm1.1Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167081
|
| decreased double-positive T cell number
|
J:167081
|
Gba1tm1.1Pmis/Gba1tm1.2Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167081
|
| decreased double-positive T cell number
|
J:167081
|
Gba1tm1Clk/Gba1tm1.1Clk
Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6J)
|
abnormal macrophage morphology
|
J:117763
|
Gba1tm1Karl/Gba1tm1Karl
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal microglial cell morphology
|
J:127108
|
Gba1tm1Nsb/Gba1tm1Nsb
(involves: 129S/SvEv * C57BL/6)
|
abnormal macrophage morphology
|
J:1100
|
Gba1tm1Rlp/Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6)
|
abnormal Kupffer cell morphology
|
J:76409
|
| abnormal macrophage morphology
|
J:76409
|
Gba1tm2Karl/Gba1tm2Karl
Tg(KRT14-cre)8Brn/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal macrophage morphology
|
J:127108
|
Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:86387
|
Gcnt2tm1Tmu/Gcnt2tm1Tmu
(involves: 129S2/SvPas * C57BL/6)
|
decreased B cell number
|
J:100533
|
Gdatm1a(KOMP)Wtsi/Gdatm1a(KOMP)Wtsi
(C57BL/6N-Gdatm1a(KOMP)Wtsi/Wtsi)
|
decreased T-helper cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
Gdf5em1(IMPC)H/Gdf5em1(IMPC)H
(C57BL/6NTac-Gdf5em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Gemin5em1(IMPC)H/Gemin5+
(C57BL/6N-Gemin5em1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
Gfi1Gen/Gfi1+
(C57BL/6J-Gfi1Gen)
|
abnormal NK cell differentiation
|
J:182679
|
Gfi1tm1.1Wep/Gfi1tm1.1Wep
(B6.129-Gfi1tm1.1Wep)
|
arrested T cell differentiation
|
J:117105
|
| decreased B cell number
|
J:117105
|
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal monocyte differentiation
|
J:75143
|
| abnormal T cell differentiation
|
J:75143
|
| decreased B cell number
|
J:75143
|
| decreased lymphocyte cell number
|
J:75143
|
| decreased T cell number
|
J:75143
|
| decreased thymocyte number
|
J:75143
|
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased B cell number
|
J:192927
|
| decreased thymocyte number
|
J:192927
|
| increased monocyte cell number
|
J:192927
|
Gfi1tm1Wep/Gfi1tm1Wep
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell subpopulation ratio
|
J:117105
|
Gfi1tm2Tmo/Gfi1tm2Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:93337
|
| decreased thymocyte number
|
J:93337
|
Gfi1tm3(Gfib1)Tmo/Gfi1tm3(Gfib1)Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal monocyte morphology
|
J:116870
|
Gfi1tm4Tmo/Gfi1tm4Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphopoiesis
|
J:116870
|
| abnormal monocyte morphology
|
J:116870
|
| abnormal T cell differentiation
|
J:116870
|
| decreased double-negative T cell number
|
J:116870
|
| decreased lymphocyte cell number
|
J:116870
|
| decreased thymocyte number
|
J:116870
|
Gfi1tm5.1(GFI1*)Tmo/Gfi1tm5.1(GFI1*)Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased monocyte cell number
|
J:192927
|
Gfi1btm1b(EUCOMM)Hmgu/Gfi1b+
(C57BL/6N-Gfi1btm1b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
Ggt1dwg/Ggt1dwg
((STOCK Pou1f1dw x T(8;16)17H)F1)
|
increased osteoclast cell number
|
J:14281
|
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Igh+
Igktm1Jiac/Igktm1Jiac
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
decreased mature B cell number
|
J:133032
|
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igk+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
decreased mature B cell number
|
J:133032
|
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igktm1Jiac
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal B cell selection
|
J:133032
|
| decreased mature B cell number
|
J:133032
|
Gimap1m1Btlr/Gimap1m1Btlr
(C57BL/6J-Gimap1m1Btlr)
|
decreased B cell number
|
J:267546
|
| decreased B-1 B cell number
|
J:267546
|
| decreased CD8-positive, alpha-beta T cell number
|
J:267546
|
| increased CD4-positive, alpha-beta T cell number
|
J:267546
|
Gimap1tm1.1Gwb/Gimap1tm1.1Gwb
Tg(CD2-icre)4Kio/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:160782
|
| decreased B-1a cell number
|
J:160782
|
| decreased B-1b cell number
|
J:160782
|
| decreased B-2 B cell number
|
J:160782
|
| decreased CD4-positive, alpha-beta T cell number
|
J:160782
|
| decreased CD8-positive, alpha-beta T cell number
|
J:160782
|
| decreased follicular B cell number
|
J:160782
|
| decreased lymphocyte cell number
|
J:160782
|
| decreased marginal zone B cell number
|
J:160782
|
| decreased T cell number
|
J:160782
|
| decreased thymocyte number
|
J:160782
|
| decreased transitional stage T2 B cell number
|
J:160782
|
Gimap3tm1.1Yout/Gimap3tm1.1Yout
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased T cell number
|
J:209926
|
| decreased thymocyte number
|
J:209926
|
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:160090
|
| decreased B-1 B cell number
|
J:160090
|
| decreased CD8-positive, alpha-beta T cell number
|
J:160090
|
| decreased lymphocyte cell number
|
J:160090
|
| decreased mature B cell number
|
J:160090
|
| decreased NK cell number
|
J:160090
|
| decreased NK T cell number
|
J:160090
|
Gimap5m1Btlr/Gimap5m1Btlr
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6J * DBA/2J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:160090
|
| decreased thymocyte number
|
J:160090
|
Gimap5tm1Wlr/Gimap5tm1Wlr
(either: B6.129-Gimap5tm1Wlr or C.129-Gimap5tm1Wlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:143620
|
| abnormal lymphocyte cell number
|
J:143620
|
| decreased B cell number
|
J:143620
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143620
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143620
|
| decreased NK cell number
|
J:143620
|
| decreased NK T cell number
|
J:143620
|
| decreased T cell number
|
J:143620
|
Gimap5tm1Yout/Gimap5tm1Yout
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased T cell number
|
J:209926
|
Gimap6tm1.1Gwb/Gimap6tm1.1Gwb
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:262059
|
| decreased T cell number
|
J:262059
|
| increased B cell number
|
J:262059
|
Gimap6tm1a(KOMP)Wtsi/Gimap6tm1a(KOMP)Wtsi
(C57BL/6N-Gimap6tm1a(KOMP)Wtsi/Wtsi)
|
decreased CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Git2Gt(XG510)Byg/Git2Gt(XG510)Byg
(B6.129P2-Git2Gt(XG510)Byg)
|
decreased marginal zone B cell number
|
J:160613
|
Git2Gt(XG510)Byg/Git2Gt(XG510)Byg
(C.129P2-Git2Gt(XG510)Byg)
|
decreased marginal zone B cell number
|
J:160613
|
Git2Gt(XG510)Byg/Git2Gt(XG510)Byg
Tg(DO11.10)10Dlo/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:160613
|
Git2Gt(XG510)Byg/Git2Gt(XG510)Byg
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:160613
|
| decreased CD8-positive, alpha-beta T cell number
|
J:160613
|
Git2Gt(XG510)Byg/Git2Gt(XG510)Byg
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:160613
|
Gjb1tm1Kwi/Y
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
microgliosis
|
J:219594
|
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
microgliosis
|
J:174197
|
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
microgliosis
|
J:219594
|
Gjc2tm2.1Kwi/Gjc2+
(involves: C57BL/6 * SJL)
|
microgliosis
|
J:174197
|
Gjc2tm2.1Kwi/Gjc2tm2.1Kwi
(involves: C57BL/6 * SJL)
|
microgliosis
|
J:174197
|
Gjd4tm1.1Malt/Gjd4tm1.1Malt
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
decreased macrophage cell number
|
J:172698
|
Gk5m5Btlr/Gk5m5Btlr
(C57BL/6J-Gk5m5Btlr)
|
increased alpha-beta T cell number
|
J:265118
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265118
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265118
|
Glb1tm1Jmat/Glb1tm1Jmat
(involves: C57BL/6 * CBA * ICR)
|
abnormal lymphopoiesis
|
J:43534
|
Glb1l2tm1Lex/Glb1l2tm1Lex
(B6;129S5-Glb1l2tm1Lex/Mmucd)
|
decreased lymphocyte cell number
|
J:171883
|
| decreased NK cell number
|
J:171883
|
GlmpGt(P084H04)Wrst/GlmpGt(P084H04)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
abnormal Kupffer cell morphology
|
J:208774
|
Glra2tm1b(KOMP)Wtsi/Y
(C57BL/6N-Glra2tm1b(KOMP)Wtsi/H)
|
decreased monocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Gm5544tm1a(KOMP)Wtsi/Gm5544+
(C57BL/6N-Gm5544tm1a(KOMP)Wtsi/Wtsi)
|
decreased marginal zone B cell number
|
J:211773
|
Gm26330em1Liuq/Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq)
|
decreased NK cell number
|
J:341056
|
Gm36723em1Flv/Gm36723em1Flv
(C57BL/6-Gm36723em1Flv)
|
abnormal lymphopoiesis
|
J:258967
|
| decreased lymphocyte cell number
|
J:258967
|
| decreased mature NK cell number
|
J:258967
|
| decreased NK cell number
|
J:258967
|
| increased immature NK cell number
|
J:258967
|
Gm36723em3Flv/Gm36723em3Flv
(C57BL/6-Gm36723em3Flv)
|
decreased mature NK cell number
|
J:258967
|
Gm40600em1Cya/Gm40600em1Cya
(C57BL/6-Gm40600em1Cya)
|
abnormal plasmablast number
|
J:311878
|
| decreased B cell number
|
J:311878
|
| decreased plasma cell number
|
J:311878
|
| increased B cell number
|
J:311878
|
| increased plasma cell number
|
J:311878
|
Gmdstm1a(KOMP)Wtsi/Gmdstm1a(KOMP)Wtsi
(C57BL/6N-Gmdstm1a(KOMP)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased macrophage cell number
|
J:211773
|
| decreased mature NK cell number
|
J:211773
|
| decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| decreased transitional stage T2 B cell number
|
J:211773
|
| increased CD4-negative NK T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased immature NK cell number
|
J:211773
|
| increased Ly6C-positive NK T cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
Gmnntm1.1Kio/Gmnntm1.2Kio
Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
decreased CD4-positive, alpha-beta T cell number
|
J:159657
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:159657
|
| decreased CD8-positive, alpha-beta T cell number
|
J:159657
|
| decreased DN1 thymic pro-T cell number
|
J:159657
|
| decreased DN4 thymocyte number
|
J:159657
|
| decreased double-positive T cell number
|
J:159657
|
| decreased memory T cell number
|
J:159657
|
| decreased thymocyte number
|
J:159657
|
Gmpsem1(IMPC)Tcp/Gmps+
(C57BL/6NCrl-Gmpsem1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Gna12tm1.1Cgh/Gna12tm1.1Cgh
Gna13tm2Cgh/Gna13tm2Cgh
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal germinal center B cell morphology
|
J:174313
|
| increased germinal center B cell number
|
J:174313
|
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased CD4-positive, alpha-beta T cell number
|
J:149560
|
| increased CD8-positive, alpha-beta T cell number
|
J:149560
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd)
|
increased single-positive T cell number
|
J:30507
|
| increased T cell number
|
J:30507
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(either: 129 or (involves: 129S7/SvEvBrd * C57BL/6J))
|
increased thymocyte number
|
J:24434
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(B6.129S7-Gnai2tm1Lbi)
|
increased lymphocyte cell number
|
J:120069
|
| increased monocyte cell number
|
J:120069
|
Gnai2tm2.1Lbi/Gnai2tm2.1Lbi
Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA)
|
decreased T-helper 17 cell number
|
J:194587
|
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6)
|
decreased monocyte cell number
|
J:147857
|
Gnptabtm1Kkol/Gnptabtm1Kkol
(involves: 129 * C57BL/6)
|
increased osteoclast cell number
|
J:202751
|
Gnrh1hpg/Gnrh1hpg
(HPG/BmJ)
|
increased B cell number
|
J:19436
|
| increased immature B cell number
|
J:19436
|
| increased mature B cell number
|
J:19436
|
Gnstm1e(EUCOMM)Hmgu/Gnstm1e(EUCOMM)Hmgu
(C57BL/6N-Atm1Brd Gnstm1e(EUCOMM)Hmgu)
|
microgliosis
|
J:242250
|
Golga2tm1(KOMP)Vlcg/Golga2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
increased alveolar macrophage number
|
J:270564
|
Gon4ljusty/Gon4ljusty
(C3HeB/FeJ-Gon4ljusty)
|
absent B cells
|
J:163412
|
| arrested B cell differentiation
|
J:163412
|
| decreased B cell number
|
J:163412
|
| decreased immature B cell number
|
J:163412
|
| decreased pro-B cell number
|
J:163412
|
| decreased T cell number
|
J:163412
|
Got1tm1b(EUCOMM)Hmgu/Got1+
(C57BL/6N-Got1tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
Gp6tm2b(EUCOMM)Hmgu/Gp6tm2b(EUCOMM)Hmgu
(C57BL/6N-Gp6tm2b(EUCOMM)Hmgu/Orl)
|
increased lymphocyte cell number
|
J:211773
|
Gpatch2em1Boui/Gpatch2em1Boui
(C57BL/6-Gpatch2em1Boui)
|
decreased B cell number
|
J:336774
|
Gpc3tm1Snd/Y
(involves: 129X1/SvJ * C57BL/6)
|
abnormal osteoclast differentiation
|
J:104555
|
Gper1tm1Dgen/Gper1tm1Dgen
(B6.129-Gper1tm1Dgen)
|
decreased CD4-positive, alpha-beta T cell number
|
J:151816
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151816
|
| decreased T cell number
|
J:151816
|
Gpm6btm1KanPlp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
microgliosis
|
J:193310
|
Gpr15tm1.1Litt/Gpr15tm1.1Litt
(B6.129P2-Gpr15tm1.1Litt)
|
decreased CD4-positive, alpha-beta T cell number
|
J:199126
|
| decreased double-negative T cell number
|
J:199126
|
| decreased regulatory T cell number
|
J:199126
|
| increased CD8-positive, alpha-beta T cell number
|
J:199126
|
Gpr15tm1.1Litt/Gpr15tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased regulatory T cell number
|
J:199126
|
Gpr18tm1.1Cys/Gpr18tm1.1Cys
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:219661
|
| decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:219661
|
Gpr55tm1.1Mijr/Gpr55tm1.1Mijr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast differentiation
|
J:153225
|
| abnormal osteoclast morphology
|
J:153225
|
| decreased osteoclast cell number
|
J:153225
|
| increased osteoclast cell number
|
J:153225
|
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(B6.Cg-Gpr68tm1.1Yaxu)
|
abnormal osteoclast differentiation
|
J:149315
|
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal osteoclast differentiation
|
J:149315
|
| decreased macrophage cell number
|
J:149315
|
| increased monocyte cell number
|
J:149315
|
Gpr68tm1Yaxu/Gpr68tm1Yaxu
(involves: C57BL/6)
|
abnormal osteoclast differentiation
|
J:149315
|
| decreased monocyte cell number
|
J:149315
|
Gpr83em1(IMPC)Ccpcz/Gpr83em1(IMPC)Ccpcz
(C57BL/6NCrl-Gpr83em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
Gpr83tm1.1Fpow/Gpr83tm1.1Fpow
(C.129-Gpr83tm1.1Fpow)
|
decreased CD4-positive, alpha-beta T cell number
|
J:144445
|
Gpr89ex/Gpr89ex
(C57BL/6J-Gpr89ex)
|
abnormal T cell morphology
|
J:287198
|
| abnormal T cell number
|
J:287198
|
Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys)
|
abnormal T-helper 1 cell differentiation
|
J:222307
|
| increased single-positive T cell number
|
J:222307
|
Gpr182tm2c(KOMP)Wtsi/Gpr182tm2c(KOMP)Wtsi
Tg(Cdh5-cre/ERT2)1Rha/0
(B6.Cg-Gpr182tm2c(KOMP)Wtsi Tg(Cdh5-cre/ERT2)1Rha)
|
increased monocyte cell number
|
J:305796
|
Gpr183tm1.2Rbr/Gpr183tm1.2Rbr
(involves: C57BL/6 * FVB/N * SJL)
|
decreased plasma cell number
|
J:151883
|
Gpr183tm1.2Rbr/Gpr183tm1.2Rbr
Ightm1Rbr/Ightm1Rbr
Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased B cell number
|
J:151883
|
| decreased plasma cell number
|
J:151883
|
Gpr183tm1Lex/Gpr183tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased myeloid dendritic cell number
|
J:211122
|
Gpsm3Gt(IST12408A1)Tigm/Gpsm3Gt(IST12408A1)Tigm
(involves: C57BL/6N)
|
decreased monocyte cell number
|
J:193270
|
Grap2tm1Amch/Grap2tm1Amch
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:76696
|
| decreased CD4-positive, alpha-beta T cell number
|
J:76696
|
| decreased CD8-positive, alpha-beta T cell number
|
J:76696
|
| decreased thymocyte number
|
J:76696
|
| increased double-negative T cell number
|
J:76696
|
Grap2tm1Amch/Grap2tm1Amch
Lcp2tm1.1Wz/Lcp2tm1.1Wz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:150304
|
| decreased CD4-positive, alpha-beta T cell number
|
J:150304
|
| decreased CD8-positive, alpha-beta T cell number
|
J:150304
|
| decreased double-positive T cell number
|
J:150304
|
| decreased single-positive T cell number
|
J:150304
|
Grap2tm1Eac/Grap2tm1Eac
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:92023
|
| abnormal double-negative T cell morphology
|
J:92023
|
| decreased T cell number
|
J:92023
|
| decreased thymocyte number
|
J:92023
|
| increased activated T cell number
|
J:92023
|
| increased memory T cell number
|
J:92023
|
Graptm1Gsf/Graptm1Gsf
(B6.129-Graptm1Gsf)
|
increased CD4-positive, alpha-beta T cell number
|
J:76243
|
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(DO11.10)10Dlo/0
Tg(Lck-cre)1Jtak/0
(involves: 129 * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:161294
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161294
|
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:161294
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161294
|
| decreased CD8-positive, alpha-beta T cell number
|
J:161294
|
| decreased double-positive T cell number
|
J:161294
|
| decreased thymocyte number
|
J:161294
|
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(Lck-cre)1Jtak/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:161294
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161294
|
| decreased CD8-positive, alpha-beta T cell number
|
J:161294
|
| increased CD8-positive, alpha-beta T cell number
|
J:161294
|
| increased double-positive T cell number
|
J:161294
|
Grb2tm1Lnit/Grb2tm1Lnit
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * BALB/cJ)
|
abnormal B cell differentiation
|
J:171222
|
| decreased B cell number
|
J:171222
|
| decreased follicular B cell number
|
J:171222
|
| decreased mature B cell number
|
J:171222
|
| decreased transitional stage T1 B cell number
|
J:171222
|
| decreased transitional stage T2 B cell number
|
J:171222
|
| increased plasma cell number
|
J:171222
|
Grk2tm1Gwd/Grk2tm1Gwd
Cd79atm1(cre)Reth/Cd79a+
(involves: 129 * BALB/c * C57BL/6)
|
decreased B cell number
|
J:176118
|
| increased B cell number
|
J:176118
|
| increased CD4-positive, alpha-beta T cell number
|
J:176118
|
| increased CD8-positive, alpha-beta T cell number
|
J:176118
|
| increased follicular B cell number
|
J:176118
|
| increased marginal zone B cell number
|
J:176118
|
Grk2tm1Gwd/Grk2tm1Mca
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:176118
|
| decreased CD8-positive, alpha-beta T cell number
|
J:176118
|
| decreased T cell number
|
J:176118
|
| increased B cell number
|
J:176118
|
Grk6tm1.1Mca/Grk6tm1.1Mca
(B6.129S4-Grk6tm1.1Mca)
|
abnormal T cell subpopulation ratio
|
J:225063
|
| decreased CD8-positive, alpha-beta T cell number
|
J:225063
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:225063
|
| increased memory T cell number
|
J:225063
|
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6 * C57BL/6J)
|
microgliosis
|
J:156824
|
Grntm1.1Far/Grntm1.1Far
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
|
microgliosis
|
J:188324
|
Grntm1.1Geno/Grntm1.1Geno
(involves: 129 * C57BL/6J)
|
microgliosis
|
J:188420
|
Grntm1Blrl/Grntm1Blrl
(involves: C57BL/6J)
|
microgliosis
|
J:182051
|
Grntm1Far/Grntm1Far
Tg(ITGAM-cre)2781Gkl/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
microgliosis
|
J:188324
|
Grntm2.1Far/Grntm2.1Far
(involves: 129S4/SvJae * C57BL/6)
|
microgliosis
|
J:259651
|
Gsdma3tm1(KOMP)Vlcg/Gsdma3tm1(KOMP)Vlcg
(C57BL/6N-Gsdma3tm1(KOMP)Vlcg/Nju)
|
increased lymphocyte cell number
|
J:211773
|
Gsdmcem1(IMPC)Tcp/Gsdmcem1(IMPC)Tcp
(C57BL/6NCrl-Gsdmcem1(IMPC)Tcp/TcpMmucd)
|
increased monocyte cell number
|
J:211773
|
Gsntm1Djk/Gsntm1Djk
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal osteoclast differentiation
|
J:60625
|
Gsx1tm1Ssp/Gsx1tm1Ssp
(involves: 129P2/OlaHsd)
|
decreased lymphocyte cell number
|
J:31764
|
Gt(ROSA)26Sortm1(CAG-Bcl3,-EGFP)Hoev/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:208980
|
| abnormal B-2 B cell morphology
|
J:208980
|
| abnormal class switch recombination
|
J:208980
|
| abnormal follicular B cell morphology
|
J:208980
|
| abnormal transitional stage T3 B cell morphology
|
J:208980
|
| absent marginal zone B cells
|
J:208980
|
| decreased B-1 B cell number
|
J:208980
|
| decreased B-1a cell number
|
J:208980
|
| decreased immature B cell number
|
J:208980
|
| decreased marginal zone B cell number
|
J:208980
|
| decreased transitional stage T1 B cell number
|
J:208980
|
| increased lymphocyte cell number
|
J:208980
|
Gt(ROSA)26Sortm1(CAG-Foxn1/ERT2,-GFP)Cbln/Gt(ROSA)26Sor+
Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell number
|
J:208852
|
Gt(ROSA)26Sortm1(CAG-Slc39a14*L438R)Wvh/Gt(ROSA)26Sor+
Tg(Runx2-icre)1Jtuc/0
(involves: FVB/N)
|
increased osteoclast cell number
|
J:261326
|
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sortm1(Tcfe2a/Tal1)Xhsu
(involves: 129/Sv * C57BL/6)
|
abnormal lymphopoiesis
|
J:144569
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sortm1(Pyy)Paba
(involves: 129S4/SvJae)
|
abnormal osteoclast morphology
|
J:189512
|
| increased osteoclast cell number
|
J:189512
|
Gt(ROSA)26Sortm1(CTNNB1)Nerl/Gt(ROSA)26Sortm1(CTNNB1)Nerl
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
arrested T cell differentiation
|
J:112660
|
| decreased double-negative T cell number
|
J:112660
|
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:234435
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sortm1(DTA)Lky
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:133382
|
| abnormal T cell receptor V(D)J recombination
|
J:133382
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133382
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133382
|
| decreased double-positive T cell number
|
J:133382
|
| decreased lymphocyte cell number
|
J:133382
|
| decreased NK T cell number
|
J:133382
|
| decreased regulatory T cell number
|
J:133382
|
Gt(ROSA)26Sortm1(DTA)Riet/Gt(ROSA)26Sortm1(DTA)Riet
Tg(Rorc-cre)1Litt/?
(involves: 129P2/OlaHsd)
|
abnormal effector T cell morphology
|
J:137020
|
Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/Gt(ROSA)26Sor+
Cd79atm3(cre/ERT2)Reth/Cd79a+
(involves: 129S6/SvEvTac * BALB/c)
|
abnormal plasma cell differentiation
|
J:208904
|
| increased B cell number
|
J:208904
|
Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/Gt(ROSA)26Sor+
Cd79atm3(cre/ERT2)Reth/Cd79a+
Tg(BCL2)22Wehi/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6JWehi * SJL/JWehi)
|
abnormal plasma cell differentiation
|
J:208904
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Rev3ltm1.1Diaz/Rev3ltm1.1Diaz
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac)
|
abnormal class switch recombination
|
J:188723
|
| abnormal somatic hypermutation frequency
|
J:188723
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal plasma cell differentiation
|
J:167612
|
| increased germinal center B cell number
|
J:167612
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:157757
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:157757
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157757
|
| decreased CD8-positive, alpha-beta T cell number
|
J:157757
|
| decreased single-positive T cell number
|
J:157757
|
| decreased T cell number
|
J:157757
|
| increased double-positive T cell number
|
J:157757
|
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
| decreased B cell number
|
J:172031
|
| decreased germinal center B cell number
|
J:172031
|
| decreased plasma cell number
|
J:172031
|
| increased B cell number
|
J:172031
|
| increased macrophage cell number
|
J:172031
|
| increased marginal zone B cell number
|
J:172031
|
| increased T cell number
|
J:172031
|
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
| decreased B cell number
|
J:172031
|
| decreased follicular B cell number
|
J:172031
|
| decreased germinal center B cell number
|
J:172031
|
| decreased plasma cell number
|
J:172031
|
| increased B cell number
|
J:172031
|
| increased macrophage cell number
|
J:172031
|
| increased marginal zone B cell number
|
J:172031
|
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/Gt(ROSA)26Sortm9(cre/ESR1)Arte
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:170965
|
| increased memory B cell number
|
J:170965
|
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sortm1(HBEGF)Awai
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymphocyte cell number
|
J:131076
|
| decreased single-positive T cell number
|
J:131076
|
Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:160931
|
| decreased double-positive T cell number
|
J:160931
|
| decreased single-positive T cell number
|
J:160931
|
| decreased T cell number
|
J:160931
|
Gt(ROSA)26Sortm1(Mirn155)Rsky/Gt(ROSA)26Sortm1(Mirn155)Rsky
(involves: BALB/c * C57BL/6)
|
increased germinal center B cell number
|
J:121084
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Hes1tm1.1Frad/Hes1tm1.1Frad
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
decreased B cell number
|
J:167000
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
decreased B cell number
|
J:167000
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased B cell number
|
J:260047
|
| decreased lymphocyte cell number
|
J:260047
|
| increased monocyte cell number
|
J:260047
|
| increased T cell number
|
J:260047
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+
Tg(Itgax-cre)1-1Reiz/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased monocyte cell number
|
J:260047
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+
Tg(S100A8-cre,-EGFP)1Ilw/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased monocyte cell number
|
J:260047
|
Gt(ROSA)26Sortm1(Ptpn22*)Draw/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:201448
|
| increased germinal center B cell number
|
J:201448
|
Gt(ROSA)26Sortm1(rtTA)Awu/Gt(ROSA)26Sortm1(rtTA)Awu
Xisttm1Awu/Y
(involves: 129S4/SvJae)
|
abnormal B cell differentiation
|
J:112954
|
| abnormal T cell differentiation
|
J:112954
|
| absent pre-B cells
|
J:112954
|
| decreased double-positive T cell number
|
J:112954
|
| decreased immature B cell number
|
J:112954
|
| decreased macrophage cell number
|
J:112954
|
| decreased pro-B cell number
|
J:112954
|
| decreased thymocyte number
|
J:112954
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Col2a1-cre)1Bhr/0
Tg(tetO-Vegfa)90Ala/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N * SJL)
|
decreased osteoclast cell number
|
J:156474
|
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:205858
|
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased regulatory T cell number
|
J:205858
|
| increased T-helper 1 cell number
|
J:205858
|
| increased T-helper 17 cell number
|
J:205858
|
Gt(ROSA)26Sortm1.1(Ubc-BCL3)Sbn/Gt(ROSA)26Sor+
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
decreased follicular B cell number
|
J:207111
|
| decreased marginal zone B cell number
|
J:207111
|
| increased follicular B cell number
|
J:207111
|
Gt(ROSA)26Sortm1.2(CAG-PLS3,-GFP)Bwir/Gt(ROSA)26Sor+
(B6N.Cg-Gt(ROSA)26Sortm1.1(CAG-PLS3,-GFP)Bwir)
|
decreased osteoclast cell number
|
J:267292
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
arrested B cell differentiation
|
J:202090
|
| decreased B cell number
|
J:202090
|
| decreased double-positive T cell number
|
J:202090
|
| decreased mature B cell number
|
J:202090
|
| decreased pre-B cell number
|
J:202090
|
| decreased pro-B cell number
|
J:202090
|
| increased CD8-positive, alpha-beta T cell number
|
J:202090
|
| increased large unstained cell number
|
J:202090
|
| increased single-positive T cell number
|
J:202090
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
arrested B cell differentiation
|
J:202090
|
| decreased B cell number
|
J:202090
|
| decreased double-positive T cell number
|
J:202090
|
| decreased mature B cell number
|
J:202090
|
| decreased pre-B cell number
|
J:202090
|
| decreased pro-B cell number
|
J:202090
|
| increased CD8-positive, alpha-beta T cell number
|
J:202090
|
| increased large unstained cell number
|
J:202090
|
| increased single-positive T cell number
|
J:202090
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Id3tm2.1Zhu/Id3tm2.1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased T cell number
|
J:172701
|
Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:179036
|
| decreased B cell number
|
J:179036
|
| decreased B-1a cell number
|
J:179036
|
| decreased B-2 B cell number
|
J:179036
|
| decreased follicular B cell number
|
J:179036
|
| decreased transitional stage T2 B cell number
|
J:179036
|
| increased marginal zone B cell number
|
J:179036
|
| increased T cell number
|
J:179036
|
| increased transitional stage T1 B cell number
|
J:179036
|
Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:179036
|
| decreased follicular B cell number
|
J:179036
|
| decreased mature B cell number
|
J:179036
|
| decreased pre-B cell number
|
J:179036
|
| decreased transitional stage T2 B cell number
|
J:179036
|
| increased marginal zone B cell number
|
J:179036
|
| increased transitional stage T1 B cell number
|
J:179036
|
Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/Gt(ROSA)26Sor+
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6J)
|
arrested B cell differentiation
|
J:179036
|
| decreased B cell number
|
J:179036
|
| increased T cell number
|
J:179036
|
Gt(ROSA)26Sortm2(H1/tetO-RNAi:Kdm1a)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
abnormal monocyte differentiation
|
J:192055
|
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:207306
|
| increased CD4-positive, alpha-beta T cell number
|
J:207306
|
| increased mature B cell number
|
J:207306
|
| increased plasma cell number
|
J:207306
|
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Lck-cre)I57Jxm/0
(involves: 129S6/SvEvTac * ICR)
|
increased activated T cell number
|
J:207306
|
| increased CD4-positive, alpha-beta T cell number
|
J:207306
|
| increased mature B cell number
|
J:207306
|
| increased plasma cell number
|
J:207306
|
Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:137122
|
| increased B cell number
|
J:137122
|
| increased follicular B cell number
|
J:137122
|
| increased marginal zone B cell number
|
J:137122
|
| increased T cell number
|
J:137122
|
Gt(ROSA)26Sortm2(Mirn150)Rsky/Gt(ROSA)26Sor+
(involves: C57BL/6 * SJL/J)
|
decreased mature B cell number
|
J:127234
|
Gt(ROSA)26Sortm2(Mirn150)Rsky/Gt(ROSA)26Sortm2(Mirn150)Rsky
(involves: C57BL/6 * SJL/J)
|
decreased B-1 B cell number
|
J:127234
|
| decreased B-2 B cell number
|
J:127234
|
| decreased CD4-positive, alpha-beta T cell number
|
J:127234
|
| decreased CD8-positive, alpha-beta T cell number
|
J:127234
|
Gt(ROSA)26Sortm2.1(Mirn150)Rsky/Gt(ROSA)26Sor+
(involves: C57BL/6 * SJL/J)
|
decreased mature B cell number
|
J:127234
|
Gt(ROSA)26Sortm2.1(Mirn150)Rsky/Gt(ROSA)26Sortm2.1(Mirn150)Rsky
(involves: C57BL/6 * SJL/J)
|
arrested B cell differentiation
|
J:127234
|
| arrested T cell differentiation
|
J:127234
|
| decreased B-1 B cell number
|
J:127234
|
| decreased B-2 B cell number
|
J:127234
|
| decreased lymphocyte cell number
|
J:127234
|
Gt(ROSA)26Sortm2Sho/Gt(ROSA)26Sor+
Lef1tm1Hhx/Lef1tm1Hhx
Tg(GZMB-cre)1Jcb/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:189838
|
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+
Stat5atm2Mam Stat5btm1Mam/Del(11Stat5a-Stat5b)1Mam
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sor+
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased marginal zone B cell number
|
J:133215
|
| increased B-1a cell number
|
J:133215
|
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal B cell morphology
|
J:133215
|
| abnormal CD4-positive, alpha beta T cell morphology
|
J:133215
|
| abnormal T cell differentiation
|
J:133215
|
| decreased marginal zone B cell number
|
J:133215
|
| increased B cell number
|
J:133215
|
| increased B-1a cell number
|
J:133215
|
| increased CD4-positive, alpha-beta T cell number
|
J:133215
|
| increased CD8-positive, alpha-beta T cell number
|
J:133215
|
| increased germinal center B cell number
|
J:133215
|
| increased lymphocyte cell number
|
J:133215
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
Hnrnpltm1.1Tmo/Hnrnpltm1.1Tmo
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:188749
|
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased germinal center B cell number
|
J:167612
|
| increased B cell number
|
J:167612
|
| increased plasma cell number
|
J:167612
|
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasma cell differentiation
|
J:167612
|
| increased germinal center B cell number
|
J:167612
|
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sortm4(Ikbkb)Rsky
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:157297
|
Gt(ROSA)26Sortm4(Wnt7b)Flng/Gt(ROSA)26Sor+
Tg(Col1a1-cre)1Ack/0
(involves: FVB/N)
|
decreased osteoclast cell number
|
J:208766
|
Gt(ROSA)26Sortm4(Wnt7b)Flng/Gt(ROSA)26Sor+
Tg(Runx2-rtTA*M2)#Flng/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6)
|
decreased osteoclast cell number
|
J:208766
|
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:191824
|
| increased germinal center B cell number
|
J:191824
|
Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:157297
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
Map3k14tm1.1Gne/Map3k14tm1.1Gne
(B6(Cg)-Map3k14tm1.1Gne Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
decreased B cell number
|
J:240453
|
| decreased germinal center B cell number
|
J:240453
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
Ripk3tm1Arte/Ripk3tm1Arte
(involves: C57BL/6NTac)
|
abnormal lymphocyte morphology
|
J:209137
|
Gt(ROSA)26Sortm9(Rac1*,EGFP)Rsky/Gt(ROSA)26Sortm9(Rac1*,EGFP)Rsky
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:157297
|
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
(involves: BALB/cJ)
|
abnormal B cell morphology
|
J:181546
|
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/cJ)
|
abnormal B cell differentiation
|
J:181546
|
| decreased B cell number
|
J:181546
|
| decreased mature B cell number
|
J:181546
|
| decreased pre-B cell number
|
J:181546
|
| increased B cell number
|
J:181546
|
| increased CD4-positive, alpha-beta T cell number
|
J:181546
|
| increased CD8-positive, alpha-beta T cell number
|
J:181546
|
| increased pro-B cell number
|
J:181546
|
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrb+
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ)
|
increased B cell number
|
J:181546
|
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ)
|
increased B cell number
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:181546
|
| decreased B cell number
|
J:181546
|
| decreased mature B cell number
|
J:181546
|
| decreased pre-B cell number
|
J:181546
|
| increased B cell number
|
J:181546
|
| increased CD4-positive, alpha-beta T cell number
|
J:181546
|
| increased CD8-positive, alpha-beta T cell number
|
J:181546
|
| increased pro-B cell number
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Cd19tm1(cre/ERT2)Rsky/Cd19+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased activated T cell number
|
J:217520
|
| increased B cell number
|
J:217520
|
| increased CD4-positive, alpha-beta T cell number
|
J:217520
|
| increased CD8-positive, alpha-beta T cell number
|
J:217520
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrb+
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased B cell number
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased B cell number
|
J:181546
|
Gulosfx/Gulosfx
(BALB/cBy-Gulosfx/J)
|
abnormal osteoclast differentiation
|
J:66648
|
Gzmbtm1Ley/Gzmbtm1Ley
Serpinb9tm1Arp/Serpinb9tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:113349
|
H2-Aab-tm1Blt/H2-Aab-tm1Blt
(C57BL/6-H2-Aab-tm1Blt)
|
abnormal T cell morphology
|
J:16372
|
| decreased CD4-positive, alpha-beta T cell number
|
J:16372
|
| increased CD8-positive, alpha-beta T cell number
|
J:16372
|
H2-Ab1b-tm1.1Jssh/H2-Ab1b-tm1.1Jssh
(C57BL/6-H2-Ab1b-tm1.1Jssh)
|
abnormal T cell differentiation
|
J:201198
|
| decreased regulatory T cell number
|
J:201198
|
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:65736
|
| decreased CD4-positive, alpha-beta T cell number
|
J:51885,
J:65736
|
| increased CD4-positive, alpha-beta T cell number
|
J:64283
|
| increased CD8-positive, alpha-beta T cell number
|
J:65736,
J:64283
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(involves: 129S2/SvPas * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:74418
|
| increased CD8-positive, alpha-beta T cell number
|
J:74418
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(B6.129S2-H2-Ab1b-tm1Gru)
|
decreased CD4-positive, alpha-beta T cell number
|
J:91341
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(involves: 129S2/SvPas * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:67941
|
| decreased single-positive T cell number
|
J:67941
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Runx1tm1Toku/Runx1tm1Toku
Runx3tm1Itan/Runx3tm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/2)
|
increased CD4-positive, alpha-beta T cell number
|
J:131081
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tespa1tm1Smoc/Tespa1tm1Smoc
(involves: 129 * 129S2/SvPas * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:186446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(Ab1TL)1Gru/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(Ab1TL)1Gru)
|
abnormal CD4-positive T cell differentiation
|
J:91341
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(HLA-DRB1)31Dmz/0
Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:68641
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:68641
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DRB1)31Dmz/0
Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:68641
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:68641
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Themistm1Lov/Themistm1Lov
(involves: 129)
|
abnormal negative T cell selection
|
J:151075
|
H2-Ab1b-tm1Koni/H2-Ab1b-tm1.1Koni
Tg(Tek-cre)12Flv/0
(involves: 129X1/SvJ * C3H * C57BL/6 * C57BL/6J)
|
abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:131774
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:131774
|
| increased CD4-positive, alpha-beta T cell number
|
J:131774
|
H2-Ab1b-tm1Wug/H2-Ab1b-tm1Wug
(involves: C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:204951
|
H2-Ab1bm12/H2-Ab1bm12
(NZB.B6(C)-H2-Ab1bm12)
|
decreased CD8-positive, alpha-beta T cell number
|
J:4554
|
| increased B cell number
|
J:104189
|
| increased CD4-positive, alpha-beta T cell number
|
J:4554
|
| increased double-negative T cell number
|
J:4554
|
H2-Ab1g7-em1Dvs/H2-Ab1g7-em1Dvs
H2-D1b-em5Dvs/H2-D1b-em5Dvs
H2-K1d-em1Dvs/H2-K1d-em1Dvs
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-Ab1g7-em1Dvs H2-D1em5Dvs/Dvs)
|
abnormal T cell subpopulation ratio
|
J:257229
|
| decreased alpha-beta T cell number
|
J:257229
|
| decreased CD4-positive, alpha-beta T cell number
|
J:257229
|
H2-Ab1g7-em1Ygch/H2-Ab1g7-em1Ygch
(NOD/ShiLtJ-H2-Ab1g7-em1Ygch)
|
decreased CD4-positive, alpha-beta T cell number
|
J:101977
|
H2-D1b-em5Dvs/H2-D1b-em5Dvs
H2-K1d-em1Dvs/H2-K1d-em1Dvs
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs/Dvs)
|
abnormal T cell subpopulation ratio
|
J:257229
|
H2-D1b-tm1Bpe/H2-D1b-tm1Bpe
H2-K1b-tm1Bpe/H2-K1b-tm1Bpe
(involves: 129P2/OlaHsd * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:57703
|
| decreased CD8-positive, alpha-beta T cell number
|
J:54709
|
| increased CD4-positive, alpha-beta T cell number
|
J:54709
|
H2-DMatm1Liz/H2-DMatm1Liz
(involves: BALB/cJ)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:113714
|
H2-DMatm1Lkrl/H2-DMatm1Lkrl
(involves: 129P2/OlaHsd)
|
abnormal positive T cell selection
|
J:31786
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31786
|
H2-DMatm1Luc/H2-DMatm1Luc
(involves: 129S4/SvJae)
|
abnormal positive T cell selection
|
J:125548
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31625,
J:45185
|
H2-K1b-tm1Bpe/H2-K1b-tm1Bpe
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:54709
|
| increased CD4-positive, alpha-beta T cell number
|
J:54709
|
H2-Kbm1/H2-Kbm1
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:92867
|
H2-Kbm5/H2-Kbm5
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:133645
|
H2-M3tm1Crw/H2-M3tm1Crw
(B6.129-H2-M3tm1Crw)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:118960
|
| decreased activated T cell number
|
J:118960
|
H2-Oatm1Dma/H2-Oatm1Dma
(involves: 129/Sv * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:65235
|
H2-Q10tm1.1(KOMP)Mbp/H2-Q10tm1.1(KOMP)Mbp
(involves: C57BL/6 * C57BL/6N)
|
decreased gamma-delta T cell number
|
J:294888
|
| decreased immature NK cell number
|
J:294888
|
| decreased mature NK cell number
|
J:294888
|
| decreased NK cell number
|
J:294888
|
| increased NK cell number
|
J:294888
|
H2-T18b/H2-T18b
H2-T3tm1Luc/H2-T3tm1Luc
(C57BL/6-H2-T3tm1Luc)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:142515
|
| abnormal CD8-positive, gamma-delta intraepithelial T cell morphology
|
J:142515
|
| abnormal intraepithelial T cell morphology
|
J:142515
|
H2-T18b/H2-T18b
H2-T3tm1Luc/H2-T3tm1Luc
Tcratm1Mom/Tcratm1Mom
(B6.Cg-Tcratm1Mom H2-T3tm1Luc)
|
abnormal intraepithelial T cell number
|
J:142515
|
H2b/H2b
Itktm1Ljb/Itktm1Ljb
Tg(TcrAND)53Hed/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
abnormal positive T cell selection
|
J:123795
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
H2b/H2b
Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
H2b/H2b
Ptcratm1Vbo/Ptcratm1Vbo
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
H2b/H2b
Ptcratm1Vbo/Ptcratm1Vbo
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
H2b/H2b
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:133112
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133112
|
| increased CD8-positive, alpha-beta T cell number
|
J:133112
|
H2b/H2b
Tcra/Tcrdtm1.1(Tcra)Rsky/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
H2b/H2b
Tcra/Tcrdtm1.1(Tcra)Rsky/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
H2b/H2b
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:131357
|
| abnormal double-positive T cell morphology
|
J:81564
|
| abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
| decreased double-positive T cell number
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
H2b/H2d
((C57BL/6 x DBA/2)F1)
|
abnormal T cell differentiation
|
J:106141
|
H2b/H2d
Tg(TcraTcrb)1100Mjb/?
(involves: BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:133645
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133645
|
H2b/H2d
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * DBA/2)
|
abnormal negative T cell selection
|
J:151074
|
H2b/H2k
Itktm1Ljb/Itktm1Ljb
Tg(TcrAND)53Hed/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
abnormal positive T cell selection
|
J:123795
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
H2b/H2k
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * C57BL/10Sg * C57BR/c)
|
abnormal negative T cell selection
|
J:133645
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133645
|
H2b/H2s
Tg(TcraTcrb)1100Mjb/?
(involves: A/WySn * C57BL/6 * C57BL/10Sg * Swiss)
|
abnormal negative T cell selection
|
J:133645
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133645
|
H2d/H2d
(DBA/2)
|
abnormal T cell differentiation
|
J:106141
|
H2d/H2d
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:133112
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133112
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133112
|
H2d/H2d
Tcra/Tcrdtm1.1(Tcra)Rsky/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
H2d/H2d
Tg(TcraP1.5,TcrbP1.5)29Amsv/0
Trap1atm1.1Jvde/Y
(involves: 129 * BALB/cJ * C57BL/10 * DBA/2)
|
abnormal T cell clonal deletion
|
J:180807
|
H2dlAb1-Ea/H2dlAb1-Ea
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell number
|
J:57484
|
| decreased CD4-positive, alpha-beta T cell number
|
J:57484
|
| increased CD8-positive, alpha-beta T cell number
|
J:57484
|
H2dlAb1-Ea/H2dlAb1-Ea
Psmb11tm1(Psmb8)Khog/Psmb11tm1(Psmb8)Khog
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:196156
|
| decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
H2dlAb1-Ea/H2dlAb1-Ea
Rr381em2Kap/Rr381em2Kap
(involves: 129S2/SvPas * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:333471
|
H2dlAb1-Ea/H2dlAb1-Ea
Rr381em4Kap/Rr381em4Kap
(involves: 129S2/SvPas * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
H2dlAb1-Ea/H2dlAb1-Ea
Rr381em5Kap/Rr381em5Kap
(involves: 129S2/SvPas * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
H2dlAb1-Ea/H2dlAb1-Ea
Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:189816
|
| increased T-helper 1 cell number
|
J:189816
|
| increased T-helper 17 cell number
|
J:189816
|
H2g7/H2g7
Tg(Ins2-Vtcn1)#Xxz/0
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: C57BL/6 * NOD * SJL)
|
decreased regulatory T cell number
|
J:177612
|
H2k/H2k
Tg(TcraTcrbAD10)1Hed/?
(involves: C57BL/6 * SJL)
|
increased CD4-positive, alpha-beta T cell number
|
J:124701
|
H2u/H2u
Tg(TCRA)B1Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92992
|
| decreased double-positive T cell number
|
J:92992
|
| decreased thymocyte number
|
J:92992
|
| increased double-negative T cell number
|
J:92992
|
H2u/H2u
Tg(TCRA)B1Jg/?
Tg(TCRB)C14Jg/?
(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)
|
abnormal effector T cell morphology
|
J:92991
|
| decreased CD8-positive, alpha-beta T cell number
|
J:92991
|
| decreased double-positive T cell number
|
J:92991
|
| increased CD4-positive, alpha-beta T cell number
|
J:92991
|
H2u/H2u
Tg(TCRA)B1Jg/0
Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg)
|
abnormal double-negative T cell morphology
|
J:92992
|
| abnormal double-positive T cell morphology
|
J:92992
|
| absent gamma-delta T cells
|
J:92992
|
| decreased double-positive T cell number
|
J:92992
|
| increased CD4-positive, alpha-beta T cell number
|
J:92992
|
| increased double-negative T cell number
|
J:92992
|
H2u/H2u
Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRB)C14Jg/J)
|
abnormal double-negative T cell morphology
|
J:92992
|
| abnormal double-positive T cell morphology
|
J:92992
|
| absent gamma-delta T cells
|
J:92992
|
H2axtm1Fwa/H2axtm1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:84879
|
| decreased lymphocyte cell number
|
J:84879
|
H2axtm1Nus/H2axtm1Nus
(Not Specified)
|
abnormal class switch recombination
|
J:194603,
J:120658
|
| decreased B cell number
|
J:76360
|
| decreased T cell number
|
J:76360
|
Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch)
|
abnormal T cell differentiation
|
J:186484
|
| increased activated T cell number
|
J:186484
|
| increased CD4-positive, alpha-beta T cell number
|
J:186484
|
| increased CD8-positive, alpha-beta T cell number
|
J:186484
|
| increased double-negative T cell number
|
J:186484
|
| increased T cell number
|
J:186484
|
Havcr2tm1Vlcg/Havcr2tm1Vlcg
(B6.129-Havcr2tm1Vlcg)
|
decreased T cell number
|
J:209885
|
Havcr2tm1Vlcg/Havcr2tm1Vlcg
Tg(TcraTcrb)1100Mjb/?
(B6.Cg-Havcr2tm1Vlcg Tg(TcraTcrb)1100Mjb)
|
decreased T cell number
|
J:209885
|
Hax1tm1.1Gach/Hax1tm1.1Gach
(involves: BALB/c)
|
abnormal B cell number
|
J:174159
|
| abnormal lymphocyte morphology
|
J:174159
|
| abnormal T cell number
|
J:174159
|
| decreased B cell number
|
J:174159
|
| decreased B-1a cell number
|
J:174159
|
| decreased CD4-positive, alpha-beta T cell number
|
J:174159
|
| decreased CD8-positive, alpha-beta T cell number
|
J:174159
|
| decreased double-positive T cell number
|
J:174159
|
| decreased immature B cell number
|
J:174159
|
| decreased marginal zone B cell number
|
J:174159
|
| decreased mature B cell number
|
J:174159
|
| decreased pre-B cell number
|
J:174159
|
| decreased pro-B cell number
|
J:174159
|
| decreased thymocyte number
|
J:174159
|
| decreased transitional stage T1 B cell number
|
J:174159
|
| decreased transitional stage T2 B cell number
|
J:174159
|
| increased follicular B cell number
|
J:174159
|
Hax1tm1Jni/Hax1tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased double-positive T cell number
|
J:132627
|
| decreased immature B cell number
|
J:132627
|
| decreased lymphocyte cell number
|
J:132627
|
| decreased single-positive T cell number
|
J:132627
|
| decreased T cell number
|
J:132627
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow
Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow
(Not Specified)
|
abnormal Kupffer cell morphology
|
J:134980
|
Hbbd4/Hbbd4
(involves: 101/H)
|
abnormal macrophage morphology
|
J:7972
|
Hbs1ltm1a(KOMP)Wtsi/Hbs1ltm1a(KOMP)Wtsi
(C57BL/6N-Hbs1ltm1a(KOMP)Wtsi/Wtsi)
|
decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased Langerhans cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD5-positive gamma-delta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased regulatory T cell number
|
J:211773
|
Hcar1em1(IMPC)Ccpcz/Hcar1em1(IMPC)Ccpcz
(C57BL/6N-Hcar1em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
Hcktm1Ern/Hcktm1Ern
(involves: 129S1/Sv * C57BL/6)
|
abnormal alveolar macrophage morphology
|
J:111432
|
Hcktm1Hev/Hcktm1Hev
Srctm1Sor/Srctm1Sor
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased macrophage cell number
|
J:31647
|
Hcls1tm1Wtn/Hcls1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:28146
|
Hcls1tm1Wtn/Hcls1tm1Wtn
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:28146
|
| decreased double-positive T cell number
|
J:28146
|
Hcls1tm2Wtn/Hcls1tm2Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:28146
|
Hcn2m1Btlr/Hcn2m1Btlr
(C57BL/6J-Hcn2m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255187
|
| increased CD4-positive, alpha-beta T cell number
|
J:255187
|
Hcrttm1.1(KOMP)Vlcg/Hcrttm1.1(KOMP)Vlcg
(C57BL/6N-Hcrttm1.1(KOMP)Vlcg/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
Hcsttm1.1Cln/Hcsttm1.1Cln
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:80426
|
Hcsttm1.1Cln/Hcsttm1.1Cln
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased uterine NK cell number
|
J:100668
|
Hcsttm1.1Cln/Hcsttm1.1Cln
(B6.129P2-Hcsttm1.1Cln)
|
abnormal osteoclast differentiation
|
J:147155
|
| decreased osteoclast cell number
|
J:147155
|
Hdac1tm1.1Pmt/Hdac1tm1.1Pmt
Hdac2tm1.1Pmt/Hdac2tm1.1Pmt
Cd79atm1(cre)Reth/Cd79a+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB/N)
|
arrested B cell differentiation
|
J:157903
|
| decreased B cell number
|
J:157903
|
| decreased pre-B cell number
|
J:157903
|
| decreased pro-B cell number
|
J:157903
|
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc
Hdac2tm1.1Shmc/Hdac2+
Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:194769
|
| decreased CD4-positive, alpha-beta T cell number
|
J:194769
|
| decreased CD8-positive, alpha-beta T cell number
|
J:194769
|
| decreased double-positive T cell number
|
J:194769
|
| increased double-negative T cell number
|
J:194769
|
| increased double-positive T cell number
|
J:194769
|
| increased single-positive T cell number
|
J:194769
|
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc
Hdac2tm1.1Shmc/Hdac2tm1.1Shmc
Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:194769
|
| decreased double-positive T cell number
|
J:194769
|
| decreased thymocyte number
|
J:194769
|
| increased double-positive T cell number
|
J:194769
|
| increased single-positive T cell number
|
J:194769
|
| increased thymocyte number
|
J:194769
|
Hdac4em1(IMPC)Ccpcz/Hdac4+
(C57BL/6N-Hdac4em1(IMPC)Ccpcz/Ccpcz)
|
increased NK cell number
|
J:211773
|
Hddc2em1(IMPC)H/Hddc2em1(IMPC)H
(C57BL/6NTac-Hddc2em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Hellstm1Kmu/Hellstm1Kmu
(involves: 129S1/Sv)
|
decreased B cell number
|
J:61948
|
| increased CD8-positive, alpha-beta T cell number
|
J:61948
|
| increased double-negative T cell number
|
J:61948
|
Herc1em3(IMPC)Wtsi/Herc1em3(IMPC)Wtsi
(C57BL/6N-Herc1em3(IMPC)Wtsi/Wtsi)
|
increased Ly6C high monocyte number
|
J:211773
|
| increased Ly6C low monocyte number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Hes1tm1.1Frad/Hes1tm1.1Frad
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167000
|
| decreased DN1 thymic pro-T cell number
|
J:167000
|
| decreased DN2 thymocyte number
|
J:167000
|
| decreased DN3 thymocyte number
|
J:167000
|
| decreased DN4 thymocyte number
|
J:167000
|
| decreased double-positive T cell number
|
J:167000
|
| decreased gamma-delta T cell number
|
J:167000
|
| increased DN1 thymic pro-T cell number
|
J:167000
|
| increased immature B cell number
|
J:167000
|
Hexbtm1b(EUCOMM)Hmgu/Hexbtm1b(EUCOMM)Hmgu
(C57BL/6N-Hexbtm1b(EUCOMM)Hmgu/H)
|
increased monocyte cell number
|
J:211773
|
Hexbtm1Rlp/Hexbtm1Rlp
Tg(Hexb-tTA2S,tetO-Hexb)#Tjsa/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
microgliosis
|
J:190450
|
Hexbtm1Rlp/Hexbtm1Rlp
Tg(SYN1-tTA2S,tetO-Hexb)#Tjsa/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
microgliosis
|
J:190450
|
Hfetm1Gfn/Hfetm1Gfn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased osteoclast cell number
|
J:262906
|
Hfgi1C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
abnormal lymphopoiesis
|
J:123483
|
Hfgi2C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
abnormal lymphopoiesis
|
J:123483
|
Hgsnattm1a(EUCOMM)Wtsi/Hgsnattm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
abnormal Kupffer cell morphology
|
J:235361
|
| microgliosis
|
J:235361
|
Hhextm1Ngu/Hhextm1Ngu
(involves: 129/Sv * C57BL/6)
|
abnormal monocyte differentiation
|
J:65105
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(Tal1-cre/ERT)42-056Jrg/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:192126
|
| abnormal T cell differentiation
|
J:192126
|
Hivep2tm1Sis/Hivep2+
(involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased CD8-positive, alpha-beta T cell number
|
J:72249
|
| decreased single-positive T cell number
|
J:72249
|
Hivep2tm1Sis/Hivep2tm1Sis
(involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased single-positive T cell number
|
J:72249
|
Hivep2tm1Sis/Hivep2tm1Sis
(C.Cg-Hivep2tm1Sis)
|
abnormal T-helper 2 cell morphology
|
J:96024
|
Hivep2tm1Sis/Hivep2tm1Sis
Tg(DO11.10)10Dlo/?
(involves: BALB/cA * C3H * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal positive T cell selection
|
J:96024
|
| abnormal T-helper 2 cell morphology
|
J:96024
|
| decreased single-positive T cell number
|
J:72249
|
Hivep3tm1Glm/Hivep3tm1Glm
(Not Specified)
|
abnormal osteoclast differentiation
|
J:184764
|
| decreased osteoclast cell number
|
J:184764
|
Hivep3tm1Lcw/Hivep3tm1Lcw
(chimera involves: 129S/SvEv * 129X1/SvJ)
|
decreased double-positive T cell number
|
J:79652
|
Hjvtm1Kpan/Hjvtm1Kpan
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage morphology
|
J:231428
|
Hjvtm1Nca/Hjvtm1Nca
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage morphology
|
J:160248
|
Hjvtm1Nca/Hjvtm1Nca
Tmprss6tm1Dgen/Tmprss6+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage morphology
|
J:160248
|
Hjvtm1Nca/Hjvtm1Nca
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage morphology
|
J:160248
|
Hmbox1em1(IMPC)Tcp/Hmbox1em1(IMPC)Tcp
(C57BL/6N-Hmbox1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
decreased macrophage cell number
|
J:205499
|
Hmgn5tm1.2Mbus/Y
(involves: 129S4/SvJae * C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:199604
|
Hmgn5tm1.2Mbus/Hmgn5tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:199604
|
Hmox1tm1.1Gkl/Hmox1tm1.1Gkl
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased B cell number
|
J:148498
|
| increased CD4-positive, alpha-beta T cell number
|
J:148498
|
| increased CD8-positive, alpha-beta T cell number
|
J:148498
|
| increased macrophage cell number
|
J:148498
|
Hmox1tm1Poss/Hmox1+
Slc48a1em1Ih/Slc48a1em1Ih
(involves: 129 * 129S2/SvPas * C57BL/6J)
|
decreased macrophage cell number
|
J:282829
|
Hmox1tm1Poss/Hmox1tm1Poss
(involves: 129 * 129S2/SvPas * C57BL/6J)
|
decreased macrophage cell number
|
J:282829
|
Hmox1tm1Poss/Hmox1tm1Poss
Slc48a1em1Ih/Slc48a1em1Ih
(involves: 129 * 129S2/SvPas * C57BL/6J)
|
decreased macrophage cell number
|
J:282829
|
Hmox1tm1Poss/Hmox1tm1Poss
Spictm2Kmm/Spictm2Kmm
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased macrophage cell number
|
J:210804
|
Hmox2tm1b(EUCOMM)Hmgu/Hmox2tm1b(EUCOMM)Hmgu
(C57BL/6N-Hmox2tm1b(EUCOMM)Hmgu/H)
|
decreased monocyte cell number
|
J:211773
|
Hnrnpdtm1b(KOMP)Wtsi/Hnrnpd+
(C57BL/6N-Hnrnpdtm1b(KOMP)Wtsi/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
Hnrnph1tm1b(KOMP)Wtsi/Hnrnph1+
(C57BL/6N-Hnrnph1tm1b(KOMP)Wtsi/Nju)
|
increased lymphocyte cell number
|
J:211773
|
Hnrnpltm1.1Tmo/Hnrnpltm1.1Tmo
Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm)
|
abnormal T cell differentiation
|
J:188749
|
| decreased CD4-positive, alpha-beta T cell number
|
J:188749
|
| decreased CD8-positive, alpha-beta T cell number
|
J:188749
|
| decreased double-positive T cell number
|
J:188749
|
| decreased T cell number
|
J:188749
|
| increased double-negative T cell number
|
J:188749
|
Hnrnpllthdr/Hnrnpllthdr
(C57BL/6JSfdAnu-Hnrnpllthdr/Anu)
|
abnormal memory T cell morphology
|
J:142641
|
| abnormal T cell differentiation
|
J:142641
|
| decreased CD4-positive, alpha-beta T cell number
|
J:142641
|
Hoxa5tm1Rob/Hoxa5tm1Rob
(involves: 129S/SvEv * C57BL/6 * MF1)
|
abnormal alveolar macrophage morphology
|
J:113378
|
Hoxb8tm1.1Mrc/Hoxb8tm1.1Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal microglial cell morphology
|
J:162102
|
Hoxc4tm2.1Mrc/Hoxc4tm2.1Mrc
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:148278
|
| abnormal somatic hypermutation frequency
|
J:148278
|
Hprt1b-m3/Y
Impdh1tm1Bmi/Impdh1tm1Bmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:85443
|
Hprt1b-m3/Y
Impdh2tm1Bmi/Impdh2+
(involves: 129P2/OlaHsd)
|
abnormal lymphocyte cell number
|
J:86045
|
Hprt1tm1(CUX1)Anep/Hprt1+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * FVB))
|
decreased B cell number
|
J:113393
|
Hpsetm1.2Mdh/Hpsetm1.2Mdh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal Langerhans cell morphology
|
J:209913
|
Hrem1(IMPC)H/Hrem1(IMPC)H
(C57BL/6NTac-Hrem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Hrhr/Hrhr
(HRS/J)
|
decreased T cell number
|
J:6087
|
| increased macrophage cell number
|
J:150402
|
Hrgtm1Wja/Hrgtm1Wja
(involves: 129P2/OlaHsd * C57BL/6)
|
increased monocyte cell number
|
J:134621
|
Hrh1tm1Wtn/Hrh1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell number
|
J:111704
|
Hsd17b4tm1Baes/Hsd17b4tm1Baes
(involves: 129S1/Sv * 129X1/SvJ)
|
microgliosis
|
J:201698
|
Hsd17b4tm2Baes/Hsd17b4tm2Baes
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
microgliosis
|
J:201698
|
Hsd17b11Gt(OST237628)Lex/Hsd17b11Gt(OST237628)Lex
(B6;129S5-Hsd17b11Gt(OST237628)Lex/Mmucd)
|
increased immature B cell number
|
J:171883
|
Hspa9Gt(IST14901H6)Tigm/Hspa9+
(involves: C57BL/6N)
|
decreased pre-B cell number
|
J:227164
|
Hspa12atm1.1Zdi/Hspa12atm1.1Zdi
(involves: 129 * C57BL/6)
|
abnormal macrophage morphology
|
J:302786
|
Hspa13tm1.1Smoc/Hspa13tm1.1Smoc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S * C57BL/6)
|
abnormal class switch recombination
|
J:303927
|
| abnormal plasmablast number
|
J:303927
|
| abnormal somatic hypermutation frequency
|
J:303927
|
| decreased plasma cell number
|
J:303927
|
Hspg2tm1Rdgr/Hspg2tm1Rdgr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal osteoclast morphology
|
J:121855
|
| increased osteoclast cell number
|
J:121855
|
Htr3atm1Ckn/Htr3atm1Ckn
(involves: 129S1/Sv * C57BL/6J * DBA/2)
|
decreased lymphocyte cell number
|
J:90942
|
Htra2mnd2/Htra2mnd2
(involves: C57BL/6J)
|
decreased double-positive T cell number
|
J:132627
|
| decreased pre-B cell number
|
J:132627
|
| decreased pro-B cell number
|
J:132627
|
| decreased single-positive T cell number
|
J:132627
|
Htra2tm1.2Hohj/Htra2tm1.2Hohj
(involves: C57BL/6 * C57BL/6J)
|
decreased lymphocyte cell number
|
J:225666
|
Htttm2Detl/Htt+
(B6J.129P2-Htttm2Detl)
|
microgliosis
|
J:220868
|
Hycc1em1(IMPC)Ccpcz/Hycc1em1(IMPC)Ccpcz
(C57BL/6N-Hycc1em1(IMPC)Ccpcz/Ccpcz)
|
increased monocyte cell number
|
J:211773
|
Iapptm1Sgm/Iapp+
(involves: 129P2/OlaHsd)
|
increased osteoclast cell number
|
J:88964
|
Iapptm1Sgm/Iapptm1Sgm
(involves: 129P2/OlaHsd)
|
increased osteoclast cell number
|
J:88964
|
Ibsptm1Jeau/Ibsptm1Jeau
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal osteoclast morphology
|
J:228156,
J:136223
|
| decreased osteoclast cell number
|
J:136223
|
| increased osteoclast cell number
|
J:228156
|
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay)
|
increased lymphocyte cell number
|
J:48271
|
| increased monocyte cell number
|
J:48271
|
Icam1tm1Bay/Icam1tm1Bay
Selltm1Tft/Selltm1Tft
(B6.129-Selltm1Tft Icam1tm1Bay)
|
increased lymphocyte cell number
|
J:48271
|
| increased monocyte cell number
|
J:48271
|
Icam1tm1Cws/Icam1tm1Cws
(involves: C57BL/6)
|
abnormal macrophage morphology
|
J:100353
|
Icam1tm1Jcgr/Icam1tm1Jcgr
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased lymphocyte cell number
|
J:18743
|
Icam1tm1Jcgr/Icam1tm1Jcgr
Ldlrtm1Her/Ldlrtm1Her
Vcam1tm1Dmil/Vcam1tm1Dmil
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
increased lymphocyte cell number
|
J:69597
|
| increased monocyte cell number
|
J:69597
|
Icostm1.1Wks/Icostm1.1Wks
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell number
|
J:155586
|
| abnormal B cell selection
|
J:155586
|
| abnormal class switch recombination
|
J:155586
|
| decreased CD4-positive, alpha-beta T cell number
|
J:155586
|
Icostm1Dgry/Icostm1Dgry
(B6.129P2-Icostm1Dgry)
|
abnormal memory B cell number
|
J:123477
|
| decreased germinal center B cell number
|
J:123477
|
| decreased plasma cell number
|
J:123477
|
| increased plasma cell number
|
J:123477
|
Icostm1Flv/Icostm1Flv
(NOD.129S1-Icostm1Flv)
|
decreased T cell number
|
J:131529
|
Icostm1Mak/Icostm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:155586
|
| abnormal class switch recombination
|
J:66702
|
| decreased CD4-positive, alpha-beta T cell number
|
J:155586
|
Icostm1Shr/Icostm1Shr
(Not Specified)
|
abnormal T cell differentiation
|
J:87124
|
Icosltm1Cdon/Icosltm1Cdon
(involves: 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:86697
|
Icosltm1Mak/Icosltm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:84668
|
| abnormal T-helper 2 cell differentiation
|
J:84668
|
Id1tm1Zhu/Id1tm1Zhu
(involves: 129S1/Sv * C57BL/6)
|
abnormal osteoclast differentiation
|
J:155384
|
| decreased lymphocyte cell number
|
J:119519
|
| increased monocyte cell number
|
J:155384
|
| increased osteoclast cell number
|
J:155384
|
Id1tm1Zhu/Id1tm1Zhu
Tcf3tm1Wein/Tcf3tm1Wein
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
absent B cells
|
J:44278
|
| arrested B cell differentiation
|
J:44278
|
| decreased lymphocyte cell number
|
J:44278
|
Id2tm1Ago/Id2tm1Ago
(B6.129-Id2tm1Ago)
|
absent NK cells
|
J:116119
|
| decreased CD8-positive, alpha-beta T cell number
|
J:116119
|
Id2tm1Yyk/Id2tm1Yyk
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased NK cell number
|
J:53267
|
Id2tm1Yyk/Id2tm1Yyk
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
decreased NK cell number
|
J:53267
|
Id2tm1Yyk/Id2tm1Yyk
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * FVB/NJ))
|
decreased NK T cell number
|
J:125739
|
Id2tm1Yyk/Id2tm1Yyk
Tcf3tm1Cmu/Tcf3+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased NK T cell number
|
J:125739
|
Id2tm1Yyk/Id2tm1Yyk
Tcf3tm1Cmu/Tcf3tm1Cmu
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased B cell number
|
J:125739
|
| decreased NK T cell number
|
J:125739
|
Id3tm1Cmu/Id3tm1Cmu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal double-positive T cell morphology
|
J:59969
|
| abnormal T cell differentiation
|
J:59969
|
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal T cell differentiation
|
J:144696
|
Id3tm2.1Cmu/Id3tm2.1Cmu
(Not Specified)
|
decreased thymocyte number
|
J:176462
|
| increased B cell number
|
J:176462
|
| increased gamma-delta T cell number
|
J:176462
|
| increased T follicular helper cell number
|
J:176462
|
Id3tm2.1Cmu/Id3tm2.1Cmu
Tcf3tm4Zhu/Tcf3tm4Zhu
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:176462
|
Id3tm2.1Zhu/Id3tm2.1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
abnormal T cell differentiation
|
J:172701
|
| decreased CD4-positive, alpha-beta T cell number
|
J:172701
|
| decreased CD8-positive, alpha-beta T cell number
|
J:172701
|
| decreased T cell number
|
J:172701
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:172701
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:172701
|
| increased gamma-delta T cell number
|
J:172701
|
Idd1NOD/Uf/Idd1NOD/Uf
(B6.NOD-(D17Mit164-D17Mit152))
|
increased CD4-positive, alpha-beta T cell number
|
J:92304
|
Idd2NOD/Smrf/Idd2NOD/Smrf
(involves: NON/Lt * NOD/Smrf)
|
increased CD4-positive, alpha-beta T cell number
|
J:30526
|
Idd4NOD/Idd4NOD
(B6.NOD-Idd4)
|
decreased NK T cell number
|
J:85823
|
Idd6.2C3H/HeJ/Idd6.2C3H/HeJ
(NOD.C3-Idd6.2C3H/HeJ)
|
decreased NK cell number
|
J:137837
|
Idd6.2NOD/Idd6.2NOD
(B6.NOD-(D6Mit259-D6Mit304))
|
abnormal T cell differentiation
|
J:120148
|
Idd6C3H/HeJ/Idd6C3H/HeJ
(NOD.C3-Idd6C3H/HeJ)
|
decreased NK cell number
|
J:137837
|
Idd7NOD/ShiLt/Idd7NOD/ShiLt
(involves: C57BL/6 * NOD/ShiLt)
|
abnormal T cell clonal deletion
|
J:131557
|
Idd9.1C57BL/10SnJ/Idd9.1C57BL/10SnJ
(NOD.B10-Idd9.1C57BL/10SnJ)
|
increased NK T cell number
|
J:85823
|
Idh1tm1Mak/Idh1tm1Mak
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:186700
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186700
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186700
|
| increased CD4-positive, alpha-beta T cell number
|
J:186700
|
Idh1tm2Mak/Idh1tm2Mak
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:186700
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186700
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186700
|
| increased CD4-positive, alpha-beta T cell number
|
J:186700
|
Idh2tm1Jwpk/Idh2tm1Jwpk
(involves: 129S4/SvJae * C57BL/6)
|
increased osteoclast cell number
|
J:272241
|
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal macrophage morphology
|
J:282516
|
Iduatm1Efn/Iduatm1Efn
(involves: C57BL/6)
|
abnormal microglial cell morphology
|
J:81974
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: 129 * C57BL/6)
|
decreased regulatory T cell number
|
J:157504
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: C57BL/6)
|
increased T-helper 17 cell number
|
J:194587
|
Ifi44tm1b(KOMP)Wtsi/Ifi44tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
increased CD8-positive, alpha-beta T cell number
|
J:297991
|
Ifih1Rgsc422/Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422)
|
increased macrophage cell number
|
J:209917
|
| increased plasma cell number
|
J:209917
|
Ifitm1tm1.1Ieg/Ifitm1tm1.1Ieg
(B6.129P2-Ifitm1tm1.1Ieg)
|
decreased T cell number
|
J:192287
|
Ifitm5em1Pmof/Ifitm5+
(involves: CD-1)
|
abnormal osteoclast morphology
|
J:255349
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(B6.129S2-Ifnar1tm1Agt)
|
abnormal osteoclast morphology
|
J:76097
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas * BALB/c)
|
abnormal mononuclear phagocyte morphology
|
J:291874
|
| decreased Ly6C high monocyte number
|
J:291874
|
| increased CD4-positive, alpha-beta T cell number
|
J:291874
|
| increased CD8-positive, alpha-beta T cell number
|
J:291874
|
Ifnar1tm1Agt/Ifnar1tm1Agt
Slamf1tm1Oono/Slamf1tm1Oono
(B6.129-Slamf1tm1Oono Ifnar1tm1Agt)
|
abnormal lymphopoiesis
|
J:117810
|
Ifnar1tm1Pjh/Ifnar1tm1Pjh
(B6.129S2-Ifnar1tm1Pjh)
|
decreased NK cell number
|
J:125812
|
Ifnar2tm1Pjh/Ifnar2tm1Pjh
(B6.Cg-Ifnar2tm1Pjh)
|
decreased NK cell number
|
J:125812
|
Ifnb1tm1Acgp/Ifnb1tm1Acgp
(involves: 129P2/OlaHsd)
|
decreased macrophage cell number
|
J:86527
|
| decreased mature B cell number
|
J:86527
|
| decreased monocyte cell number
|
J:86527
|
| decreased pro-B cell number
|
J:86527
|
Ifnb1tm1Ttg/Ifnb1tm1Ttg
(B6.Cg-Ifnb1tm1Ttg)
|
abnormal osteoclast morphology
|
J:76097
|
Ifnetm1.2Pjh/Ifnetm1.2Pjh
(involves: C57BL/6)
|
decreased NK cell number
|
J:197569
|
Ifngtm1.1Hayg/Ifngtm1.1Hayg
(Not Specified)
|
abnormal B cell differentiation
|
J:220784
|
| decreased mature B cell number
|
J:220784
|
| decreased pre-B cell number
|
J:220784
|
| increased T cell number
|
J:220784
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
increased monocyte cell number
|
J:47459
|
| increased NK T cell number
|
J:122801
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts)
|
increased CD8-positive, alpha-beta T cell number
|
J:112048
|
Ifngtm1Ts/Ifngtm1Ts
(C.129S7(B6)-Ifngtm1Ts/J)
|
abnormal uterine NK cell morphology
|
J:56503
|
| increased monocyte cell number
|
J:47459
|
| increased uterine NK cell number
|
J:56503
|
Ifngtm1Ts/Ifngtm1Ts
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her Ifngtm1Ts)
|
increased T cell number
|
J:103072
|
Ifngtm1Ts/Ifngtm1Ts
Pld4tm1.2Nemz/Pld4tm1.2Nemz
(involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N)
|
decreased NK T cell number
|
J:281205
|
Ifngtm1Ts/Ifngtm1Ts
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
increased lymphocyte cell number
|
J:119206
|
Ifngr1m1Btlr/Ifngr1m1Btlr
(C57BL/6J-Ifngr1m1Btlr)
|
decreased macrophage cell number
|
J:236694
|
| increased B cell number
|
J:236694
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
abnormal uterine NK cell morphology
|
J:56503
|
| increased uterine NK cell number
|
J:56503
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt/J)
|
abnormal lymphopoiesis
|
J:138728
|
| abnormal osteoclast differentiation
|
J:233116
|
| decreased CD4-positive, alpha-beta T cell number
|
J:138728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:138728
|
| decreased lymphocyte cell number
|
J:138728
|
Ifngr1tm1Agt/Ifngr1tm1Agt
Tg(GZMB-Tax)#Lera/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:147601
|
| increased osteoclast cell number
|
J:147601
|
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(involves: 129S1/Sv)
|
abnormal class switch recombination
|
J:48016
|
| abnormal T-helper 1 cell differentiation
|
J:48016
|
Igbp1tm1Cbt/Y
Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:93221
|
Igbp1tm1Cbt/Igbp1+
Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:93221
|
Igbp1tm1Imku/Y
Tg(Lck-cre)I57Jxm/?
(involves: 129P2/OlaHsd * ICR)
|
decreased double-negative T cell number
|
J:84395
|
| decreased T cell number
|
J:84395
|
| decreased thymocyte number
|
J:84395
|
Igf1rtm2Arge/Igf1rtm2Arge
Tg(BGLAP-cre)1Clem/0
(involves: 129 * FVB/N)
|
decreased osteoclast cell number
|
J:80190
|
Igf1sl2C3H/HeJ/Igf1sl2C3H/HeJ
(B6.C3H-Igf1sl2C3H/HeJ)
|
increased osteoclast cell number
|
J:111677
|
Igf2tm1Snha/Igf2+
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal osteoclast differentiation
|
J:167738
|
Igh-7tm1.1Lam/Igh-7tm1.1Lam
(involves: BALB/c)
|
decreased mature B cell number
|
J:146733
|
Igh-7tm1Gach/Igh-7tm1Gach
(BALB/c-Igh-7tm1Gach)
|
abnormal B cell number
|
J:143266
|
| increased memory B cell number
|
J:143266
|
| increased plasma cell number
|
J:143266
|
Igh-7tm1Lam/Igh-7tm1Lam
(involves: BALB/c)
|
decreased mature B cell number
|
J:146733
|
Igh-7tm1Lcwu/Igh-7tm1Lcwu
(involves: C57BL/6)
|
decreased mature B cell number
|
J:161452
|
Igh-7tm1Led/Igh-7tm1Led
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased B cell number
|
J:161523
|
Igh-8tm1.1Aak/Igh-8tm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
Igh-8tm1Aak/Igh-8tm1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:107063
|
Igh-8tm2(Ighg1)Aak/Igh-8tm2(Ighg1)Aak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:130574
|
Igh-Jtm1(3H9-VDJ)Mwg/Igh-Jtm1(3H9-VDJ)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
Igh-Jtm1(CB20)Riho/Igh-J+
(involves: C57BL/10 * DBA/1)
|
abnormal B cell differentiation
|
J:179456
|
| decreased pre-B cell number
|
J:179456
|
| increased immature B cell number
|
J:179456
|
| increased marginal zone B cell number
|
J:179456
|
| increased mature B cell number
|
J:179456
|
Igh-Jtm1(CB20)Riho/Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1)
|
abnormal B cell differentiation
|
J:179456
|
| decreased pre-B cell number
|
J:179456
|
| increased immature B cell number
|
J:179456
|
| increased marginal zone B cell number
|
J:179456
|
| increased mature B cell number
|
J:179456
|
Igh-Jtm1.1Lave/Igh-J+
(Not Specified)
|
abnormal B cell differentiation
|
J:155798
|
| decreased B cell number
|
J:155798
|
| decreased immature B cell number
|
J:155798
|
| decreased mature B cell number
|
J:155798
|
| decreased T cell number
|
J:155798
|
| decreased transitional stage B cell number
|
J:155798
|
| decreased transitional stage T1 B cell number
|
J:155798
|
| decreased transitional stage T2 B cell number
|
J:155798
|
| increased pre-B cell number
|
J:155798
|
| increased pro-B cell number
|
J:155798
|
Igh-Jtm1.1Lave/Igh-Jtm1.1Lave
(Not Specified)
|
abnormal B cell differentiation
|
J:155798
|
| arrested B cell differentiation
|
J:179317
|
| decreased B cell number
|
J:155798,
J:179317
|
| decreased immature B cell number
|
J:155798
|
| decreased mature B cell number
|
J:155798
|
| decreased T cell number
|
J:155798
|
| decreased transitional stage B cell number
|
J:155798
|
| decreased transitional stage T1 B cell number
|
J:155798
|
| decreased transitional stage T2 B cell number
|
J:155798
|
| increased pre-B cell number
|
J:155798
|
| increased pro-B cell number
|
J:155798
|
Igh-Jtm1.1Lave/Igh-Jtm1.1Lave
Igk-Jtm1.1Lave/Igk-Jtm1.1Lave
(Not Specified)
|
abnormal B cell clonal deletion
|
J:179317
|
| abnormal B cell differentiation
|
J:205708
|
| arrested B cell differentiation
|
J:205708,
J:179317
|
| decreased B cell number
|
J:205708,
J:179317
|
| decreased immature B cell number
|
J:205708
|
| decreased mature B cell number
|
J:205708
|
Igh-Jtm1.1Lave/Igh-Jtm1.1Lave
Igk-Jtm1.1Lave/Igk-Jtm1.1Lave
Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:179317
|
Igh-Jtm1Aigl/Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell morphology
|
J:111543
|
| decreased B cell number
|
J:111543
|
| decreased B-1 B cell number
|
J:111543
|
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
(Not Specified)
|
decreased B cell number
|
J:79299
|
| decreased follicular B cell number
|
J:79299
|
| decreased marginal zone B cell number
|
J:79299
|
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd)
|
decreased mature B cell number
|
J:157297
|
Igh-Jtm1Cgn/Ightm11.1Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113434
|
Igh-Jtm1Cgn/Igh-J+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:64285
|
Igh-Jtm1Cgn/Ightm1Leck
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
Igh-Jtm1Cgn/Igh-Jtm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
absent mature B cells
|
J:64285
|
| arrested B cell differentiation
|
J:64285
|
Igh-Jtm1Dhu/Ightm3Tim
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
| decreased B cell number
|
J:102308
|
Igh-Jtm1Dhu/Ightm1Tim
(involves: 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:88410
|
| abnormal B cell morphology
|
J:87624
|
Igh-Jtm1Dhu/Ightm2Tim
(involves: 129X1/SvJ * C57BL/6)
|
decreased marginal zone B cell number
|
J:87624
|
Igh-Jtm1Dhu/Igh-Jtm1(VDJ-17.2.25)Wabl
Igktm1Dhu/Igktm1Dhu
(Not Specified)
|
abnormal B cell differentiation
|
J:33628
|
| abnormal immature B cell morphology
|
J:89757
|
Igh-Jtm1Dim/Igh-J+
Igk-Jtm1Dim/Igk-J+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:107241
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell number
|
J:113083
|
| absent B cells
|
J:70038
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
(involves: 129P2/OlaHsd)
|
absent mature B cells
|
J:137738
|
| arrested B cell differentiation
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
(involves: 129P2/OlaHsd)
|
absent B cells
|
J:23827
|
| absent mature B cells
|
J:137738,
J:70620
|
| arrested B cell differentiation
|
J:137738,
J:23827
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH1)2BJkbv/0
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
| increased mature B cell number
|
J:23827
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH1)2BJkbv/0
Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv
Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv
Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2)J9.2Jkbv/0
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell morphology
|
J:70620
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:70620
|
| abnormal immunoglobulin light chain V-J recombination
|
J:70620
|
| increased mature B cell number
|
J:70620
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2)J9.2Jkbv/0
Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2BM)7Amgn/0
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:139792
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2CM)2Amgn/0
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:139792
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@*)SALed/0
(involves: 129P2/OlaHsd)
|
decreased mature B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH1)2BJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH1)2BJkbv/0
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
| increased late pro-B cell number
|
J:23827
|
| increased mature B cell number
|
J:23827
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH2)J9.2Jkbv/0
(involves: 129P2/OlaHsd)
|
decreased mature B cell number
|
J:137738
|
Igh-Jtm1Khyk/Igh-J+
(CB17.129X1-Igh-Jtm1Khyk)
|
increased B-1 B cell number
|
J:109979
|
Igh-Jtm1Mcdl/Igh-Jtm1Mcdl
Igk-Jtm1Mcdl/Igk-Jtm1Mcdl
Rag1tm1Mom/Rag1tm1Mom
Tg(DO11.10)10Dlo/?
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:100072
|
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell receptor editing
|
J:131138
|
| abnormal marginal zone B cell morphology
|
J:131138
|
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(B6.129P2-Igh-Jtm2(3H9-VDJ*)Mwg)
|
decreased B cell number
|
J:142389
|
| increased marginal zone B cell number
|
J:142389
|
Igh-Jtm2.1(4E10)Lave/Igh-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:205708
|
| decreased B-1a cell number
|
J:205708
|
Igh-Jtm2.1(4E10)Lave/Igh-Jtm2.1(4E10)Lave
Igk-Jtm2.1(4E10)Lave/Igk-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:205708
|
| arrested B cell differentiation
|
J:205708
|
| decreased immature B cell number
|
J:205708
|
| decreased mature B cell number
|
J:205708
|
Igh-Jtm3(3H9-VDJ*)Mwg/Igh-Jtm3(3H9-VDJ*)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
Igh-Jtm3.1(48d)Lave/Igh-Jtm3.1(48d)Lave
(involves: C57BL/6)
|
decreased B-1a cell number
|
J:205708
|
IghdeltaD/Igh+
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:95981
|
| decreased B cell number
|
J:95981
|
IghdeltaD/IghdeltaD
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:95981
|
| arrested B cell differentiation
|
J:95981
|
| decreased B cell number
|
J:95981
|
| decreased follicular B cell number
|
J:95981
|
| increased marginal zone B cell number
|
J:95981
|
IghdeltaD/Ightm11.1Cgn
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:113434
|
Ightm1(PAX5)Mbu/Igh+
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal T cell differentiation
|
J:118111
|
| decreased double-negative T cell number
|
J:118111
|
| decreased double-positive T cell number
|
J:118111
|
| increased pro-B cell number
|
J:118111
|
Ightm1(PAX5)Mbu/Igh+
Pax5tm1Mbu/Pax5tm1Mbu
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:118111
|
| decreased B cell number
|
J:118111
|
Ightm1(PAX5)Mbu/Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal T cell differentiation
|
J:118111
|
| decreased double-negative T cell number
|
J:118111
|
| decreased double-positive T cell number
|
J:118111
|
| increased pro-B cell number
|
J:118111
|
Ightm1(VH558)Mss/Igh+
(involves: FVB/N)
|
abnormal B cell differentiation
|
J:130421
|
Ightm1(VH558)Mss/Ightm1(VH558)Mss
(involves: FVB/N)
|
abnormal B cell differentiation
|
J:130421
|
Ightm1.1(b12)Nemz/Ightm1.1(b12)Nemz
(involves: C57BL/6N * FVB/N)
|
decreased immature B cell number
|
J:205766
|
| increased B cell number
|
J:205766
|
Ightm1.1(b12)Nemz/Ightm1.1(b12)Nemz
Igktm1.1(b12)Nemz/Igktm1.1(b12)Nemz
(involves: C57BL/6N * C57BL/6NTac * FVB/N)
|
decreased immature B cell number
|
J:205766
|
| increased B cell number
|
J:205766
|
Ightm1.1(Rr361-HBB)Aak/Ightm1.1(Rr361-HBB)Aak
(129.129S2(Cg)-Ightm1.1(Rr361-HBB)Aak)
|
abnormal class switch recombination
|
J:333279
|
Ightm1.1(Tag)Rwhe/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:150315
|
| increased B cell number
|
J:150315
|
Ightm1.1Hmj/Ightm1.1Hmj
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal B cell differentiation
|
J:140486
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:140486
|
| decreased mature B cell number
|
J:140486
|
Ightm1.1Hws/Ightm1.1Hws
(BALB/cJ-Ightm1.1Hws)
|
decreased immature B cell number
|
J:119391
|
| decreased pre-B cell number
|
J:119391
|
| increased late pro-B cell number
|
J:119391
|
Ightm1.1Hws/Ightm1.1Hws
(involves: BALB/c)
|
decreased immature B cell number
|
J:142069
|
| decreased late pro-B cell number
|
J:142069
|
| increased early pro-B cell number
|
J:142069
|
Ightm1.1Lnit/Igh+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:119484
|
Ightm1.1Rsky/Ightm1.1Rsky
(BALB/c-Ightm1.1Rsky)
|
abnormal class switch recombination
|
J:125719
|
Ightm1.1Twin/Igh+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
decreased pre-B cell number
|
J:174233
|
| increased pro-B cell number
|
J:174233
|
Ightm1.1Twin/Ightm1.1Twin
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:174233
|
| abnormal B cell morphology
|
J:174233
|
| abnormal B cell number
|
J:174233
|
| abnormal marginal zone B cell morphology
|
J:174233
|
| absent plasma cells
|
J:174233
|
| decreased B cell number
|
J:174233
|
| decreased B-1a cell number
|
J:174233
|
| decreased follicular B cell number
|
J:174233
|
| decreased immature B cell number
|
J:174233
|
| decreased mature B cell number
|
J:174233
|
| decreased transitional stage T2 B cell number
|
J:174233
|
Ightm1.1Twin/Ightm1.1Twin
Plcg2Ali5/Plcg2+
(involves: 129 * 129S4/SvJae * C3HeB/FeJ * C57BL/6)
|
increased B-1a cell number
|
J:174233
|
Ightm1.1Vmd/Igh+
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
Ightm1.1Vmd/Ightm1.1Vmd
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
Ightm1.2Rsky/Igh+
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(involves: BALB/c * C57BL/6)
|
decreased mature B cell number
|
J:125719
|
Ightm1.2Rsky/Ightm1.2Rsky
(BALB/c-Ightm1.2Rsky)
|
abnormal B cell morphology
|
J:125719
|
| abnormal mature B cell morphology
|
J:125719
|
| decreased B-1a cell number
|
J:125719
|
| decreased pre-B cell number
|
J:125719
|
| decreased transitional stage B cell number
|
J:125719
|
| increased marginal zone B cell number
|
J:125719
|
| increased pro-B cell number
|
J:125719
|
Ightm1.2Rsky/Ightm1.2Rsky
Tg(CD19-cre/ERT2)1Cgn/?
(involves: BALB/c)
|
abnormal class switch recombination
|
J:125719
|
Ightm1Aak/Ightm1Aak
(Not Specified)
|
abnormal B cell differentiation
|
J:158402
|
| decreased B cell number
|
J:158402
|
| decreased pre-B cell number
|
J:158402
|
| increased pro-B cell number
|
J:158402
|
Ightm1Cgn/Igh+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:79556
|
Ightm1Cgn/Ightm2Cgn
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
Ightm1Cog/Ightm1Cog
(involves: 129S2/SvPas * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:80654
|
| absent B cells
|
J:80654
|
| arrested B cell differentiation
|
J:80654
|
Ightm1Kplm/Igh+
(involves: A/WySnJ * BALB/c)
|
abnormal B-1 B cell morphology
|
J:115788
|
Ightm1Kplm/Igh+
(Not Specified)
|
abnormal B cell differentiation
|
J:115292
|
| increased B cell number
|
J:115292
|
Ightm1Kplm/Igh+
Tg(Igk-V4CH27)1-2Shc/0
(involves: C57BL/6 * SJL)
|
increased B cell number
|
J:115292
|
Ightm1Kplm/Ightm3Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:115292
|
| abnormal B cell number
|
J:115292
|
Ightm1Kplm/Ightm4Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:115292
|
| abnormal B cell number
|
J:115292
|
| abnormal B-1 B cell morphology
|
J:115292
|
Ightm1Kplm/Ightm4Cgn
Tg(Igk-V4CH27)1-2Shc/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased B cell number
|
J:115292
|
Ightm1Ktom/Ightm1Ktom
(involves: ICR)
|
absent mature B cells
|
J:178635
|
Ightm1Leck/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:144033
|
| abnormal B-1a B cell morphology
|
J:144033
|
| abnormal immature B cell morphology
|
J:144033
|
| abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
| abnormal mature B cell morphology
|
J:144033
|
Ightm1Leck/Ightm1Leck
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:144033
|
Ightm1Mnz/Ightm1Mnz
Dis3tm1.1Uba/Dis3tm1.1Uba
Aicdatm1(cre)Uba/Aicda+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:302856
|
Ightm1Rbr/Igh+
(C57BL/6-Ightm1Rbr)
|
abnormal B cell morphology
|
J:132538
|
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:132538
|
| abnormal B-2 B cell morphology
|
J:132538
|
| increased immature B cell number
|
J:132538
|
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6 * C57BL/6JSfd)
|
abnormal B cell morphology
|
J:132538
|
| decreased follicular B cell number
|
J:132538
|
| decreased marginal zone B cell number
|
J:132538
|
| increased immature B cell number
|
J:132538
|
Ightm2.1(4E10)Nemz/Ightm2.1(4E10)Nemz
Igktm2.1(4E10)Nemz/Igktm2.1(4E10)Nemz
(involves: C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)
|
decreased B cell number
|
J:101977
|
Ightm2.1(Tag)Rwhe/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:150315
|
| increased B cell number
|
J:150315
|
Ightm2.1Fwa/Ightm2.1Fwa
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:161437
|
| abnormal somatic hypermutation frequency
|
J:161437
|
| decreased mature B cell number
|
J:161437
|
Ightm2.1Hws/Ightm2.1Hws
(involves: BALB/c * C57BL/6NCrl * DBA/2NCrl)
|
decreased B cell number
|
J:124421
|
| decreased B-1a cell number
|
J:124421
|
| decreased B-1b cell number
|
J:124421
|
| decreased follicular B cell number
|
J:124421
|
| decreased pre-B cell number
|
J:124421
|
| decreased transitional stage B cell number
|
J:124421
|
| increased early pro-B cell number
|
J:124421
|
| increased marginal zone B cell number
|
J:124421
|
Ightm2.1Hws/Ightm2.1Hws
(involves: BALB/c)
|
abnormal B cell differentiation
|
J:142069
|
| decreased B-1a cell number
|
J:142069
|
| decreased follicular B cell number
|
J:142069
|
| decreased immature B cell number
|
J:142069
|
| decreased late pro-B cell number
|
J:142069
|
| decreased mature B cell number
|
J:142069
|
| decreased transitional stage B cell number
|
J:142069
|
| increased early pro-B cell number
|
J:142069
|
| increased marginal zone B cell number
|
J:142069
|
Ightm2Cgn/Igh+
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
Ightm2Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
Ightm2Cgn/Igh+
Igktm1Rsky/Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
| absent pre-B cells
|
J:111431
|
Ightm2Cgn/Igh+
Igktm2Rsky/Igk+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:150435
|
Ightm2Cgn/Igh+
Igktm2Rsky/Igk+
Prkdcscid/Prkdcscid
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal class switch recombination
|
J:150435
|
Ightm2Cgn/Igh+
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:44361
|
Ightm2Cgn/Ightm2Cgn
Igktm1Rsky/Igktm1Rsky
Lig4tm1Fwa/Lig4tm1Fwa
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
Ightm2Cgn/Ightm2Cgn
Igktm1Rsky/Igktm1Rsky
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc4tm1Fwa/Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
Ightm2Cgn/Ightm3Cgn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
Ightm2Cgn/Ightm4.1Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal immunoglobulin V(D)J recombination
|
J:176649
|
Ightm2Cog/Ightm2Cog
(involves: 129S2/SvPas * C57BL/6)
|
increased pre-B cell number
|
J:90548
|
Ightm2Emo/Ightm2Emo
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:108098
|
| absent pre-B cells
|
J:108098
|
Ightm2Rsky/Igh+
Igktm1Rsky/Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
Ightm2Rsky/Igh+
Igktm2Rsky/Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
Ightm3.1Cog/Ightm3.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:71300
|
Ightm3.1Tim/Igh+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
Ightm3Cgn/Igh+
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:79556,
J:115292
|
Ightm3Cgn/Ightm3Cgn
(involves: C57BL/6)
|
decreased immature B cell number
|
J:76117
|
Ightm3Hws/Ightm3Hws
(BALB/c-Ightm3Hws)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:142068
|
Ightm3Hws/Ightm3Hws
(involves: BALB/c)
|
decreased B cell number
|
J:142069
|
| decreased follicular B cell number
|
J:142069
|
| decreased immature B cell number
|
J:142069
|
| decreased late pro-B cell number
|
J:142069
|
| decreased mature B cell number
|
J:142069
|
| decreased transitional stage B cell number
|
J:142069
|
Ightm3Tim/Igh+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
Ightm4.1Cog/Ightm4.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:184094
|
Ightm4.1Fwa/Igh+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| abnormal immunoglobulin V(D)J recombination
|
J:176649
|
Ightm4.1Fwa/Ightm4.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| abnormal immunoglobulin V(D)J recombination
|
J:176649
|
Ightm4Cgn/Igh+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:115292
|
Ightm5.1Cgn/Ightm5.1Cgn
(BALB/c-Ightm5.1Cgn)
|
abnormal B cell differentiation
|
J:88472
|
| abnormal mature B cell morphology
|
J:88472
|
| absent B-1 B cells
|
J:88472
|
| absent B-1a cells
|
J:88472
|
| absent B-1b cells
|
J:88472
|
| decreased B cell number
|
J:88472
|
| decreased immature B cell number
|
J:88472
|
| decreased marginal zone B cell number
|
J:88472
|
| increased pro-B cell number
|
J:88472
|
Ightm5.1Cog/Ightm5.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:164513
|
| abnormal somatic hypermutation frequency
|
J:164513,
J:333348
|
Ightm5.1Fwa/Igh+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| decreased pre-B cell number
|
J:176649
|
Ightm5.1Fwa/Ightm5.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| decreased pre-B cell number
|
J:176649
|
Ightm5Cgn/Ightm5Cgn
(involves: BALB/c)
|
absent B cells
|
J:88472
|
| arrested B cell differentiation
|
J:88472
|
Ightm5Cgn/Ightm5Cgn
Tg(CD19-cre/ERT2)1Cgn/0
(C.Cg-Ightm5Cgn Tg(CD19-cre/ERT2)1Cgn)
|
abnormal B cell differentiation
|
J:88472
|
| abnormal mature B cell morphology
|
J:88472
|
| absent follicular B cells
|
J:88472
|
| absent marginal zone B cells
|
J:88472
|
| increased B cell number
|
J:88472
|
| increased pro-B cell number
|
J:88472
|
Ightm7(VHB1-8)Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
Ightm8(VHB1-8)Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
Ightm9(VHB1-8)Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
Ightm11.1Cgn/Ightm11.1Cgn
(Not Specified)
|
abnormal B cell differentiation
|
J:113434
|
| decreased B cell number
|
J:113434
|
| decreased immature B cell number
|
J:113434
|
| decreased mature B cell number
|
J:113434
|
| increased pro-B cell number
|
J:113434
|
Ightm12Cgn/Ightm12Cgn
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:66031
|
Ighatm1(Myc)Janz/Igha+
(involves: 129S1/Sv * C57BL/6)
|
increased plasma cell number
|
J:90901
|
Ighatm1(Myc)Janz/Igha+
Tg(Igk-V21-Bax)1967Bvn/0
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
abnormal plasma cell morphology
|
J:90901
|
| increased plasma cell number
|
J:90901
|
Ighatm1(Myc)Janz/Igha+
Tg(Tnfsf13b)1Fma/0
(involves: 129S1/Sv * C57BL/6 * DBA/2J)
|
increased B cell number
|
J:166158
|
| increased lymphocyte cell number
|
J:166158
|
| increased mature B cell number
|
J:166158
|
Ighatm2Grh/Ighatm2Grh
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:72521
|
IghdM1Btlr/Ighd+
(C57BL/6J-IghdM1Btlr)
|
decreased B cell number
|
J:255202
|
IghdM1Btlr/IghdM1Btlr
(C57BL/6J-IghdM1Btlr)
|
decreased B cell number
|
J:255202
|
Ighdm2Btlr/Ighd+
(C57BL/6J-Ighdm2Btlr)
|
decreased B cell number
|
J:255203
|
Ighdm2Btlr/Ighdm2Btlr
(C57BL/6J-Ighdm2Btlr)
|
decreased B cell number
|
J:255203
|
Ighdtm1Lam/Ighd+
(involves: 129S2/SvPas * C57BL/6)
|
decreased B cell number
|
J:111020
|
Ighg1em1Wliu/Ighg1em1Wliu
(C57BL/6-Ighg1em1Wliu)
|
abnormal plasma cell differentiation
|
J:266937
|
| increased germinal center B cell number
|
J:266937
|
| increased plasma cell number
|
J:266937
|
Ighg1tm1(cre)Cgn/0
Mef2btm1.1Rdf/Mef2b+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased germinal center B cell number
|
J:265465
|
Ighg1tm1(cre)Cgn/0
Mef2btm1.1Rdf/Mef2btm1.1Rdf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:265465
|
| decreased germinal center B cell number
|
J:265465
|
Ighg1tm1(cre)Cgn/0
Mef2btm1.1Rdf/Mef2btm1.1Rdf
Mef2ctm2Eno/Mef2ctm2Eno
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
decreased germinal center B cell number
|
J:265465
|
Ighg1tm1(cre)Cgn/0
Mef2btm2Rdf/Mef2b+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:265465
|
| increased germinal center B cell number
|
J:265465
|
Ighg1tm1(cre)Cgn/0
Mef2btm2Rdf/Mef2btm1.1Rdf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:265465
|
| increased germinal center B cell number
|
J:265465
|
Ighg1tm1(cre)Cgn/0
Mef2ctm2Eno/Mef2ctm2Eno
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
decreased germinal center B cell number
|
J:265465
|
Ighg1tm1(cre)Cgn/Ighg1+
Irf4tm1Rdf/Irf4tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal class switch recombination
|
J:112643
|
| abnormal memory B cell morphology
|
J:112643
|
| absent plasma cells
|
J:112643
|
Ighg1tm1(cre)Cgn/Ighg1+
Myd88em1.1Rsky/Myd88+
(involves: 129P2/OlaHsd * C57BL/6NTac)
|
abnormal somatic hypermutation frequency
|
J:308792
|
| increased germinal center B cell number
|
J:308792
|
| increased plasma cell number
|
J:308792
|
Ighg1tm1(cre)Cgn/Ighg1+
Tbl1xr1tm1.1Meln/Tbl1xr1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:292118
|
Ighg1tm1(cre)Cgn/Ighg1+
Tbl1xr1tm1c(EUCOMM)Hmgu/Tbl1xr1tm1c(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:292118
|
Ighg1tm1Ksho/Ighg1tm1Ksho
(involves: 129P2/OlaHsd * C57BL/6)
|
absent memory B cells
|
J:39568
|
Ighg1tm2Cgn/Ighg1+
((C57BL/6 x 129P2/OlaHsd)F1)
|
abnormal class switch recombination
|
J:146428
|
Ighg1tm3Cgn/Ighg1+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:166887
|
Ighmtm1(Bcl6)Rdf/?
(involves: 129/Sv * C57BL/6)
|
decreased plasma cell number
|
J:98937
|
Ighmtm1.1(IGH-2)Cog/Ighmtm1.1(IGH-2)Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:157575
|
| abnormal plasma cell differentiation
|
J:157575
|
| decreased B cell number
|
J:157575
|
| decreased B-1 B cell number
|
J:157575
|
| decreased follicular B cell number
|
J:157575
|
| decreased marginal zone B cell number
|
J:157575
|
| decreased mature B cell number
|
J:157575
|
| decreased pre-B cell number
|
J:157575
|
| decreased transitional stage B cell number
|
J:157575
|
| increased B cell number
|
J:157575
|
| increased plasma cell number
|
J:157575
|
| increased pro-B cell number
|
J:157575
|
Ighmtm1.1Aak/Ighmtm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
| decreased B cell number
|
J:171251
|
| decreased pre-B cell number
|
J:171251
|
| increased pro-B cell number
|
J:171251
|
Ighmtm1Cgn/Ightm3Tim
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
| decreased B cell number
|
J:102308
|
Ighmtm1Cgn/Ighm+
(involves: 129S2/SvPas * C57BL/6)
|
arrested B cell differentiation
|
J:70398
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:64298,
J:70398
|
| absent immature B cells
|
J:64298
|
| absent mature B cells
|
J:64298
|
| arrested B cell differentiation
|
J:64298
|
Ighmtm1Cgn/Ighmtm1Cgn
(B6.129S2-Ighmtm1Cgn/J)
|
arrested B cell differentiation
|
J:119584
|
| decreased CD4-positive, alpha-beta T cell number
|
J:73100,
J:118565
|
| decreased CD8-positive, alpha-beta T cell number
|
J:73100
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas)
|
abnormal metallophilic macrophage morphology
|
J:88620
|
| abnormal spleen marginal zone macrophage morphology
|
J:88620
|
| absent mature B cells
|
J:118453
|
| arrested B cell differentiation
|
J:118453
|
| increased osteoclast cell number
|
J:157619
|
Ighmtm1Cgn/Ighmtm1Cgn
(B6.129S2-Ighmtm1Cgn)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:126867
|
Ighmtm1Cgn/Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn/DvsJ)
|
abnormal T cell number
|
J:80859
|
| absent B cells
|
J:80859
|
Ighmtm1Cgn/Ighmtm1Cgn
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ)
|
abnormal mature B cell morphology
|
J:80859
|
| decreased CD8-positive, alpha-beta T cell number
|
J:80859
|
Ighmtm1Che/Ighmtm1Che
(involves: 129S4/SvJae * C57BL/6)
|
abnormal metallophilic macrophage morphology
|
J:125338
|
| increased B-1 B cell number
|
J:47425
|
Ighmtm1Msn/Ighmtm1Msn
(involves: 129S/SvEv)
|
abnormal B-1a B cell morphology
|
J:49405
|
| abnormal immature B cell morphology
|
J:49405
|
| abnormal mature B cell morphology
|
J:49405
|
Ighmtm1Msn/Ighmtm1Msn
(B6.129S-Ighmtm1Msn)
|
abnormal B-1a B cell morphology
|
J:80656
|
| decreased follicular B cell number
|
J:80656
|
| increased marginal zone B cell number
|
J:80656
|
Ighmtm1Msn/Ighmtm1Msn
Tg(Igh-6)1Msn/?
(B6.129S-Ighmtm1Msn)
|
abnormal B-1a B cell morphology
|
J:80656
|
| decreased follicular B cell number
|
J:80656
|
| increased marginal zone B cell number
|
J:80656
|
Ighmtm1Sls/Ighmtm1Sls
(Not Specified)
|
abnormal class switch recombination
|
J:99465
|
Ighmtm2.1Bgmn/Ighmtm2.1Bgmn
(involves: 129/Sv * C57BL/6 * CBA)
|
absent mature B cells
|
J:118453
|
| arrested B cell differentiation
|
J:118453
|
Ighmtm3Bgmn/Ighmtm3Bgmn
(involves: 129)
|
decreased immature B cell number
|
J:131633
|
| decreased mature B cell number
|
J:131633
|
| increased B-1 B cell number
|
J:131633
|
Ighmtm3Bgmn/Ighmtm3Bgmn
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2.1Bgmn/Igltm2.1Bgmn
(involves: 129P2/OlaHsd * 129/Sv)
|
abnormal B cell differentiation
|
J:130864
|
Ighmtm4Bgmn/Ighmtm4Bgmn
(involves: 129)
|
decreased immature B cell number
|
J:131633
|
| decreased mature B cell number
|
J:131633
|
| increased B-1 B cell number
|
J:131633
|
Igk-Jtm1Cog/Igk-Jtm1.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:110100
|
| abnormal plasma cell morphology
|
J:110100
|
| decreased B cell number
|
J:110100
|
| decreased naive B cell number
|
J:110100
|
| increased plasma cell number
|
J:110100
|
| increased pre-B cell number
|
J:110100
|
Igk-Jtm1Cog/Igk-Jtm1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:110100
|
Igktm1Dhu/Igktm1Dhu
Iglc1tm1.1Ust/Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
decreased B cell number
|
J:68144
|
Igktm1Dhu/Igktm1Dhu
Iglc1tm1.1Ust/Iglc1tm1.1Ust
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
decreased B cell number
|
J:68144
|
Igktm1Dhu/Igktm1Dhu
Iglc1tm1Ust/Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell differentiation
|
J:68144
|
| increased B cell number
|
J:68144
|
Igktm1Dhu/Igktm1Dhu
Iglc1tm1Ust/Iglc1tm1Ust
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased B cell number
|
J:68144
|
Igktm1Dhu/Igktm1Dhu
Iglc1tm2Ust/Iglc1tm2Ust
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal B cell differentiation
|
J:74717
|
| decreased B cell number
|
J:74717
|
| decreased immature B cell number
|
J:74717
|
| decreased marginal zone B cell number
|
J:74717
|
| decreased mature B cell number
|
J:74717
|
| decreased transitional stage T1 B cell number
|
J:74717
|
| decreased transitional stage T2 B cell number
|
J:74717
|
Igktm1Dhu/Igktm1Dhu
Iglc1tm2Ust/Iglc1tm2Ust
(involves: 129S7/SvEvBrd)
|
increased B-1a cell number
|
J:113218
|
Igktm1Dhu/Igktm1Dhu
Tg(H2-Ea-HA)HACIIAjca/0
Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Igktm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:209872
|
| absent B cells
|
J:209872
|
| increased CD4-positive, alpha-beta T cell number
|
J:209872
|
Igktm1Rsky/Igk+
Igll1tm1Cgn/Igll1tm1Cgn
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:35357
|
| decreased B cell number
|
J:35357
|
| decreased immature B cell number
|
J:35357
|
| decreased mature B cell number
|
J:35357
|
| decreased pre-B cell number
|
J:35357
|
Igktm2Ybgn/Igktm2Ybgn
(Not Specified)
|
decreased pre-B cell number
|
J:123344
|
| increased immature B cell number
|
J:123344
|
Igkctm1(IGKC)Mnz/Igkc+
Igk-Jtm1(CD4*)Mss/Igk-J+
(involves: 129S4/SvJae)
|
abnormal immunoglobulin light chain V-J recombination
|
J:143876
|
Igkctm1(IGKC)Mnz/Igkc+
Rr158tm1(Igh)Xu/Rr158+
(Not Specified)
|
decreased B cell number
|
J:124407
|
Igkctm1Bgmn/Igkctm1Bgmn
(involves: 129P2/OlaHsd)
|
abnormal B cell number
|
J:28868,
J:118712
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm1.1Bgmn/Igltm1.1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:118712
|
| absent B cells
|
J:118712
|
| absent B-1 B cells
|
J:118712
|
| absent B-2 B cells
|
J:118712
|
| decreased B cell number
|
J:118712
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm1Bgmn/Igltm1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:118712
|
| absent B-1 B cells
|
J:118712
|
| absent B-2 B cells
|
J:118712
|
| absent mature B cells
|
J:118712
|
| decreased B cell number
|
J:118712
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2.1Bgmn/Igltm2.1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
absent B cells
|
J:118712
|
| arrested B cell differentiation
|
J:118712
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2.1Bgmn/Igltm2.1Bgmn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:130864
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:130864
|
| abnormal plasma cell morphology
|
J:130864
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2Bgmn/Igltm2Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
absent B cells
|
J:118712
|
| arrested B cell differentiation
|
J:118712
|
Igkctm1Cgn/Igkc+
(involves: C57BL/6)
|
increased mature B cell number
|
J:64287
|
Igkctm1Cgn/Igkctm1Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:64287
|
| decreased mature B cell number
|
J:64287
|
| increased immature B cell number
|
J:64287
|
| increased mature B cell number
|
J:64287
|
Igkctm1Jkbv/Igkctm1Jkbv
(Not Specified)
|
abnormal B cell differentiation
|
J:137738
|
| abnormal immunoglobulin light chain V-J recombination
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| increased pre-B cell number
|
J:137738
|
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| increased pre-B cell number
|
J:137738
|
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| increased pre-B cell number
|
J:137738
|
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:137738
|
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:137738
|
Igkctm2(IGKC)Cgn/Igkctm2(IGKC)Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113008
|
Igkrstm1Nemz/Igkrstm1Nemz
(B6.129-Igkrstm1Nemz)
|
abnormal immunoglobulin light chain V-J recombination
|
J:132125
|
| decreased immature B cell number
|
J:132125
|
| decreased mature B cell number
|
J:132125
|
Igkrstm1Nemz/Igkrstm1Nemz
Tg(UBC-scFv)2Nemz/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal B cell clonal deletion
|
J:132125
|
| decreased immature B cell number
|
J:132125
|
| decreased mature B cell number
|
J:132125
|
Iglc1tm1Ust/Iglc1tm1Ust
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell number
|
J:68144
|
| increased lymphocyte cell number
|
J:68144
|
Iglc1tm2Ust/Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal immunoglobulin light chain V-J recombination
|
J:74717
|
Iglc1tm2Ust/Iglc1tm2Ust
(involves: 129S7/SvEvBrd)
|
decreased B cell number
|
J:113218
|
Iglc1tm2Ust/Iglc1tm2Ust
Ptpn6me-v/Ptpn6me-v
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:113218
|
Igll1tm1Cgn/Igll1tm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell morphology
|
J:64284
|
| abnormal B-1 B cell number
|
J:64284
|
| abnormal lymphopoiesis
|
J:64284
|
| abnormal pre-B cell morphology
|
J:64284
|
| decreased B cell number
|
J:64284,
J:35357
|
| increased pro-B cell number
|
J:64284
|
Igll1tm1Cgn/Igll1tm1Cgn
Tg(Igk-V4CH27)1-2Shc/0
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:35357
|
| decreased pre-B cell number
|
J:35357
|
Igll1tm1Shim/Igll1tm1Shim
Vpreb1atm1Shim/Vpreb1atm1Shim
Vpreb1btm1Shim/Vpreb1btm1Shim
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:76947
|
| decreased B cell number
|
J:76947
|
| decreased B-1a cell number
|
J:76947
|
| decreased immature B cell number
|
J:76947
|
| decreased mature B cell number
|
J:76947
|
| decreased pre-B cell number
|
J:76947
|
| increased late pro-B cell number
|
J:76947
|
Igs2em1(Alb-Golm1)Jdon/Igs2+
(involves: C57BL/6N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:306528
|
Ikbkbem1Macc/Ikbkb+
(involves: C57BL/6NCrl)
|
abnormal effector T cell number
|
J:290616
|
| decreased B cell number
|
J:290616
|
| decreased CD4-positive, alpha-beta T cell number
|
J:290616
|
| decreased CD8-positive, alpha-beta T cell number
|
J:290616
|
| decreased memory B cell number
|
J:290616
|
| decreased T cell number
|
J:290616
|
| increased regulatory T cell number
|
J:290616
|
Ikbkbem1Macc/Ikbkbem1Macc
(involves: C57BL/6NCrl)
|
abnormal effector T cell number
|
J:290616
|
| decreased B cell number
|
J:290616
|
| decreased CD4-positive, alpha-beta T cell number
|
J:290616
|
| decreased CD8-positive, alpha-beta T cell number
|
J:290616
|
| decreased memory B cell number
|
J:290616
|
| decreased T cell number
|
J:290616
|
| increased regulatory T cell number
|
J:290616
|
Ikbkbem1Smoc/Ikbkbem1Smoc
(C57BL/6J-Ikbkbem1Smoc)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:309163
|
IkbkbM1Btlr/Ikbkb+
(C57BL/6J-IkbkbM1Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225271
|
IkbkbM1Btlr/IkbkbM1Btlr
(C57BL/6J-IkbkbM1Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225271
|
IkbkbM2Btlr/IkbkbM2Btlr
(C57BL/6J-IkbkbM2Btlr)
|
decreased central memory CD4-positive, alpha-beta T cell number
|
J:274802
|
Ikbkbtm1Cgn/Ikbkbtm1.1Cgn
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85810
|
| decreased single-positive T cell number
|
J:85810
|
| decreased T cell number
|
J:85810
|
Ikbkbtm1Cgn/Ikbkbtm1Cgn
Tg(Lck-cre)I57Jxm/0
(involves: C57BL/6 * ICR)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85810
|
Ikbkbtm2Cgn/Ikbkbtm2.1Cgn
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85810
|
Ikbkbtm2Cgn/Ikbkbtm2Cgn
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased memory T cell number
|
J:85810
|
| decreased regulatory T cell number
|
J:85810
|
Ikbkgm1Btlr/Y
(C57BL/6J-Ikbkgm1Btlr)
|
decreased regulatory T cell number
|
J:139558
|
Ikbkgtm1.1Chtr/Y
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased NK cell number
|
J:151485
|
| decreased NK T cell number
|
J:151485
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased NK cell number
|
J:151485
|
| decreased NK T cell number
|
J:151485
|
Ikbkgtm1.1Dwat/Ikbkg+
(B6.Cg-Ikbkgtm1.1Dwat)
|
decreased B cell number
|
J:202106
|
Ikbkgtm1.1Mpa/Y
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85810
|
| decreased single-positive T cell number
|
J:85810
|
| decreased T cell number
|
J:85810
|
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:113365
|
| decreased B cell number
|
J:113365
|
| decreased mature B cell number
|
J:113365
|
Ikzf1m1Btlr/Ikzf1m1Btlr
(C57BL/6J-Ikzf1m1Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:265249
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265249
|
| increased B-1 B cell number
|
J:265249
|
| increased CD4-positive, alpha-beta T cell number
|
J:265249
|
| increased CD8-positive, alpha-beta T cell number
|
J:265249
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265249
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265249
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265249
|
| increased single-positive T cell number
|
J:265249
|
| increased T cell number
|
J:265249
|
Ikzf1m2Btlr/Ikzf1m2Btlr
(C57BL/6J-Ikzf1m2Btlr)
|
decreased B cell number
|
J:265250
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265250
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265250
|
| decreased single-positive T cell number
|
J:265250
|
| decreased T cell number
|
J:265250
|
| increased CD8-positive, alpha-beta T cell number
|
J:265250
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265250
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265250
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265250
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265250
|
| increased single-positive T cell number
|
J:265250
|
Ikzf1m3Btlr/Ikzf1m3Btlr
(C57BL/6J-Ikzf1m3Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265251
|
| increased B-1 B cell number
|
J:265251
|
| increased CD8-positive, alpha-beta T cell number
|
J:265251
|
| increased single-positive T cell number
|
J:265251
|
| increased T cell number
|
J:265251
|
Ikzf1plstc/Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc)
|
abnormal B cell differentiation
|
J:84569
|
| abnormal lymphopoiesis
|
J:84569
|
| abnormal T cell differentiation
|
J:84569
|
| decreased double-negative T cell number
|
J:84569
|
| decreased double-positive T cell number
|
J:84569
|
| decreased mature B cell number
|
J:84569
|
| decreased pre-B cell number
|
J:84569
|
| decreased thymocyte number
|
J:84569
|
| increased pro-B cell number
|
J:84569
|
Ikzf1plstc/Ikzf1plstc
(C57BL/6JSfdAnu-Ikzf1plstc)
|
abnormal lymphopoiesis
|
J:84569
|
| abnormal macrophage differentiation
|
J:84569
|
| absent pro-B cells
|
J:84569
|
| absent T cells
|
J:84569
|
| arrested B cell differentiation
|
J:84569
|
| increased macrophage cell number
|
J:84569
|
Ikzf1tm1(Pax5)Mbu/Ikzf1tm1(Pax5)Mbu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:80815
|
| abnormal T cell differentiation
|
J:80815
|
Ikzf1tm1(Pax5)Mbu/Ikzf1tm1(Pax5)Mbu
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:80815
|
| arrested T cell differentiation
|
J:80815
|
| increased B cell number
|
J:80815
|
| increased early pro-B cell number
|
J:80815
|
Ikzf1tm1.1(Pax5)Mbu/Ikzf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:80815
|
| decreased double-positive T cell number
|
J:118111
|
| increased B cell number
|
J:80815
|
| increased pro-B cell number
|
J:80815
|
Ikzf1tm1.1(Pax5)Mbu/Ikzf1+
Tcf3tm1Mbu/Tcf3tm1Mbu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:137719
|
Ikzf1tm1.1Smale/Ikzf1tm1.1Smale
(B6.Cg-Ikzf1tm1.1Smale)
|
decreased B cell number
|
J:208211
|
| decreased B-1a cell number
|
J:208211
|
| decreased B-1b cell number
|
J:208211
|
| decreased DN1 thymic pro-T cell number
|
J:208211
|
| decreased immature B cell number
|
J:208211
|
| decreased mature B cell number
|
J:208211
|
| decreased pre-B cell number
|
J:208211
|
Ikzf1tm1Kast/Ikzf1tm1Kast
(involves: 129S2/SvPas)
|
abnormal B cell differentiation
|
J:82813
|
| decreased B cell number
|
J:82813
|
| decreased B-1a cell number
|
J:82813
|
| decreased B-1b cell number
|
J:82813
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:29355
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell differentiation
|
J:29355
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal NK cell morphology
|
J:20671
|
| absent B cells
|
J:20671
|
| absent pre-B cells
|
J:20671
|
| arrested T cell differentiation
|
J:20671
|
| decreased gamma-delta intraepithelial T cell number
|
J:20671
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c)
|
abnormal NK cell morphology
|
J:20671
|
| absent B cells
|
J:20671
|
| absent pre-B cells
|
J:20671
|
| arrested T cell differentiation
|
J:20671
|
| decreased gamma-delta intraepithelial T cell number
|
J:20671
|
Ikzf1tm2.1Smale/Ikzf1tm2.1Smale
(B6.Cg-Ikzf1tm2.1Smale)
|
abnormal lymphopoiesis
|
J:208211
|
| abnormal T cell differentiation
|
J:208211
|
| absent NK cells
|
J:208211
|
| decreased B cell number
|
J:208211
|
| decreased DN2 thymocyte number
|
J:208211
|
| decreased DN3 thymocyte number
|
J:208211
|
| decreased double-negative T cell number
|
J:208211
|
| decreased double-positive T cell number
|
J:208211
|
| decreased immature B cell number
|
J:208211
|
| decreased mature B cell number
|
J:208211
|
| decreased pre-pro B cell number
|
J:208211
|
| increased gamma-delta T cell number
|
J:208211
|
| increased pre-B cell number
|
J:208211
|
Ikzf1tm2Kge/Ikzf1tm2Kge
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:208211,
J:37317
|
| absent B cells
|
J:208211,
J:37317
|
| absent B-1a cells
|
J:37317
|
| absent NK cells
|
J:208211,
J:37317
|
| absent pre-B cells
|
J:37317
|
| absent pro-B cells
|
J:37317
|
| decreased double-positive T cell number
|
J:37317
|
| decreased gamma-delta intraepithelial T cell number
|
J:37317
|
| decreased mature gamma-delta T cell number
|
J:37317
|
Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu
Cd79atm1(cre)Reth/Cd79a+
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv * BALB/c * C57BL/6 * SJL)
|
decreased pro-B cell number
|
J:209928
|
Ikzf1tm3Kge/Ikzf1tm3Kge
Tg(CD19-cre/ERT2)1Cgn/?
(Not Specified)
|
absent pre-B cells
|
J:209927
|
| decreased pre-B cell number
|
J:209927
|
Ikzf3tm1(KOMP)Vlcg/Ikzf3tm1(KOMP)Vlcg
(C57BL/6N-Ikzf3tm1(KOMP)Vlcg/Rbrc)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:50626
|
| decreased B cell number
|
J:81805
|
| decreased naive B cell number
|
J:81805
|
| increased pre-B cell number
|
J:50626
|
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae)
|
decreased marginal zone B cell number
|
J:69477
|
| increased follicular B cell number
|
J:69477
|
Ikzf5tm1(KOMP)Wtsi/Ikzf5tm1(KOMP)Wtsi
(C57BL/6N-Ikzf5tm1(KOMP)Wtsi/Rbrc)
|
increased large unstained cell number
|
J:211773
|
Il1r1tm1Imx/Il1r1tm1Imx
Vsig4tm1Gne/Vsig4tm1Gne
(B6.Cg-Il1r1tm1Imx Vsig4tm1Gne)
|
decreased T helper 1 cell number
|
J:281762
|
| decreased T-helper 17 cell number
|
J:281762
|
Il1r1tm1Roml/Il1r1tm1Roml
(C.Cg-Il1r1tm1Roml)
|
decreased T cell number
|
J:82863
|
Il1r1tm1Roml/Il1r1tm1Roml
Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S1/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:191055
|
| decreased monocyte cell number
|
J:191055
|
Il1rl2tm1Hblu/Il1rl2tm1Hblu
(involves: 129)
|
decreased gamma-delta T cell number
|
J:193548
|
| decreased macrophage cell number
|
J:193548
|
| increased regulatory T cell number
|
J:256437
|
Il1rntm1Sush/Il1rntm1Sush
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:97684
|
| abnormal T-helper 1 cell morphology
|
J:97684
|
| abnormal T-helper 2 cell morphology
|
J:97684
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:39981,
J:15223
|
| abnormal class switch recombination
|
J:15573
|
| abnormal gamma-delta intraepithelial T cell morphology
|
J:15223
|
| abnormal lymphocyte cell number
|
J:15223
|
| abnormal lymphocyte morphology
|
J:37220
|
| abnormal T-helper 1 cell differentiation
|
J:37220
|
| decreased double-negative T cell number
|
J:15223
|
| decreased double-positive T cell number
|
J:37220
|
| increased double-negative T cell number
|
J:37220
|
| increased pre-B cell number
|
J:16662
|
| increased pro-B cell number
|
J:16662
|
| increased single-positive T cell number
|
J:37220
|
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor)
|
abnormal lymphocyte morphology
|
J:29799
|
| increased germinal center B cell number
|
J:29799
|
| increased plasma cell number
|
J:29799
|
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor)
|
increased activated T cell number
|
J:28924
|
| increased CD4-positive, alpha-beta T cell number
|
J:28924
|
| increased CD8-positive, alpha-beta T cell number
|
J:28924
|
| increased T cell number
|
J:125748
|
Il2tm1Hor/Il2tm1Hor
(C3.129P2-Il2tm1Hor)
|
increased CD4-positive, alpha-beta T cell number
|
J:28924
|
| increased CD8-positive, alpha-beta T cell number
|
J:28924
|
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor/J)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:131774
|
| decreased regulatory T cell number
|
J:113547
|
| increased CD4-positive, alpha-beta T cell number
|
J:131774
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd)
|
increased regulatory T cell number
|
J:208318
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased T-helper 17 cell number
|
J:120176
|
Il2tm1Hor/Il2tm1Hor
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pre-B cell number
|
J:16662
|
| increased pro-B cell number
|
J:16662
|
Il2tm1Hor/Il2tm1Hor
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Tcra5CC7,Tcrb5CC7)IWep/0
(involves: 129P2/OlaHsd * C57BL/10)
|
abnormal T cell number
|
J:120176
|
| increased T-helper 17 cell number
|
J:120176
|
Il2tm1Hor/Il2tm1Hor
Tg(DO11.10)10Dlo/?
(C.Cg-Il2tm1Hor Tg(DO11.10)10Dlo)
|
increased activated T cell number
|
J:88349
|
Il2tm1Hor/Il2tm1Hor
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
(C.Cg-Il2tm1Hor Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)
|
decreased regulatory T cell number
|
J:112603
|
| increased regulatory T cell number
|
J:112603
|
Il2ratm1b(EUCOMM)Wtsi/Il2ratm1b(EUCOMM)Wtsi
(C57BL/6N-Il2ratm1b(EUCOMM)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
Il2ratm1Dw/Il2ratm1Dw
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell morphology
|
J:64279
|
| increased lymphocyte cell number
|
J:64279
|
| increased memory T cell number
|
J:64279
|
Il2ratm1Dw/Il2ratm1Dw
Tg(CD2-Ccdc86)1Hfuj/?
(B6.Cg-Il2ratm1Dw Tg(CD2-Ccdc86)1Hfuj)
|
increased activated T cell number
|
J:151722
|
Il2ratm1Dw/Il2ratm1Dw
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
(C.Cg-Il2ratm1Dw Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)
|
decreased regulatory T cell number
|
J:112603
|
| increased regulatory T cell number
|
J:112603
|
Il2rbm1Btlr/Il2rbm1Btlr
(C57BL/6J-Il2rbm1Btlr)
|
decreased B cell number
|
J:267694
|
| decreased CD4-positive, alpha-beta T cell number
|
J:267694
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:267694
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267694
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:267694
|
Il2rbM3Btlr/Il2rbM3Btlr
(C57BL/6J-Il2rbM3Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272833
|
| abnormal T cell morphology
|
J:272833
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272833
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:272833
|
| decreased NK cell number
|
J:272833
|
| decreased NK T cell number
|
J:272833
|
| increased CD4-positive, alpha-beta T cell number
|
J:272833
|
Il2rbtm1Mak/Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))
|
abnormal mononuclear cell morphology
|
J:25940
|
| decreased B cell number
|
J:25940
|
| decreased double-positive T cell number
|
J:25940
|
| decreased memory T cell number
|
J:25940
|
| increased activated T cell number
|
J:25940
|
| increased CD4-positive, alpha-beta T cell number
|
J:25940
|
| increased CD8-positive, alpha-beta T cell number
|
J:25940
|
| increased plasma cell number
|
J:25940
|
Il2rbtm1Mak/Il2rbtm1Mak
(B6.129-Il2rbtm1Mak)
|
abnormal lymphocyte morphology
|
J:113547
|
| decreased regulatory T cell number
|
J:113547
|
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak)
|
abnormal lymphocyte morphology
|
J:113547
|
| abnormal marginal zone B cell morphology
|
J:113547
|
| abnormal T cell clonal deletion
|
J:113547
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113547
|
Il2rbtm1Mak/Il2rbtm1Mak
(D2.129-Il2rbtm1Mak)
|
abnormal T cell clonal deletion
|
J:113547
|
Il2rbtm1Mak/Il2rbtm1Mak
Lcktm1Mak/Lcktm1Mak
(involves: 129)
|
absent uterine NK cells
|
J:134589
|
Il2rbtm1Mak/Il2rbtm1Mak
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129 * 129S/SvEv)
|
decreased NK cell number
|
J:142654
|
Il2rgtm1.1Asin/Il2rgtm1Wjl
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:190889
|
| decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
Il2rgtm1.1Asin/Il2rgtm1Wjl
Tg(Cd8a*-cre)B8Asin/0
(involves: 129S4/SvJae * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:190889
|
| decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
| decreased NK T cell number
|
J:190889
|
| decreased regulatory T cell number
|
J:190889
|
Il2rgtm1.1Asin/Il2rgtm1Wjl
Tg(Cd8a*-cre)B8Asin/0
Tg(LCKprBCL2)36Sjk/0
(involves: 129S4/SvJae * C57BL/6)
|
decreased NK T cell number
|
J:190889
|
Il2rgtm1Cgn/Y
(involves: 129 * CB20)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:22521
|
| abnormal class switch recombination
|
J:22521
|
| abnormal gamma-delta T cell differentiation
|
J:111821
|
| absent gamma-delta intraepithelial T cell
|
J:111821
|
| absent gamma-delta T cells
|
J:111821
|
| absent NK cells
|
J:22521
|
| decreased mature B cell number
|
J:22521
|
| decreased plasma cell number
|
J:22521
|
| decreased pre-B cell number
|
J:22521
|
| decreased T cell number
|
J:22521
|
Il2rgtm1Cgn/Y
Rag2tm1Fwa/Rag2tm1Fwa
(B6.129-Rag2tm1Fwa Il2rgtm1Cgn)
|
absent B cells
|
J:132257
|
| absent NK cells
|
J:132257
|
| absent T cells
|
J:132257
|
Il2rgtm1Cgn/Il2rgtm1Cgn
(involves: 129 * CB20)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:22521
|
| abnormal class switch recombination
|
J:22521
|
| absent NK cells
|
J:22521
|
| decreased mature B cell number
|
J:22521
|
| decreased plasma cell number
|
J:22521
|
| decreased pre-B cell number
|
J:22521
|
| decreased T cell number
|
J:22521
|
Il2rgtm1Cgn/Il2rgtm1Cgn
Kittm1.1Bsm/Kittm1.1Bsm
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
arrested T cell differentiation
|
J:90485
|
Il2rgtm1Cgn/Il2rgtm1Cgn
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased NK cell number
|
J:142654
|
Il2rgtm1Krf/Il2rgtm1Krf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))
|
decreased thymocyte number
|
J:114561
|
Il2rgtm1Krf/Il2rgtm1Krf
Tg(BCL2/IGH)1Tjd/0
(either: (involves: 129P2/OlaHsd * C3H/He * C57BL/6) or (involves: 129P2/OlaHsd * C3H/He * C57BL/6 * FVB/N))
|
decreased thymocyte number
|
J:114561
|
Il2rgtm1Krf/Il2rgtm1Krf
Tg(Igh-Pim1)1Brn/0
(either: (involves: 129P2/OlaHsd * C57BL/6 * CBA) or (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N))
|
decreased thymocyte number
|
J:114561
|
Il2rgtm1Sug/Y
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6))
|
absent NK cells
|
J:31167
|
| arrested B cell differentiation
|
J:31167
|
| decreased lymphocyte cell number
|
J:31167
|
| decreased T cell number
|
J:31167
|
| decreased thymocyte number
|
J:31167
|
| increased macrophage cell number
|
J:31167
|
| increased monocyte cell number
|
J:31167
|
Il2rgtm1Sug/Il2rgtm1Sug
(B6.129-Il2rgtm1Sug)
|
absent uterine NK cells
|
J:116952
|
Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell number
|
J:108209
|
| abnormal CD4-positive, alpha beta T cell morphology
|
J:108209
|
| abnormal lymphocyte morphology
|
J:108209
|
| absent gamma-delta intraepithelial T cell
|
J:24117
|
| absent gamma-delta T cells
|
J:24117
|
| absent NK cells
|
J:24117
|
| decreased CD8-positive, alpha-beta T cell number
|
J:24117
|
| decreased double-negative T cell number
|
J:24117
|
| decreased double-positive T cell number
|
J:24117
|
| decreased immature B cell number
|
J:24117
|
| decreased single-positive T cell number
|
J:24117
|
Il2rgtm1Wjl/Y
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:109833
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109833
|
| decreased immature B cell number
|
J:109833
|
| decreased mature B cell number
|
J:109833
|
| decreased NK cell number
|
J:109833
|
Il2rgtm1Wjl/Y
Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJ)
|
absent NK T cells
|
J:140388
|
| decreased macrophage cell number
|
J:140388
|
Il2rgtm1Wjl/Il2rgtm1Wjl
(B6.129S4-Il2rgtm1Wjl/J)
|
decreased myeloid dendritic cell number
|
J:123902
|
Il2rgtm1Wjl/Il2rgtm1Wjl
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:109833
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109833
|
| decreased immature B cell number
|
J:109833
|
| decreased mature B cell number
|
J:109833
|
| decreased NK cell number
|
J:109833
|
Il2rgtm1Wjl/Il2rgtm1Wjl
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S4/SvJae)
|
absent NK cells
|
J:140483
|
| absent T cells
|
J:140483
|
Il2rgtm1Wjl/Il2rgtm1Wjl
Tg(CD2-Ccdc86)1Hfuj/?
(B6.Cg-Il2rgtm1Wjl Tg(CD2-Ccdc86)1Hfuj)
|
decreased CD4-positive, alpha-beta T cell number
|
J:151722
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151722
|
| decreased regulatory T cell number
|
J:151722
|
Il2rgtm2Cgn/Y
Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased NK cell number
|
J:132257
|
Il4tm1.1Wep/Il4+
Stat6tm1Gru/Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
Il4tm1.1Wep/Il4tm1.1Wep
(C.129P2-Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
Il4tm1.1Wep/Il4tm1.1Wep
Stat6tm1Gru/Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
Il4tm1Cgn/Il4tm1Cgn
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd)
|
increased CD4-positive, alpha-beta T cell number
|
J:205692
|
| increased T cell number
|
J:205692
|
Il4tm1Kopf/Il4tm1Kopf
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased B cell number
|
J:161523
|
Il4tm1Nnt/Il4tm1Nnt
(C57BL/6-Il4tm1Nnt/J)
|
abnormal microglial cell morphology
|
J:125605
|
Il4ratm1Fbb/Il4ratm1Fbb
(involves: BALB/cJ)
|
decreased T-helper 2 cell number
|
J:172134
|
Il4ratm1Sz/Il4ratm1Sz
(BALB/c-Il4ratm1Sz/J)
|
abnormal microglial cell morphology
|
J:125605
|
Il4ratm1Sz/Il4ratm1Sz
Il7rtm1.1Asin/Il7rtm1Imx
Tg(Cd8a*-cre)B8Asin/0
(involves: 129S7/SvEvBrd * BALB/cJ * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
Il4ratm1Tch/Il4ratm1Tch
(involves: 129X1/SvJ * BALB/c)
|
abnormal T-helper 2 cell morphology
|
J:86215
|
Il4ratm2Tch/Il4ratm2Tch
(C.129X1-Il4ratm2Tch)
|
increased monocyte cell number
|
J:152376
|
Il5tm1Kopf/Il5tm1Kopf
(C57BL/6-Il5tm1Kopf)
|
increased lymphocyte cell number
|
J:30641
|
Il5tm1Ktk/Il5tm1Ktk
(B6.129S4-Il5tm1Ktk)
|
abnormal B-1 B cell morphology
|
J:180790
|
Il5ratm1Ktk/Il5ratm1Ktk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:33140
|
| abnormal lymphopoiesis
|
J:33140
|
| abnormal T cell differentiation
|
J:33140
|
| decreased CD4-positive, alpha-beta T cell number
|
J:33140
|
Il5ratm1Ktk/Il5ratm1Ktk
(B6.129P2-Il5ratm1Ktk)
|
abnormal B-1 B cell morphology
|
J:89849
|
| decreased B-1 B cell number
|
J:89849
|
Il5ratm1Ktk/Il5ratm1Ktk
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:91089
|
Il6tm1.1Jho/Il6tm1.1Jho
Tg(GFAP-cre)8Gtm/0
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * CBA)
|
microgliosis
|
J:211914
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal microglial cell morphology
|
J:79142
|
| abnormal T cell differentiation
|
J:17360
|
| decreased T cell number
|
J:17360
|
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J)
|
decreased pro-B cell number
|
J:117320
|
Il6tm1Kopf/Il6tm1Kopf
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129 * C57BL/6)
|
abnormal lymphopoiesis
|
J:117320
|
| decreased pro-B cell number
|
J:117320
|
Il6tm1Kopf/Il6tm1Kopf
Tg(Rorc-EGFP)1Ebe/?
(involves: 129S2/SvPas * C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
Il6tm1Mur/Il6tm1Mur
(involves: 129/Sv * C57BL/6)
|
abnormal lymphocyte cell number
|
J:40579
|
| absent NK cells
|
J:40579
|
Il6tm1Mur/Il6tm1Mur
(B6.129P2(B6)-Il6tm1Mur)
|
abnormal microglial cell morphology
|
J:85581
|
| abnormal osteoclast differentiation
|
J:65093
|
Il6tm1Poli/Il6tm1Poli
(involves: 129S/SvEv * MF1)
|
abnormal T-helper 1 cell morphology
|
J:79314
|
Il6ratm1.1(IL6R)Csk/Il6ratm1.1(IL6R)Csk
Tg(H2-L-IL6)40Csk/0
(involves: 129S6/SvEvTac * C57BL/6)
|
increased plasma cell number
|
J:207264
|
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * C57BL/6)
|
increased osteoclast cell number
|
J:87612
|
Il6sttm1Kish/Il6sttm1Kish
(involves: 129P2/OlaHsd * CD-1)
|
abnormal osteoclast differentiation
|
J:88710
|
| abnormal osteoclast morphology
|
J:88710
|
| increased osteoclast cell number
|
J:88710
|
Il6sttm1Thir/Il6sttm1Thir
(Not Specified)
|
increased B cell number
|
J:59922
|
| increased CD4-positive, alpha-beta T cell number
|
J:59922
|
| increased CD8-positive, alpha-beta T cell number
|
J:59922
|
Il6sttm1Thir/Il6sttm1Thir
(involves: 129 * C57BL/6)
|
abnormal T cell clonal deletion
|
J:133059
|
| decreased double-positive T cell number
|
J:133059
|
| increased activated T cell number
|
J:133059
|
| increased double-negative T cell number
|
J:133059
|
| increased single-positive T cell number
|
J:133059
|
Il6sttm1Thir/Il6sttm1Thir
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129 * C57BL/6 * DBA)
|
abnormal negative T cell selection
|
J:133059
|
Il6sttm1Wme/Il6sttm1Wme
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:67677
|
| decreased thymocyte number
|
J:67677
|
Il6sttm2Thir/Il6sttm2Thir
(Not Specified)
|
decreased B-1a cell number
|
J:59922
|
Il7hlb368/Il7hlb368
(C57BL/6J-Il7hlb368/J)
|
abnormal T cell subpopulation ratio
|
J:118450
|
| decreased T cell number
|
J:118450
|
Il7m1Jyen/Il7m1Jyen
(involves: C3H * C57BL/6)
|
decreased B cell number
|
J:136470
|
| decreased single-positive T cell number
|
J:136470
|
Il7tm1.1Mysl/Il7+
(B6.129P2(Cg)-Il7tm1.1Mysl)
|
decreased T cell number
|
J:200544
|
Il7tm1.1Mysl/Il7tm1.1Mysl
(B6.129P2(Cg)-Il7tm1.1Mysl)
|
arrested B cell differentiation
|
J:200544
|
| decreased T cell number
|
J:200544
|
| decreased thymocyte number
|
J:200544
|
Il7tm1Dnax/Il7tm1Dnax
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
| arrested B cell differentiation
|
J:24165
|
| decreased lymphocyte cell number
|
J:24165
|
Il7tm1Dnax/Il7tm1Dnax
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:64861
|
Il7tm1Dnax/Il7tm1Dnax
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased NK cell number
|
J:132257
|
Il7tm2.1Iku/Il7tm2.1Iku
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
abnormal B cell differentiation
|
J:190615
|
| decreased B cell number
|
J:190615
|
| decreased double-negative T cell number
|
J:190615
|
| decreased lymphocyte cell number
|
J:190615
|
| decreased NK T cell number
|
J:190615
|
| decreased T cell number
|
J:190615
|
Il7rtm1.1Asin/Il7rtm1Imx
Tg(Cd4-cre)1Cwi/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
Il7rtm1.1Asin/Il7rtm1Imx
Tg(Cd8a*-cre)B8Asin/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
Il7rtm1Abra/Il7rtm1Abra
(B6.129S4-Il7rtm1Abra)
|
abnormal T cell differentiation
|
J:125360
|
| decreased B cell number
|
J:125360
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125360
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125360
|
| decreased memory T cell number
|
J:125360
|
| decreased thymocyte number
|
J:125360
|
| increased double-positive T cell number
|
J:125360
|
Il7rtm1Iku/Il7rtm1Iku
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:34658
|
| abnormal gamma-delta T cell differentiation
|
J:34658
|
| abnormal T cell subpopulation ratio
|
J:34658
|
| absent mature gamma-delta T cells
|
J:34658
|
| decreased B-1 B cell number
|
J:34658
|
| decreased double-positive T cell number
|
J:34658
|
| decreased immature B cell number
|
J:34658
|
| decreased lymphocyte cell number
|
J:34658
|
| decreased mature B cell number
|
J:34658
|
| decreased T cell number
|
J:34658
|
| increased double-negative T cell number
|
J:34658
|
Il7rtm1Imx/Il7rtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd)
|
arrested B cell differentiation
|
J:21135
|
| arrested T cell differentiation
|
J:21135
|
| decreased B cell number
|
J:21135
|
| decreased T cell number
|
J:21135
|
Il7rtm1Imx/Il7rtm1Imx
(B6.129S7-Il7rtm1Imx)
|
abnormal T cell differentiation
|
J:125360
|
| decreased double-positive T cell number
|
J:125360
|
| decreased thymocyte number
|
J:125360
|
Il7rtm1Imx/Il7rtm1Imx
(involves: 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:64861
|
Il7rtm1Imx/Il7rtm1Imx
Tg(Lck-Il7r)1676Trma/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
decreased thymocyte number
|
J:66400
|
Il7rtm2Iku/Il7rtm2Iku
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:193283
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:193283
|
| abnormal T cell morphology
|
J:193283
|
| decreased NK T cell number
|
J:193283
|
| increased B cell number
|
J:193283
|
| increased gamma-delta T cell number
|
J:193283
|
| increased thymocyte number
|
J:193283
|
Il9rtm1Jcrd/Il9rtm1Jcrd
(involves: C57BL/6)
|
increased T-helper 1 cell number
|
J:151907
|
Il10tm1.1Roer/Il10tm1.1Roer
(involves: 129P2/OlaHsd)
|
increased B cell number
|
J:151551
|
| increased myeloid dendritic cell number
|
J:151551
|
| increased plasma cell number
|
J:151551
|
| increased T cell number
|
J:151551
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte cell number
|
J:35020
|
| increased CD4-positive, alpha-beta T cell number
|
J:35020
|
Il10tm1Cgn/Il10tm1Cgn
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:111712
|
Il10tm1Cgn/Il10tm1Cgn
Il12btm1Jm/Il12btm1Jm
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:111712
|
Il10tm1Cgn/Il10tm1Cgn
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:107077
|
| increased macrophage cell number
|
J:107077
|
Il10ratm1.1Tlg/Il10ratm1.1Tlg
Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Il10ratm1.1Tlg)
|
abnormal lymphocyte cell number
|
J:189797
|
| abnormal regulatory T cell number
|
J:189797
|
| decreased T cell number
|
J:189797
|
Il10ratm1b(KOMP)Wtsi/Il10ratm1b(KOMP)Wtsi
(C57BL/6N-Il10ratm1b(KOMP)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
Il11ra1tm1Gos/Il11ra1tm1Gos
(involves: 129S2/SvPas * C57BL/6J * CD-1)
|
abnormal NK cell differentiation
|
J:93811
|
| abnormal uterine NK cell morphology
|
J:93811
|
Il12rb1tm1Jm/Il12rb1tm1Jm
Tg(Rorc-EGFP)1Ebe/?
(involves: 129S1/Sv * C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
Il13tm1.1Anjm/Il13tm1.1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:67965
|
| decreased T-helper 2 cell number
|
J:67965
|
Il13tm2Anjm/Il13tm2Anjm
(involves: 129)
|
abnormal T-helper 2 cell differentiation
|
J:67965
|
| decreased T-helper 2 cell number
|
J:67965
|
Il13tm2Anjm/Il13tm2Anjm
(B6.129P2-Il13tm2Anjm)
|
decreased macrophage cell number
|
J:131969
|
Il13ra1tm1Twy/Y
(C.Cg-Il13ra1tm1Twy)
|
increased CD4-positive, alpha-beta T cell number
|
J:130488
|
| increased T-helper 2 cell number
|
J:130488
|
Il15m1Hwata/Il15m1Hwata
(Not Specified)
|
abnormal NK T cell number
|
J:184570
|
| decreased NK cell number
|
J:184570
|
| decreased NK T cell number
|
J:184570
|
Il15tm1Imx/Il15+
Myctm1Atp/Myc+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased memory T cell number
|
J:132730
|
Il15tm1Imx/Il15tm1Imx
(involves: C57BL/6)
|
abnormal lymphocyte morphology
|
J:60915
|
| absent uterine NK cells
|
J:84009
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113408,
J:60915
|
| decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:155298
|
| decreased memory T cell number
|
J:132730
|
| decreased NK cell number
|
J:132730,
J:142654,
J:60915
|
| decreased regulatory T cell number
|
J:208318
|
Il15tm1Imx/Il15tm1Imx
(C57BL/6-Il15tm1Imx/Tac)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111786
|
| decreased CD8-positive, alpha-beta T cell number
|
J:111786
|
Il15tm1Imx/Il15tm1Imx
Il7rtm1.1Asin/Il7rtm1Imx
Tg(Cd8a*-cre)B8Asin/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
Il15tm1Imx/Il15tm1Imx
Itktm1Ljb/Itktm1Ljb
(involves: 129 * C57BL/6 * C57BL/10)
|
decreased CD8-positive, alpha-beta T cell number
|
J:113408
|
Il15tm1Imx/Il15tm1Imx
Myctm1Atp/Myc+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased memory T cell number
|
J:132730
|
| decreased NK cell number
|
J:132730
|
Il15tm1Imx/Il15tm1Imx
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
decreased NK cell number
|
J:132257
|
Il15ratm1.1Nsl/Il15ratm1.1Nsl
(involves: 129X1/SvJ * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:73738
|
| decreased memory T cell number
|
J:73738
|
| decreased NK cell number
|
J:73738
|
| decreased NK T cell number
|
J:73738
|
| decreased single-positive T cell number
|
J:73738
|
| increased CD4-positive, alpha-beta T cell number
|
J:73738
|
Il15ratm1Ama/Il15ratm1Ama
(involves: 129X1/SvJ)
|
decreased CD8-positive, alpha-beta T cell number
|
J:142570
|
| decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:155298
|
| decreased memory T cell number
|
J:142570
|
| decreased NK cell number
|
J:119213,
J:142570
|
| decreased NK T cell number
|
J:142570
|
Il15ratm1Ama/Il15ratm2.1Ama
Lyz2tm1(cre)Ifo/0
Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
decreased CD8-positive, alpha-beta T cell number
|
J:155298
|
| decreased memory T cell number
|
J:155298
|
| decreased NK cell number
|
J:155298
|
Il15ratm1Ama/Il15ratm2.1Ama
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
abnormal NK cell differentiation
|
J:155298
|
| decreased CD8-positive, alpha-beta T cell number
|
J:155298
|
| decreased memory T cell number
|
J:155298
|
| decreased NK cell number
|
J:155298
|
Il15ratm1Ama/Il15ratm2.1Ama
Tg(Itgax-cre)1-1Reiz/0
(involves: 129X1/SvJ * C57BL/6J * CBA)
|
abnormal NK cell differentiation
|
J:155298
|
| abnormal T cell subpopulation ratio
|
J:155298
|
| decreased CD8-positive, alpha-beta T cell number
|
J:155298
|
| decreased memory T cell number
|
J:155298
|
| decreased NK cell number
|
J:155298
|
Il15ratm1Ama/Il15ratm2.1Ama
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * SJL)
|
decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:155298
|
Il15ratm1Wjl/Il15ratm1Wjl
(involves: 129 * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:142570
|
| decreased memory T cell number
|
J:142570
|
| decreased NK cell number
|
J:142570
|
| decreased NK T cell number
|
J:142570
|
Il17a/Il17ftm1.1Impr/Il17a/Il17ftm1.1Impr
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:187400
|
| absent gamma-delta T cells
|
J:187400
|
| increased gamma-delta T cell number
|
J:187400
|
Il17a/Il17ftm1.1Impr/Il17a/Il17ftm1.1Impr
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:187400
|
| absent gamma-delta T cells
|
J:187400
|
| increased gamma-delta T cell number
|
J:187400
|
Il17atm1Cdon/Il17atm1Cdon
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:136279
|
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd)
|
increased gamma-delta T cell number
|
J:193548
|
Il17bGt(371C12)Cmhd/Il17bGt(371C12)Cmhd
(B6.129-Il17bGt(371C12)Cmhd)
|
increased T-helper 2 cell number
|
J:229778
|
Il17ctm1.1Cdon/Il17ctm1.1Cdon
(involves: 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:177650
|
Il17ratm1.2Kurs/Il17ratm1.2Kurs
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * SJL)
|
increased CD4-positive, alpha-beta T cell number
|
J:196483
|
| increased gamma-delta T cell number
|
J:196483
|
| increased T-helper 17 cell number
|
J:196483
|
Il17ratm1Koll/Il17ratm1Koll
(involves: 129)
|
abnormal T-helper 2 cell differentiation
|
J:158594
|
Il17rbtm1Lex/Il17rbtm1Lex
(C.129-Il17rbtm1Lex)
|
abnormal osteoclast differentiation
|
J:159874
|
Il17rbtm1Tgi/Il17rbtm1Tgi
(B6.Cg-Il17rbtm1Tgi)
|
decreased NK T cell number
|
J:184570
|
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal microglial cell morphology
|
J:122031
|
Il18tm1Khe/Il18tm1Khe
(involves: 129P2/OlaHsd)
|
abnormal T cell morphology
|
J:62263
|
Il18tm1Khe/Il18tm1Khe
(B6.129P2-Il18tm1Khe)
|
increased macrophage cell number
|
J:138759
|
| increased NK cell number
|
J:138759
|
Il18bptm1(KOMP)Vlcg/Il18bptm1(KOMP)Vlcg
(C57BL/6-Il18bptm1(KOMP)Vlcg)
|
abnormal NK cell differentiation
|
J:255309
|
| decreased KLRG1-positive NK cell number
|
J:255309
|
| decreased mature NK cell number
|
J:255309
|
| decreased NK cell number
|
J:255309
|
| increased immature NK cell number
|
J:255309
|
Il18bptm1.1(KOMP)Vlcg/Il18bptm1.1(KOMP)Vlcg
(involves: C57BL/6N)
|
increased B cell number
|
J:261967
|
| increased macrophage cell number
|
J:261967
|
| increased monocyte cell number
|
J:261967
|
Il20ratm1.1Misc/Il20ratm1.1Misc
(involves: C57BL/6)
|
abnormal osteoclast differentiation
|
J:177783
|
Il20rbtm1Uwe/Il20rbtm1Uwe
(B6.129P2-Il20rbtm1Uwe)
|
increased memory T cell number
|
J:143497
|
Il21tm1Lex/Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal gamma-delta T cell morphology
|
J:123351
|
| abnormal T cell differentiation
|
J:123351
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123351
|
Il21tm1Lex/Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:137867
|
| decreased germinal center B cell number
|
J:137867
|
Il21tm1Llit/Il21tm1Llit
(involves: 129 * C57BL/6J)
|
abnormal class switch recombination
|
J:114783
|
Il21rtm1Day/Il21rtm1Day
(involves: BALB/c * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:136955,
J:123352
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123352
|
Il21rtm1Wjl/Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl)
|
abnormal CD4-positive T cell differentiation
|
J:139075
|
Il23atm1Dnax/Il23atm1Dnax
(Not Specified)
|
decreased gamma-delta T cell number
|
J:193548
|
| decreased T cell number
|
J:193548
|
Il23atm1Ngh/Il23atm1Ngh
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:88235
|
Il23atm1Ngh/Il23atm1Ngh
(involves: 129 * C57BL/6)
|
decreased activated T cell number
|
J:120806
|
Il23rtm1Kuch/Il23rtm1Kuch
(C57BL/6-Il23rtm1Kuch)
|
abnormal CD4-positive T cell differentiation
|
J:148248
|
Il25tm1.1Cdon/Il25tm1.1Cdon
(involves: 129S6/SvEvTac)
|
decreased T-helper 2 cell number
|
J:229778
|
Il25tm1Dart/Il25tm1Dart
(involves: C57BL/6)
|
increased T cell number
|
J:125296
|
Il27tm1b(EUCOMM)Wtsi/Il27tm1b(EUCOMM)Wtsi
(C57BL/6N-Il27tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
Il27tm1Cua/Il27tm1Cua
(C57BL/6-Il27tm1Cua)
|
abnormal CD4-positive T cell differentiation
|
J:147706
|
Il27ratm1Fjs/Il27ratm1Fjs
(B6.Cg-Il27ratm1Fjs)
|
increased lymphocyte cell number
|
J:94856
|
Il33tm1Amgn/Il33tm1Amgn
(B6.129-Il33tm1Amgn)
|
decreased lymphocyte cell number
|
J:192531
|
Il34tm1b(EUCOMM)Wtsi/Il34tm1b(EUCOMM)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
abnormal microglial cell morphology
|
J:187643
|
| absent Langerhans cell
|
J:187643
|
| decreased Langerhans cell number
|
J:187643
|
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal macrophage morphology
|
J:264077
|
| decreased alveolar macrophage number
|
J:264077
|
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:256437
|
| increased CD4-positive, alpha-beta T cell number
|
J:256437
|
| increased regulatory T cell number
|
J:256437
|
Ilktm1Star/Ilktm2Star
Tg(Acp5-cre)1Star/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased osteoclast cell number
|
J:197593
|
Immp2lTg(HLA-A/H2-D)2Enge/?
((C57BL/6 x CBA)F1)
|
abnormal negative T cell selection
|
J:31937
|
| abnormal positive T cell selection
|
J:31937
|
Impdh1tm1Bmi/Impdh1tm1Bmi
Impdh2tm1Bmi/Impdh2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:85443
|
Impdh2tm1Bmi/Impdh2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte cell number
|
J:86045
|
Impg1em1Visu/Impg1em1Visu
Impg2em1Visu/Impg2em1Visu
(involves: C57BL/6J * DBA/2)
|
microgliosis
|
J:288311
|
Impg2em1Visu/Impg2em1Visu
(involves: C57BL/6J * DBA/2)
|
microgliosis
|
J:288311
|
In(2a;Itch)18H/In(2a;Itch)18H
(involves: 101/H * C3H/HeH)
|
abnormal alveolar macrophage morphology
|
J:24934
|
Ing1Gt(OST206270)Lex/Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased thymocyte number
|
J:118602
|
Ing4em1(IMPC)Tcp/Ing4em1(IMPC)Tcp
(C57BL/6NCrl-Ing4em2(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Inpp4btm1.1Jva/Inpp4btm1.1Jva
(B6.129-Inpp4btm1.1Jva)
|
abnormal osteoclast differentiation
|
J:177648
|
| abnormal osteoclast morphology
|
J:177648
|
| increased osteoclast cell number
|
J:177648
|
Inpp5del20/Inpp5del20
(B6.129-Inpp5del20)
|
abnormal lymphocyte cell number
|
J:173266
|
| decreased lymphocyte cell number
|
J:173266
|
| decreased pre-B cell number
|
J:173266
|
| decreased thymocyte number
|
J:173266
|
| increased macrophage cell number
|
J:173266
|
Inpp5dm1Btlr/Inpp5dm1Btlr
(C57BL/6J-Inpp5dm1Btlr)
|
abnormal B cell differentiation
|
J:140987
|
Inpp5dm2Btlr/Inpp5dm2Btlr
(C57BL/6J-Inpp5dm2Btlr)
|
decreased B cell number
|
J:216053
|
Inpp5dM3Btlr/Inpp5d+
(C57BL/6J-Inpp5dM3Btlr)
|
decreased NK cell number
|
J:254907
|
Inpp5dm5Btlr/Inpp5dm5Btlr
(C57BL/6J-Inpp5dm5Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272856
|
| abnormal lymphocyte morphology
|
J:272856
|
| abnormal T cell differentiation
|
J:272856
|
| decreased alpha-beta T cell number
|
J:272856
|
| decreased B cell number
|
J:272856
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272856
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272856
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272856
|
| decreased NK cell number
|
J:272856
|
| increased B-1 B cell number
|
J:272856
|
| increased CD8-positive, alpha-beta T cell number
|
J:272856
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272856
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272856
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272856
|
Inpp5dtm1.1Wgk/Inpp5dtm1.1Wgk
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal NK cell morphology
|
J:95215
|
| increased monocyte cell number
|
J:94861
|
| increased NK cell number
|
J:95215
|
Inpp5dtm1Dmt/Inpp5dtm1Dmt
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:77739
|
Inpp5dtm1Dmt/Inpp5dtm1Dmt
(B6.129P2/OlaHsd-Inpp5dtm1Dmt)
|
decreased lymphocyte cell number
|
J:173266
|
| decreased pre-B cell number
|
J:173266
|
Inpp5dtm1Rav/Inpp5dtm1.1Rav
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal spleen marginal zone macrophage morphology
|
J:119256
|
| absent marginal zone B cells
|
J:119256
|
Inpp5dtm1Rav/Inpp5dtm1Rav
Cd79atm1(cre)Reth/Cd79a+
Tg(IghAb36-65)1Wys/0
(involves: 129 * BALB/c * C57BL/6 * FVB/N)
|
abnormal B cell negative selection
|
J:178833
|
| decreased B cell number
|
J:178833
|
| increased plasma cell number
|
J:178833
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal lymphopoiesis
|
J:48193
|
| abnormal monocyte differentiation
|
J:48193
|
| decreased lymphocyte cell number
|
J:48193
|
| increased monocyte cell number
|
J:48193
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased pro-B cell number
|
J:117320
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal osteoclast differentiation
|
J:78771
|
| abnormal osteoclast morphology
|
J:78771
|
| increased osteoclast cell number
|
J:78771
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
Rag1tm1(GFP)Imku/Rag1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:117320
|
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita/J)
|
abnormal microglial cell morphology
|
J:99412
|
Ins2Akita/Ins2+
Prf1tm1Sdz/Prf1tm1Sdz
Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Ins2Akita Prf1tm1Sdz)
|
absent mature B cells
|
J:138005
|
| absent T cells
|
J:138005
|
| increased macrophage cell number
|
J:138005
|
| increased monocyte cell number
|
J:138005
|
Iqcetm1b(EUCOMM)Hmgu/Iqcetm1b(EUCOMM)Hmgu
(C57BL/6N-Iqcetm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Iqgap1tm1b(EUCOMM)Wtsi/Iqgap1tm1b(EUCOMM)Wtsi
(C57BL/6N-Iqgap1tm1b(EUCOMM)Wtsi/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Irag1em1(IMPC)Ccpcz/Irag1em1(IMPC)Ccpcz
(C57BL/6NCrl-Irag1em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
Irak3tm1Flv/Irak3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
increased osteoclast cell number
|
J:98035
|
Irak3tm1Flv/Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv)
|
abnormal T cell differentiation
|
J:229884
|
| increased effector memory T-helper cell number
|
J:229884
|
Irf1M1Btlr/Irf1+
(C57BL/6J-Irf1M1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:162995
|
| decreased NK cell number
|
J:162995
|
Irf1M1Btlr/Irf1M1Btlr
(C57BL/6J-Irf1M1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:162995
|
| decreased NK cell number
|
J:162995
|
Irf1m2Btlr/Irf1m2Btlr
(C57BL/6J-Irf1m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:267675
|
| decreased NK cell number
|
J:267675
|
| increased B-1 B cell number
|
J:267675
|
| increased CD4-positive, alpha-beta T cell number
|
J:267675
|
Irf1M3Btlr/Irf1M3Btlr
(C57BL/6J-Irf1M3Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:267677
|
| increased CD4-positive, alpha-beta T cell number
|
J:267677
|
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129/Sv * C57BL/6)
|
abnormal T cell morphology
|
J:21235,
J:36025
|
| decreased CD8-positive, alpha-beta T cell number
|
J:21235
|
| increased T-helper 2 cell number
|
J:110672
|
Irf1tm1Mak/Irf1tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
abnormal T cell number
|
J:64286
|
| decreased CD8-positive, alpha-beta T cell number
|
J:64286
|
| increased CD4-positive, alpha-beta T cell number
|
J:64286
|
| increased double-positive T cell number
|
J:64286
|
Irf2tm1Mak/Irf2tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
decreased mature B cell number
|
J:64286
|
| decreased T cell number
|
J:64286
|
Irf2tm1Mak/Irf2tm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
increased memory T cell number
|
J:66034
|
Irf3tm1Ttg/Irf3tm1Ttg
Sting1em1Jmin/Sting1em1Jmin
(involves: 129S/SvEv * C57BL/6N)
|
decreased single-positive T cell number
|
J:251372
|
Irf4em1(IMPC)Mbp/Irf4em1(IMPC)Mbp
(C57BL/6N-Irf4em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Irf4m1Btlr/Irf4m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Irf4tm1.1Rdf/Irf4tm1.1Rdf
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:112643
|
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:42683
|
| absent plasma cells
|
J:42683
|
| arrested B cell differentiation
|
J:42683
|
| increased lymphocyte cell number
|
J:42683
|
Irf4tm1Mak/Irf4tm1Mak
(B6.129P2-Irf4tm1Mak)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78909
|
| abnormal T-helper 1 cell differentiation
|
J:78909
|
Irf5tm1e(EUCOMM)Wtsi/Irf5tm1e(EUCOMM)Wtsi
(C57BL/6N-Irf5tm1e(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
Irf8em1Kmm/Irf8em1Kmm
Rr253em6Kmm/Rr253em6Kmm
(C57BL/6J-Irf8em1Kmm Rr253em6Kmm)
|
decreased monocyte cell number
|
J:334296
|
Irf8M1Btlr/Irf8M1Btlr
(C57BL/6J-Irf8M1Btlr)
|
decreased macrophage cell number
|
J:166600
|
| decreased monocyte cell number
|
J:166600
|
Irf8m2Btlr/Irf8m2Btlr
(C57BL/6J-Irf8m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:274937
|
| increased CD4-positive, alpha-beta T cell number
|
J:274937
|
Irf8myls/Irf8+
(involves: BXH2/TyJ * C57BL/6)
|
increased B cell number
|
J:168923
|
| increased B-1b cell number
|
J:168923
|
| increased follicular B cell number
|
J:168923
|
| increased transitional stage B cell number
|
J:168923
|
Irf8tm1Hor/Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal plasma cell number
|
J:36038
|
| decreased B cell number
|
J:36038
|
| decreased lymphocyte cell number
|
J:36038
|
| decreased T cell number
|
J:36038
|
| increased B cell number
|
J:36038
|
| increased lymphocyte cell number
|
J:36038
|
| increased macrophage cell number
|
J:36038
|
| increased mature B cell number
|
J:36038
|
Irf8tm1Hor/Irf8tm1Hor
(B6.129P2-Irf8tm1Hor)
|
decreased follicular B cell number
|
J:168923
|
| increased B-1b cell number
|
J:168923
|
| increased marginal zone B cell number
|
J:168923
|
Irf8tm1Hor/Irf8tm1Hor
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:84577
|
| abnormal pre-B cell morphology
|
J:84577
|
| absent B cells
|
J:84577
|
| arrested B cell differentiation
|
J:84577
|
| decreased lymphocyte cell number
|
J:84577
|
| decreased T cell number
|
J:84577
|
| increased pre-B cell number
|
J:84577
|
Irgcem1(IMPC)Tcp/Irgcem1(IMPC)Tcp
(C57BL/6N-Irgcem1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Irs1Sml/Irs1Sml
(C3.Cg-Irs1Sml H2b/GrsrJ)
|
increased osteoclast cell number
|
J:163661
|
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
abnormal osteoclast differentiation
|
J:61479
|
Is(14)1Rdf Is(14)2Rdf/Del(14Trim13-Dleu2)4Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased B cell number
|
J:156946
|
| increased B-1a cell number
|
J:156946
|
Is(14)1Rdf Is(14)5Rdf/Del(14Trim13-Rnaseh2b)6Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
| increased B cell number
|
J:179879
|
Is(14)1Rdf/Is(14)1Rdf
Is(14)5Rdf/Is(14)5Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
| increased B cell number
|
J:179879
|
Itchtm1.1Alta/Itchtm1.1Alta
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:204685
|
| abnormal T-helper 2 cell differentiation
|
J:204685
|
| decreased CD4-positive, alpha-beta T cell number
|
J:204685
|
| increased CD4-positive, alpha-beta T cell number
|
J:204685
|
| increased CD8-positive, alpha-beta T cell number
|
J:204685
|
| increased regulatory T cell number
|
J:204685
|
Itfg2Gt(OST215121)Lex/Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:205951
|
| decreased lymphocyte cell number
|
J:205951
|
| decreased T follicular helper cell number
|
J:205951
|
| increased B cell number
|
J:205951
|
Itga4tm1Mgin/Itga4tm1Mgin
(B6.129-Itga4tm1Mgin)
|
decreased monocyte cell number
|
J:106471
|
Itga4tm1Mshi/Itga4tm1Mshi
(C57BL/6-Itga4tm1Mshi)
|
abnormal mononuclear cell morphology
|
J:144092
|
| decreased B cell number
|
J:144092
|
| decreased lymphocyte cell number
|
J:144092
|
| decreased T cell number
|
J:144092
|
Itga4tm1Tpa/Itga4tm1Tpa
Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:86861
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86861
|
Itga6tm1Son/Itga6tm1Son
(involves: 129P2/OlaHsd * FVB)
|
decreased T cell number
|
J:50235
|
Itgadtm1Bll/Itgadtm1Bll
(B6.129S7-Itgadtm1Bll)
|
abnormal lymphocyte cell number
|
J:90954
|
| abnormal T cell subpopulation ratio
|
J:90954
|
| decreased CD4-positive, alpha-beta T cell number
|
J:90954
|
| increased CD8-positive, alpha-beta T cell number
|
J:90954
|
Itgaetm1b(EUCOMM)Wtsi/Itgaetm1b(EUCOMM)Wtsi
(C57BL/6N-Itgaetm1b(EUCOMM)Wtsi/H)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
Itgaetm1Cmp/Itgaetm1Cmp
(involves: 129S2/SvPas * BALB/c)
|
decreased lymphocyte cell number
|
J:55333
|
| decreased T cell number
|
J:55333
|
Itgaltm1.1Mshi/Itgaltm1.1Mshi
(involves: C57BL/6)
|
decreased lymphocyte cell number
|
J:168533
|
Itgaltm1Bll/Itgaltm1Bll
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased monocyte cell number
|
J:83226
|
Itgaltm1Hlz/Itgaltm1Hlz
(involves: 129P2/OlaHsd)
|
decreased lymphocyte cell number
|
J:99286
|
Itgaltm1Hogg/Itgaltm1Hogg
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:82587
|
| decreased CD4-positive, alpha-beta T cell number
|
J:82587
|
| decreased CD8-positive, alpha-beta T cell number
|
J:82587
|
| decreased lymphocyte cell number
|
J:82587
|
| increased CD4-positive, alpha-beta T cell number
|
J:82587
|
| increased CD8-positive, alpha-beta T cell number
|
J:82587
|
Itgamm1Btlr/Itgam+
(C57BL/6J-Itgamm1Btlr)
|
decreased macrophage cell number
|
J:236681
|
Itgamm1Btlr/Itgamm1Btlr
(C57BL/6J-Itgamm1Btlr)
|
decreased macrophage cell number
|
J:236681
|
Itgamtm1Bll/Itgamtm1Bll
(B6.129S7-Itgamtm1Bll)
|
abnormal lymphocyte cell number
|
J:90954
|
| abnormal T cell subpopulation ratio
|
J:90954
|
| decreased CD4-positive, alpha-beta T cell number
|
J:90954
|
| increased CD8-positive, alpha-beta T cell number
|
J:90954
|
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL)
|
decreased regulatory T cell number
|
J:125508
|
| increased regulatory T cell number
|
J:125508
|
Itgb2M1Btlr/Itgb2M1Btlr
(C57BL/6J-Itgb2M1Btlr)
|
abnormal NK cell differentiation
|
J:139559
|
Itgb2m3Btlr/Itgb2m3Btlr
(C57BL/6J-Itgb2m3Btlr)
|
decreased B cell number
|
J:265126
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265126
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265126
|
| decreased macrophage cell number
|
J:265126
|
| decreased single-positive T cell number
|
J:265126
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265126
|
| increased NK T cell number
|
J:265126
|
Itgb2M4Btlr/Itgb2M4Btlr
(C57BL/6J-Itgb2M4Btlr)
|
abnormal T cell differentiation
|
J:272843
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272843
|
Itgb2m5Btlr/Itgb2m5Btlr
(C57BL/6J-Itgb2m5Btlr)
|
increased B-1b cell number
|
J:272844
|
Itgb2tm1.1Arte/Itgb2tm1.1Arte
(involves: C57BL/6NTac)
|
increased B cell number
|
J:202261
|
| increased T cell number
|
J:202261
|
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd)
|
increased lymphocyte cell number
|
J:13599
|
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd * PL/J)
|
increased lymphocyte cell number
|
J:32126
|
| increased monocyte cell number
|
J:32126
|
| increased T cell number
|
J:109598
|
| increased T-helper 1 cell number
|
J:109598
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased lymphocyte cell number
|
J:48542
|
| increased monocyte cell number
|
J:48542
|
Itgb2tm2Bay/Itgb2tm2Bay
(B6.129S7-Itgb2tm2Bay)
|
increased lymphocyte cell number
|
J:83226
|
| increased monocyte cell number
|
J:83226
|
Itgb3tm1Hyn/Itgb3tm1.1Wlbcr
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal osteoclast differentiation
|
J:224675
|
| abnormal osteoclast morphology
|
J:224675
|
| decreased osteoclast cell number
|
J:224675
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
increased monocyte cell number
|
J:119666
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas)
|
abnormal osteoclast morphology
|
J:60672
|
| decreased macrophage cell number
|
J:96049
|
| increased osteoclast cell number
|
J:60672
|
Itgb6tm1Des/Itgb6tm1Des
(involves: 129S4/SvJae)
|
absent Langerhans cell
|
J:120085
|
| decreased Langerhans cell number
|
J:120085
|
Itgb7tm1Cgn/Itgb7tm1Cgn
(involves: C57BL/6)
|
abnormal uterine NK cell morphology
|
J:44813
|
| decreased B cell number
|
J:34306
|
| decreased CD4-positive, alpha-beta T cell number
|
J:34306
|
| increased uterine NK cell number
|
J:44813
|
Itkm2Btlr/Itkm2Btlr
(C57BL/6J-Itkm2Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254826
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:254826
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254826
|
| increased B cell number
|
J:254826
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254826
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254826
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254826
|
Itktm1Lex/Itktm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:103485
|
| decreased CD8-positive, alpha-beta T cell number
|
J:103485
|
| increased B cell number
|
J:103485
|
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae * C57BL/6J)
|
decreased B cell number
|
J:31230
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31230
|
| decreased T cell number
|
J:31230
|
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111786
|
| decreased CD8-positive, alpha-beta T cell number
|
J:111786
|
Itktm1Litt/Itktm1Litt
(B6.129S4-Itktm1Litt)
|
abnormal positive T cell selection
|
J:141390
|
| abnormal T cell morphology
|
J:141390
|
| decreased T cell number
|
J:141390
|
| increased double-negative T cell number
|
J:141390
|
Itktm1Litt/Itktm1Litt
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:31230
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31230
|
| increased double-positive T cell number
|
J:31230
|
Itktm1Litt/Itktm1Litt
Tg(TcrAND)53Hed/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
abnormal lymphocyte morphology
|
J:31230
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31230
|
| increased double-negative T cell number
|
J:31230
|
Itktm1Litt/Itktm1Litt
Txktm1Pls/Txktm1Pls
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:54449
|
| decreased single-positive T cell number
|
J:54449
|
Itktm1Litt/Itktm1Litt
Vav1tm2Bbd/Vav1tm2Bbd
(B6.129-Itktm1Litt Vav1tm2Bbd)
|
abnormal CD4-positive T cell differentiation
|
J:141390
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141390
|
| abnormal positive T cell selection
|
J:141390
|
| abnormal T cell morphology
|
J:141390
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141390
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141390
|
| decreased double-positive T cell number
|
J:141390
|
| decreased T cell number
|
J:141390
|
| decreased thymocyte number
|
J:141390
|
| increased B cell number
|
J:141390
|
Itktm1Ljb/Itktm1Ljb
(B6.129-Itktm1Ljb)
|
abnormal NK T cell morphology
|
J:120689
|
| decreased NK T cell number
|
J:120689
|
Itktm1Ljb/Itktm1Ljb
(involves: 129 * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:48231
|
Itktm1Ljb/Itktm1Ljb
(B10.129-Itktm1Ljb)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:113408
|
| abnormal gamma-delta T cell morphology
|
J:148531
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
| increased CD8-positive, alpha-beta T cell number
|
J:113408,
J:123795
|
| increased germinal center B cell number
|
J:148531
|
| increased mature gamma-delta T cell number
|
J:148531
|
| increased memory T cell number
|
J:113408
|
Itktm1Ljb/Itktm1Ljb
Rag1tm1Mom/Rag1tm1Mom
Tg(Tcra5CC7,Tcrb5CC7)IWep/?
(involves: 129 * C57BL/10)
|
abnormal CD4-positive T cell differentiation
|
J:93606
|
Itktm1Ljb/Itktm1Ljb
Tg(Tcra2B4)1Mmd/?
Tg(Tcrb2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
Itktm1Ljb/Itktm1Ljb
Tg(Tcra5CC7,Tcrb5CC7)IWep/?
(involves: 129 * C57BL/10)
|
decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
Itktm1Ljb/Itktm1Ljb
Txktm1Pls/Txktm1Pls
(B6.129-Txktm1Pls Itktm1Ljb)
|
increased CD8-positive, alpha-beta T cell number
|
J:113408
|
| increased memory T cell number
|
J:113408
|
Itln1em1Cya/Itln1em1Cya
(involves: C57BL/6)
|
increased osteoclast cell number
|
J:282124
|
ItpkbT-less/ItpkbT-less
(C57BL/6-ItpkbT-less)
|
arrested T cell differentiation
|
J:89286
|
Itpkbtm1Ssch/Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent CD4-positive, alpha-beta T cells
|
J:86257
|
| absent CD8-positive, alpha-beta T cells
|
J:86257
|
| absent T cells
|
J:86257
|
| arrested T cell differentiation
|
J:86257
|
| increased double-positive T cell number
|
J:86257
|
Itpkbtm1Ssch/Itpkbtm1Ssch
Itpkctm1Ssch/Itpkctm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent CD4-positive, alpha-beta T cells
|
J:86257
|
| absent CD8-positive, alpha-beta T cells
|
J:86257
|
| arrested T cell differentiation
|
J:86257
|
Jag2tm1Grid/Jag2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal gamma-delta T cell differentiation
|
J:46930
|
| decreased gamma-delta T cell number
|
J:46930
|
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda)
|
abnormal plasma cell morphology
|
J:199153
|
| increased plasma cell number
|
J:199153
|
Jak1tm1Rds/Jak1tm1Rds
(involves: 129)
|
abnormal B cell differentiation
|
J:47300
|
| abnormal lymphopoiesis
|
J:47300
|
| abnormal T cell differentiation
|
J:47300
|
| arrested B cell differentiation
|
J:47300
|
| decreased B cell number
|
J:47300
|
| decreased thymocyte number
|
J:47300
|
| increased double-negative T cell number
|
J:47300
|
Jak2tm1.1Jlvl/Jak2tm1.1Jlvl
(involves: 129S2/SvPas * C57BL/6)
|
increased lymphocyte cell number
|
J:163497
|
| increased monocyte cell number
|
J:163497
|
Jak2tm1.2Ble/Jak2+
Picalmtm1.1Tmae/Picalmtm1.1Tmae
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:220728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:220728
|
Jak2tm1Mohi/Jak2+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:183821
|
Jak2tm1Mohi/Jak2tm1Mohi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:183821
|
Jak2tm2.1Jlvl/Jak2+
Tg(Vav1-cre)#Cgp/0
(involves: 129S2/SvPas * C57BL/6NTac)
|
decreased B cell number
|
J:202234
|
Jak3bfy/Jak3bfy
(C57BL/6JSfdAnu-Jak3bfy/AnuApb)
|
abnormal lymphopoiesis
|
J:104190
|
| abnormal T cell subpopulation ratio
|
J:104190
|
| decreased B cell number
|
J:104190
|
| decreased lymphocyte cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
| decreased thymocyte number
|
J:104190
|
Jak3m1Btlr/Jak3m1Btlr
(C57BL/6J-Jak3m1Btlr)
|
abnormal T cell subpopulation ratio
|
J:217795
|
| decreased NK cell number
|
J:217795
|
| decreased single-positive T cell number
|
J:217795
|
| decreased T cell number
|
J:217795
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:217795
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:217795
|
| increased single-positive T cell number
|
J:217795
|
Jak3M1Pgrs/Jak3M1Pgrs
(involves: C57BL/6J * C57BL/10J)
|
absent B cells
|
J:185217
|
| decreased B cell number
|
J:185217
|
| decreased NK cell number
|
J:185217
|
| increased CD4-positive, alpha-beta T cell number
|
J:185217
|
| increased CD8-positive, alpha-beta T cell number
|
J:185217
|
Jak3m2Btlr/Jak3m2Btlr
(C57BL/6J-Jak3m2Btlr)
|
increased B cell number
|
J:217796
|
| increased memory B cell number
|
J:217796
|
Jak3m3Btlr/Jak3m3Btlr
(C57BL/6J-Jak3m3Btlr)
|
abnormal T cell subpopulation ratio
|
J:225935
|
| decreased B cell number
|
J:225935
|
| decreased B-1 B cell number
|
J:225935
|
| decreased immature B cell number
|
J:225935
|
| decreased mature B cell number
|
J:225935
|
| decreased memory B cell number
|
J:225935
|
| decreased NK cell number
|
J:225935
|
| decreased single-positive T cell number
|
J:225935
|
| decreased T cell number
|
J:225935
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:225935
|
| increased macrophage cell number
|
J:225935
|
| increased myeloid dendritic cell number
|
J:225935
|
Jak3m4Btlr/Jak3m4Btlr
(C57BL/6J-Jak3m4Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:272398
|
Jak3M5Btlr/Jak3M5Btlr
(C57BL/6J-Jak3M5Btlr)
|
decreased NK T cell number
|
J:272399
|
Jak3m6Btlr/Jak3m6Btlr
(C57BL/6J-Jak3m6Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272400
|
| increased CD4-positive, alpha-beta T cell number
|
J:272400
|
Jak3M7Btlr/Jak3M7Btlr
(C57BL/6J-Jak3M7Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272401
|
Jak3m8Btlr/Jak3m8Btlr
(C57BL/6J-Jak3m8Btlr)
|
decreased B cell number
|
J:274939
|
| decreased B-1 B cell number
|
J:274939
|
| decreased B-2 B cell number
|
J:274939
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274939
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274939
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274939
|
| decreased T cell number
|
J:274939
|
| increased B-1b cell number
|
J:274939
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274939
|
Jak3tm1Flv/Jak3tm1Flv
(involves: 129S1/Sv)
|
arrested B cell differentiation
|
J:95794
|
| decreased CD8-positive, alpha-beta T cell number
|
J:95794
|
| increased CD4-positive, alpha-beta T cell number
|
J:95794
|
Jak3tm1Jni/Jak3tm1Jni
Crlf2tm1Jni/Crlf2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:89031
|
| decreased B cell number
|
J:89031
|
Jak3tm1Ljb/Jak3+
(involves: 129S4/SvJae)
|
decreased lymphocyte cell number
|
J:56629
|
| increased monocyte cell number
|
J:56629
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell morphology
|
J:29722
|
| arrested B cell differentiation
|
J:29722
|
| decreased immature B cell number
|
J:29722
|
| decreased mature B cell number
|
J:29722
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:64861
|
| absent B cells
|
J:128694
|
| decreased lymphocyte cell number
|
J:56629
|
| decreased thymocyte number
|
J:64861
|
| increased monocyte cell number
|
J:56629
|
Jak3tm1Ljb/Jak3tm1Ljb
(B6;129S4-Jak3tm1Ljb/J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:123902
|
| decreased CD8-positive, alpha-beta T cell number
|
J:123902
|
| decreased myeloid dendritic cell number
|
J:123902
|
Jak3tm1Ljb/Jak3tm1Ljb
Tg(Lck-Jak3)1Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)
|
absent B cells
|
J:128694
|
Jak3tm1Ljb/Jak3tm1Ljb
Tg(Lck-Jak3)2Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)
|
absent B cells
|
J:128694
|
Jak3tm1Tks/Jak3tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:31231
|
| abnormal CD4-positive, alpha beta T cell morphology
|
J:31231
|
| abnormal lymphopoiesis
|
J:31231
|
| abnormal T cell morphology
|
J:31231
|
| abnormal T cell number
|
J:31231
|
| absent NK cells
|
J:31231
|
| decreased B cell number
|
J:31231
|
| decreased pre-B cell number
|
J:31231
|
| decreased thymocyte number
|
J:31231
|
Jak3wil/Jak3wil
(C57BL/6JSfdAnu-Jak3wil/Anu)
|
arrested B cell differentiation
|
J:104190
|
| decreased CD8-positive, alpha-beta T cell number
|
J:104190
|
Jak3X887Y/Jak3X887Y
(Not Specified)
|
abnormal lymphocyte morphology
|
J:112658
|
Jchaintm3Tl/Jchain+
(involves: 129P2/OlaHsd)
|
decreased plasma cell number
|
J:49168
|
Jchaintm3Tl/Jchaintm3Tl
(involves: 129P2/OlaHsd)
|
decreased plasma cell number
|
J:49168,
J:56158
|
Jdp2tm1Aki/Jdp2tm1Aki
(Not Specified)
|
abnormal osteoclast differentiation
|
J:191061
|
| abnormal osteoclast morphology
|
J:191061
|
Junbtm3Wag/Junbtm3Wag
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast morphology
|
J:88126
|
Junbtm3Wag/Junbtm3Wag
Meox2tm1(cre)Sor/Meox2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
abnormal osteoclast differentiation
|
J:88126
|
| decreased osteoclast cell number
|
J:88126
|
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)
|
increased plasma cell number
|
J:155575
|
Kat6atm1.1Glac/Kat6atm1.1Glac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:148955
|
| decreased immature B cell number
|
J:148955
|
| decreased pre-B cell number
|
J:148955
|
| decreased pro-B cell number
|
J:148955
|
Kat6atm1Avo/Kat6atm1Avo
(involves: 129/Sv * BALB/c * FVB/N)
|
decreased double-negative T cell number
|
J:108453
|
Kat6atm1Iki/Kat6atm1Iki
(Not Specified)
|
decreased B cell number
|
J:108699
|
Katnal2em1(IMPC)Tcp/Katnal2em1(IMPC)Tcp
(C57BL/6N-Katnal2em1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Kcna5tm1Hket/Kcna5tm1Hket
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
abnormal microglial cell morphology
|
J:116545
|
Kcne1tm1b(EUCOMM)Hmgu/Kcne1tm1b(EUCOMM)Hmgu
(C57BL/6N-Kcne1tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Kcng3em1(IMPC)Mbp/Kcng3em1(IMPC)Mbp
(C57BL/6NCrl-Kcng3em1(IMPC)Mbp/MbpMmucd)
|
increased monocyte cell number
|
J:211773
|
Kcnk13em1(IMPC)H/Kcnk13em1(IMPC)H
(involves: C57BL/6NTac)
|
abnormal microglial cell morphology
|
J:256020
|
Kcnk13em1(IMPC)H/Kcnk13em1(IMPC)H
(C57BL/6N-Kcnk13em1(IMPC)H/H)
|
increased monocyte cell number
|
J:211773
|
Kctd9em1Beij/Kctd9em1Beij
(BALB/c-Kctd9em1Beij)
|
abnormal immature NK cell morphology
|
J:281803
|
| abnormal NK cell differentiation
|
J:281803
|
| decreased mature NK cell number
|
J:281803
|
| increased immature NK cell number
|
J:281803
|
| increased NK cell number
|
J:281803
|
Kdelr1em1Btlr/Kdelr1em1Btlr
(involves: C57BL/6J * C57BL/6JJcl)
|
decreased lymphocyte cell number
|
J:224970
|
Kdelr1em1Btlr/Kdelr1em1Btlr
Tg(Gt(ROSA)26Sor-Kdelr1)#Btlr/0
(C57BL/6J-Kdelr1em1Btlr Tg(Gt(ROSA)26Sor-Kdelr1)#Btlr)
|
abnormal lymphocyte morphology
|
J:224970
|
Kdelr1m1Btlr/Kdelr1m1Btlr
(C57BL/6J-Kdelr1m1Btlr)
|
abnormal lymphocyte morphology
|
J:224970
|
| abnormal T cell differentiation
|
J:224970
|
| absent NK T cells
|
J:224970
|
| decreased B cell number
|
J:224970
|
| decreased CD4-positive, alpha-beta T cell number
|
J:224970,
J:158794
|
| decreased CD8-positive, alpha-beta T cell number
|
J:224970,
J:158794
|
| decreased follicular B cell number
|
J:224970
|
| decreased lymphocyte cell number
|
J:224970
|
| decreased transitional stage T1 B cell number
|
J:224970
|
| decreased transitional stage T2 B cell number
|
J:224970
|
| increased marginal zone B cell number
|
J:224970
|
Kdm4ctm1a(KOMP)Wtsi/Kdm4c+
(C57BL/6N-Kdm4ctm1a(KOMP)Wtsi/Wtsi)
|
increased B cell number
|
J:165965
|
Kdm6atm1.1Afst/Kdm6atm1.1Afst
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac)
|
increased B cell number
|
J:196401
|
Kdm6atm1Cdcn/Y
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J * CBA)
|
increased monocyte cell number
|
J:263565
|
Kdm6atm1Cdcn/Y
Tg(CAG-cre/Esr1*)5Amc/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J * CBA * FVB/N)
|
increased monocyte cell number
|
J:263565
|
Kdm6atm1Cdcn/Kdm6atm1Cdcn
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J * CBA)
|
increased monocyte cell number
|
J:263565
|
Kdm8tm1a(EUCOMM)Wtsi/Kdm8+
(C57BL/6N-Kdm8tm1a(EUCOMM)Wtsi/Ics)
|
increased B cell number
|
J:165965
|
Kif5ctm1dIcs/Kif5c+
(C57BL/6N-Kif5ctm1dIcs/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Kif15em1Lium/Kif15em1Lium
(C57BL/6-Kif15em1Lium)
|
increased CD8-positive, alpha-beta T cell number
|
J:336767
|
Kiss1rtm1.1Lex/Kiss1r+
(involves: 129S4/SvJae)
|
decreased lymphocyte cell number
|
J:181650
|
Kiss1rtm1.1Lex/Kiss1rtm1.1Lex
(involves: 129S4/SvJae)
|
decreased lymphocyte cell number
|
J:181650
|
| decreased monocyte cell number
|
J:181650
|
Kittm3.1Bsm/Kittm3.1Bsm
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:90485
|
| abnormal T cell differentiation
|
J:90485
|
| decreased B cell number
|
J:90485
|
Kittm3Ber/Kittm3Ber
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
arrested B cell differentiation
|
J:89602
|
| increased B cell number
|
J:89602
|
KitW-sh/KitW-sh
Lyntm1Ard/Lyntm1Ard
(involves: 101 * 129P2/OlaHsd * C3H/HeH)
|
decreased B cell number
|
J:161523
|
KitW-vkd/KitW-vkd
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * WB)
|
abnormal B cell differentiation
|
J:79128
|
| abnormal T cell differentiation
|
J:79128
|
| decreased B cell number
|
J:79128
|
| decreased thymocyte number
|
J:79128
|
KitW/KitW
Tg(PDGFB-EPO)321Zbz/?
(involves: C3H * C57BL/6)
|
abnormal B cell differentiation
|
J:79128
|
| abnormal T cell differentiation
|
J:79128
|
| decreased B cell number
|
J:79128
|
| decreased thymocyte number
|
J:79128
|
KitlSl/KitlSl-d
((WC/ReJ KitlSl x B6.D2-KitlSl-d/J)F1-KitlSl/KitlSl-d/J)
|
abnormal osteoclast morphology
|
J:111273
|
Kitltm3.1Pbes/Kitltm3.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
decreased double-negative T cell number
|
J:157170
|
| decreased double-positive T cell number
|
J:157170
|
| decreased T cell number
|
J:157170
|
| decreased thymocyte number
|
J:157170
|
Klkl/Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J))
|
decreased osteoclast cell number
|
J:44109
|
Klkl/Klkl
(involves: C3H/HeJ * C57BL/6J)
|
decreased B cell number
|
J:80503
|
| decreased osteoclast cell number
|
J:80503
|
Klkl/Klkl
(involves: C3H/J * C57BL/6J)
|
abnormal osteoclast morphology
|
J:56666
|
Klkl/Klkl
Tnfrsf11btm1Khs/Tnfrsf11b+
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
decreased B cell number
|
J:80503
|
Klf2tm1Mlkn/Klf2tm1Mlkn
Tg(VAV1-cre)1Graf/0
(Not Specified)
|
absent T cells
|
J:127228
|
Klf2tm2Ling/Klf2tm2Ling
Lyz2tm1(cre)Ifo/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased Ly6C low monocyte number
|
J:239509
|
Klf2tm2Ling/Klf2tm2Ling
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:151604
|
| decreased T cell number
|
J:151604
|
| increased single-positive T cell number
|
J:151604
|
Klf4tm1Khk/Klf4tm1Khk
Lyz2tm1(cre)Ifo/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased Ly6C low monocyte number
|
J:239509
|
Klf13tm1Coll/Klf13tm1Coll
(involves: 129S/SvEv)
|
decreased lymphocyte cell number
|
J:136545
|
Klf13tm1Kren/Klf13tm1Kren
(B6.129-Klf13tm1Kren)
|
abnormal T cell number
|
J:145839
|
| decreased thymocyte number
|
J:145839
|
| increased double-positive T cell number
|
J:145839
|
| increased thymocyte number
|
J:145839
|
Klf15tm1Jain/Klf15tm1Jain
(involves: 129X1/SvJ)
|
increased macrophage cell number
|
J:203920
|
Klhdc2tm1b(EUCOMM)Hmgu/Klhdc2+
(C57BL/6N-Klhdc2tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
Klhdc7bem1(IMPC)H/Klhdc7bem1(IMPC)H
(C57BL/6N-Klhdc7bem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Klhl6m1Anu/Klhl6m1Anu
(C57BL/6JAnu-Klhl6m1Anu)
|
decreased B cell number
|
J:104190
|
| decreased mature B cell number
|
J:104190
|
| increased immature B cell number
|
J:104190
|
Klhl6m1Btlr/Klhl6m1Btlr
(C57BL/6J-Klhl6m1Btlr)
|
decreased B cell number
|
J:265167
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:265167
|
| increased B-1b cell number
|
J:265167
|
| increased CD4-positive, alpha-beta T cell number
|
J:265167
|
| increased single-positive T cell number
|
J:265167
|
| increased T cell number
|
J:265167
|
Klhl6m2Btlr/Klhl6m2Btlr
(C57BL/6J-Klhl6m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:265168
|
| increased CD4-positive, alpha-beta T cell number
|
J:265168
|
| increased single-positive T cell number
|
J:265168
|
| increased T cell number
|
J:265168
|
Klhl6M3Btlr/Klhl6M3Btlr
(C57BL/6J-Klhl6M3Btlr)
|
increased alpha-beta T cell number
|
J:267699
|
| increased B-1a cell number
|
J:267699
|
| increased CD4-positive, alpha-beta T cell number
|
J:267699
|
| increased CD8-positive, alpha-beta T cell number
|
J:267699
|
Klhl6m4Btlr/Klhl6m4Btlr
(C57BL/6J-Klhl6m4Btlr)
|
increased B-1 B cell number
|
J:272394
|
Klhl6M5Btlr/Klhl6M5Btlr
(C57BL/6J-Klhl6M5Btlr)
|
increased B-1 B cell number
|
J:272395
|
Klhl6m6Btlr/Klhl6m6Btlr
(C57BL/6J-Klhl6m6Btlr)
|
increased alpha-beta T cell number
|
J:272396
|
| increased CD4-positive, alpha-beta T cell number
|
J:272396
|
Klhl6M7Btlr/Klhl6M7Btlr
(C57BL/6J-Klhl6M7Btlr)
|
abnormal B cell differentiation
|
J:272397
|
Klhl6M8Btlr/Klhl6M8Btlr
(C57BL/6J-Klhl6M8Btlr)
|
decreased B cell number
|
J:274963
|
| increased CD4-positive, alpha-beta T cell number
|
J:274963
|
| increased T cell number
|
J:274963
|
Klhl6tm1Sato/Klhl6tm1Sato
(either: (involves: 129T2/SvEms) or (involves: BALB/c) or (involves: CD-1))
|
abnormal B cell differentiation
|
J:101363
|
| decreased B cell number
|
J:101363
|
| decreased follicular B cell number
|
J:101363
|
Klhl14tm1.1Jyw/Klhl14+
(involves: C57BL/6)
|
decreased B-1a cell number
|
J:263511
|
| increased B-1b cell number
|
J:263511
|
Klhl29tm1b(EUCOMM)Hmgu/Klhl29+
(C57BL/6N-Klhl29tm1b(EUCOMM)Hmgu/Ics)
|
increased large unstained cell number
|
J:211773
|
Klk8em1(IMPC)Ccpcz/Klk8em1(IMPC)Ccpcz
(C57BL/6N-Klk8em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
Klrb1tm1b(EUCOMM)Wtsi/Klrb1tm1b(EUCOMM)Wtsi
(C57BL/6N-Klrb1tm1b(EUCOMM)Wtsi/Ieg)
|
increased follicular B cell number
|
J:211773
|
Klrc1tm1Mmka/Klrc1tm1Mmka
(B6.129-Klrc1tm1Mmka)
|
decreased CD8-positive, alpha-beta T cell number
|
J:222503
|
Klrk1tm1.1Bpol/Klrk1tm1.1Bpol
(C57BL/6-Klrk1tm1.1Bpol)
|
abnormal NK cell differentiation
|
J:151878
|
| decreased B cell number
|
J:151878
|
| decreased T cell number
|
J:151878
|
Klrk1tm2.1Bpol/Klrk1tm2.1Bpol
(Not Specified)
|
abnormal NK cell differentiation
|
J:215590
|
Kmt2atm1(AFF1)Ksy/Kmt2a+
(involves: 129S1/Sv * C57BL/6 * FVB)
|
abnormal lymphocyte morphology
|
J:110241
|
| increased monocyte cell number
|
J:110241
|
| increased pro-B cell number
|
J:110241
|
Kmt2atm1Brad/Kmt2atm1Brad
Commd10Tg(Vav1-icre)A2Kio/?
(involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased pre-B cell number
|
J:149811
|
Kmt2atm1Sjk/Kmt2a+
(involves: 129S2/SvPas * C3H * C57BL/6)
|
decreased B cell number
|
J:29958
|
Kmt2atm2(MLLT3)Thr/Kmt2atm2(MLLT3)Thr
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
increased pro-B cell number
|
J:110241
|
Kmt2dtm1.1Kaig/Kmt2d+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased germinal center B cell number
|
J:228913
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:228913
|
| decreased B cell number
|
J:228913
|
| decreased follicular B cell number
|
J:228913
|
| decreased mature B cell number
|
J:228913
|
| increased germinal center B cell number
|
J:228913
|
Kmt2etm1.1Hjf/Kmt2e+
(B6.129P2-Kmtetm1.1Hjf)
|
decreased thymocyte number
|
J:145579
|
Kmt2etm1.1Hjf/Kmt2etm1.1Hjf
(B6.129P2-Kmtetm1.1Hjf)
|
abnormal lymphopoiesis
|
J:145579
|
| decreased B cell number
|
J:145579
|
| decreased double-negative T cell number
|
J:145579
|
| decreased double-positive T cell number
|
J:145579
|
| decreased macrophage cell number
|
J:145579
|
| decreased pre-B cell number
|
J:145579
|
| decreased pro-B cell number
|
J:145579
|
| decreased T cell number
|
J:145579
|
| decreased thymocyte number
|
J:145579
|
Kmt2etm1Nik/Kmt2etm1Nik
(B6.Cg-Kmtetm1Nik)
|
decreased NK cell number
|
J:145449
|
| decreased NK T cell number
|
J:145449
|
Kmt5btm1Jnw/Kmt5btm1Jnw
Kmt5ctm1.1Jnw/Kmt5ctm1.1Jnw
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129/Sv * C57BL/6J * C57BL/10 * CBA/Ca)
|
abnormal class switch recombination
|
J:139510
|
| abnormal lymphopoiesis
|
J:139510
|
| decreased B cell number
|
J:139510
|
| decreased double-positive T cell number
|
J:139510
|
Knl1tm1c(EUCOMM)Hmgu/Knl1tm1c(EUCOMM)Hmgu
Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)
|
microgliosis
|
J:278483
|
Krastm4.1Bbd/Krastm4.1Bbd
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:223433
|
Krastm4Tyj/Kras+
(involves: 129S4/SvJae)
|
increased regulatory T cell number
|
J:154046
|
Krastm4Tyj/Kras+
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:247853
|
| decreased double-negative T cell number
|
J:247853
|
| decreased double-positive T cell number
|
J:247853
|
| decreased T cell number
|
J:247853
|
| increased monocyte cell number
|
J:247853
|
Krastm4Tyj/Kras+
Pggt1btm1Mbrg/Pggt1b+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased lymphocyte cell number
|
J:122107
|
Krastm4Tyj/Kras+
Stk11tm1.2Rdp/Stk11tm1.2Rdp
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
increased macrophage cell number
|
J:197037
|
Krastm4Tyj/Kras+
Tg(MUC1)79.24Gend/0
(involves: 129S4/SvJae * C57BL/6)
|
increased regulatory T cell number
|
J:154046
|
Krastm4Tyj/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased monocyte cell number
|
J:87429
|
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
(B6.129-Krastm4Tyj Tgfbr2tm1.2Hlm)
|
increased B cell number
|
J:177379
|
| increased T cell number
|
J:177379
|
Krt27em1(IMPC)Ccpcz/Krt27em1(IMPC)Ccpcz
(C57BL/6N-Krt27em1(IMPC)Ccpcz/Ccpcz)
|
increased CD8-positive, alpha-beta T cell number
|
J:211773
|
Krtap8-1em1(IMPC)Ccpcz/Krtap8-1em1(IMPC)Ccpcz
(C57BL/6N-Krtap8-1em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
Ksr1tm1Shaw/Ksr1tm1Shaw
Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:75739
|
Lacc1tm1a(KOMP)Wtsi/Lacc1tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
abnormal macrophage morphology
|
J:244365
|
Lag3tm1Daav/Lag3tm1Daav
Tg(Foxp3-EGFP/cre)1cJbs/0
(NOD.Cg-Lag3tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)
|
abnormal effector T cell number
|
J:260063
|
Lag3tm1Doi/Lag3tm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:89653
|
| increased CD8-positive, alpha-beta T cell number
|
J:89653
|
| increased single-positive T cell number
|
J:89653
|
Lair1tm1.1Jco/Lair1tm1.1Jco
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:180203
|
| decreased CD8-positive, alpha-beta T cell number
|
J:180203
|
| decreased thymocyte number
|
J:180203
|
| increased activated T cell number
|
J:180203
|
| increased B cell number
|
J:180203
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:180203
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:180203
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:180203
|
| increased marginal zone B cell number
|
J:180203
|
Lama2tm1Stk/Lama2tm1Stk
(involves: 129P2/OlaHsd * BALB/c)
|
decreased double-positive T cell number
|
J:61802
|
| decreased T cell number
|
J:61802
|
Lama3tm1.1Grsb/Lama3tm1.1Grsb
(involves: C57BL/6)
|
increased alveolar macrophage number
|
J:235712
|
Lama5tm1Lsor/Lama5tm1Lsor
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
decreased marginal zone B cell number
|
J:198783
|
| decreased transitional stage T2 B cell number
|
J:198783
|
| increased B cell number
|
J:198783
|
| increased transitional stage T1 B cell number
|
J:198783
|
Lamp1em1(IMPC)Mbp/Lamp1em1(IMPC)Mbp
(C57BL/6N-Lamp1em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
Lamp3em1Damme/Lamp3em1Damme
(involves: C57BL/6N)
|
increased macrophage cell number
|
J:324174
|
Lancl2tm2a(KOMP)Wtsi/Lancl2tm2a(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased macrophage cell number
|
J:250673
|
| decreased regulatory T cell number
|
J:250673
|
Lancl2tm2c(KOMP)Wtsi/Lancl2tm2c(KOMP)Wtsi
Lyz2tm1(cre)Ifo/Lyz2+
(involves: C57BL/6N)
|
decreased macrophage cell number
|
J:250673
|
| decreased regulatory T cell number
|
J:250673
|
Lat2tm2Wz/Lat2tm2Wz
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6)
|
increased activated T cell number
|
J:116157
|
Lat2tm3.1Wz/Lat2tm3.1Wz
(B6.Cg-Lat2tm3.1Wz)
|
increased memory T cell number
|
J:181866
|
Lattm1.1Lov/Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:116157,
J:77099
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:77099
|
| abnormal double-negative T cell morphology
|
J:77099
|
| abnormal T cell differentiation
|
J:77099
|
| decreased double-positive T cell number
|
J:77099
|
| decreased thymocyte number
|
J:77099
|
| increased activated T cell number
|
J:77099
|
Lattm1.1Lov/Lattm1.1Lov
Lat2tm1Wz/Lat2tm1Wz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:116157
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell differentiation
|
J:77098
|
| abnormal lymphocyte morphology
|
J:77098
|
| abnormal T cell selection
|
J:77098
|
| abnormal T cell subpopulation ratio
|
J:77098
|
| decreased double-positive T cell number
|
J:77098
|
| increased B cell number
|
J:77098
|
| increased CD4-positive, alpha-beta T cell number
|
J:125722,
J:77098
|
| increased memory T cell number
|
J:77098
|
| increased plasma cell number
|
J:125722
|
| increased T-helper 2 cell number
|
J:77098
|
Lattm1Bpay/Lattm1Bpay
(involves: 129S2/SvPas)
|
abnormal T cell differentiation
|
J:103904
|
| arrested T cell differentiation
|
J:103904
|
| decreased double-negative T cell number
|
J:103904
|
| decreased T cell number
|
J:103904
|
| decreased thymocyte number
|
J:103904
|
Lattm1Les/Lattm1.1Wz
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:147946
|
Lattm1Les/Lattm1.1Wz
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal effector T cell morphology
|
J:147946
|
| abnormal T cell differentiation
|
J:147946
|
| decreased CD4-positive, alpha-beta T cell number
|
J:147946
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147946
|
| decreased regulatory T cell number
|
J:147946
|
| decreased thymocyte number
|
J:147946
|
| increased double-positive T cell number
|
J:147946
|
| increased gamma-delta T cell number
|
J:147946
|
Lattm1Les/Lattm1.2Wz
(involves: C57BL/6 * FVB/N)
|
absent T cells
|
J:147946
|
| arrested T cell differentiation
|
J:147946
|
Lattm1Les/Lattm1Les
(Not Specified)
|
abnormal T cell morphology
|
J:54059
|
| arrested T cell differentiation
|
J:116964,
J:54059
|
| decreased double-negative T cell number
|
J:54059
|
| decreased T cell number
|
J:54059
|
| decreased thymocyte number
|
J:54059
|
Lattm1Les/Lattm1Les
Lcp2tm5(Lat/Lcp2)Gak/Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:147721
|
| decreased double-positive T cell number
|
J:147721
|
Lattm1Les/Lattm1Les
Tg(CD2-LAT2)1Wz/0
(Not Specified)
|
abnormal single-positive T cell number
|
J:116964
|
| abnormal T cell differentiation
|
J:116964
|
| decreased double-positive T cell number
|
J:116964
|
Lattm2.1Lov/Lattm2.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:77695
|
| decreased T cell number
|
J:77695
|
Lattm2.1Mal/Lattm2.1Mal
(involves: 129S2/SvPas)
|
abnormal B cell differentiation
|
J:94074
|
| abnormal gamma-delta T cell differentiation
|
J:94074
|
| abnormal lymphocyte morphology
|
J:94074
|
| abnormal lymphopoiesis
|
J:94074
|
| abnormal mature gamma-delta T cell morphology
|
J:94074
|
| abnormal plasma cell morphology
|
J:94074
|
| abnormal T-helper 2 cell morphology
|
J:94074
|
| absent CD4-positive, alpha-beta T cells
|
J:94074
|
| absent CD8-positive, alpha-beta T cells
|
J:94074
|
| arrested T cell differentiation
|
J:94074
|
| decreased double-positive T cell number
|
J:94074
|
| increased B cell number
|
J:94074
|
| increased mature gamma-delta T cell number
|
J:94074
|
Lattm3.1Mal/Lattm3.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell differentiation
|
J:94074
|
| absent CD4-positive, alpha-beta T cells
|
J:94074
|
| absent CD8-positive, alpha-beta T cells
|
J:94074
|
| absent mature gamma-delta T cells
|
J:94074
|
| arrested T cell differentiation
|
J:94074
|
| decreased double-positive T cell number
|
J:94074
|
| decreased T cell number
|
J:94074
|
| increased T cell number
|
J:94074
|
Lattm4.1Mal/Lattm4.1Mal
(involves: 129P2/OlaHsd)
|
abnormal gamma-delta T cell differentiation
|
J:94074
|
| abnormal lymphocyte morphology
|
J:94074
|
| absent CD4-positive, alpha-beta T cells
|
J:94074
|
| absent CD8-positive, alpha-beta T cells
|
J:94074
|
| absent mature gamma-delta T cells
|
J:94074
|
| arrested T cell differentiation
|
J:94074
|
| decreased double-positive T cell number
|
J:94074
|
| decreased T cell number
|
J:94074
|
Lattm4.1Mal/Lattm4.1Mal
Tg(Lck*F505)3073Rmp/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased CD4-positive, alpha-beta T cell number
|
J:151840
|
Lattm4.1Mal/Lattm4.1Mal
Trdctm1Mal/Trdctm1Mal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112658
|
Lattm5.1Mal/Lattm5.1Mal
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:152363
|
Lattm8.1(CD2,-ECFP)Mal/Lattm8.1(CD2,-ECFP)Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal lymphocyte morphology
|
J:152149
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:152149
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:152149
|
| arrested T cell differentiation
|
J:152149
|
| increased double-negative T cell number
|
J:152149
|
Lattm9Mal/Lattm9Mal
(involves: C57BL/6)
|
abnormal B cell number
|
J:205441
|
| abnormal lymphopoiesis
|
J:205441
|
| increased T-helper 2 cell number
|
J:205441
|
Lbrem1(IMPC)Tcp/Lbrem1(IMPC)Tcp
(C57BL/6N-Lbrem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
LbrGt(XE569)Byg/LbrGt(XE569)Byg
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
abnormal lymphocyte morphology
|
J:138854
|
Lbric-J/Lbric-J
(C57BL/6J-Lbric-J)
|
abnormal lymphocyte morphology
|
J:80915
|
Lbric-J/Lbrlym3
(C57BL/6-Lbric-J/Lbrlym3)
|
decreased lymphocyte cell number
|
J:180355
|
Lbrlym3/Lbrlym3
(C57BL/6-Lbrlym3)
|
abnormal lymphocyte cell number
|
J:180355
|
| abnormal lymphocyte morphology
|
J:180355
|
| decreased B cell number
|
J:180355
|
| decreased CD4-positive, alpha-beta T cell number
|
J:180355
|
| decreased CD8-positive, alpha-beta T cell number
|
J:180355
|
| decreased lymphocyte cell number
|
J:180355
|
| decreased T cell number
|
J:180355
|
Lckm1Btlr/Lckm1Btlr
(C57BL/6J-Lckm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:144695
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:144695
|
| decreased CD4-positive, alpha-beta T cell number
|
J:144695
|
| decreased CD8-positive, alpha-beta T cell number
|
J:144695
|
Lckm2Btlr/Lckm2Btlr
(C57BL/6J-Lckm2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:203759
|
| decreased CD8-positive, alpha-beta T cell number
|
J:203759
|
Lckm3Btlr/Lckm3Btlr
(C57BL/6J-Lckm3Btlr)
|
abnormal T cell subpopulation ratio
|
J:217863
|
| decreased single-positive T cell number
|
J:217863
|
| increased activated T cell number
|
J:217863
|
| increased single-positive T cell number
|
J:217863
|
Lcktm1.1Litt/Lcktm1.1Litt
(Not Specified)
|
abnormal lymphocyte morphology
|
J:152472
|
Lcktm1Dbs/Lcktm1Dbs
(involves: C3H * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:114660
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:114660
|
| abnormal double-negative T cell morphology
|
J:114660
|
| abnormal T cell differentiation
|
J:114660
|
| decreased T cell number
|
J:114660
|
| decreased thymocyte number
|
J:114660
|
Lcktm1Dbs/Lcktm1Dbs
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C3H * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:114660
|
| abnormal T cell differentiation
|
J:114660
|
| arrested T cell differentiation
|
J:114660
|
Lcktm1Dbs/Lcktm1Dbs
Tg(TcraTcrb)425Cbn/0
(involves: C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:114660
|
| arrested T cell differentiation
|
J:114660
|
Lcktm1Dbs/Lcktm1Dbs
Tg(TcraTcrb)1100Mjb/0
(involves: C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:114660
|
Lcktm1Litt/Lcktm1.1Litt
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ)
|
decreased regulatory T cell number
|
J:152472
|
| increased regulatory T cell number
|
J:152472
|
| increased T cell number
|
J:152472
|
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:112977
|
| abnormal double-negative T cell morphology
|
J:110847
|
| abnormal lymphocyte morphology
|
J:1119
|
| abnormal single-positive T cell number
|
J:37062
|
| abnormal T cell morphology
|
J:110847
|
| decreased CD4-positive, alpha-beta T cell number
|
J:37940
|
| decreased CD8-positive, alpha-beta T cell number
|
J:37940
|
| decreased double-positive T cell number
|
J:1119,
J:110847
|
| decreased gamma-delta intraepithelial T cell number
|
J:112977,
J:37940
|
| decreased gamma-delta T cell number
|
J:37062
|
| decreased T cell number
|
J:1119,
J:37062
|
| decreased thymocyte number
|
J:1119
|
Lcktm1Mak/Lcktm1Mak
(B6.129S2-Lcktm1Mak)
|
abnormal intraepithelial T cell morphology
|
J:111646
|
| abnormal intraepithelial T cell number
|
J:111646
|
| abnormal T cell differentiation
|
J:111646
|
| decreased gamma-delta intraepithelial T cell number
|
J:111646
|
Lcktm1Mak/Lcktm1Mak
Rag1tm1Mom/Rag1+
Tg(Lck-Fyn*Y528F)5525Cjg/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:37062
|
| decreased T cell number
|
J:37062
|
Lcn2tm1Mrgr/Lcn2tm1Mrgr
(129(B6)-Lcn2tm1Mrgr)
|
increased B cell number
|
J:173490
|
| increased lymphocyte cell number
|
J:173490
|
| increased macrophage cell number
|
J:173490
|
| increased monocyte cell number
|
J:173490
|
Lcp2tm1.1Wz/Lcp2tm1.1Wz
(B6.Cg-Lcp2tm1.1Wz)
|
abnormal effector T cell morphology
|
J:150304
|
| abnormal T cell differentiation
|
J:150304
|
| abnormal T cell subpopulation ratio
|
J:150304
|
| decreased CD4-positive, alpha-beta T cell number
|
J:150304
|
| decreased CD8-positive, alpha-beta T cell number
|
J:150304
|
| decreased double-negative T cell number
|
J:150304
|
| decreased T cell number
|
J:150304
|
| decreased thymocyte number
|
J:150304
|
| increased double-negative T cell number
|
J:150304
|
Lcp2tm1.1Wz/Lcp2tm1.1Wz
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:150304
|
Lcp2tm1Geha/Lcp2tm1Geha
(involves: 129S4/SvJae)
|
increased NK cell number
|
J:131621
|
Lcp2tm2Gak/Lcp2tm2Gak
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:107467
|
| increased CD8-positive, alpha-beta T cell number
|
J:107467
|
| increased gamma-delta T cell number
|
J:107467
|
Lcp2tm3Gak/Lcp2tm3Gak
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:132995
|
| abnormal negative T cell selection
|
J:132995
|
| abnormal T cell subpopulation ratio
|
J:132995
|
| decreased NK T cell number
|
J:132995
|
Lcp2tm3Gak/Lcp2tm3Gak
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:132995
|
Lcp2tm3Gak/Lcp2tm3Gak
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2J)
|
abnormal negative T cell selection
|
J:132995
|
| increased CD8-positive, alpha-beta T cell number
|
J:132995
|
| increased double-positive T cell number
|
J:132995
|
Lcp2tm3Gak/Lcp2tm3Gak
Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal double-negative T cell morphology
|
J:132995
|
| abnormal negative T cell selection
|
J:132995
|
| abnormal T cell subpopulation ratio
|
J:132995
|
| decreased NK T cell number
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
abnormal negative T cell selection
|
J:132995
|
| increased double-positive T cell number
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:132995
|
Lcp2tm5(Lat/Lcp2)Gak/Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:147721
|
| decreased double-positive T cell number
|
J:147721
|
| decreased single-positive T cell number
|
J:147721
|
Lcp2twm/Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu)
|
abnormal double-positive T cell morphology
|
J:104190
|
| abnormal negative T cell selection
|
J:104190
|
| abnormal positive T cell selection
|
J:104190
|
| arrested T cell differentiation
|
J:104190
|
| decreased T cell number
|
J:104190
|
| decreased thymocyte number
|
J:104190
|
Lctlp1DBA/1J/Lctlp1DBA/1J
(involves: DBA/1J * FVB/NJ)
|
increased CD8-positive, alpha-beta T cell number
|
J:122919
|
Lctlp1DBA/1J/Lctlp1FVB/NJ
(involves: DBA/1J * FVB/NJ)
|
increased CD8-positive, alpha-beta T cell number
|
J:122919
|
Lctlp2DBA/1J/Lctlp2DBA/1J
(involves: DBA/1J * FVB/NJ)
|
increased CD8-positive, alpha-beta T cell number
|
J:122919
|
Lctlp2DBA/1J/Lctlp2FVB/NJ
(involves: DBA/1J * FVB/NJ)
|
increased CD8-positive, alpha-beta T cell number
|
J:122919
|
Ldb3tm2b(EUCOMM)Hmgu/Ldb3+
(C57BL/6N-Ldb3tm2b(EUCOMM)Hmgu/Bay)
|
increased large unstained cell number
|
J:211773
|
LdlrHlb301/Ldlr+
(C57BL/6J-LdlrHlb301/J)
|
increased macrophage derived foam cell number
|
J:82961
|
LdlrHlb301/LdlrHlb301
(C57BL/6J-LdlrHlb301/J)
|
increased macrophage derived foam cell number
|
J:82961
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal microglial cell morphology
|
J:116493
|
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her)
|
abnormal microglial cell morphology
|
J:137264
|
Ldlrtm1Her/Ldlrtm1Her
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal macrophage derived foam cell morphology
|
J:142788
|
| decreased macrophage cell number
|
J:142788
|
Ldlrad4tm1b(EUCOMM)Wtsi/Ldlrad4tm1b(EUCOMM)Wtsi
(C57BL/6N-Ldlrad4tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased monocyte cell number
|
J:211773
|
Lect2tm1Ymg/Lect2tm1Ymg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased T cell number
|
J:90961
|
Lef1tm1.1(KOMP)Vlcg/Lef1+
(C57BL/6N-Lef1tm1.1(KOMP)Vlcg/Ucd)
|
increased monocyte cell number
|
J:211773
|
Lef1tm1Hhx/Lef1tm1Hhx
Tcf7tm1Cle/Tcf7tm1Cle
Gt(ROSA)26Sortm2Sho/Gt(ROSA)26Sor+
Tg(GZMB-cre)1Jcb/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:189838
|
Lepm1Yst/Lepm1Yst
(C57BL/6J-Lepm1Yst)
|
increased macrophage cell number
|
J:167736
|
Lepob/Lepob
(involves: C57BL/6J)
|
abnormal osteoclast differentiation
|
J:60001
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
decreased NK cell number
|
J:117826
|
Lepob/Lepob
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:164339
|
Leprdb-5J/Leprdb-5J
(NOD/ShiLt-Leprdb-5J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:118304
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:118304
|
Leprdb/Leprdb
(involves: C57BL/6)
|
abnormal osteoclast differentiation
|
J:60001
|
Leprm8Btlr/Leprm8Btlr
(C57BL/6J-Leprm8Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:267679
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267679
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:267679
|
Leprtm1b(EUCOMM)Wtsi/Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Leprtm4Mgmj/Leprtm4Mgmj
(B6.Cg-Leprtm4Mgmj)
|
decreased CD4-positive, alpha-beta T cell number
|
J:164339
|
Lgals2tm1.1Cfg/Lgals2tm1.1Cfg
(involves: C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:217719
|
| increased CD8-positive, alpha-beta T cell number
|
J:217719
|
| increased lymphocyte cell number
|
J:217719
|
| increased T cell number
|
J:217719
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(B6.129S2-Lgals3tm1Ftl)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:109126
|
| decreased macrophage cell number
|
J:109126
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal monocyte morphology
|
J:60741
|
| decreased lymphocyte cell number
|
J:60741
|
| decreased macrophage cell number
|
J:313172,
J:60741
|
| decreased monocyte cell number
|
J:60741
|
Lgals9tm1.1Cfg/Lgals9tm1.1Cfg
(involves: C57BL/6)
|
increased lymphocyte cell number
|
J:217719
|
Lgals9tm1Glp/Lgals9tm1Glp
(B6.129S6-Lgals9tm1Glp)
|
decreased regulatory T cell number
|
J:132889
|
| increased T-helper 1 cell number
|
J:132889
|
Lgmntm1Ihn/Lgmntm1Ihn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:143886
|
Lgr5em1(IMPC)Kmpc/Lgr5+
(C57BL/6NTac-Lgr5em1(IMPC)Kmpc/Kmpc)
|
increased CD4-negative, CD25-positive NK T cell number
|
J:211773
|
| increased CD8-positive, CD25-positive alpha-beta T cell number
|
J:211773
|
Lgr6em1(IMPC)Ccpcz/Lgr6em1(IMPC)Ccpcz
(C57BL/6NCrl-Lgr6em1(IMPC)Ccpcz/Ccpcz)
|
increased lymphocyte cell number
|
J:211773
|
Lhcgrtm1(KOMP)Vlcg/Lhcgrtm1(KOMP)Vlcg
(C57BL/6N-Lhcgrtm1(KOMP)Vlcg/Nju)
|
increased lymphocyte cell number
|
J:211773
|
Liftm1Cgre/Liftm1Cgre
(involves: MF1)
|
abnormal macrophage morphology
|
J:96965
|
| increased uterine NK cell number
|
J:96965
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * MF1)
|
abnormal osteoclast differentiation
|
J:137646
|
| abnormal osteoclast morphology
|
J:137646
|
| increased osteoclast cell number
|
J:137646
|
Lifrtm1Imx/Lifrtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd * C57BL/6)
|
increased osteoclast cell number
|
J:25253
|
Lig4m1Btlr/Lig4m1Btlr
(C57BL/6J-Lig4m1Btlr)
|
decreased B cell number
|
J:267684
|
| decreased CD4-positive, alpha-beta T cell number
|
J:267684
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:267684
|
| increased CD8-positive, alpha-beta T cell number
|
J:267684
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:267684
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267684
|
| increased NK cell number
|
J:267684
|
Lig4m2Btlr/Lig4m2Btlr
(C57BL/6J-Lig4m2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:267692
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267692
|
Lig4tiny/Lig4tiny
(C57BL/6-Lig4tiny)
|
absent CD8-positive, alpha-beta T cells
|
J:104190
|
| decreased B cell number
|
J:122725
|
| decreased lymphocyte cell number
|
J:122725
|
Lig4tm1Fwa/Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:50865
|
| abnormal lymphopoiesis
|
J:50865
|
| abnormal T cell differentiation
|
J:63078
|
| arrested B cell differentiation
|
J:63078
|
| arrested T cell differentiation
|
J:50865
|
| decreased thymocyte number
|
J:63078
|
Lig4tm1Fwa/Lig4tm1Fwa
Tg(Cr2-cre)3Cgn/0
Xrcc4tm2Fwa/Xrcc4tm2Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
Lig4tm1Fwa/Lig4tm1Fwa
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:63078
|
| increased B cell number
|
J:63078
|
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:157574
|
| abnormal lymphocyte cell number
|
J:157574
|
| abnormal regulatory T cell morphology
|
J:157574
|
| abnormal T cell differentiation
|
J:157574
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:157574
|
| abnormal T cell receptor V(D)J recombination
|
J:157574
|
| decreased B cell number
|
J:157574
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157574
|
| decreased CD8-positive, alpha-beta T cell number
|
J:157574
|
| decreased double-negative T cell number
|
J:157574
|
| decreased double-positive T cell number
|
J:157574
|
| decreased thymocyte number
|
J:157574
|
Lig4tm3.1Fwa/Lig4tm3.1Fwa
Tg(Cr2-cre)3Cgn/0
(Not Specified)
|
abnormal class switch recombination
|
J:157537
|
Lilrb4atm1Eol/Lilrb4atm1Eol
(B6.129P2-Lilrb4atm1Eol)
|
increased macrophage cell number
|
J:129969
|
| increased plasma cell number
|
J:129969
|
Limd1tm1Gdl/Limd1tm1Gdl
(involves: 129X1/SvJ)
|
abnormal osteoclast cell number
|
J:118130
|
Lime1tm1.1Mal/Lime1tm1.1Mal
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)1Pas/?
(B6.Cg-Rag2tm1Fwa Lime1tm1.1Mal Tg(TcraH-Y,TcrbH-Y)1Pas)
|
abnormal CD4-positive T cell differentiation
|
J:126321
|
| increased CD4-positive, alpha-beta T cell number
|
J:126321
|
Lipatm1Ggb/Lipatm1Ggb
(involves: 129P2/OlaHsd * CF-1)
|
abnormal alveolar macrophage morphology
|
J:101217
|
| abnormal Kupffer cell morphology
|
J:68812
|
Litaftm1.1Ics/Litaftm1.1Ics
(Not Specified)
|
increased macrophage cell number
|
J:186411
|
ll/ll
X/Yaa
(BXSB/MpJScr-ll)
|
abnormal monocyte morphology
|
J:10973
|
| decreased CD4-positive, alpha-beta T cell number
|
J:10973
|
Lmb1C57BL/6Scr/Lmb1C57BL/6Scr
(MRL.Cg-Lmb1C57BL/6Scr Faslpr)
|
increased CD8-positive, alpha-beta T cell number
|
J:125557
|
| increased double-negative T cell number
|
J:125557
|
Lmb2MRL/MpScr/Lmb2MRL/MpScr
(B6.MRL-Lmb2MRL/MpScr Faslpr)
|
decreased double-negative T cell number
|
J:125557
|
Lmbr1lem1Btlr/Lmbr1lem1Btlr
(C57BL/6J-Lmbr1lem1Btlr)
|
abnormal alpha-beta T cell morphology
|
J:274568
|
| abnormal B cell differentiation
|
J:274568
|
| abnormal lymphocyte morphology
|
J:274568
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274568
|
| decreased lymphocyte cell number
|
J:274568
|
| decreased monocyte cell number
|
J:274568
|
| decreased T cell number
|
J:274568
|
Lmbr1lm1Btlr/Lmbr1lm1Btlr
(C57BL/6J-Lmbr1lm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274568
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274568
|
| abnormal T cell differentiation
|
J:274568
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274568
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274568
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274568
|
| decreased NK cell number
|
J:274568
|
| decreased NK T cell number
|
J:274568
|
| decreased T cell number
|
J:274568
|
| increased B-1 B cell number
|
J:274568
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274568
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274568
|
| increased macrophage cell number
|
J:274568
|
Lmbr1lm2Btlr/Lmbr1lm2Btlr
(C57BL/6J-Lmbr1lm2Btlr)
|
increased central memory CD4-positive, alpha-beta T cell number
|
J:274857
|
LmnaDhe/Lmna+
(B6(D2)-LmnaDhe/TyGrsrJ)
|
abnormal peritoneal macrophage morphology
|
J:188496
|
Lmo2tm2(cre)Thr/Lmo2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased monocyte cell number
|
J:155870
|
Lmo4tm1Slp/Lmo4tm1Slp
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
Lmo4tm1Slp/Lmo4tm1Slp
Yeats4em1Zfa/Yeats4em1Zfa
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
Lnx1tm1Lex/Lnx1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased B-1b cell number
|
J:171883
|
Loxtm1.1Khki/Loxtm1.1Khki
(involves: C57BL/6)
|
increased lymphocyte cell number
|
J:264295
|
Lpin3tm1b(KOMP)Wtsi/Lpin3tm1b(KOMP)Wtsi
(C57BL/6N-Lpin3tm1b(KOMP)Wtsi/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Lpxntm1b(EUCOMM)Hmgu/Lpxntm1b(EUCOMM)Hmgu
(C57BL/6N-Lpxntm1b(EUCOMM)Hmgu/Wtsi)
|
abnormal plasma cell differentiation
|
J:305662
|
Lratd2em1(IMPC)Ccpcz/Lratd2em1(IMPC)Ccpcz
(C57BL/6N-Lratd2em1(IMPC)Ccpcz/Ccpcz)
|
increased B-2 B cell number
|
J:211773
|
LrbaGt(OST69142)Lex/LrbaGt(OST69142)Lex
(involves: 129 * 129S5/SvEvBrd)
|
increased regulatory T cell number
|
J:237187
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2+
(involves: C57BL/10 * CBA)
|
decreased T cell number
|
J:126456
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2Tg(CD2-Myb/en)5Kmw
(involves: C57BL/10 * CBA)
|
decreased CD8-positive, alpha-beta T cell number
|
J:126456
|
| decreased double-negative T cell number
|
J:126456
|
| decreased T cell number
|
J:126456
|
Lrfn2tm1.1Jaru/Lrfn2tm1.1Jaru
(B6.129P2(Cg)-Lrfn2tm1.1Jaru)
|
decreased lymphocyte cell number
|
J:301285
|
Lrp5tm1Grw/Lrp5tm1Grw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased osteoclast cell number
|
J:104382
|
Lrp12em1Gpt/Lrp12em1Gpt
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JGpt * DBA/2)
|
increased T cell number
|
J:338432
|
Lrrc3tm1b(EUCOMM)Hmgu/Lrrc3tm1b(EUCOMM)Hmgu
(C57BL/6N-Lrrc3tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Lrrc8atm1.1Geha/Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
abnormal B cell differentiation
|
J:211308
|
| abnormal T cell differentiation
|
J:211308
|
| abnormal T cell selection
|
J:211308
|
| decreased B cell number
|
J:211308
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211308
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211308
|
| decreased DN2 thymocyte number
|
J:211308
|
| decreased DN3 thymocyte number
|
J:211308
|
| decreased DN4 thymocyte number
|
J:211308
|
| decreased double-negative T cell number
|
J:211308
|
| decreased double-positive T cell number
|
J:211308
|
| decreased immature B cell number
|
J:211308
|
| decreased marginal zone B cell number
|
J:211308
|
| decreased pre-B cell number
|
J:211308
|
| decreased T cell number
|
J:211308
|
| decreased thymocyte number
|
J:211308
|
| decreased transitional stage B cell number
|
J:211308
|
| increased pro-B cell number
|
J:211308
|
| increased regulatory T cell number
|
J:211308
|
Lrrk1tm1.1Smo/Lrrk1tm1.1Smo
(involves: 129S/Sv)
|
increased osteoclast cell number
|
J:208677
|
Lrrk1tm1b(KOMP)Wtsi/Lrrk1tm1b(KOMP)Wtsi
(C57BL/6N-Lrrk1tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
Lrrk2tm1.1Cai/Lrrk2+
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: 129X1/SvJ * C57BL/6)
|
microgliosis
|
J:156512
|
Lrrk2tm1.1Cai/Lrrk2tm1.1Cai
(involves: 129X1/SvJ * C57BL/6)
|
microgliosis
|
J:156512
|
Lsp1tm1Jejb/Lsp1tm1Jejb
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphopoiesis
|
J:64219
|
| increased macrophage cell number
|
J:64219
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129)
|
decreased T cell number
|
J:31129
|
| increased B cell number
|
J:31129
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129)
|
decreased T cell number
|
J:31129
|
| increased B cell number
|
J:31129
|
Lta/Tnftm1Jods/Lta/Tnftm1Jods
(involves: C57BL/6)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
Lta/Tnftm1Jods/Lta/Tnftm1Jods
(involves: C57BL/6)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
Ltahlb382/Ltahlb382
(C57BL/6J-Ltahlb382/J)
|
absent marginal zone B cells
|
J:134498
|
| decreased NK cell number
|
J:134498
|
| decreased transitional stage B cell number
|
J:134498
|
| increased B-1b cell number
|
J:134498
|
Ltatm1.1(KOMP)Vlcg/Ltatm1.1(KOMP)Vlcg
(C57BL/6N-Ltatm1.1(KOMP)Vlcg/Ucd)
|
decreased monocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Ltatm1.1Sned/Ltatm1.1Sned
(B6.129-Ltatm1.1Sned)
|
abnormal class switch recombination
|
J:109621
|
| abnormal lymphopoiesis
|
J:109621
|
Ltatm1Dch/Ltatm1Dch
(B6.129S2-Ltatm1Dch)
|
abnormal class switch recombination
|
J:80616
|
Ltatm1Dch/Ltatm1Dch
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:109621
|
| decreased T cell number
|
J:17976
|
| increased B cell number
|
J:17976
|
Ltatm1Dch/Ltatm1Dch
(involves: 129S2/SvPas)
|
abnormal lymphocyte morphology
|
J:173115
|
Ltatm1Dch/Ltatm1Dch
Tnfsf14tm1Lpc/Tnfsf14tm1Lpc
(involves: 129S2/SvPas * 129X1/SvJ)
|
abnormal lymphocyte morphology
|
J:173115
|
Ltatm1Jods/Ltatm1Jods
(C57BL/6-Ltatm1Jods)
|
increased lymphocyte cell number
|
J:47428
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
Ltb/Tnftm1.1Dvk/Ltb/Tnftm1.1Dvk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
absent germinal center B cells
|
J:58981
|
Ltb/Tnftm1.1Dvk/Ltb/Tnftm1.1Dvk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
absent germinal center B cells
|
J:58981
|
Ltbtm1Kpf/Ltbtm1Kpf
(B6.129P2-Ltbtm1Kpf)
|
abnormal class switch recombination
|
J:80616
|
Ltbtm1Kpf/Ltbtm1Kpf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:42508
|
Ltbrm3Btlr/Ltbrm3Btlr
(C57BL/6J-Ltbrm3Btlr)
|
increased NK T cell number
|
J:264642
|
Ltbrm4Btlr/Ltbrm4Btlr
(C57BL/6J-Ltbrm4Btlr)
|
decreased alpha-beta T cell number
|
J:264820
|
| decreased CD4-positive, alpha-beta T cell number
|
J:264820
|
| decreased CD8-positive, alpha-beta T cell number
|
J:264820
|
| decreased NK cell number
|
J:264820
|
| decreased single-positive T cell number
|
J:264820
|
| increased B cell number
|
J:264820
|
| increased B-1 B cell number
|
J:264820
|
Ltbrtm1Kpf/Ltbrtm1Kpf
(involves: 129P2/OlaHsd)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
| absent marginal zone B cells
|
J:48837
|
| increased B cell number
|
J:48837
|
| increased lymphocyte cell number
|
J:48837
|
| increased T cell number
|
J:48837
|
Ltbrtm1Mmat/Ltbrtm1Mmat
(involves: C57BL/6 * CBA)
|
abnormal lymphocyte morphology
|
J:173115
|
Ltn1tm1b(EUCOMM)Hmgu/Ltn1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ltn1tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
Ly6atm1Pmf/Ly6atm1Pmf
(B6.129P2-Ly6atm1Pmf)
|
decreased monocyte cell number
|
J:81387
|
| increased lymphocyte cell number
|
J:81387
|
Ly6atm1Pmf/Ly6atm1Pmf
(C.129P2-Ly6atm1Pmf)
|
abnormal osteoclast differentiation
|
J:83409
|
| decreased osteoclast cell number
|
J:83409
|
Ly6etm1c(EUCOMM)Hmgu/Ly6etm1c(EUCOMM)Hmgu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio)
|
abnormal mononuclear cell morphology
|
J:291868
|
| decreased B cell number
|
J:291868
|
| decreased CD4-positive, alpha-beta T cell number
|
J:291868
|
| decreased macrophage cell number
|
J:291868
|
| decreased NK cell number
|
J:291868
|
Ly9tm1Mckn/Ly9tm1Mckn
(involves: 129/Sv * C57BL/6)
|
abnormal T-helper 2 cell morphology
|
J:105482
|
Ly75tm1Mnz/Ly75tm1Mnz
(Not Specified)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:97290
|
Ly86tm1a(KOMP)Wtsi/Ly86+
(C57BL/6N-Ly86tm1a(KOMP)Wtsi/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
Ly86tm1a(KOMP)Wtsi/Ly86tm1a(KOMP)Wtsi
(C57BL/6N-Ly86tm1a(KOMP)Wtsi/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
Lyg1tm1(KOMP)Vlcg/Lyg1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:256594
|
| decreased CD8-positive, alpha-beta T cell number
|
J:256594
|
Lyl1tm1Fsky/Lyl1tm1Fsky
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:116300
|
| arrested B cell differentiation
|
J:116300
|
| decreased B cell number
|
J:116300
|
| decreased pro-B cell number
|
J:116300
|
Lynm1Anu/Lynm1Anu
(C57BL/6JAnu-Lynm1Anu)
|
decreased B cell number
|
J:195155
|
LynM1Btlr/Lyn+
(C57BL/6J-LynM1Btlr)
|
decreased B cell number
|
J:214511
|
LynM1Btlr/LynM1Btlr
(C57BL/6J-LynM1Btlr)
|
decreased B cell number
|
J:214511
|
Lynm2Anu/Lynm2Anu
(C57B/6JAnu-Lynm2Anu/AnuApb)
|
decreased mature B cell number
|
J:104190
|
| increased immature B cell number
|
J:104190
|
LynM3Btlr/Lyn+
(C57BL/6J-LynM3Btlr)
|
decreased T cell number
|
J:236679
|
| increased B-1 B cell number
|
J:236679
|
| increased macrophage cell number
|
J:236679
|
LynM3Btlr/LynM3Btlr
(C57BL/6J-LynM3Btlr)
|
decreased T cell number
|
J:236679
|
| increased B-1 B cell number
|
J:236679
|
| increased macrophage cell number
|
J:236679
|
Lynmld4/Lynmld4
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:144799
|
| decreased follicular B cell number
|
J:144799
|
| decreased marginal zone B cell number
|
J:144799
|
| decreased transitional stage B cell number
|
J:144799
|
| increased macrophage cell number
|
J:144799
|
| increased T cell number
|
J:144799
|
Lyntm1.1Calo/Lyntm1.1Calo
Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased activated T cell number
|
J:200745
|
| increased monocyte cell number
|
J:200745
|
| increased plasma cell number
|
J:200745
|
| increased T cell number
|
J:200745
|
Lyntm1Ard/Lyn+
Ptpn6me-v/Ptpn6+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:110531
|
Lyntm1Ard/Lyn+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:110531
|
Lyntm1Ard/Lyntm1Ard
(B6.129P2-Lyntm1Ard)
|
abnormal B cell morphology
|
J:144799
|
| decreased follicular B cell number
|
J:144799
|
| decreased marginal zone B cell number
|
J:144799
|
| decreased transitional stage B cell number
|
J:144799
|
| increased T cell number
|
J:144799
|
Lyntm1Ard/Lyntm1Ard
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
| abnormal mature B cell morphology
|
J:110531
|
| absent B-1 B cells
|
J:110531
|
Lyntm1b(EUCOMM)Hmgu/Lyntm1b(EUCOMM)Hmgu
(C57BL/6N-Lyntm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJae)
|
decreased B cell number
|
J:42037
|
| decreased mature B cell number
|
J:42037
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor)
|
decreased B cell number
|
J:200745
|
| decreased follicular B cell number
|
J:146161
|
| decreased marginal zone B cell number
|
J:146161
|
| decreased mature B cell number
|
J:146161
|
| decreased transitional stage B cell number
|
J:146161
|
| increased plasma cell number
|
J:200745
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased B cell number
|
J:71174
|
| decreased B-1 B cell number
|
J:71174
|
| decreased mature B cell number
|
J:71174
|
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:29751
|
| decreased B cell number
|
J:29751
|
| decreased lymphocyte cell number
|
J:29751
|
Lynweeb/Lynweeb
(C57BL/6-Lynweeb)
|
decreased follicular B cell number
|
J:146161
|
| decreased marginal zone B cell number
|
J:146161
|
| decreased mature B cell number
|
J:146161
|
| decreased transitional stage B cell number
|
J:146161
|
Lystbg-J/Lystbg-J
(C57BL/6J-Lystbg-J/J)
|
decreased macrophage cell number
|
J:34814
|
Lystbg-J/Lystbg-J
Prkdcscid/Prkdcscid
(B6.Cg-Lystbg-J Prkdcscid/Sz)
|
decreased B cell number
|
J:34814
|
| decreased CD4-positive, alpha-beta T cell number
|
J:34814
|
| decreased CD8-positive, alpha-beta T cell number
|
J:34814
|
| decreased lymphocyte cell number
|
J:34814
|
| decreased pre-B cell number
|
J:34814
|
| decreased T cell number
|
J:34814
|
| increased macrophage cell number
|
J:34814
|
| increased monocyte cell number
|
J:34814
|
| increased NK cell number
|
J:34814
|
Lystbg-Lac/Lystbg-Lac
(CBA/CaLac-Lystbg-Lac)
|
absent NK T cells
|
J:29745
|
Lystbg/Lystbg
(B6.C3Rl-Lystbg)
|
abnormal lymphocyte morphology
|
J:5078
|
Lyve1tm1.1(EGFP/cre)Cys/Lyve1+
Sphk1tm2Cgh/Sphk1tm2Cgh
Sphk2tm1.1Cgh/Sphk2tm1.1Cgh
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal lymphocyte cell number
|
J:156826
|
| decreased B cell number
|
J:156826
|
| decreased T cell number
|
J:156826
|
Lyz2tm1(cre)Ifo/0
Nup85tm1.1Yter/Nup85tm1.1Yter
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased macrophage cell number
|
J:292726
|
Lyz2tm1(cre)Ifo/Lyz2+
Pikfyvetm1b(EUCOMM)Hmgu/Pikfyvetm1b(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal alveolar macrophage morphology
|
J:244776
|
| decreased alveolar macrophage number
|
J:244776
|
| decreased regulatory T cell number
|
J:244776
|
Lyz2tm1(cre)Ifo/Lyz2+
Selenowtm1c(EUCOMM)Wtsi/Selenowtm1c(EUCOMM)Wtsi
(B6.Cg-Selenowtm1c(EUCOMM)Wtsi Lyz2tm1(cre)Ifo)
|
abnormal osteoclast differentiation
|
J:317012
|
Lyz2tm1(HBEGF)Mtka/Lyz2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal alveolar macrophage morphology
|
J:145285
|
m1Hefl/m1Hefl
(C3HeB/FeJ-m1Hefl)
|
decreased B cell number
|
J:137446
|
X/m1Nish
(involves: BALB/c * C57BL/6N)
|
absent B cells
|
J:204833
|
| decreased NK cell number
|
J:204833
|
X/m1Nish
(involves: C57BL/6N)
|
abnormal B cell differentiation
|
J:204833
|
| abnormal NK cell differentiation
|
J:204833
|
| absent B cells
|
J:204833
|
| absent B-1 B cells
|
J:204833
|
| absent B-2 B cells
|
J:204833
|
| decreased B cell number
|
J:204833
|
| decreased B-1 B cell number
|
J:204833
|
| decreased immature B cell number
|
J:204833
|
| decreased NK cell number
|
J:204833
|
m2Hefl/m2Hefl
(C3HeB/FeJ-m2Hefl)
|
absent B cells
|
J:137446
|
| absent T cells
|
J:137446
|
m3Hefl/m3Hefl
(C3HeB/FeJ-m3Hefl)
|
decreased CD8-positive, alpha-beta T cell number
|
J:137446
|
| decreased NK cell number
|
J:137446
|
m4Hefl/m4Hefl
(C3HeB/FeJ-m4Hefl)
|
decreased T cell number
|
J:137446
|
m5Hefl/m5Hefl
(C3HeB/FeJ-m5Hefl)
|
decreased T cell number
|
J:137446
|
m12137Asr/m12137Asr+
(C57BL/6J-m12137Asr)
|
decreased osteoclast cell number
|
J:132290
|
Macroh2a1tm1.1Oxbo/Macroh2a1tm1.1Oxbo
(B6.Cg-Macroh2a1tm1.1Oxbo)
|
decreased B cell number
|
J:293382
|
| increased lymphocyte cell number
|
J:293382
|
Madcam1tm1.2Nwag/Madcam1tm1.2Nwag
(B6.129P2-Madcam1tm1.2Nwag)
|
decreased B cell number
|
J:169739
|
| decreased plasma cell number
|
J:169739
|
| increased plasma cell number
|
J:169739
|
MaeaGt(XG702)Byg/MaeaGt(XG702)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased macrophage cell number
|
J:114865
|
Magt1Gt(IST13422E1)Tigm/Y
(involves: C57BL/6N)
|
abnormal B cell morphology
|
J:260923
|
| decreased plasma cell number
|
J:260923
|
| decreased T cell number
|
J:260923
|
| increased B cell number
|
J:260923
|
| increased marginal zone B cell number
|
J:260923
|
Malt1tm1Vmd/Malt1tm1Vmd
(involves: C57BL/6N)
|
abnormal B cell differentiation
|
J:86770
|
| abnormal double-negative T cell morphology
|
J:86770
|
| abnormal T cell differentiation
|
J:86770
|
| absent B-1a cells
|
J:86770
|
Maml1tm1Mkit/Maml1tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased marginal zone B cell number
|
J:122286
|
| decreased thymocyte number
|
J:122286
|
| increased double-negative T cell number
|
J:122286
|
Mamld1tm1.1(NCOM)Mfgc/Y
(C57BL/6N-Mamld1tm1.1(NCOM)Mfgc/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Man2a1tm1Jxm/Man2a1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased memory T cell number
|
J:74579
|
Man2b1tm1Psa/Man2b1tm1Psa
(involves: 129 * C57BL/6J)
|
abnormal Kupffer cell morphology
|
J:56659
|
Man2b2tm1b(KOMP)Wtsi/Man2b2tm1b(KOMP)Wtsi
(C57BL/6N-Man2b2tm1b(KOMP)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Manbatm1Khf/Manbatm1Khf
(B6.129-Manbatm1Khf)
|
abnormal Kupffer cell morphology
|
J:105427
|
Map3k3tm1Bisu/Map3k3tm2Bisu
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:145923
|
| decreased CD8-positive, alpha-beta T cell number
|
J:145923
|
Map3k3tm1Kuro/Map3k3tm1Kuro
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:147103
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147103
|
| decreased double-positive T cell number
|
J:147103
|
| decreased single-positive T cell number
|
J:147103
|
| decreased thymocyte number
|
J:147103
|
| increased double-negative T cell number
|
J:147103
|
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
absent regulatory T cells
|
J:112837
|
| decreased CD4-positive, alpha-beta T cell number
|
J:112837
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112837
|
| decreased single-positive T cell number
|
J:112837
|
| decreased T cell number
|
J:112837
|
| increased memory T cell number
|
J:112837
|
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:238318
|
| abnormal intraepithelial T cell number
|
J:238318
|
| abnormal regulatory T cell number
|
J:238318
|
| abnormal T cell morphology
|
J:238318
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:238318
|
| decreased NK T cell number
|
J:238318
|
| increased CD4-positive, alpha-beta T cell number
|
J:238318
|
| increased gamma-delta intraepithelial T cell number
|
J:238318
|
Map3k7tm1Zjc/Map3k7tm1Zjc
Tg(Lck-cre)548Jxm/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:111794
|
| decreased CD8-positive, alpha-beta T cell number
|
J:111794
|
| decreased T cell number
|
J:111794
|
Map3k8tm1Pnt/Map3k8tm1Pnt
Tnftm2Gkl/Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:108572
|
| increased single-positive T cell number
|
J:108572
|
Map3k14aly/Map3k14+
RelbTg(H2-K1/GH1)106Bri/Relb+
(involves: C57BL/6 * C57BL/6J)
|
decreased NK T cell number
|
J:120659
|
Map3k14aly/Map3k14aly
(involves: C57BL/6J)
|
abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:87993,
J:128211
|
| abnormal NK T cell morphology
|
J:120659
|
| decreased NK T cell number
|
J:120659
|
| decreased regulatory T cell number
|
J:128211
|
Map3k14aly/Map3k14aly
(involves: AEJ/GnRk * C57BL/6J)
|
abnormal lymphocyte morphology
|
J:16865
|
| abnormal lymphopoiesis
|
J:16865
|
| decreased B cell number
|
J:54529
|
Map3k14m1Btlr/Map3k14m1Btlr
(C57BL/6J-Map3k14m1Btlr)
|
arrested B cell differentiation
|
J:152065
|
| decreased B cell number
|
J:152065
|
Map3k14m1Btlr/Map3k14m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| arrested B cell differentiation
|
J:185495
|
Map3k14tm1.1Gne/Map3k14tm1.1Gne
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)
|
decreased B cell number
|
J:280549
|
Map3k14tm1.2Gne/Map3k14tm1.2Gne
(B6(Cg)-Map3k14tm1.2Gne)
|
decreased B cell number
|
J:240453
|
| decreased B-2 B cell number
|
J:240453
|
| decreased follicular B cell number
|
J:240453
|
| decreased germinal center B cell number
|
J:240453
|
| decreased marginal zone B cell number
|
J:240453
|
| decreased transitional stage T1 B cell number
|
J:240453
|
| decreased transitional stage T2 B cell number
|
J:240453
|
Map3k14tm1Rds/Map3k14tm1Rds
(involves: 129)
|
abnormal class switch recombination
|
J:188560
|
Map4k3Gt(RRO270)Byg/Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd)
|
abnormal T-helper 1 cell differentiation
|
J:177642
|
| abnormal T-helper 2 cell differentiation
|
J:177642
|
| abnormal T-helper 17 cell differentiation
|
J:177642
|
Map4k5Gt(OST218153)Lex/Map4k5Gt(OST218153)Lex
(B6;129S5-Map4k5Gt(OST218153)Lex/Ieg)
|
increased CD4-positive, alpha-beta T cell number
|
J:82809
|
Mapk1tm1.1Hed/Mapk1tm1.1Hed
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell subpopulation ratio
|
J:113280
|
| decreased CD4-positive, alpha-beta T cell number
|
J:113280
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Cd4-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Cd4-cre)1Cwi/0
Tg(TcrAND)53Hed/0
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL)
|
abnormal positive T cell selection
|
J:113280
|
| abnormal T cell subpopulation ratio
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:113280
|
| increased double-positive T cell number
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(TcraTcrb)1100Mjb/0
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:113280
|
| decreased CD4-positive, alpha-beta T cell number
|
J:113280
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113280
|
| increased double-positive T cell number
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell subpopulation ratio
|
J:113280
|
| decreased double-positive T cell number
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(Lck-cre)1Cwi/0
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal positive T cell selection
|
J:113280
|
| abnormal T cell subpopulation ratio
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal double-positive T cell morphology
|
J:113280
|
| abnormal positive T cell selection
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
decreased thymocyte number
|
J:113280
|
Mapk1tm2Moga/Mapk1tm2Moga
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Mx1-cre)1Cgn/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pro-B cell differentiation
|
J:134528
|
| abnormal pro-B cell morphology
|
J:134528
|
| decreased pre-B cell number
|
J:134528
|
Mapk3tm1Gpg/Mapk3tm1Gpg
(involves: 129)
|
decreased T cell number
|
J:58468
|
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 cell differentiation
|
J:51510
|
Mapk8tm1Rjd/Mapk8tm1Rjd
Mapk9tm2.1Rjd/Mapk9tm2.1Rjd
Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
abnormal macrophage differentiation
|
J:192551
|
| decreased macrophage cell number
|
J:192551
|
Mapk9tm1Flv/Mapk9tm1Flv
(involves: 129S2/SvPas)
|
abnormal T-helper 1 cell differentiation
|
J:50628
|
Mapk11tm1Jda/Mapk11tm1Jda
Mapk14tm1Jda/Mapk14tm1Jda
(involves: 129 * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:165966
|
| abnormal T-helper 2 cell differentiation
|
J:165966
|
| abnormal T-helper 17 cell differentiation
|
J:165966
|
Mapk14tm1Jda/Mapk14tm1Jda
(B6.Cg-Mapk14tm1Jda)
|
increased double-negative T cell number
|
J:146088
|
Mapkapk2tm1b(EUCOMM)Hmgu/Mapkapk2tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapkapk2tm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal macrophage derived foam cell morphology
|
J:142788
|
Mapttm2.1(FUS)Neas/Mapt+
(B6J.129P2(129S)-Mapttm2.1(FUS)Neas)
|
microgliosis
|
J:232167
|
Mapttm3.1(FUS)Neas/Mapt+
(B6J.129P2(129S)-Mapttm3.1(FUS)Neas)
|
microgliosis
|
J:232167
|
Mar1tm1Wtg/Mar1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
Mar1tm1Wtg/Mar1tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
Marchf1tm1.1Sish/Marchf1tm1.1Sish
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:201198
|
| decreased regulatory T cell number
|
J:201198
|
Marchf9tm1a(EUCOMM)Wtsi/Marchf9tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased B cell number
|
J:165965
|
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:68830
|
| increased B cell number
|
J:68830
|
Matn1tm1Ref/Matn1tm1Ref
Matn2tm1Asz/Matn2tm1Asz
Matn3tm1Asz/Matn3tm1Asz
Matn4tm1.1Asz/Matn4tm1.1Asz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased double-positive T cell number
|
J:237230
|
Mavstm1Aki/Mavstm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:130954
|
Mavstm1Aki/Mavstm1Aki
(involves: 129S/SvEv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:162888
|
| decreased CD8-positive, alpha-beta T cell number
|
J:162888
|
Mavstm1Aki/Mavstm1Aki
Ifna6tm1Aki/Ifna6+
(involves: 129P2/OlaHsd)
|
abnormal alveolar macrophage morphology
|
J:124340
|
| abnormal macrophage morphology
|
J:124340
|
| abnormal myeloid dendritic cell morphology
|
J:124340
|
Mavstm1Aki/Mavstm1Aki
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:130954
|
Mbd2tm1Bh/Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:323838
|
| abnormal effector T cell morphology
|
J:323838
|
| increased T-helper 1 cell number
|
J:323838
|
| increased T-helper 2 cell number
|
J:323838
|
Mbd5tm1b(EUCOMM)Wtsi/Mbd5+
(C57BL/6N-Mbd5tm1b(EUCOMM)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Mbl1tm1Kata/Mbl1tm1Kata
Mbl2tm1Kata/Mbl2tm1Kata
(involves: 129 * C57BL/6)
|
abnormal B cell number
|
J:97686
|
| decreased germinal center B cell number
|
J:97686
|
| decreased macrophage cell number
|
J:98124
|
| decreased monocyte cell number
|
J:98124
|
| increased B-1 B cell number
|
J:97686
|
Mboat7tm1b(KOMP)Wtsi/Mboat7+
(C57BL/6N-Mboat7tm1b(KOMP)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
Mc4rtm1Dhu/Mc4rtm1Dhu
(involves: 129S4/SvJae * C57BL/6J)
|
decreased osteoclast cell number
|
J:97566
|
Mcattm1.1Ssmi/Mcattm1.1Ssmi
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
decreased lymphocyte cell number
|
J:192213
|
Mcl1tm1Dmta/Mcl1+
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(B6.Cg-Mcl1tm1Dmta Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
decreased germinal center B cell number
|
J:166069
|
| decreased memory B cell number
|
J:166069
|
Mcl1tm1Dmta/Mcl1+
Tg(Aicda-cre)9Mbu/0
(B6.Cg-Mcl1tm1Dmta Tg(Aicda-cre)9Mbu)
|
decreased germinal center B cell number
|
J:166069
|
| decreased memory B cell number
|
J:166069
|
Mcl1tm1Dmta/Mcl1tm1Dmta
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(B6.Cg-Mcl1tm1Dmta Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
abnormal B cell differentiation
|
J:166069
|
| absent germinal center B cells
|
J:166069
|
| absent memory B cells
|
J:166069
|
| decreased naive B cell number
|
J:166069
|
Mcl1tm1Dmta/Mcl1tm1Dmta
Tg(Aicda-cre)9Mbu/0
(B6.Cg-Mcl1tm1Dmta Tg(Aicda-cre)9Mbu)
|
absent germinal center B cells
|
J:166069
|
| absent memory B cells
|
J:166069
|
Mcl1tm1Yen/Mcl1tm1Yen
(B6.129-Mcl1tm1Yen)
|
abnormal double-positive T cell morphology
|
J:146246
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146246
|
| decreased double-negative T cell number
|
J:146246
|
| decreased single-positive T cell number
|
J:146246
|
Mcl1tm1Yen/Mcl1tm1Yen
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal double-positive T cell morphology
|
J:146246
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146246
|
Mcl1tm1Yen/Mcl1tm1Yen
Tg(TcraTcrb)425Cbn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:146246
|
| decreased CD4-positive, alpha-beta T cell number
|
J:146246
|
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:137400
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137400
|
| decreased T cell number
|
J:137400
|
| increased double-positive T cell number
|
J:137400
|
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:137400
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137400
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137400
|
| decreased double-negative T cell number
|
J:137400
|
| decreased double-positive T cell number
|
J:137400
|
| decreased T cell number
|
J:137400
|
Mcl1tm2Sjk/Mcl1tm3Sjk
Tg(Lck-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:86906
|
| decreased double-negative T cell number
|
J:86906
|
| decreased double-positive T cell number
|
J:86906
|
| decreased T cell number
|
J:86906
|
| decreased thymocyte number
|
J:86906
|
Mcl1tm2Sjk/Mcl1tm3Sjk
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased B cell number
|
J:86906
|
| decreased T cell number
|
J:86906
|
Mcm3aptm1Imku/Mcm3aptm1Imku
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal memory B cell number
|
J:88276
|
| decreased B cell number
|
J:88276
|
| decreased germinal center B cell number
|
J:88276
|
Mcm4Sdla/Mcm4+
(involves: C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:194117
|
Mcph1tm1a(EUCOMM)Wtsi/Mcph1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased B cell number
|
J:213427
|
Mdc1Gt(OST441263)Lex/Mdc1Gt(OST441263)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:137341
|
Mdga2Tg(Prnp-PFN1*G118V)838Kiaei/Mdga2+
(involves: C57BL/6N)
|
microgliosis
|
J:241428
|
Mdktm1Tmu/Mdktm1Tmu
(B6.129S2-Mdktm1Tmu)
|
decreased macrophage cell number
|
J:102069
|
Mdm2tm1Bay/Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell differentiation
|
J:81065
|
| decreased double-negative T cell number
|
J:81065
|
| decreased double-positive T cell number
|
J:81065
|
| decreased immature B cell number
|
J:81065
|
| decreased lymphocyte cell number
|
J:81065
|
| decreased T cell number
|
J:81065
|
| decreased thymocyte number
|
J:81065
|
Mdm4m1Btlr/Mdm4m1Btlr
(C57BL/6J-Mdm4m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:265262
|
| decreased single-positive T cell number
|
J:265262
|
| increased CD4-positive, alpha-beta T cell number
|
J:265262
|
| increased single-positive T cell number
|
J:265262
|
Mdm4m2Btlr/Mdm4m2Btlr
(C57BL/6J-Mdm4m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272830
|
| increased CD4-positive, alpha-beta T cell number
|
J:272830
|
Mecomtm2.2Aspe/Mecomtm2.2Aspe
(involves: 129 * C57BL/6J * FVB/N)
|
decreased B cell number
|
J:213829
|
Mef2btm2Rdf/Mef2b+
Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6)
|
abnormal mature B cell morphology
|
J:265465
|
| increased germinal center B cell number
|
J:265465
|
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae
(B6.129S6-Mefvtm5.1(MEFV)Chae)
|
decreased B cell number
|
J:172117
|
| decreased lymphocyte cell number
|
J:172117
|
| decreased T cell number
|
J:172117
|
| increased macrophage cell number
|
J:172117
|
| increased monocyte cell number
|
J:172117
|
Men1tm1.2Zqw/Men1tm1.2Zqw
Pgrtm2(cre)Lyd/Pgr+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased uterine NK cell number
|
J:322043
|
Meox2tm1(cre)Sor/Meox2+
Tg(CAG-lacZ,-FUS*R521G,-EGFP)682Gyu/0
(involves: 129S4/SvJaeSor * C57BL/6)
|
microgliosis
|
J:216672
|
Meox2tm1(cre)Sor/Meox2+
Tg(CAG-lacZ,-FUS,-EGFP)629Gyu/0
(involves: 129S4/SvJaeSor * C57BL/6)
|
microgliosis
|
J:216672
|
Mepetm1Tbrw/Mepetm1Tbrw
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast morphology
|
J:81218
|
Mertktm1Gkm/Mertktm1Gkm
(NOD.129P2-Mertktm1Gkm)
|
abnormal mononuclear cell morphology
|
J:147153
|
| decreased T cell number
|
J:147153
|
Mertktm1Gkm/Mertktm1Gkm
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Mertktm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
|
decreased double-positive T cell number
|
J:147153
|
| increased CD8-positive, alpha-beta T cell number
|
J:147153
|
Mexistm1.1Pton/Mexistm1.1Pton
(involves: C57BL/6)
|
increased macrophage derived foam cell number
|
J:264834
|
Mfap2tm1a(KOMP)Wtsi/Mfap2tm1a(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased B cell number
|
J:236092
|
| increased B cell number
|
J:236092
|
| increased macrophage cell number
|
J:236092
|
| increased monocyte cell number
|
J:236092
|
| increased myeloid dendritic cell number
|
J:236092
|
Mfap2tm1Mech/Mfap2tm1Mech
(involves: 129X1/SvJ)
|
decreased macrophage cell number
|
J:203960
|
| decreased monocyte cell number
|
J:203960
|
Mfap2tm1Mech/Mfap2tm1Mech
Mfap5tm1Mech/Mfap5tm1Mech
(involves: 129X1/SvJ)
|
decreased monocyte cell number
|
J:203960
|
Mfge8tm1Mcu/Mfge8tm1Mcu
Tg(RIP1-Tag)2Dh/?
(involves: 129X1/SvJ * C57BL/6J * C57BL/6NCr * DBA/2J)
|
decreased Langerhans cell number
|
J:123138
|
Mfngem1(IMPC)Ccpcz/Mfngem1(IMPC)Ccpcz
(C57BL/6NCrl-Mfngem1(IMPC)Ccpcz/Ccpcz)
|
decreased NK T cell number
|
J:211773
|
Mfngtm1.1Cfg/Mfngtm1.1Cfg
(involves: C57BL/6)
|
decreased macrophage cell number
|
J:217719
|
| decreased mature B cell number
|
J:217719
|
| increased B cell number
|
J:217719
|
| increased lymphocyte cell number
|
J:217719
|
Mfngtm1Cjg/Mfngtm1Cjg
(B6.Cg-Mfngtm1Cjg)
|
abnormal marginal zone B cell morphology
|
J:146621
|
Mfsd1em1(IMPC)Tcp/Mfsd1em1(IMPC)Tcp
(C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(C57BL/6-Mfsd2btm1a(KOMP)Wtsi)
|
decreased B cell number
|
J:250123
|
| decreased T cell number
|
J:250123
|
Mfsd8tm1a(EUCOMM)Hmgu/Mfsd8tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
microgliosis
|
J:211608
|
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal B cell differentiation
|
J:80661
|
| decreased T cell number
|
J:80661
|
Mgat5btm1.1Cfg/Mgat5btm1.1Cfg
(involves: 129S6/SvEvTac)
|
decreased pre-B cell number
|
J:217719
|
Mgl2tm1.1(HBEGF/EGFP)Aiwsk/Mgl2+
(involves: C57BL/6 * FVB/N)
|
abnormal T-helper 2 cell morphology
|
J:201044
|
| decreased B cell number
|
J:201044
|
| decreased CD4-positive, alpha-beta T cell number
|
J:201044
|
| decreased CD8-positive, alpha-beta T cell number
|
J:201044
|
| decreased Langerhans cell number
|
J:201044
|
Mgrn1em1(IMPC)Tcp/Mgrn1+
(C57BL/6NCrl-Mgrn1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Micu1em#Fink/Micu1em#Fink
(C57BL/6N-Micu1em#Fink)
|
decreased B cell number
|
J:238984
|
| decreased follicular B cell number
|
J:238984
|
Micu1em#Fink/Micu1em#Fink
Smdt1em1Fink/Smdt1+
(involves: C57BL/6J * C57BL/6N * CBA)
|
decreased B cell number
|
J:238984
|
Mir34atm1.2Arte/Mir34atm1.2Arte
(involves: C57BL/6N)
|
increased B cell number
|
J:221990
|
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6)
|
increased macrophage cell number
|
J:190066
|
| increased monocyte cell number
|
J:190066
|
Mir122tm1.2Kgh/Mir122tm1.2Kgh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased monocyte cell number
|
J:190067
|
Mir125atm1Smoc/Mir125atm1Smoc
(involves: C57BL/6)
|
decreased regulatory T cell number
|
J:224880
|
Mir142tm1.1Sbel/Mir142tm1.1Sbel
(involves: C57BL/6N)
|
decreased lymphocyte cell number
|
J:227228
|
| decreased monocyte cell number
|
J:227228
|
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:167922
|
| decreased lymphocyte cell number
|
J:173230
|
| decreased monocyte cell number
|
J:173230
|
| increased regulatory T cell number
|
J:167922
|
Mir146tm1.1Bal/Mir146tm1.1Bal
Tifabtm1.1Dsta/Tifabtm1.1Dsta
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased lymphocyte cell number
|
J:229024
|
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased germinal center B cell number
|
J:266124
|
| increased T follicular helper cell number
|
J:266124
|
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Mir146btm1.1Lfl/Mir146btm1.1Lfl
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased germinal center B cell number
|
J:266124
|
| increased T follicular helper cell number
|
J:266124
|
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
increased germinal center B cell number
|
J:266124
|
| increased T follicular helper cell number
|
J:266124
|
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6)
|
increased germinal center B cell number
|
J:266124
|
| increased plasma cell number
|
J:266124
|
| increased T follicular helper cell number
|
J:266124
|
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
decreased lymphocyte cell number
|
J:173671
|
| decreased monocyte cell number
|
J:173671
|
Mir148atm2942.1Arte/Mir148atm2942.1Arte
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasmablast number
|
J:307366
|
| decreased plasma cell number
|
J:307366
|
| increased memory B cell number
|
J:307366
|
Mir148atm2942.1Arte/Mir148atm2942.1Arte
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal plasmablast number
|
J:307366
|
| decreased plasma cell number
|
J:307366
|
| increased plasma cell number
|
J:307366
|
Mir148atm2942.2Arte/Mir148atm2942.2Arte
(involves: C57BL/6 * FVB/N)
|
decreased plasma cell number
|
J:307366
|
Mir150tm1Rsky/Mir150tm1Rsky
(involves: C57BL/6)
|
decreased B-2 B cell number
|
J:127234
|
| increased B-1 B cell number
|
J:127234
|
Mir155tm1.1Brd/Mir155tm1.1Brd
(B6.Cg-Mir155tm1.1Brd Tyrc-Brd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:121095
|
| abnormal T-helper 1 cell morphology
|
J:121095
|
| increased T-helper 2 cell number
|
J:121095
|
Mir155tm1.1Brd/Mir155tm1.1Brd
(B6.129S7-Mir155tm1.1Brd)
|
decreased regulatory T cell number
|
J:146268
|
Mir155tm1.1Rsky/Mir155tm1.1Rsky
(involves: 129 * C57BL/6)
|
decreased germinal center B cell number
|
J:121084
|
Mir155tm1.1Rsky/Mir155tm1.1Rsky
(B6.Cg-Mir155tm1Rsky/J)
|
abnormal T-helper 17 cell differentiation
|
J:226678
|
| decreased effector memory T-helper cell number
|
J:226678
|
| decreased regulatory T cell number
|
J:226678
|
| decreased T-helper 17 cell number
|
J:226678
|
Mir155tm1Brd/Mir155tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:121095
|
Mir155tm1Rsky/Mir155tm1Rsky
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:136224
|
Mir181dtm1.1Oers/Mir181dtm1.1Oers
(involves: C57BL/6)
|
increased T cell number
|
J:212571
|
Mir210tm1.1Wtsi/Mir210tm1.1Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased germinal center B cell number
|
J:205868
|
Mir338em1Zchn/Mir338em1Zchn
(C57BL/6-Mir338em1Zchn)
|
decreased osteoclast cell number
|
J:285968
|
Mirc1tm1.1Aven/Mirc1tm1.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased alpha-beta T cell number
|
J:223213
|
| decreased B cell number
|
J:223213
|
| decreased pre-B cell number
|
J:223213
|
| decreased pro-B cell number
|
J:223213
|
Mirc1tm1.2Tyj/Mirc1tm1.2Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)
|
abnormal B cell differentiation
|
J:134861
|
| decreased pre-B cell number
|
J:134861
|
Mirc1tm1.3Tyj/Mirc1tm1.3Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:134861
|
| decreased pre-B cell number
|
J:134861
|
Mirc1tm1Tyj/Mirc1tm1Tyj
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:134861
|
| decreased pre-B cell number
|
J:134861
|
Mirc1tm2.1Aven/Mirc1tm2.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased B cell number
|
J:223213
|
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(IghMyc)22Bri/?
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
abnormal pre-B cell morphology
|
J:223213
|
Mirc1tm3.1Aven/Mirc1tm3.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased alpha-beta T cell number
|
J:223213
|
| decreased B cell number
|
J:223213
|
| decreased pre-B cell number
|
J:223213
|
| decreased pro-B cell number
|
J:223213
|
Mirc11tm1Rdhl/Mirc11tm1Rdhl
(B6.129-Mirc11tm1Rdhl)
|
abnormal B cell differentiation
|
J:243248
|
| increased B cell number
|
J:243248
|
| increased follicular B cell number
|
J:243248
|
| increased immature B cell number
|
J:243248
|
| increased mature B cell number
|
J:243248
|
| increased plasma cell number
|
J:243248
|
| increased pre-pro B cell number
|
J:243248
|
| increased pro-B cell number
|
J:243248
|
| increased transitional stage T1 B cell number
|
J:243248
|
Mirc14tm1.1Ankr/Mirc14tm1.1Ankr
(involves: C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:196134
|
| abnormal NK T cell morphology
|
J:196134
|
| abnormal T cell differentiation
|
J:196134
|
| decreased double-positive T cell number
|
J:196134
|
| decreased NK T cell number
|
J:196134
|
| increased CD4-positive, alpha-beta T cell number
|
J:196134
|
Mirc14tm1.1Czc/Mirc14tm1.1Czc
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(either: (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor * C57BL/6))
|
decreased double-positive T cell number
|
J:188125
|
Mirc14tm1.1Flv/Mirc14tm1.1Flv
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2 * SJL)
|
decreased NK T cell number
|
J:203157
|
Mirc14tm1.2Czc/Mirc14tm1.2Czc
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))
|
decreased B cell number
|
J:188125
|
| decreased DN3 thymocyte number
|
J:188125
|
| decreased double-positive T cell number
|
J:188125
|
| decreased germinal center B cell number
|
J:188125
|
| decreased thymocyte number
|
J:188125
|
| increased CD4-positive, alpha-beta T cell number
|
J:188125
|
| increased marginal zone B cell number
|
J:188125
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
abnormal T cell differentiation
|
J:203157
|
| abnormal T cell receptor V(D)J recombination
|
J:203157
|
| decreased B cell number
|
J:203157
|
| decreased CD4-positive, alpha-beta T cell number
|
J:203157
|
| decreased CD8-positive, alpha-beta T cell number
|
J:203157
|
| decreased DN1 thymic pro-T cell number
|
J:203157
|
| decreased double-positive T cell number
|
J:203157
|
| decreased NK T cell number
|
J:203157
|
| decreased thymocyte number
|
J:203157
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
Mirc15tm1.2Flv/Mirc15tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased B cell number
|
J:203157
|
| decreased immature B cell number
|
J:203157
|
| decreased pre-B cell number
|
J:203157
|
| increased pro-B cell number
|
J:203157
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
Tg(Cd4-TcraDN32D3)1Aben/0
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased NK T cell number
|
J:203157
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
Tg(LCKprBCL2L1)12Sjk/0
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased NK T cell number
|
J:203157
|
Mirc16tm1.2Czc/Mirc16tm1.2Czc
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))
|
increased CD8-positive, alpha-beta T cell number
|
J:188125
|
Mirc30em1Hhzg/Mirc30em1Hhzg
Tg(Vav1-cre)#Cgp/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6NRj)
|
abnormal NK cell morphology
|
J:320883
|
| increased B cell number
|
J:320883
|
| increased pre-B cell number
|
J:320883
|
| increased pro-B cell number
|
J:320883
|
Mirc30tm1.2Rdf/Mirc30tm1.2Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased B cell number
|
J:156946
|
| increased B-1a cell number
|
J:156946
|
Mirc33tm1.1Cwh/Mirc33tm1.1Cwh
(involves: 129X1/SvJ)
|
abnormal T cell morphology
|
J:189763
|
| increased T-helper 1 cell number
|
J:189763
|
Mitfmi-ew/Mitfmi-ew
Tfe3tm1Est/Tfe3tm1Est
(either: (involves: 129/Sv * 129S1/Sv * C57BL/6Bn * NAW) or (involves: 129S1/Sv * C57BL/6Bn * C57BL/6J * NAW))
|
abnormal osteoclast morphology
|
J:89821
|
MitfMi-Or/MitfMi-Or
(involves: 101/Rl * C3H/Rl)
|
abnormal osteoclast morphology
|
J:30149
|
| decreased osteoclast cell number
|
J:30149
|
| increased osteoclast cell number
|
J:30149
|
Mitfmi-vga9/Mitfmi-vga9
Tfe3tm1Est/Tfe3tm1Est
(either: (involves: 129/Sv * 129S1/Sv * C57BL/6 * CBA) or (involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA))
|
abnormal osteoclast morphology
|
J:89821
|
MitfMi/MitfMi
(Not Specified)
|
abnormal osteoclast morphology
|
J:5046
|
| increased osteoclast cell number
|
J:5046
|
MitfMi/MitfMi
(involves: C57BL/6J)
|
abnormal osteoclast morphology
|
J:89821
|
MitfMi/MitfMi
Tfe3tm1Est/Tfe3tm1Est
(either: (involves: 129/Sv * 129S1/Sv * C57BL/6J) or (involves: 129S1/Sv * C57BL/6J))
|
abnormal osteoclast morphology
|
J:89821
|
Mkrn2tm1b(KOMP)Wtsi/Mkrn2tm1b(KOMP)Wtsi
(C57BL/6N-Mkrn2tm1b(KOMP)Wtsi/Wtsi)
|
decreased dendritic epidermal T cell number
|
J:211773
|
Mlf1tm1Swm/Mlf1tm1Swm
(involves: 129 * C57BL/6)
|
increased B cell number
|
J:266833
|
Mllt6em1(IMPC)Tcp/Mllt6em1(IMPC)Tcp
(C57BL/6NCrl-Mllt6em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Mllt10em1(IMPC)Mbp/Mllt10+
(C57BL/6N-Mllt10em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Mmdtm1Beij/Mmdtm1Beij
(Not Specified)
|
abnormal macrophage differentiation
|
J:304637
|
Mmgt2tm1b(EUCOMM)Wtsi/Mmgt2tm1b(EUCOMM)Wtsi
(C57BL/6N-Mmgt2tm1b(EUCOMM)Wtsi/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd)
|
decreased osteoclast cell number
|
J:121780
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6)
|
increased lymphocyte cell number
|
J:88065
|
| increased macrophage cell number
|
J:88065
|
| increased monocyte cell number
|
J:88065
|
| increased T-helper 2 cell number
|
J:88065
|
Mmp11tm1b(EUCOMM)Hmgu/Mmp11tm1b(EUCOMM)Hmgu
(C57BL/6N-Mmp11tm1b(EUCOMM)Hmgu/Ics)
|
increased monocyte cell number
|
J:211773
|
Mmp19tm1Rase/Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase)
|
abnormal T cell differentiation
|
J:137128
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137128
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137128
|
| increased double-positive T cell number
|
J:137128
|
Mmp20em1(IMPC)Ccpcz/Mmp20em1(IMPC)Ccpcz
(C57BL/6NCrl-Mmp20em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
Mmrn1tm1b(EUCOMM)Hmgu/Mmrn1tm1b(EUCOMM)Hmgu
(C57BL/6N-Mmrn1tm1b(EUCOMM)Hmgu/Cnrm)
|
increased large unstained cell number
|
J:211773
|
Morc3tm1b(EUCOMM)Hmgu/Morc3+
(C57BL/6N-Morc3tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Morrbidem1Flv/Morrbid+
(C57BL/6N-Morrbidem1Flv)
|
decreased Ly6C high monocyte number
|
J:236609
|
Morrbidem1Flv/Morrbidem1Flv
(C57BL/6N-Morrbidem1Flv)
|
decreased Ly6C high monocyte number
|
J:236609
|
| decreased Ly6C low monocyte number
|
J:236609
|
Mpgtm1Rhe/Mpgtm1Rhe
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased CD4-positive, alpha-beta T cell number
|
J:70603
|
Mpltm1Wsa/Mpltm1Wsa
MybPlt3/MybPlt3
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:89601
|
Mpltm1Wsa/Mpltm1Wsa
Suz12Gt(Betageo)1Khe/Suz12+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
increased lymphocyte cell number
|
J:136262
|
Mpltm1Wsa/Mpltm1Wsa
Suz12Plt8/Suz12+
(B6.Cg-Mpltm1Wsa Suz12Plt8)
|
increased lymphocyte cell number
|
J:136262
|
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J)
|
increased monocyte cell number
|
J:67586
|
Mpztm1Msch/Mpz+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased monocyte cell number
|
J:82432
|
Mpztm1Msch/Mpz+
(involves: 129S7/SvEvBrd)
|
increased macrophage cell number
|
J:133028
|
Mpztm1Msch/Mpz+
Rag1tm1Mom/Rag1tm1Mom
(B6.129S7-Mpztm1Msch Rag1tm1Mom)
|
absent CD4-positive, alpha-beta T cells
|
J:59319
|
| absent CD8-positive, alpha-beta T cells
|
J:59319
|
Mpztm1Msch/Mpz+
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * BALB/c * C57BL/6)
|
decreased T cell number
|
J:59319
|
Mpzl2tm1Lex/Mpzl2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:171883
|
| increased CD8-positive, alpha-beta T cell number
|
J:171883
|
Mr1tm1Gfn/Mr1tm1Gfn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal T cell number
|
J:113083
|
MrasGt(OST108223)Lex/MrasGt(OST108223)Lex
(B6;129S5-MrasGt(OST108223)Lex/Ieg)
|
decreased B cell number
|
J:82809
|
Mrc1tm1Mnz/Mrc1tm1Mnz
(B6.129P2-Mrc1tm1Mnz)
|
decreased T cell number
|
J:194065
|
Mre11atm1.1Rchd/Mre11atm1.1Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:184053
|
Ms4a1tm1Tft/Ms4a1tm1Tft
(involves: 129 * C57BL/6)
|
abnormal B cell number
|
J:88933
|
| decreased B-1 B cell number
|
J:88933
|
| increased transitional stage B cell number
|
J:88933
|
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:80893
|
| abnormal somatic hypermutation frequency
|
J:155454
|
Msh2tm1Htr/Msh2tm1Htr
Pcnatm1Jcbs/Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
Msh2tm1Mak/Msh2tm1Mak
(C57BL/6NTac-Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
Msh2tm1Rak/Msh2tm1Rak
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:56764
|
| decreased mature B cell number
|
J:56764
|
Msh2tm1Wed/Msh2tm1Wed
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:86278
|
Msi2em1(IMPC)Mbp/Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Msi2Gt(E035H03)Wrst/Msi2Gt(E035H03)Wrst
(B6.129P2-Msi2Gt(E035H03)Wrst)
|
decreased B cell number
|
J:174870
|
| decreased CD4-positive, alpha-beta T cell number
|
J:174870
|
| decreased CD8-positive, alpha-beta T cell number
|
J:174870
|
| decreased DN2 thymocyte number
|
J:174870
|
| decreased DN3 thymocyte number
|
J:174870
|
| decreased double-negative T cell number
|
J:174870
|
| decreased double-positive T cell number
|
J:174870
|
| decreased immature B cell number
|
J:174870
|
| decreased macrophage cell number
|
J:174870
|
| decreased mature B cell number
|
J:174870
|
| decreased pre-B cell number
|
J:174870
|
Msmpem1Jzx/Msmpem1Jzx
(C57BL/6-Msmpem1Jzx)
|
abnormal macrophage differentiation
|
J:311042
|
Msntm1Sts/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:189837
|
| decreased CD4-positive, alpha-beta T cell number
|
J:189837
|
| decreased lymphocyte cell number
|
J:189837
|
Msx2tm1Rilm/Msx2tm1Rilm
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6J))
|
decreased osteoclast cell number
|
J:61509
|
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd)
|
abnormal microglial cell morphology
|
J:103102,
J:53929
|
| increased macrophage cell number
|
J:53929
|
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
abnormal microglial cell morphology
|
J:89429
|
| decreased B cell number
|
J:110643
|
| decreased T cell number
|
J:110643
|
| increased CD4-positive, alpha-beta T cell number
|
J:110643
|
| increased CD8-positive, alpha-beta T cell number
|
J:110643
|
| increased lymphocyte cell number
|
J:110643
|
| increased plasma cell number
|
J:110643
|
Mtch2tm1b(EUCOMM)Hmgu/Mtch2+
(C57BL/6N-Mtch2tm1b(EUCOMM)Hmgu/Cnrm)
|
increased monocyte cell number
|
J:211773
|
Mtf1tm1Wsc/Mtf1tm1Wsc
Tg(Mx1-cre)1Cgn/0
Tg(UBC-Mtf1)1Wsc/0
(involves: 129/Sv * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:91119
|
Mtorchino/Mtorchino
(involves: C57BL/6JAnu)
|
decreased CD4-positive, alpha-beta T cell number
|
J:207898
|
Mtortm1.2Koz/Mtortm1.2Koz
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:150108
|
| abnormal T cell subpopulation ratio
|
J:150108
|
| increased regulatory T cell number
|
J:150108
|
Mtortm1Lgm/Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:168600
|
| abnormal T cell morphology
|
J:168600
|
| decreased B cell number
|
J:168600
|
| decreased double-positive T cell number
|
J:168600
|
| decreased follicular B cell number
|
J:168600
|
| decreased marginal zone B cell number
|
J:168600
|
| decreased monocyte cell number
|
J:168600
|
| decreased plasma cell number
|
J:168600
|
| decreased thymocyte number
|
J:168600
|
| decreased transitional stage T1 B cell number
|
J:168600
|
| increased CD4-positive, alpha-beta T cell number
|
J:168600
|
| increased CD8-positive, alpha-beta T cell number
|
J:168600
|
Mtss1Gt(CSC156)Byg/Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg)
|
abnormal B cell differentiation
|
J:186118
|
| abnormal B cell number
|
J:186118
|
| decreased immature B cell number
|
J:186118
|
| increased pre-B cell number
|
J:186118
|
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:212144
|
Muc2wnn/Muc2wnn
(C57BL/6-Muc2wnn)
|
increased lymphocyte cell number
|
J:194148
|
Mug1tm2Vln/Mug1tm2Vln
Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln Mug1tm2Vln)
|
abnormal uterine NK cell morphology
|
J:117841
|
Mx1s1/Mx1s1
(C57BL/6)
|
abnormal peritoneal macrophage morphology
|
J:23752
|
Mxi1tm1Rdp/Mxi1tm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal lymphocyte morphology
|
J:48236
|
Mybboo/Mybboo
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:167270
|
MybM303V/MybM303V
(involves: 129S1/SvlmJ * C57BL/6)
|
arrested B cell differentiation
|
J:96507
|
| arrested T cell differentiation
|
J:96507
|
| decreased B cell number
|
J:96507
|
| decreased single-positive T cell number
|
J:96507
|
| decreased thymocyte number
|
J:96507
|
Mybtm1.1Cgn/Myb+
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:127234
|
| decreased B-1 B cell number
|
J:127234
|
| decreased mature B cell number
|
J:127234
|
| decreased pre-B cell number
|
J:127234
|
Mybtm1Cgn/Mybtm1.1Cgn
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:91122
|
| decreased double-positive T cell number
|
J:91122
|
Mybtm1Cgn/Mybtm1Cgn
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:91122
|
| decreased CD4-positive, alpha-beta T cell number
|
J:91122
|
| decreased CD8-positive, alpha-beta T cell number
|
J:91122
|
| decreased double-negative T cell number
|
J:91122
|
| decreased double-positive T cell number
|
J:91122
|
| decreased gamma-delta T cell number
|
J:91122
|
Mybtm1Cgn/Mybtm1Cgn
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:91122
|
| decreased double-positive T cell number
|
J:91122
|
Mybtm1Epr/Mybtm1Epr
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:93481
|
| decreased CD4-positive, alpha-beta T cell number
|
J:93481
|
| decreased double-positive T cell number
|
J:93481
|
| increased CD8-positive, alpha-beta T cell number
|
J:93481
|
Mybtm1Epr/Mybtm1Epr
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal double-negative T cell morphology
|
J:93481
|
| abnormal T cell differentiation
|
J:93481
|
| decreased double-positive T cell number
|
J:93481
|
Mybtm1Jof/Mybtm1Jof
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:85344
|
| abnormal double-negative T cell morphology
|
J:85344
|
| abnormal T cell differentiation
|
J:85344
|
| decreased thymocyte number
|
J:85344
|
Mybtm1Jof/Mybtm1Ssp
(involves: 129/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:85344
|
| decreased thymocyte number
|
J:85344
|
Mybl1tm1Epr/Mybl1tm1Epr
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:67604
|
Mybl2tm1.1Epr/Mybl2tm1.1Epr
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
decreased B cell number
|
J:206816
|
| decreased lymphocyte cell number
|
J:206816
|
| decreased T cell number
|
J:206816
|
Mybl2tm1.1Jof/Mybl2+
Tg(Zp3-cre)3Mrt/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
increased monocyte cell number
|
J:196804
|
Myctm1Atp/Myc+
(B6.129P2-Myctm1Atp)
|
decreased memory T cell number
|
J:132730
|
Myctm1Lbox/Myc+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased B cell number
|
J:97900
|
Myctm1Lbox/Myctm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased T cell number
|
J:97900
|
| increased B cell number
|
J:97900
|
Myctm3(Tcrb)Fwa/Myc+
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:131995
|
Myct1em1Choi/Myct1em1Choi
(involves: C57BL/6)
|
abnormal macrophage cell number
|
J:303692
|
| decreased regulatory T cell number
|
J:303692
|
| increased CD8-positive, alpha-beta T cell number
|
J:303692
|
Myd88tm1.1Defr/Myd88tm1.1Defr
(B6.129P2(SJL)-Myd88tm1.1Defr)
|
decreased effector memory CD4-positive, alpha-beta T cell number
|
J:224849
|
| decreased macrophage cell number
|
J:224849
|
| decreased monocyte cell number
|
J:224849
|
Myd88tm1Aki/Myd88tm1Aki
Tg(IghelMD4)4Ccg/0
Tg(KLK4mHEL)6Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:115059
|
| increased B-1 B cell number
|
J:115059
|
Myd88tm1Defr/Myd88tm1Defr
Tg(Itgax-cre)1-1Reiz/0
(B6.Cg-Myd88tm1Defr Tg(Itgax-cre)1-1Reiz)
|
abnormal T-helper 1 cell differentiation
|
J:139001
|
Myh9tm5Rsad/Myh9tm5Rsad
Tg(Lck-cre)#Nik/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:164684
|
Myo1gtm1.2Mfk/Myo1gtm1.2Mfk
(Not Specified)
|
decreased B cell number
|
J:209304
|
| increased B cell number
|
J:209304
|
Myoz1tm1b(EUCOMM)Hmgu/Myoz1tm1b(EUCOMM)Hmgu
(C57BL/6N-Myoz1tm1b(EUCOMM)Hmgu/Ieg)
|
increased marginal zone B cell number
|
J:211773
|
Mysm1tm1a(KOMP)Wtsi/Mysm1tm1a(KOMP)Wtsi
(Not Specified)
|
decreased B cell number
|
J:165965
|
| decreased mature B cell number
|
J:165965
|
| increased T cell number
|
J:165965
|
Mysm1tm1b(KOMP)Wtsi/Mysm1tm1b(KOMP)Wtsi
Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6N * FVB/N)
|
abnormal T cell differentiation
|
J:179287
|
| arrested B cell differentiation
|
J:179287
|
| decreased B cell number
|
J:179287
|
| decreased immature B cell number
|
J:179287
|
| decreased pre-B cell number
|
J:179287
|
| decreased pro-B cell number
|
J:179287
|
Mzb1tm1.2Rug/Mzb1tm1.2Rug
(involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL)
|
decreased pre-B cell number
|
J:211639
|
| increased pro-B cell number
|
J:211639
|
N4bp1tm1.2Vmd/N4bp1tm1.2Vmd
(involves: C57BL/6)
|
increased activated T cell number
|
J:297419
|
| increased germinal center B cell number
|
J:297419
|
| increased Ly6C high monocyte number
|
J:297419
|
Naglutm1Efn/Naglutm1Efn
(either: (involves: 129S/SvEv * C57BL/6) or (involves: C57BL/6))
|
abnormal Kupffer cell morphology
|
J:58950
|
| abnormal macrophage morphology
|
J:58950
|
Nampttm1Oleo/Nampttm1Oleo
Tg(CD2-icre)4Kio/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:141448
|
| decreased double-negative T cell number
|
J:141448
|
| decreased T cell number
|
J:141448
|
Nba10NZB/Nba10NZB
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZB)
|
increased B cell number
|
J:134128
|
| increased marginal zone B cell number
|
J:134128
|
Nba10NZB/Nba10NZB
Tlr7tm1Aki/Y
X/Yaa
(B6.Cg-Nba10NZB Tlr7tm1Aki Yaa)
|
increased monocyte cell number
|
J:137656
|
Nba10NZB/Nba10NZB
X/Yaa
(C57BL/6-Nba2 Yaa)
|
increased monocyte cell number
|
J:137656,
J:129409
|
Nbnem7Jpt/Nbntm2Zqw
Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd)
|
abnormal T cell morphology
|
J:277750
|
| absent mature B cells
|
J:277750
|
| decreased B cell number
|
J:277750
|
| decreased T cell number
|
J:277750
|
| decreased thymocyte number
|
J:277750
|
| increased CD8-positive, alpha-beta T cell number
|
J:277750
|
| increased pro-B cell number
|
J:277750
|
Nbntm1Xu/Nbntm1Xu
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:75272
|
| decreased mature B cell number
|
J:75272
|
| decreased pre-B cell number
|
J:75272
|
| decreased T cell number
|
J:75272
|
Nbr1tm1.1Jmos/Nbr1tm1.1Jmos
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:165438
|
| abnormal T-helper 2 cell differentiation
|
J:165438
|
Ncaph2nes/Ncaph2nes
(C57BL/6JSfdAnu-Ncaph2nes/Anu)
|
abnormal double-negative T cell morphology
|
J:123300
|
| abnormal T cell morphology
|
J:123300
|
| decreased CD8-positive, alpha-beta T cell number
|
J:123300
|
| decreased double-negative T cell number
|
J:123300
|
| decreased double-positive T cell number
|
J:123300
|
| decreased T cell number
|
J:123300
|
| decreased thymocyte number
|
J:123300
|
Ncaph2nes/Ncaph2nes
Tg(TcrHEL3A9)1Mmd/0
(C57BL/6-Ncaph2nes Tg(TcrHEL3A9)1Mmd)
|
abnormal double-negative T cell morphology
|
J:123300
|
| decreased double-positive T cell number
|
J:123300
|
Ncf2tm1a(EUCOMM)Wtsi/Ncf2tm1a(EUCOMM)Wtsi
(C57BL/6N-Ncf2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
Ncf2tm1b(EUCOMM)Wtsi/Ncf2+
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
increased activated T cell number
|
J:260777
|
| increased B cell number
|
J:260777
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:260777
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:260777
|
| increased CD8-positive, alpha-beta T cell number
|
J:260777
|
| increased follicular B cell number
|
J:260777
|
| increased germinal center B cell number
|
J:260777
|
| increased T cell number
|
J:260777
|
Ncf2tm1b(EUCOMM)Wtsi/Ncf2tm1b(EUCOMM)Wtsi
(B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
decreased CD8-positive, alpha-beta T cell number
|
J:260777
|
Ncf2tm1b(EUCOMM)Wtsi/Ncf2tm1b(EUCOMM)Wtsi
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
increased activated T cell number
|
J:260777
|
| increased B cell number
|
J:260777
|
| increased follicular B cell number
|
J:260777
|
| increased germinal center B cell number
|
J:260777
|
| increased T cell number
|
J:260777
|
Nckap1lm1Btlr/Nckap1lm1Btlr
(C57BL/6J-Nckap1lm1Btlr)
|
decreased alpha-beta T cell number
|
J:272079
|
| decreased B cell number
|
J:272079
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272079
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272079
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272079
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:272079
|
| decreased NK cell number
|
J:272079
|
| increased alpha-beta T cell number
|
J:272079
|
| increased CD8-positive, alpha-beta T cell number
|
J:272079
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272079
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272079
|
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:141377
|
| abnormal lymphopoiesis
|
J:141377
|
| abnormal regulatory T cell number
|
J:141377
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141377
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141377
|
| decreased double-positive T cell number
|
J:141377
|
| decreased lymphocyte cell number
|
J:141377
|
| decreased mature B cell number
|
J:141377
|
| decreased mature gamma-delta T cell number
|
J:141377
|
| increased double-negative T cell number
|
J:141377
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell morphology
|
J:109522
|
| abnormal lymphopoiesis
|
J:109522
|
| increased B cell number
|
J:109522
|
| increased CD4-positive, alpha-beta T cell number
|
J:109522
|
| increased CD8-positive, alpha-beta T cell number
|
J:109522
|
| increased lymphocyte cell number
|
J:109522
|
Ncor1tm1Rsd/Ncor1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
arrested T cell differentiation
|
J:65417
|
Ncor2tm1Rev/Ncor2tm1Rev
(involves: 129/Sv * C57BL/6)
|
increased osteoclast cell number
|
J:202976
|
Ncr1noe/Ncr1noe
(involves: C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:179728
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:179728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:179728
|
| increased NK cell number
|
J:179728
|
Ncr1tm1Oman/Ncr1tm1Oman
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased NK cell number
|
J:112394
|
Ncstntm1.1Akli/Ncstntm1.1Akli
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
increased monocyte cell number
|
J:172442
|
Ncstntm1.1Akli/Ncstntm1.1Akli
Tg(VAV1-cre)1Graf/0
(involves: 129 * C57BL/6 * SJL)
|
increased monocyte cell number
|
J:172442
|
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased activated T cell number
|
J:116617
|
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd)
|
increased activated T cell number
|
J:205692
|
Ndfip1kru/Ndfip1kru
(involves: C57BL/6JSfdAnu)
|
increased T-helper 2 cell number
|
J:188722
|
Ndfip1tm1.1Pmo/Ndfip1tm1.1Pmo
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:205692
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rnpc3tm1c(EUCOMM)Wtsi/Rnpc3tm1c(EUCOMM)Wtsi
(involves: 129S/SvEv * C57BL/6 * C57BL/6N)
|
decreased lymphocyte cell number
|
J:267519
|
| decreased monocyte cell number
|
J:267519
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rragatm2Dmsa/Rragatm2Dmsa
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:213516
|
| increased monocyte cell number
|
J:213516
|
Ndst3tm1.1Grob/Ndst3tm1.1Grob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:138557
|
| decreased lymphocyte cell number
|
J:138557
|
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(involves: 129S4/SvJaeSor)
|
microgliosis
|
J:161393
|
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(B6.129S4-Ndufs4tm1.1Rpa)
|
microgliosis
|
J:190475
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa
(B6.129S4-Ndufs4tm1Rpa)
|
microgliosis
|
J:190475
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
microgliosis
|
J:161393
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Tg(Nes-cre)1Kln/0
(B6.Cg-Tg(Nes-cre)1Kln Ndufs4tm1Rpa)
|
microgliosis
|
J:190475
|
Nedd4Gt(XA209)Byg/Nedd4Gt(XA209)Byg
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:143560
|
| increased CD4-positive, alpha-beta T cell number
|
J:143560
|
| increased CD8-positive, alpha-beta T cell number
|
J:143560
|
| increased T cell number
|
J:143560
|
Nedd4Gt(XB398)Byg/Nedd4Gt(XB398)Byg
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:143560
|
| increased CD4-positive, alpha-beta T cell number
|
J:143560
|
| increased CD8-positive, alpha-beta T cell number
|
J:143560
|
| increased T cell number
|
J:143560
|
Nedd4tm2b(EUCOMM)Hmgu/Nedd4+
(C57BL/6N-Nedd4tm2b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
Nedd9m1Btlr/Nedd9m1Btlr
(C57BL/6J-Nedd9m1Btlr)
|
decreased B-1a cell number
|
J:267702
|
| decreased B-1b cell number
|
J:267702
|
Nedd9tm1Miku/Nedd9tm1Miku
(B6.CBA-Nedd9tm1Miku)
|
abnormal B cell number
|
J:116716
|
| decreased lymphocyte cell number
|
J:116716
|
| decreased marginal zone B cell number
|
J:116716
|
| increased follicular B cell number
|
J:116716
|
Nek8m1Btlr/Nek8m1Btlr
(C57BL/6J-Nek8m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:267544
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:267544
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:267544
|
| increased CD4-positive, alpha-beta T cell number
|
J:267544
|
Neu1a/Neu1a
(SM/J)
|
abnormal Kupffer cell morphology
|
J:147881
|
Neu1tm1Adz/Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))
|
abnormal Kupffer cell morphology
|
J:76937
|
| abnormal microglial cell morphology
|
J:76937
|
Nexmifem1(IMPC)Tcp/Y
(C57BL/6N-Nexmifem1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Nf1tm1Fcr/Nf1+
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Nf1tm1Fcr Ptentm1Hwu)
|
decreased B cell number
|
J:232645
|
| decreased lymphocyte cell number
|
J:232645
|
| decreased T cell number
|
J:232645
|
| increased macrophage cell number
|
J:232645
|
| increased monocyte cell number
|
J:232645
|
Nf1tm1Par/Nf1tm1Fcr
Tg(GFAP-cre)#Gtm/0
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal microglial cell morphology
|
J:165209
|
Nf1tm1Par/Nf1tm1Par
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased lymphocyte cell number
|
J:90973
|
| increased monocyte cell number
|
J:90973
|
Nf1tm1Par/Nf1tm1Par
Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * SJL/J)
|
increased osteoclast cell number
|
J:193350
|
Nfatc1tm1Glm/Nfatc1tm2Glm
(chimera involves: 129S2/SvPas)
|
abnormal lymphocyte cell number
|
J:78376
|
| decreased double-positive T cell number
|
J:78376
|
| decreased lymphocyte cell number
|
J:78376
|
| increased double-negative T cell number
|
J:78376
|
Nfatc1tm1Rao/Nfatc1tm1Rao
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
abnormal class switch recombination
|
J:177319
|
| decreased B cell number
|
J:177319
|
| decreased B-1a cell number
|
J:177319
|
Nfatc1tm1Rao/Nfatc1tm1Rao
Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:177319
|
Nfatc1tm3Glm/Nfatc1tm3Glm
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal osteoclast differentiation
|
J:144598
|
| decreased osteoclast cell number
|
J:144598
|
Nfatc1tm3Glm/Nfatc1tm3Glm
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal osteoclast differentiation
|
J:144598
|
| decreased osteoclast cell number
|
J:144598
|
Nfatc2tm1Glm/Nfatc2tm1Glm
Nfatc3tm1Glm/Nfatc3tm1Glm
(involves: 129S2/SvPas)
|
abnormal lymphocyte cell number
|
J:51339
|
| decreased T cell number
|
J:51339
|
| increased B cell number
|
J:51339
|
| increased T cell number
|
J:51339
|
Nfatc2tm1Rao/Nfatc2tm1Rao
Nfatc3tm1Grc/Nfatc3tm1Grc
Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal double-negative T cell morphology
|
J:141917
|
| abnormal T cell differentiation
|
J:141917
|
Nfatc2tm1Srf/Nfatc2tm1Srf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:110686
|
| increased activated T cell number
|
J:110686
|
Nfatc2tm1Srf/Nfatc2tm1Srf
(involves: 129P2/OlaHsd)
|
increased B cell number
|
J:45252
|
| increased lymphocyte cell number
|
J:45252
|
| increased T cell number
|
J:45252
|
Nfatc2iptm1.1Glm/Nfatc2iptm1.1Glm
(either: B6.129-Nfatc2iptm1.1Glm or C.129-Nfatc2iptm1.1Glm)
|
decreased T-helper 2 cell number
|
J:157559
|
Nfatc3tm1Glm/Nfatc3tm1Glm
Tg(DO11.10)10Dlo/?
(involves: 129S2/SvPas * BALB/c * C3H * C57BL/6)
|
decreased double-positive T cell number
|
J:50124
|
| increased double-negative T cell number
|
J:50124
|
Nfatc3tm1Grc/Nfatc3tm1Grc
Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal T cell differentiation
|
J:141917
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141917
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141917
|
| decreased thymocyte number
|
J:141917
|
| increased double-negative T cell number
|
J:141917
|
Nfe2tm1Sho/Nfe2tm1Sho
(involves: 129/Sv * 129S4/SvJae)
|
increased osteoclast cell number
|
J:111270
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR)
|
decreased CD4-positive, alpha-beta T cell number
|
J:104016
|
| decreased T cell number
|
J:104016
|
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(involves: 129X1/SvJ)
|
increased macrophage cell number
|
J:100106
|
Nfil3tm1.1Brad/Nfil3+
(B6.Cg-Nfil3tm1.1Brad)
|
decreased NK cell number
|
J:152774
|
Nfil3tm1.1Brad/Nfil3tm1.1Brad
(B6.Cg-Nfil3tm1.1Brad)
|
abnormal NK cell differentiation
|
J:152774
|
| decreased NK cell number
|
J:152774
|
| increased memory T cell number
|
J:152774
|
| increased NK T cell number
|
J:152774
|
Nfil3tm1Look/Nfil3tm1Look
(B6.129X1-Nfil3tm1Look)
|
abnormal NK cell differentiation
|
J:155677
|
| decreased NK cell number
|
J:155677
|
Nfil3tm1Pbro/Nfil3tm1Pbro
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:156521
|
Nfil3tm1Pbro/Nfil3tm1Pbro
(B6.129S6-Nfil3tm1Pbro)
|
abnormal plasma cell morphology
|
J:209365
|
| decreased NK cell number
|
J:209365
|
| increased T-helper 17 cell number
|
J:209365
|
Nfkb1m2Btlr/Nfkb1+
(C57BL/6J-Nfkb1m2Btlr)
|
decreased central memory CD4-positive, alpha-beta T cell number
|
J:254822
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:254822
|
Nfkb1m2Btlr/Nfkb1m2Btlr
(C57BL/6J-Nfkb1m2Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:254822
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:254822
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:254822
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254822
|
Nfkb1M3Btlr/Nfkb1+
(C57BL/6J-Nfkb1M3Btlr)
|
increased central memory CD8 positive, alpha-beta T cell number
|
J:254821
|
Nfkb1M3Btlr/Nfkb1M3Btlr
(C57BL/6J-Nfkb1M3Btlr)
|
increased central memory CD8 positive, alpha-beta T cell number
|
J:254821
|
Nfkb1M4Btlr/Nfkb1M4Btlr
(C57BL/6J-Nfkb1M4Btlr)
|
decreased B-1 B cell number
|
J:265169
|
Nfkb1M5Btlr/Nfkb1M5Btlr
(C57BL/6J-Nfkb1M5Btlr)
|
decreased B-1a cell number
|
J:272117
|
Nfkb1tm1a(KOMP)Wtsi/Nfkb1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased NK cell number
|
J:213427
|
| decreased regulatory T cell number
|
J:213427
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:30268
|
| decreased myeloid dendritic cell number
|
J:77049
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(involves: 129P2/OlaHsd)
|
decreased marginal zone B cell number
|
J:65246
|
Nfkb1tm1Bal/Nfkb1tm1Bal
Nfkb2tm1Sbn/Nfkb2tm1Sbn
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal osteoclast differentiation
|
J:45119
|
| arrested B cell differentiation
|
J:45119
|
| decreased B cell number
|
J:45119
|
| decreased CD4-positive, alpha-beta T cell number
|
J:45119
|
| decreased CD8-positive, alpha-beta T cell number
|
J:45119
|
| decreased double-positive T cell number
|
J:45119
|
| decreased mature B cell number
|
J:45119
|
| decreased osteoclast cell number
|
J:45119
|
| decreased single-positive T cell number
|
J:45119
|
| decreased T cell number
|
J:45119
|
| increased macrophage cell number
|
J:45119
|
Nfkb1tm1Bal/Nfkb1tm1Bal
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Nfkb1tm1Bal Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
| decreased marginal zone B cell number
|
J:113556
|
| increased transitional stage B cell number
|
J:113556
|
Nfkb1tm1Brv/Nfkb1tm1Brv
(involves: 129S1/Sv)
|
decreased single-positive T cell number
|
J:46912
|
Nfkb1tm1Brv/Nfkb1tm1Brv
(involves: 129S1/Sv * C57BL/6)
|
decreased osteoclast cell number
|
J:44112
|
Nfkb1tm1Brv/Nfkb1tm1Brv
Nfkb2tm1Brv/Nfkb2+
(involves: 129S1/Sv * C57BL/6)
|
abnormal osteoclast differentiation
|
J:44112
|
| decreased osteoclast cell number
|
J:44112
|
Nfkb1tm1Brv/Nfkb1tm1Brv
Nfkb2tm1Brv/Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6)
|
abnormal osteoclast differentiation
|
J:44112
|
| decreased osteoclast cell number
|
J:44112
|
| increased macrophage cell number
|
J:44112
|
Nfkb1tm1Sley/Nfkb1tm1Sley
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased memory T cell number
|
J:142340
|
| decreased regulatory T cell number
|
J:142340
|
Nfkb1tm1Sley/Nfkb1tm1Sley
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/6)
|
decreased memory T cell number
|
J:142340
|
| decreased NK T cell number
|
J:142340
|
| decreased regulatory T cell number
|
J:142340
|
Nfkb2Lym1/Nfkb2+
(BALB/c-Nfkb2Lym1)
|
increased lymphocyte cell number
|
J:154812
|
Nfkb2Lym1/Nfkb2+
(involves: BALB/c)
|
abnormal B cell differentiation
|
J:188560
|
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c)
|
abnormal class switch recombination
|
J:154812
|
| abnormal osteoclast differentiation
|
J:154812
|
| abnormal plasma cell differentiation
|
J:154812
|
| abnormal T cell differentiation
|
J:154812
|
| decreased follicular B cell number
|
J:154812
|
| decreased marginal zone B cell number
|
J:154812
|
| decreased mature B cell number
|
J:154812
|
| decreased transitional stage B cell number
|
J:154812
|
| increased CD4-positive, alpha-beta T cell number
|
J:154812
|
| increased CD8-positive, alpha-beta T cell number
|
J:154812
|
| increased double-negative T cell number
|
J:154812
|
| increased double-positive T cell number
|
J:154812
|
| increased transitional stage B cell number
|
J:154812
|
Nfkb2m2Btlr/Nfkb2m2Btlr
(C57BL/6J-Nfkb2m2Btlr)
|
increased B-1a cell number
|
J:221493
|
Nfkb2m3Btlr/Nfkb2m3Btlr
(C57BL/6J-Nfkb2m3Btlr)
|
abnormal B cell differentiation
|
J:274960
|
| abnormal CD4-positive T cell differentiation
|
J:274960
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274960
|
| abnormal T cell differentiation
|
J:274960
|
| decreased B cell number
|
J:274960
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274960
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:274960
|
| decreased NK cell number
|
J:274960
|
| increased B-1 B cell number
|
J:274960
|
| increased CD4-positive, alpha-beta T cell number
|
J:274960
|
| increased CD8-positive, alpha-beta T cell number
|
J:274960
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:274960
|
| increased T cell number
|
J:274960
|
Nfkb2M4Btlr/Nfkb2M4Btlr
(C57BL/6J-Nfkb2M4Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:274961
|
| increased CD8-positive, alpha-beta T cell number
|
J:274961
|
| increased T cell number
|
J:274961
|
Nfkb2m5Btlr/Nfkb2m5Btlr
(C57BL/6J-Nfkb2m5Btlr)
|
increased B-1 B cell number
|
J:274962
|
Nfkb2tm1Brv/Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6)
|
abnormal lymphocyte cell number
|
J:43469
|
| abnormal T cell number
|
J:43469
|
| abnormal T cell subpopulation ratio
|
J:43469
|
| decreased double-positive T cell number
|
J:43469
|
Nfkb2tm1Rsch/Nfkb2tm1Rsch
(involves: 129P2/OlaHsd)
|
abnormal myeloid dendritic cell morphology
|
J:77049
|
| decreased B cell number
|
J:77049
|
| decreased myeloid dendritic cell number
|
J:77049
|
Nfkb2tm1Sbn/Nfkb2tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:45437
|
| abnormal lymphocyte cell number
|
J:45437
|
| abnormal metallophilic macrophage morphology
|
J:45437
|
| abnormal spleen marginal zone macrophage morphology
|
J:45437
|
| decreased B cell number
|
J:45437
|
| increased T cell number
|
J:45437
|
Nfkb2tm2Brv/Nfkb2tm2Brv
(involves: 129S1/Sv * C57BL/6)
|
abnormal metallophilic macrophage morphology
|
J:76380
|
| decreased B cell number
|
J:76380
|
| increased CD4-positive, alpha-beta T cell number
|
J:76380
|
| increased CD8-positive, alpha-beta T cell number
|
J:76380
|
Nfkb2tm2Brv/Nfkb2tm2Brv
(involves: 129S1/Sv)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
| decreased gamma-delta T cell number
|
J:169863
|
Nfkb2tm2Brv/Nfkb2tm2Brv
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Nfkb2tm2Brv Tg(Tnfsf13b)1Fma)
|
decreased marginal zone B cell number
|
J:113556
|
Nfkb2xdr/Nfkb2xdr
(C57BL/6JSfdAnu-Nfkb2xdr/Anu)
|
abnormal metallophilic macrophage morphology
|
J:79725
|
| decreased B-2 B cell number
|
J:79725
|
| decreased follicular B cell number
|
J:79725
|
| decreased marginal zone B cell number
|
J:79725
|
| decreased mature B cell number
|
J:79725
|
| decreased transitional stage T2 B cell number
|
J:79725
|
| increased B-1 B cell number
|
J:79725
|
Nfkb2xdr/Nfkb2xdr
(involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd * NOD)
|
decreased B cell number
|
J:79725
|
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6)
|
abnormal T cell number
|
J:163686
|
| decreased CD4-positive, alpha-beta T cell number
|
J:163686
|
| decreased CD8-positive, alpha-beta T cell number
|
J:163686
|
| increased activated T cell number
|
J:163686
|
| increased double-positive T cell number
|
J:163686
|
| increased memory T cell number
|
J:163686
|
| increased thymocyte number
|
J:163686
|
Nfkbiatm1.1Smiy/Nfkbia+
(B6.129-Nfkbiatm1.1Smiy)
|
decreased B cell number
|
J:168977
|
| decreased follicular B cell number
|
J:168977
|
| decreased marginal zone B cell number
|
J:168977
|
| decreased transitional stage T2 B cell number
|
J:168977
|
| increased pro-B cell number
|
J:168977
|
Nfkbiatm1.1Smiy/Nfkbiatm1.1Smiy
(B6.129-Nfkbiatm1.1Smiy)
|
abnormal B cell differentiation
|
J:168977
|
| abnormal marginal zone B cell morphology
|
J:168977
|
| decreased B cell number
|
J:168977
|
| decreased B-2 B cell number
|
J:168977
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:168977
|
| decreased follicular B cell number
|
J:168977
|
| decreased marginal zone B cell number
|
J:168977
|
| decreased mature B cell number
|
J:168977
|
| decreased regulatory T cell number
|
J:168977
|
| decreased transitional stage T2 B cell number
|
J:168977
|
| increased immature B cell number
|
J:168977
|
| increased pre-B cell number
|
J:168977
|
| increased pro-B cell number
|
J:168977
|
Nfkbiatm1Bal/Nfkbiatm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
decreased double-positive T cell number
|
J:30058
|
Nfkbiatm1Bal/Nfkbiatm1Bal
Nfkbietm1Syme/Nfkbietm1Syme
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:88142
|
| abnormal T cell differentiation
|
J:88142
|
| decreased immature B cell number
|
J:88142
|
| decreased pre-B cell number
|
J:88142
|
Nfkbiatm1Fey/Nfkbiatm1Fey
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:110817
|
| decreased double-negative T cell number
|
J:110817
|
| decreased thymocyte number
|
J:110817
|
| increased single-positive T cell number
|
J:110817
|
Nfkbiatm1Stw/Nfkbiatm1Stw
(involves: 129S1/Sv)
|
increased macrophage cell number
|
J:32527
|
| increased monocyte cell number
|
J:32527
|
Nfkbibtm1.2Rsch/Nfkbibtm1.2Rsch
(B6.129P2-Nfkbibtm1.2Rsch)
|
decreased B cell number
|
J:176877
|
| increased macrophage cell number
|
J:176877
|
| increased marginal zone B cell number
|
J:176877
|
| increased memory T cell number
|
J:176877
|
Nfkbidm1Btlr/Nfkbidm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| absent marginal zone B cells
|
J:185495
|
| decreased B-1 B cell number
|
J:185495
|
| decreased B-1a cell number
|
J:185495
|
Nfkbidtm1a(EUCOMM)Wtsi/Nfkbid+
(C57BL/6N-Nfkbidtm1a(EUCOMM)Wtsi/Cnrm)
|
decreased B cell number
|
J:165965
|
Nfkbidtm1a(EUCOMM)Wtsi/Nfkbidtm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:185495
|
Nfkbietm1Syme/Nfkbietm1Syme
(either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal double-negative T cell morphology
|
J:88538
|
Nfkbiztm1Aki/Nfkbiztm1Aki
(involves: 129P2/OlaHsd)
|
abnormal lymphocyte morphology
|
J:194832
|
| abnormal T-helper 1 cell morphology
|
J:194832
|
Ngfrtm1Jae/Ngfrtm1Jae
(B6.129S4-Ngfrtm1Jae)
|
abnormal Kupffer cell morphology
|
J:120368
|
Nhej1tm1.1Ics/Nhej1+
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:194422
|
Nhej1tm1.1Ics/Nhej1tm1.1Ics
(involves: 129 * C57BL/6)
|
abnormal T cell receptor V(D)J recombination
|
J:194422
|
| decreased lymphocyte cell number
|
J:194422
|
| decreased NK T cell number
|
J:194422
|
| decreased thymocyte number
|
J:194422
|
Nhej1tm1.1Ics/Nhej1tm1.1Ics
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell receptor V(D)J recombination
|
J:194422
|
| decreased NK T cell number
|
J:194422
|
Nhej1tm1Fwa/Nhej1tm1Fwa
(involves: 129)
|
abnormal class switch recombination
|
J:138774
|
Niban3tm1Jyw/Niban3tm1Jyw
(B6.Cg-Niban3tm1Jyw)
|
abnormal B cell differentiation
|
J:282961
|
| abnormal class switch recombination
|
J:282961
|
| abnormal transitional stage B cell morphology
|
J:282961
|
| decreased B-1a cell number
|
J:282961
|
| increased B cell number
|
J:282961
|
| increased follicular B cell number
|
J:282961
|
| increased transitional stage T2 B cell number
|
J:282961
|
Nipal3tm1Pbfd/Nipal3tm1Pbfd
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased NK cell number
|
J:152829
|
Nipsnap3atm1b(KOMP)Wtsi/Nipsnap3atm1b(KOMP)Wtsi
(C57BL/6N-Nipsnap3atm1b(KOMP)Wtsi/Wtsi)
|
increased effector memory T-helper cell number
|
J:211773
|
Nkaptm1.1Viss/Y
Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:165961
|
| decreased CD4-positive, alpha-beta T cell number
|
J:165961
|
| decreased CD8-positive, alpha-beta T cell number
|
J:165961
|
| decreased DN4 thymocyte number
|
J:165961
|
| decreased double-positive T cell number
|
J:165961
|
| decreased thymocyte number
|
J:165961
|
| increased DN3 thymocyte number
|
J:165961
|
Nkg7tm1.1(KOMP)Vlcg/Nkg7tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:301637
|
| abnormal mononuclear cell morphology
|
J:301637
|
| decreased CD4-positive, alpha-beta T cell number
|
J:301637
|
| decreased T helper 1 cell number
|
J:301637
|
Nktcn1C57BL/6J/Nktcn1C57BL/6J
(involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))
|
increased NK T cell number
|
J:85376
|
Nktcn1C57BL/6J/Nktcn1C57BL/6J
(NOD.B6-(D1Mit369-D1Mit155)(D6Mit105-D6Mit135))
|
abnormal T cell differentiation
|
J:137521
|
| increased NK T cell number
|
J:137521
|
Nktcn1C57BL/6J/Nktcn1NOD/ShiLt
(involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))
|
increased NK T cell number
|
J:85376
|
Nktcn2C57BL/6J/Nktcn2C57BL/6J
(involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))
|
increased NK T cell number
|
J:85376
|
Nktcn2C57BL/6J/Nktcn2NOD/ShiLt
(involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))
|
increased NK T cell number
|
J:85376
|
Nkx2-3tm1Hha/Nkx2-3tm1Hha
(involves: 129S4/SvJae)
|
abnormal marginal zone B cell morphology
|
J:62129
|
| abnormal metallophilic macrophage morphology
|
J:62129
|
| abnormal spleen marginal zone macrophage morphology
|
J:62129
|
| absent marginal zone B cells
|
J:62129
|
| decreased B cell number
|
J:62129
|
| decreased lymphocyte cell number
|
J:62129
|
| decreased T cell number
|
J:62129
|
Nkx2-3tm1Rph/Nkx2-3tm1Rph
(involves: 129S1/Sv * C57BL/6)
|
abnormal metallophilic macrophage morphology
|
J:64018
|
| decreased CD4-positive, alpha-beta T cell number
|
J:64018
|
| decreased plasma cell number
|
J:64018
|
Nle1tm1Cba/Nle1tm1.1Cota
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased macrophage cell number
|
J:204063
|
| decreased NK cell number
|
J:204063
|
| decreased T cell number
|
J:204063
|
Nlktm1Tbo/Nlktm1Tbo
(129S1/Sv-Nlktm1Tbo)
|
decreased double-positive T cell number
|
J:73353
|
| decreased gamma-delta T cell number
|
J:73353
|
| decreased lymphocyte cell number
|
J:73353
|
| decreased NK cell number
|
J:73353
|
| decreased pro-B cell number
|
J:73353
|
| decreased thymocyte number
|
J:73353
|
Nlrc3tm1Bhk/Nlrc3tm1Bhk
(B6.129S6-Nlrc3tm1Bhk)
|
increased monocyte cell number
|
J:187586
|
Nlrc5tm1.1Ggaur/Nlrc5tm1.1Ggaur
(involves: BALB/cJ)
|
decreased CD8-positive, alpha-beta T cell number
|
J:184076
|
Nlrp1am1Btlr/Nlrp1am1Btlr
(C57BL/6J-Nlrp1am1Btlr)
|
decreased B cell number
|
J:265173
|
| decreased B-1 B cell number
|
J:265173
|
| decreased B-1b cell number
|
J:265173
|
| decreased B-2 B cell number
|
J:265173
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265173
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:265173
|
| decreased NK cell number
|
J:265173
|
| decreased single-positive T cell number
|
J:265173
|
| decreased T cell number
|
J:265173
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265173
|
Nlrp1am2Btlr/Nlrp1am2Btlr
(C57BL/6J-Nlrp1am2Btlr)
|
decreased B cell number
|
J:265174
|
| decreased NK cell number
|
J:265174
|
Nlrp1aNeut1/Nlrp1aNeut1
(C.B6-Nlrp1aNeut1)
|
decreased lymphocyte cell number
|
J:191055
|
| decreased macrophage cell number
|
J:191055
|
Nlrp3tm1Hhf/Nlrp3+
Rag1tm1Mom/Rag1tm1Mom
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
absent B cells
|
J:150054
|
| absent T cells
|
J:150054
|
Nlrp3tm1Wstr/Nlrp3+
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:150053
|
| increased activated T cell number
|
J:150053
|
| increased T-helper 1 cell number
|
J:150053
|
Nlrp3tm3.1Hhf/Nlrp3+
(involves: 129)
|
abnormal osteoclast differentiation
|
J:202147
|
| decreased lymphocyte cell number
|
J:202147
|
| increased lymphocyte cell number
|
J:202147
|
| increased monocyte cell number
|
J:202147
|
| increased osteoclast cell number
|
J:202147
|
Nlrp6tm1Flv/Nlrp6tm1Flv
(B6.Cg-Nlrp6tm1Flv)
|
increased B cell number
|
J:173245
|
Nmt1tm1.1Poru/Nmt1tm1.1Poru
Nmt2tm1.1Poru/Nmt2tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:226234
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:226234
|
| decreased DN4 thymocyte number
|
J:226234
|
| decreased double-positive T cell number
|
J:226234
|
| decreased single-positive T cell number
|
J:226234
|
| decreased T cell number
|
J:226234
|
| increased double-negative T cell number
|
J:226234
|
| increased gamma-delta T cell number
|
J:226234
|
Nmt1tm1.1Poru/Nmt1tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:226234
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:226234
|
| decreased double-positive T cell number
|
J:226234
|
| decreased single-positive T cell number
|
J:226234
|
| decreased T cell number
|
J:226234
|
Nmt2tm1.1Poru/Nmt2tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased double-positive T cell number
|
J:226234
|
| decreased single-positive T cell number
|
J:226234
|
| decreased T cell number
|
J:226234
|
Noc2ltm1.1Arte/Noc2ltm1.1Arte
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal B cell morphology
|
J:216490
|
| abnormal T cell morphology
|
J:216490
|
| absent T cells
|
J:216490
|
| arrested T cell differentiation
|
J:216490
|
| decreased alpha-beta T cell number
|
J:216490
|
| decreased DN3 thymocyte number
|
J:216490
|
| decreased DN4 thymocyte number
|
J:216490
|
| decreased double-positive T cell number
|
J:216490
|
| decreased immature B cell number
|
J:216490
|
| decreased mature B cell number
|
J:216490
|
| decreased pre-B cell number
|
J:216490
|
| decreased pro-B cell number
|
J:216490
|
| decreased single-positive T cell number
|
J:216490
|
Noc2ltm1.1Arte/Noc2ltm1.1Arte
Trp53tm1Brn/Trp53tm1Brn
Tg(CD2-icre)4Kio/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased pre-B cell number
|
J:216490
|
Nod2tm1Jhgt/Nod2tm1Jhgt
(B6.Cg-Nod2tm1Jhgt)
|
increased CD4-positive, alpha-beta T cell number
|
J:124575
|
| increased double-negative T cell number
|
J:124575
|
Nod2tm1Mka/Nod2tm1Mka
(involves: C57BL/6)
|
abnormal macrophage morphology
|
J:96128
|
Nodaltm1b(EUCOMM)Wtsi/Nodal+
(C57BL/6N-Nodaltm1b(EUCOMM)Wtsi/H)
|
increased large unstained cell number
|
J:211773
|
Nop53tm2.1Asuz/Nop53tm2.1Asuz
Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:241062
|
Nop53tm2.1Asuz/Nop53tm2.1Asuz
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:241062
|
Nos1tm1Plh/Nos1tm1Plh
(B6;129S4-Nos1tm1Plh/J)
|
abnormal osteoclast differentiation
|
J:105612
|
Nos1tm1Plh/Nos1tm1Plh
Nos2tm1Mrl/Nos2tm1Mrl
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
increased osteoclast cell number
|
J:150159
|
Nos2tm1Lau/Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6)
|
increased single-positive T cell number
|
J:90903
|
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau)
|
abnormal osteoclast morphology
|
J:112399
|
Nos2tm1Mrl/Nos2tm1Mrl
(B6.129S7-Nos2tm1Mrl)
|
abnormal osteoclast differentiation
|
J:98070
|
| abnormal osteoclast morphology
|
J:98070
|
| decreased osteoclast cell number
|
J:98070
|
Nos3em1(IMPC)Mbp/Nos3em1(IMPC)Mbp
(C57BL/6N-Nos3em1(IMPC)Mbp/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
Notch1tm1Agt/Notch1tm1Agt
Notch2tm1Frad/Notch2tm1Frad
Tg(Mx1-cre)1Cgn/0
(involves: 129 * BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:125373
|
| arrested T cell differentiation
|
J:125373
|
Notch1tm1Agt/Notch1tm1Agt
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:125373
|
| abnormal T cell differentiation
|
J:125373,
J:55400
|
| decreased CD4-positive, alpha-beta T cell number
|
J:55400
|
| decreased CD8-positive, alpha-beta T cell number
|
J:55400
|
| decreased double-negative T cell number
|
J:55400
|
| decreased double-positive T cell number
|
J:55400
|
| decreased single-positive T cell number
|
J:55400
|
| decreased thymocyte number
|
J:55400
|
| increased immature B cell number
|
J:143472
|
Notch1tm2Pst/Notch1tm2Pst
(B6.Cg-Notch1tm2Pst)
|
abnormal T cell differentiation
|
J:131563
|
| decreased double-negative T cell number
|
J:131563
|
| decreased T cell number
|
J:131563
|
| decreased thymocyte number
|
J:131563
|
Notch2Gt(betageo)1Byg/Notch2+
(B6.129P2-Notch2Gt(betageo)1Byg)
|
decreased marginal zone B cell number
|
J:146621
|
Notch2tm1.1Ecan/Notch2+
(involves: 129 * 129S1/Sv * C57BL/6J)
|
abnormal osteoclast differentiation
|
J:230045
|
| abnormal osteoclast morphology
|
J:230045
|
| increased osteoclast cell number
|
J:230045
|
Notch2tm1.1Hhtg/Notch2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal osteoclast differentiation
|
J:311038
|
| increased osteoclast cell number
|
J:311038
|
Notch2tm1Frad/Notch2tm1Frad
Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:125373
|
| absent marginal zone B cells
|
J:125373
|
Notch2tm1Yha/Notch2+
(B6.129-Notch2tm1Yha)
|
decreased B-1 B cell number
|
J:85379
|
| decreased marginal zone B cell number
|
J:85379
|
Notch2tm2.1Ecan/Notch2tm2.1Ecan
Tg(BGLAP-cre)1Clem/0
(involves: C57BL/6J * FVB/NJ)
|
increased osteoclast cell number
|
J:246017
|
Notch2tm2Hhi/Notch2tm1.1Hhi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased marginal zone B cell number
|
J:83476
|
Notch3em1Ecan/Notch3+
(C57BL/6J-Notch3em1Ecan)
|
abnormal osteoclast differentiation
|
J:270682
|
| increased osteoclast cell number
|
J:270682
|
Notch3tm1Khan/Notch3tm1Khan
(involves: C57BL/6 * CBA)
|
decreased thymocyte number
|
J:98284
|
Npas2em1(IMPC)Mbp/Npas2em1(IMPC)Mbp
(C57BL/6N-Npas2em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Npc1m1N/Npc1m1N
(involves: BALB/c)
|
abnormal alveolar macrophage morphology
|
J:204311
|
Npc1m1N/Npc1m1N
(BALB/cNctr-Npc1m1N/J)
|
microgliosis
|
J:209834
|
Npc1m1N/Npc1m1N
(B6.C-Npc1m1N)
|
microgliosis
|
J:157113
|
Npc1m1N/Npc1m1N
(BALB/c-Npc1m1N)
|
abnormal macrophage morphology
|
J:221855
|
| increased macrophage derived foam cell number
|
J:221855
|
Npc1m1N/Npc1m1N
(involves: BALB/c * C3H/HeJ * C57BL/6J)
|
microgliosis
|
J:188345
|
Npc1m1N/Npc1m1N
Tg(PRNP-APPSweInd)8Dwst/0
(involves: BALB/c * C3H/HeJ * C57BL/6J)
|
microgliosis
|
J:188345
|
Npc1m1N/Npc1tm1.1Apl
Tg(CAG-cre/Esr1*)5Amc/0
(B6J.Cg-Npc1m1N/Npc1tm1.1Apl Tg(CAG-cre/Esr1*)5Amc)
|
microgliosis
|
J:176888
|
Npc1m1N/Npc1tm1.1Apl
Tg(Syn1-cre)671Jxm/0
(B6J.Cg-Npc1m1N/Npc1tm1.1Apl Tg(Syn1-cre)671Jxm)
|
microgliosis
|
J:176888
|
Npc1m1N/Npc1tm1.2Apl
(B6.Cg-Npc1m1N/Npc1tm1.2Apl)
|
microgliosis
|
J:157113
|
Npc1nmf164/Npc1nmf164
(C57BL/6J-Npc1nmf164/J)
|
increased macrophage derived foam cell number
|
J:179744
|
Npc1spm/Npc1spm
(C57BLKS/J-Npc1spm/J)
|
increased macrophage derived foam cell number
|
J:7245
|
Npc1tm1.1Apl/Npc1tm1.2Apl
Tg(Pcp2-cre)2Mpin/0
(B6.Cg-Npc1tm1.1Apl/Npc1tm1.2Apl Tg(Pcp2-cre)2Mpin)
|
microgliosis
|
J:157113
|
Npc1tm1.1Dso/Npc1tm1.1Dso
(B6.129-Npc1tm1.1Dso)
|
abnormal macrophage morphology
|
J:221855
|
| increased macrophage cell number
|
J:221855
|
| increased macrophage derived foam cell number
|
J:221855
|
| microgliosis
|
J:221855
|
Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * C57BL/6)
|
decreased NK cell number
|
J:125609
|
Npc2tm1Plob/Npc2tm1Plob
(C.129S1-Npc2tm1Plob)
|
decreased NK cell number
|
J:125609
|
Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * BALB/c)
|
abnormal alveolar macrophage morphology
|
J:204311
|
Npffr2tm1.2Ics/Npffr2tm1.2Ics
(involves: C57BL/6N)
|
decreased macrophage cell number
|
J:245025
|
Npm1tm1Gsva/Npm1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:172071
|
Npm1tm1Hft/Npm1+
(involves: 129)
|
increased monocyte cell number
|
J:194999
|
Npr3tm1Unc/Npr3tm1Unc
(involves: 129 * C57BL/6)
|
abnormal osteoclast morphology
|
J:56058
|
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6)
|
abnormal T cell number
|
J:118850
|
| decreased B cell number
|
J:118850
|
| decreased CD8-positive, alpha-beta T cell number
|
J:118850
|
| decreased marginal zone B cell number
|
J:118850
|
| decreased mature B cell number
|
J:118850
|
| decreased transitional stage B cell number
|
J:118850
|
| increased CD4-positive, alpha-beta T cell number
|
J:118850
|
| increased CD8-positive, alpha-beta T cell number
|
J:118850
|
| increased single-positive T cell number
|
J:118850
|
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * BALB/cJ * C57BL/6)
|
decreased osteoclast cell number
|
J:84570
|
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
decreased osteoclast cell number
|
J:97455
|
Nqo2tm1Akj/Nqo2tm1Akj
(Not Specified)
|
abnormal lymphopoiesis
|
J:80549
|
Nr1d1tm1(KOMP)Vlcg/Nr1d1tm1(KOMP)Vlcg
(C57BL/6N-Nr1d1tm1(KOMP)Vlcg/Bay)
|
decreased NK cell number
|
J:211773
|
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased macrophage derived foam cell number
|
J:81790,
J:234268
|
Nr1h2tm1Djm/Nr1h2tm1Djm
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage morphology
|
J:125452
|
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Rag2tm1.1Cgn/Rag2tm1.1Cgn
Tg(Lck-cre)548Jxm/0
Tg(TcrAND)53Hed/0
(B6.Cg-Rag2tm1.1Cgn Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm Tg(TcrAND)53Hed)
|
decreased double-positive T cell number
|
J:189951
|
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Tcratm1Mom/Tcratm1Mom
Tg(Lck-cre)548Jxm/0
(B6.Cg-Tcratm1Mom Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased double-positive T cell number
|
J:189951
|
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased CD4-positive, alpha-beta T cell number
|
J:189951
|
| decreased CD8-positive, alpha-beta T cell number
|
J:189951
|
| decreased double-positive T cell number
|
J:189951
|
| decreased single-positive T cell number
|
J:189951
|
Nr3c1tm1Dage/Nr3c1+
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased B cell number
|
J:147914
|
Nr3c1tm1Dage/Nr3c1tm1Dage
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased B cell number
|
J:147914
|
| decreased CD4-positive, alpha-beta T cell number
|
J:147914
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147914
|
| decreased macrophage cell number
|
J:147914
|
Nr3c1tm2.1Ljm/Nr3c1tm2.1Ljm
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal monocyte cell number
|
J:197150
|
Nr4a1tm1Jmi/Nr4a1tm1Jmi
(involves: 129S2/SvPas * C57BL/6)
|
decreased Ly6C low monocyte number
|
J:239509
|
Nr4a1tm1Jmi/Nr4a1tm1Jmi
Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
decreased lymphocyte cell number
|
J:121903
|
Nr4a2tm1.1Pcn/Nr4a2+
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal regulatory T cell morphology
|
J:205658
|
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal regulatory T cell morphology
|
J:205658
|
| abnormal T-helper 1 cell differentiation
|
J:205658
|
| abnormal T-helper 17 cell differentiation
|
J:205658
|
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Tg(Lck-cre)1Jtak/0
(Not Specified)
|
abnormal regulatory T cell morphology
|
J:205658
|
| abnormal T-helper 1 cell differentiation
|
J:205658
|
| abnormal T-helper 17 cell differentiation
|
J:205658
|
| decreased regulatory T cell number
|
J:205658
|
| increased CD4-positive, alpha-beta T cell number
|
J:205658
|
| increased T-helper 1 cell number
|
J:205658
|
Nrastm1.1Emfu/Nrastm1.1Emfu
(involves: 129S1/Sv * FVB/N)
|
decreased monocyte cell number
|
J:189834
|
| increased T cell number
|
J:189834
|
Nrastm1Tyj/Nrastm1Tyj
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased monocyte cell number
|
J:204263
|
Nrbp1tm3b(EUCOMM)Wtsi/Nrbp1+
(C57BL/6N-Nrbp1tm3b(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
Nsg1tm1.1(KOMP)Vlcg/Nsg1tm1.1(KOMP)Vlcg
(C57BL/6N-Nsg1tm1.1(KOMP)Vlcg/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Nsrp1tm1.1Cdj/Nsrp1tm1.1Cdj
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal T cell number
|
J:306261
|
| decreased CD4-positive, alpha-beta T cell number
|
J:306261
|
| decreased CD8-positive, alpha-beta T cell number
|
J:306261
|
| increased memory T cell number
|
J:306261
|
Nsun5tm2b(EUCOMM)Wtsi/Nsun5tm2b(EUCOMM)Wtsi
(C57BL/6N-Nsun5tm2b(EUCOMM)Wtsi/J)
|
decreased lymphocyte cell number
|
J:211773
|
Ntrk1tm1Tes/Ntrk1tm1Tes
Tg(Tuba1-cre)1Tes/0
(involves: 129S1/Sv)
|
increased B-1 B cell number
|
J:93578
|
Nub1tm1b(EUCOMM)Hmgu/Nub1tm1b(EUCOMM)Hmgu
(C57BL/6N-Nub1tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased CD4-negative NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD5-positive Ly6C-positive T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased Ly6C-positive NK T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased Ly6C-positive NK T cell number
|
J:211773
|
Nudt1tm1Tts/Nudt1tm1Tts
Ogg1tm1Yun/Ogg1tm1Yun
(involves: 129S/SvEv * C57BL/6JJcl)
|
microgliosis
|
J:193978
|
Nuggctm1Diaz/Nuggctm1Diaz
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal somatic hypermutation frequency
|
J:190402
|
Nup35m1Apb/Nup35m1Apb
(involves: C57BL/6N)
|
abnormal macrophage morphology
|
J:235141
|
Nup85tm1.1Yter/Nup85tm1.1Yter
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
decreased Ly6C high monocyte number
|
J:292726
|
| decreased Ly6C low monocyte number
|
J:292726
|
| decreased macrophage cell number
|
J:292726
|
Nup98tm1Bmaf/Nup98+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased B cell number
|
J:110907
|
| decreased CD4-positive, alpha-beta T cell number
|
J:110907
|
Nup210enuI476T/Nup210enuI476T
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal alpha-beta T cell morphology
|
J:266693
|
| decreased CD4-positive, alpha-beta T cell number
|
J:266693
|
Nup210enuI476T/Nup210tm1a(EUCOMM)Hmgu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:266693
|
Nup210tm1.1Mdan/Nup210tm1.1Mdan
(B6.Cg-Nup210tm1.1Mdan)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:282451
|
| abnormal lymphocyte morphology
|
J:282451
|
| decreased CD4-positive, alpha-beta T cell number
|
J:282451
|
| increased effector memory T-helper cell number
|
J:282451
|
Nup210tm1b(EUCOMM)Hmgu/Nup210tm1b(EUCOMM)Hmgu
(involves: C57BL/6N)
|
decreased alpha-beta T cell number
|
J:266693
|
| decreased CD4-positive, alpha-beta T cell number
|
J:266693
|
| decreased CD8-positive, alpha-beta T cell number
|
J:266693
|
| decreased T cell number
|
J:266693
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:266693
|
| increased CD8-positive, alpha-beta T cell number
|
J:266693
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:266693
|
| increased T-helper 1 cell number
|
J:266693
|
Nwd2em1(IMPC)Ccpcz/Nwd2em1(IMPC)Ccpcz
(C57BL/6N-Nwd2em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
Nxntm1b(EUCOMM)Wtsi/Nxn+
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
Nxnl1tm1.2Tlev/Nxnl1tm1.2Tlev
(involves: BALB/c * BALB/cJ * C57BL/6)
|
microgliosis
|
J:186370
|
Ociad1tm1.1Msin/Ociad1tm1.1Msin
(involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased B cell number
|
J:279239
|
| decreased T cell number
|
J:279239
|
| increased macrophage cell number
|
J:279239
|
| increased monocyte cell number
|
J:279239
|
Ocstamptm2a(KOMP)Wtsi/Ocstamptm2a(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal osteoclast morphology
|
J:233553
|
Ogg1tm1Yun/Ogg1tm1Yun
(involves: 129S/SvEv * C57BL/6JJcl)
|
microgliosis
|
J:193978
|
Ogttm1Gwh/Y
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:93112
|
| decreased CD8-positive, alpha-beta T cell number
|
J:93112
|
| decreased double-positive T cell number
|
J:93112
|
| decreased T cell number
|
J:93112
|
| decreased thymocyte number
|
J:93112
|
oh/oh
(Not Specified)
|
increased macrophage cell number
|
J:5300
|
Orai1tm1.1Hjm/Orai1tm1.1Hjm
Orai2tm1.1(KOMP)Vlcg/Orai2tm1.1(KOMP)Vlcg
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Orai1tm1.1Hjm Orai2tm1.1(KOMP)Vlcg)
|
abnormal CD4-positive helper T cell morphology
|
J:241365
|
| decreased germinal center B cell number
|
J:241365
|
| decreased regulatory T cell number
|
J:241365
|
| decreased single-positive T cell number
|
J:241365
|
Oscartm1Ywc/Oscartm1Ywc
(involves: 129P2/OlaHsd)
|
abnormal osteoclast differentiation
|
J:178250
|
Oscartm1Ywc/Oscartm1Ywc
Tyrobptm1Ttk/Tyrobptm1Ttk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:178250
|
| abnormal osteoclast morphology
|
J:178250
|
| decreased osteoclast cell number
|
J:178250
|
Otub1tm1c(EUCOMM)Hmgu/Otub1tm1c(EUCOMM)Hmgu
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal follicular B cell morphology
|
J:280549
|
| decreased B-1 B cell number
|
J:280549
|
| decreased immature B cell number
|
J:280549
|
| decreased T cell number
|
J:280549
|
| increased B cell number
|
J:280549
|
| increased B-2 B cell number
|
J:280549
|
| increased marginal zone B cell number
|
J:280549
|
| increased mature B cell number
|
J:280549
|
Otud5tm1Vmd/Otud5tm1Vmd
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:219495
|
| decreased regulatory T cell number
|
J:219495
|
| decreased thymocyte number
|
J:219495
|
Otud5tm1Vmd/Otud5tm1Vmd
Tg(Vav1-cre)#Cgp/0
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:219495
|
Otud7btm1Dgen/Otud7btm1Dgen
(involves: 129 * C57BL/6)
|
increased B cell number
|
J:194553
|
P2rx5tm1Lex/P2rx5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:82809
|
| increased NK cell number
|
J:82809
|
P2rx7tm1Gab/P2rx7tm1Gab
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
increased osteoclast cell number
|
J:84145
|
p23-ST1/p23-ST1
(C57BL/6J-p23-ST1)
|
microgliosis
|
J:158278
|
Pag1tm1Kplm/Pag1tm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte number
|
J:101365
|
Pals1tm1Caw/Pals1tm1Caw
Tg(rx3-icre)1Mjam/0
(Not Specified)
|
microgliosis
|
J:184469
|
Pank2em1(IMPC)Ccpcz/Pank2em1(IMPC)Ccpcz
(C57BL/6NCrl-Pank2em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
Pank3tm1b(KOMP)Mbp/Pank3tm1b(KOMP)Mbp
(C57BL/6N-Pank3tm1b(KOMP)Mbp/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell morphology
|
J:116017
|
| decreased B cell number
|
J:116017
|
| decreased double-positive T cell number
|
J:116017
|
| decreased lymphocyte cell number
|
J:116017
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd)
|
microgliosis
|
J:269785
|
Parp1tm1b(EUCOMM)Hmgu/Parp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Parp1tm1b(EUCOMM)Hmgu/Ics)
|
decreased NK cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
Parp14Gt(OST415485)Lex/Parp14Gt(OST415485)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased marginal zone B cell number
|
J:146533
|
| increased follicular B cell number
|
J:146533
|
Parvbtm1a(EUCOMM)Wtsi/Parvbtm1a(EUCOMM)Wtsi
(C57BL/6N-Parvbtm1a(EUCOMM)Wtsi/Cnrm)
|
decreased mature B cell number
|
J:165965
|
| decreased NK cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
Patz1tm1.1Welm/Patz1tm1.1Welm
(involves: 129P2/OlaHsd)
|
abnormal T cell subpopulation ratio
|
J:158947
|
| decreased thymocyte number
|
J:158947
|
Patz1tm1.1Welm/Patz1tm1.1Welm
Tg(TcraTcrb)425Cbn/0
(involves: C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:158947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158947
|
| increased CD4-positive, alpha-beta T cell number
|
J:158947
|
Patz1tm1.1Welm/Patz1tm1.1Welm
Tg(TcraTcrb)1100Mjb/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:158947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158947
|
| increased CD4-positive, alpha-beta T cell number
|
J:158947
|
Pawrtm1Jmos/Pawrtm1Jmos
(involves: 129/Sv * CD-1)
|
increased lymphocyte cell number
|
J:85495
|
Pax1un-i/Pax1+
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased CD4-positive, alpha-beta T cell number
|
J:100951
|
| decreased CD8-positive, alpha-beta T cell number
|
J:100951
|
| decreased thymocyte number
|
J:100951
|
Pax1un-i/Pax1un-i
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased CD4-positive, alpha-beta T cell number
|
J:100951
|
| decreased CD8-positive, alpha-beta T cell number
|
J:100951
|
| decreased double-negative T cell number
|
J:100951
|
| decreased double-positive T cell number
|
J:100951
|
| decreased thymocyte number
|
J:100951
|
| increased double-negative T cell number
|
J:100951
|
Pax1un/Pax1+
Tcf3tm1Cmu/Tcf3tm1Cmu
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:103567
|
| abnormal T cell subpopulation ratio
|
J:103567
|
Pax5m1Btlr/Pax5m1Btlr
(C57BL/6J-Pax5m1Btlr)
|
decreased B cell number
|
J:220072
|
| increased macrophage cell number
|
J:220072
|
| increased monocyte cell number
|
J:220072
|
| increased single-positive T cell number
|
J:220072
|
| increased T cell number
|
J:220072
|
Pax5m2Btlr/Pax5+
(C57BL/6J-Pax5m2Btlr)
|
decreased B-1b cell number
|
J:254824
|
Pax5m2Btlr/Pax5m2Btlr
(C57BL/6J-Pax5m2Btlr)
|
decreased B-1b cell number
|
J:254824
|
| increased B-1 B cell number
|
J:254824
|
Pax5m3Btlr/Pax5+
(C57BL/6J-Pax5m3Btlr)
|
decreased B cell number
|
J:254825
|
Pax5m3Btlr/Pax5m3Btlr
(C57BL/6J-Pax5m3Btlr)
|
decreased B cell number
|
J:254825
|
| decreased B-1 B cell number
|
J:254825
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254825
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254825
|
Pax5tm1b(EUCOMM)Wtsi/Pax5+
(C57BL/6N-Pax5tm1b(EUCOMM)Wtsi/Ieg)
|
increased CD4-positive NK T cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
Pax5tm1Mbu/Pax5tm1Mbu
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:38813
|
| abnormal lymphopoiesis
|
J:38813
|
| absent B-2 B cells
|
J:113076
|
| absent mature B cells
|
J:113076
|
| arrested B cell differentiation
|
J:113076
|
| decreased B cell number
|
J:113076
|
| decreased B-1 B cell number
|
J:113076
|
| decreased immature B cell number
|
J:113076
|
| increased T cell number
|
J:113076
|
Pax5tm1Mbu/Pax5tm1Mbu
(involves: 129S2/SvPas)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:139510
|
| arrested B cell differentiation
|
J:75504
|
Pax5tm1Mbu/Pax5tm1Mbu
(either: 129 or (involves: 129S2/SvPas * C57BL/6J))
|
abnormal late pro-B cell
|
J:21935
|
| abnormal lymphopoiesis
|
J:21935
|
| absent late pro-B cells
|
J:21935
|
| arrested B cell differentiation
|
J:21935
|
Pax5tm1Mbu/Pax5tm3Mbu
Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)
|
decreased mature B cell number
|
J:75504
|
Pax5tm3.1Mbu/Pax5tm3.1Mbu
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:75504
|
Pax5tm3Mbu/Pax5+
Tcf3tm1(PBX1)Mlc/Tcf3+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:226241
|
| arrested B cell differentiation
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
Paxxem1Spj/Paxxem1Spj
(C57BL/6NTac-Paxxem1Spj)
|
decreased B cell number
|
J:236776
|
| decreased CD4-positive, alpha-beta T cell number
|
J:236776
|
| decreased CD8-positive, alpha-beta T cell number
|
J:236776
|
| decreased follicular B cell number
|
J:236776
|
| decreased T cell number
|
J:236776
|
| decreased transitional stage B cell number
|
J:236776
|
| increased mature B cell number
|
J:236776
|
Paxxem1Spj/Paxxem1Spj
Nhej1tm1Fwa/Nhej1tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
absent lymphocyte
|
J:236776
|
Pbbcp1C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased B cell number
|
J:74270
|
Pbrm1tm1Zhwa/Pbrm1tm1Zhwa
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T-helper 2 cell differentiation
|
J:236906
|
Pbx1tm1Mlc/Pbx1tm2.1Mlc
(involves: 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:132963
|
| decreased CD8-positive, alpha-beta T cell number
|
J:132963
|
| decreased mature B cell number
|
J:132963
|
Pbx1tm1Mlc/Pbx1tm3.1Mlc
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased B cell number
|
J:149799
|
| decreased double-negative T cell number
|
J:149799
|
| decreased pre-B cell number
|
J:149799
|
| decreased pro-B cell number
|
J:149799
|
| decreased T cell number
|
J:149799
|
Pcd4ts1DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Pcd4ts2BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Pcd4ts3BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
Pcd8ts1C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
Pcdh7em1Ywc/Pcdh7em1Ywc
(Not Specified)
|
decreased osteoclast cell number
|
J:298915
|
Pcdhgem5Rwb/Pcdhgem5Rwb
(C57BL/6J-Pcdhgem5Rwb/Rwb)
|
microgliosis
|
J:285314
|
Pcdhgem41Rwb/Pcdhgem41Rwb
(C57BL/6J-Pcdhgem41Rwb/Rwb)
|
microgliosis
|
J:285314
|
Pcdhgtm1.1Tman/Pcdhgtm1.1Tman
(involves: 129S4/SvJae * C57BL/6)
|
microgliosis
|
J:188341
|
Pcgf2tm1Hko/Pcgf2tm1Hko
(involves: BALB/c * C57BL/6)
|
decreased lymphocyte cell number
|
J:71268
|
| decreased thymocyte number
|
J:71268
|
Pcid2tm1Imku/Pcid2tm1Imku
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased follicular B cell number
|
J:166080
|
| decreased marginal zone B cell number
|
J:166080
|
| decreased mature B cell number
|
J:166080
|
Pclaftm1a(EUCOMM)Wtsi/Pclaftm1a(EUCOMM)Wtsi
(C57BL/6N-Pclaftm1a(EUCOMM)Wtsi/Wtsi)
|
decreased immature NK cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| increased mature NK cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased pro-B cell number
|
J:211773
|
Pcnatm1.1Mdsc/Pcnatm1.1Mdsc
Tg(Pcna*K164R)1Mdsc/0
(involves: FVB/N)
|
abnormal class switch recombination
|
J:141098
|
| abnormal somatic hypermutation frequency
|
J:141098
|
Pcnatm1Jcbs/Pcnatm1Jcbs
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:125916
|
Pcnatm1Jcbs/Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454,
J:177630
|
Pcnatm1Jcbs/Pcnatm1Jcbs
Ungtm1Tld/Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
Pcsk1tm1Dfs/Pcsk1tm1Dfs
(involves: 129 * C57BL/6J)
|
abnormal peritoneal macrophage morphology
|
J:184882
|
| abnormal T-helper 1 cell differentiation
|
J:184882
|
| decreased NK T cell number
|
J:184882
|
| decreased T cell number
|
J:184882
|
| increased lymphocyte cell number
|
J:184882
|
Pdap1em1Rkuhn/Pdap1em1Rkuhn
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal class switch recombination
|
J:298705
|
| abnormal somatic hypermutation frequency
|
J:298705
|
| decreased germinal center B cell number
|
J:298705
|
| decreased mature B cell number
|
J:298705
|
Pdcd1tm1.1Liux/Pdcd1tm1.1Liux
(involves: C57BL/6)
|
decreased regulatory T cell number
|
J:190150
|
| increased T-helper 1 cell number
|
J:190150
|
Pdcd1tm1.1Liux/Pdcd1tm1.1Liux
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N)
|
decreased regulatory T cell number
|
J:190150
|
| decreased T-helper 2 cell number
|
J:190150
|
| decreased T-helper 17 cell number
|
J:190150
|
| increased T-helper 1 cell number
|
J:190150
|
Pdcd1tm1.1Shr/Pdcd1tm1.1Shr
(involves: C57BL/6)
|
decreased B-1 B cell number
|
J:153040
|
| increased regulatory T cell number
|
J:153040
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas * C57BL/6)
|
increased B cell number
|
J:50688
|
| increased B-1 B cell number
|
J:50688
|
| increased lymphocyte cell number
|
J:50688
|
Pdcd1tm1Llc/Pdcd1tm1Llc
(involves: 129S5/SvEvBrd)
|
decreased CD8-positive, alpha-beta T cell number
|
J:126829
|
Pdcd1lg2tm1.1Lex/Pdcd1lg2tm1.1Lex
(involves: 129S5/SvEvBrd)
|
decreased CD8-positive, alpha-beta T cell number
|
J:126829
|
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac)
|
increased CD4-positive, alpha-beta T cell number
|
J:123785
|
| increased CD8-positive, alpha-beta T cell number
|
J:123785
|
Pdgfbtm1Cbet/Pdgfbtm2Cbet
Tg(Tie1-cre)9Ref/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal microglial cell morphology
|
J:89186
|
Pdgfctm1b(EUCOMM)Hmgu/Pdgfc+
(C57BL/6N-Pdgfctm1b(EUCOMM)Hmgu/Ieg)
|
increased monocyte cell number
|
J:211773
|
Pdia6em1Btlr/Pdia6m1Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:288824
|
| decreased double-negative T cell number
|
J:288824
|
| decreased double-positive T cell number
|
J:288824
|
| decreased follicular B cell number
|
J:288824
|
| decreased lymphocyte cell number
|
J:288824
|
| decreased monocyte cell number
|
J:288824
|
| decreased NK T cell number
|
J:288824
|
| decreased pre-B cell number
|
J:288824
|
| decreased transitional stage B cell number
|
J:288824
|
| increased marginal zone B cell number
|
J:288824
|
| increased marginal zone precursor B cell number
|
J:288824
|
| increased mature B cell number
|
J:288824
|
Pdia6tm1b(EUCOMM)Hmgu/Pdia6+
(C57BL/6N-Pdia6tm1b(EUCOMM)Hmgu/Ieg)
|
decreased CD4-positive NK T cell number
|
J:211773
|
Pdk4tm1Tok/Pdk4tm1Tok
(B6.129P2-Pdk4tm1Tok)
|
abnormal osteoclast cell number
|
J:179789
|
| abnormal osteoclast differentiation
|
J:179789
|
| abnormal osteoclast morphology
|
J:179789
|
Pdlim7Gt(OST445990)Lex/Pdlim7Gt(OST445990)Lex
(B6.129S5-Pdlim7Gt(OST445990)Lex)
|
increased lymphocyte cell number
|
J:209780
|
| increased monocyte cell number
|
J:209780
|
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal regulatory T cell number
|
J:226194
|
Pdpk1tm1Mlw/Pdpk1tm1.1Daca
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:165626
|
| decreased NK T cell number
|
J:165626
|
| decreased T cell number
|
J:165626
|
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:165626
|
| abnormal NK T cell morphology
|
J:165626
|
| abnormal T cell differentiation
|
J:165626
|
| absent NK T cells
|
J:165626
|
| decreased NK T cell number
|
J:165626
|
| decreased T cell number
|
J:165626
|
Pdpntm2.1Mlkn/Pdpntm2.1Mlkn
Rag1tm1Mom/Rag1tm1Mom
Tg(Pdgfrb-cre)9Rha/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
absent lymphocyte
|
J:205423
|
Pdprtm1b(EUCOMM)Wtsi/Pdprtm1b(EUCOMM)Wtsi
(C57BL/6N-Pdprtm1b(EUCOMM)Wtsi/Ics)
|
decreased large unstained cell number
|
J:211773
|
Pdzd8tm1b(EUCOMM)Wtsi/Pdzd8+
(C57BL/6N-Pdzd8tm1b(EUCOMM)Wtsi/Wtsi)
|
increased large unstained cell number
|
J:211773
|
Penk-rstm1Pig/Penk-rstm1Pig
(B6.129-Penk-rstm1Pig)
|
decreased T-helper 2 cell number
|
J:62435
|
Pepdtm1a(KOMP)Wtsi/Pepdtm1a(KOMP)Wtsi
(C57BL/6N-Pepdtm1a(KOMP)Wtsi/Ucd)
|
decreased immature B cell number
|
J:211773
|
| decreased Ly6C-positive NK T cell number
|
J:211773
|
| decreased transitional stage T1 B cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
Pepdtm1b(KOMP)Wtsi/Pepdtm1b(KOMP)Wtsi
(C57BL/6N-Pepdtm1b(KOMP)Wtsi/Ieg)
|
decreased B cell number
|
J:211773
|
| decreased B-2 B cell number
|
J:211773
|
| decreased CD5-positive Ly6C-positive T cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
Pex5tm1Pec/Pex5tm1Pec
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ)
|
microgliosis
|
J:123503
|
Pex7tm1Rjaw/Pex7tm1Rjaw
(Swiss)
|
abnormal osteoclast morphology
|
J:92346
|
PfasSofa-2J/Pfas+
(B6(Cg)-PfasSofa-2J/GrsrJ)
|
abnormal transitional stage B cell morphology
|
J:223062
|
Pfdn1Gt(GTR1.3)1Rul/Pfdn1Gt(GTR1.3)1Rul
(involves: 129)
|
abnormal B cell differentiation
|
J:137415
|
| abnormal B cell morphology
|
J:137415
|
| decreased B-1 B cell number
|
J:137415
|
| decreased B-2 B cell number
|
J:137415
|
| decreased pre-B cell number
|
J:137415
|
Pfkfb2tm1b(KOMP)Wtsi/Pfkfb2tm1b(KOMP)Wtsi
(C57BL/6N-Pfkfb2tm1b(KOMP)Wtsi/Nju)
|
increased lymphocyte cell number
|
J:211773
|
Pfkfb3tm1.1Pec/Pfkfb3tm1.1Pec
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)
|
abnormal macrophage morphology
|
J:296552
|
Pgam1tm1.1Hiko/Pgam1tm1.1Hiko
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:293746
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:293746
|
| abnormal effector T cell number
|
J:293746
|
| decreased CD4-positive, alpha-beta T cell number
|
J:293746
|
| decreased CD8-positive, alpha-beta T cell number
|
J:293746
|
| decreased NK T cell number
|
J:293746
|
| decreased T-helper 2 cell number
|
J:293746
|
| decreased T-helper 17 cell number
|
J:293746
|
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(involves: 129 * C57BL/6)
|
abnormal T cell morphology
|
J:181221
|
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra)
|
abnormal T-helper 2 cell differentiation
|
J:203443
|
Pgap4em1Osbir/Pgap4em1Osbir
(involves: C57BL/6NSlc)
|
increased Ly6C-positive immature NK cell number
|
J:333707
|
Pgdtm1.1Pse/Pgdtm1.1Pse
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal alpha-beta T cell morphology
|
J:306553
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:306553
|
| abnormal T cell differentiation
|
J:306553
|
| decreased CD4-positive, alpha-beta T cell number
|
J:306553
|
| decreased CD8-positive, alpha-beta T cell number
|
J:306553
|
Pgm3Gt(W037B08)Wrst/Pgm3mld1
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:125094
|
| absent follicular B cells
|
J:125094
|
| decreased B cell number
|
J:125094
|
| decreased T cell number
|
J:125094
|
| increased pro-B cell number
|
J:125094
|
Pgm3mld1/Pgm3mld1
(C57BL/6-Pgm3mld1)
|
absent follicular B cells
|
J:125094
|
| decreased B cell number
|
J:125094
|
| increased pro-B cell number
|
J:125094
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd)
|
abnormal osteoclast morphology
|
J:145383
|
Pgrmc2tm1.1Jjp/Pgrmc2tm1.1Jjp
Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased uterine NK cell number
|
J:247103
|
Phb1em1(IMPC)H/Phb1+
(C57BL/6NTac-Phb1em1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
Phc1tm1Os/Phc1tm1Os
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:75707
|
Phf6em1Wencc/Y
Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
abnormal effector T cell number
|
J:278804
|
| decreased CD4-positive, alpha-beta T cell number
|
J:278804
|
| decreased CD8-positive, alpha-beta T cell number
|
J:278804
|
| decreased double-negative T cell number
|
J:278804
|
| decreased lymphocyte cell number
|
J:278804
|
| increased B cell number
|
J:278804
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:278804
|
| increased pro-B cell number
|
J:278804
|
Phf6em1Wencc/Phf6em1Wencc
Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
abnormal effector T cell number
|
J:278804
|
| decreased CD4-positive, alpha-beta T cell number
|
J:278804
|
| decreased CD8-positive, alpha-beta T cell number
|
J:278804
|
| decreased double-negative T cell number
|
J:278804
|
| decreased lymphocyte cell number
|
J:278804
|
| increased B cell number
|
J:278804
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:278804
|
| increased pro-B cell number
|
J:278804
|
Phf6tm1.1Avo/Y
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:276228
|
| decreased DN2 thymocyte number
|
J:276228
|
Phf8tm1dIcs/Phf8tm1dIcs
(C57BL/6N-Phf8tm1dIcs/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Phf20Gt(XN131)Byg/Phf20Gt(XN131)Byg
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:228714
|
| decreased double-positive T cell number
|
J:228714
|
| decreased thymocyte number
|
J:228714
|
| increased double-negative T cell number
|
J:228714
|
Phf20l1em1(IMPC)Tcp/Phf20l1em1(IMPC)Tcp
(C57BL/6N-Phf20l1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Phyhtm1b(EUCOMM)Wtsi/Phyhtm1b(EUCOMM)Wtsi
(C57BL/6N-Phyhtm1b(EUCOMM)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Pi4kam2Btlr/Pi4kam2Btlr
(C57BL/6J-Pi4kam2Btlr)
|
increased alpha-beta T cell number
|
J:272852
|
| increased CD4-positive, alpha-beta T cell number
|
J:272852
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272852
|
Pi4katm1b(EUCOMM)Wtsi/Pi4ka+
(C57BL/6N-Pi4katm1b(EUCOMM)Wtsi/Tcp)
|
increased monocyte cell number
|
J:211773
|
Pi16Gt(OST292194)Lex/Pi16Gt(OST292194)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased regulatory T cell number
|
J:94077
|
Picalmtm1.1Tmae/Picalmtm1.1Tmae
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:220728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:220728
|
Picalmtm1.1Tmae/Picalmtm1.1Tmae
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:220728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:220728
|
Picalmtm1Towa/Picalmtm1Towa
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal B cell differentiation
|
J:185312
|
Pigatm1Tak/Pigatm1Tak
Tg(FES-cre)31Bsl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/Ca)
|
abnormal T cell morphology
|
J:162065
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:162065
|
Pigrtm1Ohw/Pigrtm1Ohw
(B6.129X1-Pigrtm1Ohw)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:97824
|
| abnormal intraepithelial T cell number
|
J:97824
|
Pigrtm1Ohw/Pigrtm1Ohw
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
decreased lymphocyte cell number
|
J:97824
|
Pik3ap1m1Btlr/Pik3ap1m1Btlr
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:185495
|
Pik3ap1m2Btlr/Pik3ap1m2Btlr
(C57BL/6J-Pik3ap1m2Btlr)
|
decreased B-1a cell number
|
J:255271
|
| increased B-1b cell number
|
J:255271
|
Pik3ap1M3Btlr/Pik3ap1M3Btlr
(C57BL/6J-Pik3ap1M3Btlr)
|
decreased B-1 B cell number
|
J:272019
|
Pik3ap1tm1b(KOMP)Wtsi/Pik3ap1tm1b(KOMP)Wtsi
(C57BL/6N-Pik3ap1tm1b(KOMP)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Pik3ap1tm1Kuro/Pik3ap1tm1Kuro
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:75075
|
| absent B-1a cells
|
J:84669
|
| decreased B cell number
|
J:84669
|
| decreased follicular B cell number
|
J:84669
|
| decreased pre-B cell number
|
J:75075
|
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased B cell number
|
J:169710
|
| increased CD4-positive, alpha-beta T cell number
|
J:169710
|
| increased CD8-positive, alpha-beta T cell number
|
J:169710
|
| increased monocyte cell number
|
J:169710
|
Pik3c2atm1b(EUCOMM)Hmgu/Pik3c2a+
(C57BL/6N-Pik3c2atm1b(EUCOMM)Hmgu/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Pik3c3tm1.1Flv/Pik3c3tm1.1Flv
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal T cell number
|
J:184753
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184753
|
| decreased CD8-positive, alpha-beta T cell number
|
J:184753
|
Pik3c3tm1.1Flv/Pik3c3tm1.1Flv
Tg(Cd8a-cre)1Itan/0
(involves: C57BL/6 * C57BL/6N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:184753
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:184753
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184753
|
| decreased CD8-positive, alpha-beta T cell number
|
J:184753
|
| decreased lymphocyte cell number
|
J:184753
|
Pik3cdGt(OST451938)Lex/Pik3cdGt(OST451938)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased lymphocyte cell number
|
J:103485
|
Pik3cdm2Btlr/Pik3cd+
(C57BL/6J-Pik3cdm2Btlr)
|
decreased B-1 B cell number
|
J:236693
|
Pik3cdm2Btlr/Pik3cdm2Btlr
(C57BL/6J-Pik3cdm2Btlr)
|
decreased B-1 B cell number
|
J:236693
|
| decreased B-1a cell number
|
J:236693
|
Pik3cdtm1.1Bvan/Pik3cdtm1.1Bvan
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell differentiation
|
J:78412
|
| decreased B-1 B cell number
|
J:78412
|
Pik3cdtm1Jni/Pik3cdtm1Jni
(involves: 129P2/OlaHsd)
|
absent B-1 B cells
|
J:80614
|
| decreased B cell number
|
J:80614
|
| decreased mature B cell number
|
J:80614
|
Pik3cdtm1Jni/Pik3cdtm1Jni
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:124330
|
| decreased NK cell number
|
J:124330
|
| decreased T cell number
|
J:124330
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(involves: 129S4/SvJae)
|
decreased B cell number
|
J:79133
|
| decreased B-1 B cell number
|
J:79133
|
| decreased B-2 B cell number
|
J:79133
|
| decreased marginal zone B cell number
|
J:79133
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:125791
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125791
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125791
|
| decreased double-positive T cell number
|
J:125791
|
| decreased lymphocyte cell number
|
J:125791
|
| decreased T cell number
|
J:125791
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Ptentm2.1Ppp/Ptentm2.1Ppp
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:130950
|
| increased marginal zone B cell number
|
J:130950
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Tg(BCL2)36Wehi/0
(involves: 129S4/SvJae * C57BL/6JWehi * SJL/JWehi)
|
decreased follicular B cell number
|
J:130950
|
Pik3cdtm2.1Tnr/Pik3cdtm2.1Tnr
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:164283
|
| decreased CD8-positive, alpha-beta T cell number
|
J:164283
|
| decreased germinal center B cell number
|
J:164283
|
| decreased T cell number
|
J:164283
|
| decreased T follicular helper cell number
|
J:164283
|
Pik3cdtm2.1Tnr/Pik3cdtm2.1Tnr
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
decreased germinal center B cell number
|
J:164283
|
| decreased T follicular helper cell number
|
J:164283
|
Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Pik3cgtm1Dwu)
|
decreased CD8-positive, alpha-beta T cell number
|
J:131923
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:124330
|
| abnormal T cell differentiation
|
J:60347
|
| decreased CD4-positive, alpha-beta T cell number
|
J:60347
|
| decreased thymocyte number
|
J:60347
|
| increased monocyte cell number
|
J:60347
|
Pik3cgtm2Ehi/Pik3cgtm2Ehi
(Not Specified)
|
decreased macrophage cell number
|
J:124856
|
Pik3r1m1Btlr/Pik3r1m1Btlr
(C57BL/6J-Pik3r1m1Btlr)
|
decreased B cell number
|
J:254890
|
| decreased B-1a cell number
|
J:254890
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254890
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254890
|
Pik3r1M2Btlr/Pik3r1+
(C57BL/6J-Pik3r1M2Btlr)
|
decreased B-1 B cell number
|
J:254892
|
| decreased B-1a cell number
|
J:254892
|
| decreased B-1b cell number
|
J:254892
|
| decreased B-2 B cell number
|
J:254892
|
| decreased NK T cell number
|
J:254892
|
| increased B-1b cell number
|
J:254892
|
Pik3r1m3Btlr/Pik3r1m3Btlr
(C57BL/6J-Pik3r1m3Btlr)
|
increased B-1b cell number
|
J:272853
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:52229
|
| decreased mature B cell number
|
J:52229
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:104166
|
| decreased immature B cell number
|
J:104166
|
| decreased mature B cell number
|
J:104166
|
| decreased pre-B cell number
|
J:104166
|
| increased pro-B cell number
|
J:104166
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:104166
|
| arrested B cell differentiation
|
J:104166
|
| decreased immature B cell number
|
J:104166
|
| decreased mature B cell number
|
J:104166
|
| decreased pre-B cell number
|
J:104166
|
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:52228
|
| decreased mature B cell number
|
J:52228
|
| decreased pre-B cell number
|
J:52228
|
| decreased pro-B cell number
|
J:52228
|
Pik3r1tm2Dfr/Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))
|
abnormal B cell differentiation
|
J:94077
|
Pik3r6tm1.1Lste/Pik3r6tm1.1Lste
(Not Specified)
|
decreased lymphocyte cell number
|
J:238900
|
Pim1tm1Pwl/Pim1tm1Pwl
Pim2tm1Brn/Pim2tm1Brn
Pim3tm1Brn/Pim3tm1Brn
(involves: 129P/Ola * FVB/N)
|
decreased B cell number
|
J:91592
|
| decreased pre-B cell number
|
J:91592
|
| decreased pro-B cell number
|
J:91592
|
| increased early pro-B cell number
|
J:91592
|
Pip4k2ctm1b(KOMP)Wtsi/Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased regulatory T cell number
|
J:234283
|
| increased CD4-positive, alpha-beta T cell number
|
J:234283
|
| increased CD8-positive, alpha-beta T cell number
|
J:234283
|
| increased T-helper cell number
|
J:234283
|
Pip4p1em1(IMPC)Ccpcz/Pip4p1em1(IMPC)Ccpcz
(C57BL/6N-Pip4p1em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-negative, CD25-positive NK T cell number
|
J:211773
|
Pip5k1ctm1.2Ref/Pip5k1ctm1.2Ref
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
decreased B cell number
|
J:164732
|
Pirbtm1Ttk/Pirbtm1Ttk
(involves: 129X1/SvJ)
|
increased B-1 B cell number
|
J:76770
|
Pitx3eyl/Pitx3eyl
(involves: C3H/He * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:156878
|
| increased CD8-positive, alpha-beta T cell number
|
J:156878
|
Pitx3tm1.1Cai/Pitx3+
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: 129 * C57BL/6J * FVB/N)
|
microgliosis
|
J:185958
|
Pkd1l2tm1b(KOMP)Mbp/Pkd1l2tm1b(KOMP)Mbp
(C57BL/6N-Pkd1l2tm1b(KOMP)Mbp/H)
|
increased large unstained cell number
|
J:211773
|
Pkn1tm1b(KOMP)Wtsi/Pkn1tm1b(KOMP)Wtsi
(C57BL/6N-Pkn1tm1b(KOMP)Wtsi/H)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
Pkn1tm1Kik/Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik)
|
abnormal somatic hypermutation frequency
|
J:193187
|
| increased germinal center B cell number
|
J:193187
|
Pknox1Gt(OST71835)Lex/Pknox1Gt(OST71835)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased single-positive T cell number
|
J:103769
|
| increased double-negative T cell number
|
J:103769
|
Pknox1tm2.1Fbla/Pknox1tm2.1Fbla
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
decreased pre-B cell number
|
J:192251
|
| increased pro-B cell number
|
J:192251
|
Pla1aem1Appsc/Pla1aem1Appsc
(C57BL/6J-Pla1aem1Appsc)
|
increased lymphocyte cell number
|
J:333902
|
Pla2g2dtm1.1Mhg/Pla2g2dtm1.1Mhg
(B6NCrSlc.Cg-Pla2g2dtm1.1Mhg)
|
abnormal effector T cell morphology
|
J:201008
|
| increased CD4-positive, alpha-beta T cell number
|
J:229035,
J:201008
|
| increased CD8-positive, alpha-beta T cell number
|
J:229035
|
Pla2g6m1Sein/Pla2g6m1Sein
(C57BL/6JJcl-Pla2g6m1Sein)
|
decreased double-positive T cell number
|
J:155328
|
Pla2g10Gt712Lex/Pla2g10Gt712Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:125607
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125607
|
| decreased T cell number
|
J:125607
|
Pla2g15tm1.1Jash/Pla2g15tm1.1Jash
(involves: 129S1/Sv * C57BL/6)
|
abnormal macrophage morphology
|
J:111561
|
| increased macrophage cell number
|
J:111561
|
| increased macrophage derived foam cell number
|
J:111561
|
Plag1em1(IMPC)Hmgu/Plag1em1(IMPC)Hmgu
(C57BL/6N-Plag1em1(IMPC)Hmgu/Ieg)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
Plattm1Mlg/Plattm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased macrophage cell number
|
J:63134
|
Plautm1b(EUCOMM)Wtsi/Plautm1b(EUCOMM)Wtsi
(C57BL/6N-Plautm1b(EUCOMM)Wtsi/H)
|
increased monocyte cell number
|
J:211773
|
Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased lymphocyte cell number
|
J:63134
|
Plcd1tm1.1Kfu/Plcd1tm1.1Kfu
Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6JJcl * CBA)
|
decreased B cell number
|
J:205633
|
| increased NK T cell number
|
J:205633
|
Plcd1tm1Tta/Plcd1tm1Tta
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:205633
|
Plce1em1(IMPC)Mbp/Plce1em1(IMPC)Mbp
(C57BL/6N-Plce1em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2))
|
decreased regulatory T cell number
|
J:157757
|
| decreased T cell number
|
J:157757
|
| increased CD4-positive, alpha-beta T cell number
|
J:157757
|
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:157757
|
| decreased double-negative T cell number
|
J:157757
|
| increased CD8-positive, alpha-beta T cell number
|
J:157757
|
| increased double-positive T cell number
|
J:157757
|
Plcg2Ali5/Plcg2+
(C3HeB/FeJ-Plcg2Ali5)
|
decreased B-2 B cell number
|
J:97930
|
Plcg2Ali5/Plcg2Ali5
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5)
|
decreased mature B cell number
|
J:97930
|
| decreased transitional stage B cell number
|
J:97930
|
Plcg2m1Btlr/Plcg2m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
Plcg2M3Btlr/Plcg2M3Btlr
(C57BL/6J-Plcg2M3Btlr)
|
decreased B-1a cell number
|
J:265101
|
Plcg2m4Btlr/Plcg2m4Btlr
(C57BL/6J-Plcg2m4Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:272862
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272862
|
Plcg2tm1.1Kuro/Plcg2tm1.1Kuro
(Not Specified)
|
abnormal B cell differentiation
|
J:131161
|
| increased pro-B cell number
|
J:131161
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd)
|
arrested B cell differentiation
|
J:86373
|
| decreased follicular B cell number
|
J:86373
|
| decreased mature B cell number
|
J:104166
|
| increased pro-B cell number
|
J:104166
|
| increased transitional stage T2 B cell number
|
J:86373
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:117023
|
| abnormal osteoclast differentiation
|
J:114607
|
| decreased osteoclast cell number
|
J:114607
|
| increased pre-B cell number
|
J:117023
|
Plcg2tm1Kuro/Plcg2tm1Kuro
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased mature B cell number
|
J:63744
|
| decreased pre-B cell number
|
J:63744
|
| increased B-1a cell number
|
J:63744
|
| increased immature B cell number
|
J:63744
|
| increased pro-B cell number
|
J:63744
|
Plcl2tm1Tta/Plcl2tm1Tta
(involves: 129P2/OlaHsd)
|
decreased B-1a cell number
|
J:85960
|
| decreased mature B cell number
|
J:85960
|
Pld4em1(IMPC)Mbp/Pld4em1(IMPC)Mbp
(C57BL/6N-Pld4em1(IMPC)Mbp/MbpMmucd)
|
increased monocyte cell number
|
J:211773
|
Pld4thss/Pld4thss
(BALB/cJ-Pld4thss/GrsrJ)
|
abnormal alpha-beta T cell morphology
|
J:278304
|
| increased macrophage cell number
|
J:278304
|
| increased marginal zone B cell number
|
J:278304
|
| increased plasma cell number
|
J:278304
|
Pld4tm1.1Nemz/Pld4tm1.1Nemz
Tg(Itgax-cre)1-1Reiz/0
(involves: 129 * C57BL/6 * C57BL/6J * CBA)
|
abnormal peritoneal macrophage morphology
|
J:281205
|
Pld4tm1.2Nemz/Pld4tm1.2Nemz
(B6.129(Cg)-Pld4tm1.1Nemz)
|
abnormal peritoneal macrophage morphology
|
J:281205
|
| decreased B-1 B cell number
|
J:281205
|
| decreased NK T cell number
|
J:281205
|
| increased marginal zone B cell number
|
J:281205
|
| increased monocyte cell number
|
J:281205
|
Pld4tm1.2Nemz/Pld4tm1.2Nemz
Rag1tm1Mom/Rag1tm1Mom
(involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N)
|
abnormal peritoneal macrophage morphology
|
J:281205
|
| decreased NK T cell number
|
J:281205
|
Plekhm1tm1.2Hzhao/Plekhm1tm1.2Hzhao
(involves: 129S1/Sv * C57BL/6J)
|
abnormal osteoclast morphology
|
J:236517
|
Plekho2em1Lzhn/Plekho2em1Lzhn
(C57BL/6-Plekho2em1Lzhn)
|
decreased macrophage cell number
|
J:270531
|
Plp1jp-rsh/Plp1+
(either: STOCK Rb(1.3)1Bnr or (involves: BALB/c * DBA/2 * STOCK Rb(1.3)1Bnr))
|
abnormal microglial cell morphology
|
J:604
|
Plp1tm1c(EUCOMM)Wtsi/Y
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
increased T cell number
|
J:245100
|
| microgliosis
|
J:245100
|
Plp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal microglial cell morphology
|
J:48031
|
| microgliosis
|
J:245100
|
Plp1tm1Kan/Y
(B6.129-Plp1tm1Kan)
|
microgliosis
|
J:201143
|
Plp1tm1Kan/Y
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased T cell number
|
J:245100
|
| microgliosis
|
J:245100
|
Plp1tm1Kan/Y
Tspan2tm1Hbw/Tspan2tm1Hbw
(B6.Cg-Tspan2tm1Hbw Plp1tm1Kan)
|
microgliosis
|
J:201143
|
plt/plt
(involves: DDD/1)
|
decreased single-positive T cell number
|
J:15290
|
| decreased T cell number
|
J:47819
|
| increased memory T cell number
|
J:47460
|
| increased T cell number
|
J:47819
|
plt/plt
(C.DDD-plt)
|
decreased single-positive T cell number
|
J:119345
|
Pmaip1tm1Ast/Pmaip1tm1Ast
(C57BL/6-Pmaip1tm1Ast)
|
abnormal NK cell morphology
|
J:123409
|
Pmepa1em1Akt/Pmepa1em1Akt
(C57BL/6N-Pmepa1em1Akt)
|
abnormal osteoclast differentiation
|
J:329578
|
| decreased osteoclast cell number
|
J:329578
|
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
abnormal class switch recombination
|
J:162378
|
Pms2tm1Lisk/Pms2tm1Lisk
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:162378
|
Pnpbata/Pnpbata
(C57BL/6JSfdAnu-Pnpbata)
|
decreased marginal zone B cell number
|
J:104190
|
| increased T follicular helper cell number
|
J:104190
|
Pnpf/Pnpf
(involves: C3H/HeHa * C57BL/6J)
|
increased double-negative T cell number
|
J:522
|
Pnpf/Pnpf
(C57BL/6J-Pnpf)
|
decreased CD8-positive, alpha-beta T cell number
|
J:39328
|
| decreased double-positive T cell number
|
J:39328
|
Pnpg/Pnpg
(involves: C57BL/6 * DBA/2J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:39328
|
| decreased double-positive T cell number
|
J:39328
|
| increased double-negative T cell number
|
J:39328
|
Pnpm2Btlr/Pnpm2Btlr
(C57BL/6J-Pnpm2Btlr)
|
decreased B-1a cell number
|
J:265150
|
| decreased B-2 B cell number
|
J:265150
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265150
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265150
|
| decreased T cell number
|
J:265150
|
| increased B-1b cell number
|
J:265150
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265150
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265150
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265150
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265150
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265150
|
Pnptm1Cmr/Pnptm1Cmr
(involves: 129)
|
decreased CD4-positive, alpha-beta T cell number
|
J:62870
|
| decreased CD8-positive, alpha-beta T cell number
|
J:62870
|
| decreased double-positive T cell number
|
J:62870
|
| decreased single-positive T cell number
|
J:62870
|
| increased double-negative T cell number
|
J:62870
|
| increased pre-B cell number
|
J:62870
|
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:206872
|
| abnormal somatic hypermutation frequency
|
J:206872
|
| increased germinal center B cell number
|
J:206872
|
| increased T-helper 2 cell number
|
J:206872
|
Pole3em1Tbo/Pole3em1Tbo
(FVB-Pole3em1Tbo)
|
decreased B cell number
|
J:298827
|
| decreased lymphocyte cell number
|
J:298827
|
| decreased thymocyte number
|
J:298827
|
Pole3em2Tbo/Pole3em2Tbo
(FVB-Pole3em2Tbo)
|
decreased B cell number
|
J:298827
|
| decreased lymphocyte cell number
|
J:298827
|
| decreased thymocyte number
|
J:298827
|
Pole3em3Tbo/Pole3em3Tbo
(FVB-Pole3em3Tbo)
|
decreased B cell number
|
J:298827
|
| decreased DN4 thymocyte number
|
J:298827
|
| decreased double-positive T cell number
|
J:298827
|
| decreased gamma-delta T cell number
|
J:298827
|
| decreased immature B cell number
|
J:298827
|
| decreased lymphocyte cell number
|
J:298827
|
| decreased pre-B cell number
|
J:298827
|
| decreased thymocyte number
|
J:298827
|
| increased DN3 thymocyte number
|
J:298827
|
Pole3em4Tbo/Pole3em4Tbo
(FVB-Pole3em4Tbo)
|
decreased B cell number
|
J:298827
|
| decreased DN4 thymocyte number
|
J:298827
|
| decreased immature B cell number
|
J:298827
|
| decreased lymphocyte cell number
|
J:298827
|
| decreased pre-B cell number
|
J:298827
|
| decreased thymocyte number
|
J:298827
|
| increased DN3 thymocyte number
|
J:298827
|
Pole3tm1(KOMP)Vlcg/Pole3tm1(KOMP)Vlcg
(involves: C57BL/6NTac * FVB)
|
decreased DN4 thymocyte number
|
J:298827
|
| increased DN3 thymocyte number
|
J:298827
|
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N)
|
abnormal B cell differentiation
|
J:261973
|
| abnormal T cell differentiation
|
J:261973
|
| arrested B cell differentiation
|
J:261973
|
| decreased B cell number
|
J:261973
|
| decreased lymphocyte cell number
|
J:261973
|
| decreased single-positive T cell number
|
J:261973
|
| increased double-negative T cell number
|
J:261973
|
| increased monocyte cell number
|
J:261973
|
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg
Trp53tm1Brd/Trp53+
(involves: C57BL/6J * C57BL/6NTac)
|
decreased lymphocyte cell number
|
J:261973
|
| increased monocyte cell number
|
J:261973
|
Polgtm1Prol/Polgtm1Prol
(B6J.129S7-Polgtm1Prol)
|
abnormal lymphopoiesis
|
J:154187
|
| decreased double-positive T cell number
|
J:154187
|
| decreased immature B cell number
|
J:154187
|
| decreased lymphocyte cell number
|
J:154187
|
| decreased mature B cell number
|
J:154187
|
| decreased pre-B cell number
|
J:154187
|
| decreased pro-B cell number
|
J:154187
|
| decreased thymocyte number
|
J:154187
|
Polltm1Crey/Polltm1Crey
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:113406
|
Polltm1Crey/Polltm1Crey
Polmtm1Crey/Polmtm1Crey
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113406
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:113406
|
| abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
| decreased B cell number
|
J:113406
|
Polmm1Btlr/Polmm1Btlr
(C57BL/6J-Polmm1Btlr)
|
decreased B cell number
|
J:272866
|
Polmm2Btlr/Polmm2Btlr
(C57BL/6J-Polmm2Btlr)
|
abnormal lymphocyte morphology
|
J:272867
|
| decreased B cell number
|
J:272867
|
Polmtm1Abnd/Polmtm1Abnd
(involves: 129/Sv * BALB/c)
|
abnormal B cell number
|
J:97782
|
Polmtm1Crey/Polmtm1Crey
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:75927,
J:85190
|
Polmtm1Crey/Polmtm1Crey
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
Polqtm1Jcs/Polqtm1Jcs
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal somatic hypermutation frequency
|
J:103365
|
Polqtm1Jow/Polqtm1Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal somatic hypermutation frequency
|
J:101409
|
Polqtm2Jow/Polqtm2Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:115989
|
Polr2atm1(cre/ERT2)Bbd/Polr2a+
Rnf2tm1Mvi/Rnf2tm1Mvi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * SJL)
|
decreased B cell number
|
J:130397
|
Postntm1Sjc/Postntm1Sjc
(B6.Cg-Postntm1Sjc)
|
increased osteoclast cell number
|
J:200192
|
Pou1f1dw/Pou1f1dw
(DW/J Pou1f1dw)
|
decreased B cell number
|
J:110683
|
Pou2af1tm1b(KOMP)Wtsi/Pou2af1tm1b(KOMP)Wtsi
(C57BL/6N-Pou2af1tm1b(KOMP)Wtsi/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
Pou2af1tm1Pjln/Pou2af1tm1Pjln
(C57BL/6-Pou2af1tm1Pjln)
|
decreased B cell number
|
J:37085
|
Pou2af1tm1Pjln/Pou2af1tm1Pjln
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:67362
|
| decreased B cell number
|
J:123039,
J:67362
|
| decreased immature B cell number
|
J:67362
|
| decreased mature B cell number
|
J:67362
|
| decreased T cell number
|
J:123039
|
Pou2af1tm1Pjln/Pou2af1tm1Pjln
Tg(tetO-Pou2af1)1Pjln/0
Tg(tTA)1Pjln/0
(involves: C57BL/6)
|
decreased B cell number
|
J:67362
|
| decreased mature B cell number
|
J:67362
|
Pou2af1tm1Pmt/Pou2af1tm1Pmt
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:81805
|
Pou2af1tm1Rgr/Pou2af1tm1Rgr
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv))
|
abnormal B cell differentiation
|
J:114816,
J:35785
|
| abnormal pre-B cell morphology
|
J:114816
|
| arrested B cell differentiation
|
J:114816
|
| decreased B cell number
|
J:114816
|
Pou2af3tm1b(NCOM)Mfgc/Pou2af3tm1b(NCOM)Mfgc
(C57BL/6N-Pou2af3tm1b(NCOM)Mfgc/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Pou2f2tm1Bal/Pou2f2+
(involves: 129S2/SvPas)
|
decreased mature B cell number
|
J:4555
|
Pou2f2tm1Bal/Pou2f2tm1Bal
(involves: 129S2/SvPas * C57BL/6)
|
arrested B cell differentiation
|
J:88240
|
| decreased B cell number
|
J:88240
|
Pou2f2tm1Bal/Pou2f2tm1Bal
(involves: 129S2/SvPas)
|
decreased mature B cell number
|
J:4555
|
Pou2f2tm1Lmc/Pou2f2tm1Lmc
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:88240
|
| decreased B cell number
|
J:88240
|
| decreased B-1 B cell number
|
J:88240
|
Ppardtm1Dsvg/Ppardtm1Dsvg
(involves: 129S2/SvPas * C57BL/6)
|
increased osteoclast cell number
|
J:219677
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal peritoneal macrophage morphology
|
J:168799
|
Ppargtm2Rev/Ppargtm2Rev
Tg(Cd4-cre)1Cwi/?
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:153358
|
Ppargtm2Rev/Ppargtm2Rev
Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
abnormal osteoclast differentiation
|
J:160910
|
| abnormal osteoclast morphology
|
J:130475
|
| decreased osteoclast cell number
|
J:130475
|
Ppargc1btm1.2Rev/Ppargc1btm1.2Rev
Tg(Tek-cre)1Ywa/0
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)
|
abnormal osteoclast differentiation
|
J:160910
|
Ppbptm1.1(KOMP)Vlcg/Ppbptm1.1(KOMP)Vlcg
(C57BL/6N-Ppbptm1.1(KOMP)Vlcg/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
Ppiatm1Lubn/Ppiatm1Lubn
(129S6.129P2-Ppiatm1Lubn)
|
increased T cell number
|
J:93591
|
Ppicem1Igc/Ppicem1Igc
(C57BL/6-Ppicem1Igc)
|
decreased NK cell number
|
J:321155
|
| increased transitional stage T1 B cell number
|
J:321155
|
| increased transitional stage T2 B cell number
|
J:321155
|
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:74284
|
| increased CD4-positive, alpha-beta T cell number
|
J:74284
|
Ppm1mtm2b(EUCOMM)Hmgu/Ppm1mtm2b(EUCOMM)Hmgu
(C57BL/6N-Ppm1mtm2b(EUCOMM)Hmgu/Bay)
|
decreased large unstained cell number
|
J:211773
|
Ppp1r17em1(IMPC)H/Ppp1r17em1(IMPC)H
(C57BL/6NTac-Ppp1r17em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Ppp1r18em1Mgin/Ppp1r18em1Mgin
(B6J.B6N-Ppp1r18em1Mgin)
|
decreased B cell number
|
J:331428
|
| decreased T cell number
|
J:331428
|
Ppp1r18em3Mgin/Ppp1r18em3Mgin
(B6J.B6N-Ppp1r18em3Mgin)
|
decreased B cell number
|
J:331428
|
| decreased T cell number
|
J:331428
|
Ppp2r2btm1b(KOMP)Wtsi/Ppp2r2btm1b(KOMP)Wtsi
(C57BL/6N-Ppp2r2btm1b(KOMP)Wtsi/Tcp)
|
increased monocyte cell number
|
J:211773
|
Ppp2r3ctm1Imku/Ppp2r3ctm1Imku
Tg(CD19-cre/ERT2)1Cgn/?
(involves: C57BL/6)
|
decreased B cell number
|
J:100706
|
| decreased B-1a cell number
|
J:100706
|
| decreased follicular B cell number
|
J:100706
|
| decreased immature B cell number
|
J:100706
|
| decreased mature B cell number
|
J:100706
|
| decreased pre-B cell number
|
J:100706
|
| decreased transitional stage B cell number
|
J:100706
|
| increased pro-B cell number
|
J:100706
|
| increased T cell number
|
J:100706
|
| increased transitional stage B cell number
|
J:100706
|
Ppp2r5cem1(IMPC)Mbp/Ppp2r5cem1(IMPC)Mbp
(C57BL/6N-Ppp2r5cem1(IMPC)Mbp/Ucd)
|
increased monocyte cell number
|
J:211773
|
Ppp3cbM3Btlr/Ppp3cb+
(C57BL/6J-Ppp3cbM3Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254889
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254889
|
Ppp3cbM3Btlr/Ppp3cbM3Btlr
(C57BL/6J-Ppp3cbM3Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254889
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254889
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254889
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254889
|
Ppp3cbM4Btlr/Ppp3cb+
(C57BL/6J-Ppp3cbM4Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254905
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254905
|
Ppp3cbM4Btlr/Ppp3cbM4Btlr
(C57BL/6J-Ppp3cbM4Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254905
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254905
|
Ppp3cbm5Btlr/Ppp3cbm5Btlr
(C57BL/6J-Ppp3cbm5Btlr)
|
abnormal T cell morphology
|
J:272839
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272839
|
Ppp3cbM6Btlr/Ppp3cbM6Btlr
(C57BL/6J-Ppp3cbM6Btlr)
|
abnormal lymphocyte morphology
|
J:272840
|
| decreased alpha-beta T cell number
|
J:272840
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272840
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272840
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell differentiation
|
J:77729
|
| decreased single-positive T cell number
|
J:77729
|
| decreased T cell number
|
J:77729
|
Ppp3r1tm2Grc/Ppp3r1tm2.1Grc
Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:89771
|
Ppp3r1tm2Grc/Ppp3r1tm2Grc
Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:89771
|
Ppp4ctm1Tht/Ppp4ctm1Tht
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:117684
|
| abnormal T cell differentiation
|
J:117684
|
| decreased CD4-positive, alpha-beta T cell number
|
J:117684
|
| decreased CD8-positive, alpha-beta T cell number
|
J:117684
|
| decreased double-positive T cell number
|
J:117684
|
| decreased single-positive T cell number
|
J:117684
|
| increased double-negative T cell number
|
J:117684
|
Ppp4ctm1Tht/Ppp4ctm1Tht
Tg(Lck-cre)548Jxm/0
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:117684
|
| decreased double-positive T cell number
|
J:117684
|
| decreased single-positive T cell number
|
J:117684
|
Ppp5ctm1a(EUCOMM)Wtsi/Ppp5ctm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased CD4-positive, alpha-beta T cell number
|
J:213427
|
| increased CD8-positive, alpha-beta T cell number
|
J:213427
|
| increased T cell number
|
J:213427
|
Ppt1tm1Hof/Ppt1tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
microgliosis
|
J:280337
|
Ppt2tm1Hof/Ppt2tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased macrophage cell number
|
J:86202
|
Prdm1tm1.1Liz/Prdm1tm1.1Liz
(involves: 129S/SvEv)
|
absent plasma cells
|
J:196531
|
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T follicular helper cell differentiation
|
J:178876
|
| increased germinal center B cell number
|
J:178876
|
| increased T follicular helper cell number
|
J:178876
|
Prdm11tm1.1Ahl/Prdm11tm1.1Ahl
(B6.129(C)-Prdm11tm1.1Ahl)
|
decreased CD4-positive, alpha-beta T cell number
|
J:233986
|
| increased B cell number
|
J:233986
|
Prdm14tm1a(EUCOMM)Wtsi/Prdm14tm1a(EUCOMM)Wtsi
(C57BL/6N-Prdm14tm1a(EUCOMM)Wtsi/Bay)
|
increased effector memory T-helper cell number
|
J:211773
|
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Tg(Adipoq-cre)1Evdr/0
(involves: 129/Sv * C57BL/6 * FVB/N)
|
increased macrophage cell number
|
J:208683
|
Prdx1flro/Prdx1flro
(C57BL/10JAnu-Prdx1flro/AnuApb)
|
abnormal lymphocyte morphology
|
J:104190
|
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal NK T cell number
|
J:84677
|
Prf1tm1Clrk/Prf1tm1Clrk
(C.129S7(B6)-Prf1tm1Clrk)
|
increased activated T cell number
|
J:71576
|
Primpolem1Nki/Primpolem1Nki
(C57BL/6-Primpolem1Nki)
|
abnormal somatic hypermutation frequency
|
J:242620
|
Prkab1tm1b(KOMP)Wtsi/Prkab1+
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Ccpcz)
|
decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Wtsi)
|
increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
Prkag1tm1.2Mfor/Prkag1tm1.2Mfor
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * FVB/N)
|
abnormal Kupffer cell morphology
|
J:167779
|
Prkar1atm2Gsm/Prkar1atm2Gsm
Tg(Cr2-cre)3Cgn/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147785
|
PrkcbM4Btlr/PrkcbM4Btlr
(C57BL/6J-PrkcbM4Btlr)
|
decreased B-1 B cell number
|
J:274860
|
| increased CD4-positive, alpha-beta T cell number
|
J:274860
|
| increased CD8-positive, alpha-beta T cell number
|
J:274860
|
| increased T cell number
|
J:274860
|
PrkcbM6Btlr/PrkcbM6Btlr
(C57BL/6J-PrkcbM6Btlr)
|
decreased B-1 B cell number
|
J:274862
|
Prkcbtilc/Prkcbtilc
(involves: C57BL/6JSfdAnu)
|
decreased B-1a cell number
|
J:221236
|
Prkcbtm1Tara/Prkcbtm1Tara
(involves: 129)
|
decreased B cell number
|
J:34818
|
| decreased B-1 B cell number
|
J:34818
|
| decreased B-1a cell number
|
J:34818
|
Prkcdm2Btlr/Prkcdm2Btlr
(C57BL/6J-Prkcdm2Btlr)
|
increased NK cell number
|
J:265146
|
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasma cell differentiation
|
J:143854
|
| increased B cell number
|
J:76135
|
| increased follicular B cell number
|
J:143854
|
| increased marginal zone B cell number
|
J:143854
|
| increased transitional stage B cell number
|
J:143854
|
Prkcdtm1Qxu/Prkcdtm1Qxu
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:76134
|
Prkcdtm1Qxu/Prkcdtm1Qxu
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:76134
|
Prkcem1Btlr/Prkcem1Btlr
(C57BL/6J-Prkcem1Btlr)
|
decreased NK cell number
|
J:267703
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal effector T cell morphology
|
J:186080
|
| decreased B cell number
|
J:186080
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186080
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186080
|
| decreased DN1 thymic pro-T cell number
|
J:186080
|
| decreased DN4 thymocyte number
|
J:186080
|
| decreased double-positive T cell number
|
J:186080
|
| decreased lymphocyte cell number
|
J:186080
|
| decreased T cell number
|
J:186080
|
| increased B cell number
|
J:186080
|
| increased CD4-positive, alpha-beta T cell number
|
J:186080
|
| increased CD8-positive, alpha-beta T cell number
|
J:186080
|
| increased memory T cell number
|
J:186080
|
| increased T cell number
|
J:186080
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal positive T cell selection
|
J:186080
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186080
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186080
|
| decreased DN1 thymic pro-T cell number
|
J:186080
|
| decreased DN4 thymocyte number
|
J:186080
|
| decreased double-negative T cell number
|
J:186080
|
| decreased double-positive T cell number
|
J:186080
|
Prkcqtm1Litt/Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt)
|
abnormal T-helper 1 cell differentiation
|
J:94285
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal effector T cell morphology
|
J:186080
|
| abnormal positive T cell selection
|
J:186080
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186080
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186080
|
| decreased DN1 thymic pro-T cell number
|
J:186080
|
| decreased NK T cell number
|
J:141128
|
Prkcqtm1Litt/Prkcqtm1Litt
Tg(LCKprBCL2L1)12Sjk/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased NK T cell number
|
J:141128
|
Prkcztm1Jmos/Prkcztm1Jmos
(involves: 129P2/OlaHsd * 129/Sv)
|
decreased B cell number
|
J:72720
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy
Prkd3tm1.1Shoy/Prkd3tm1.1Shoy
Tg(BCL2)25Wehi/0
Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6 * C57BL/6JWehi * SJL/JWehi)
|
decreased thymocyte number
|
J:236298
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy
Prkd3tm1.1Shoy/Prkd3tm1.1Shoy
Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:236298
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy
Prkd3tm1.1Shoy/Prkd3tm1.1Shoy
Tg(Lck-cre)1Jtak/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)
|
decreased thymocyte number
|
J:236298
|
| increased double-positive T cell number
|
J:236298
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy
Prkd3tm1.1Shoy/Prkd3tm1.1Shoy
Tg(Lck-cre)1Jtak/0
Tg(TcraTcrb)425Cbn/0
(involves: 129 * BALB/c * C57BL/6)
|
decreased thymocyte number
|
J:236298
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy
Prkd3tm1.1Shoy/Prkd3tm1.1Shoy
Tg(Lck-cre)1Jtak/0
Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:236298
|
Prkdcberty/Prkdcberty
(C57BL/6JAnu-Prkdcberty)
|
absent B cells
|
J:104190
|
| absent T cells
|
J:104190
|
Prkdcem2(IMPC)Ics/Prkdcem2(IMPC)Ics
(C57BL/6N-Prkdcem2(IMPC)Ics/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Prkdchanky/Prkdchanky
(either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ))
|
decreased lymphocyte cell number
|
J:104190
|
| increased plasma cell number
|
J:104190
|
Prkdcm1Anu/Prkdcm1Anu
(C57BL/6JAnu-Prkdcm1Anu)
|
abnormal lymphocyte morphology
|
J:104190
|
Prkdcm1Btlr/Prkdcm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
Prkdcm2Btlr/Prkdcm2Btlr
(C57BL/6J-Prkdcm2Btlr)
|
decreased B cell number
|
J:204502
|
| decreased CD4-positive, alpha-beta T cell number
|
J:204502
|
| decreased CD8-positive, alpha-beta T cell number
|
J:204502
|
Prkdcm4Btlr/Prkdcm4Btlr
(C57BL/6J-Prkdcm4Btlr)
|
decreased B cell number
|
J:255217
|
| increased B-1b cell number
|
J:255217
|
Prkdcm5Btlr/Prkdcm5Btlr
(C57BL/6J-Prkdcm5Btlr)
|
increased alpha-beta T cell number
|
J:255220
|
| increased CD4-positive, alpha-beta T cell number
|
J:255220
|
Prkdcm6Btlr/Prkdcm6Btlr
(C57BL/6J-Prkdcm6Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:255221
|
| increased alpha-beta T cell number
|
J:255221
|
| increased CD4-positive, alpha-beta T cell number
|
J:255221
|
| increased CD8-positive, alpha-beta T cell number
|
J:255221
|
Prkdcm7Btlr/Prkdcm7Btlr
(C57BL/6J-Prkdcm7Btlr)
|
increased effector memory CD4-positive, alpha-beta T cell number
|
J:255223
|
PrkdcM8Btlr/Prkdc+
(C57BL/6J-PrkdcM8Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255224
|
PrkdcM8Btlr/PrkdcM8Btlr
(C57BL/6J-PrkdcM8Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255224
|
| increased CD4-positive, alpha-beta T cell number
|
J:255224
|
PrkdcM9Btlr/Prkdc+
(C57BL/6J-PrkdcM9Btlr)
|
decreased B-1a cell number
|
J:255268
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:255268
|
| increased B cell number
|
J:255268
|
| increased B-1b cell number
|
J:255268
|
PrkdcM9Btlr/PrkdcM9Btlr
(C57BL/6J-PrkdcM9Btlr)
|
decreased B-1a cell number
|
J:255268
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:255268
|
| increased B cell number
|
J:255268
|
| increased B-1b cell number
|
J:255268
|
PrkdcM10Btlr/Prkdc+
(C57BL/6J-PrkdcM10Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255269
|
PrkdcM10Btlr/PrkdcM10Btlr
(C57BL/6J-PrkdcM10Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255269
|
Prkdcm12Btlr/Prkdcm12Btlr
(C57BL/6J-Prkdcm12Btlr)
|
decreased B cell number
|
J:264708
|
| decreased B-1 B cell number
|
J:264708
|
| decreased CD4-positive, alpha-beta T cell number
|
J:264708
|
| decreased CD8-positive, alpha-beta T cell number
|
J:264708
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:264708
|
| decreased NK T cell number
|
J:264708
|
| decreased single-positive T cell number
|
J:264708
|
| decreased T cell number
|
J:264708
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:264708
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:264708
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:264708
|
| increased NK cell number
|
J:264708
|
Prkdcm13Btlr/Prkdcm13Btlr
(C57BL/6J-Prkdcm13Btlr)
|
increased effector memory CD4-positive, alpha-beta T cell number
|
J:272441
|
Prkdcm14Btlr/Prkdcm14Btlr
(C57BL/6J-Prkdcm14Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272442
|
PrkdcM15Btlr/PrkdcM15Btlr
(C57BL/6J-PrkdcM15Btlr)
|
decreased B-1 B cell number
|
J:272445
|
PrkdcM16Btlr/PrkdcM16Btlr
(C57BL/6J-PrkdcM16Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272520
|
Prkdcm18Btlr/Prkdcm18Btlr
(C57BL/6J-Prkdcm18Btlr)
|
abnormal B cell differentiation
|
J:274730
|
| abnormal CD4-positive T cell differentiation
|
J:274730
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274730
|
| abnormal T cell differentiation
|
J:274730
|
| decreased alpha-beta T cell number
|
J:274730
|
| decreased B cell number
|
J:274730
|
| decreased B-1 B cell number
|
J:274730
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274730
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274730
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274730
|
| increased CD4-positive, alpha-beta T cell number
|
J:274730
|
| increased CD8-positive, alpha-beta T cell number
|
J:274730
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274730
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274730
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274730
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274730
|
| increased T cell number
|
J:274730
|
Prkdcm19Btlr/Prkdcm19Btlr
(C57BL/6J-Prkdcm19Btlr)
|
abnormal B cell differentiation
|
J:274763
|
| abnormal CD4-positive T cell differentiation
|
J:274763
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274763
|
| abnormal T cell differentiation
|
J:274763
|
| decreased B cell number
|
J:274763
|
| decreased B-1 B cell number
|
J:274763
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274763
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274763
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274763
|
| decreased T cell number
|
J:274763
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274763
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274763
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274763
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274763
|
| increased NK cell number
|
J:274763
|
Prkdcscid/Prkdcscid
(C.BKa-Prkdcscid)
|
absent B cells
|
J:6958
|
| absent pre-B cells
|
J:6958
|
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid)
|
decreased B cell number
|
J:22026
|
| decreased CD4-positive, alpha-beta T cell number
|
J:109833,
J:22026
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109833,
J:22026
|
| decreased lymphocyte cell number
|
J:22026
|
| decreased mature B cell number
|
J:109833
|
| decreased NK cell number
|
J:22026
|
| decreased pre-B cell number
|
J:22026
|
| decreased T cell number
|
J:22026
|
| increased macrophage cell number
|
J:22026
|
Prkdcscid/Prkdcscid
(B6.Cg-Prkdcscid/Sz)
|
decreased B cell number
|
J:34814
|
| decreased CD4-positive, alpha-beta T cell number
|
J:34814
|
| decreased CD8-positive, alpha-beta T cell number
|
J:34814
|
| decreased lymphocyte cell number
|
J:34814
|
| decreased pre-B cell number
|
J:34814
|
| decreased T cell number
|
J:34814
|
| increased macrophage cell number
|
J:34814
|
| increased monocyte cell number
|
J:34814
|
| increased NK cell number
|
J:34814
|
Prkdcscid/Prkdcscid
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz/Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
(NOD.Cg-Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz Prkdcscid/Gck)
|
absent T cells
|
J:126700
|
Prkdcscid/Prkdcscid
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Prkdcscid Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93553
|
Prkdcscid/Prkdcscid
Tg(Tcrb)93Vbo/0
(involves: Balb/c * C57BL/Ka * C57BL/Lia * CBA/BrA)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:111476
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:111476
|
| abnormal double-positive T cell morphology
|
J:111476
|
| abnormal single-positive T cell number
|
J:111476
|
| abnormal T cell differentiation
|
J:111476
|
Prkdctm1.1Bpcc/Prkdctm1.1Bpcc
(involves: 129 * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:171351
|
| arrested B cell differentiation
|
J:171351
|
| decreased CD4-positive, alpha-beta T cell number
|
J:171351
|
| decreased CD8-positive, alpha-beta T cell number
|
J:171351
|
| decreased double-negative T cell number
|
J:171351
|
| decreased double-positive T cell number
|
J:171351
|
| decreased gamma-delta T cell number
|
J:171351
|
| decreased lymphocyte cell number
|
J:171351
|
| decreased macrophage cell number
|
J:171351
|
| decreased mature B cell number
|
J:171351
|
| decreased T cell number
|
J:171351
|
Prkdctm1Fwa/Prkdctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:50221
|
| abnormal T cell receptor V(D)J recombination
|
J:50221
|
| absent pre-B cells
|
J:50221
|
| arrested B cell differentiation
|
J:50221
|
| arrested T cell differentiation
|
J:50221
|
| decreased double-positive T cell number
|
J:50221
|
| decreased thymocyte number
|
J:50221
|
Prkdctm1Gcl/Prkdctm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:53765
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:53765
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:53765
|
| absent mature B cells
|
J:53765
|
| arrested B cell differentiation
|
J:53765
|
Prkdctm1Get/Prkdctm1Get
(involves: 129S4/SvJae * Black Swiss)
|
abnormal B cell differentiation
|
J:50222
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:50222
|
| abnormal immunoglobulin light chain V-J recombination
|
J:50222
|
| abnormal T cell differentiation
|
J:50222
|
| abnormal T cell number
|
J:50222
|
| abnormal T cell receptor alpha chain V-J recombination
|
J:50222
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:50222
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:50222
|
| arrested B cell differentiation
|
J:50222
|
| arrested T cell differentiation
|
J:50222
|
| decreased single-positive T cell number
|
J:50222
|
| increased double-negative T cell number
|
J:50222
|
| increased double-positive T cell number
|
J:50222
|
| increased NK cell number
|
J:50222
|
Prl7d1em1Liga/Prl7d1em1Liga
(involves: C57BL/6)
|
increased uterine NK cell number
|
J:288761
|
Prmt3tm1a(EUCOMM)Wtsi/Prmt3tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased CD4-positive, alpha-beta T cell number
|
J:213427
|
| increased CD8-positive, alpha-beta T cell number
|
J:213427
|
| increased T cell number
|
J:213427
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Lck-Prnp)33Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased CD8-positive, alpha-beta T cell number
|
J:129512
|
| increased gamma-delta T cell number
|
J:129512
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp)a20Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell morphology
|
J:129512
|
| abnormal T cell differentiation
|
J:129512
|
| decreased CD4-positive, alpha-beta T cell number
|
J:129512
|
| decreased CD8-positive, alpha-beta T cell number
|
J:129512
|
| decreased DN2 thymocyte number
|
J:129512
|
| decreased DN4 thymocyte number
|
J:129512
|
| decreased double-positive T cell number
|
J:129512
|
| decreased thymocyte number
|
J:129512
|
| increased DN3 thymocyte number
|
J:129512
|
| increased double-negative T cell number
|
J:129512
|
| increased gamma-delta T cell number
|
J:129512
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp*S170N*N174T)1020Aag/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
microgliosis
|
J:143528
|
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
increased macrophage cell number
|
J:102652
|
Prph2Rd2/Prph2Rd2
(O20/A-Prph2Rd2)
|
abnormal macrophage morphology
|
J:6432
|
Prr7tm1(KOMP)Vlcg/Prr7tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:237776
|
Prss16tm1.1Mal/Prss16+
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal positive T cell selection
|
J:148034
|
| decreased CD4-positive, alpha-beta T cell number
|
J:148034
|
| decreased single-positive T cell number
|
J:148034
|
Prss16tm1.1Mal/Prss16tm1.1Mal
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal positive T cell selection
|
J:148034
|
| decreased CD4-positive, alpha-beta T cell number
|
J:148034
|
| decreased double-positive T cell number
|
J:148034
|
| decreased single-positive T cell number
|
J:148034
|
Prss27tm1.1(NCOM)Mfgc/Prss27tm1.1(NCOM)Mfgc
(C57BL/6N-Prss27tm1.1(NCOM)Mfgc/Tcp)
|
decreased monocyte cell number
|
J:211773
|
Prss50tm1a(EUCOMM)Hmgu/Prss50tm1a(EUCOMM)Hmgu
(C57BL/6N-Prss50tm1a(EUCOMM)Hmgu/H)
|
decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
Prss57em1(IMPC)Ccpcz/Prss57em1(IMPC)Ccpcz
(C57BL/6N-Prss57em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK T cell number
|
J:211773
|
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd)
|
abnormal macrophage morphology
|
J:113052
|
Psaptm2Ggb/Psaptm2Ggb
(involves: 129S/SvEv * C57BL/6J)
|
microgliosis
|
J:198242
|
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J)
|
abnormal macrophage morphology
|
J:78223
|
| microgliosis
|
J:198242
|
Psaptm4.1Ggb/Psaptm4.1Ggb
(involves: 129S/SvEv * C57BL/6J)
|
microgliosis
|
J:198242
|
Psen1tm1.1Ruvi/Psen1tm1.1Ruvi
Tg(APP)8.9Btla/0
(involves: 129S2/SvPas * C57BL/6J)
|
microgliosis
|
J:187475
|
Psen1tm1Bdes/Psen1+
Psen2tm1Bdes/Psen2tm1Bdes
(involves: 129P2/OlaHsd)
|
abnormal T cell subpopulation ratio
|
J:91235
|
Psen1tm2Shn/Psen1tm4.1Shn
Psen2tm1Haa/Psen2tm1Haa
Tg(Camk2a-cre)1Shn/0
(involves: 129 * 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)
|
microgliosis
|
J:219929
|
Psma8em1(IMPC)Tcp/Psma8em1(IMPC)Tcp
(C57BL/6N-Psma8em1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Psmb8tm1Hjf/Psmb8tm1Hjf
Tg(TcraTcrb)1100Mjb/?
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:107657
|
Psmb9tm1Stl/Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:21549
|
| decreased CD8-positive, alpha-beta T cell number
|
J:21549
|
Psmb10tm1Mgro/Psmb10tm1Mgro
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:125058
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125058
|
Psmb10tm1Mgro/Psmb10tm1Mgro
Psmb9/Psmb8tm1Klr/Psmb9/Psmb8tm1Klr
(B6.129-Psmb10tm1Mgro Psmb9/Psmb8tm1Klr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:180765
|
Psmb10tm1Mgro/Psmb10tm1Mgro
Psmb9/Psmb8tm1Klr/Psmb9/Psmb8tm1Klr
(B6.129-Psmb10tm1Mgro Psmb9/Psmb8tm1Klr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:180765
|
Psmb10tm1Mgro/Psmb10Tub6
(involves: 129S2/SvPas * C3HeB/FeJ)
|
decreased NK cell number
|
J:261081
|
| decreased T cell number
|
J:261081
|
Psmb10Tub6/Psmb10+
(C3HeB/FeJ-Psmb10Tub6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:261081
|
| decreased CD8-positive, alpha-beta T cell number
|
J:261081
|
| decreased T cell number
|
J:261081
|
Psmb10Tub6/Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6)
|
decreased B cell number
|
J:261081
|
| decreased NK cell number
|
J:261081
|
| decreased T cell number
|
J:261081
|
Psmb11em1(IMPC)Ccpcz/Psmb11em1(IMPC)Ccpcz
(C57BL/6NCrl-Psmb11em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| increased CD4-positive NK T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
Psmb11tm1(Psmb8)Khog/Psmb11+
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
Psmb11tm1(Psmb8)Khog/Psmb11tm1(Psmb8)Khog
(involves: C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:196156
|
| abnormal T cell differentiation
|
J:196156
|
| abnormal T cell receptor V(D)J recombination
|
J:196156
|
| decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
| decreased memory T cell number
|
J:196156
|
Psmb11tm1(Psmb8)Khog/Psmb11tm1(Psmb8)Khog
Psmb8tm1Hjf/Psmb8tm1Hjf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
Psmb11tm1.1(Psmb8)Khog/Psmb11tm1.1(Psmb8)Khog
Psmb8tm1Hjf/Psmb8tm1Hjf
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)
|
abnormal T cell receptor V(D)J recombination
|
J:196156
|
| decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
Psmb11tm1Smta/Psmb11tm1Smta
(involves: C57BL/6 * CBA)
|
decreased CD8-positive, alpha-beta T cell number
|
J:121869
|
Psmc4tm1.1Ryot/Psmc4tm1.2Ryot
Tg(SLC18A3-cre)KMisa/0
(involves: C57BL/6 * C57BL/6N)
|
microgliosis
|
J:193770
|
Psme3tm1Jjm/Psme3tm1Jjm
(B6.129X1-Psme3tm1Jjm)
|
decreased double-positive T cell number
|
J:88626
|
Psmf1tm1c(EUCOMM)Hmgu/Psmf1tm1c(EUCOMM)Hmgu
Tg(Pcp2-cre)GN135Gsat/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
microgliosis
|
J:282431
|
Pstpip1em1(IMPC)Ccpcz/Pstpip1em1(IMPC)Ccpcz
(C57BL/6N-Pstpip1em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
Pstpip2m1Bcs/Pstpip2m1Bcs
(involves: C57BL/6)
|
abnormal microglial cell morphology
|
J:196534
|
Ptch1tm1Hahn/Ptch1tm1Hahn
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:127207
|
| decreased B cell number
|
J:127207
|
| decreased double-positive T cell number
|
J:127207
|
| decreased immature B cell number
|
J:127207
|
| decreased lymphocyte cell number
|
J:127207
|
| decreased pre-B cell number
|
J:127207
|
| decreased transitional stage B cell number
|
J:127207
|
| increased B cell number
|
J:127207
|
| increased double-negative T cell number
|
J:127207
|
| increased mature B cell number
|
J:127207
|
| increased single-positive T cell number
|
J:127207
|
Ptch2tm3b(EUCOMM)Hmgu/Ptch2tm3b(EUCOMM)Hmgu
(C57BL/6N-Ptch2tm3b(EUCOMM)Hmgu/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
Ptcratm1(icre)Hjf/Ptcratm1(icre)Hjf
(B6.129P2-Ptcratm1(icre)Hjf)
|
decreased DN4 thymocyte number
|
J:197923
|
| decreased double-positive T cell number
|
J:197923
|
| decreased thymocyte number
|
J:197923
|
Ptcratm1.1Shoy/Ptcratm1.1Shoy
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:166147
|
| decreased T cell number
|
J:166147
|
| decreased thymocyte number
|
J:166147
|
| increased DN3 thymocyte number
|
J:166147
|
| increased gamma-delta T cell number
|
J:166147
|
| increased T cell number
|
J:166147
|
Ptcratm1Bjf/Ptcra+
(involves: 129X1/SvJ)
|
abnormal T cell differentiation
|
J:94338
|
| decreased double-negative T cell number
|
J:94338
|
| decreased single-positive T cell number
|
J:94338
|
Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested T cell differentiation
|
J:91542
|
| increased double-negative T cell number
|
J:91542
|
Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
abnormal double-positive T cell morphology
|
J:123569
|
| decreased DN4 thymocyte number
|
J:123569
|
| increased DN3 thymocyte number
|
J:123569
|
Ptdss1tm1b(EUCOMM)Hmgu/Ptdss1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ptdss1tm1b(EUCOMM)Hmgu/Ics)
|
decreased large unstained cell number
|
J:211773
|
Ptentm1Hwu/Ptentm1Hwu
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal alveolar macrophage morphology
|
J:148947
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Ptentm1Hwu)
|
decreased B cell number
|
J:232645
|
| decreased lymphocyte cell number
|
J:232645
|
| decreased T cell number
|
J:232645
|
| increased macrophage cell number
|
J:232645
|
| increased monocyte cell number
|
J:232645
|
Ptentm2.1Ppp/Ptentm2.1Ppp
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased germinal center B cell number
|
J:164283
|
| increased T follicular helper cell number
|
J:164283
|
Ptgdrtm1Sna/Ptgdrtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:243958
|
| increased regulatory T cell number
|
J:243958
|
Ptger1tm1Sna/Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:128435
|
| abnormal T-helper 1 cell differentiation
|
J:128435
|
Ptger2tm1Rsz/Ptger2tm1Rsz
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal osteoclast differentiation
|
J:77408
|
Ptger4tm1Sna/Ptger4tm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:63070
|
Ptgs2tm1Unc/Ptgs2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:124756
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:124756
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
abnormal class switch recombination
|
J:140698
|
| abnormal memory B cell differentiation
|
J:140698
|
Pthtm1Dgo/Pthtm1Dgo
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal osteoclast morphology
|
J:76407
|
| decreased osteoclast cell number
|
J:76407
|
Pthtm1Dgo/Pthtm1Dgo
Pthlhtm1Hmk/Pthlhtm1Hmk
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal osteoclast morphology
|
J:76407
|
| decreased osteoclast cell number
|
J:76407
|
Pthlhtm1Ack/Pthlhtm1Ack
Tg(Col1a1-cre)1Ack/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal osteoclast morphology
|
J:100918
|
| decreased osteoclast cell number
|
J:100918
|
Pthlhtm1Ack/Pthlhtm1Hmk
Tg(LGB-cre)74Acl/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal osteoclast morphology
|
J:86536
|
Pthlhtm1Hmk/Pthlh+
(involves: 129S2/SvPas)
|
abnormal osteoclast morphology
|
J:100918
|
Pthlhtm1Hmk/Pthlhtm1Hmk
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal osteoclast morphology
|
J:76407
|
| decreased osteoclast cell number
|
J:76407
|
Pthlhtm2Ack/Pthlhtm2Ack
(involves: 129S2/SvPas * C57BL/6)
|
decreased osteoclast cell number
|
J:142669
|
Ptntm1Tmu/Ptntm1Tmu
(B6.Cg-Ptntm1Tmu)
|
decreased macrophage cell number
|
J:102069
|
Ptpn2tm1.1Kry/Ptpn2tm1.1Kry
Tg(Col1a1-cre)1Kry/0
(involves: 129 * C57BL/6J * FVB)
|
abnormal osteoclast differentiation
|
J:183709
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(involves: 129S4/SvJae * BALB/c)
|
abnormal B cell number
|
J:42595
|
| decreased B cell number
|
J:42595
|
| decreased double-positive T cell number
|
J:42595
|
| increased B cell number
|
J:42595
|
| increased macrophage cell number
|
J:42595
|
| increased mature B cell number
|
J:42595
|
| increased pre-B cell number
|
J:42595
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(C.129S4-Ptpn2tm1Mtr)
|
abnormal negative T cell selection
|
J:186843
|
| abnormal positive T cell selection
|
J:186843
|
| abnormal T cell differentiation
|
J:186843
|
| abnormal T cell subpopulation ratio
|
J:186843
|
| decreased B cell number
|
J:186843
|
| decreased B-1 B cell number
|
J:186843
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186843
|
| decreased double-positive T cell number
|
J:186843
|
| decreased follicular B cell number
|
J:186843
|
| decreased immature B cell number
|
J:186843
|
| decreased marginal zone B cell number
|
J:186843
|
| decreased mature B cell number
|
J:186843
|
| decreased single-positive T cell number
|
J:186843
|
| decreased T cell number
|
J:186843
|
| decreased thymocyte number
|
J:186843
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(B6.129S4(C)-Ptpn2tm1Mtr)
|
decreased B cell number
|
J:186843
|
| decreased B-1 B cell number
|
J:186843
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186843
|
| decreased double-positive T cell number
|
J:186843
|
| decreased follicular B cell number
|
J:186843
|
| decreased immature B cell number
|
J:186843
|
| decreased marginal zone B cell number
|
J:186843
|
| decreased mature B cell number
|
J:186843
|
| decreased single-positive T cell number
|
J:186843
|
| decreased T cell number
|
J:186843
|
| decreased thymocyte number
|
J:186843
|
Ptpn2tm2.1Ttig/Ptpn2tm2.1Ttig
(B6.Cg-Ptpn2tm2.1Ttig)
|
abnormal negative T cell selection
|
J:186843
|
| abnormal positive T cell selection
|
J:186843
|
| abnormal T cell differentiation
|
J:186843
|
| abnormal T cell subpopulation ratio
|
J:186843
|
| decreased B cell number
|
J:186843
|
| decreased B-1 B cell number
|
J:186843
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186843
|
| decreased double-positive T cell number
|
J:186843
|
| decreased follicular B cell number
|
J:186843
|
| decreased immature B cell number
|
J:186843
|
| decreased marginal zone B cell number
|
J:186843
|
| decreased mature B cell number
|
J:186843
|
| decreased single-positive T cell number
|
J:186843
|
| decreased thymocyte number
|
J:186843
|
Ptpn6em1.1Shoy/Ptpn6em1.1Shoy
(involves: C57BL/6)
|
decreased thymocyte number
|
J:236298
|
Ptpn6m1Btlr/Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd)
|
decreased mature B cell number
|
J:142845
|
Ptpn6m3Btlr/Ptpn6+
(C57BL/6J-Ptpn6m3Btlr)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:234259
|
| decreased B cell number
|
J:234259
|
| decreased B-2 B cell number
|
J:234259
|
| decreased immature B cell number
|
J:234259
|
| decreased mature B cell number
|
J:234259
|
| increased B-1 B cell number
|
J:234259
|
| increased B-1a cell number
|
J:234259
|
| increased macrophage cell number
|
J:234259
|
Ptpn6m3Btlr/Ptpn6m3Btlr
(C57BL/6J-Ptpn6m3Btlr)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:234259
|
| decreased B cell number
|
J:234259
|
| decreased B-2 B cell number
|
J:234259
|
| decreased immature B cell number
|
J:234259
|
| decreased mature B cell number
|
J:234259
|
| increased B-1 B cell number
|
J:234259
|
| increased B-1b cell number
|
J:234259
|
| increased macrophage cell number
|
J:234259
|
Ptpn6m4Btlr/Ptpn6m4Btlr
(C57BL/6J-Ptpn6m4Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:264807
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:264807
|
| increased B-1 B cell number
|
J:264807
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:264807
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:264807
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:264807
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:264807
|
Ptpn6M5Btlr/Ptpn6M5Btlr
(C57BL/6J-Ptpn6M5Btlr)
|
decreased B cell number
|
J:265075
|
| decreased B-1 B cell number
|
J:265075
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265075
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265075
|
Ptpn6m6Btlr/Ptpn6m6Btlr
(C57BL/6J-Ptpn6m6Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272439
|
| abnormal T cell differentiation
|
J:272439
|
Ptpn6m7Btlr/Ptpn6m7Btlr
(C57BL/6J-Ptpn6m7Btlr)
|
abnormal T cell differentiation
|
J:272440
|
Ptpn6me-v/Ptpn6+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:110531
|
Ptpn6me-v/Ptpn6me-v
(C57BL/6J-Ptpn6me-v)
|
abnormal plasma cell morphology
|
J:14936
|
| decreased B cell number
|
J:113218
|
| decreased mature B cell number
|
J:7905
|
| increased plasma cell number
|
J:7905
|
Ptpn6me/Ptpn6me
(C57BL/6J-Ptpn6me/J)
|
increased monocyte cell number
|
J:5579
|
Ptpn6me/Ptpn6me
(involves: C3HeB/FeJ * C57BL/6)
|
abnormal microglial cell morphology
|
J:72655
|
Ptpn9tm1Dny/Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny)
|
abnormal T cell differentiation
|
J:118880
|
Ptpn11tm1Bgn/Ptpn11+
(involves: 129S4/SvJae * C57BL/6J)
|
increased lymphocyte cell number
|
J:91609
|
Ptpn11tm1Ckq/Ptpn11+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)
|
arrested B cell differentiation
|
J:177285
|
Ptpn11tm6Bgn/Ptpn11+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
increased monocyte cell number
|
J:148430
|
Ptpn13tm1Wjh/Ptpn13tm1Wjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T-helper 2 cell number
|
J:144351
|
Ptpn22tm1.1Draw/Ptpn22+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:201448
|
| abnormal B cell morphology
|
J:201448
|
| abnormal B cell number
|
J:201448
|
| abnormal T cell morphology
|
J:201448
|
| abnormal T cell number
|
J:201448
|
| decreased follicular B cell number
|
J:201448
|
| decreased mature B cell number
|
J:201448
|
| increased B cell number
|
J:201448
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:201448
|
| increased double-positive T cell number
|
J:201448
|
| increased germinal center B cell number
|
J:201448
|
| increased regulatory T cell number
|
J:201448
|
| increased transitional stage T1 B cell number
|
J:201448
|
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:201448
|
| abnormal B cell morphology
|
J:201448
|
| abnormal T cell differentiation
|
J:201448
|
| abnormal T cell morphology
|
J:201448
|
| decreased follicular B cell number
|
J:201448
|
| decreased mature B cell number
|
J:201448
|
| increased B cell number
|
J:201448
|
| increased double-positive T cell number
|
J:201448
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:201448
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:201448
|
| increased germinal center B cell number
|
J:201448
|
| increased regulatory T cell number
|
J:201448
|
| increased transitional stage T1 B cell number
|
J:201448
|
Ptpn22tm1.1Kas/Ptpn22tm1.1Kas
(involves: C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:176519
|
| increased CD8-positive, alpha-beta T cell number
|
J:176519
|
| increased T cell number
|
J:176519
|
Ptpn22tm1.1Kas/Ptpn22tm1.1Kas
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:176519
|
Ptpn22tm1Achn/Ptpn22tm1Achn
(involves: C57BL/6)
|
increased B cell number
|
J:90029
|
| increased follicular B cell number
|
J:90029
|
Ptpn22tm2Achn/Ptpn22tm2Achn
(involves: C57BL/6)
|
increased B cell number
|
J:90029
|
| increased follicular B cell number
|
J:90029
|
Ptpn22tm2Achn/Ptpn22tm2Achn
(B6.Cg-Ptpn22tm2Achn)
|
abnormal double-positive T cell morphology
|
J:147129
|
| abnormal T cell subpopulation ratio
|
J:147129
|
| increased memory T cell number
|
J:147129
|
Ptpn22tm2Achn/Ptpn22tm2Achn
Ptprctm1Weis/Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn)
|
abnormal double-positive T cell morphology
|
J:147129
|
| abnormal lymphocyte cell number
|
J:147129
|
| abnormal T cell subpopulation ratio
|
J:147129
|
| decreased follicular B cell number
|
J:147129
|
| increased memory T cell number
|
J:147129
|
| increased plasma cell number
|
J:147129
|
| increased transitional stage B cell number
|
J:147129
|
Ptprcloc/Ptprcloc
(C57BL/6JSfdAnu-Ptprcloc/AnuApb)
|
abnormal B cell number
|
J:104190
|
| abnormal double-positive T cell morphology
|
J:104190
|
| abnormal memory T cell number
|
J:104190
|
| abnormal T cell morphology
|
J:104190
|
| abnormal T cell selection
|
J:104190
|
| arrested T cell differentiation
|
J:104190
|
| decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
| decreased CD8-positive, alpha-beta T cell number
|
J:104190
|
| decreased double-positive T cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
Ptprcltng/Ptprcltng
(C57BL/6-Ptprcltng)
|
abnormal T cell differentiation
|
J:158876
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158876
|
| decreased double-positive T cell number
|
J:158876
|
Ptprcltng/Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158876
|
| decreased double-positive T cell number
|
J:158876
|
Ptprcltng/Ptprctm1Mak
Tg(TcraTcrb)425Cbn/0
(involves: 129/Sv * BALB/c * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:158876
|
Ptprcm1Btlr/Ptprcm1Btlr
(involves: C57BL/6J)
|
absent T cells
|
J:152064
|
Ptprcm1Smv/Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J)
|
abnormal CD4-positive T cell differentiation
|
J:214487
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:214487
|
| decreased DN4 thymocyte number
|
J:214487
|
| increased DN3 thymocyte number
|
J:214487
|
| increased double-negative T cell number
|
J:214487
|
Ptprcm2Btlr/Ptprcm2Btlr
(C57BL/6J-Ptprcm2Btlr)
|
decreased B-1a cell number
|
J:216796
|
| decreased B-2 B cell number
|
J:216796
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:216796
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:216796
|
| decreased mature B cell number
|
J:216796
|
| decreased memory B cell number
|
J:216796
|
| decreased memory T cell number
|
J:216796
|
| decreased single-positive T cell number
|
J:216796
|
| increased B-1 B cell number
|
J:216796
|
| increased B-1b cell number
|
J:216796
|
| increased single-positive T cell number
|
J:216796
|
Ptprcm3Btlr/Ptprcm3Btlr
(C57BL/6J-Ptprcm3Btlr)
|
decreased B cell number
|
J:254899
|
| decreased B-1a cell number
|
J:254899
|
| decreased B-2 B cell number
|
J:254899
|
| decreased CD8-positive, alpha-beta T cell number
|
J:254899
|
| increased B-1b cell number
|
J:254899
|
Ptprcm4Btlr/Ptprcm4Btlr
(C57BL/6J-Ptprcm4Btlr)
|
decreased B cell number
|
J:264808
|
| decreased CD4-positive, alpha-beta T cell number
|
J:264808
|
| decreased CD8-positive, alpha-beta T cell number
|
J:264808
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:264808
|
| decreased single-positive T cell number
|
J:264808
|
| decreased T cell number
|
J:264808
|
| increased B-1 B cell number
|
J:264808
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:264808
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:264808
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:264808
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:264808
|
PtprcM5Btlr/PtprcM5Btlr
(C57BL/6J-PtprcM5Btlr)
|
increased alpha-beta T cell number
|
J:265143
|
PtprcM6Btlr/PtprcM6Btlr
(C57BL/6J-PtprcM6Btlr)
|
decreased B-1a cell number
|
J:265186
|
| decreased B-1b cell number
|
J:265186
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265186
|
| increased B-1 B cell number
|
J:265186
|
Ptprcm7Btlr/Ptprcm7Btlr
(C57BL/6J-Ptprcm7Btlr)
|
decreased alpha-beta T cell number
|
J:267486
|
| decreased B cell number
|
J:267486
|
| decreased CD4-positive, alpha-beta T cell number
|
J:267486
|
| decreased CD8-positive, alpha-beta T cell number
|
J:267486
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:267486
|
| decreased NK T cell number
|
J:267486
|
| increased B-1 B cell number
|
J:267486
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:267486
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:267486
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267486
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:267486
|
PtprcM8Btlr/PtprcM8Btlr
(C57BL/6J-PtprcM8Btlr)
|
increased B-1 B cell number
|
J:267487
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:267487
|
PtprcM9Btlr/PtprcM9Btlr
(C57BL/6J-PtprcM9Btlr)
|
abnormal B cell differentiation
|
J:272745
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:272745
|
| abnormal lymphocyte morphology
|
J:272745
|
| decreased B cell number
|
J:272745
|
| decreased NK cell number
|
J:272745
|
| increased CD8-positive, alpha-beta T cell number
|
J:272745
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272745
|
PtprcM10Btlr/PtprcM10Btlr
(C57BL/6J-PtprcM10Btlr)
|
decreased B-1b cell number
|
J:272777
|
PtprcM11Btlr/PtprcM11Btlr
(C57BL/6J-PtprcM11Btlr)
|
abnormal B cell differentiation
|
J:274863
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274863
|
| increased B-1 B cell number
|
J:274863
|
Ptprcm12Btlr/Ptprcm12Btlr
(C57BL/6J-Ptprcm12Btlr)
|
decreased B cell number
|
J:274972
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274972
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274972
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274972
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:274972
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:274972
|
| decreased T cell number
|
J:274972
|
| increased B-1 B cell number
|
J:274972
|
Ptprcnim/Ptprcnim
(C57BL/6JAnu-Ptprcnim)
|
decreased B cell number
|
J:225105
|
| decreased T cell number
|
J:225105
|
Ptprcstrm/Ptprcstrm
(C57BL/6JAnu-Ptprcstrm/AnuApb)
|
decreased B cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
Ptprctm1Holm/Ptprctm1Holm
(involves: 129/Sv * C57BL/6)
|
abnormal B cell number
|
J:33466
|
| abnormal lymphopoiesis
|
J:33466
|
| abnormal T cell differentiation
|
J:33466
|
| decreased CD4-positive, alpha-beta T cell number
|
J:33466
|
| decreased CD8-positive, alpha-beta T cell number
|
J:33466
|
| decreased double-positive T cell number
|
J:33466
|
| decreased T cell number
|
J:33466
|
| decreased thymocyte number
|
J:33466
|
| increased double-negative T cell number
|
J:33466
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:13163
|
| arrested T cell differentiation
|
J:158876
|
| decreased CD4-positive, alpha-beta T cell number
|
J:13163
|
| decreased CD8-positive, alpha-beta T cell number
|
J:13163
|
| decreased T cell number
|
J:13163
|
| decreased thymocyte number
|
J:13163
|
| increased double-negative T cell number
|
J:13163
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129)
|
abnormal osteoclast morphology
|
J:141275
|
Ptprctm1Mak/Ptprctm1Mak
(B6.Cg-Ptprctm1Mak)
|
abnormal CD4-positive, alpha-beta intraepithelial T cell morphology
|
J:111646
|
| abnormal intraepithelial T cell morphology
|
J:111646
|
| abnormal intraepithelial T cell number
|
J:111646
|
| abnormal T cell differentiation
|
J:111646
|
| decreased gamma-delta intraepithelial T cell number
|
J:111646
|
Ptprctm1Mak/Ptprctm1Mak
Ptprjtm1.2Weis/Ptprjtm1.2Weis
(involves: 129/Sv * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal follicular B cell morphology
|
J:131736
|
| decreased B cell number
|
J:131736
|
Ptprctm1Mak/Ptprctm1Mak
Ptprjtm1.2Weis/Ptprjtm1.2Weis
(B6.Cg-Ptprctm1Mak Ptprjtm1.2Weis)
|
abnormal B cell differentiation
|
J:131736
|
| abnormal follicular B cell morphology
|
J:131736
|
| abnormal transitional stage B cell morphology
|
J:131736
|
| decreased B cell number
|
J:131736
|
| decreased immature B cell number
|
J:131736
|
| decreased mature B cell number
|
J:131736
|
Ptprctm1Mak/Ptprctm1Mak
Tg(TcraTcrb)425Cbn/0
(involves: 129/Sv * BALB/c * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:158876
|
Ptprctm1Tyb/Ptprctm1Tyb
(C.129S2-Ptprctm1Tyb)
|
abnormal positive T cell selection
|
J:57681
|
| abnormal T cell differentiation
|
J:57681
|
| decreased CD4-positive, alpha-beta T cell number
|
J:57681
|
| decreased CD8-positive, alpha-beta T cell number
|
J:57681
|
| decreased double-positive T cell number
|
J:57681
|
| increased double-negative T cell number
|
J:57681
|
Ptprctm1Tyb/Ptprctm1Tyb
(B6.129S2-Ptprctm1Tyb)
|
increased NK cell number
|
J:98190
|
Ptprctm1Weis/Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6)
|
increased B cell number
|
J:66501
|
| increased T cell number
|
J:66501
|
Ptprctm1Weis/Ptprctm1Weis
(B6.129X1-Ptprctm1Weis)
|
abnormal double-positive T cell morphology
|
J:147129
|
| abnormal T cell subpopulation ratio
|
J:147129
|
| decreased follicular B cell number
|
J:147129
|
| increased memory T cell number
|
J:147129
|
| increased plasma cell number
|
J:147129
|
| increased transitional stage B cell number
|
J:147129
|
Ptpretm1Ael/Ptpretm1Ael
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal osteoclast differentiation
|
J:90031
|
Ptprjtm1.2Weis/Ptprjtm1.2Weis
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal B cell differentiation
|
J:131736
|
| increased B-2 B cell number
|
J:131736
|
| increased marginal zone B cell number
|
J:131736
|
Ptstm1b(EUCOMM)Wtsi/Pts+
(C57BL/6N-Ptstm1b(EUCOMM)Wtsi/H)
|
increased large unstained cell number
|
J:211773
|
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell number
|
J:72267
|
Pycardtm1Flv/Pycardtm1Flv
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased NK cell number
|
J:158969
|
Pycr2m1J/Pycr2m1J
(involves: C3H/HeJ * C57BL/6J)
|
decreased lymphocyte cell number
|
J:308336
|
Pycr2tm1a(EUCOMM)Wtsi/Pycr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Pycr2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased Ly6C low monocyte number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
Qpcttm1.1Gne/Qpcttm1.1Gne
Qpctltm1.1Gne/Qpctltm1.1Gne
(C57BL/6N-Qpctltm1.1Gne Qpcttm1.1Gne)
|
decreased monocyte cell number
|
J:324112
|
Qpctltm1.1Gne/Qpctltm1.1Gne
(C57BL/6N-Qpctltm1.1Gne)
|
decreased monocyte cell number
|
J:324112
|
| increased monocyte cell number
|
J:324112
|
QprtGt(OST337946)Lex/QprtGt(OST337946)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal macrophage morphology
|
J:282516
|
Rab7tm1.1Ale/Rab7tm1.1Ale
Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell morphology
|
J:211733
|
| abnormal T cell subpopulation ratio
|
J:211733
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211733
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211733
|
| decreased T cell number
|
J:211733
|
Rab13tm1.1Ktg/Rab13tm1.1Ktg
(involves: C57BL/6)
|
decreased lymphocyte cell number
|
J:259093
|
Rab19tm1b(EUCOMM)Hmgu/Rab19tm1b(EUCOMM)Hmgu
(C57BL/6N-Rab19tm1b(EUCOMM)Hmgu/Ics)
|
decreased large unstained cell number
|
J:211773
|
Rab33bem1Rmr/Rab33b+
(involves: C57BL/6)
|
abnormal osteoclast differentiation
|
J:338833
|
| abnormal osteoclast morphology
|
J:338833
|
| increased osteoclast cell number
|
J:338833
|
Rab33bem1Rmr/Rab33bem1Rmr
(involves: C57BL/6)
|
abnormal osteoclast morphology
|
J:338833
|
| increased osteoclast cell number
|
J:338833
|
Rabl3xm/Rabl3em1Btlr
(C57BL/6J-Rabl3xm Rabl3em1Btlr)
|
decreased lymphocyte cell number
|
J:287198
|
Rabl3xm/Rabl3xm
(C57BL/6J-Rabl3xm)
|
abnormal T cell morphology
|
J:287198
|
| abnormal T cell number
|
J:287198
|
Rac2em1Shl/Rac2+
(involves: C57BL/6)
|
decreased alpha-beta T cell number
|
J:276213
|
| decreased CD4-positive, alpha-beta T cell number
|
J:276213
|
| decreased CD8-positive, alpha-beta T cell number
|
J:276213
|
| decreased lymphocyte cell number
|
J:276213
|
| decreased T cell number
|
J:276213
|
Rac2M2Btlr/Rac2+
(C57BL/6J-Rac2M2Btlr)
|
decreased B-1 B cell number
|
J:231801
|
| decreased B-1a cell number
|
J:231801
|
| increased B-1b cell number
|
J:231801
|
Rac2M2Btlr/Rac2M2Btlr
(C57BL/6J-Rac2M2Btlr)
|
decreased B-1 B cell number
|
J:231801
|
| decreased B-1a cell number
|
J:231801
|
| increased B-1b cell number
|
J:231801
|
Rac2m3Btlr/Rac2+
(C57BL/6J-Rac2m3Btlr)
|
decreased B-1a cell number
|
J:236680
|
| increased B-1 B cell number
|
J:236680
|
Rac2m3Btlr/Rac2m3Btlr
(C57BL/6J-Rac2m3Btlr)
|
decreased B cell number
|
J:236680
|
| decreased B-1a cell number
|
J:236680
|
| increased B-1b cell number
|
J:236680
|
Rac2M4Btlr/Rac2+
(C57BL/6J-Rac2M4Btlr)
|
decreased alpha-beta T cell number
|
J:255273
|
| decreased CD4-positive, alpha-beta T cell number
|
J:255273
|
| decreased CD8-positive, alpha-beta T cell number
|
J:255273
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:255273
|
| increased alpha-beta T cell number
|
J:255273
|
| increased CD8-positive, alpha-beta T cell number
|
J:255273
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:255273
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:255273
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:255273
|
Rac2M4Btlr/Rac2M4Btlr
(C57BL/6J-Rac2M4Btlr)
|
decreased alpha-beta T cell number
|
J:255273
|
| decreased CD4-positive, alpha-beta T cell number
|
J:255273
|
| decreased CD8-positive, alpha-beta T cell number
|
J:255273
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:255273
|
| increased alpha-beta T cell number
|
J:255273
|
| increased CD8-positive, alpha-beta T cell number
|
J:255273
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:255273
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:255273
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:255273
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:255273
|
Rac2M5Btlr/Rac2+
(C57BL/6J-Rac2M5Btlr)
|
increased CD8-positive, alpha-beta T cell number
|
J:255283
|
Rac2M5Btlr/Rac2M5Btlr
(C57BL/6J-Rac2M5Btlr)
|
decreased B-1a cell number
|
J:255283
|
| increased B-1b cell number
|
J:255283
|
| increased CD8-positive, alpha-beta T cell number
|
J:255283
|
Racgap1tm1Mahi/Racgap1tm1Mahi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:137760
|
| decreased pro-B cell number
|
J:137760
|
| decreased transitional stage B cell number
|
J:137760
|
Rad21tm1.1Mmk/Rad21tm1.1Mmk
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:175827
|
| abnormal T cell differentiation
|
J:175827
|
| decreased CD4-positive, alpha-beta T cell number
|
J:175827
|
| decreased CD8-positive, alpha-beta T cell number
|
J:175827
|
| decreased double-positive T cell number
|
J:175827
|
Rad50tm2.1Flv/Rad50tm2.2Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:165055
|
Rad50tm2Jpt/Rad50tm2Jpt
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
decreased B cell number
|
J:78820
|
| decreased immature B cell number
|
J:78820
|
| decreased pre-B cell number
|
J:78820
|
| decreased T cell number
|
J:78820
|
| increased late pro-B cell number
|
J:78820
|
| increased macrophage cell number
|
J:78820
|
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-negative T cell number
|
J:103922
|
| decreased macrophage cell number
|
J:103922
|
| decreased pro-B cell number
|
J:103922
|
Rad50tm2Jpt/Rad50tm2Jpt
Smc1atm1Mbk/Smc1atm1Mbk
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:103922
|
| decreased double-negative T cell number
|
J:103922
|
| decreased macrophage cell number
|
J:103922
|
Raf1tm1.1Bgn/Raf1+
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
increased monocyte cell number
|
J:172034
|
Rag1/Rag2tm1Mnz/Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:90487
|
| abnormal double-positive T cell morphology
|
J:90487
|
| abnormal T cell morphology
|
J:90487
|
| decreased T cell number
|
J:90487
|
Rag1/Rag2tm1Mnz/Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:90487
|
| abnormal double-positive T cell morphology
|
J:90487
|
| abnormal T cell morphology
|
J:90487
|
| decreased T cell number
|
J:90487
|
Rag1coln/Rag1coln
(C57BL/6JAnu-Rag1coln/AnuApb)
|
absent B cells
|
J:104190
|
| absent T cells
|
J:104190
|
Rag1em2Mvw/Rag1em2Mvw
(A/J-Rag1em2Mvw/MvwJ)
|
absent B cells
|
J:332675
|
| absent T cells
|
J:332675
|
| arrested B cell differentiation
|
J:332675
|
| arrested T cell differentiation
|
J:332675
|
Rag1em3Mvw/Rag1em3Mvw
(129S1/SvImJ-Rag1em3Mvw/Mvw)
|
absent B cells
|
J:332675
|
| absent T cells
|
J:332675
|
| arrested B cell differentiation
|
J:332675
|
| arrested T cell differentiation
|
J:332675
|
Rag1m1Anu/Rag1m1Anu
(C57BL/6NCrlAnu-Rag1m1Anu)
|
decreased lymphocyte cell number
|
J:104190
|
Rag1m1Btlr/Rag1m1Btlr
(C57BL/6J-Rag1m1Btlr)
|
absent late pro-B cells
|
J:150635
|
| decreased CD4-positive, alpha-beta T cell number
|
J:150635
|
| decreased CD8-positive, alpha-beta T cell number
|
J:150635
|
Rag1m2Btlr/Rag1m2Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
| decreased T cell number
|
J:185495
|
Rag1m3Btlr/Rag1m3Btlr
(C57BL/6J-Rag1m3Btlr)
|
increased central memory CD8 positive, alpha-beta T cell number
|
J:272858
|
Rag1m4Btlr/Rag1m4Btlr
(C57BL/6J-Rag1m4Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272094
|
| abnormal T cell differentiation
|
J:272094
|
| decreased B cell number
|
J:272094
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272094
|
| increased alpha-beta T cell number
|
J:272094
|
| increased CD8-positive, alpha-beta T cell number
|
J:272094
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272094
|
Rag1tm1(cre)Thr/Rag1tm1(cre)Thr
(Not Specified)
|
abnormal lymphopoiesis
|
J:86869
|
| absent lymphocyte
|
J:86869
|
Rag1tm1(GFP)Imku/?
Zfp335blt/Zfp335blt
(involves: C57BL/6 * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:214793
|
Rag1tm1(GFP)Imku/Rag1tm1(GFP)Imku
(involves: C57BL/6 * CBA)
|
abnormal immunoglobulin V(D)J recombination
|
J:79416
|
Rag1tm1.1Sadu/Rag1tm1.1Sadu
(involves: BALB/c)
|
arrested B cell differentiation
|
J:155473
|
Rag1tm1.1Sadu/Rag1tm1.1Sadu
Trdctm1Mal/Trdctm1Mal
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
absent gamma-delta T cells
|
J:187400
|
| decreased gamma-delta T cell number
|
J:187400
|
| increased gamma-delta T cell number
|
J:187400
|
Rag1tm1Bal/Rag1tm1Bal
Tg(TcraTcrb)1100Mjb/?
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:133645
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133645
|
| increased CD8-positive, alpha-beta T cell number
|
J:133645
|
Rag1tm1Bal/Rag1tm1Bal
Vav1tm2Tyb/Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
arrested T cell differentiation
|
J:113270
|
Rag1tm1Bal/Rag1tm1Bal
Vav1tm2Tyb/Vav1tm2Tyb
Tg(TcrAND)53Hed/0
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113270
|
Rag1tm1Fwa/Rag1tm1Fwa
(involves: 129)
|
abnormal B cell differentiation
|
J:86464
|
| abnormal T cell differentiation
|
J:86464
|
| decreased B cell number
|
J:86464
|
| increased double-negative T cell number
|
J:86464
|
Rag1tm1Jsek/Rag1+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:146912
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:146912
|
| abnormal T cell differentiation
|
J:146912
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:146912
|
| decreased double-positive T cell number
|
J:146912
|
Rag1tm1Jsek/Rag1tm1Jsek
(involves: 129S6/SvEvTac)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:146912
|
| abnormal lymphopoiesis
|
J:146912
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:146912
|
| abnormal T cell receptor V(D)J recombination
|
J:146912
|
| absent immature B cells
|
J:146912
|
| absent mature B cells
|
J:146912
|
| arrested B cell differentiation
|
J:146912
|
| arrested T cell differentiation
|
J:146912
|
| decreased CD4-positive, alpha-beta T cell number
|
J:146912
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146912
|
| decreased double-positive T cell number
|
J:146912
|
| decreased gamma-delta T cell number
|
J:146912
|
| increased double-negative T cell number
|
J:146912
|
| increased pro-B cell number
|
J:146912
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * CD-1)
|
abnormal B cell differentiation
|
J:1934
|
| abnormal immunoglobulin V(D)J recombination
|
J:1934
|
| abnormal T cell differentiation
|
J:1934
|
| abnormal T cell morphology
|
J:1934
|
| abnormal T cell receptor V(D)J recombination
|
J:1934
|
| absent mature B cells
|
J:1934
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
decreased lymphocyte cell number
|
J:111874
|
Rag1tm1Mom/Rag1tm1Mom
(NOD.129S7(B6)-Rag1tm1Mom)
|
decreased CD4-positive, alpha-beta T cell number
|
J:109843
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109843
|
| decreased mature B cell number
|
J:109843
|
| increased immature B cell number
|
J:109843
|
| increased macrophage cell number
|
J:109843
|
| increased NK cell number
|
J:109843
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd)
|
abnormal double-negative T cell morphology
|
J:112990
|
Rag1tm1Mom/Rag1tm1Mom
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/Sz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:109843
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109843
|
| decreased mature B cell number
|
J:109843
|
| increased immature B cell number
|
J:109843
|
| increased macrophage cell number
|
J:109843
|
| increased NK cell number
|
J:109843
|
Rag1tm1Mom/Rag1tm1Mom
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * 129S7/SvEvBrd * BALB/cJ * C57BL/6J)
|
abnormal osteoclast differentiation
|
J:117880
|
Rag1tm1Mom/Rag1tm1Mom
Slc46a2tm1Moki/Slc46a2+
Tg(TcraB12,TcrbB12)1Rest/0
(involves: 129 * C57BL/6)
|
arrested T cell differentiation
|
J:140121
|
| decreased double-positive T cell number
|
J:140121
|
Rag1tm1Mom/Rag1tm1Mom
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S7/SvEvBrd * C3H/He * C57BL/6)
|
increased double-positive T cell number
|
J:135903
|
| increased thymocyte number
|
J:135903
|
Rag1tm1Mom/Rag1tm1Mom
Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal T cell receptor V(D)J recombination
|
J:47667
|
Rag1tm1Mom/Rag1tm1Mom
Tg(Tcra,Tcrb)HRCAll/0
(B6.Cg-Rag1tm1Mom Tg(Tcra,Tcrb)HRCAll)
|
abnormal T cell differentiation
|
J:131347
|
| abnormal T cell subpopulation ratio
|
J:131347
|
| absent CD4-positive, alpha-beta T cells
|
J:131347
|
| increased CD8-positive, alpha-beta T cell number
|
J:131347
|
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
decreased CD4-positive, alpha-beta T cell number
|
J:111874
|
| decreased lymphocyte cell number
|
J:111874
|
| increased double-positive T cell number
|
J:111874
|
Rag1tm1Mom/Rag1tm1Mom
Tnfrsf25tm1Mjo/Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:84536
|
Rag1tm1Mom/Rag1tm1Mom
Tnfsf14tm1Kpf/Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased osteoclast cell number
|
J:294030
|
Rag2m1Btlr/Rag2m1Btlr
(C57BL/6J-Rag2m1Btlr)
|
decreased B cell number
|
J:203045
|
| decreased CD4-positive, alpha-beta T cell number
|
J:203045
|
Rag2tm1.1Cgn/Rag2tm1.1Cgn
(C57BL/6-Rag2tm1.1Cgn)
|
arrested B cell differentiation
|
J:72214
|
| arrested T cell differentiation
|
J:72214
|
Rag2tm1.1Desi/Rag2tm1.1Desi
(involves: 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:168974
|
Rag2tm1.1Mss/Rag2tm1.1Mss
(involves: 129S6/SvEvTac)
|
abnormal lymphopoiesis
|
J:171970
|
| abnormal pre-B cell morphology
|
J:171970
|
| decreased pre-B cell number
|
J:171970
|
| increased DN3 thymocyte number
|
J:171970
|
Rag2tm1Avla/Rag2tm1Avla
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:122108
|
| arrested T cell differentiation
|
J:122108
|
| decreased double-positive T cell number
|
J:122108
|
| decreased lymphocyte cell number
|
J:122108
|
| decreased NK T cell number
|
J:122108
|
Rag2tm1Cgn/Rag2tm1.1Cgn
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
absent immature B cells
|
J:72214
|
| absent pre-B cells
|
J:72214
|
| arrested B cell differentiation
|
J:72214
|
| arrested T cell differentiation
|
J:72214
|
| decreased follicular B cell number
|
J:72214
|
| decreased marginal zone B cell number
|
J:72214
|
| decreased mature B cell number
|
J:72214
|
| increased plasma cell number
|
J:72214
|
Rag2tm1Cgn/Rag2tm1Cgn
Xrcc4tm1Fwa/Xrcc4tm2Fwa
Tg(Cr2-cre)3Cgn/?
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:150339
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * MF1)
|
abnormal effector T cell morphology
|
J:1935
|
| abnormal immunoglobulin V(D)J recombination
|
J:1935
|
| abnormal T cell receptor V(D)J recombination
|
J:1935
|
| absent mature B cells
|
J:1935
|
| arrested B cell differentiation
|
J:1935
|
| arrested T cell differentiation
|
J:1935
|
| decreased CD4-positive, alpha-beta T cell number
|
J:1935
|
| decreased CD8-positive, alpha-beta T cell number
|
J:1935
|
| decreased double-positive T cell number
|
J:1935
|
| increased macrophage cell number
|
J:1935
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv)
|
decreased thymocyte number
|
J:114561
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
abnormal B cell morphology
|
J:81133
|
| arrested T cell differentiation
|
J:91542
|
| decreased double-negative T cell number
|
J:81133,
J:91542
|
| increased double-negative T cell number
|
J:91542
|
Rag2tm1Fwa/Rag2tm1Fwa
Cd47tm1Fpl/Cd47tm1Fpl
Il2rgtm1Cgn/Y
(involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:203904
|
| decreased lymphocyte cell number
|
J:203904
|
| increased activated T cell number
|
J:203904
|
| increased CD8-positive, alpha-beta T cell number
|
J:203904
|
Rag2tm1Fwa/Rag2tm1Fwa
Rr299391tm1.1Fwa/Rr299391tm1.1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:149413
|
Rag2tm1Fwa/Rag2tm1Fwa
Sos1tm1.1Les/Sos1tm1.1Les
Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell differentiation
|
J:174536
|
Rag2tm1Fwa/Rag2tm1Fwa
Tbatatm1Faf/Tbatatm1Faf
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
abnormal T cell differentiation
|
J:166065
|
| increased thymocyte number
|
J:166065
|
Rag2tm1Fwa/Rag2tm1Fwa
TcraLn3Jae/Tcra+
TcrbLn3Jae/Tcrb+
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143006
|
| absent gamma-delta T cells
|
J:143006
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143006
|
| increased CD8-positive, alpha-beta T cell number
|
J:143006
|
Rag2tm1Fwa/Rag2tm1Fwa
TcrbLn3Jae/Tcrb+
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143006
|
| absent gamma-delta T cells
|
J:143006
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143006
|
| increased double-positive T cell number
|
J:143006
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster)
|
increased DN3 thymocyte number
|
J:235890
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(EmuSR-tTa)83Bop/0
Tg(tetO-Nfatct1*)1Grc/0
(involves: 129S/SvEv * C57BL/6J * CBA/J * FVB/N)
|
abnormal double-positive T cell morphology
|
J:141917
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Igh-Pim1)1Brn/0
(involves: 129S/SvEv * C57BL/6LiA * CBA)
|
decreased thymocyte number
|
J:114561
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Lck-Akt1*)M-1Pnt/0
(involves: 129S/SvEv * C3H/He * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:135903
|
| absent CD8-positive, alpha-beta T cells
|
J:135903
|
| increased double-positive T cell number
|
J:135903
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Tcra5CC7,Tcrb5CC7)IWep/?
Themis5AT161/Themis5AT161
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:151076
|
| increased double-positive T cell number
|
J:151076
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:125548
|
| abnormal positive T cell selection
|
J:125548
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125548
|
| increased double-positive T cell number
|
J:125548
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
Themis5AT161/Themis5AT161
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
decreased single-positive T cell number
|
J:151076
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| abnormal double-positive T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
Rag2tm1Fwa/Rag2tm1Mao
(involves: 129S/SvEv * C57BL/6)
|
abnormal B cell number
|
J:81837
|
| abnormal gamma-delta T cell differentiation
|
J:81837
|
| arrested B cell differentiation
|
J:81837
|
| arrested T cell differentiation
|
J:81837
|
| decreased double-negative T cell number
|
J:81837
|
| decreased immature B cell number
|
J:81837
|
| decreased mature B cell number
|
J:81837
|
| decreased pre-B cell number
|
J:81837
|
| increased immature B cell number
|
J:81837
|
Rag2tm1Libo/Rag2tm1Libo
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:84563
|
| decreased B cell number
|
J:84563
|
| decreased monocyte cell number
|
J:84563
|
| decreased pre-B cell number
|
J:84563
|
Rag2tm1Mao/Rag2tm1Mao
(involves: 129 * C57BL/6)
|
abnormal B cell number
|
J:81837
|
| abnormal gamma-delta T cell differentiation
|
J:81837
|
| arrested B cell differentiation
|
J:81837
|
| arrested T cell differentiation
|
J:81837
|
| decreased double-negative T cell number
|
J:81837
|
| decreased immature B cell number
|
J:81837
|
| decreased mature B cell number
|
J:81837
|
| decreased pre-B cell number
|
J:81837
|
| increased immature B cell number
|
J:81837
|
Rag2tm1Tgi/Rag2tm1Tgi
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested B cell differentiation
|
J:113641
|
| arrested T cell differentiation
|
J:113641
|
| decreased B cell number
|
J:113641
|
| decreased double-positive T cell number
|
J:113641
|
| decreased thymocyte number
|
J:113641
|
Rap1gapem1(IMPC)H/Rap1gapem1(IMPC)H
(C57BL/6NTac-Rap1gapem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Rap1gds1tm1Ytk/Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased thymocyte number
|
J:62244
|
Raratm1.1Ybe/Raratm1.1Ybe
(involves: C57BL/6N)
|
abnormal lymphopoiesis
|
J:207485
|
Rarres1tm1.2Mhl/Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss)
|
abnormal B cell differentiation
|
J:324270
|
| abnormal plasma cell differentiation
|
J:324270
|
Rarres2tm1Yktk/Rarres2tm1Yktk
(B6.Cg-Rarres2tm1Yktk)
|
decreased macrophage cell number
|
J:206120
|
Rasa3scat/Rasa3scat
(involves: BALB/cBy)
|
decreased B cell number
|
J:186485
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186485
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186485
|
| decreased T cell number
|
J:186485
|
Rasal3tm1.1Fuj/Rasal3tm1.1Fuj
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased NK T cell number
|
J:229641
|
Rasal3tm1b(EUCOMM)Hmgu/Rasal3tm1b(EUCOMM)Hmgu
(C57BL/6N-Rasal3tm1b(EUCOMM)Hmgu/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6)
|
abnormal positive T cell selection
|
J:85189
|
| increased B cell number
|
J:85189
|
| increased T cell number
|
J:85189
|
Rasgrp1m1Anu/Rasgrp1m1Anu
(C57BL/6JSfdAnu-Rasgrp1m1Anu)
|
abnormal T cell differentiation
|
J:104190
|
Rasgrp1m1Anu/Rasgrp1m1Anu
(involves: C57BL/6JSfdAnu * CBA/J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:207898
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:207898
|
Rasgrp1m1Btlr/Rasgrp1m1Btlr
(C57BL/6J-Rasgrp1m1Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:265163
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265163
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265163
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265163
|
| increased NK cell number
|
J:265163
|
Rasgrp1m2Btlr/Rasgrp1m2Btlr
(C57BL/6J-Rasgrp1m2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265163
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265163
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265163
|
| decreased single-positive T cell number
|
J:265163
|
| decreased T cell number
|
J:265163
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265163
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265163
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265163
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265163
|
| increased NK cell number
|
J:265163
|
Rasgrp1m3Btlr/Rasgrp1m3Btlr
(C57BL/6J-Rasgrp1m3Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265255
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265255
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265255
|
| decreased single-positive T cell number
|
J:265255
|
| decreased T cell number
|
J:265255
|
| increased B cell number
|
J:265255
|
| increased B-1b cell number
|
J:265255
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265255
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265255
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265255
|
| increased NK cell number
|
J:265255
|
Rasgrp1M4Btlr/Rasgrp1M4Btlr
(C57BL/6J-Rasgrp1M4Btlr)
|
abnormal T cell morphology
|
J:267490
|
Rasgrp1m5Btlr/Rasgrp1m5Btlr
(C57BL/6J-Rasgrp1m5Btlr)
|
increased NK cell number
|
J:272846
|
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz)
|
abnormal CD4-positive T cell differentiation
|
J:225109
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225109
|
| abnormal T cell differentiation
|
J:225109
|
| decreased single-positive T cell number
|
J:225109
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:225109
|
| increased single-positive T cell number
|
J:225109
|
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * DBA/2J)
|
decreased single-positive T cell number
|
J:225109
|
| increased double-positive T cell number
|
J:225109
|
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
Tg(TcraTcrb)425Cbn/?
(involves: C57BL/6 * BALB/c)
|
abnormal CD4-positive T cell differentiation
|
J:225109
|
Rasgrp1tm1Jstn/Rasgrp1tm1Jstn
(involves: 129P3/J * C57BL/6J)
|
decreased B cell number
|
J:108677
|
| decreased thymocyte number
|
J:108677
|
| increased plasma cell number
|
J:108677
|
Rasgrp1tm1Jstn/Rasgrp1tm1Jstn
(involves: 129P3/J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:207898
|
| abnormal double-positive T cell morphology
|
J:207898
|
| decreased CD4-positive, alpha-beta T cell number
|
J:207898
|
| decreased CD8-positive, alpha-beta T cell number
|
J:207898
|
Rasgrp1tm1Jstn/Rasgrp1tm1Jstn
Rasgrp3tm1Jstn/Rasgrp3tm1Jstn
(involves: 129P3/J * C57BL/6J)
|
decreased B cell number
|
J:108677
|
| decreased plasma cell number
|
J:108677
|
Rasgrp3em1(IMPC)Wtsi/Rasgrp3em1(IMPC)Wtsi
(C57BL/6N-Rasgrp3em1(IMPC)Wtsi/Wtsi)
|
increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
Rasgrp3tm1Jstn/Rasgrp3tm1Jstn
(involves: 129P3/J * C57BL/6J)
|
decreased B cell number
|
J:108677
|
Rassf2tm1Dlim/Rassf2tm1Dlim
(B6.Cg-Rassf2tm1Dlim)
|
abnormal osteoclast differentiation
|
J:181952
|
| decreased B cell number
|
J:181952
|
| decreased CD4-positive, alpha-beta T cell number
|
J:181952
|
| decreased CD8-positive, alpha-beta T cell number
|
J:181952
|
| decreased osteoclast cell number
|
J:181952
|
| decreased T cell number
|
J:181952
|
Rassf5tm1Kina/Rassf5tm1Kina
(involves: C57BL/6 * CBA * ICR)
|
abnormal B cell differentiation
|
J:92670
|
| decreased thymocyte number
|
J:92670
|
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina)
|
increased B cell number
|
J:168749
|
| increased memory T cell number
|
J:168749
|
| increased plasma cell number
|
J:168749
|
| increased T cell number
|
J:168749
|
Rb1tm1Dwg/Rb1tm1Dwg
(involves: 129/Sv * C57BL/6)
|
abnormal macrophage morphology
|
J:105548
|
Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas)
|
abnormal macrophage differentiation
|
J:105548
|
Rb1cc1tm1.1Guan/Rb1cc1tm1.1Guan
Tg(BEST1-cre)1Jdun/0
(involves: 129P2/OlaHsd * C57BL/6)
|
microgliosis
|
J:282249
|
Rbm7em1Aki/Rbm7em1Aki
(B6.Cg-Rbm7em1Aki)
|
decreased monocyte cell number
|
J:288329
|
Rbm15tm1Dgg/Rbm15tm1.1Dgg
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA * FVB/N)
|
abnormal B cell differentiation
|
J:120321
|
| decreased B cell number
|
J:120321
|
| decreased pre-B cell number
|
J:120321
|
Rbm15tm1Swm/Rbm15tm1Swm
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:152262
|
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal T-helper 2 cell differentiation
|
J:90018
|
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Lck-cre)19Hhan/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal CD4-positive helper T cell morphology
|
J:168475
|
| increased macrophage cell number
|
J:168475
|
| increased single-positive T cell number
|
J:168475
|
| increased T cell number
|
J:168475
|
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:99747
|
| abnormal lymphopoiesis
|
J:99747
|
| arrested T cell differentiation
|
J:125869,
J:99747
|
| decreased double-positive T cell number
|
J:99747
|
| decreased marginal zone B cell number
|
J:76240,
J:99747
|
| decreased single-positive T cell number
|
J:99747
|
| decreased thymocyte number
|
J:99747
|
| increased B cell number
|
J:125869,
J:99747
|
| increased double-negative T cell number
|
J:99747
|
| increased follicular B cell number
|
J:99747
|
| increased macrophage cell number
|
J:125869
|
| increased monocyte cell number
|
J:125869
|
Rc3h1san/Rc3h1+
(involves: C57BL/6JSfdAnu)
|
increased T follicular helper cell number
|
J:189087
|
Rc3h1san/Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca))
|
abnormal T cell differentiation
|
J:98938
|
Rc3h1san/Rc3h1san
(involves: C57BL/6JSfdAnu)
|
abnormal effector T cell morphology
|
J:199407
|
| abnormal intraepithelial T cell number
|
J:199407
|
| increased activated T cell number
|
J:199407
|
| increased CD4-positive, alpha-beta T cell number
|
J:199407
|
Rc3h1san/Rc3h1san
Rc3h2tm1.2Cgv/Rc3h2tm1.2Cgv
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
increased T follicular helper cell number
|
J:196137
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * NZB * SJL)
|
abnormal effector T cell morphology
|
J:177784
|
| increased B cell number
|
J:177784
|
| increased regulatory T cell number
|
J:177784
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca * NZB * SJL)
|
abnormal B cell differentiation
|
J:177784
|
| abnormal effector T cell morphology
|
J:177784
|
| decreased B cell number
|
J:177784
|
| decreased immature B cell number
|
J:177784
|
| increased macrophage cell number
|
J:177784
|
| increased regulatory T cell number
|
J:177784
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass
Rc3h2tm1c(KOMP)Wtsi/Rc3h2tm1c(KOMP)Wtsi
Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6N * DBA/2)
|
abnormal B cell number
|
J:196136
|
| decreased CD4-positive, alpha-beta T cell number
|
J:196136
|
| decreased CD8-positive, alpha-beta T cell number
|
J:196136
|
| decreased T cell number
|
J:196136
|
| increased germinal center B cell number
|
J:196136
|
| increased T follicular helper cell number
|
J:196136
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * NZB * SJL)
|
increased CD8-positive, alpha-beta T cell number
|
J:177784
|
| increased macrophage cell number
|
J:177784
|
Rc3h1tm1.2Cgv/Rc3h1san
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
increased CD4-positive, alpha-beta T cell number
|
J:196137
|
| increased T follicular helper cell number
|
J:196137
|
Rc3h1tm1.2Mass/Rc3h1tm1.2Mass
(involves: C57BL/6 * CBA * CD-1 * NZB * SJL)
|
abnormal effector T cell morphology
|
J:177784
|
Rcan1tm1Jmol/Rcan1tm1Jmol
Rcan2tm1Jmol/Rcan2tm1Jmol
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:109586
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:109586
|
Rdh7tm1c(KOMP)Wtsi/Rdh7tm1c(KOMP)Wtsi
Tg(RARE-Hspa1b/lacZ)12Jrt/0
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * C57BL/6N * CD-1 * SJL)
|
decreased lymphocyte cell number
|
J:279231
|
Reg3gtm1.1Lvh/Reg3gtm1.1Lvh
(B6.129-Reg3gtm1.1Lvh)
|
increased T-helper 1 cell number
|
J:177506
|
RelM1Btlr/Rel+
(C57BL/6J-RelM1Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:236682
|
| increased T cell number
|
J:236682
|
RelM1Btlr/RelM1Btlr
(C57BL/6J-RelM1Btlr)
|
decreased B-1 B cell number
|
J:236682
|
| decreased CD4-positive, alpha-beta T cell number
|
J:236682
|
| decreased CD8-positive, alpha-beta T cell number
|
J:236682
|
| increased CD4-positive, alpha-beta T cell number
|
J:236682
|
| increased CD8-positive, alpha-beta T cell number
|
J:236682
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:236682
|
| increased T cell number
|
J:236682
|
RelM2Btlr/RelM2Btlr
(C57BL/6J-RelM2Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272778
|
| abnormal T cell differentiation
|
J:272778
|
| decreased alpha-beta T cell number
|
J:272778
|
| decreased B-1 B cell number
|
J:272778
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272778
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:272778
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:272778
|
Reltm1b(EUCOMM)Wtsi/Reltm1b(EUCOMM)Wtsi
(C57BL/6N-Reltm1b(EUCOMM)Wtsi/H)
|
decreased monocyte cell number
|
J:211773
|
Reltm1Brv/Reltm1Brv
(involves: 129S1/Sv)
|
abnormal macrophage morphology
|
J:46911
|
Reltm1Grd/Reltm1Grd
Relatm1Bal/Relatm1Bal
(B6.129S-Reltm1Grd Relatm1Bal)
|
abnormal monocyte differentiation
|
J:111325
|
Reltm1Hcl/Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6)
|
abnormal memory B cell number
|
J:75621
|
| abnormal T-helper 1 cell differentiation
|
J:79107
|
Relatm1Bal/Relatm1Bal
(involves: 129S4/SvJae)
|
decreased marginal zone B cell number
|
J:65246
|
Relatm1Rsch/Relatm1Rsch
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
Relatm1Rsch/Relatm1Rsch
Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
Relatm1Yuo/Relatm1Yuo
(involves: 129S/SvEv)
|
decreased double-positive T cell number
|
J:63099
|
RelbTg(H2-K1/GH1)106Bri/Relb+
(involves: C57BL/6)
|
decreased NK T cell number
|
J:120659
|
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri)
|
decreased B cell number
|
J:76450
|
| decreased pre-B cell number
|
J:76450
|
| decreased T cell number
|
J:76450
|
| increased macrophage cell number
|
J:23081,
J:76450
|
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(involves: C57BL/6)
|
decreased NK T cell number
|
J:120659
|
Relbtm1.1Fwei/Relbtm1.1Fwei
Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
decreased T cell number
|
J:22675
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
Relttm1Hlee/Relttm1Hlee
(Not Specified)
|
abnormal T cell morphology
|
J:266480
|
Rev1tm1.1Jow/Rev1tm1.1Jow
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:151700
|
Rev1tm1Ndew/Rev1tm1Ndew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:119176
|
Rev3ltm1.1Kunk/Rev3ltm1.1Kunk
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:188723
|
Rev3ltm1Rsky/Rev3ltm1.1Rsky
Tg(Cr2-cre)3Cgn/?
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:146453
|
| abnormal somatic hypermutation frequency
|
J:146453
|
| decreased germinal center B cell number
|
J:146453
|
Rexo2tm1b(EUCOMM)Wtsi/Rexo2+
(C57BL/6N-Rexo2tm1b(EUCOMM)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
Rft1tm1b(KOMP)Wtsi/Rft1+
(C57BL/6N-Rft1tm1b(KOMP)Wtsi/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Rftn1tm1Ayos/Rftn1tm1Ayos
(B6.Cg-Rftn1tm1Ayos)
|
abnormal CD4-positive T cell differentiation
|
J:150299
|
Rfx5tm1.1Ifo/Rfx5tm1.1Ifo
(involves: 129 * C57BL/6)
|
abnormal Kupffer cell morphology
|
J:67941
|
| decreased CD4-positive, alpha-beta T cell number
|
J:67941
|
| decreased single-positive T cell number
|
J:67941
|
Rfx7tm1.1Ggaur/Rfx7tm1.1Ggaur
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal NK cell morphology
|
J:282535
|
| decreased NK cell number
|
J:282535
|
Rfx7tm1.1Ggaur/Rfx7tm1.1Ggaur
Ncr1tm1.1(icre)Viv/Ncr1+
(involves: C57BL/6)
|
decreased NK cell number
|
J:282535
|
Rfx7tm1.1Ggaur/Rfx7tm1.1Ggaur
Rptortm1.1Dmsa/Rptor+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S/SvEv * C57BL/10 * CBA/Ca)
|
abnormal NK cell morphology
|
J:282535
|
| decreased NK cell number
|
J:282535
|
Rgs1tm1Jhk/Rgs1tm1Jhk
(B6.129P2-Rgs1tm1Jhk)
|
decreased plasma cell number
|
J:90780
|
| increased marginal zone B cell number
|
J:90780
|
Rgs2em1(IMPC)H/Rgs2+
(C57BL/6NTac-Rgs2em1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
Rgs3tm1Ndul/Rgs3tm1Ndul
(B6.129-Rgs3tm1Ndul)
|
increased B cell number
|
J:210195
|
| increased CD4-positive, alpha-beta T cell number
|
J:210195
|
| increased CD8-positive, alpha-beta T cell number
|
J:210195
|
Rgs4em1(IMPC)H/Rgs4em1(IMPC)H
(C57BL/6N-Rgs4em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Rgs5tm1Jhk/Rgs5tm1Jhk
(involves: 129S/SvEv * C57BL/6)
|
decreased lymphocyte cell number
|
J:133897
|
Rgs10tm1Ypl/Rgs10tm1Ypl
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal osteoclast differentiation
|
J:123167
|
| decreased osteoclast cell number
|
J:123167
|
Rgs12tm1.1Syy/Rgs12tm1.1Syy
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
decreased osteoclast cell number
|
J:194057
|
Rgs13tm1.1Jhk/Rgs13tm1.1Jhk
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:199530
|
| decreased B cell number
|
J:199530
|
| increased B cell number
|
J:199530
|
| increased germinal center B cell number
|
J:199530
|
Rgsc14/Rgsc14+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased lymphocyte cell number
|
J:133634
|
Rgsc15/Rgsc15+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased lymphocyte cell number
|
J:133634
|
Rgsc17/Rgsc17+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased lymphocyte cell number
|
J:133634
|
Rhbdd3tm1Caox/Rhbdd3tm1Caox
(B6.129S6-Rhbdd3tm1Caox)
|
increased NK cell number
|
J:197348
|
Rhotm2.1Kpal/Rhotm2.1Kpal
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
microgliosis
|
J:194158
|
Rhoatm1.1Tpal/Rhoa+
Tg(Cd4-cre/ERT2)11Gnri/0
(involves: C57BL/6)
|
increased regulatory T cell number
|
J:257764
|
| increased T follicular helper cell number
|
J:257764
|
Rhobtb1em2(IMPC)Ccpcz/Rhobtb1em2(IMPC)Ccpcz
(C57BL/6N-Rhobtb1em2(IMPC)Ccpcz/Ccpcz)
|
increased Ly6C-positive NK T cell number
|
J:211773
|
Rhoftm1.2Dash/Rhoftm1.2Dash
(involves: 129)
|
decreased marginal zone B cell number
|
J:303076
|
Rhohtm1Brak/Rhohtm1Brak
(involves: 129/Sv * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143161
|
| abnormal lymphocyte cell number
|
J:143161
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143161
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143161
|
| decreased double-positive T cell number
|
J:143161
|
| decreased single-positive T cell number
|
J:143161
|
| decreased T cell number
|
J:143161
|
| increased double-negative T cell number
|
J:143161
|
| increased gamma-delta T cell number
|
J:143161
|
| increased NK cell number
|
J:143161
|
| increased NK T cell number
|
J:143161
|
| increased T cell number
|
J:143161
|
Rhohtm1Brak/Rhohtm1Brak
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:143161
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143161
|
| decreased double-positive T cell number
|
J:143161
|
| decreased single-positive T cell number
|
J:143161
|
| increased double-negative T cell number
|
J:143161
|
Rhohtm1Brak/Rhohtm1Brak
Tg(TcraTcrb)425Cbn/?
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:143161
|
Rhohtm1Daw/Rhohtm1Daw
(involves: 129 * C57BL/6)
|
arrested T cell differentiation
|
J:113565
|
| decreased double-positive T cell number
|
J:113565
|
| decreased T cell number
|
J:113565
|
Ric1tm1a(EUCOMM)Hmgu/Ric1tm1a(EUCOMM)Hmgu
(C57BL/6N-Ric1tm1a(EUCOMM)Hmgu/H)
|
decreased B cell number
|
J:165965
|
| decreased mature B cell number
|
J:165965
|
Ric8btm1b(EUCOMM)Hmgu/Ric8b+
(C57BL/6N-Ric8btm1b(EUCOMM)Hmgu/Cnrm)
|
increased lymphocyte cell number
|
J:211773
|
Rictortm1.1Klg/Rictortm1.1Klg
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn)
|
abnormal double-negative T cell morphology
|
J:189736
|
| decreased DN1 thymic pro-T cell number
|
J:189736
|
| decreased DN2 thymocyte number
|
J:189736
|
| decreased DN3 thymocyte number
|
J:189736
|
| decreased DN4 thymocyte number
|
J:189736
|
| decreased double-positive T cell number
|
J:189736
|
| decreased single-positive T cell number
|
J:189736
|
| increased double-negative T cell number
|
J:189736
|
Rif1Gt(XT0278)Wtsi/Rif1Gt(XT0278)Wtsi
(involves: 129P2/OlaHsd * CD-1 * MF1)
|
abnormal class switch recombination
|
J:195061
|
Rigitm1Zgwg/Rigitm1Zgwg
(involves: 129S1/Sv)
|
abnormal B cell differentiation
|
J:139016
|
| decreased T cell number
|
J:139868
|
| increased activated T cell number
|
J:139868
|
| increased memory T cell number
|
J:139868
|
Riok2tm1c(KOMP)Wtsi/Riok2+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:305794
|
| increased monocyte cell number
|
J:305794
|
| increased NK T cell number
|
J:305794
|
Riox1tm1Qch/Riox1tm1Qch
Tg(Prrx1-cre)1Cjt/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL/J)
|
decreased osteoclast cell number
|
J:224562
|
Riox2tm1Mtsun/Riox2tm1Mtsun
(B6CrSlc.Cg-Riox2tm1Mtsun)
|
decreased macrophage cell number
|
J:201871
|
Ripk1tm1Led/Ripk1tm1Led
(involves: 129S6/SvEvTac)
|
decreased thymocyte number
|
J:46522
|
Rnase6em1(IMPC)Tcp/Rnase6em1(IMPC)Tcp
(C57BL/6N-Rnase6em1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Rnase11em1(IMPC)Mbp/Rnase11em1(IMPC)Mbp
(C57BL/6N-Rnase11em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
Rnaseh2aem1(IMPC)Tcp/Rnaseh2a+
(C57BL/6NCrl-Rnaseh2aem1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Rnaseh2bem1Anu/Rnaseh2b+
Tlr7em2Anu/Tlr7+
(C57BL/6NCrl-Rnaseh2bem1Anu Tlr7em2Anu)
|
abnormal mature B cell morphology
|
J:324448
|
| increased CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased germinal center B cell number
|
J:324448
|
| increased plasma cell number
|
J:324448
|
| increased T follicular helper cell number
|
J:324448
|
Rnd3tm1b(EUCOMM)Hmgu/Rnd3+
(C57BL/6N-Rnd3tm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
Rnf2tm1Mvi/Rnf2tm1Mvi
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * CBA)
|
abnormal B cell differentiation
|
J:130397
|
| decreased B cell number
|
J:130397
|
| decreased monocyte cell number
|
J:130397
|
Rnf8Gt(AS0574)Wtsi/Rnf8+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
| decreased B cell number
|
J:161240
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161240
|
| decreased CD8-positive, alpha-beta T cell number
|
J:161240
|
| decreased double-negative T cell number
|
J:161240
|
| decreased double-positive T cell number
|
J:161240
|
| decreased immature B cell number
|
J:161240
|
| decreased pre-B cell number
|
J:161240
|
| decreased pro-B cell number
|
J:161240
|
| decreased T cell number
|
J:161240
|
| decreased thymocyte number
|
J:161240
|
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
| decreased B cell number
|
J:161240
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161240
|
| decreased CD8-positive, alpha-beta T cell number
|
J:161240
|
| decreased double-negative T cell number
|
J:161240
|
| decreased double-positive T cell number
|
J:161240
|
| decreased immature B cell number
|
J:161240
|
| decreased pre-B cell number
|
J:161240
|
| decreased pro-B cell number
|
J:161240
|
| decreased T cell number
|
J:161240
|
| decreased thymocyte number
|
J:161240
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/H)
|
increased large unstained cell number
|
J:211773
|
Rnf31tm1.1Kiwa/Rnf31tm1.1Kiwa
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal B-1 B cell morphology
|
J:201885
|
| decreased B-1a cell number
|
J:201885
|
| decreased B-1b cell number
|
J:201885
|
Rnf128tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Rnf128tm1.1(KOMP)Vlcg/Ccpcz)
|
increased effector memory T-helper cell number
|
J:211773
|
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal osteoclast differentiation
|
J:243612
|
| increased osteoclast cell number
|
J:243612
|
Rnf168Gt(156B6)Cmhd/Rnf168Gt(156B6)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:198260
|
| decreased gamma-delta T cell number
|
J:198260
|
| increased DN3 thymocyte number
|
J:198260
|
| increased double-negative T cell number
|
J:198260
|
Rnf168Gt(405F11)Cmhd/Rnf168Gt(405F11)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:198260
|
| decreased gamma-delta T cell number
|
J:198260
|
| increased DN3 thymocyte number
|
J:198260
|
| increased double-negative T cell number
|
J:198260
|
Rnf169tm1a(EUCOMM)Hmgu/Rnf169tm1a(EUCOMM)Hmgu
(B6NTac;B6N-Rnf169tm1a(EUCOMM)Hmgu/H)
|
increased monocyte cell number
|
J:165965
|
Rnf216tm1b(EUCOMM)Wtsi/Rnf216tm1b(EUCOMM)Wtsi
(C57BL/6N-Rnf216tm1b(EUCOMM)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Rorcm1Btlr/Rorcm1Btlr
(C57BL/6J-Rorcm1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:203039
|
| decreased CD8-positive, alpha-beta T cell number
|
J:203039
|
Rorcm3Btlr/Rorcm3Btlr
(C57BL/6J-Rorcm3Btlr)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:234257
|
| decreased B-2 B cell number
|
J:234257
|
| decreased CD4-positive, alpha-beta T cell number
|
J:234257
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:234257
|
| increased B-1a cell number
|
J:234257
|
| increased B-1b cell number
|
J:234257
|
| increased CD8-positive, alpha-beta T cell number
|
J:234257
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:234257
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:234257
|
Rorctm1.1Zsun/Rorctm1.1Zsun
(B6(129S4)-Rorctm1.1Zsun)
|
abnormal T-helper 17 cell differentiation
|
J:248565
|
Rorctm1Amj/Rorctm1Amj
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))
|
decreased CD4-positive, alpha-beta T cell number
|
J:64381
|
| decreased CD8-positive, alpha-beta T cell number
|
J:64381
|
| decreased double-positive T cell number
|
J:64381
|
| decreased T cell number
|
J:64381
|
| increased double-negative T cell number
|
J:64381
|
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:248565
|
| abnormal T cell differentiation
|
J:128344,
J:248565
|
| abnormal T cell morphology
|
J:248565
|
| abnormal T-helper 17 cell differentiation
|
J:248565
|
| decreased CD4-positive, alpha-beta T cell number
|
J:248565
|
| decreased double-positive T cell number
|
J:248565
|
| decreased thymocyte number
|
J:248565
|
Rorctm1Litt/Rorctm1Litt
Tcra-Jtm3.1Krg/Tcra-Jtm3.1Krg
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:128344
|
Rorctm2Litt/Rorctm2Litt
(involves: 129P2/OlaHsd)
|
abnormal CD4-positive, alpha-beta intraepithelial T cell morphology
|
J:91566
|
| abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:91566
|
| decreased double-negative T cell number
|
J:91566
|
| decreased double-positive T cell number
|
J:87395
|
| decreased NK cell number
|
J:142654
|
Rpa1tm1Wed/Rpa1+
(involves: 129/Sv * C57BL/6J * SJL)
|
increased lymphocyte cell number
|
J:99303
|
Rpl22Gt(GST000137)Lex/Rpl22Gt(GST000137)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell differentiation
|
J:123569
|
| abnormal T cell number
|
J:123569
|
| arrested T cell differentiation
|
J:123569
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123569
|
| decreased CD8-positive, alpha-beta T cell number
|
J:123569
|
| decreased double-negative T cell number
|
J:123569
|
| decreased T cell number
|
J:123569
|
Rpl22Gt(YHB332)Byg/Rpl22Gt(YHB332)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:201164
|
| decreased T cell number
|
J:201164
|
Rps9tm1.1Geno/Rps9tm1.1Geno
(involves: C57BL/6)
|
increased monocyte cell number
|
J:329922
|
Rr7tm1.1Kio/Rr7tm1.1Kio
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:179326,
J:164573
|
Rr7tm2.1Kio/Rr7tm2.1Kio
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:164573
|
Rr7tm3.1Kio/Rr7+
(B6.129S4-Rr7tm3.1Kio)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:179326
|
Rr7tm3.1Kio/Rr7+
Tg(Lck-cre)#Nik/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:179326
|
Rr7tm4.1Kio/Rr7tm4.1Kio
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:179326
|
Rr38tm1.2Aafo/Rr38+
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
decreased thymocyte number
|
J:227747
|
Rr38tm1.2Aafo/Rr38tm1.2Aafo
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:227747
|
| decreased CD8-positive, alpha-beta T cell number
|
J:227747
|
| decreased double-positive T cell number
|
J:227747
|
| decreased single-positive T cell number
|
J:227747
|
| decreased thymocyte number
|
J:227747
|
| increased DN3 thymocyte number
|
J:227747
|
Rr39em1Ched/Rr39em1Ched
(C57BL/6-Rr39em1Ched)
|
decreased Ly6C low monocyte number
|
J:239509
|
Rr79em2Rtew/Rr79em2Rtew
(C57BL/6J-Rr79em2Rtew/J)
|
abnormal T cell subpopulation ratio
|
J:332957
|
Rr94tm3.1Litt/Rr94+
Tg(Cd4-cre)1Cwi/0
Rr112tm4.1Litt/Rr112+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
Rr94tm3.1Litt/Rr94tm3.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| decreased double-positive T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
Rr94tm3.2Litt/Rr94+
Rr112tm4.1Litt/Rr112+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
Rr94tm3.2Litt/Rr94tm3.2Litt
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:158962
|
| abnormal double-positive T cell morphology
|
J:158962
|
| abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| decreased double-positive T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
Rr94tm3.2Litt/Rr94tm3.2Litt
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)
|
abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
Rr96tm1.1Tich/Rr96+
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:191711
|
Rr96tm1.1Tich/Rr96+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:191711
|
Rr96tm1.1Tich/Rr96tm1.1Tich
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:191711
|
Rr96tm1.1Tich/Rr96tm1.1Tich
Tg(ACTB-tTS)1Mllo/?
(involves: 129 * C57BL/6)
|
decreased double-positive T cell number
|
J:191711
|
Rr96tm1.1Yzo/Rr96tm1.1Yzo
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:130559
|
| increased CD4-positive, alpha-beta T cell number
|
J:130559
|
| increased double-positive T cell number
|
J:130559
|
Rr96tm1.1Yzo/Rr96tm1.1Yzo
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal T cell differentiation
|
J:130559
|
Rr96tm1Yzo/Rr96tm1Yzo
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:130559
|
| increased double-positive T cell number
|
J:130559
|
Rr96tm1Yzo/Rr96tm1Yzo
Tg(Cd8a-cre,-GFP)1Yzo/?
(involves: 129P2/OlaHsd)
|
increased double-positive T cell number
|
J:130559
|
Rr96tm2Litt/Rr96+
Zbtb7btm1Itan/Zbtb7btm1Tani
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:141142
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141142
|
Rr96tm2Litt/Rr96+
Zbtb7btm1Tani/Zbtb7btm1Tani
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
Rr96tm2Litt/Rr96tm2Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:80690
|
Rr96tm2Litt/Rr96tm2Litt
Tfap4tm1.1Litt/Tfap4tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:176461
|
Rr97tm3Welm/Rr97tm3Welm
(involves: 129 * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:126027
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:126027
|
| abnormal double-positive T cell morphology
|
J:126027
|
| abnormal gamma-delta intraepithelial T cell morphology
|
J:126027
|
| abnormal T cell differentiation
|
J:126027
|
Rr99tm1Litt/Rr99tm1Litt
(either: (involves: 129P2/OlaHsd * AKR) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:50624
|
Rr100tm2.1Welm/Rr100+
(involves: 129P2/OlaHsd * AKR.1 * C57BL/6)
|
abnormal T cell differentiation
|
J:113136
|
Rr100tm2.1Welm/Rr100tm2.1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:113136
|
| abnormal T cell subpopulation ratio
|
J:113136
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113136
|
| decreased double-positive T cell number
|
J:113136
|
| increased CD4-positive, alpha-beta T cell number
|
J:113136
|
Rr100tm2.1Welm/Rr100tm2.1Welm
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:158947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158947
|
| decreased double-positive T cell number
|
J:158947
|
| increased CD4-positive, alpha-beta T cell number
|
J:158947
|
Rr100tm2.1Welm/Rr100tm2.1Welm
Tcratm1Mom/Tcratm1Mom
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal T cell morphology
|
J:113136
|
Rr123tm1.1Vbo/Rr123tm1.1Vbo
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal regulatory T cell morphology
|
J:191815
|
| increased regulatory T cell number
|
J:191815
|
Rr148tm1.1Fwa/Rr148tm1.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
| arrested B cell differentiation
|
J:101400
|
| decreased immature B cell number
|
J:101400
|
Rr148tm1.1Fwa/Rr148tm1.1Fwa
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
Rr148tm1Anbo/Rr148tm1Anbo
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:136307
|
| decreased immature B cell number
|
J:136307
|
| decreased mature B cell number
|
J:136307
|
| decreased pre-B cell number
|
J:136307
|
Rr148tm1Fwa/Rr148tm1Fwa
(129S6/SvEvTac-Rr148tm1Fwa)
|
abnormal immature B cell morphology
|
J:101400
|
| absent B cells
|
J:101400
|
| arrested B cell differentiation
|
J:101400
|
Rr148tm1Fwa/Rr148tm1Fwa
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
Rr148tm2Anbo/Rr148tm2Anbo
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:136307
|
| decreased immature B cell number
|
J:136307
|
| decreased mature B cell number
|
J:136307
|
| decreased pre-B cell number
|
J:136307
|
Rr156tm6.1Cog/Rr156tm6.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:165617
|
Rr156tm6Cog/Rr156tm6Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:165617
|
Rr158tm1(Igh)Xu/Rr158tm1(Igh)Xu
(Not Specified)
|
decreased B cell number
|
J:124407
|
| decreased immature B cell number
|
J:124407
|
| increased pre-B cell number
|
J:124407
|
Rr158tm1Cgn/Rr158tm1Cgn
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal B cell differentiation
|
J:12574,
J:64287
|
| decreased mature B cell number
|
J:64287
|
| increased mature B cell number
|
J:64287
|
Rr158tm2Cgn/Rr158tm2Cgn
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal B cell differentiation
|
J:12574
|
Rr158tm2Xu/Rr158tm2Xu
(Not Specified)
|
decreased B cell number
|
J:124407
|
Rr159tm1.1Fwa/Rr159+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
Rr159tm1.1Fwa/Rr159tm1.1Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
| decreased B cell number
|
J:113715
|
Rr159tm1Fwa/Rr159+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:113715
|
Rr159tm1Fwa/Rr159tm1Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
| decreased B cell number
|
J:113715
|
Rr160tm1Wtg/Rr160tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal mature B cell morphology
|
J:134885
|
| abnormal somatic hypermutation frequency
|
J:134885
|
| decreased follicular B cell number
|
J:134885
|
| increased transitional stage B cell number
|
J:134885
|
Rr161tm2.2Wtg/Rr161tm2.2Wtg
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:167472
|
| abnormal immunoglobulin V(D)J recombination
|
J:167472
|
| decreased B cell number
|
J:167472
|
| decreased pro-B cell number
|
J:167472
|
| increased pre-B cell number
|
J:167472
|
Rr162tm3.1Wtg/Rr162tm3.1Wtg
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:172855
|
Rr166tm4.1Wtg/Rr166tm4.1Wtg
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:193015
|
| abnormal immunoglobulin light chain V-J recombination
|
J:193015
|
| abnormal pre-B cell morphology
|
J:193015
|
Rr169tm2Rao/Rr169+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:94039
|
Rr169tm2Rao/Rr169tm2Rao
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:94039
|
Rr170tm1.1Iku/Rr170tm1.1Iku
(B6.Cg-Rr170tm1.1Iku)
|
decreased T cell number
|
J:333539
|
Rr185tm3Cog/Rr185tm3Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:71300
|
| abnormal class switch recombination
|
J:71300
|
Rr253em1Kmm/Rr253em1Kmm
(C57BL/6-Rr253em1Kmm)
|
abnormal class switch recombination
|
J:316113
|
| abnormal effector T cell number
|
J:316113
|
| abnormal peritoneal macrophage morphology
|
J:316113
|
| decreased B cell number
|
J:316113
|
| decreased mature NK cell number
|
J:316113
|
| decreased monocyte cell number
|
J:316113
|
| increased lymphocyte cell number
|
J:316113
|
| increased NK cell number
|
J:316113
|
| increased T cell number
|
J:316113
|
Rr253em6Kmm/Rr253em6Kmm
(C57BL/6J-Rr253em6Kmm)
|
decreased monocyte cell number
|
J:334296
|
Rr308tm1.1Fwa/Rr308tm1.1Fwa
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:82616,
J:82395
|
| abnormal T cell receptor alpha chain V-J recombination
|
J:82616
|
Rr308tm1Fwa/Rr308tm1Fwa
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:82616
|
| abnormal T cell receptor alpha chain V-J recombination
|
J:82616
|
Rr308tm2Fwa/Rr308tm2Fwa
(Not Specified)
|
abnormal T cell differentiation
|
J:82395
|
Rr338em1Jeng/Rr338em1Jeng
(Not Specified)
|
abnormal T cell differentiation
|
J:232438
|
| abnormal T cell number
|
J:232438
|
| decreased CD4-positive, alpha-beta T cell number
|
J:232438
|
Rr347em1Prdns/Rr347em1Prdns
(CBA/Ca-Rr347em1Prdns)
|
absent Langerhans cell
|
J:281171
|
| decreased macrophage cell number
|
J:281171
|
| decreased microglial cell number
|
J:281171
|
| increased Ly6C low monocyte number
|
J:281171
|
Rr364tm1.1Aak/Rr364tm1.1Aak
(129.129S2(Cg)-Rr364tm1.1Aak)
|
abnormal class switch recombination
|
J:242276
|
Rr381em1Kap/Rr381em1Kap
(involves: C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
Rr381em4Kap/Rr381em4Kap
(involves: C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
Rr381em5Kap/Rr381em5Kap
(involves: C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
Rr383tm1Caob/Rr383tm1Caob
(B6.Cg-Rr383tm1Caob)
|
decreased osteoclast cell number
|
J:131132
|
Rr394em1Bhao/Rr394em1Bhao
(Not Specified)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:333961
|
| decreased thymocyte number
|
J:333961
|
| increased DN3 thymocyte number
|
J:333961
|
Rr395em1Bhao/Rr395em1Bhao
(Not Specified)
|
decreased double-positive T cell number
|
J:333961
|
| decreased thymocyte number
|
J:333961
|
| increased DN4 thymocyte number
|
J:333961
|
Rr149356tm1.1Pf/Rr149356tm1.1Pf
(either: 129P2/OlaHsd-Rr149356tm1.1Pf or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal T cell differentiation
|
J:34311
|
| arrested T cell differentiation
|
J:34311
|
| decreased double-positive T cell number
|
J:34311
|
| decreased single-positive T cell number
|
J:34311
|
| decreased T cell number
|
J:34311
|
| decreased thymocyte number
|
J:34311
|
| increased double-negative T cell number
|
J:34311
|
| increased gamma-delta T cell number
|
J:34311
|
Rr149356tm1Abnd/Rr149356tm1Abnd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:137580
|
| arrested T cell differentiation
|
J:137580
|
| decreased double-positive T cell number
|
J:137580
|
| decreased single-positive T cell number
|
J:137580
|
| decreased T cell number
|
J:137580
|
| increased double-negative T cell number
|
J:137580
|
| increased gamma-delta T cell number
|
J:137580
|
Rr149356tm1Che/Rr149356tm1Che
(involves: 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246,
J:107306
|
| abnormal double-positive T cell morphology
|
J:106246,
J:107306
|
Rr149356tm1Che/Rr149356tm1Che
Tcrdtm1Mom/Tcrdtm1Mom
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246
|
Rr149356tm1Che/Rr149356tm1Che
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246
|
| abnormal double-positive T cell morphology
|
J:106246
|
Rr275254tm2.1Dhr/Rr275254tm2.1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Rr275254tm2Dhr/Rr275254tm2Dhr
(involves: 129S4/SvJae)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Rr282726tm1Dhr/Rr282726tm1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Rr282729tm1.1Iku/Rr282729tm1.1Iku
(C57BL/6J-Rr316tm1.1Iku)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:288442
|
| decreased gamma-delta T cell number
|
J:288442
|
Rr299391tm1.1Fwa/Rr299391+
(involves: 129P2/OlaHsd * FVB/N)
|
decreased T cell number
|
J:55401
|
| decreased thymocyte number
|
J:55401
|
Rr299391tm1.1Fwa/Rr299391tm1.1Fwa
(involves: 129P2/OlaHsd * FVB/N)
|
decreased T cell number
|
J:55401
|
| decreased thymocyte number
|
J:55401
|
Rragcem1Efe/Rragc+
(Not Specified)
|
abnormal class switch recombination
|
J:320567
|
| decreased germinal center B cell number
|
J:320567
|
| decreased plasma cell number
|
J:320567
|
Rragcem1Efe/Rragc+
Tg(Vav-BCL2)69Jad/0
(Not Specified)
|
decreased germinal center B cell number
|
J:320567
|
Rras2em1(IMPC)Ccpcz/Rras2em1(IMPC)Ccpcz
(C57BL/6NCrl-Rras2em1(IMPC)Ccpcz/Ccpcz)
|
increased NK cell number
|
J:211773
|
Rras2Gt(OST361011)Lex/Rras2+
(involves: 129S5/SvEvBrd)
|
decreased B cell number
|
J:151653
|
| decreased follicular B cell number
|
J:151653
|
| decreased marginal zone B cell number
|
J:151653
|
| decreased memory T cell number
|
J:151653
|
| decreased T cell number
|
J:151653
|
Rras2Gt(OST361011)Lex/Rras2Gt(OST361011)Lex
(involves: 129S5/SvEvBrd)
|
decreased B cell number
|
J:151653
|
| decreased follicular B cell number
|
J:151653
|
| decreased marginal zone B cell number
|
J:151653
|
| decreased memory T cell number
|
J:151653
|
| decreased T cell number
|
J:151653
|
Rras2Gt(OST361011)Lex/Rras2Gt(OST361011)Lex
(B6.129S5-Rras2Gt(OST361011)Lex)
|
decreased B cell number
|
J:151653
|
| decreased memory T cell number
|
J:151653
|
| decreased T cell number
|
J:151653
|
RrasGt(OST24882)Lex/RrasGt(OST24882)Lex
(B6;129S5-RrasGt(OST24882)Lex/Ieg)
|
decreased B cell number
|
J:82809
|
| increased CD4-positive, alpha-beta T cell number
|
J:82809
|
| increased CD8-positive, alpha-beta T cell number
|
J:82809
|
Rsad2tm1Kchc/Rsad2tm1Kchc
(B6.129-Rsad2tm1Kchc)
|
abnormal T-helper 2 cell differentiation
|
J:148305
|
Rsph9em1Jwji/Rsph9em1Jwji
(B6.Cg-Rsph9em1Jwji)
|
microgliosis
|
J:294184
|
Rspo1tm2b(KOMP)Wtsi/Rspo1tm2b(KOMP)Wtsi
(C57BL/6N-Rspo1tm2b(KOMP)Wtsi/Ics)
|
increased lymphocyte cell number
|
J:211773
|
Rtcbtm1c(KOMP)Wtsi/Rtcbtm1c(KOMP)Wtsi
Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA * SJL)
|
abnormal B cell number
|
J:216740
|
| abnormal plasma cell morphology
|
J:216740
|
Rthyd1NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
Rthyd2B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
Rthyd3B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
Rthyd5NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
Rubcnem1Dgre/Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N)
|
increased CD8-positive, alpha-beta T cell number
|
J:235399
|
| increased lymphocyte cell number
|
J:235399
|
| increased monocyte cell number
|
J:235399
|
Rubcnem1Dgre/Rubcnem1Dgre
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * C57BL/6NCrlj * DBA/2)
|
abnormal macrophage morphology
|
J:261225
|
Runx1tm1(RUNX1)Gcg/Runx1tm1(RUNX1)Gcg
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:106800
|
| decreased CD4-positive, alpha-beta T cell number
|
J:106800
|
| decreased double-positive T cell number
|
J:106800
|
| increased CD8-positive, alpha-beta T cell number
|
J:106800
|
Runx1tm1Soga/Runx1tm1.1Soga
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:88511
|
| abnormal T cell differentiation
|
J:88511
|
Runx1tm1Spe/Runx1+
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
Runx1tm1Tani/Runx1tm1Tani
Runx3tm1Itan/Runx3tm1Itan
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:125959
|
Runx1tm1Tani/Runx1tm1Tani
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:125959
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125959
|
| abnormal double-positive T cell morphology
|
J:125959
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125959
|
Runx1tm1Tani/Runx1tm1Tani
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:125959
|
| decreased double-positive T cell number
|
J:125959
|
| decreased thymocyte number
|
J:125959
|
| increased double-negative T cell number
|
J:125959
|
Runx1tm1Toku/Runx1+
Runx3tm1Itan/Runx3tm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
Runx1tm1Toku/Runx1tm1Toku
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:87697
|
| increased CD4-positive, alpha-beta T cell number
|
J:87697
|
Runx1tm1Toku/Runx1tm1Toku
Runx3tm1Itan/Runx3+
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:131081
|
| decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
Runx1tm1Toku/Runx1tm1Toku
Runx3tm1Itan/Runx3tm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:131081
|
| decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
Runx1tm1Toku/Runx1tm1Toku
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
Runx1tm1Yg/Runx1tm1Yg
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal T cell differentiation
|
J:125830
|
| decreased single-positive T cell number
|
J:125830
|
| decreased thymocyte number
|
J:125830
|
| increased double-positive T cell number
|
J:125830
|
Runx1tm1Yg/Runx1tm1Yg
Tg(Lck-cre)1Jtak/?
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
decreased T cell number
|
J:125830
|
Runx1tm2(Runx1)Toku/Runx1tm2(Runx1)Toku
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:87697
|
Runx1tm2.1Gss/Runx1tm2.1Gss
(involves: 129S4/SvJae * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:214025
|
| decreased immature B cell number
|
J:214025
|
| decreased pre-pro B cell number
|
J:214025
|
| increased macrophage cell number
|
J:214025
|
| increased mature B cell number
|
J:214025
|
| increased monocyte cell number
|
J:214025
|
| increased pro-B cell number
|
J:214025
|
Runx1tm2Buch/Runx1tm2Buch
Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:105709
|
| decreased CD8-positive, alpha-beta T cell number
|
J:105709
|
| decreased double-positive T cell number
|
J:105709
|
| decreased lymphocyte cell number
|
J:105709
|
| decreased mature B cell number
|
J:105709
|
| decreased T cell number
|
J:105709
|
| increased monocyte cell number
|
J:105709
|
Runx1tm3(Runx3)Toku/Runx1tm3(Runx3)Toku
(involves: 129P2/OlaHsd)
|
decreased lymphocyte cell number
|
J:98965
|
| decreased thymocyte number
|
J:98965
|
Runx1tm3Itan/Runx1tm3Itan
(involves: 129P2/OlaHsd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:168918
|
| decreased thymocyte number
|
J:168918
|
Runx1tm3Spe/Runx1tm3Spe
Spi1tm2.1Dgt/Spi1tm2.1Dgt
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased B cell number
|
J:131217
|
Runx1tm3Spe/Runx1tm3Spe
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
arrested T cell differentiation
|
J:131217
|
| decreased B cell number
|
J:151639
|
| decreased double-negative T cell number
|
J:131217
|
| increased double-negative T cell number
|
J:131217
|
Runx1tm3Spe/Runx1tm3Spe
Tg(VAV1-cre)1Graf/0
(involves: 129S4/SvJae)
|
decreased B cell number
|
J:145700
|
| decreased double-positive T cell number
|
J:145700
|
| decreased lymphocyte cell number
|
J:145700
|
| decreased thymocyte number
|
J:145700
|
| increased monocyte cell number
|
J:145700
|
Runx1tm4Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
Runx1tm4Spe/Runx1tm4Spe
(involves: 129/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:120100
|
| increased monocyte cell number
|
J:120100
|
Runx1tm5Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
Runx1tm6Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
Runx1tm7Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
Runx1tm8Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
Runx2tm1Kish/Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:59821,
J:40783
|
| decreased B cell number
|
J:53069
|
| decreased thymocyte number
|
J:40783
|
Runx3tm1Itan/Runx3tm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125953
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125953
|
| decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
Runx3tm1Litt/Runx3tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141144
|
| abnormal double-positive T cell morphology
|
J:141144
|
Runx3tm1Yg/Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
absent Langerhans cell
|
J:88424
|
Runx3tm1Yg/Runx3tm1Yg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:109584
|
Runx3tm2Yg/Runx3tm2Yg
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * ICR)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:109584
|
Runx3tm3.1Yg/Runx3tm3.1Yg
(Not Specified)
|
absent Langerhans cell
|
J:224898
|
Ruvbl2M1Btlr/Ruvbl2+
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased CD4-positive, alpha-beta T cell number
|
J:185495
|
| decreased CD8-positive, alpha-beta T cell number
|
J:185495
|
| decreased double-positive T cell number
|
J:185495
|
| decreased T cell number
|
J:185495
|
| increased thymocyte number
|
J:185495
|
Rwdd1tm1b(KOMP)Wtsi/Rwdd1tm1b(KOMP)Wtsi
(C57BL/6N-Rwdd1tm1b(KOMP)Wtsi/Wtsi)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
Rxfp2tm1a(EUCOMM)Wtsi/Rxfp2tm1a(EUCOMM)Wtsi
(C57BL/6N-Rxfp2tm1a(EUCOMM)Wtsi/Ieg)
|
increased monocyte cell number
|
J:165965
|
Rxrapke/Rxrapke
(C57BL/6J-Rxrapke)
|
abnormal T-helper 2 cell morphology
|
J:103186
|
Rxratm1Krc/Rxratm1Krc
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal peritoneal macrophage morphology
|
J:168799
|
Rxratm2Ipc/Rxratm4Ipc
Tg(KRT14-cre)1Ipc/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal Langerhans cell morphology
|
J:67149
|
Rykem1(IMPC)Mbp/Ryk+
(C57BL/6NCrl-Rykem1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
S1pr1tm1.1Cys/S1pr1tm1.1Cys
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
decreased B cell number
|
J:176118
|
S1pr1tm1.1Thla/S1pr1tm1.1Thla
(B6.Cg-S1pr1tm1.1Thla)
|
increased CD4-positive, alpha-beta T cell number
|
J:163389
|
| increased CD8-positive, alpha-beta T cell number
|
J:163389
|
S1pr1tm1Cys/S1pr1tm1Cys
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:176118
|
S1pr1tm1Rlp/S1pr1tm1Rlp
(involves: 129S6/SvEvTac)
|
abnormal NK cell differentiation
|
J:154069
|
| decreased NK cell number
|
J:154069
|
S1pr2tm1Ajml/S1pr2tm1Ajml
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased germinal center B cell number
|
J:154439
|
| increased T cell number
|
J:154439
|
S1pr2tm1Rlp/S1pr2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
increased B cell number
|
J:174313
|
| increased germinal center B cell number
|
J:174313
|
| increased T cell number
|
J:174313
|
S1pr5tm1Club/S1pr5tm1Club
(B6.129P2-S1pr5tm1Club)
|
abnormal NK cell morphology
|
J:178789
|
| decreased NK cell number
|
J:178789
|
S1pr5tm1Jch/S1pr5tm1Jch
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:154069
|
Samd3tm1.1(HBEGF)Wfkr/Samd3+
(C57BL/6J-Samd3tm1.1(HBEGF)Wfkr)
|
abnormal NK cell differentiation
|
J:322359
|
| decreased memory T cell number
|
J:322359
|
| decreased NK cell number
|
J:322359
|
Samd3tm1.1(HBEGF)Wfkr/Samd3tm1.1(HBEGF)Wfkr
(C57BL/6J-Samd3tm1.1(HBEGF)Wfkr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:322359
|
Samsn1tm1Xyw/Samsn1tm1Xyw
(B6.129P2-Samsn1tm1Xyw)
|
increased B-1a cell number
|
J:158032
|
Sash3tm1Hlz/Sash3tm1Hlz
(B6.129P2-Sash3tm1Hlz)
|
abnormal B cell morphology
|
J:102171
|
| abnormal CD4-positive T cell differentiation
|
J:102171
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:102171
|
| abnormal T cell morphology
|
J:102171
|
| decreased double-positive T cell number
|
J:102171
|
| decreased marginal zone B cell number
|
J:102171
|
Satb1m1Anu/Satb1+
(C57L/6JAnu-Satb1m1Anu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:104190
|
Satb1m1Anu/Satb1m1Anu
(C57L/6JAnu-Satb1m1Anu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:104190
|
Satb1tm1Kos/Satb1tm1Kos
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:61085
|
| arrested T cell differentiation
|
J:61085
|
| decreased thymocyte number
|
J:61085
|
Satb1tm2Kos/Satb1tm2Kos
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
absent regulatory T cells
|
J:252606
|
Saxo1tm1b(EUCOMM)Hmgu/Saxo1tm1b(EUCOMM)Hmgu
(C57BL/6N-Saxo1tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Sbdstm1Dats/Sbdstm1Dats
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6 * CD-1)
|
decreased B cell number
|
J:158901
|
| decreased lymphocyte cell number
|
J:158901
|
Sbf1em1(IMPC)Mbp/Sbf1em1(IMPC)Mbp
(C57BL/6N-Sbf1em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Sbno2tm1.1Aki/Sbno2tm1.1Aki
(involves: 129 * C57BL/6)
|
abnormal osteoclast morphology
|
J:202853
|
Scarb2em2(IMPC)Tcp/Scarb2em2(IMPC)Tcp
(C57BL/6NCrl-Scarb2em2(IMPC)Tcp/Tcp)
|
decreased monocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Scarb2tm1Psa/Scarb2tm1Psa
(involves: 129P2/OlaHsd * C57BL/6N)
|
microgliosis
|
J:216676
|
Scarf1tm1Tkms/Scarf1tm1Tkms
(involves: C57BL/6)
|
increased B cell number
|
J:208237
|
| increased CD4-positive, alpha-beta T cell number
|
J:208237
|
| increased lymphocyte cell number
|
J:208237
|
| increased T follicular helper cell number
|
J:208237
|
Scg5em1(IMPC)Mbp/Scg5em1(IMPC)Mbp
(C57BL/6NCrl-Scg5em1(IMPC)Mbp/MbpMmucd)
|
increased monocyte cell number
|
J:211773
|
Scintm1Glog/Scintm1Glog
Tg(Acp5-cre)4Rda/0
(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * CBA))
|
abnormal osteoclast differentiation
|
J:223220
|
| abnormal osteoclast morphology
|
J:223220
|
Scmh1tm1Yota/Scmh1tm1Yota
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:194424
|
| decreased T cell number
|
J:194424
|
Sctrtm1Bkcc/Sctrtm1Bkcc
(B6.129S7-Sctrtm1Bkcc)
|
increased macrophage cell number
|
J:121376
|
Scyl1tm1.1Spel/Scyl1tm1.1Spel
(involves: 129S6/SvEvTac * C57BL/6J)
|
microgliosis
|
J:192445
|
Scyl1tm1Spel/Scyl1tm1Spel
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)
|
microgliosis
|
J:192445
|
Scyl2tm1.1Spel/Scyl2tm1.1Spel
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
microgliosis
|
J:225808
|
Sdc4tm2b(KOMP)Wtsi/Sdc4tm2b(KOMP)Wtsi
(C57BL/6N-Sdc4tm2b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
Sec63tm1b(EUCOMM)Hmgu/Sec63+
(C57BL/6N-Sec63tm1b(EUCOMM)Hmgu/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
Secisbp2tm1a(EUCOMM)Wtsi/Secisbp2+
(Not Specified)
|
increased NK cell number
|
J:165965
|
Seletm1Hyn/Seletm1Hyn
Selltm1Hyn/Selltm1Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
increased monocyte cell number
|
J:57973
|
Seletm1Hyn/Seletm1Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas)
|
increased lymphocyte cell number
|
J:31626
|
| increased monocyte cell number
|
J:31626
|
Seletm1Hyn/Seletm1Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
increased monocyte cell number
|
J:57973
|
Seletm2Alb/Seletm2Alb
Selltm2Alb/Selltm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased monocyte cell number
|
J:70682
|
Seletm2Alb/Seletm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased monocyte cell number
|
J:70682
|
Selenowem#Hwl/Selenowem#Hwl
(C57BL/6-Selenowem#Hwl)
|
abnormal osteoclast differentiation
|
J:317012
|
| decreased osteoclast cell number
|
J:317012
|
Sellm1Btlr/Sellm1Btlr
(C57BL/6J-Sellm1Btlr)
|
decreased single-positive T cell number
|
J:217794
|
Sellm2Btlr/Sellm2Btlr
(C57BL/6J-Sellm2Btlr)
|
decreased single-positive T cell number
|
J:231806
|
Selltm1Flv/Selltm1Flv
(involves: 129S2/SvPas * C57BL/6)
|
decreased activated T cell number
|
J:89253
|
Selltm1Tft/Selltm1Tft
(B6.129P2-Selltm1Tft)
|
abnormal regulatory T cell number
|
J:141931
|
| increased monocyte cell number
|
J:48271,
J:142184
|
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * C57BL/6)
|
decreased monocyte cell number
|
J:57973
|
Selltm2Tft/Selltm2.1Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal regulatory T cell number
|
J:141931
|
Selplgtm1Rpmc/Selplgtm1Rpmc
(involves: 129S1/Sv * C57BL/6J)
|
increased lymphocyte cell number
|
J:75829
|
Sema4atm1Kik/Sema4atm1Kik
(either: B6.Cg-Sema4atm1Kik or C.Cg-Sema4atm1Kik)
|
abnormal T-helper 1 cell differentiation
|
J:97027
|
Sema4dtm1Kik/Sema4dtm1Kik
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B-1 B cell morphology
|
J:66033
|
| decreased B-1a cell number
|
J:66033
|
| decreased CD4-positive, alpha-beta T cell number
|
J:66033
|
| decreased T cell number
|
J:66033
|
| increased B cell number
|
J:66033
|
Sema5btm1a(EUCOMM)Wtsi/Sema5btm1a(EUCOMM)Wtsi
(C57BL/6N-Sema5btm1a(EUCOMM)Wtsi/Cnrm)
|
decreased T cell number
|
J:165965
|
Senp1tm1.1Wami/Senp1tm1.1Wami
(involves: 129 * C57BL/6)
|
abnormal monocyte differentiation
|
J:163428
|
Septin9tm2.1Emfu/Septin9tm2.1Emfu
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:205027
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:205027
|
| decreased CD4-positive, alpha-beta T cell number
|
J:205027
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:205027
|
| decreased CD8-positive, alpha-beta T cell number
|
J:205027
|
| decreased DN4 thymocyte number
|
J:205027
|
| decreased regulatory T cell number
|
J:205027
|
| decreased single-positive T cell number
|
J:205027
|
| decreased T cell number
|
J:205027
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:205027
|
| increased DN3 thymocyte number
|
J:205027
|
| increased double-negative T cell number
|
J:205027
|
Septin9tm2.1Emfu/Septin9tm2.1Emfu
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased CD8-positive, alpha-beta T cell number
|
J:205027
|
Serf1tm1a(EUCOMM)Hmgu/Serf1tm1a(EUCOMM)Hmgu
(C57BL/6N-Serf1tm1a(EUCOMM)Hmgu/H)
|
decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
Serpina3gtm1.1Arp/Serpina3gtm1.1Arp
(involves: C57BL/6)
|
abnormal memory T cell morphology
|
J:189782
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:189782
|
Serpinb2tm1Dgi/Serpinb2tm1Dgi
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
decreased lymphocyte cell number
|
J:52283
|
| decreased monocyte cell number
|
J:52283
|
Serpinb2tm2Dgi/Serpinb2tm2Dgi
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
decreased lymphocyte cell number
|
J:52283
|
| decreased monocyte cell number
|
J:52283
|
Serpinb9tm1Arp/Serpinb9tm1Arp
(involves: C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:113349
|
Serpini2pq/Serpini2pq
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:115744
|
| abnormal pre-B cell morphology
|
J:115744
|
| abnormal pro-B cell morphology
|
J:115744
|
| decreased B cell number
|
J:115744
|
| decreased immature B cell number
|
J:115744
|
| decreased lymphocyte cell number
|
J:115744
|
| decreased pre-B cell number
|
J:115744
|
| decreased pro-B cell number
|
J:115744
|
| decreased T cell number
|
J:115744
|
| decreased thymocyte number
|
J:115744
|
Sesn1tm1a(EUCOMM)Wtsi/Sesn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:240602
|
| abnormal effector T cell number
|
J:240602
|
| decreased B cell number
|
J:240602
|
| increased NK T cell number
|
J:240602
|
| increased single-positive T cell number
|
J:240602
|
Setd2tm1c(NCOM)Mfgc/Setd2tm1c(NCOM)Mfgc
Tg(Lck-cre)#Zhu/0
(involves: C57BL/6 * SJL/J)
|
increased gamma-delta T cell number
|
J:243973
|
Setd3tm1.1(NCOM)Mfgc/Setd3tm1.1(NCOM)Mfgc
(C57BL/6N-Setd3tm1.1(NCOM)Mfgc/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Setd5tm1a(EUCOMM)Wtsi/Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi)
|
increased monocyte cell number
|
J:211773
|
| increased regulatory T cell number
|
J:211773
|
Setxtm1b(EUCOMM)Wtsi/Setxtm1b(EUCOMM)Wtsi
(C57BL/6N-Setxtm1b(EUCOMM)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
Sf3b1tm1.1Mdf/Sf3b1+
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tg(Mx1-cre)1Cgn/?
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA/J)
|
decreased B cell number
|
J:234976
|
Sfntm1Mak/Sfntm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:168328
|
| decreased B cell number
|
J:168328
|
| decreased B-1a cell number
|
J:168328
|
| decreased follicular B cell number
|
J:168328
|
| decreased marginal zone B cell number
|
J:168328
|
Sfrp1tm1Bsk/Sfrp1tm1Bsk
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased lymphocyte cell number
|
J:89547
|
Sfrp4tm1.1Blan/Sfrp4tm1.1Blan
(Not Specified)
|
increased osteoclast cell number
|
J:234467
|
Sfrp4tm1.1Lex/Sfrp4tm1.1Lex
(Not Specified)
|
increased osteoclast cell number
|
J:234467
|
Sftpa1tm2Haw/Sftpa1tm2Haw
Sftpdtm2Haw/Sftpdtm2Haw
(involves: C57BL/6J * CD-1)
|
abnormal alveolar macrophage morphology
|
J:86022
|
| increased monocyte cell number
|
J:86022
|
Sftpdtm1Haw/Sftpdtm1Haw
(involves: C57BL/6J * CD-1)
|
abnormal alveolar macrophage morphology
|
J:98220,
J:50147
|
Sftpdtm1Jhf/Sftpdtm1Jhf
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal alveolar macrophage morphology
|
J:50436
|
| abnormal macrophage morphology
|
J:62282,
J:50436
|
| increased macrophage cell number
|
J:62282,
J:50436
|
Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129 * C57BL/6)
|
abnormal macrophage morphology
|
J:162226
|
Sgpl1Gt(OST58278)Lex/Sgpl1Gt(OST58278)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal lymphopoiesis
|
J:145159
|
| abnormal osteoclast morphology
|
J:145159
|
| decreased B cell number
|
J:145159
|
| decreased double-positive T cell number
|
J:145159
|
| decreased lymphocyte cell number
|
J:145159
|
| decreased pre-B cell number
|
J:145159
|
| decreased T cell number
|
J:145159
|
| increased CD4-positive, alpha-beta T cell number
|
J:145159
|
| increased CD8-positive, alpha-beta T cell number
|
J:145159
|
| increased monocyte cell number
|
J:145159
|
| increased osteoclast cell number
|
J:145159
|
Sgpl1Gt(OST58278)Lex/Sgpl1tm1(SGPL1)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal osteoclast morphology
|
J:145159
|
| decreased T cell number
|
J:145159
|
Sgpl1Gt(ROSA)78Sor/Sgpl1Gt(ROSA)78Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased lymphocyte cell number
|
J:187619
|
Sgpl1tm1(SGPL1)Lex/Sgpl1tm1(SGPL1)Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:145159
|
| decreased CD4-positive, alpha-beta T cell number
|
J:145159
|
| decreased CD8-positive, alpha-beta T cell number
|
J:145159
|
| decreased lymphocyte cell number
|
J:145159
|
| decreased T cell number
|
J:145159
|
| increased single-positive T cell number
|
J:145159
|
Sgsm1tm1b(EUCOMM)Wtsi/Sgsm1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sgsm1tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
Sh2b2tm1Yeb/Sh2b2tm1Yeb
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:88527
|
| increased B-1 B cell number
|
J:88527
|
Sh2b3tm1Paw/Sh2b3tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal monocyte differentiation
|
J:77248
|
| increased B cell number
|
J:77248
|
Sh2b3tm1Paw/Sh2b3tm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased B cell number
|
J:161643
|
| increased lymphocyte cell number
|
J:161643
|
| increased monocyte cell number
|
J:161643
|
Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased NK T cell number
|
J:189126
|
Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * BALB/c)
|
abnormal germinal center B cell morphology
|
J:189126
|
| decreased germinal center B cell number
|
J:189126
|
| decreased NK T cell number
|
J:189126
|
Sh2d1atm1Cpt/Y
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)
|
decreased germinal center B cell number
|
J:189126
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(B6.129S4-Sh2d1atm1Cpt)
|
absent NK T cells
|
J:97690
|
| decreased NK T cell number
|
J:97690
|
| decreased transitional stage B cell number
|
J:97690
|
| increased B cell number
|
J:97388
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
decreased NK T cell number
|
J:189126
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(involves: 129S4/SvJae * BALB/c)
|
abnormal germinal center B cell morphology
|
J:189126
|
| decreased germinal center B cell number
|
J:189126
|
| decreased NK T cell number
|
J:189126
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)
|
decreased germinal center B cell number
|
J:189126
|
Sh2d1atm1Lyin/Y
(involves: 129S2/SvPas * C57BL/6)
|
increased CD8-positive, alpha-beta T cell number
|
J:97346
|
Sh2d1atm1Lyin/Sh2d1atm1Lyin
(involves: 129S2/SvPas * C57BL/6)
|
increased CD8-positive, alpha-beta T cell number
|
J:97346
|
Sh2d1atm1Pls/Y
(involves: 129S6/SvEvTac)
|
abnormal long lived plasma cell morphology
|
J:157915
|
| abnormal NK T cell morphology
|
J:196692
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157915
|
Sh2d1atm1Pls/Sh2d1atm1Pls
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal lymphocyte cell number
|
J:70032
|
| abnormal T-helper 1 cell morphology
|
J:70032
|
| abnormal T-helper 2 cell morphology
|
J:70032
|
Sh2d1atm1Pls/Sh2d1atm1Pls
(involves: 129S6/SvEvTac)
|
abnormal long lived plasma cell morphology
|
J:157915
|
| abnormal NK T cell morphology
|
J:196692
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157915
|
Sh2d1atm2.1Vei/Sh2d1atm2.1Vei
(involves: C57BL/6)
|
decreased germinal center B cell number
|
J:131618
|
| decreased NK T cell number
|
J:131618
|
Sh2d1atm2Vei/Sh2d1atm2Vei
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased germinal center B cell number
|
J:131618
|
| decreased NK T cell number
|
J:131618
|
Sh2d1atm2Vei/Sh2d1atm2Vei
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6)
|
decreased germinal center B cell number
|
J:131618
|
| decreased NK T cell number
|
J:131618
|
Sh2d3ctm1Lex/Sh2d3ctm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased marginal zone B cell number
|
J:161448
|
Sh3bp2tm1.1Ics/Sh3bp2tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
increased monocyte cell number
|
J:221901
|
Sh3bp2tm1Bjro/Sh3bp2+
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
abnormal osteoclast differentiation
|
J:117880
|
| increased osteoclast cell number
|
J:117880
|
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
abnormal B cell number
|
J:117880
|
| abnormal osteoclast differentiation
|
J:117880
|
| increased osteoclast cell number
|
J:117880
|
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * 129S4/SvJae * BALB/cJ * C57BL/6J)
|
abnormal osteoclast differentiation
|
J:117880
|
Sh3bp2tm1Geha/Sh3bp2tm1Geha
(Not Specified)
|
abnormal B cell number
|
J:110319
|
| increased pre-B cell number
|
J:110319
|
Sh3bp2tm1Rtpl/Sh3bp2tm1Rtpl
(B6.129P2-Sh3bp2tm1Rtpl)
|
abnormal B cell number
|
J:121380
|
| decreased B-1 B cell number
|
J:121380
|
| decreased pro-B cell number
|
J:121380
|
| decreased transitional stage B cell number
|
J:121380
|
| increased marginal zone B cell number
|
J:121380
|
Sh3kbp1tm1Kuro/Sh3kbp1tm1Kuro
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6 * NZB)
|
abnormal lymphocyte cell number
|
J:176805
|
| decreased B cell number
|
J:176805
|
| decreased B-1a cell number
|
J:176805
|
| decreased follicular B cell number
|
J:176805
|
| decreased immature B cell number
|
J:176805
|
| decreased transitional stage T2 B cell number
|
J:176805
|
| decreased transitional stage T3 B cell number
|
J:176805
|
Sh3kbp1tm1Kuro/Sh3kbp1tm1Kuro
Cd79atm1(cre)Reth/Cd79a+
Gt(ROSA)26Sortm4(Ikbkb)Rsky/?
(involves: BALB/c * C57BL/6 * NZB)
|
decreased B-1a cell number
|
J:176805
|
Sh3tc1tm1b(EUCOMM)Hmgu/Sh3tc1tm1b(EUCOMM)Hmgu
(C57BL/6N-Sh3tc1tm1b(EUCOMM)Hmgu/Orl)
|
increased monocyte cell number
|
J:211773
|
Sharpincpdm/Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm)
|
decreased B cell number
|
J:53575
|
| decreased CD4-positive, alpha-beta T cell number
|
J:53575
|
| decreased T cell number
|
J:53575
|
Shc1tm1Ravi/Shc1tm1Ravi
Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:78180
|
| decreased double-positive T cell number
|
J:78180
|
| decreased single-positive T cell number
|
J:78180
|
Shcbp1tm1d(EUCOMM)Wtsi/Shcbp1tm1d(EUCOMM)Wtsi
(involves: C57BL/6N * FVB/N)
|
decreased B cell number
|
J:212898
|
| decreased CD4-positive, alpha-beta T cell number
|
J:212898
|
| decreased macrophage cell number
|
J:212898
|
| decreased T cell number
|
J:212898
|
Shisa6em1(IMPC)Tcp/Shisa6em1(IMPC)Tcp
(C57BL/6N-Shisa6em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Shld1em1Nus/Shld1em1Nus
(involves: C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
Siglec1tm1(HBEGF)Mtka/Siglec1tm1(HBEGF)Mtka
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal metallophilic macrophage morphology
|
J:123958
|
| abnormal spleen marginal zone macrophage morphology
|
J:123958
|
Siglec1tm1Croc/Siglec1tm1Croc
(B6.129-Siglec1tm1Croc)
|
abnormal B cell number
|
J:105546
|
| abnormal T cell subpopulation ratio
|
J:105546
|
| decreased follicular B cell number
|
J:105546
|
| increased CD8-positive, alpha-beta T cell number
|
J:105546
|
| increased marginal zone B cell number
|
J:105546
|
Siglec15tm1Yohi/Siglec15tm1Yohi
(B6.129S6-Siglec15tm1Yohi)
|
abnormal osteoclast differentiation
|
J:193852
|
SiglecgM1Btlr/SiglecgM1Btlr
(C57BL/6J-SiglecgM1Btlr)
|
increased B-1 B cell number
|
J:265179
|
Siglecgm2Btlr/Siglecgm2Btlr
(C57BL/6J-Siglecgm2Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:265183
|
| increased B-1 B cell number
|
J:265183
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:265183
|
SiglecgM3Btlr/SiglecgM3Btlr
(C57BL/6J-SiglecgM3Btlr)
|
decreased B-2 B cell number
|
J:265185
|
| increased B-1 B cell number
|
J:265185
|
| increased B-1a cell number
|
J:265185
|
SiglecgM4Btlr/SiglecgM4Btlr
(C57BL/6J-SiglecgM4Btlr)
|
increased B-1 B cell number
|
J:272021
|
SiglecgM5Btlr/SiglecgM5Btlr
(C57BL/6J-SiglecgM5Btlr)
|
increased B-1a cell number
|
J:272022
|
Siglecgtm1Lnit/Siglecgtm1Lnit
(involves: BALB/c)
|
abnormal plasma cell differentiation
|
J:123353
|
| increased B-1 B cell number
|
J:123353
|
| increased B-1a cell number
|
J:123353
|
| increased B-1b cell number
|
J:123353
|
Siglecgtm1Yliu/Siglecgtm1Yliu
(C57BL/6-Siglecgtm1Yliu)
|
increased B-1a cell number
|
J:130017
|
| increased pre-B cell number
|
J:130017
|
Siglechtm1.1Ksat/Siglechtm1.1Ksat
(B6.Cg-Siglechtm1.1Ksat)
|
abnormal regulatory T cell morphology
|
J:179283
|
| decreased T-helper 17 cell number
|
J:179283
|
| increased T-helper 17 cell number
|
J:179283
|
Sik3tm1a(EUCOMM)Hmgu/Sik3tm1a(EUCOMM)Hmgu
(C57BL/6N-Sik3tm1a(EUCOMM)Hmgu/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD5-positive gamma-delta T cell number
|
J:211773
|
| decreased early germinal center B cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| decreased gamma-delta T cell number
|
J:211773
|
| decreased germinal center B cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased KLRG1-positive T-helper cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased CD4-negative NK T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased follicular B cell number
|
J:211773
|
| increased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-negative NK T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive T-helper cell number
|
J:211773
|
| increased Ly6C-positive NK T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
Sirpatm1Nog/Sirpatm1Nog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell number
|
J:79592
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129)
|
decreased CD8-positive, alpha-beta T cell number
|
J:81010
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased CD8-positive, alpha-beta T cell number
|
J:81010
|
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:112817
|
| abnormal lymphopoiesis
|
J:112817
|
| decreased double-positive T cell number
|
J:112817
|
Sirt7tm1Fwa/Sirt7tm1Fwa
(involves: 129S1/Sv)
|
increased macrophage cell number
|
J:205529
|
Sit1tm1Lsmn/Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn)
|
abnormal lymphocyte cell number
|
J:100408
|
| abnormal T cell differentiation
|
J:100408
|
| abnormal T-helper 1 cell differentiation
|
J:100408
|
| decreased CD4-positive, alpha-beta T cell number
|
J:100408
|
| decreased CD8-positive, alpha-beta T cell number
|
J:100408
|
| increased double-positive T cell number
|
J:100408
|
| increased mature gamma-delta T cell number
|
J:100408
|
Sit1tm1Lsmn/Sit1tm1Lsmn
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:100408
|
| abnormal positive T cell selection
|
J:100408
|
| abnormal T cell differentiation
|
J:100408
|
Sit1tm1Lsmn/Sit1tm1Lsmn
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:100408
|
| abnormal T cell selection
|
J:100408
|
Skint1m1Tac/Skint1m1Tac
(FVB/NTac)
|
abnormal T cell differentiation
|
J:139711
|
| abnormal T cell morphology
|
J:139711
|
Skint2em2Htaka/Skint2em2Htaka
(C57BL/6-Skint2em2Htaka)
|
decreased dendritic epidermal T cell number
|
J:291989
|
Skp2tm1Kin/Skp2tm1Kin
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin V(D)J recombination
|
J:168974
|
Sla2em1(IMPC)Ccpcz/Sla2em1(IMPC)Ccpcz
(C57BL/6N-Sla2em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK cell number
|
J:211773
|
Slatm1Weis/Slatm1Weis
(involves: 129 * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:71804
|
Slatm1Weis/Slatm1Weis
Tg(DO11.10)10Dlo/0
(involves: 129 * BALB/c * C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:71804
|
| abnormal T cell differentiation
|
J:71804
|
Slatm1Weis/Slatm1Weis
Zap70tm1Weis/Zap70tm1Weis
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:71804
|
| decreased CD4-positive, alpha-beta T cell number
|
J:71804
|
Slc1a5tm1Tac/Slc1a5tm1Tac
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:254980
|
| abnormal T-helper 2 cell differentiation
|
J:254980
|
| abnormal T-helper 17 cell differentiation
|
J:254980
|
| decreased B cell number
|
J:254980
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:254980
|
| decreased T helper 1 cell number
|
J:254980
|
| decreased T-helper 17 cell number
|
J:254980
|
| increased CD4-positive, alpha-beta T cell number
|
J:254980
|
Slc3a2tm1.1Yait/Slc3a2tm1.1Yait
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrSlc)
|
abnormal macrophage differentiation
|
J:188365
|
| abnormal macrophage morphology
|
J:188365
|
Slc4a2tm1Ges/Slc4a2tm1Ges
(involves: 129S6/SvEvTac)
|
abnormal osteoclast morphology
|
J:193823
|
Slc4a2tm2Ges/Slc4a2tm2Ges
Ctsktm1(cre)Ska/Ctsk+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal osteoclast morphology
|
J:193823
|
Slc4a2tm2Ges/Slc4a2tm2Ges
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal osteoclast morphology
|
J:193823
|
Slc4a4tm1Ges/Slc4a4tm1Ges
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased lymphocyte cell number
|
J:120867
|
Slc6a6em1(IMPC)Mbp/Slc6a6em1(IMPC)Mbp
(C57BL/6N-Slc6a6em1(IMPC)Mbp/MbpMmucd)
|
increased monocyte cell number
|
J:211773
|
Slc6a8tm1.2Lbar/Y
(involves: 129 * 129S1/Sv * C57BL/6J * C57BL/6N)
|
microgliosis
|
J:238578
|
Slc7a7em1Lbu/Slc7a7em1Lbu
(involves: 129/SvEv * C57BL/6)
|
decreased lymphocyte cell number
|
J:293773
|
Slc9a6tm1Dgen/Y
(B6.129P2-Slc9a6tm1Dgen/J)
|
microgliosis
|
J:262453
|
Slc11a1em1(IMPC)Mbp/Slc11a1em1(IMPC)Mbp
(C57BL/6N-Slc11a1em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Slc12a2em1Dlp/Slc12a2em1Dlp
(involves: C57BL/6J * DBA/2J)
|
increased lymphocyte cell number
|
J:285398
|
Slc13a3tm1b(KOMP)Wtsi/Slc13a3tm1b(KOMP)Wtsi
(C57BL/6N-Slc13a3tm1b(KOMP)Wtsi/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Slc15a3tm1a(KOMP)Wtsi/Slc15a3tm1a(KOMP)Wtsi
(C57BL/6N-Slc15a3tm1a(KOMP)Wtsi)
|
abnormal myeloid dendritic cell morphology
|
J:210445
|
Slc15a3tm1b(KOMP)Wtsi/Slc15a3tm1b(KOMP)Wtsi
(C57BL/6N-Slc15a3tm1b(KOMP)Wtsi/H)
|
increased monocyte cell number
|
J:211773
|
Slc19a1tm1Gold/Slc19a1tm1Gold
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:68666
|
| decreased lymphocyte cell number
|
J:68666
|
Slc20a2tm1a(EUCOMM)Wtsi/Slc20a2tm1a(EUCOMM)Wtsi
(C57BL/6NTac-Slc20a2tm1a(EUCOMM)Wtsi/Ieg)
|
microgliosis
|
J:223197
|
Slc25a17Gt(XB686)Byg/Slc25a17Gt(XB686)Byg
(involves: 129P2/OlaHsd * C57BL/6 * Swiss Webster)
|
abnormal Kupffer cell morphology
|
J:291257
|
Slc25a37tm1.1Kapl/Slc25a37tm1.2Kapl
Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * CBA)
|
abnormal B cell morphology
|
J:173284
|
| abnormal lymphocyte morphology
|
J:173284
|
| abnormal T cell morphology
|
J:173284
|
Slc25a46atc/Slc25a46atc
(B6.Cg-Slc25a46atc)
|
microgliosis
|
J:242350
|
Slc28a3em1(IMPC)H/Slc28a3em1(IMPC)H
(C57BL/6N-Slc28a3em1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Slc29a3tm1Lex/Slc29a3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal macrophage morphology
|
J:179286
|
| increased macrophage cell number
|
J:179286
|
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased B cell number
|
J:211266
|
| increased B cell number
|
J:211266
|
| microgliosis
|
J:211266
|
Slc35c1tm1Cknr/Slc35c1tm1Cknr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:121151
|
| increased monocyte cell number
|
J:121151
|
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:86005
|
Slc39a3tm1Gka/Slc39a3tm1Gka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:99161
|
| decreased double-positive T cell number
|
J:99161
|
| increased CD4-positive, alpha-beta T cell number
|
J:99161
|
Slc48a1em1Ih/Slc48a1em1Ih
(involves: 129 * C57BL/6J)
|
abnormal macrophage morphology
|
J:282829
|
| decreased macrophage cell number
|
J:282829
|
Slco1a5tm1Lex/Slco1a5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:103485
|
| increased B cell number
|
J:103485
|
Sle1NZM2410/Aeg/Sle1NZM2410/Aeg
Sle3NZM2410/Aeg/Sle3NZM2410/Aeg
(B6;NZM-Sle1NZM2410/Aeg Sle2NZM2410/Aeg Sle3NZM2410/Aeg/LmoJ)
|
increased marginal zone B cell number
|
J:138314
|
Sle1NZW/Sle1NZW
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZW)
|
increased B cell number
|
J:134128
|
| increased marginal zone B cell number
|
J:134128
|
Slfn2m1Btlr/Slfn2m1Btlr
(C57BL/6J-Slfn2m1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:158985
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158985
|
| decreased monocyte cell number
|
J:158985
|
Slfn4tm1c(EUCOMM)Wtsi/Slfn4tm1c(EUCOMM)Wtsi
Gli1tm3(cre/ERT2)Alj/Gli1+
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * Swiss Webster)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:337060
|
Slx4tm1a(EUCOMM)Wtsi/Slx4tm1a(EUCOMM)Wtsi
(C57BL/6N-Slx4tm1a(EUCOMM)Wtsi)
|
abnormal lymphopoiesis
|
J:168567
|
Smad3tm1Cxd/Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
increased monocyte cell number
|
J:53510
|
Smad3tm1Cxd/Smad3tm1Cxd
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:136955
|
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1)
|
decreased osteoclast cell number
|
J:211171
|
Smad7tm1.1Ink/Smad7tm1.1Ink
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T-helper 1 cell differentiation
|
J:184670
|
| decreased activated T cell number
|
J:184670
|
Smad7tm1Rheu/Smad7tm1Rheu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal class switch recombination
|
J:120714
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(Lck-cre)1Cwi/0
(Not Specified)
|
abnormal T cell morphology
|
J:144072
|
| decreased double-negative T cell number
|
J:144072
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(Lck-cre)1Cwi/0
Tg(LCKprBCL2L1)12Sjk/0
(Not Specified)
|
abnormal T cell morphology
|
J:144072
|
| decreased double-positive T cell number
|
J:144072
|
| increased double-negative T cell number
|
J:144072
|
| increased thymocyte number
|
J:144072
|
Smarca4tm1.2Pcn/Smarca4tm1Mag
Tg(Lck-cre)1Cwi/?
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:85191
|
| absent CD8-positive, alpha-beta T cells
|
J:85191
|
| arrested T cell differentiation
|
J:85191
|
| decreased CD4-positive, alpha-beta T cell number
|
J:85191
|
| decreased double-negative T cell number
|
J:85191
|
| decreased double-positive T cell number
|
J:85191
|
Smarca4tm1.2Pcn/Smarca4tm1Mag
Tg(Lck-cre)1Cwi/?
Tg(LCKprBCL2)36Sjk/?
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:85191
|
Smarca4tm1.2Pcn/Smarca4tm1Tich
Tg(Lck-cre)1Cwi/0
(involves: 129)
|
abnormal T cell morphology
|
J:144072
|
| decreased double-negative T cell number
|
J:144072
|
| decreased thymocyte number
|
J:144072
|
Smarca4tm1.2Pcn/Smarca4tm1Tich
Tg(Lck-cre)1Cwi/0
Tg(LCKprBCL2L1)12Sjk/0
(involves: 129)
|
abnormal T cell morphology
|
J:144072
|
| decreased double-positive T cell number
|
J:144072
|
| increased double-negative T cell number
|
J:144072
|
| increased thymocyte number
|
J:144072
|
Smarca4tm1Tich/Smarca4+
Tg(Lck-cre)1Cwi/0
(involves: 129)
|
decreased double-negative T cell number
|
J:144072
|
| decreased double-positive T cell number
|
J:144072
|
| decreased single-positive T cell number
|
J:144072
|
| decreased thymocyte number
|
J:144072
|
Smarcal1tm1.1Cfbo/Smarcal1tm1.1Cfbo
(either: B6.129-Smarcal1tm1.1Cfbo or (involves: 129 * C57BL/6))
|
decreased B cell number
|
J:183899
|
Smarcc1tm2.1Rhs/Smarcc1tm2.1Rhs
Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:184060
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:184060
|
| abnormal pre-B cell morphology
|
J:184060
|
| abnormal pro-B cell morphology
|
J:184060
|
| arrested B cell differentiation
|
J:184060
|
| decreased B cell number
|
J:184060
|
| decreased early pro-B cell number
|
J:184060
|
| decreased follicular B cell number
|
J:184060
|
| decreased late pro-B cell number
|
J:184060
|
| decreased pro-B cell number
|
J:184060
|
Smc3tm1a(EUCOMM)Wtsi/Smc3+
(involves: C57BL/6N)
|
increased T cell number
|
J:200082
|
Smc5tm1b(KOMP)Wtsi/Smc5+
(C57BL/6N-Smc5tm1b(KOMP)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Smcr8em1Btlr/Smcr8em1Btlr
(C57BL/6J-Smcr8em1Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:268243
|
| increased CD8-positive, alpha-beta T cell number
|
J:268243
|
Smcr8em2Btlr/Smcr8em2Btlr
(C57BL/6J-Smcr8em2Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:268243
|
| increased CD8-positive, alpha-beta T cell number
|
J:268243
|
Smim3tm1Anjm/Smim3+
Cd74tm1Anjm/Cd74+
Lmo2tm2(cre)Thr/Lmo2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased monocyte cell number
|
J:155870
|
Smoc1tm1b(EUCOMM)Wtsi/Smoc1+
(C57BL/6N-Smoc1tm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
Smoc1tm1b(EUCOMM)Wtsi/Smoc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Smoc1tm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
Smpd1tm1Esc/Smpd1tm1Esc
(involves: 129S1/Sv * C57BL/6J)
|
increased macrophage derived foam cell number
|
J:81982
|
Smpd1tm1Wst/Smpd1tm1Wst
(involves: 129P2/OlaHsd * C57BL/6)
|
increased macrophage derived foam cell number
|
J:26748
|
Smpdl3btm1a(EUCOMM)Wtsi/Smpdl3btm1a(EUCOMM)Wtsi
(C57BL/6-Smpdl3btm1a(EUCOMM)Wtsi)
|
abnormal macrophage morphology
|
J:224870
|
Smstm1a(EUCOMM)Wtsi/Y
(involves: C57BL/6 * C57BL/6N)
|
increased NK cell number
|
J:213427
|
| increased NK T cell number
|
J:213427
|
Snai2tm2Grid/Snai2+
Snai3tm1.2Jhws/Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
decreased B cell number
|
J:204710
|
Snai2tm2Grid/Snai2tm2Grid
(involves: 129S1/Sv)
|
abnormal T cell differentiation
|
J:78323
|
Snai2tm2Grid/Snai2tm2Grid
Snai3tm1.2Jhws/Snai3+
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
decreased B cell number
|
J:204710
|
| increased macrophage cell number
|
J:204710
|
Snai2tm2Grid/Snai2tm2Grid
Snai3tm1.2Jhws/Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
decreased B cell number
|
J:204710
|
| decreased double-positive T cell number
|
J:204710
|
| increased macrophage cell number
|
J:204710
|
| increased single-positive T cell number
|
J:204710
|
Snd1em1(IMPC)Tcp/Snd1+
(C57BL/6NCrl-Snd1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Snrnp40em1Btlr/Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp)
|
decreased B cell number
|
J:282417
|
| decreased CD4-positive, alpha-beta T cell number
|
J:282417
|
| decreased CD8-positive, alpha-beta T cell number
|
J:282417
|
| decreased DN1 thymic pro-T cell number
|
J:282417
|
| decreased DN4 thymocyte number
|
J:282417
|
| decreased lymphocyte cell number
|
J:282417
|
| decreased monocyte cell number
|
J:282417
|
| decreased NK cell number
|
J:282417
|
| decreased T cell number
|
J:282417
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:282417
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:282417
|
Snrnp200tm1b(KOMP)Mbp/Snrnp200+
(C57BL/6N-Snrnp200tm1b(KOMP)Mbp/H)
|
increased monocyte cell number
|
J:211773
|
Snx10em1Ael/Snx10em1Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal osteoclast morphology
|
J:289051
|
| decreased osteoclast cell number
|
J:289051
|
Snx10em2Ael/Snx10em2Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal osteoclast morphology
|
J:289051
|
| decreased osteoclast cell number
|
J:289051
|
Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * C57BL/6)
|
abnormal macrophage morphology
|
J:37049
|
Socs1tm1.1Ayr/Socs1tm1.1Ayr
(involves: C57BL/6)
|
decreased effector memory T-helper cell number
|
J:226678
|
Socs1tm1Ayos/Socs1tm1Ayos
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased regulatory T cell number
|
J:167922
|
Socs1tm1Ayos/Socs1tm1Ayos
Tg(Lck-cre)1Jtak/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:132905
|
Socs1tm1Ayos/Socs1tm1Ayos
Tg(Tek-cre)1Ywa/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:132905
|
| increased CD8-positive, alpha-beta T cell number
|
J:132905
|
Socs1tm1Jni/Socs1tm1Jni
(Not Specified)
|
abnormal T cell differentiation
|
J:57475
|
| decreased B cell number
|
J:57475
|
| decreased thymocyte number
|
J:57475
|
Socs1tm1Kish/Socs1tm1Kish
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased lymphocyte cell number
|
J:51685
|
Socs1tm1Kish/Socs1tm1Kish
(B6.129P2-Socs1tm1Kish)
|
increased activated T cell number
|
J:69472
|
| increased NK T cell number
|
J:69472
|
Socs1tm1Kish/Socs1tm1Kish
Stat1tm1Rds/Stat1tm1Rds
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased activated T cell number
|
J:69472
|
Socs1tm1Kish/Socs1tm1Kish
Stat6tm1Aki/Stat6tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
increased activated T cell number
|
J:69472
|
Socs1tm1Wehi/Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6)
|
abnormal follicular B cell morphology
|
J:51281
|
| abnormal mature B cell morphology
|
J:51281
|
| decreased B cell number
|
J:51281
|
| decreased lymphocyte cell number
|
J:51281
|
| decreased pre-B cell number
|
J:51281
|
Socs1tm1Wehi/Socs1tm3Wehi
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83009
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:83009
|
| abnormal T cell differentiation
|
J:83009
|
| abnormal T cell subpopulation ratio
|
J:83009
|
| decreased B cell number
|
J:83009
|
| increased CD4-positive, alpha-beta T cell number
|
J:83009
|
| increased CD8-positive, alpha-beta T cell number
|
J:83009
|
Socs4m1Nch/Socs4m1Nch
(C.C3Fe-Socs4m1Nch)
|
decreased T cell number
|
J:241977
|
| increased T cell number
|
J:241977
|
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J)
|
microgliosis
|
J:219360
|
Sorbs1tm1Krc/Sorbs1tm1Krc
(B6.129-Sorbs1tm1Krc)
|
decreased lymphocyte cell number
|
J:121762
|
| decreased monocyte cell number
|
J:121762
|
Sos1tm1.1Les/Sos1tm1.1Les
Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:174536
|
| decreased CD8-positive, alpha-beta T cell number
|
J:174536
|
| decreased DN4 thymocyte number
|
J:174536
|
| decreased double-negative T cell number
|
J:174536
|
| decreased double-positive T cell number
|
J:174536
|
| decreased gamma-delta T cell number
|
J:174536
|
| decreased thymocyte number
|
J:174536
|
Sostdc1tm1Snd/Sostdc1tm1Snd
(involves: C57BL/6)
|
decreased osteoclast cell number
|
J:216098
|
Sox4tm1Cle/Sox4tm1Cle
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:32741
|
| absent pre-B cells
|
J:32741
|
| decreased pro-B cell number
|
J:32741
|
Sox4tm2Cle/Sox4tm2Cle
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:32741
|
| absent pre-B cells
|
J:32741
|
| decreased pro-B cell number
|
J:32741
|
Sox9em1(cre/ERT2)Smoc/Sox9+
Tnfsf18em1Pwan/Tnfsf18em1Pwan
(involves: C57BL/6J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:346395
|
Sox13tm1Jskg/Sox13+
(involves: C57BL/6)
|
decreased gamma-delta T cell number
|
J:117301
|
Sox13tm1Jskg/Sox13tm1Jskg
(involves: C57BL/6)
|
decreased gamma-delta T cell number
|
J:117301
|
Sox21em1(IMPC)Mbp/Sox21em1(IMPC)Mbp
(C57BL/6NCrl-Sox21em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Sp3tm1Sus/Sp3tm1Sus
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:84837
|
| decreased CD4-positive, alpha-beta T cell number
|
J:84837
|
Spag11aem1(IMPC)Mbp/Spag11aem1(IMPC)Mbp
(C57BL/6NCrl-Spag11aem1(IMPC)Mbp/Mmucd)
|
increased monocyte cell number
|
J:211773
|
Sparctm1Hwe/Sparctm1Hwe
(involves: 129S/SvEv * C57BL/6J)
|
abnormal osteoclast morphology
|
J:61480
|
| decreased osteoclast cell number
|
J:61480
|
Spata2tm1.1(KOMP)Vlcg/Spata2tm1.1(KOMP)Vlcg
(C57BL/6N-Spata2tm1.1(KOMP)Vlcg/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
Spata31f3em1(IMPC)Ccpcz/Spata31f3em1(IMPC)Ccpcz
(C57BL/6NCrl-Spata31f3em1(IMPC)Ccpcz/Ccpcz)
|
increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
Spentm1Hon/Spentm1Hon
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:82332
|
Sphk1tm1.1Cgh/Sphk1tm2Cgh
Sphk2tm1.1Cgh/Sphk2tm1.1Cgh
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal NK cell differentiation
|
J:154069
|
| abnormal T cell differentiation
|
J:120783
|
| decreased B cell number
|
J:120783
|
| decreased NK cell number
|
J:154069
|
| decreased T cell number
|
J:120783
|
| increased NK cell number
|
J:154069
|
Sphk1tm1Npa/Sphk1tm1Npa
(BALB/c-Sphk1tm1Npa)
|
increased B cell number
|
J:129314
|
Sphk2tm1Npa/Sphk2tm1Npa
(BALB/c-Sphk2tm1Npa)
|
increased B cell number
|
J:129314
|
Spi1tm1.1Dgt/Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased B cell number
|
J:90331
|
Spi1tm1.2Nutt/Spi1tm1.2Nutt
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:98188
|
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106040
|
| abnormal T cell subpopulation ratio
|
J:106040
|
| arrested B cell differentiation
|
J:106040
|
| decreased B-1a cell number
|
J:106040
|
| decreased mature B cell number
|
J:106040
|
| decreased pre-B cell number
|
J:106040
|
| decreased pro-B cell number
|
J:106040
|
| decreased T cell number
|
J:106040
|
| decreased thymocyte number
|
J:106040
|
| increased B-1 B cell number
|
J:106040
|
| increased B-1b cell number
|
J:106040
|
| increased lymphocyte cell number
|
J:106040
|
| increased T cell number
|
J:106040
|
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6)
|
decreased B cell number
|
J:90331
|
Spi1tm1Kast/Spi1tm1Kast
(B6.129S2-Spi1tm1Kast)
|
absent B cells
|
J:90543
|
Spi1tm1Ram/Spi1tm1Ram
(involves: 129S2/SvPas)
|
decreased macrophage cell number
|
J:101493
|
Spi1tm1Ram/Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell number
|
J:36473
|
| abnormal macrophage differentiation
|
J:36473
|
| abnormal microglial cell morphology
|
J:116087
|
| abnormal T cell differentiation
|
J:36473
|
| abnormal T cell number
|
J:36473
|
| absent mature B cells
|
J:36473
|
| decreased CD4-positive, alpha-beta T cell number
|
J:36473
|
| decreased CD8-positive, alpha-beta T cell number
|
J:36473
|
| decreased double-positive T cell number
|
J:36473
|
| decreased macrophage cell number
|
J:36473
|
| decreased thymocyte number
|
J:36473
|
Spi1tm1Rpd/Spi1tm1Rpd
(involves: 129/Sv * C57BL/6 * Black Swiss)
|
arrested B cell differentiation
|
J:123079
|
Spi1tm1Sing/Spi1+
Spibtm1Mcs/Spibtm1Mcs
(involves: 129S/SvEv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:88257
|
| abnormal immature B cell morphology
|
J:88257
|
| decreased B cell number
|
J:88257
|
Spi1tm1Sing/Spi1tm1Sing
(involves: 129S/SvEv)
|
abnormal B cell differentiation
|
J:20348
|
| abnormal monocyte morphology
|
J:20348
|
| abnormal T cell differentiation
|
J:20348
|
Spi1tm3Dgt/Spi1tm3Dgt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:131217
|
| decreased double-negative T cell number
|
J:131217
|
| increased double-negative T cell number
|
J:131217
|
Spibtm1Mcs/Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immature B cell morphology
|
J:88257
|
Spictm1.1Kmm/Spictm1.1Kmm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage morphology
|
J:143900
|
Spictm1Kmm/Spictm1Kmm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage morphology
|
J:143900
|
Spink6em1(IMPC)Ccpcz/Spink6em1(IMPC)Ccpcz
(C57BL/6N-Spink6em1(IMPC)Ccpcz/Ccpcz)
|
decreased Ly6C-positive immature NK cell number
|
J:211773
|
| decreased macrophage cell number
|
J:211773
|
| increased Ly6C-positive mature NK cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Spink14tm1e(KOMP)Wtsi/Spink14tm1e(KOMP)Wtsi
(C57BL/6N-Spink14tm1e(KOMP)Wtsi/Wtsi)
|
decreased immature NK cell number
|
J:211773
|
| decreased macrophage cell number
|
J:211773
|
| decreased mature NK cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
Spns2tm1.1Nmoc/Spns2tm1.1Nmoc
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL)
|
abnormal effector T cell morphology
|
J:184558
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184558
|
| decreased CD8-positive, alpha-beta T cell number
|
J:184558
|
| decreased mature B cell number
|
J:184558
|
| increased CD4-positive, alpha-beta T cell number
|
J:184558
|
| increased CD8-positive, alpha-beta T cell number
|
J:184558
|
Spns2tm1.2Nmoc/Spns2tm1.2Nmoc
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased B-1 B cell number
|
J:184558
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184558
|
| decreased CD8-positive, alpha-beta T cell number
|
J:184558
|
| decreased follicular B cell number
|
J:184558
|
| decreased immature B cell number
|
J:184558
|
| decreased mature B cell number
|
J:184558
|
| decreased transitional stage T1 B cell number
|
J:184558
|
| increased CD4-positive, alpha-beta T cell number
|
J:184558
|
| increased CD8-positive, alpha-beta T cell number
|
J:184558
|
| increased single-positive T cell number
|
J:184558
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased B cell number
|
J:188933,
J:213427
|
| decreased B-1 B cell number
|
J:188933
|
| decreased CD4-positive, alpha-beta T cell number
|
J:188933,
J:213427
|
| decreased CD8-positive, alpha-beta T cell number
|
J:188933,
J:213427
|
| decreased follicular B cell number
|
J:188933
|
| decreased mature B cell number
|
J:213427
|
| decreased T cell number
|
J:213427
|
| increased CD4-positive, alpha-beta T cell number
|
J:188933
|
| increased CD8-positive, alpha-beta T cell number
|
J:188933
|
| increased monocyte cell number
|
J:213427
|
| increased NK cell number
|
J:213427
|
| increased NK T cell number
|
J:213427
|
Spns2tm1b(KOMP)Wtsi/Spns2tm1b(KOMP)Wtsi
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6N)
|
decreased B cell number
|
J:188933
|
| decreased CD4-positive, alpha-beta T cell number
|
J:188933
|
| decreased CD8-positive, alpha-beta T cell number
|
J:188933
|
| increased CD4-positive, alpha-beta T cell number
|
J:188933
|
| increased CD8-positive, alpha-beta T cell number
|
J:188933
|
Spns2tm1Tni/Spns2tm1Tni
(B6.Cg-Spns2tm1Tni)
|
abnormal mature B cell number
|
J:225108
|
| decreased lymphocyte cell number
|
J:225108
|
| decreased monocyte cell number
|
J:225108
|
| decreased single-positive T cell number
|
J:225108
|
| decreased thymocyte number
|
J:225108
|
Spp1Ric-r/Spp1+
(C3H/Rv)
|
increased macrophage cell number
|
J:7240
|
Spp1tm1.1Dhd/Spp1tm1.1Dhd
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage morphology
|
J:237104
|
| decreased osteoclast cell number
|
J:237104
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased macrophage cell number
|
J:127389
|
| increased lymphocyte cell number
|
J:103050
|
Spp1tm1Blh/Spp1tm1Blh
(B6.129S6-Spp1tm1Blh)
|
abnormal microglial cell morphology
|
J:118432
|
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased osteoclast cell number
|
J:115395
|
| increased osteoclast cell number
|
J:56353,
J:56535
|
Sppl2achompB/Sppl2achompB
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:194595
|
| decreased follicular B cell number
|
J:194595
|
| decreased marginal zone B cell number
|
J:194595
|
| decreased mature B cell number
|
J:194595
|
| decreased myeloid dendritic cell number
|
J:194595
|
| decreased transitional stage T2 B cell number
|
J:194595
|
Sppl2am1Anu/Sppl2am1Anu
(involves: C57BL/6JAnu)
|
abnormal mature B cell morphology
|
J:194663
|
| abnormal transitional stage B cell morphology
|
J:194663
|
| decreased marginal zone B cell number
|
J:194663
|
| decreased transitional stage T2 B cell number
|
J:194663
|
| decreased transitional stage T3 B cell number
|
J:194663
|
Sppl2am1Anu/Sppl2am1Anu
Tg(Vav-BCL2)69Jad/?
(involves: C57BL/6JAnu)
|
abnormal T cell number
|
J:194663
|
| decreased CD4-positive, alpha-beta T cell number
|
J:194663
|
| decreased double-negative T cell number
|
J:194663
|
| increased mature B cell number
|
J:194663
|
Sppl2atm1Basc/Sppl2atm1Basc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
arrested B cell differentiation
|
J:194664
|
| decreased B cell number
|
J:194664
|
| decreased B-1 B cell number
|
J:194664
|
| decreased B-2 B cell number
|
J:194664
|
| decreased follicular B cell number
|
J:194664
|
| decreased marginal zone B cell number
|
J:194664
|
| decreased mature B cell number
|
J:194664
|
| decreased T cell number
|
J:194664
|
| decreased transitional stage T2 B cell number
|
J:194664
|
Sppl2atm1Basc/Sppl2atm1Basc
Sppl2bGt(Ayu21-T160)Imeg/Sppl2bGt(Ayu21-T160)Imeg
(B6N.Cg-Sppl2atm1Basc Sppl2bGt(Ayu21-T160)Imeg)
|
abnormal mature B cell morphology
|
J:213519
|
| decreased B cell number
|
J:213519
|
Sppl2atm1Dgen/Sppl2atm1Dgen
(B6.129P2-Sppl2atm1Dgen)
|
decreased B cell number
|
J:194595
|
| decreased B-1 B cell number
|
J:194595
|
| decreased follicular B cell number
|
J:194595
|
| decreased myeloid dendritic cell number
|
J:194595
|
| decreased transitional stage T2 B cell number
|
J:194595
|
Sppl3tm1Itl/Sppl3em1Pomz
Ncr1tm1.1(icre)Viv/Ncr1+
(involves: 129S/SvEv * C57BL/6 * C57BL/6J)
|
abnormal NK cell differentiation
|
J:280182
|
| decreased mature NK cell number
|
J:280182
|
| decreased NK cell number
|
J:280182
|
| increased immature NK cell number
|
J:280182
|
Sppl3tm1Itl/Sppl3tm1Itl
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S/SvEv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal NK cell differentiation
|
J:280182
|
| decreased mature NK cell number
|
J:280182
|
| decreased NK cell number
|
J:280182
|
| increased immature NK cell number
|
J:280182
|
Sppl3tm1Itl/Sppl3tm1Itl
Ncr1tm1.1(icre)Viv/Ncr1+
(involves: 129S/SvEv * C57BL/6)
|
abnormal NK cell differentiation
|
J:280182
|
| decreased mature NK cell number
|
J:280182
|
| decreased NK cell number
|
J:280182
|
| increased immature NK cell number
|
J:280182
|
Spred1em1(IMPC)Ccpcz/Spred1em1(IMPC)Ccpcz
(C57BL/6N-Spred1em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
| increased CD4-positive NK T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
Sprol1STS/A/?
(involves: B10.O20/Dem * O20/A)
|
increased lymphocyte cell number
|
J:56029
|
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1)
|
increased B cell number
|
J:1967
|
| increased CD4-positive, alpha-beta T cell number
|
J:1967
|
| increased CD8-positive, alpha-beta T cell number
|
J:1967
|
| increased lymphocyte cell number
|
J:12830,
J:1967
|
| increased monocyte cell number
|
J:12830
|
| increased T cell number
|
J:1967
|
Sptlc2tm1Yhir/Sptlc2tm1Yhir
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
decreased lymphocyte cell number
|
J:202954
|
Sptlc2tm1Yhir/Sptlc2tm1Yhir
Tg(KRT5-cre)1Tak/0
(involves: C3H * C57BL/6)
|
abnormal dendritic epidermal T cell morphology
|
J:202388
|
| abnormal Langerhans cell morphology
|
J:202388
|
| increased gamma-delta T cell number
|
J:202388
|
| increased T-helper 17 cell number
|
J:202388
|
Sqstm1tm1.1Sral/Sqstm1+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:173755
|
| increased osteoclast cell number
|
J:173755
|
Sqstm1tm1.1Sral/Sqstm1tm1.1Sral
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:173755
|
| abnormal osteoclast morphology
|
J:173755
|
| increased osteoclast cell number
|
J:173755
|
Sqstm1tm1Jjw/Sqstm1tm1Jjw
(involves: 129 * C57BL/6)
|
abnormal osteoclast differentiation
|
J:141179
|
Sqstm1tm1Jmos/Sqstm1tm1Jmos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast differentiation
|
J:90010
|
| decreased osteoclast cell number
|
J:90010
|
Sqstm1tm1Keta/Sqstm1tm1Keta
(involves: 129 * C57BL/6N)
|
abnormal osteoclast differentiation
|
J:264183
|
Srftm2Nor/Srftm2Nor
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
abnormal mature B cell morphology
|
J:124767
|
| absent marginal zone B cells
|
J:124767
|
| decreased B cell number
|
J:124767
|
| decreased B-1 B cell number
|
J:124767
|
Srftm2Nor/Srftm2Nor
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:124767
|
| decreased CD8-positive, alpha-beta T cell number
|
J:124767
|
| decreased T cell number
|
J:124767
|
| decreased thymocyte number
|
J:124767
|
Srpk3tm1b(KOMP)Wtsi/Y
(C57BL/6N-Srpk3tm1b(KOMP)Wtsi/Ucd)
|
increased monocyte cell number
|
J:211773
|
Srpxtm1Hzi/Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphocyte morphology
|
J:119999
|
Srsf2tm1.1Oaw/Srsf2+
Tg(Mx1-cre)1Cgn/?
(B6.Cg-Tg(Mx1-cre)1Cgn Srsf2tm1.1Oaw)
|
decreased B cell number
|
J:221404
|
Srsf2tm1Xdfu/Srsf2+
Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR)
|
decreased thymocyte number
|
J:88668
|
Srsf2tm1Xdfu/Srsf2tm1Xdfu
Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR)
|
abnormal T cell differentiation
|
J:88668
|
| decreased double-positive T cell number
|
J:88668
|
| decreased T cell number
|
J:88668
|
| decreased thymocyte number
|
J:88668
|
| increased double-negative T cell number
|
J:88668
|
Srsf3tm1Pjln/Srsf3tm1Pjln
Cd79atm1(cre)Reth/Cd79a+
(involves: 129P2/OlaHsd * BALB/c)
|
decreased B cell number
|
J:113645
|
| decreased pre-B cell number
|
J:113645
|
| decreased pro-B cell number
|
J:113645
|
Ssbtm1Rjma/Ssbtm2.1Rjma
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S/SvEv * BALB/c)
|
arrested B cell differentiation
|
J:207687
|
| decreased B cell number
|
J:207687
|
Ssbp2tm1Lana/Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6)
|
decreased lymphocyte cell number
|
J:162035
|
| increased pre-B cell number
|
J:162035
|
St3gal2tm1Jxm/St3gal2tm1Jxm
(Not Specified)
|
increased T cell number
|
J:217719
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased lymphocyte cell number
|
J:189086
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
St3gal6tm1.1Jxm/St3gal6tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased lymphocyte cell number
|
J:189086
|
St6gal1tm1Jxm/St6gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased marginal zone B cell number
|
J:132991
|
| decreased transitional stage B cell number
|
J:132991
|
St6galnac2tm1.1Cfg/St6galnac2tm1.1Cfg
(involves: 129S1/Sv * 129X1/SvJ)
|
increased pre-B cell number
|
J:217719
|
St8sia1tm1Kfk/St8sia1tm1Kfk
(Not Specified)
|
decreased CD8-positive, alpha-beta T cell number
|
J:73818
|
St14tm1Bug/St14tm1Bug
(involves: 129P2/OlaHsd * Black Swiss)
|
decreased double-positive T cell number
|
J:87125
|
St14tm2Bug/St14tm3Bug
Tg(MMTV-cre)4Mam/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss)
|
decreased CD4-positive, alpha-beta T cell number
|
J:213072
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:213072
|
| decreased CD8-positive, alpha-beta T cell number
|
J:213072
|
| decreased regulatory T cell number
|
J:213072
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:213072
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:213072
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:213072
|
Stag2tm1.1Soga/Y
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased B cell number
|
J:289000
|
| increased monocyte cell number
|
J:289000
|
Stamtm2Sug/Stamtm2Sug
Stam2tm1Sug/Stam2tm1Sug
Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
decreased T cell number
|
J:80617
|
Stat1m4Btlr/Stat1m4Btlr
(C57BL/6J-Stat1m4Btlr)
|
abnormal CD8-positive, naive alpha-beta T cell number
|
J:264800
|
| decreased B cell number
|
J:264800
|
| decreased B-1 B cell number
|
J:264800
|
| decreased CD8-positive, alpha-beta T cell number
|
J:264800
|
| decreased NK cell number
|
J:264800
|
| decreased single-positive T cell number
|
J:264800
|
| increased CD4-positive, alpha-beta T cell number
|
J:264800
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:264800
|
| increased NK T cell number
|
J:264800
|
Stat1m5Btlr/Stat1m5Btlr
(C57BL/6J-Stat1m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274938
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274938
|
| abnormal T cell differentiation
|
J:274938
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274938
|
| increased CD4-positive, alpha-beta T cell number
|
J:274938
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274938
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274938
|
| increased T cell number
|
J:274938
|
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
abnormal osteoclast differentiation
|
J:131353
|
| increased NK T cell number
|
J:122801
|
Stat1tm1Rds/Stat1tm1Rds
(B6.129-Stat1tm1Rds)
|
increased osteoclast cell number
|
J:84894
|
Stat1tm1Rds/Stat1tm1Rds
Stat3tm2Aki/Stat3tm2Aki
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:83280
|
Stat1tm2b(EUCOMM)Wtsi/Stat1tm2b(EUCOMM)Wtsi
(C57BL/6N-Stat1tm2b(EUCOMM)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Stat2m1Btlr/Stat2m1Btlr
(C57BL/6J-Stat2m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:265265
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:265265
|
| decreased single-positive T cell number
|
J:265265
|
Stat2tm1Shnd/Stat2tm1Shnd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:66564
|
Stat3tm1Dlv/Stat3tm1Dlv
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:124293
|
Stat3tm1Dlv/Stat3tm1Dlv
Tg(Csf1r-icre)1Jwp/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
increased macrophage cell number
|
J:156593
|
| increased T cell number
|
J:156593
|
Stat3tm1Dlv/Stat3tm1Dlv
Tg(MMTV-cre)4Mam/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB)
|
decreased T-helper 17 cell number
|
J:120176
|
Stat3tm1Dnl/Stat3tm1Dlv
(involves: C57BL/6)
|
decreased thymocyte number
|
J:87599
|
Stat3tm1Xyfu/Stat3tm1.1Xyfu
Tg(Ttr-cre)10-3Xyfu/?
(involves: 129S1/Sv * C57BL/6)
|
increased monocyte cell number
|
J:128719
|
Stat3tm2Aki/Stat3tm2Aki
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:83280
|
| increased macrophage cell number
|
J:83280
|
Stat4tm1Gru/Stat4tm1Gru
(C.129S2-Stat4tm1Gru)
|
abnormal CD4-positive T cell differentiation
|
J:143729
|
Stat5atm1.1Wjl/Stat5atm1.1Wjl
Stat5btm2.1Wjl/Stat5btm2.1Wjl
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal T cell subpopulation ratio
|
J:187325
|
| decreased CD8-positive, alpha-beta T cell number
|
J:187325
|
| decreased NK cell number
|
J:187325
|
Stat5atm1Jni/Stat5atm1Jni
Stat5btm2Jni/Stat5btm2Jni
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ))
|
decreased T cell number
|
J:77412
|
Stat5atm1Jni/Stat5atm1Jni
Stat5btm2Jni/Stat5btm2Jni
(involves: 129 * C57BL/6)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:122463
|
Stat5atm1Mam/Stat5atm1Mam
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased NK cell number
|
J:112035
|
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5b+
(involves: 129S6/SvEvTac)
|
abnormal lymphopoiesis
|
J:258967
|
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Lck-cre)I57Jxm/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)
|
abnormal T cell subpopulation ratio
|
J:122463
|
| decreased CD8-positive, alpha-beta T cell number
|
J:122463
|
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:155489
|
| decreased monocyte cell number
|
J:155489
|
Stat5btm1Hwd/Stat5btm1Hwd
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112035
|
| abnormal lymphocyte cell number
|
J:112035
|
| abnormal lymphocyte morphology
|
J:112035
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112035
|
| decreased NK cell number
|
J:112035
|
| decreased thymocyte number
|
J:112035
|
Stat5btm1Mam/Stat5btm1Mam
Tg(Lck-cre)I57Jxm/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)
|
abnormal T cell subpopulation ratio
|
J:122463
|
| decreased CD8-positive, alpha-beta T cell number
|
J:122463
|
Stat5btm1Mam/Stat5btm1Mam
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:155489
|
| decreased monocyte cell number
|
J:155489
|
Stat6tm1Aki/Stat6tm1Aki
(involves: 129P2/OlaHsd)
|
decreased T-helper 2 cell number
|
J:172134
|
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru/J)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
Stat6tm1Gru/Stat6tm1Gru
(129S2/SvPas-Stat6tm1Gru)
|
abnormal T-helper 2 cell differentiation
|
J:31932
|
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv)
|
abnormal class switch recombination
|
J:32607
|
| abnormal T-helper 1 cell differentiation
|
J:32607
|
| abnormal T-helper 2 cell differentiation
|
J:32607
|
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:51096
|
Stau2em1(IMPC)Mbp/Stau2em1(IMPC)Mbp
(C57BL/6N-Stau2em1(IMPC)Mbp/MbpMmucd)
|
increased monocyte cell number
|
J:211773
|
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd)
|
increased macrophage cell number
|
J:187736
|
Stim1em1(IMPC)Mbp/Stim1+
(C57BL/6N-Stim1em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
Stim1tm1.1Pg/Stim1+
(involves: C57BL/6)
|
decreased Ly6C low monocyte number
|
J:285187
|
| decreased NK cell number
|
J:285187
|
| increased Ly6C high monocyte number
|
J:285187
|
Stim1tm1Kuro/Stim1tm1Kuro
Stim2tm1.1Kuro/Stim2tm1.1Kuro
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:172608
|
| increased CD8-positive, alpha-beta T cell number
|
J:172608
|
| increased regulatory T cell number
|
J:172608
|
Stim1tm1Rao/Stim1tm1Rao
Stim2tm1Rao/Stim2tm1Rao
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal B cell differentiation
|
J:133262
|
| abnormal T cell differentiation
|
J:133262
|
| decreased regulatory T cell number
|
J:133262
|
| increased germinal center B cell number
|
J:133262
|
| increased lymphocyte cell number
|
J:133262
|
Stim1tm1Rao/Stim1tm1Rao
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
increased lymphocyte cell number
|
J:133262
|
Sting1em1Jmin/Sting1+
(involves: C57BL/6N)
|
decreased single-positive T cell number
|
J:251372
|
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(B6.129P2-Stk4Gt(AJ0315)Wtsi)
|
abnormal memory T cell number
|
J:142674
|
| abnormal T cell differentiation
|
J:142674
|
| decreased CD4-positive, alpha-beta T cell number
|
J:142674
|
| decreased CD8-positive, alpha-beta T cell number
|
J:142674
|
Stk4m1Btlr/Stk4m1Btlr
(C57BL/6J-Stk4m1Btlr)
|
decreased B cell number
|
J:265233
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265233
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265233
|
| decreased single-positive T cell number
|
J:265233
|
| decreased T cell number
|
J:265233
|
| increased macrophage cell number
|
J:265233
|
| increased NK cell number
|
J:265233
|
Stk4m2Btlr/Stk4m2Btlr
(C57BL/6J-Stk4m2Btlr)
|
decreased B-1 B cell number
|
J:265237
|
| decreased B-2 B cell number
|
J:265237
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265237
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265237
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265237
|
| decreased single-positive T cell number
|
J:265237
|
| decreased T cell number
|
J:265237
|
| increased B-1b cell number
|
J:265237
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265237
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265237
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265237
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265237
|
| increased macrophage cell number
|
J:265237
|
| increased NK cell number
|
J:265237
|
Stk4m3Btlr/Stk4m3Btlr
(C57BL/6J-Stk4m3Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265245
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265245
|
| decreased single-positive T cell number
|
J:265245
|
| decreased T cell number
|
J:265245
|
Stk4m4Btlr/Stk4m4Btlr
(C57BL/6J-Stk4m4Btlr)
|
increased B-1b cell number
|
J:272536
|
Stk4m5Btlr/Stk4m5Btlr
(C57BL/6J-Stk4m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272743
|
| abnormal T cell differentiation
|
J:272743
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272743
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272743
|
Stk4tm1.1Kina/Stk4tm1.1Kina
(involves: C57BL/6)
|
abnormal marginal zone B cell morphology
|
J:148791
|
| decreased B cell number
|
J:148791
|
| decreased lymphocyte cell number
|
J:148791
|
| decreased marginal zone B cell number
|
J:148791
|
| decreased myeloid dendritic cell number
|
J:148791
|
| decreased T cell number
|
J:148791
|
| increased single-positive T cell number
|
J:148791
|
Stk4tm1.1Wtao/Stk4tm1.2Wtao
Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL/J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:152323
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152323
|
| decreased T cell number
|
J:152323
|
| increased single-positive T cell number
|
J:152323
|
| increased thymocyte number
|
J:152323
|
Stk4tm1.2Wtao/Stk4tm1.2Wtao
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
decreased B cell number
|
J:152323
|
| decreased CD4-positive, alpha-beta T cell number
|
J:152323
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152323
|
| decreased lymphocyte cell number
|
J:152323
|
| increased single-positive T cell number
|
J:152323
|
| increased thymocyte number
|
J:152323
|
Stk4tm1Dlim/Stk4tm1Dlim
(Not Specified)
|
decreased T cell number
|
J:155001
|
Stk17btm1Hed/Stk17btm1Hed
(B6.129X1-Stk17btm1Hed)
|
decreased double-positive T cell number
|
J:94685
|
| increased CD4-positive, alpha-beta T cell number
|
J:94685
|
| increased memory T cell number
|
J:94685
|
Stk26tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased NK T cell number
|
J:211773
|
Stk26tm1b(EUCOMM)Hmgu/Stk26tm1b(EUCOMM)Hmgu
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased monocyte cell number
|
J:211773
|
Stra6ltm1b(KOMP)Wtsi/Stra6ltm1b(KOMP)Wtsi
(C57BL/6N-Stra6ltm1b(KOMP)Wtsi/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
Stx7em1(IMPC)Rbrc/Stx7em1(IMPC)Rbrc
(C57BL/6NJcl-Stx7em1(IMPC)Rbrc/Rbrc)
|
decreased large unstained cell number
|
J:211773
|
Stx11em1(IMPC)Mbp/Stx11em1(IMPC)Mbp
(C57BL/6N-Stx11em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
SucoGt(KST050)Byg/SucoGt(KST050)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased osteoclast cell number
|
J:159823
|
Sugcttm1.2Kald/Sugcttm1.2Kald
(B6.Cg-Sugcttm1.2Kald)
|
increased macrophage cell number
|
J:293423
|
Sumf1Gt(RST760)Byg/Sumf1Gt(RST760)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage morphology
|
J:120146
|
| abnormal microglial cell morphology
|
J:120146
|
| increased macrophage cell number
|
J:120146
|
Sun1tm1b(EUCOMM)Wtsi/Sun1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sun1tm1b(EUCOMM)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Sun2tm1b(EUCOMM)Hmgu/Sun2tm1b(EUCOMM)Hmgu
(C57BL/6N-Sun2tm1b(EUCOMM)Hmgu/Bay)
|
increased large unstained cell number
|
J:211773
|
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:144991
|
| decreased CD4-positive, alpha-beta T cell number
|
J:144991
|
| decreased CD8-positive, alpha-beta T cell number
|
J:144991
|
| decreased double-negative T cell number
|
J:144991
|
| decreased double-positive T cell number
|
J:144991
|
| increased macrophage derived foam cell number
|
J:144991
|
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:144991
|
| decreased CD4-positive, alpha-beta T cell number
|
J:144991
|
| decreased CD8-positive, alpha-beta T cell number
|
J:144991
|
| decreased double-negative T cell number
|
J:144991
|
| decreased double-positive T cell number
|
J:144991
|
| increased macrophage derived foam cell number
|
J:144991
|
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased macrophage derived foam cell number
|
J:144991
|
| increased plasma cell number
|
J:144991
|
Susd4tm1Lex/Susd4tm1Lex
(B6.129S5-Susd4tm1Lex)
|
abnormal microglial cell morphology
|
J:306852
|
Susd6tm1b(KOMP)Wtsi/Susd6tm1b(KOMP)Wtsi
(C57BL/6N-Susd6tm1b(KOMP)Wtsi/Bay)
|
decreased monocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Suz12Plt8/Suz12+
(involves: 129 * C57BL/6)
|
increased lymphocyte cell number
|
J:136262
|
Swap70tm1Jess/Swap70tm1Jess
(involves: 129T2/SvEms * 129X1/SvJ)
|
abnormal class switch recombination
|
J:71160
|
Sykm1Btlr/Sykm1Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:199281
|
SykM2Btlr/Syk+
(C57BL/6J-SykM2Btlr)
|
abnormal NK cell differentiation
|
J:231803
|
SykM2Btlr/SykM2Btlr
(C57BL/6J-SykM2Btlr)
|
abnormal NK cell differentiation
|
J:231803
|
Syktm1.1Tara/Syktm1.1Tara
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:115080
|
Syktm1.2Tara/Syktm1.2Tara
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:208904
|
Syktm1Kuro/Syktm1Kuro
Zap70tm1Dlo/Zap70tm1Dlo
Cd79atm1(cre)Reth/?
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:134528
|
Syktm1Paw/Syktm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:29797
|
| absent pre-B cells
|
J:29797
|
| decreased late pro-B cell number
|
J:29797
|
Syktm1Tyb/Syktm1Tyb
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal T cell number
|
J:29796
|
| arrested B cell differentiation
|
J:29796
|
Syktm1Tyb/Syktm1Tyb
(involves: 129S2/SvPas * C57BL/6)
|
abnormal osteoclast differentiation
|
J:89583
|
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr)
|
arrested B cell differentiation
|
J:188422
|
| decreased B cell number
|
J:188422
|
| decreased DN1 thymic pro-T cell number
|
J:188422
|
| decreased marginal zone B cell number
|
J:188422
|
| decreased mature B cell number
|
J:188422
|
| decreased transitional stage B cell number
|
J:188422
|
| decreased transitional stage T1 B cell number
|
J:188422
|
| decreased transitional stage T2 B cell number
|
J:188422
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:188422
|
| increased CD4-positive, alpha-beta T cell number
|
J:188422
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:188422
|
| increased CD8-positive, alpha-beta T cell number
|
J:188422
|
| increased DN3 thymocyte number
|
J:188422
|
Syngr3em1Pave/Syngr3+
Tg(Prnp-MAPT*P301S)PS19Vle/0
(involves: C3H * C57BL/6)
|
microgliosis
|
J:303506
|
Synj1tm1b(EUCOMM)Wtsi/Synj1+
(C57BL/6N-Synj1tm1b(EUCOMM)Wtsi/H)
|
decreased monocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Synpo2tm1b(EUCOMM)Wtsi/Synpo2+
(C57BL/6N-Synpo2tm1b(EUCOMM)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Sytl1tm1a(KOMP)Wtsi/Sytl1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:213427
|
| decreased mature B cell number
|
J:213427
|
| decreased T cell number
|
J:213427
|
| increased regulatory T cell number
|
J:213427
|
Tab2tm2.1Aki/Tab2tm2.1Aki
Tab3tm1Aki/Tab3tm1Aki
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1a cell number
|
J:195289
|
| decreased mature B cell number
|
J:195289
|
| decreased plasma cell number
|
J:195289
|
Tac4tm1Albe/Tac4tm1Albe
(B6.129P2-Tac4tm1Albe)
|
increased pro-B cell number
|
J:166471
|
Tacc3tm1Jni/Tacc3tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:74762
|
Taf7tm1.1Dss/Taf7tm1.2Dss
Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:185745
|
| decreased CD4-positive, alpha-beta T cell number
|
J:185745
|
| decreased CD8-positive, alpha-beta T cell number
|
J:185745
|
| decreased double-positive T cell number
|
J:185745
|
| decreased single-positive T cell number
|
J:185745
|
| decreased T cell number
|
J:185745
|
| decreased thymocyte number
|
J:185745
|
Taf7tm1.1Dss/Taf7tm1.2Dss
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:185745
|
| decreased CD4-positive, alpha-beta T cell number
|
J:185745
|
| decreased CD8-positive, alpha-beta T cell number
|
J:185745
|
| decreased double-positive T cell number
|
J:185745
|
| decreased thymocyte number
|
J:185745
|
| increased double-negative T cell number
|
J:185745
|
Taf15em1(IMPC)Mbp/Taf15em1(IMPC)Mbp
(C57BL/6NCrl-Taf15em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
Tagln2em1(IMPC)Tcp/Tagln2em1(IMPC)Tcp
(C57BL/6N-Tagln2em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Tanktm1Aki/Tanktm1Aki
(involves: 129/Sv * C57BL/6)
|
increased mature B cell number
|
J:151757
|
| increased plasma cell number
|
J:151757
|
Tap1m1Btlr/Tap1m1Btlr
(C57BL/6J-Tap1m1Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254888
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254888
|
Tap1m2Btlr/Tap1m2Btlr
(C57BL/6J-Tap1m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:236697
|
Tap1rose/Tap1rose
(C57BL/6JAnu-Tap1rose/AnuApb)
|
decreased CD8-positive, alpha-beta T cell number
|
J:166104
|
Tap1tm1Arp/Tap1tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:3524
|
| decreased double-negative T cell number
|
J:3524
|
Tap1tm1Arp/Tap1tm1Arp
(involves: 129S2/SvPas)
|
decreased CD8-positive, alpha-beta T cell number
|
J:64177,
J:64349
|
Tap1tm1Arp/Tap1tm1Arp
(B6.129S2-Tap1tm1Arp/J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:123934
|
| increased T-helper 1 cell number
|
J:123934
|
Tap2jas/Tap2jas
(C57BL/6JSfdAnu-Tap2jas/AnuApb)
|
absent CD8-positive, alpha-beta T cells
|
J:104190
|
| decreased CD8-positive, alpha-beta T cell number
|
J:166104
|
Tap2m1Btlr/Tap2m1Btlr
(C57BL/6J-Tap2m1Btlr)
|
absent CD8-positive, alpha-beta T cells
|
J:159355
|
Tap2m2Btlr/Tap2m2Btlr
(C57BL/6J-Tap2m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:217145
|
| increased CD4-positive, alpha-beta T cell number
|
J:217145
|
Tap2m3Btlr/Tap2m3Btlr
(C57BL/6J-Tap2m3Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:254929
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254929
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:254929
|
| decreased NK T cell number
|
J:254929
|
| increased CD4-positive, alpha-beta T cell number
|
J:254929
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254929
|
Tap2M4Btlr/Tap2M4Btlr
(C57BL/6J-Tap2M4Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:272847
|
Tapbptm1Gjh/Tapbptm1Gjh
(involves: 129S2/SvPas)
|
decreased T cell number
|
J:64349
|
Tapbptm1Luc/Tapbptm1Luc
(involves: 129S6/SvEvTac)
|
decreased CD8-positive, alpha-beta T cell number
|
J:64177
|
Tapbptm1Luc/Tapbptm1Luc
Tg(TcraTcrb)1100Mjb/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:64177
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:64177
|
| abnormal negative T cell selection
|
J:64177
|
| abnormal positive T cell selection
|
J:64177
|
Tardbptm1.1Neas/Tardbptm1.1Neas
(B6(C3)-Tardbptm1.1Neas)
|
microgliosis
|
J:283769
|
Tardbptm2.1Neas/Tardbptm2.1Neas
(B6(C3)-Tardbptm2.1Neas)
|
microgliosis
|
J:283769
|
Tarm1tm1Yiw/Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc)
|
decreased B cell number
|
J:301164
|
| decreased CD4-positive, alpha-beta T cell number
|
J:301164
|
Tasp1tm1Jjdh/Tasp1tm1Jjdh
Tg(Mx1-cre)1Cgn/?
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:112159
|
| decreased thymocyte number
|
J:112159
|
Tbatatm1Faf/Tbatatm1Faf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:166065
|
| increased thymocyte number
|
J:166065
|
Tbk1tm1.1Lex/Tbk1tm1.1Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd)
|
decreased NK T cell number
|
J:166476
|
| increased monocyte cell number
|
J:166476
|
| increased NK T cell number
|
J:166476
|
Tbk1tm1Arte/Tbk1tm1Arte
Cd19tm1(cre)Cgn/Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:188560
|
| increased mature B cell number
|
J:188560
|
Tbk1tm1Arte/Tbk1tm1Arte
Map3k14tm1Rds/Map3k14tm1Rds
Cd19tm1(cre)Cgn/Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:188560
|
Tbkbp1tm1b(EUCOMM)Wtsi/Tbkbp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Tbkbp1tm1b(EUCOMM)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
Tbrg1tm1a(KOMP)Wtsi/Tbrg1tm1a(KOMP)Wtsi
(C57BL/6N-Tbrg1tm1a(KOMP)Wtsi)
|
increased marginal zone B cell number
|
J:225146
|
Tbx21duane/Tbx21duane
(C57BL/6-Tbx21duane)
|
abnormal NK cell differentiation
|
J:154069
|
| absent NK T cells
|
J:154069
|
| decreased NK cell number
|
J:154069
|
| increased NK cell number
|
J:154069
|
Tbx21m1Btlr/Tbx21m1Btlr
(C57BL/6J-Tbx21m1Btlr)
|
increased CD8-positive, alpha-beta T cell number
|
J:267478
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:267478
|
Tbx21tm1Glm/Tbx21+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T helper 1 cell number
|
J:73833
|
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:73833
|
| abnormal T-helper 1 cell differentiation
|
J:73833
|
| decreased T helper 1 cell number
|
J:73833
|
| increased T-helper 2 cell number
|
J:73833
|
Tbx21tm1Glm/Tbx21tm1Glm
(B6.129S6-Tbx21tm1Glm)
|
abnormal CD4-positive T cell differentiation
|
J:143729
|
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:163822
|
| decreased memory T cell number
|
J:163822
|
Tbx21tm1Srnr/Tbx21+
(involves: C57BL/6)
|
absent NK T cells
|
J:112679
|
| decreased NK cell number
|
J:112679
|
Tbx21tm1Srnr/Tbx21tm1Srnr
(involves: C57BL/6)
|
abnormal T-helper 1 cell morphology
|
J:112679
|
| decreased NK T cell number
|
J:112679
|
Tbx21tm2Srnr/Tbx21+
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:174315
|
Tbx21tm2Srnr/Tbx21tm2Srnr
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:174315
|
Tcaimtm1b(EUCOMM)Wtsi/Tcaimtm1b(EUCOMM)Wtsi
(C57BL/6N-Tcaimtm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
Tcdel1C57BL/6/Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
Tcdel1NOD/ShiLtDoi/Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
Tcdel2C57BL/6/Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
Tcdel2NOD/ShiLtDoi/Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
Tcf3tm1(PBX1)Mlc/Tcf3+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:226241
|
| abnormal pro-B cell morphology
|
J:226241
|
| arrested B cell differentiation
|
J:226241
|
| decreased B cell number
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
Tcf3tm1(PBX1)Mlc/Tcf3+
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
arrested B cell differentiation
|
J:226241
|
| decreased B cell number
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
Tcf3tm1(PBX1)Mlc/Tcf3+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J)
|
arrested B cell differentiation
|
J:226241
|
| decreased B cell number
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
Tcf3tm1(TCF3/HLF)Homy/Tcf3+
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:160392
|
| increased B cell number
|
J:160392
|
Tcf3tm1.1Mbu/Tcf3+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:137719
|
Tcf3tm1Cmu/Tcf3+
(either: 129P2/OlaHsd-Tcf3tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))
|
decreased B cell number
|
J:67011
|
Tcf3tm1Cmu/Tcf3tm1Cmu
(either: 129P2/OlaHsd-Tcf3tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:67011
|
| abnormal immunoglobulin V(D)J recombination
|
J:67011
|
| abnormal T cell subpopulation ratio
|
J:67011
|
| decreased B cell number
|
J:67011
|
| decreased lymphocyte cell number
|
J:67011
|
Tcf3tm1Mbu/Tcf3tm1.2Mbu
Tg(Aicda-cre)9Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)
|
abnormal germinal center B cell morphology
|
J:137719
|
| decreased B cell number
|
J:137719
|
| decreased germinal center B cell number
|
J:137719
|
Tcf3tm1Mbu/Tcf3tm1.2Mbu
Tg(Fcer2a-cre)5Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)
|
abnormal germinal center B cell morphology
|
J:137719
|
| decreased B cell number
|
J:137719
|
| decreased germinal center B cell number
|
J:137719
|
| increased marginal zone B cell number
|
J:137719
|
Tcf3tm1Mbu/Tcf3tm1Mbu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)
|
decreased pro-B cell number
|
J:137719
|
Tcf3tm1Wein/Tcf3+
(either: (involves: 129/Sv * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J))
|
decreased B cell number
|
J:22134
|
Tcf3tm1Wein/Tcf3+
(involves: 129S4/SvJaeSor)
|
abnormal B cell number
|
J:91042
|
| decreased pre-B cell number
|
J:91042
|
Tcf3tm1Wein/Tcf3tm1Wein
(either: (involves: 129 * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J))
|
abnormal B cell number
|
J:22134
|
| abnormal lymphocyte cell number
|
J:22134
|
Tcf3tm1Wein/Tcf3tm3Zhu
(involves: 129/Sv * 129S4/SvJaeSor * C57BL/6)
|
decreased pro-B cell number
|
J:47671
|
Tcf3tm1Xhsu/Tcf3tm1Xhsu
(B6.129X1-Tcf3tm1Xhsu)
|
increased B cell number
|
J:132669
|
Tcf3tm1Zhu/Tcf3tm1Zhu
(involves: 129)
|
decreased B cell number
|
J:47671
|
Tcf3tm1Zhu/Tcf3tm1Zhu
(involves: 129 * C57BL/6J)
|
decreased double-positive T cell number
|
J:136143
|
| increased double-negative T cell number
|
J:136143
|
| increased single-positive T cell number
|
J:136143
|
Tcf3tm1Zhu/Tcf3tm2Zhu
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:47671
|
Tcf3tm2Cmu/Tcf3tm2Cmu
(involves: 129P2/OlaHsd)
|
abnormal lymphopoiesis
|
J:118827
|
| absent pre-B cells
|
J:118827
|
| absent pro-B cells
|
J:118827
|
| decreased NK cell number
|
J:118827
|
Tcf3tm2Zhu/Tcf3tm2Zhu
(involves: 129 * C57BL/6)
|
decreased pre-B cell number
|
J:47671
|
| decreased pro-B cell number
|
J:47671
|
Tcf3tm3.1Cmu/Tcf3tm3.1Cmu
(involves: 129S/SvEv * FVB/N)
|
abnormal B cell differentiation
|
J:153423
|
| abnormal immunoglobulin light chain V-J recombination
|
J:153423
|
| decreased pre-B cell number
|
J:153423
|
Tcf3tm3Zhu/Tcf3tm3Zhu
(involves: 129/Sv * C57BL/6)
|
decreased B cell number
|
J:47671
|
Tcf3tm4.1Cmu/Tcf3tm4.1Cmu
(involves: 129S/SvEv * FVB/N)
|
abnormal immunoglobulin light chain V-J recombination
|
J:153423
|
| absent B cells
|
J:153423
|
| arrested B cell differentiation
|
J:153423
|
| decreased pro-B cell number
|
J:153423
|
Tcf3tm6(Esr1*)Zhu/Tcf3tm6(Esr1*)Zhu
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:154788
|
| arrested B cell differentiation
|
J:154788
|
Tcf4tm1.1Hmb/Tcf4+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased double-negative T cell number
|
J:136143
|
Tcf4tm1.1Hmb/Tcf4tm1.1Hmb
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal T cell differentiation
|
J:136143
|
| increased double-negative T cell number
|
J:136143
|
Tcf4tm1Hmb/Tcf4tm1Zhu
Tg(Kit-cre)143Hmb/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:65236
|
| decreased double-positive T cell number
|
J:65236
|
| decreased thymocyte number
|
J:65236
|
Tcf4tm1Zhu/Tcf4+
Tcf3tm1Wein/Tcf3+
(involves: 129P2/OlaHsd)
|
decreased pro-B cell number
|
J:43324
|
Tcf4tm1Zhu/Tcf4tm1Zhu
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pro-B cell number
|
J:43324
|
Tcf7tm1a(EUCOMM)Wtsi/Tcf7tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7tm1a(EUCOMM)Wtsi/Ics)
|
decreased CD4-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
| increased B cell number
|
J:165965
|
Tcf7tm1Cle/Tcf7tm1Cle
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:23255
|
| decreased CD8-positive, alpha-beta T cell number
|
J:189838
|
| decreased double-positive T cell number
|
J:23255
|
| decreased single-positive T cell number
|
J:23255
|
| decreased T cell number
|
J:23255
|
| increased osteoclast cell number
|
J:98430
|
Tcf7tm2Cle/Tcf7tm2Cle
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:23255
|
| decreased single-positive T cell number
|
J:23255
|
Tcf12m1Btlr/Tcf12m1Btlr
(C57BL/6J-Tcf12M1Btlr)
|
increased CD8-positive, alpha-beta T cell number
|
J:267564
|
Tcf12M2Btlr/Tcf12M2Btlr
(C57BL/6J-Tcf12M2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:267666
|
| increased CD8-positive, alpha-beta T cell number
|
J:267666
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267666
|
Tcf12M3Btlr/Tcf12M3Btlr
(C57BL/6J-Tcf12M3Btlr)
|
decreased B cell number
|
J:271971
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271971
|
| increased CD8-positive, alpha-beta T cell number
|
J:271971
|
Tcf12m4Btlr/Tcf12m4Btlr
(C57BL/6J-Tcf12m4Btlr)
|
abnormal B cell morphology
|
J:271972
|
| abnormal T cell morphology
|
J:271972
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271972
|
| increased CD8-positive, alpha-beta T cell number
|
J:271972
|
Tcf12tm1Zhu/Tcf12+
Tcf3tm1Wein/Tcf3+
(involves: 129S4/SvJaeSor)
|
decreased pro-B cell number
|
J:43324
|
Tcf12tm1Zhu/Tcf12+
Tcf3tm4Zhu/Tcf3tm4Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:75746
|
| increased double-negative T cell number
|
J:75746
|
| increased single-positive T cell number
|
J:75746
|
Tcf12tm1Zhu/Tcf12+
Tcf4tm1Zhu/Tcf4+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
decreased pro-B cell number
|
J:43324
|
Tcf12tm1Zhu/Tcf12tm1Zhu
(involves: 129/Sv * C57BL/6)
|
decreased pro-B cell number
|
J:43324
|
Tcf12tm1Zhu/Tcf12tm1Zhu
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:120411
|
| decreased thymocyte number
|
J:120411
|
Tcf12tm1Zhu/Tcf12tm1Zhu
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased double-positive T cell number
|
J:136143
|
| increased CD8-positive, alpha-beta T cell number
|
J:136143
|
| increased double-negative T cell number
|
J:136143
|
Tcf12tm1Zhu/Tcf12tm2Zhu
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:120411
|
Tcf12tm2Zhu/Tcf12tm2Zhu
(Not Specified)
|
abnormal B cell differentiation
|
J:120411
|
| abnormal T cell differentiation
|
J:120411
|
| absent T cells
|
J:120411
|
| arrested T cell differentiation
|
J:120411
|
| decreased double-positive T cell number
|
J:120411
|
| decreased immature B cell number
|
J:120411
|
| decreased pre-B cell number
|
J:120411
|
| decreased pro-B cell number
|
J:120411
|
| decreased thymocyte number
|
J:120411
|
| increased double-negative T cell number
|
J:120411
|
Tcf12tm2Zhu/Tcf12tm2Zhu
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:120411
|
| abnormal T cell subpopulation ratio
|
J:120411
|
| arrested T cell differentiation
|
J:120411
|
| increased T cell number
|
J:120411
|
Tcf12tm3Zhu/Tcf12tm3Zhu
Tcf3tm4Zhu/Tcf3tm4Zhu
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:129171
|
| abnormal T cell differentiation
|
J:129171
|
| decreased CD4-positive, alpha-beta T cell number
|
J:129171
|
| increased CD8-positive, alpha-beta T cell number
|
J:129171
|
Tcf12tm3Zhu/Tcf12tm3Zhu
Tcf3tm4Zhu/Tcf3tm4Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased double-positive T cell number
|
J:129570
|
| decreased T cell number
|
J:129570
|
| increased double-negative T cell number
|
J:129570
|
Tcf12tm3Zhu/Tcf12tm3Zhu
Tg(Lck-cre)#Zhu/0
(involves: C57BL/6 * SJL/J)
|
decreased thymocyte number
|
J:129570
|
| increased CD8-positive, alpha-beta T cell number
|
J:129570
|
Tcimtm1Icle/Tcimtm1Icle
(B6.129-Tcimtm1Icle)
|
abnormal mononuclear cell morphology
|
J:217318
|
| increased lymphocyte cell number
|
J:217318
|
| increased monocyte cell number
|
J:217318
|
Tcirg1M1Jeau/Tcirg1+
(either: (involves: C3H/HeJ * C57BL/6) or (involves: C3H/HeJ * C57BL/6 * FVB/N))
|
abnormal osteoclast morphology
|
J:196503
|
| increased osteoclast cell number
|
J:196503
|
Tcirg1oc/Tcirg1oc
(B6C3Fe a/a-Tcirg1oc/J)
|
abnormal osteoclast morphology
|
J:7870
|
Tcirg1tm1Utku/Tcirg1tm1Utku
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:92730
|
| decreased lymphocyte cell number
|
J:92730
|
| decreased T cell number
|
J:92730
|
Tcpm1BALB/c/Tcpm1BALB/c
(involves: BALB/c * C57BL/10)
|
abnormal effector T cell morphology
|
J:36255
|
Tcpm1BALB/c/Tcpm1C57BL/10Sn
(involves: BALB/c * C57BL/10)
|
abnormal effector T cell morphology
|
J:36255
|
Tcra-Jtm1Jpdv/Tcra-Jtm1Jpdv
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:77518
|
Tcra-Jtm1Kgwa/Tcra-Jtm1Kgwa
Tg(Tcrb2B4)1Mmd/0
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:50143
|
| increased double-positive T cell number
|
J:50143
|
Tcra-Jtm1Slek/Tcra-Jtm1Slek
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:101398
|
| decreased double-positive T cell number
|
J:101398
|
| decreased single-positive T cell number
|
J:101398
|
| increased double-negative T cell number
|
J:101398
|
| increased thymocyte number
|
J:101398
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi)
|
decreased activated T cell number
|
J:99107
|
| decreased B cell number
|
J:99107
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased NK T cell number
|
J:89695
|
Tcra-Jtm2.3Krg/Tcra-Jtm2.3Krg
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
Tcra-Jtm3.1Krg/Tcra-Jtm3.1Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:128344
|
Tcra-Jtm4.1Krg/Tcra-Jtm4.1Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
Tcra-Jtm5Krg/Tcra-Jtm5Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
TcraLn1Ogu/Tcra+
(involves: 129/Sv * C57BL/6)
|
abnormal NK T cell morphology
|
J:152041
|
| abnormal T cell subpopulation ratio
|
J:152041
|
| decreased thymocyte number
|
J:152041
|
| increased NK T cell number
|
J:152041
|
TcraLn1Ogu/Tcra+
TcrbLn1Ogu/Tcrb+
(involves: 129/Sv * C57BL/6)
|
abnormal T cell morphology
|
J:152069
|
TcraLn2Ogu/Tcra+
TcrbLn2Ogu/Tcrb+
(involves: 129/Sv * C57BL/6)
|
abnormal T cell morphology
|
J:152069
|
TcraLn3Jae/Tcra+
(B6.Cg-TcraLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143006
|
| decreased double-positive T cell number
|
J:143006
|
| increased CD8-positive, alpha-beta T cell number
|
J:143006
|
TcraLn3Jae/Tcra+
TcrbLn3Jae/Tcrb+
(B6.Cg-TcrbLn3Jae TcraLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
| abnormal T cell differentiation
|
J:143006
|
| absent gamma-delta T cells
|
J:143006
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143006
|
| decreased double-positive T cell number
|
J:143006
|
| increased CD8-positive, alpha-beta T cell number
|
J:143006
|
Tcratm1Cgn/Tcratm1Cgn
Tg(Mx1-cre)1Cgn/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:79298
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:79298
|
| abnormal memory T cell morphology
|
J:79298
|
| abnormal T cell morphology
|
J:79298
|
Tcratm1Cgn/Tcratm1Mass
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased T cell number
|
J:201417
|
Tcratm1Mass/Tcra+
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal NK T cell morphology
|
J:201417
|
| decreased NK cell number
|
J:201417
|
| increased NK T cell number
|
J:201417
|
Tcratm1Mass/Tcra+
Tg(Nes-cre)Wme/0
(involves: C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:201417
|
| decreased NK T cell number
|
J:201417
|
| decreased thymocyte number
|
J:201417
|
| increased double-negative T cell number
|
J:201417
|
Tcratm1Mass/Tcratm1Mass
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:201417
|
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal T cell morphology
|
J:1292
|
| increased activated T cell number
|
J:111129
|
| increased B cell number
|
J:111129
|
Tcratm1Mjo/Tcratm1Mjo
(NOD.129P2-Tcratm1Mjo)
|
increased activated T cell number
|
J:52940
|
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd)
|
increased activated T cell number
|
J:110898
|
| increased gamma-delta T cell number
|
J:110898
|
| increased T cell number
|
J:110898
|
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
H2b/H2b
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:131357
|
| abnormal double-positive T cell morphology
|
J:81564
|
| abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
| decreased double-positive T cell number
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
H2d/H2d
Ptcratm1Vbo/Ptcratm1Vbo
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
Tcratm1Mom/Tcratm1Mom
(involves: 129S2/SvPas)
|
absent T cells
|
J:88620
|
Tcratm1Mom/Tcratm1Mom
(B6.129S2-Tcratm1Mom)
|
increased mature gamma-delta T cell number
|
J:135597
|
Tcratm1Mom/Tcratm1Mom
(involves: 129S2/SvPas * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
| decreased CD4-positive, alpha-beta T cell number
|
J:3206
|
| decreased CD8-positive, alpha-beta T cell number
|
J:3206
|
| increased gamma-delta intraepithelial T cell number
|
J:15221
|
Tcratm1Mom/Tcratm1Mom
Tcra-Jtm1Kgwa/Tcra-Jtm1Kgwa
(involves: 129P2/OlaHsd * 129S2/SvPas * C3H/HeJ * C57BL/6J)
|
increased double-negative T cell number
|
J:50143
|
Tcratm1Mom/Tcratm1Mom
Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
| decreased double-positive T cell number
|
J:3206
|
Tcratm1Mom/Tcratm1Mom
Tcrgtm1.1Hish/Tcrgtm1.1Hish
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
absent gamma-delta T cells
|
J:135597
|
Tcratm1Mom/Tcratm1Mom
Tg(CD19-Tnfsf7)#Rvl/0
(involves: 129P2/OlaHsd * C57BL/6)
|
absent T cells
|
J:88620
|
Tcratm1Mom/Tcratm1Mom
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S2/SvPas * C3H/He * C57BL/6)
|
arrested T cell differentiation
|
J:135903
|
Tcratm1Mom/Tcratm1Mom
Tg(TcraAV19AJ33)1Shima/?
(involves: 129S2/SvPas * C57BL/6)
|
abnormal NK T cell morphology
|
J:140924
|
TcrbLn3Jae/Tcrb+
(B6.Cg-TcrbLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
| absent gamma-delta T cells
|
J:143006
|
Tcrbtm1(Tcrb)Chb/Tcrbtm1(Tcrb)Chb
(Not Specified)
|
abnormal double-negative T cell morphology
|
J:147947
|
| abnormal T cell morphology
|
J:147947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147947
|
| increased single-positive T cell number
|
J:147947
|
Tcrbtm1(Tcrb)Chb/Tcrbtm1Slek
(Not Specified)
|
abnormal double-negative T cell morphology
|
J:147947
|
| abnormal T cell morphology
|
J:147947
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:147947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147947
|
| increased single-positive T cell number
|
J:147947
|
Tcrbtm1(Tcrb)Fwa/Tcrbtm1(Tcrb)Fwa
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:131995
|
Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129P2/OlaHsd * BALB/c)
|
arrested T cell differentiation
|
J:3206
|
| decreased CD4-positive, alpha-beta T cell number
|
J:3206
|
| decreased CD8-positive, alpha-beta T cell number
|
J:3206
|
| decreased double-positive T cell number
|
J:3206
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J)
|
abnormal transitional stage B cell morphology
|
J:187766
|
| decreased plasma cell number
|
J:187766
|
| decreased T cell number
|
J:187766
|
| increased B cell number
|
J:187766
|
| increased follicular B cell number
|
J:187766
|
| increased immature B cell number
|
J:187766
|
| increased marginal zone B cell number
|
J:187766
|
| increased mature B cell number
|
J:187766
|
| increased transitional stage T2 B cell number
|
J:187766
|
| increased transitional stage T3 B cell number
|
J:187766
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:3206
|
| absent CD8-positive, alpha-beta T cells
|
J:3206
|
| arrested T cell differentiation
|
J:3206
|
| decreased double-positive T cell number
|
J:3206
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129P2/OlaHsd)
|
decreased lymphocyte cell number
|
J:97824
|
| increased T cell number
|
J:97824
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(B6.129P2-Tcrbtm1Mom Igh-Jtm2(3H9-VDJ*)Mwg Tcrdtm1Mom)
|
increased marginal zone B cell number
|
J:142389
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(B6.129-Tcrbtm1Mom Traf3ip2tm1.1Lix Tcrdtm1Mom)
|
abnormal transitional stage B cell morphology
|
J:187766
|
| decreased T cell number
|
J:187766
|
| increased immature B cell number
|
J:187766
|
| increased marginal zone B cell number
|
J:187766
|
Tcrbtm1Mom/Tcrbtm1Mom
Tg(H2-K-Cd86)7All/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:112475
|
| abnormal B cell morphology
|
J:112475
|
| decreased B cell number
|
J:112475
|
Tcrbtm1Slek/Tcrbtm5Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrbtm1Slek/Tcrbtm6Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrbtm2(Tcrb)Fwa/Tcrbtm3Slek
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:132446
|
Tcrbtm2Slek/Tcrbtm2Slek
(Not Specified)
|
arrested T cell differentiation
|
J:119552
|
| decreased T cell number
|
J:119552
|
Tcrbtm2Slek/Tcrbtm2Slek
Trbv13-2tm1(CD2)Zhu/Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:121608
|
Tcrbtm3Slek/Tcrbtm3Slek
(Not Specified)
|
arrested T cell differentiation
|
J:119552
|
| decreased T cell number
|
J:119552
|
Tcrbtm5Slek/Tcrbtm5Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrbtm6Slek/Tcrbtm6Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrbtm7Slek/Tcrbtm7Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrd-V1tm1Kjk/Tcrd-V1tm1Kjk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:64863
|
| abnormal mature gamma-delta T cell morphology
|
J:64863
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:64863
|
| decreased gamma-delta intraepithelial T cell number
|
J:64863
|
Tcrd-V1tm1Kjk/Tcrd-V1tm1Kjk
(B6.129P2-Tcrd-V1tm1Kjk)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:128525
|
| decreased gamma-delta intraepithelial T cell number
|
J:128525
|
Tcrdtm1Mom/Tcrdtm1Mom
(either: (involves: 129P2/OlaHsd * BALB/cJ) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal gamma-delta T cell differentiation
|
J:3865
|
| absent gamma-delta T cells
|
J:3865
|
Tcrdtm1Mom/Tcrdtm1Mom
Tcrgtm2.1Dhr/Tcrgtm2.1Dhr
(involves: 129 * C57BL/6)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Tcrgtm1.1Dhr/Tcrgtm1.1Dhr
(involves: 129)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:133974
|
Tcrgtm1.1Hish/Tcrgtm1.1Hish
(involves: 129P2/OlaHsd * C57BL/6)
|
absent gamma-delta T cells
|
J:135597
|
Tcrgtm1Dhr/Tcrgtm1Dhr
(involves: 129)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:133974
|
Tcrgtm1Scar/Tcrgtm1Scar
(B6.Cg-Tcrgtm1Scar)
|
increased macrophage cell number
|
J:105477
|
| increased T cell number
|
J:105477
|
Tcrgtm2.1Dhr/Tcrgtm2.1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Tdp2tm1.1Huy/Tdp2tm1.1Huy
(involves: 129P2/OlaHsd * CD-1)
|
abnormal immature B cell morphology
|
J:195301
|
| abnormal lymphopoiesis
|
J:195301
|
| decreased double-positive T cell number
|
J:195301
|
Tdrd3Gt(RRK474)Byg/Tdrd3Gt(RRK474)Byg
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:210647
|
Tent5aem1(IMPC)Ccpcz/Tent5aem1(IMPC)Ccpcz
(C57BL/6N-Tent5aem1(IMPC)Ccpcz/Ccpcz)
|
decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Tespa1tm1Smoc/Tespa1tm1Smoc
(B6.129-Tespa1tmSmoc)
|
abnormal T cell differentiation
|
J:186446
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
| decreased regulatory T cell number
|
J:186446
|
| decreased T cell number
|
J:186446
|
| increased memory T cell number
|
J:186446
|
Tespa1tm1Smoc/Tespa1tm1Smoc
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * DBA/2J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
Tespa1tm1Smoc/Tespa1tm1Smoc
Tg(TcraTcrb)425Cbn/0
(B6.Cg-Tespa1tm1Smoc Tg(TcraTcrb)425Cbn)
|
abnormal T cell differentiation
|
J:186446
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
Tespa1tm1Smoc/Tespa1tm1Smoc
Tg(TcraTcrb)1100Mjb/0
(B6.Cg-Tespa1tm1Smoc Tg(TcraTcrb)1100Mjb)
|
abnormal T cell differentiation
|
J:186446
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
Tet1tm1.2Jae/Tet1tm1.2Jae
Tet2tm1.1Iaai/Tet2+
Tet3tm1.1Yzhg/Tet3tm1.1Yzhg
Tg(Rorc-cre)1Litt/0
(involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB)
|
decreased effector memory T-helper cell number
|
J:333574
|
Tet2Gt(AN0709)Wtsi/Tet2+
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
abnormal monocyte differentiation
|
J:174052
|
| increased B cell number
|
J:174052
|
| increased monocyte cell number
|
J:174052
|
Tet2Gt(AN0709)Wtsi/Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
abnormal monocyte differentiation
|
J:174052
|
| decreased pre-B cell number
|
J:174052
|
| decreased pro-B cell number
|
J:174052
|
| increased B cell number
|
J:174052
|
| increased DN1 thymic pro-T cell number
|
J:174052
|
| increased double-negative T cell number
|
J:174052
|
| increased monocyte cell number
|
J:174052
|
Tet2tm1.1Iaai/Tet2+
Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
increased monocyte cell number
|
J:174053
|
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
decreased B cell number
|
J:234976
|
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
increased monocyte cell number
|
J:174053
|
Tet2tm1.1Mjxu/Tet2+
(involves: 129 * C57BL/6)
|
increased monocyte cell number
|
J:178415
|
Tet2tm1.1Mjxu/Tet2tm1.1Mjxu
(involves: 129 * C57BL/6)
|
increased monocyte cell number
|
J:178415
|
Tet2tm1Ics/Tet2tm1Ics
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased pre-B cell number
|
J:174052
|
| decreased pro-B cell number
|
J:174052
|
| increased B cell number
|
J:174052
|
| increased DN1 thymic pro-T cell number
|
J:174052
|
| increased double-negative T cell number
|
J:174052
|
| increased monocyte cell number
|
J:174052
|
Tfap4tm1.1Litt/Tfap4tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:176461
|
Tfrcem1(IMPC)H/Tfrc+
(C57BL/6N-Tfrcem1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
Tg(Acp5-Adam8)#Rood/0
(involves: BALB/c * C57BL/6)
|
abnormal osteoclast differentiation
|
J:172936
|
| abnormal osteoclast morphology
|
J:172936
|
| increased osteoclast cell number
|
J:172936
|
Tg(Acp5-Selenow)#Djeo/0
(involves: FVB/N)
|
abnormal osteoclast differentiation
|
J:317012
|
| increased osteoclast cell number
|
J:317012
|
Tg(ACTB-Mgat3)2Nta/0
(involves: C57BL/6 * DBA/2)
|
decreased lymphocyte cell number
|
J:80227
|
Tg(ACTB-TNFRSF6B)754Jwu/?
(B6.Cg-Tg(Actb-TNFRSF6B)754Jwu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:148162
|
| increased B-1a cell number
|
J:148162
|
Tg(Alb1-GP33/H2-Kb)1Hpi/0
Tg(TcrLCMV)318Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:162605
|
Tg(Alb1-Myc)#Sst/0
Tg(MtTGFA)Lmb/0
(involves: C57BL/6 * CBA * CD-1)
|
decreased NK cell number
|
J:176432
|
| increased NK T cell number
|
J:176432
|
Tg(APCS-Tnfsf11*)#aKhs/0
(C57BL/6J-Tg(APCS-Tnfsf11*)#aKhs)
|
abnormal osteoclast morphology
|
J:264357
|
| increased osteoclast cell number
|
J:264357
|
Tg(APOE-FGF23*R176Q)#Ack/0
(involves: C57BL/6J * CBA)
|
decreased osteoclast cell number
|
J:93981
|
Tg(APP695)3Dbo/0
Tg(PSEN1dE9)S9Dbo/0
(Not Specified)
|
abnormal microglial cell morphology
|
J:139070
|
Tg(APPSWE)2576Kha/0
(involves: C57BL/6 * SJL)
|
microgliosis
|
J:159623
|
Tg(APPswe,PSEN1dE9)85Dbo/0
(D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo)
|
microgliosis
|
J:227541
|
Tg(B19-RNAi:Il3)241Ckn/?
(involves: BALB/cJ * C57BL/6J * FVB/N)
|
abnormal B cell differentiation
|
J:107618
|
| increased pre-B cell number
|
J:107618
|
Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:93111
|
| increased B cell number
|
J:93111
|
Tg(BCL2)22Wehi/0
(involves: C57BL/6J * C57BL/6JWehi)
|
increased B cell number
|
J:88565
|
Tg(BCL2)22Wehi/0
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * C57BL/6JWehi * SJL/J * SJL/JWehi)
|
abnormal B cell morphology
|
J:69571
|
| abnormal pre-B cell morphology
|
J:69571
|
| increased B cell number
|
J:69571
|
| increased pre-B cell number
|
J:69571
|
Tg(BCL2)25Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:131912
|
| abnormal plasma cell differentiation
|
J:131912
|
| increased T cell number
|
J:93111
|
Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
increased B cell number
|
J:93111
|
| increased T cell number
|
J:93111
|
Tg(BCL2/IGH)1Tjd/?
(involves: C3H/He * C57BL/6)
|
increased B cell number
|
J:81147
|
Tg(BCL2/IGH)#Jcre/0
Tg(H2-K/Igh-Traf2*)#Ywc/0
(involves: BALB/c * C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J)
|
increased B cell number
|
J:94116
|
| increased B-1a cell number
|
J:94116
|
| increased B-1b cell number
|
J:94116
|
| increased marginal zone B cell number
|
J:94116
|
Tg(BCL2/IGH)M23Tjd/?
(involves: C3H/He * C57BL/6)
|
increased B cell number
|
J:81147
|
Tg(C9orf72)500Lpwr/0
(FVB/NJ-Tg(C9orf72)500Lpwr)
|
microgliosis
|
J:239579
|
Tg(CAG-cre/Esr1*)5Amc/0
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
microgliosis
|
J:221181
|
Tg(CAG-DPP4)52Ctkt/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal mononuclear cell morphology
|
J:227925
|
Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu/0
(involves: C57BL/6 * C57BL/6J * FVB/NJ * SJL)
|
microgliosis
|
J:207750
|
Tg(CAG-Has2)99Nita/0
Tg(MMTV-cre)4Mam/0
Tg(MMTVneu)202Mul/0
(FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTV-cre)4Mam Tg(MMTVneu)202Mul)
|
increased macrophage cell number
|
J:164205
|
Tg(CAG-SPTLC1*C133W)8EAmcc/0
(involves: C3H * C57BL/6)
|
microgliosis
|
J:155748
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-APPSwInd)Dbo/0
(involves: C3H/HeJ * C57BL/6J)
|
microgliosis
|
J:236737
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-LRRK2)C77Cai/0
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: C57BL/6)
|
microgliosis
|
J:156512
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-LRRK2)C7874Cai/0
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: C57BL/6)
|
microgliosis
|
J:156512
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-LRRK2*G2019S)E3Cai/0
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: C57BL/6)
|
microgliosis
|
J:156512
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Mtor*)#Atai/0
(involves: C57BL/6 * DBA/2 * ICR)
|
microgliosis
|
J:211789
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: C57BL/6)
|
microgliosis
|
J:156512
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-TARDBP)12Vle/0
(involves: C3H/HeJ * C57BL/6J)
|
microgliosis
|
J:170756
|
Tg(CD2-Ccdc86)1Hfuj/?
(B6.FVB-Tg(CD2-Ccdc86)1Hfuj)
|
abnormal T cell morphology
|
J:151722
|
Tg(CD2-Ceacam1*4L)1Rsb/0
(involves: C57BL/6)
|
decreased T cell number
|
J:116136
|
Tg(CD2-Foxj1)#Stlp/0
(C57BL/6-Tg(CD2-Foxj1)#Stlp)
|
decreased CD4-positive, alpha-beta T cell number
|
J:122222
|
| decreased CD8-positive, alpha-beta T cell number
|
J:122222
|
| increased single-positive T cell number
|
J:122222
|
Tg(CD2-Ifngr2)1Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)1Pbro)
|
abnormal T-helper 1 cell differentiation
|
J:134448
|
Tg(CD2-Ifngr2)2Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)2Pbro)
|
abnormal T-helper 1 cell differentiation
|
J:134448
|
Tg(CD2-Mir181d)38Oers/0
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:212571
|
| decreased double-positive T cell number
|
J:212571
|
| decreased T cell number
|
J:212571
|
Tg(CD2-Mir181d)38Oers/0
Tg(TcraTcrb)425Cbn/0
(involves: C3H * C57BL/6)
|
decreased T cell number
|
J:212571
|
Tg(CD2-Myb/en)2Kmw/?
(involves: C57BL/10 * CBA)
|
abnormal single-positive T cell number
|
J:126456
|
| decreased T cell number
|
J:126456
|
| increased double-negative T cell number
|
J:126456
|
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA)
|
decreased double-positive T cell number
|
J:126456
|
| decreased T cell number
|
J:126456
|
| increased double-negative T cell number
|
J:126456
|
Tg(CD2-Nfat5)1Snh/0
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:80066
|
| decreased CD4-positive, alpha-beta T cell number
|
J:80066
|
| decreased CD8-positive, alpha-beta T cell number
|
J:80066
|
| decreased T cell number
|
J:80066
|
Tg(CD2-Ppp2ca)#Gct/0
(involves: C57BL/6J)
|
abnormal T cell subpopulation ratio
|
J:184067
|
| increased germinal center B cell number
|
J:184067
|
Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:236222
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:230700
|
| decreased CD8-positive, alpha-beta T cell number
|
J:236222
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:230700
|
Tg(CD2-S1PR1)1Ejg/?
(involves: C57BL/6 * DBA/2)
|
decreased activated T cell number
|
J:96558
|
| increased activated T cell number
|
J:96558
|
| increased T cell number
|
J:96558
|
Tg(Cd2-Smad7)#Chbe/0
(involves: C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:184670
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
(involves: C57BL/10)
|
abnormal positive T cell selection
|
J:113713
|
| increased CD8-positive, alpha-beta T cell number
|
J:113713
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
(involves: C57BL/10 * CBA/Ca)
|
decreased CD8-positive, alpha-beta T cell number
|
J:113713
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
(involves: BALB/c * C57BL/10)
|
decreased CD8-positive, alpha-beta T cell number
|
J:113713
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
| decreased CD4-positive, alpha-beta T cell number
|
J:126026
|
| increased CD8-positive, alpha-beta T cell number
|
J:126026
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell clonal deletion
|
J:217939
|
| increased T cell number
|
J:217939
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:93665
|
Tg(CD2-Zbtb7b)C8Rbo/?
(involves: C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:97610
|
| increased CD4-positive, alpha-beta T cell number
|
J:97610
|
Tg(CD2-Zbtb7b)C8Rbo/?
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
Tg(CD2-Zbtb7b)C8Rbo/?
Tg(TcrLCMV)327Sdz/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
Tg(CD2-Zbtb7b)C8Rbo/?
Themistm1Lov/Themistm1Lov
(involves: 129)
|
abnormal T cell differentiation
|
J:151075
|
Tg(Cd3d-Il5)NJ.1638Nal/?
(involves: C57BL/6J * CBA/J)
|
abnormal T cell number
|
J:123440
|
| increased mature B cell number
|
J:123440
|
| increased monocyte cell number
|
J:123440
|
Tg(CD3E)26Cpt/Tg(CD3E)26Cpt
(involves: C57BL/6J * CBA/J)
|
absent NK cells
|
J:81711
|
| arrested T cell differentiation
|
J:81711
|
| decreased double-positive T cell number
|
J:54756
|
| decreased T cell number
|
J:54756
|
| decreased thymocyte number
|
J:81711
|
| decreased uterine NK cell number
|
J:134589
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:217939
|
| abnormal T cell clonal deletion
|
J:217939
|
| abnormal T cell subpopulation ratio
|
J:217939
|
| decreased double-positive T cell number
|
J:217939
|
| increased activated T cell number
|
J:217939
|
| increased B cell number
|
J:217939
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:217939
|
| increased regulatory T cell number
|
J:217939
|
| increased single-positive T cell number
|
J:217939
|
| increased T cell number
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * CBA/J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(CD4-CIITA)357Ccum/?
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased osteoclast cell number
|
J:233241
|
Tg(Cd4-cre)1Cwi/0
Trmt6em1Hbgl/Trmt6em1Hbgl
(involves: C57BL/6 * DBA/2J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:336736
|
Tg(Cd4-cre)1Cwi/0
Trmt61aem1Hbgl/Trmt61aem1Hbgl
(involves: C57BL/6 * DBA/2J)
|
abnormal CD4-positive T cell differentiation
|
J:336736
|
| decreased CD4-positive, alpha-beta T cell number
|
J:336736
|
| decreased CD8-positive, alpha-beta T cell number
|
J:336736
|
| increased CD4-positive, alpha-beta T cell number
|
J:336736
|
| increased CD8-positive, alpha-beta T cell number
|
J:336736
|
Tg(Cd4-Il17rb)#Cdon/?
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:158594
|
Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: C57BL/6 * Swiss Webster)
|
abnormal T cell differentiation
|
J:235890
|
| abnormal T cell morphology
|
J:235890
|
| increased DN3 thymocyte number
|
J:235890
|
Tg(Cd4-NPM/ALK)N1Ingh/0
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster)
|
abnormal double-negative T cell morphology
|
J:235890
|
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased B cell number
|
J:97554
|
| increased memory T cell number
|
J:97554
|
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6)
|
abnormal CD8-positive, alpha-beta regulatory T cell morphology
|
J:134473
|
Tg(Cd4-Zbtb16)1797Aben/?
(C57BL/6-Tg(Cd4-Zbtb16)1797Aben)
|
decreased CD4-positive, alpha-beta T cell number
|
J:139690
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:139690
|
| increased T-helper 2 cell number
|
J:139690
|
Tg(Cd8aCd8b)3Erob/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93004
|
| abnormal double-positive T cell morphology
|
J:93004
|
| decreased CD4-positive, alpha-beta T cell number
|
J:93004
|
| decreased double-negative T cell number
|
J:93004
|
| increased CD8-positive, alpha-beta T cell number
|
J:93004
|
Tg(Cd8aCd8b)3Erob/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93004
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93004
|
| increased CD8-positive, alpha-beta T cell number
|
J:93004
|
Tg(CD8aCD8b)57Scr/?
(B6;SJL-Tg(CD8aCD8b)57Scr/J)
|
abnormal effector T cell morphology
|
J:92994
|
Tg(Cd8b1)46Erob/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal T cell subpopulation ratio
|
J:110916
|
| decreased T cell number
|
J:110916
|
| decreased thymocyte number
|
J:110916
|
Tg(CD19)1Tft/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
decreased B cell number
|
J:27236
|
Tg(CD19)1Tft/Tg(CD19)1Tft
(involves: C57BL/6 * C57BL/6J * SJL)
|
decreased B cell number
|
J:27236
|
| decreased immature B cell number
|
J:27236
|
Tg(CD19-Tnfsf7)#Rvl/0
(involves: C57BL/6)
|
abnormal metallophilic macrophage morphology
|
J:88620
|
| abnormal spleen marginal zone macrophage morphology
|
J:88620
|
| decreased B cell number
|
J:88620
|
| decreased mature B cell number
|
J:88620
|
| decreased transitional stage B cell number
|
J:88620
|
Tg(Cd74-Nlrc4*)1Kyas/0
(involves: C57BL/6N)
|
increased T cell number
|
J:219652
|
Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6)
|
increased lymphocyte cell number
|
J:79703
|
Tg(CD207-Dta)312Dhka/?
(FVB-Tg(CD207-Dta)312Dhka)
|
absent Langerhans cell
|
J:113309
|
Tg(CLEC4C-HBEGF)956Cln/0
(C57BL/6-Tg(CLEC4C-HBEGF)956Cln)
|
decreased CD8-positive, alpha-beta T cell number
|
J:166504
|
Tg(Cnp-Gpr17)1Qrlu/0
(Not Specified)
|
microgliosis
|
J:154602
|
Tg(Col1a1-cre)1Kry/0
Vdrtm2Ska/Vdrtm2Ska
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj * FVB/N)
|
abnormal osteoclast differentiation
|
J:196471
|
| decreased osteoclast cell number
|
J:196471
|
Tg(Col1a1-Dkk1)1Hmk/?
(B6.FVB-Tg(Col1a1-Dkk1)1Hmk)
|
increased osteoclast cell number
|
J:158620
|
Tg(Col1a1-FGF2*,-Sapphire)203Mmh/Tg(Col1a1-FGF2*,-Sapphire)203Mmh
(involves: FVB/N)
|
increased osteoclast cell number
|
J:159949
|
Tg(Col1a1-Runx2)#Pmt/0
(involves: BALB/c * C57BL/6)
|
increased osteoclast cell number
|
J:167992
|
Tg(Col1a1-TK*)#Rowe/0
(involves: CD-1)
|
decreased osteoclast cell number
|
J:112520,
J:217781
|
Tg(Col1a1-tTA)139Niss/0
Tg(tetO-HTR4*D100A)7Niss/0
(FVB/N-Tg(Col1a1-tTA)139Niss Tg(tetO-HTR4*D100A)7Niss)
|
increased osteoclast cell number
|
J:131617
|
Tg(Col2a1-Fgfr3/GH)BDor/0
(FVB/N-Tg(Col2a1-Fgfr3/GH)BDor)
|
abnormal osteoclast differentiation
|
J:50292
|
Tg(Col10a1-Tg*L2263P)1Rpbh/0
(Not Specified)
|
decreased osteoclast cell number
|
J:154052
|
Tg(Col10a1-Tg*L2263P)1Rpbh/Tg(Col10a1-Tg*L2263P)1Rpbh
(Not Specified)
|
decreased osteoclast cell number
|
J:154052
|
Tg(Cr2-cre)3Cgn/?
Xrcc4tm1Fwa/Xrcc4tm2Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150339
|
Tg(DMD-APP*)7Neve/0
(involves: C57BL/6 * SJL)
|
abnormal microglial cell morphology
|
J:100978
|
Tg(DMD-APP*)18Neve/0
(involves: C57BL/6 * SJL)
|
abnormal microglial cell morphology
|
J:100978
|
Tg(DO11.10)10Dlo/?
(involves: BALB/c * C3H * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:70572
|
| decreased double-positive T cell number
|
J:70572
|
Tg(DO11.10)10Dlo/?
Toxtm1.1Kay/Toxtm1.1Kay
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
arrested T cell differentiation
|
J:131287
|
| decreased T cell number
|
J:131287
|
Tg(EEF1A1-SHC1*)1Ravi/?
Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:78180
|
| decreased double-positive T cell number
|
J:78180
|
| decreased single-positive T cell number
|
J:78180
|
Tg(EIF1AX-Il31ra)1Jagr/0
(involves: C3H * C57BL/6)
|
decreased T cell number
|
J:91124
|
| increased activated T cell number
|
J:91124
|
| increased B cell number
|
J:91124
|
| increased memory T cell number
|
J:91124
|
Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6 * FVB)
|
increased regulatory T cell number
|
J:231759
|
Tg(Ela-KRAS*G12D)9Eps/0
Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: C57BL/6 * FVB)
|
increased regulatory T cell number
|
J:231759
|
Tg(Ela-KRAS*G12D)9Eps/0
Tgfbr1tm1Bopa/Tgfbr1+
(involves: 129S1/SvImJ * C57BL/6 * FVB)
|
increased CD8-positive, alpha-beta T cell number
|
J:231759
|
Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr)
|
increased B cell number
|
J:117018
|
| increased B-1 B cell number
|
J:117018
|
| increased B-2 B cell number
|
J:117018
|
| increased germinal center B cell number
|
J:117018
|
| increased marginal zone B cell number
|
J:117018
|
| increased plasma cell number
|
J:117018
|
Tg(Emu-Zfp521)1Homy/0
(Not Specified)
|
abnormal B cell differentiation
|
J:160392
|
| increased B cell number
|
J:160392
|
Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA)
|
increased B cell number
|
J:237420
|
Tg(Eno2-Hgf)1Tnak/0
Tg(SOD1*G93A)dl1Gur/0
(involves: C57BL/6 * C57BL/6J * SJL/J)
|
microgliosis
|
J:128738
|
Tg(Fabp2-Arg1)1Wla/Tg(Fabp2-Arg1)1Wla
(involves: FVB)
|
abnormal B cell differentiation
|
J:80204
|
| decreased B cell number
|
J:80204
|
| decreased pre-B cell number
|
J:80204
|
| decreased transitional stage B cell number
|
J:80204
|
Tg(Fabp4-Phb*Y114F)#Smis/0
(Not Specified)
|
increased lymphocyte cell number
|
J:227976
|
Tg(Fli1)1Ber/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased thymocyte number
|
J:33052
|
Tg(FOXJ1-ACE2)1Rba/0
(involves: C3H * C57BL/6)
|
decreased lymphocyte cell number
|
J:288386
|
Tg(Foxp3-HBEGF/EGFP)23.2Spar/0
(involves: C57BL/6NCrl)
|
decreased regulatory T cell number
|
J:125295
|
Tg(Gfap-gp120)2Lms/0
(involves: C57BL/6 * SJL)
|
abnormal microglial cell morphology
|
J:146427
|
| microgliosis
|
J:146427
|
Tg(Gfap-gp120)10Lms/0
(involves: C57BL/6 * SJL)
|
microgliosis
|
J:146427
|
Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/0
(involves: C57BL/6)
|
abnormal microglial cell morphology
|
J:132679
|
Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem/0
(either: FVB-Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem or (involves: C57BL/6 * FVB))
|
decreased thymocyte number
|
J:67796
|
Tg(H2-D-Il15)3304Clgr/?
(FVB/N-Tg(H2-D-Il15)3304Clgr)
|
abnormal T cell morphology
|
J:67478
|
| abnormal T cell subpopulation ratio
|
J:67478
|
| increased lymphocyte cell number
|
J:67478
|
| increased memory T cell number
|
J:67478
|
| increased NK cell number
|
J:67478
|
Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:117352
|
Tg(H2-Ea-HA)HACIIAjca/0
Tg(Tcra/Tcrb)1Vbo/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:209872
|
Tg(H2-Ea-HA)HACIIAjca/0
Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:209872
|
Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:81133
|
| abnormal double-negative T cell morphology
|
J:81133
|
Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6 * DBA/2)
|
increased pre-B cell number
|
J:171924
|
| increased pro-B cell number
|
J:171924
|
Tg(H2-Ea-Ins2)1Wehi/Tg(H2-Ea-Ins2)1Wehi
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:117352
|
Tg(H2-Ea-LACK)1Ngkh/0
(C.Cg-Tg(H2-Ea-LACK)1Ngkh)
|
decreased T-helper 2 cell number
|
J:181384
|
| increased T-helper 1 cell number
|
J:181384
|
Tg(H2-Ea-Tnfsf9)16Lpc/0
(involves: C57BL/6)
|
decreased B cell number
|
J:132372
|
| increased lymphocyte cell number
|
J:132372
|
| increased macrophage cell number
|
J:132372
|
| increased memory T cell number
|
J:145439
|
| increased NK cell number
|
J:132372
|
Tg(H2-K-Cd86)7All/0
(involves: C57BL/6J * CBA)
|
abnormal B cell differentiation
|
J:112475
|
| decreased B cell number
|
J:112475
|
| increased CD4-positive, alpha-beta T cell number
|
J:112475
|
| increased CD8-positive, alpha-beta T cell number
|
J:112475
|
Tg(H2-K-Cd86)7All/0
(B6.Cg-Tg(H2-K-Cd86)7All)
|
decreased B cell number
|
J:112266
|
| decreased CD4-positive, alpha-beta T cell number
|
J:112266
|
| increased CD8-positive, alpha-beta T cell number
|
J:112266
|
| increased T cell number
|
J:112266
|
Tg(H2-K-Cd86)27All/0
(involves: C57BL/6J * CBA)
|
abnormal B cell differentiation
|
J:112475
|
| decreased B cell number
|
J:112475
|
Tg(H2-K-Cd86)31All/0
(involves: C57BL/6J * CBA)
|
increased CD4-positive, alpha-beta T cell number
|
J:112475
|
| increased CD8-positive, alpha-beta T cell number
|
J:112475
|
Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA)
|
abnormal T cell number
|
J:138077
|
| decreased single-positive T cell number
|
J:138077
|
| increased CD4-positive, alpha-beta T cell number
|
J:138077
|
| increased CD8-positive, alpha-beta T cell number
|
J:138077
|
| increased double-positive T cell number
|
J:138077
|
| increased plasma cell number
|
J:138077
|
| increased single-positive T cell number
|
J:138077
|
Tg(H2-K-IL6)2Srj/0
(B6.Cg-Tg(H2-K-IL6)2Srj)
|
increased plasma cell number
|
J:185153
|
Tg(H2-K-MC159/EGFP)13Fkmc/0
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:138050
|
| increased follicular B cell number
|
J:138050
|
Tg(H2-K-MC159/EGFP)13Fkmc/Tg(H2-K-MC159/EGFP)13Fkmc
(involves: C57BL/6)
|
increased double-negative T cell number
|
J:138050
|
| increased T cell number
|
J:138050
|
Tg(H2-K-TcrbP14)128Mak/?
(involves: C57BL/6 * C57L * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111265
|
| abnormal T cell clonal deletion
|
J:111265
|
| abnormal T cell differentiation
|
J:111265
|
| increased CD8-positive, alpha-beta T cell number
|
J:111265
|
Tg(H2-Kb-IL21)5Wjl/0
(involves: 129)
|
abnormal B cell differentiation
|
J:93740
|
| abnormal class switch recombination
|
J:93740
|
| decreased follicular B cell number
|
J:93740
|
| decreased marginal zone B cell number
|
J:93740
|
| decreased mature B cell number
|
J:93740
|
| decreased transitional stage T2 B cell number
|
J:93740
|
| increased immature B cell number
|
J:93740
|
| increased transitional stage T1 B cell number
|
J:93740
|
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.FVB-Tg(H2-Kb-Tcra,-Tcrb)1640Kurs)
|
increased T-helper 1 cell number
|
J:149511
|
| increased T-helper 17 cell number
|
J:149511
|
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish)
|
increased monocyte cell number
|
J:128016
|
| increased plasma cell number
|
J:128016,
J:138762
|
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish
(C57BL/6-Tg(H2-L-IL6)46Kish)
|
increased plasma cell number
|
J:40405
|
Tg(H2KePCC)2403Stoe/?
Tg(TcraTcrbAD10)1Hed/?
(involves: C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92997
|
Tg(H2KmPCC)2939Stoe/0
Tg(Tcra2B4)1Mmd/0
Tg(Tcrb2B4)1Mmd/0
(involves: C3H/HeJ * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:50143
|
| decreased thymocyte number
|
J:50143
|
Tg(H2KmPCC)2939Stoe/?
Tg(TcrAND)53Hed/?
(involves: C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92997
|
Tg(H2KmPCC)2939Stoe/?
Tg(TcraTcrbAD10)1Hed/?
(involves: C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92997
|
Tg(HBVX*,-Myc)#Skp/Tg(HBVX*,-Myc)#Skp
(Not Specified)
|
increased macrophage cell number
|
J:81098
|
Tg(Igh3H9)41Mwg/?
(involves: C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:119625
|
Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified)
|
increased B cell number
|
J:178816
|
Tg(Igh-3/Igh-6VD93)1241Ust/?
(C57BL/6-Tg(Igh-3/Igh-6VD93)1241Ust)
|
abnormal B cell morphology
|
J:135209
|
| decreased pre-B cell number
|
J:135209
|
Tg(Igh-3VD93)343Ust/?
(involves: C57BL/6 * SJL)
|
abnormal B cell morphology
|
J:135209
|
| decreased pre-B cell number
|
J:135209
|
Tg(Igh-6-Cd80)1Gjf/0
(involves: FVB)
|
decreased B cell number
|
J:44271
|
Tg(Igh-6-Cd80)1Gjf/0
(B6.Cg-Tg(Igh-6-Cd80)1Gjf)
|
abnormal T cell number
|
J:112266
|
Tg(Igh-6-Cd80)1Gjf/0
(NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ)
|
decreased B cell number
|
J:131077
|
| decreased B-2 B cell number
|
J:131077
|
| decreased follicular B cell number
|
J:131077
|
| decreased immature B cell number
|
J:131077
|
| decreased mature B cell number
|
J:131077
|
Tg(Igh-6-Cd86)1Akab/0
(involves: FVB)
|
decreased B cell number
|
J:44271
|
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
|
abnormal B cell number
|
J:91865
|
Tg(Igh-HMGA2)#Cro/0
(FVB/N-Tg(Igh-HMGA2)#Cro)
|
decreased B cell number
|
J:233225
|
| decreased T cell number
|
J:233225
|
| increased T cell number
|
J:233225
|
Tg(Igh-HOX11)11Idd/0
(CD-1)
|
abnormal immunoglobulin V(D)J recombination
|
J:52782
|
Tg(Igh-Lmp2a)ERlon/0
(involves: C57BL/6 * SJL)
|
decreased B cell number
|
J:129571
|
Tg(Igh-Maf)68Staka/0
(C57BL/6-Tg(Igh-Maf)68Staka)
|
increased plasma cell number
|
J:168074
|
Tg(Igh-Maf)524Staka/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
increased plasma cell number
|
J:168074
|
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
(FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)
|
abnormal lymphopoiesis
|
J:162077
|
| increased B-1a cell number
|
J:162077
|
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6 * FVB/N)
|
increased B-1a cell number
|
J:162077
|
Tg(Igh-Mir155)8Cro/0
(involves: FVB/N)
|
abnormal lymphopoiesis
|
J:109591
|
| increased B cell number
|
J:109591
|
| increased pre-B cell number
|
J:109591
|
Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
(B6.Cg-Tg(Igh-Mir210)#aKgcs)
|
abnormal class switch recombination
|
J:205868
|
| decreased marginal zone B cell number
|
J:205868
|
| decreased mature B cell number
|
J:205868
|
| decreased pre-B cell number
|
J:205868
|
| decreased pro-B cell number
|
J:205868
|
| increased B-1a cell number
|
J:205868
|
Tg(Igh-ROR1)1Kip/0
(C57BL/6-Tg(Igh-ROR1)1Kip)
|
increased lymphocyte cell number
|
J:206368
|
| increased mature B cell number
|
J:206368
|
Tg(Igh-ROR1)1Kip/0
Tg(Igh-V186.2-TCL1A)3Cro/0
(B6.Cg-Tg(Igh-ROR1)1Kip Tg(Igh-V186.2-TCL1A)3Cro)
|
increased lymphocyte cell number
|
J:206368
|
| increased mature B cell number
|
J:206368
|
Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6)
|
abnormal B cell morphology
|
J:76574
|
| increased marginal zone B cell number
|
J:76574
|
Tg(IGH@*)SALed/0
(involves: C57BL/6 * CD-1)
|
abnormal mature B cell morphology
|
J:131938
|
Tg(IGH@yH1)2BJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:23827
|
Tg(IGH@yH1)2BJkbv/0
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
Tg(IghelMD4)4Ccg/0
(involves: C3H/HeJ * C57BL/6)
|
decreased pre-B cell number
|
J:115059
|
| decreased pro-B cell number
|
J:115059
|
Tg(IghelMD4)4Ccg/0
(involves: C57BL/6)
|
decreased pre-B cell number
|
J:115059
|
| decreased pro-B cell number
|
J:115059
|
Tg(IghelMD4)4Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg)
|
abnormal B cell morphology
|
J:78308,
J:109923,
J:132538
|
| abnormal B-2 B cell morphology
|
J:132538
|
| abnormal germinal center B cell morphology
|
J:109923
|
| abnormal immature B cell morphology
|
J:109923
|
| abnormal mature B cell morphology
|
J:89156,
J:109923
|
| abnormal plasma cell morphology
|
J:109923
|
| abnormal pro-B cell morphology
|
J:109923
|
| increased immature B cell number
|
J:78308,
J:132538
|
Tg(IghelMD4)4Ccg/0
Tg(KLK4mHEL)6Ccg/0
(NOD.B6-Tg(IghelMD4)4Ccg Tg(KLK4mHEL)6Ccg/Dvs)
|
decreased B cell number
|
J:89156
|
Tg(IghelMD4)4Ccg/0
Tg(KLK4mHEL)6Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg Tg(KLK4mHEL)6Ccg)
|
decreased B cell number
|
J:89156
|
Tg(IghelMD4)4Ccg/?
Tg(KLK4mHEL)6Ccg/?
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:78307
|
| decreased mature B cell number
|
J:78307
|
| increased immature B cell number
|
J:78307
|
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(NOD.B6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg/Dvs)
|
abnormal B cell clonal deletion
|
J:89156
|
| abnormal B cell morphology
|
J:89156
|
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg)
|
abnormal germinal center B cell morphology
|
J:109923
|
| abnormal immature B cell morphology
|
J:109923
|
| abnormal mature B cell morphology
|
J:109923
|
| abnormal plasma cell morphology
|
J:109923
|
| abnormal pro-B cell morphology
|
J:109923
|
| decreased B cell number
|
J:89156
|
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6)
|
decreased B cell number
|
J:76134
|
| decreased marginal zone B cell number
|
J:132538
|
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.B6-Tg(IghelMD4)4Ccg/DvsJ)
|
abnormal mature B cell morphology
|
J:80859,
J:89156
|
| decreased CD8-positive, alpha-beta T cell number
|
J:80859
|
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(involves: C57BL/6)
|
decreased pre-B cell number
|
J:171924
|
| decreased pro-B cell number
|
J:171924
|
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL)
|
increased lymphocyte cell number
|
J:121564
|
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:78177
|
| increased pre-B cell number
|
J:223213
|
Tg(IghMyc)22Bri/0
Tg(Igk-V21-Bax)1967Bvn/0
(involves: C57BL/6 * FVB/N)
|
increased transitional stage B cell number
|
J:89049
|
Tg(Igk-Eik-H2-Ead)1Flv/0
Tg(Tcra1H3.1,Tcrb1H3.1)1Vire/0
(involves: C57BL/6 * SJL)
|
decreased double-positive T cell number
|
J:124574
|
Tg(Igk-Lta/Ltb)4Cys/0
(involves: C57BL/6J * DBA/2J)
|
abnormal B cell morphology
|
J:73100
|
Tg(Igk-Lta/Ltb)10Cys/0
(involves: C57BL/6J * DBA/2J)
|
abnormal B cell morphology
|
J:73100
|
Tg(Igk-V21-Bax)1967Bvn/0
(involves: FVB/N)
|
abnormal plasma cell morphology
|
J:89049
|
| increased transitional stage B cell number
|
J:89049
|
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
| abnormal immunoglobulin light chain V-J recombination
|
J:23827
|
Tg(Igkv3-5*-MYC)24Plbe/0
(C57BL/6J-Tg(Igkv3-5*-MYC)DLoxP4Plbe/PlbeMmmh)
|
abnormal plasma cell differentiation
|
J:131912
|
| increased plasma cell number
|
J:131912
|
Tg(Igl-2MOPC315)1275Ust/?
(C57BL/6-Tg(Igl-2MOPC315)1275Ust)
|
abnormal B cell morphology
|
J:134666
|
| decreased immature B cell number
|
J:134666
|
Tg(ILK3mHEL)3Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
Tg(Ins2-GP)#Psoh/0
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
abnormal B cell selection
|
J:81285
|
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:98589
|
Tg(Ins2-TFRC/OVA)296Wehi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:135154
|
| increased double-positive T cell number
|
J:135154
|
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:93555
|
| increased CD4-positive, alpha-beta T cell number
|
J:93555
|
Tg(ITGAL-Hhex)2Hro/0
(C3HeB/FeJ-Tg(ITGAL-Hhex)2Hro)
|
abnormal double-negative T cell morphology
|
J:80777
|
| decreased double-positive T cell number
|
J:80777
|
| decreased lymphocyte cell number
|
J:80777
|
| decreased T cell number
|
J:80777
|
| increased CD8-positive, alpha-beta T cell number
|
J:80777
|
Tg(ITGAL-Ptprc)FWcr/Tg(ITGAL-Ptprc)FWcr
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
Tg(ITGAM-HBEGF/EGFP)34Lan/0
(involves: FVB/N)
|
abnormal macrophage morphology
|
J:95141
|
| decreased macrophage cell number
|
J:95141
|
Tg(ITGAM-HBEGF/EGFP)34Lan/0
(NOD.FVB-Tg(ITGAM-HBEGF/EGFP)34Lan/Jdk)
|
decreased macrophage cell number
|
J:137009
|
Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh/0
(C57BL/6-Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh)
|
increased monocyte cell number
|
J:194800
|
Tg(Itgax-TGFBR2)1Flv/0
(C.Cg-Tg(Itgax-TGFBR2)1Flv)
|
abnormal NK cell differentiation
|
J:98953
|
| increased NK cell number
|
J:98953
|
Tg(IVL-KLK5)#Hov/0
(involves: C57BL/6 * CBA)
|
increased activated T cell number
|
J:210758
|
Tg(JAK2*V617F)FF1Rsko/0
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:134364
|
| decreased T cell number
|
J:134364
|
Tg(JAK2*V617F)FF1Rsko/0
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:134364
|
| decreased T cell number
|
J:134364
|
Tg(JAK2*V617F)FF1Rsko/0
Tg(Tek-cre)1Arnd/0
(involves: C57BL/6 * CBA * DBA/2)
|
decreased T cell number
|
J:206659
|
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J)
|
increased lymphocyte cell number
|
J:302313
|
| increased macrophage cell number
|
J:294084,
J:302313
|
| increased T cell number
|
J:300960
|
| microgliosis
|
J:294084
|
Tg(KLK4mHEL)6Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
Tg(KRT5-IKBKB)2Armz/0
(involves: C57BL/6 * DBA/2)
|
abnormal melanophage morphology
|
J:160072
|
Tg(KRT5-rtTA)1Glk/0
Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:100506
|
Tg(KRT5-TGFB1)F2020Xjw/0
(involves: C57BL/6 * DBA/2 * ICR)
|
abnormal Langerhans cell morphology
|
J:90118
|
| decreased Langerhans cell number
|
J:90118
|
Tg(KRT14-CASP1)1Miz/0
(involves: C57BL/6)
|
decreased T cell number
|
J:78602
|
Tg(KRT14-FLT4/IGHG1)#Ali/0
(either: (involves: FVB/N) or (involves: BALB/c * DBA))
|
abnormal mononuclear phagocyte morphology
|
J:201429
|
Tg(KRT14-Il18)#Knak/0
(C57BL/6-Tg(KRT14-Il18)#Knak)
|
decreased T cell number
|
J:78602
|
Tg(KRT14-Vegfa)3Dtm/0
(FVB/N-Tg(KRT14-Vegfa)3Dtm)
|
increased macrophage cell number
|
J:111924
|
Tg(KRT14-VP16/NR1I2)13Sdub/?
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:258435
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:258435
|
| increased effector memory T-helper cell number
|
J:258435
|
| increased gamma-delta T cell number
|
J:258435
|
Tg(KRT18-DPP4)3Pbmj/0
(involves: C57BL/6J * SJL/J)
|
abnormal mononuclear cell morphology
|
J:286231
|
| increased lymphocyte cell number
|
J:286231
|
Tg(LANA,vFLIP,vCYC)801Dtmr/?
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:196403
|
| abnormal marginal zone B cell morphology
|
J:196403
|
| increased germinal center B cell number
|
J:196403
|
| increased marginal zone B cell number
|
J:196403
|
| increased mature B cell number
|
J:196403
|
| increased plasma cell number
|
J:196403
|
Tg(Lck-Akt1*)M-1Pnt/0
(involves: C3H/He * C57BL/6)
|
decreased thymocyte number
|
J:73487
|
| increased double-negative T cell number
|
J:135903
|
| increased single-positive T cell number
|
J:135903
|
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: C3H/He * C57BL/6)
|
decreased thymocyte number
|
J:73487
|
Tg(Lck-Akt1*E40K)E-3Pnt/0
(Not Specified)
|
abnormal T cell differentiation
|
J:144975
|
Tg(Lck-Bcl2l1)1Cant/?
(B6.Cg-Tg(Lck-Bcl2l1)1Cant)
|
increased memory T cell number
|
J:77507
|
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:226234
|
Tg(Lck-cre)548Jxm/?
Tgfb1tm2.1Doe/Tgfb1tm2.1Doe
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA)
|
abnormal T cell subpopulation ratio
|
J:150024
|
Tg(Lck-cre)548Jxm/?
Upf2tm1Btp/Upf2tm1Btp
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:134765
|
| decreased CD4-positive, alpha-beta T cell number
|
J:134765
|
| decreased CD8-positive, alpha-beta T cell number
|
J:134765
|
| decreased double-positive T cell number
|
J:134765
|
Tg(Lck-cre)I57Jxm/?
Traf2tm1Rbr/Traf2tm1Rbr
(involves: C57BL/6 * ICR)
|
absent follicular B cells
|
J:132877
|
| absent marginal zone B cells
|
J:132877
|
| decreased mature B cell number
|
J:132877
|
Tg(Lck-cre)I57Jxm/?
Traf3tm1Rbr/Traf3tm1Rbr
(involves: C57BL/6 * ICR * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:132877
|
| decreased CD8-positive, alpha-beta T cell number
|
J:132877
|
Tg(Lck-FADD)1Hed/0
(involves: BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:100451
|
| decreased T cell number
|
J:100451
|
| decreased thymocyte number
|
J:100451
|
Tg(Lck-FADD)1Hed/Tg(Lck-FADD)1Hed
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:100451
|
| decreased T cell number
|
J:100451
|
| decreased thymocyte number
|
J:100451
|
Tg(Lck-Hhex)1Hro/0
(C3HeB/FeJ-Tg(Lck-Hhex)1Hro)
|
abnormal double-negative T cell morphology
|
J:80777
|
| decreased double-positive T cell number
|
J:80777
|
| decreased lymphocyte cell number
|
J:80777
|
| decreased T cell number
|
J:80777
|
| increased CD8-positive, alpha-beta T cell number
|
J:80777
|
Tg(Lck-Il31)1Jagr/0
(involves: C3H * C57BL/6)
|
decreased T cell number
|
J:91124
|
| increased activated T cell number
|
J:91124
|
| increased B cell number
|
J:91124
|
| increased memory T cell number
|
J:91124
|
Tg(LCK-NFKBIA)5Dwb/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93003
|
| decreased CD4-positive, alpha-beta T cell number
|
J:93003
|
| decreased CD8-positive, alpha-beta T cell number
|
J:93003
|
Tg(Lck-Notch3)#Issc/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:63300
|
| increased double-negative T cell number
|
J:63300
|
| increased thymocyte number
|
J:63300
|
Tg(Lck-Socs3)1Kubo/0
(Not Specified)
|
abnormal CD4-positive T cell differentiation
|
J:132905
|
| decreased T cell number
|
J:128797
|
| decreased thymocyte number
|
J:128797
|
Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:117301
|
| decreased thymocyte number
|
J:117301
|
Tg(Lck-Stat5b*)1Mafa/0
(Not Specified)
|
decreased mature B cell number
|
J:132669
|
Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals)
|
decreased CD4-positive, alpha-beta T cell number
|
J:149973
|
| decreased CD8-positive, alpha-beta T cell number
|
J:149973
|
| decreased single-positive T cell number
|
J:149973
|
| decreased thymocyte number
|
J:149973
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:149973
|
| increased double-positive T cell number
|
J:149973
|
Tg(Lck-Stk17b)26.1Wals/?
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell differentiation
|
J:149973
|
| decreased CD8-positive, alpha-beta T cell number
|
J:149973
|
| decreased thymocyte number
|
J:149973
|
| increased CD8-positive, alpha-beta T cell number
|
J:149973
|
Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish)
|
abnormal T cell subpopulation ratio
|
J:194882
|
| increased CD4-positive, alpha-beta T cell number
|
J:194882
|
| increased regulatory T cell number
|
J:194882
|
Tg(Lck-Tnfsf4)1Nish/0
(C.Cg-Tg(Lck-Tnfsf4)1Nish)
|
increased CD4-positive, alpha-beta T cell number
|
J:194882
|
| increased regulatory T cell number
|
J:194882
|
Tg(Lck-TNFSF13)3919Mhah/0
(B6.Cg-Tg(Lck-TNFSF13)3919Mhah)
|
increased B cell number
|
J:94628
|
| increased B-1 B cell number
|
J:94628
|
| increased CD4-positive, alpha-beta T cell number
|
J:94628
|
| increased CD8-positive, alpha-beta T cell number
|
J:94628
|
Tg(Lck-Tnfsf15,-EGFP)#Targ/0
(involves: C57BL/6)
|
increased CD4-positive, alpha-beta memory T cell number
|
J:169462
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:169462
|
Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:92453
|
| abnormal T cell number
|
J:92453
|
| absent CD8-positive, alpha-beta T cells
|
J:92453
|
| decreased CD4-positive, alpha-beta T cell number
|
J:92453
|
| decreased double-positive T cell number
|
J:92453
|
| increased CD4-positive, alpha-beta T cell number
|
J:92453
|
| increased CD8-positive, alpha-beta T cell number
|
J:92453
|
| increased double-negative T cell number
|
J:92453
|
Tg(LckNotch1)9Erob/?
(involves: C57BL/6 * CBA/J)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93005
|
| decreased CD4-positive, alpha-beta T cell number
|
J:93005
|
| increased CD8-positive, alpha-beta T cell number
|
J:93005
|
Tg(LCKprBCL2)36Sjk/?
(involves: C3H * C57BL/6)
|
abnormal T cell number
|
J:28635
|
| abnormal T cell subpopulation ratio
|
J:11548
|
| increased CD8-positive, alpha-beta T cell number
|
J:11548
|
| increased T cell number
|
J:11548
|
Tg(LCKprBCL2)36Sjk/0
(B6.Cg-Tg(LCKprBCL2)36Sjk)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:217939
|
| abnormal T cell subpopulation ratio
|
J:217939
|
| increased regulatory T cell number
|
J:217939
|
Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * CBA/J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(LCKprBCL2)36Sjk/0
Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(LCKprBCL2)36Sjk/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(Ly6a-GCSAM)102AIsg/0
(involves: C57BL/6J * CBA)
|
decreased B-1 B cell number
|
J:221238
|
| increased B-1 B cell number
|
J:221238
|
Tg(Ly6a-SET/NUP214)2969Gcg/0
(involves: FVB/NJ)
|
abnormal B cell differentiation
|
J:142938
|
| decreased lymphocyte cell number
|
J:142938
|
| decreased pre-B cell number
|
J:142938
|
| decreased pro-B cell number
|
J:142938
|
Tg(Ly6e-MALT1)#Isg/0
(involves: C57BL/6 * CBA)
|
increased mature B cell number
|
J:185590
|
| increased pre-B cell number
|
J:185590
|
| increased pro-B cell number
|
J:185590
|
Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL)
|
abnormal immature B cell morphology
|
J:50604
|
| abnormal monocyte differentiation
|
J:50604
|
| increased thymocyte number
|
J:50604
|
Tg(ML5sHEL)5Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
Tg(ML5sHEL)5Ccg/0
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul)
|
increased regulatory T cell number
|
J:147923
|
Tg(Mpz-RAF1/ESR1)A668Ayld/0
(involves: C57BL/6J * CBA/J)
|
increased macrophage cell number
|
J:182703
|
| increased T cell number
|
J:182703
|
Tg(Mt1-IL6)28Gci/0
(involves: C57BL/6 * DBA/2)
|
increased plasma cell number
|
J:177825,
J:18424
|
Tg(Mx1-cre)1Cgn/0
Thoc5tm1Tate/Thoc5tm1Tate
(involves: C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:169944
|
Tg(Mx1-cre)1Cgn/0
Tnfrsf13ctm2.1Mass/Tnfrsf13ctm2.1Mass
(involves: C57BL/6 * CBA)
|
increased immature B cell number
|
J:170519
|
| increased pre-B cell number
|
J:170519
|
| increased pro-B cell number
|
J:170519
|
Tg(Mx1-cre)1Cgn/0
Traf2tm1Rbr/Traf2tm1Rbr
(involves: C57BL/6 * CBA)
|
increased B cell number
|
J:93890
|
| increased marginal zone B cell number
|
J:93890
|
Tg(Mx1-cre)1Cgn/0
Zmiz1tm1c(EUCOMM)Hmgu/Zmiz1tm1c(EUCOMM)Hmgu
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA/J)
|
decreased B cell number
|
J:234445
|
| decreased NK cell number
|
J:234445
|
| decreased T cell number
|
J:234445
|
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
(involves: 129 * BALB/c * C57BL/6J * DBA/2J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:125750
|
| increased double-positive T cell number
|
J:125750
|
| increased regulatory T cell number
|
J:125750
|
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
(C.Cg-Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)
|
increased regulatory T cell number
|
J:112603
|
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tg(Pklr-Myc)73Ak)
|
decreased NK T cell number
|
J:184496
|
Tg(Plp1-LMNB1)1108Qsp/0
(involves: FVB/N)
|
microgliosis
|
J:226169
|
Tg(Plp1-SNCA)1Haa/0
(involves: C57BL/6 * DBA/2)
|
microgliosis
|
J:96778
|
Tg(PMP22)C61Clh/0
(B6.Cg-Tg(PMP22)C61Clh)
|
increased macrophage cell number
|
J:158350
|
Tg(Prnp-APP*)1Hmor/0
(B6.Cg-Tg(Prnp-APP*)1Hmor)
|
microgliosis
|
J:159623
|
Tg(Prnp-FUS)WT3Cshw/0
(involves: C57BL/6 * Crl:CD-1(ICR))
|
microgliosis
|
J:189360
|
Tg(Prnp-FUS)WT3Cshw/Tg(Prnp-FUS)WT3Cshw
(involves: C57BL/6 * Crl:CD-1(ICR))
|
microgliosis
|
J:189360
|
Tg(Prnp-ITM2B*)7Jckr/0
(C57BL/6-Tg(Prnp-ITM2B*)7Jckr)
|
microgliosis
|
J:159279
|
Tg(Prnp-MAPT*R406W)21807Dwst/?
(FVB/N-Tg(Prnp-MAPT*R406W)21807Dwst)
|
microgliosis
|
J:95971
|
Tg(Prnp-PFN1*C71G)22Zxu/0
Tg(Thy1-PFN1*C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu
(involves: FVB/N)
|
microgliosis
|
J:235427
|
Tg(Prnp-TARDBP)96Dwc/0
Tg(Prnp-TARDBP*Q331K)31Dwc/0
(involves: C3H * C57BL/6)
|
microgliosis
|
J:239141
|
Tg(Prnp-TARDBP*Q331K)31Dwc/?
(involves: C3H * C57BL/6)
|
microgliosis
|
J:239141
|
Tg(Psp-Rbbp4)1Yoha/0
(involves: C57BL/6)
|
increased marginal zone B cell number
|
J:141378
|
Tg(PTH-CCND1)PC2Anar/0
(FVB/N-Tg(PTH-CCND1)PC2Anar)
|
increased osteoclast cell number
|
J:69423
|
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-Aimp1)29872Mcla/0
(involves: 129 * C57BL/6)
|
increased macrophage cell number
|
J:173904
|
Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli/0
(Not Specified)
|
abnormal macrophage morphology
|
J:148490
|
| increased T-helper 2 cell number
|
J:148490
|
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
(involves: C57BL/6 * CBA)
|
increased lymphocyte cell number
|
J:100854
|
| increased macrophage cell number
|
J:100854
|
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
(involves: C57BL/6 * CBA)
|
increased T-helper 2 cell number
|
J:148490
|
X/Tg(SERPINC1-SV40)BPbr
(involves: C57BL/6 * DBA/2)
|
increased macrophage cell number
|
J:84204
|
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: C57BL/6 * SJL)
|
abnormal B cell morphology
|
J:97297
|
| abnormal CD4-positive, alpha beta T cell morphology
|
J:97297
|
| abnormal T cell morphology
|
J:97297
|
| increased CD8-positive, alpha-beta T cell number
|
J:97297
|
| increased lymphocyte cell number
|
J:97297
|
Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J)
|
abnormal lymphocyte morphology
|
J:129215
|
| abnormal microglial cell morphology
|
J:165019,
J:143173
|
| decreased lymphocyte cell number
|
J:129215
|
| decreased monocyte cell number
|
J:129215
|
| microgliosis
|
J:146652,
J:165019,
J:110437,
J:143173
|
Tg(SOD1*G93A)dl1Gur/0
(involves: C57BL/6 * C57BL/6J * SJL/J)
|
microgliosis
|
J:128738
|
Tg(SOD1*H46R)LAra/0
(involves: C57BL/6 * DBA/2)
|
microgliosis
|
J:221350
|
Tg(SOD1*H46R*C111S)PAra/0
(involves: C57BL/6 * DBA/2)
|
microgliosis
|
J:221350
|
Tg(SOD1*H46R*C111S)PAra/Tg(SOD1*H46R*C111S)PAra
(involves: C57BL/6 * DBA/2)
|
microgliosis
|
J:221350
|
Tg(SOD1*H46R*C111S)QAra/0
(involves: C57BL/6 * DBA/2)
|
microgliosis
|
J:221350
|
Tg(SOD1*L126Z)45Dbo/0
(involves: C3H/HeJ * C57BL/6J)
|
microgliosis
|
J:219482
|
Tg(Stat3*)9199Alau/0
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:210877
|
Tg(SV40-Ahr)1Poe/0
(involves: C57BL/6 * CBA)
|
absent B-1a cells
|
J:82428
|
| decreased B-1 B cell number
|
J:82428
|
| increased B-2 B cell number
|
J:82428
|
| increased mature B cell number
|
J:82428
|
| increased pre-B cell number
|
J:82428
|
| increased pro-B cell number
|
J:82428
|
Tg(SV40-Igh-64C8)H3Hon/0
Tg(SV40-Igk4C8)L1Hon/0
(involves: C57BL/6)
|
abnormal B cell clonal deletion
|
J:139864
|
| abnormal B cell number
|
J:139864
|
Tg(TARDBP)#Jpj/0
(involves: C3H * C57BL/6)
|
microgliosis
|
J:195184
|
Tg(TARDBP*A315T)#Jpj/0
(involves: C3H * C57BL/6)
|
microgliosis
|
J:195184
|
Tg(TARDBP*G348C)#Jpj/0
(involves: C3H * C57BL/6)
|
microgliosis
|
J:195184
|
Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:55022
|
| arrested T cell differentiation
|
J:55022
|
| decreased CD4-positive, alpha-beta T cell number
|
J:55022
|
| decreased CD8-positive, alpha-beta T cell number
|
J:55022
|
| decreased double-positive T cell number
|
J:55022
|
| decreased T cell number
|
J:55022
|
| decreased thymocyte number
|
J:55022
|
Tg(Tcra2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92992
|
| decreased double-positive T cell number
|
J:92992
|
| decreased thymocyte number
|
J:92992
|
| increased double-negative T cell number
|
J:92992
|
Tg(Tcra2C,Tcrb2C)1Dlo/?
(involves: C57BL/6 * SJL)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
Tg(Tcra2C,Tcrb2C)1Dlo/?
(involves: C57L * DBA/2 * SJL)
|
decreased lymphocyte cell number
|
J:95380
|
| decreased thymocyte number
|
J:95380
|
| increased CD4-positive, alpha-beta T cell number
|
J:95380
|
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83278
|
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell number
|
J:189919
|
| decreased T-helper 2 cell number
|
J:189919
|
| decreased T-helper 17 cell number
|
J:189919
|
Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:125548
|
Tg(Tcra,Tcrb)3Ayr/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:125548
|
Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro)
|
abnormal T cell differentiation
|
J:104243
|
| increased memory T cell number
|
J:104243
|
Tg(Tcra,Tcrb)HRCAll/0
(B6.Cg-Tg(Tcra,Tcrb)HRCAll)
|
abnormal T cell subpopulation ratio
|
J:131347
|
| decreased CD4-positive, alpha-beta T cell number
|
J:131347
|
| increased CD8-positive, alpha-beta T cell number
|
J:131347
|
Tg(Tcra,Tcrb)HRVAll/0
(B6.Cg-Tg(Tcra,Tcrb)HRVAll)
|
abnormal T cell subpopulation ratio
|
J:131347
|
| decreased CD4-positive, alpha-beta T cell number
|
J:131347
|
| increased CD8-positive, alpha-beta T cell number
|
J:131347
|
Tg(TcraAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93553
|
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93553
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:94192
|
Tg(TcraAV19AJ33)1Shima/?
(involves: 129S4/SvJae * C57BL/6)
|
abnormal NK T cell morphology
|
J:112657
|
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
|
increased activated T cell number
|
J:52940
|
Tg(TcraCl1,TcrbCl1)1Shrm/0
(B10.Cg-Thy1a H2d Tg(TcraCl1,TcrbCl1)1Shrm)
|
abnormal T cell subpopulation ratio
|
J:97745
|
Tg(TcraCl4,TcrbCl4)1Shrm/?
(B10.Cg-H2d Tg(TcraCl4,TcrbCl4)1Shrm)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:99756
|
| abnormal T cell subpopulation ratio
|
J:99756
|
Tg(TcraDN32D3)#Alhn/0
(involves: NOD)
|
decreased NK cell number
|
J:201417
|
| decreased thymocyte number
|
J:201417
|
| increased double-negative T cell number
|
J:201417
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * C57L/J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:79738
|
| abnormal T cell differentiation
|
J:79738,
J:90776
|
| decreased thymocyte number
|
J:79738
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:151074
|
| abnormal positive T cell selection
|
J:151074
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
Themistm1Lov/Themistm1Lov
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:151075
|
| abnormal positive T cell selection
|
J:151075
|
| decreased single-positive T cell number
|
J:151075
|
| increased double-positive T cell number
|
J:151075
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
Tnfrsf25tm1Mjo/Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:84536
|
| increased thymocyte number
|
J:84536
|
Tg(TcrAND)53Hed/?
(involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)
|
abnormal positive T cell selection
|
J:85777
|
| abnormal T cell differentiation
|
J:85777
|
| abnormal T cell subpopulation ratio
|
J:85777
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85777
|
| decreased double-positive T cell number
|
J:85777
|
| increased CD4-positive, alpha-beta T cell number
|
J:85777
|
Tg(TcrAND)53Hed/?
(involves: C57BL/6 * SJL)
|
increased CD4-positive, alpha-beta T cell number
|
J:124701
|
Tg(TcrAND)53Hed/?
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:151074
|
| decreased CD4-positive, alpha-beta T cell number
|
J:151074
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151074
|
| increased double-positive T cell number
|
J:151074
|
Tg(TcrAND)53Hed/?
Themistm1Lov/Themistm1Lov
(involves: 129 * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:151075
|
| decreased single-positive T cell number
|
J:151075
|
| increased double-positive T cell number
|
J:151075
|
Tg(TcrAND)53Hed/?
Zbtb7btm1.1Rbo/Zbtb7btm1.1Rbo
(involves: C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:141145
|
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL)
|
abnormal lymphocyte cell number
|
J:36815
|
| abnormal T cell clonal deletion
|
J:36815
|
| decreased CD4-positive, alpha-beta T cell number
|
J:36815
|
| decreased CD8-positive, alpha-beta T cell number
|
J:36815
|
| increased B cell number
|
J:36815
|
Tg(TcraTcrb)8Rest/?
(C57BL/6-Tg(TcraTcrb)8Rest)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:85058
|
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
abnormal positive T cell selection
|
J:125548
|
Tg(TcraTcrb)425Cbn/?
(involves: BALB/c * C57BL/6)
|
abnormal positive T cell selection
|
J:87876
|
| increased CD4-positive, alpha-beta T cell number
|
J:87876
|
Tg(TcraTcrb)425Cbn/0
Trip10tm1.1Geha/Trip10tm1.1Geha
(B6.Cg-Trip10tm1.1Geha Tg(TcraTcrb)425Cbn)
|
abnormal effector T cell morphology
|
J:164363
|
| decreased CD4-positive, alpha-beta T cell number
|
J:164363
|
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:92867
|
| abnormal positive T cell selection
|
J:92867,
J:133645
|
| abnormal T cell clonal deletion
|
J:92867
|
| abnormal T cell subpopulation ratio
|
J:92867,
J:133645
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133645
|
| increased CD8-positive, alpha-beta T cell number
|
J:92867,
J:133645
|
Tg(TcraTcrb)1100Mjb/?
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal positive T cell selection
|
J:151074
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151074
|
| increased double-positive T cell number
|
J:151074
|
Tg(Tcrb)93Vbo/0
(involves: C57BL/LiA * CBA/BrA)
|
abnormal T cell morphology
|
J:93247
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:93247
|
Tg(Tcrb)93Vbo/0
(involves: C57BL/6 * C57BL/LiA * CBA/BrA)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:66565
|
| abnormal T cell clonal deletion
|
J:66565
|
Tg(Tcrb-TCF3/PBX1)19Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
decreased thymocyte number
|
J:95693
|
Tg(Tcrb-TCF3/PBX1)23Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
decreased thymocyte number
|
J:95693
|
Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcrbAI4)1Dvs)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93553
|
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:73608
|
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| abnormal double-positive T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
Tg(TcrLCMV)1Aox/?
(C57BL/6-Tg(TcrLCMV)1Aox)
|
decreased CD8-positive, alpha-beta T cell number
|
J:92228
|
| decreased double-positive T cell number
|
J:92228
|
| increased CD4-positive, alpha-beta T cell number
|
J:92228
|
| increased double-negative T cell number
|
J:92228
|
Tg(TcrLCMV)2Aox/?
(C57BL/6-Tg(TcrLCMV)2Aox)
|
decreased CD8-positive, alpha-beta T cell number
|
J:92228
|
| decreased double-positive T cell number
|
J:92228
|
| increased CD4-positive, alpha-beta T cell number
|
J:92228
|
| increased double-negative T cell number
|
J:92228
|
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:77696
|
| decreased double-positive T cell number
|
J:77696
|
Tg(TcrLCMV)327Sdz/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
| decreased CD4-positive, alpha-beta T cell number
|
J:97610
|
Tg(Tek-tTA)1Dmt/0
Tg(tetO-Tek)1Dmt/0
(involves: CD-1)
|
increased T cell number
|
J:137745
|
Tg(tetO-BCR/ABL1)2Dgt/0
Tg(Tal1-tTA)19Dgt/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal lymphopoiesis
|
J:96511
|
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/2)
|
microgliosis
|
J:134832
|
Tg(Thy1-App*R609D*K612E)2Vln/0
(involves: C57BL * CBA/J)
|
abnormal microglial cell morphology
|
J:32213
|
Tg(Thy1-App*R609D*K612E)4Vln/0
(involves: FVB)
|
abnormal microglial cell morphology
|
J:32213
|
Tg(Thy1-App*R609D*K612E)6Vln/0
(involves: FVB)
|
abnormal microglial cell morphology
|
J:32213
|
Tg(Thy1-APPDutch)#Jckr/0
(involves: C57BL/6J)
|
microgliosis
|
J:92796
|
Tg(Thy1-APPSw)10Jiri/0
(involves: C3H * C57BL/6)
|
microgliosis
|
J:128647
|
Tg(Thy1-APPSw)10Jiri/0
Tg(Thy1-PSEN1*M146V)#Jiri/0
(B6.Cg-Tg(Thy1-APPSw)10Jiri Tg(Thy1-PSEN1*M146V)#Jiri)
|
microgliosis
|
J:156577
|
Tg(Thy1-APPSweLon)41Ema/0
(involves: C57BL/6 * DBA/2)
|
microgliosis
|
J:162842
|
Tg(Thy1-FUS*)1Dit/0
(B6.Cg-Tg(Thy1-FUS*)1Dit)
|
microgliosis
|
J:287782
|
Tg(Thy1-FUS*)1Dit/0
Tg(Thy1-TARDBP)4Singh/0
(involves: C57BL/6J * DBA/2J * SJL/J)
|
microgliosis
|
J:287782
|
Tg(Thy1-FUS*)19Vlb/0
(B6.Cg-Tg(Thy1-FUS*)19Vlb)
|
microgliosis
|
J:203550
|
Tg(Thy1-MAPT*)1Avil/Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA)
|
microgliosis
|
J:201700
|
Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte/Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte
(involves: C57BL/6 * CBA)
|
microgliosis
|
J:155410
|
Tg(Thy1-Snca)1S13Putt/?
(involves: C57BL/6)
|
microgliosis
|
J:177661
|
Tg(Thy1-SNCA)61Ema/0
(involves: C57BL/6 * DBA/2)
|
abnormal microglial cell morphology
|
J:238066
|
Tg(Thy1-Sncg)HvP36Putt/?
(C57BL/6-Tg(Thy1-Sncg)HvP36Putt)
|
microgliosis
|
J:185793
|
Tg(Thy1-TARDBP)4Singh/0
(involves: C57BL/6J * SJL/J)
|
microgliosis
|
J:157550
|
Tg(Thy1-TARDBP)4Singh/Tg(Thy1-TARDBP)4Singh
(involves: C57BL/6J * SJL/J)
|
microgliosis
|
J:157550
|
Tg(Thy1-TARDBP)6Singh/Tg(Thy1-TARDBP)6Singh
(involves: C57BL/6 * C57BL/6J * SJL)
|
microgliosis
|
J:157550
|
Tg(Thy1/THY1)T6Gsv/0
(involves: C57BL/10 * CBA)
|
abnormal mononuclear cell morphology
|
J:294621
|
| increased macrophage derived foam cell number
|
J:294621
|
X/Tg(Tlr7)6Boll
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:127600
|
| decreased marginal zone B cell number
|
J:127600
|
| increased mature B cell number
|
J:127600
|
Tg(TNF)197Gkl/0
(involves: C57BL/6 * CBA)
|
abnormal osteoclast differentiation
|
J:97992
|
| increased osteoclast cell number
|
J:97992
|
Tg(Tnf)6074Gkl/0
(involves: C57BL/6 * CBA)
|
abnormal microglial cell morphology
|
J:106592
|
Tg(TNFSF11)5519Edou/0
(involves: C57BL/6J * CBA/J)
|
increased osteoclast cell number
|
J:233240
|
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J)
|
abnormal B cell morphology
|
J:58798
|
| abnormal T cell number
|
J:58798
|
| abnormal T cell subpopulation ratio
|
J:58798
|
| increased B cell number
|
J:58798
|
| increased lymphocyte cell number
|
J:58798
|
| increased marginal zone B cell number
|
J:58798
|
| increased mature B cell number
|
J:58798
|
| increased plasma cell number
|
J:58798
|
| increased T cell number
|
J:58798
|
Tg(Tnfsf13b)1Fma/0
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
abnormal B cell differentiation
|
J:73711
|
| abnormal B-1 B cell morphology
|
J:114782
|
| increased B cell number
|
J:114782
|
| increased B-1a cell number
|
J:114782
|
| increased B-1b cell number
|
J:114782
|
| increased plasma cell number
|
J:114782
|
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6J * DBA/2J)
|
abnormal B cell differentiation
|
J:115788
|
| abnormal B-1 B cell morphology
|
J:115788
|
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
increased B cell number
|
J:113556
|
| increased marginal zone B cell number
|
J:113556
|
| increased transitional stage B cell number
|
J:113556
|
Tg(Tnfsf13b)1Fma/?
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb
(B6.Cg-Tnfrsf13btm1Rjb Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
Tg(Tnfsf13b)1Fma/?
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(B6.Cg-Tnfrsf13ctm1Mass Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
Tg(Tnfsf13b)1Fma/0
Tnfsf14tm1Kpf/Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)
|
increased B cell number
|
J:114782
|
| increased plasma cell number
|
J:114782
|
Tg(Tnfsf13b)1Fma/Tg(Tnfsf13b)1Fma
(involves: C57BL/6 * DBA/2)
|
increased B cell number
|
J:178227
|
| increased marginal zone B cell number
|
J:178227
|
| increased transitional stage T2 B cell number
|
J:178227
|
Tg(Tox)1Kay/?
Toxtm1.1Kay/Toxtm1.1Kay
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell number
|
J:131287
|
Tg(UBC-scFv)2Nemz/0
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:96759
|
| abnormal B cell morphology
|
J:96759
|
| abnormal B cell receptor editing
|
J:96759
|
| abnormal B-1 B cell morphology
|
J:96759
|
| abnormal mature B cell morphology
|
J:96759
|
| decreased mature B cell number
|
J:96759
|
Tg(Vav1-Asxl1*Y588X)#Fcy/0
(C57BL/6-Tg(Vav1-Asxl1*Y588X)#Fcy)
|
decreased lymphocyte cell number
|
J:257690
|
| increased monocyte cell number
|
J:257690
|
Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:189197
|
| decreased CD4-positive, alpha-beta T cell number
|
J:189197
|
| decreased CD8-positive, alpha-beta T cell number
|
J:189197
|
| decreased double-positive T cell number
|
J:189197
|
| decreased lymphocyte cell number
|
J:189197
|
| decreased thymocyte number
|
J:189197
|
| increased CD8-positive, alpha-beta T cell number
|
J:189197
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:189197
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:189197
|
Tg(Vav1-NUP98/HOXD13)G2Apla/0
(C57BL/6-Tg(Vav1-NUP98/HOXD13)G2Apla)
|
decreased lymphocyte cell number
|
J:107446
|
Tg(Vav1-STAT5B*N642H)726Biat/0
(C57BL/6NCrl-Tg(Vav1-STAT5B*N642H)726Biat)
|
abnormal effector T cell number
|
J:257519
|
| increased CD4-positive, alpha-beta T cell number
|
J:257519
|
| increased CD8-positive, alpha-beta T cell number
|
J:257519
|
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:88565
|
| abnormal lymphocyte cell number
|
J:88565
|
| abnormal somatic hypermutation frequency
|
J:88565
|
| increased B cell number
|
J:88565
|
| increased CD4-positive, alpha-beta T cell number
|
J:88565
|
| increased CD8-positive, alpha-beta T cell number
|
J:88565
|
| increased T cell number
|
J:88565
|
Tg(Vil1-cre)997Gum/0
Tnfrsf11atm1.1Irw/Tnfrsf11atm1.1Irw
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * SJL)
|
decreased plasma cell number
|
J:226603
|
Tg(VIM-Tag)3Pau/0
(involves: C57BL/6 * SJL/J)
|
increased double-negative T cell number
|
J:91542
|
Tgm3Btlr/Tgm3Btlr
(C57BL/6J-Tgm3Btlr)
|
decreased B cell number
|
J:265197
|
Tgm4Btlr/Tgm4Btlr
(C57BL/6J-Tgm4Btlr)
|
decreased B cell number
|
J:272522
|
| decreased B-2 B cell number
|
J:272522
|
| increased alpha-beta T cell number
|
J:272522
|
| increased B-1a cell number
|
J:272522
|
| increased CD4-positive, alpha-beta T cell number
|
J:272522
|
| increased CD8-positive, alpha-beta T cell number
|
J:272522
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272522
|
| increased macrophage cell number
|
J:272522
|
TgM5Btlr/TgM5Btlr
(C57BL/6J-TgM5Btlr)
|
increased central memory CD4-positive, alpha-beta T cell number
|
J:272523
|
Tgm6Btlr/Tgm6Btlr
(C57BL/6J-Tgm6Btlr)
|
increased alpha-beta T cell number
|
J:272525
|
Tgfb1tm1(Tgfb3)Kul/Tgfb1tm1(Tgfb3)Kul
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell morphology
|
J:204892
|
| increased monocyte cell number
|
J:204892
|
| increased regulatory T cell number
|
J:204892
|
Tgfb1tm1Doe/Tgfb1tm1Doe
(C.129S2-Tgfb1tm1Doe)
|
decreased CD4-positive, alpha-beta T cell number
|
J:69346
|
| increased CD4-positive, alpha-beta T cell number
|
J:69346
|
| increased T-helper 1 cell number
|
J:69346
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
(involves: 129S6/SvEvTac * C57BL/6)
|
absent Langerhans cell
|
J:120085
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
(involves: 129S6/SvEvTac * C57BL/6 * Swiss Webster)
|
absent Langerhans cell
|
J:120085
|
Tgfb1tm1N/Tgfb1tm1N
(involves: 129S/SvEv)
|
absent Langerhans cell
|
J:120085
|
Tgfb1tm1Rif/Tgfb1tm1Rif
(either: (involves: 129) or (involves: 129S/SvEv * C57BL/6))
|
absent Langerhans cell
|
J:142353
|
Tgfb1tm2Flv/B9d2/Tgfb1tm1Flv
Tg(CD207-cre)1Dhka/?
(involves: 129S6/SvEvTac * C57BL/6J * SJL/J)
|
decreased Langerhans cell number
|
J:126147
|
Tgfb1tm3.1Flv/Tgfb1tm3.1Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD)
|
increased regulatory T cell number
|
J:196160
|
| increased T-helper 1 cell number
|
J:196160
|
Tgfb1tm3.1Flv/Tgfb1tm3.1Flv
Tg(Cd4-cre)1Cwi/0
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)
|
increased regulatory T cell number
|
J:196160
|
| increased T-helper 1 cell number
|
J:196160
|
Tgfbitm1Zhao/Tgfbitm1Zhao
(involves: 129 * C57BL/6J)
|
increased B cell number
|
J:143036
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Cd4-cre)1Cwi/0
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)
|
decreased regulatory T cell number
|
J:196160
|
| increased regulatory T cell number
|
J:196160
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(CD207-cre)1Dhka/?
(involves: 129S6/SvEvTac * C57BL/6J * SJL/J)
|
decreased Langerhans cell number
|
J:126147
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Foxp3-EGFP/cre)1cJbs/0
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129S6/SvEvTac * C57BL/6 * NOD * SJL)
|
increased regulatory T cell number
|
J:196160
|
Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6)
|
increased macrophage cell number
|
J:131975
|
TgTn(pb-CAG-Gm40600)#Rew/0
(C57BL/6-TgTn(pb-CAG-Gm40600)#Rew)
|
abnormal plasmablast number
|
J:311878
|
| decreased B cell number
|
J:311878
|
| decreased plasma cell number
|
J:311878
|
| increased B cell number
|
J:311878
|
| increased plasma cell number
|
J:311878
|
Thbs1tm1Hyn/Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))
|
increased lymphocyte cell number
|
J:46182
|
| increased monocyte cell number
|
J:46182
|
Thbs1tm1Hyn/Thbs1tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
decreased regulatory T cell number
|
J:153126
|
| increased CD4-positive, alpha-beta T cell number
|
J:153126
|
Themis5AT161/Themis5AT161
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:151076
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151076
|
| decreased regulatory T cell number
|
J:151076
|
| decreased single-positive T cell number
|
J:151076
|
Themism1Btlr/Themism1Btlr
(C57BL/6J-Themism1Btlr)
|
abnormal lymphocyte morphology
|
J:211400
|
| decreased B-1a cell number
|
J:211400
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211400
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211400
|
Themism2Btlr/Themism2Btlr
(C57BL/6J-Themism2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:236691
|
| decreased T cell number
|
J:236691
|
| increased CD8-positive, alpha-beta T cell number
|
J:236691
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:236691
|
Themism3Btlr/Themism3Btlr
(C57BL/6J-Themism3Btlr)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:254834
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254834
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:254834
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254834
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254834
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254834
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254834
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254834
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254834
|
ThemisM4Btlr/ThemisM4Btlr
(C57BL/6J-ThemisM4Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:272849
|
Themism5Btlr/Themism5Btlr
(C57BL/6J-Themism5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274716
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274716
|
| abnormal T cell differentiation
|
J:274716
|
| decreased alpha-beta T cell number
|
J:274716
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274716
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274716
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274716
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:274716
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274716
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274716
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274716
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274716
|
| increased NK T cell number
|
J:274716
|
ThemisSpotr/Themis+
(C57BL/6-ThemisSpotr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:152601
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152601
|
ThemisSpotr/ThemisSpotr
(C57BL/6-ThemisSpotr)
|
abnormal T cell differentiation
|
J:152601
|
| decreased CD4-positive, alpha-beta T cell number
|
J:152601
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152601
|
Themistm1.1Hko/Themis+
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:152601
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152601
|
Themistm1.1Hko/Themistm1.1Hko
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:152601
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152601
|
| decreased single-positive T cell number
|
J:152601
|
Themistm1Gasc/Themistm1Gasc
(B6.129S-Themistm1Gasc)
|
abnormal memory T cell morphology
|
J:151074
|
| abnormal positive T cell selection
|
J:151074
|
| abnormal regulatory T cell morphology
|
J:151074
|
| decreased CD4-positive, alpha-beta T cell number
|
J:151074
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151074
|
| decreased thymocyte number
|
J:151074
|
| increased double-positive T cell number
|
J:151074
|
Themistm1Hasu/Themis+
(involves: C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:153235
|
| decreased CD8-positive, alpha-beta T cell number
|
J:153235
|
Themistm1Hasu/Themistm1Hasu
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:153235
|
| decreased CD4-positive, alpha-beta T cell number
|
J:153235
|
| decreased CD8-positive, alpha-beta T cell number
|
J:153235
|
| decreased thymocyte number
|
J:153235
|
| increased memory T cell number
|
J:153235
|
Themistm1Lov/Themistm1Lov
(involves: 129)
|
abnormal negative T cell selection
|
J:151075
|
| abnormal T cell differentiation
|
J:151075
|
| decreased CD4-positive, alpha-beta T cell number
|
J:151075
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151075
|
| decreased regulatory T cell number
|
J:151075
|
| decreased single-positive T cell number
|
J:151075
|
| increased memory T cell number
|
J:151075
|
Thop1Gt(CSG163)Byg/Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg)
|
decreased lymphocyte cell number
|
J:290567
|
| increased monocyte cell number
|
J:290567
|
Thratm1Syc/Thra+
(involves: 129S6/SvEvTac * C57BL/6J * NIH Black Swiss)
|
decreased osteoclast cell number
|
J:217018
|
Thratm2Jas/Thratm2Jas
(involves: 129)
|
decreased osteoclast cell number
|
J:120899
|
Thrbtm1Olc/Thrbtm1Olc
(involves: 129)
|
increased osteoclast cell number
|
J:120899
|
Ticam1Lps2/Ticam1Lps2
(C57BL/6J-Ticam1Lps2/J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:288471
|
| decreased Ly6C low monocyte number
|
J:288471
|
| increased Ly6C high monocyte number
|
J:288471
|
| increased macrophage cell number
|
J:288471
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:130954
|
Tifabtm1.1Dsta/Tifabtm1.1Dsta
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased lymphocyte cell number
|
J:229024
|
| decreased monocyte cell number
|
J:229024
|
Timd2tm1(GAL4)Pdre/Timd2tm1(GAL4)Pdre
(C.129S4-Timd2tm1(GAL4)Pdre)
|
increased lymphocyte cell number
|
J:125054
|
Timd4tm1Wouy/Timd4tm1Wouy
(involves: 129)
|
increased lymphocyte cell number
|
J:160304
|
Timd6tm1b(KOMP)Wtsi/Timd6+
(C57BL/6N-Timd6tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
Timmdc1Gt(OST407011)Lex/Timmdc1+
(B6;129S5-Timmdc1Gt(OST407011)Lex/Mmucd)
|
increased CD4-positive, alpha-beta T cell number
|
J:171883
|
Timp2em1(IMPC)Hmgu/Timp2em1(IMPC)Hmgu
(C57BL/6N-Timp2em1(IMPC)Hmgu/Ieg)
|
increased B cell number
|
J:211773
|
| increased B-2 B cell number
|
J:211773
|
| increased follicular B cell number
|
J:211773
|
Tle4tm1.2Dasw/Tle4tm1.2Dasw
(B6.129S6(Cg)-Tle4tm1.2Dasw)
|
abnormal lymphopoiesis
|
J:219243
|
| decreased B cell number
|
J:219243
|
| decreased DN2 thymocyte number
|
J:219243
|
| decreased double-positive T cell number
|
J:219243
|
| decreased follicular B cell number
|
J:219243
|
| decreased lymphocyte cell number
|
J:219243
|
| decreased pre-pro B cell number
|
J:219243
|
| increased NK T cell number
|
J:219243
|
Tlf2NOD/Smrf/?
(involves: NOD/Smrf * NON/Lt)
|
increased CD8-positive, alpha-beta T cell number
|
J:49676
|
TlfNOD/Smrf/?
(involves: NOD/Smrf * NON/Lt)
|
increased CD4-positive, alpha-beta T cell number
|
J:49676
|
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
increased T cell number
|
J:118954
|
Tlr4lps-5Btlr/Tlr4lps-5Btlr
(C57BL/6J-Tlr4lps-5Btlr)
|
decreased B cell number
|
J:224666
|
| decreased memory B cell number
|
J:224666
|
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ)
|
abnormal osteoclast differentiation
|
J:131353
|
Tlr4Lps-d/Tlr4Lps-d
Tg(IghelMD4)4Ccg/0
Tg(KLK4mHEL)6Ccg/0
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6)
|
decreased B cell number
|
J:115059
|
| increased B-1 B cell number
|
J:115059
|
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu)
|
increased CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased T follicular helper cell number
|
J:324448
|
Tlr7em2Anu/Tlr7+
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal mature B cell morphology
|
J:324448
|
| decreased marginal zone B cell number
|
J:324448
|
| increased B cell number
|
J:324448
|
| increased CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased germinal center B cell number
|
J:324448
|
| increased plasma cell number
|
J:324448
|
| increased T follicular helper cell number
|
J:324448
|
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal mature B cell morphology
|
J:324448
|
| decreased marginal zone B cell number
|
J:324448
|
| increased B cell number
|
J:324448
|
| increased CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased germinal center B cell number
|
J:324448
|
| increased plasma cell number
|
J:324448
|
| increased T follicular helper cell number
|
J:324448
|
Tlr7tm1Flv/Y
(B6.129S1-Tlr7tm1Flv)
|
increased marginal zone B cell number
|
J:127600
|
Tlr8/Tlr7tm1Vlcg/Tlr8/Tlr7tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg)
|
decreased follicular B cell number
|
J:165267
|
| increased marginal zone B cell number
|
J:165267
|
Tlr8/Tlr7tm1Vlcg/Tlr7+
Tlr8/Tlr7tm1Vlcg/Tlr8tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg Tlr8tm1Vlcg)
|
decreased marginal zone B cell number
|
J:165267
|
| increased marginal zone B cell number
|
J:165267
|
Tlr8/Tlr7tm1Vlcg/Tlr8/Tlr7tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg Tlr8tm1Vlcg)
|
decreased follicular B cell number
|
J:165267
|
| increased marginal zone B cell number
|
J:165267
|
Tlr8tm1Vlcg/Tlr8tm1Vlcg
(B6.129S1-Tlr8tm1Vlcg)
|
decreased B-1a cell number
|
J:165267
|
| decreased B-1b cell number
|
J:165267
|
| decreased marginal zone B cell number
|
J:165267
|
| increased B-2 B cell number
|
J:165267
|
Tlr9tm1Aki/Tlr9tm1Aki
Tg(IghelMD4)4Ccg/0
Tg(KLK4mHEL)6Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:115059
|
| increased B-1 B cell number
|
J:115059
|
Tlx1tm1Sjk/Tlx1tm1Sjk
(involves: 129S2/SvPas)
|
increased lymphocyte cell number
|
J:17695
|
Tm7sf2tm1b(KOMP)Wtsi/Tm7sf2tm1b(KOMP)Wtsi
(C57BL/6N-Tm7sf2tm1b(KOMP)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
Tmc6tm1.1Les/Tmc6tm1.1Les
(B6.129S6(Cg)-Tmc6tm1.1Les)
|
decreased CD4-positive, alpha-beta T cell number
|
J:300461
|
| decreased CD8-positive, alpha-beta T cell number
|
J:300461
|
Tmc8tm1.1Les/Tmc8tm1.1Les
(B6.129S6(Cg)-Tmc8tm1.1Les)
|
decreased CD4-positive, alpha-beta T cell number
|
J:300461
|
| decreased CD8-positive, alpha-beta T cell number
|
J:300461
|
Tmem60em1(IMPC)Ccpcz/Tmem60em1(IMPC)Ccpcz
(C57BL/6N-Tmem60em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
Tmem64Gt(SYA242)Byg/Tmem64Gt(SYA242)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:198051
|
| decreased osteoclast cell number
|
J:198051
|
Tmem100tm1e.1(KOMP)Wtsi/Tmem100+
(C57BL/6N-Tmem100tm1e.1(KOMP)Wtsi/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Tmem121bem1(IMPC)Tcp/Tmem121bem1(IMPC)Tcp
(C57BL/6NCrl-Tmem121bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Tmem126atm1a(EUCOMM)Wtsi/Tmem126atm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem126atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
Tmem127tm1(KOMP)Wtsi/Tmem127tm1(KOMP)Wtsi
(C57BL/6N-Tmem127tm1(KOMP)Wtsi/Wtsi)
|
decreased B cell number
|
J:211773
|
| decreased B-2 B cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased KLRG1-positive T-helper cell number
|
J:211773
|
| decreased Ly6C high monocyte number
|
J:211773
|
| decreased memory-marker NK cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| increased alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased Ly6C low monocyte number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
Tmem150bem1(IMPC)Ccpcz/Tmem150bem1(IMPC)Ccpcz
(C57BL/6N-Tmem150bem1(IMPC)Ccpcz/Ccpcz)
|
decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
Tmem178tm1Lex/Tmem178tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:228311
|
| increased osteoclast cell number
|
J:228311
|
Tmem248tm1.1(KOMP)Vlcg/Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd)
|
increased monocyte cell number
|
J:211773
|
Tmem256tm1.1(KOMP)Vlcg/Tmem256tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem256tm1.1(KOMP)Vlcg/Ucd)
|
increased monocyte cell number
|
J:211773
|
Tmprss6tm1b(EUCOMM)Wtsi/Tmprss6tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmprss6tm1b(EUCOMM)Wtsi/Ics)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased Ly6C-positive mature NK cell number
|
J:211773
|
Tmub1tm1Lex/Tmub1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased monocyte cell number
|
J:171883
|
Tmub2tm1b(KOMP)Wtsi/Tmub2tm1b(KOMP)Wtsi
(C57BL/6N-Tmub2tm1b(KOMP)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Tnftm1Gkl/Tnftm1Gkl
(either: B6.129-Tnftm1Gkl or (involves: 129 * C57BL/6))
|
increased lymphocyte cell number
|
J:97783
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6J)
|
abnormal metallophilic macrophage morphology
|
J:124642
|
Tnftm1Jods/Tnftm1Jods
(involves: C57BL/6)
|
abnormal metallophilic macrophage morphology
|
J:98591
|
Tnftm1Ljo/Tnftm1Ljo
(either: B6.129-Tnftm1Ljo or (involves: 129 * C57BL/6))
|
increased lymphocyte cell number
|
J:97783
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:136667
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:136667
|
| abnormal T cell subpopulation ratio
|
J:136667
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:108572
|
Tnftm2Gkl/Tnf+
(B6.129S-Tnftm2Gkl/Jarn)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:131978
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:145626
|
| increased CD4-positive, alpha-beta T cell number
|
J:145626
|
Tnftm2Jods/Tnftm2Jods
(C57BL/6-Tnftm2Jods)
|
abnormal metallophilic macrophage morphology
|
J:98591
|
Tnfaip3m1Apb/Tnfaip3m1Apb
(C57BL/6-Tnfaip3m1Apb)
|
increased effector memory T-helper cell number
|
J:324062
|
| increased macrophage cell number
|
J:324062
|
Tnfaip3tm1Ama/Tnfaip3tm1Ama
(Not Specified)
|
increased lymphocyte cell number
|
J:92931
|
| increased macrophage cell number
|
J:92931
|
Tnfaip3tm1Homy/Tnfaip3tm1Homy
Tg(Mx1-cre)1Cgn/?
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal B cell number
|
J:212681
|
Tnfaip3tm2Ama/Tnfaip3tm2Ama
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:163917
|
| abnormal B-1a B cell morphology
|
J:163917
|
| decreased B cell number
|
J:163917
|
| increased B cell number
|
J:163917
|
| increased germinal center B cell number
|
J:163917
|
| increased immature B cell number
|
J:163917
|
| increased plasma cell number
|
J:163917
|
| increased T cell number
|
J:163917
|
Tnfaip3tm3.1Ama/Tnfaip3tm3.1Ama
(C57BL/6J-Tnfaip3tm3.1Ama)
|
increased B cell number
|
J:203160
|
| increased CD4-positive, alpha-beta T cell number
|
J:203160
|
| increased CD8-positive, alpha-beta T cell number
|
J:203160
|
Tnfaip3tm4.1Ama/Tnfaip3tm4.1Ama
(C57BL/6J-Tnfaip3tm4.1Ama)
|
increased B cell number
|
J:203160
|
| increased CD4-positive, alpha-beta T cell number
|
J:203160
|
| increased CD8-positive, alpha-beta T cell number
|
J:203160
|
Tnfaip8Gt(IST13629C1)Tigm/Tnfaip8Gt(IST13629C1)Tigm
Tnfaip8l1em1Huwa/Tnfaip8l1em1Huwa
(involves: C57BL/6 * C57BL/6N)
|
increased T-helper 17 cell number
|
J:342074
|
Tnfaip8l2tm1Yhcn/Tnfaip8l2tm1Yhcn
(129S6/SvEvTac-Tnfaip8l2tm1Yhcn)
|
abnormal myeloid dendritic cell morphology
|
J:139785
|
| increased B cell number
|
J:139785
|
| increased T cell number
|
J:139785
|
Tnfrsf1aem1(IMPC)Ccpcz/Tnfrsf1aem1(IMPC)Ccpcz
(C57BL/6NCrl-Tnfrsf1aem1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx)
|
decreased microglial cell number
|
J:112713
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
microgliosis
|
J:134832
|
Tnfrsf1atm2b(EUCOMM)Wtsi/Tnfrsf1atm2b(EUCOMM)Wtsi
(C57BL/6N-Tnfrsf1atm2b(EUCOMM)Wtsi/H)
|
decreased monocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Tnfrsf1btm1a(EUCOMM)Wtsi/Tnfrsf1btm1a(EUCOMM)Wtsi
(C57BL/6N-Tnfrsf1btm1a(EUCOMM)Wtsi/Ics)
|
decreased T cell number
|
J:165965
|
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
microgliosis
|
J:112713
|
Tnfrsf8tm1Mak/Tnfrsf8tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte number
|
J:62854
|
Tnfrsf9m1Btlr/Tnfrsf9m1Btlr
(C57BL/6J-Tnfrsf9m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:265260
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265260
|
| decreased single-positive T cell number
|
J:265260
|
| increased B cell number
|
J:265260
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265260
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265260
|
Tnfrsf10btm1Wnt/Tnfrsf10btm1Wnt
(involves: 129S6/SvEvTac * C57BL/6)
|
increased NK cell number
|
J:94681
|
Tnfrsf11adel8/Tnfrsf11adel8
(involves: 129)
|
decreased osteoclast cell number
|
J:111512
|
Tnfrsf11atm1.1Sral/Tnfrsf11a+
(B6.129P2(Cg)-Tnfrsf11atm1.1Sral)
|
abnormal osteoclast differentiation
|
J:312215
|
| increased osteoclast cell number
|
J:312215
|
Tnfrsf11atm1.1Sral/Tnfrsf11atm1.1Sral
(B6.129P2(Cg)-Tnfrsf11atm1.1Sral)
|
abnormal osteoclast differentiation
|
J:312215
|
| decreased osteoclast cell number
|
J:312215
|
Tnfrsf11atm1.2Pngr/Tnfrsf11atm1.2Pngr
(B6.Cg-Tnfrsf11atm1.2Pngr)
|
decreased osteoclast cell number
|
J:155398
|
Tnfrsf11atm1Imx/Tnfrsf11atm1Imx
(involves: 129 * C57BL/6)
|
abnormal osteoclast differentiation
|
J:57899
|
| decreased B cell number
|
J:57899
|
| decreased mature B cell number
|
J:57899
|
| decreased osteoclast cell number
|
J:57899
|
Tnfrsf11atm1Imx/Tnfrsf11atm1Imx
(involves: 129)
|
abnormal negative T cell selection
|
J:125864
|
Tnfrsf11atm1Kost/Tnfrsf11atm1Kost
(involves: 129/Sv * Black Swiss)
|
abnormal osteoclast morphology
|
J:166279
|
Tnfrsf11btm1Eac/Tnfrsf11btm1Eac
(involves: 129S4/SvJaeSor)
|
abnormal pro-B cell differentiation
|
J:67105
|
| increased B cell number
|
J:67105
|
| increased immature B cell number
|
J:67105
|
| increased pro-B cell number
|
J:67105
|
Tnfrsf11btm1Khs/Tnfrsf11btm1Khs
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:111153,
J:48325
|
| increased osteoclast cell number
|
J:80503
|
Tnfrsf11btm1Wss/Tnfrsf11btm1Wss
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * Black Swiss))
|
abnormal osteoclast morphology
|
J:47602
|
Tnfrsf13btm1Cmac/Tnfrsf13btm1Cmac
(Not Specified)
|
increased B cell number
|
J:91914
|
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb
(involves: 129X1/SvJ * C57BL/6)
|
increased B cell number
|
J:69474
|
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb
(involves: 129X1/SvJ)
|
abnormal class switch recombination
|
J:95288
|
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd
(involves: C57BL/6)
|
increased B cell number
|
J:70172,
J:82331
|
| increased follicular B cell number
|
J:70172
|
| increased marginal zone B cell number
|
J:70172
|
| increased mature B cell number
|
J:70172
|
| increased transitional stage B cell number
|
J:70172
|
Tnfrsf13cm1Btlr/Tnfrsf13cm1Btlr
(C57BL/6J-Tnfrsf13cm1Btlr)
|
decreased B cell number
|
J:265247
|
Tnfrsf13cM2Btlr/Tnfrsf13cM2Btlr
(C57BL/6J-Tnfrsf13cM2Btlr)
|
decreased B cell number
|
J:265247
|
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(C57BL/6-Tnfrsf13ctm1Mass)
|
absent marginal zone B cells
|
J:92732
|
| arrested B cell differentiation
|
J:92732
|
| decreased B-2 B cell number
|
J:92732
|
| decreased mature B cell number
|
J:92732
|
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(involves: C57BL/6)
|
decreased lymphocyte cell number
|
J:139293
|
| decreased mature B cell number
|
J:139293
|
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
Traf2tm1Rbr/Traf2tm1Rbr
(involves: C57BL/6)
|
decreased germinal center B cell number
|
J:172843
|
Tnfrsf13ctm1Msc/Tnfrsf13ctm1Msc
(involves: 129P2/OlaHsd * C57BL/6)
|
absent marginal zone B cells
|
J:92676
|
| absent transitional stage B cells
|
J:92676
|
| decreased B cell number
|
J:92676
|
| decreased B-2 B cell number
|
J:92676
|
Tnfrsf17tm1Kplm/Tnfrsf17tm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased plasma cell number
|
J:124543
|
Tnfrsf21tm1Vmd/Tnfrsf21tm1Vmd
(involves: C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:72761
|
| increased CD8-positive, alpha-beta T cell number
|
J:72761
|
| increased T cell number
|
J:72761
|
Tnfrsf25tm1Mjo/Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd)
|
abnormal negative T cell selection
|
J:84536
|
| increased thymocyte number
|
J:84536
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs)
|
abnormal negative T cell selection
|
J:82145
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs)
|
abnormal negative T cell selection
|
J:82145
|
Tnfsf11tles/Tnfsf11tles
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased osteoclast cell number
|
J:179743
|
Tnfsf11tles/Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
decreased osteoclast cell number
|
J:179743
|
Tnfsf11tm1.1Caob/Tnfsf11tm1.1Caob
Tg(Dmp1-cre)1Jqfe/0
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB)
|
abnormal osteoclast cell number
|
J:177558
|
| decreased osteoclast cell number
|
J:177558
|
Tnfsf11tm1.1Caob/Tnfsf11tm1.1Caob
Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
decreased osteoclast cell number
|
J:177558
|
Tnfsf11tm1.1Htaka/Tnfsf11tm1.2Htaka
Tg(Dmp1-cre)1Jqfe/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * FVB/N)
|
decreased osteoclast cell number
|
J:177557
|
Tnfsf11tm1.2Htaka/Tnfsf11+
(B6.Cg-Tnfsf11tm1.2Htaka)
|
decreased osteoclast cell number
|
J:177557
|
Tnfsf11tm1.2Htaka/Tnfsf11tm1.2Htaka
(B6.Cg-Tnfsf11tm1.2Htaka)
|
decreased osteoclast cell number
|
J:177557
|
Tnfsf11tm1Pngr/Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:52369
|
| arrested T cell differentiation
|
J:52369
|
| decreased immature B cell number
|
J:52369
|
| decreased mature B cell number
|
J:52369
|
| decreased osteoclast cell number
|
J:52369
|
Tnfsf11tm1Ywc/Tnfsf11tm1Ywc
(involves: 129P2/OlaHsd)
|
decreased Langerhans cell number
|
J:137471
|
| decreased osteoclast cell number
|
J:65888,
J:64737
|
Tnfsf12tm1Ash/Tnfsf12tm1Ash
(B6.129-Tnfsf12tm1Ash)
|
increased double-positive T cell number
|
J:104801
|
| increased memory T cell number
|
J:104801
|
| increased NK cell number
|
J:104801
|
| increased T-helper 1 cell number
|
J:104801
|
Tnfsf13tm1Geha/Tnfsf13tm1Geha
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:88910
|
| increased memory T cell number
|
J:88910
|
Tnfsf13bm1Anu/Tnfsf13bm1Anu
(C57BL/6JAnu-Tnfsf13bm1Anu/AnuApb)
|
abnormal B cell differentiation
|
J:104190
|
| decreased mature B cell number
|
J:104190
|
| increased immature B cell number
|
J:104190
|
Tnfsf13bM1Btlr/Tnfsf13b+
(C57BL/6J-Tnfsf13bM1Btlr)
|
decreased B cell number
|
J:220069
|
| increased single-positive T cell number
|
J:220069
|
| increased T cell number
|
J:220069
|
Tnfsf13bM1Btlr/Tnfsf13bM1Btlr
(C57BL/6J-Tnfsf13bM1Btlr)
|
decreased B cell number
|
J:220069
|
| increased single-positive T cell number
|
J:220069
|
| increased T cell number
|
J:220069
|
Tnfsf13bm2Btlr/Tnfsf13bm2Btlr
(C57BL/6J-Tnfsf13bm2Btlr)
|
decreased B cell number
|
J:220070
|
Tnfsf13bm3Btlr/Tnfsf13bm3Btlr
(C57BL/6J-Tnfsf13bm3Btlr)
|
abnormal lymphocyte morphology
|
J:272850
|
| decreased B cell number
|
J:272850
|
Tnfsf13btm1Cleg/Tnfsf13btm1Cleg
(involves: 129S5/SvEvBrd)
|
abnormal B cell differentiation
|
J:71301
|
| decreased follicular B cell number
|
J:71301
|
| decreased mature B cell number
|
J:71301
|
| decreased memory T cell number
|
J:71301
|
| increased T cell number
|
J:71301
|
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:71681
|
| arrested B cell differentiation
|
J:71681
|
| decreased B cell number
|
J:71681
|
| decreased follicular B cell number
|
J:71681
|
| decreased marginal zone B cell number
|
J:71681
|
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129S2/SvPas)
|
decreased B cell number
|
J:138560
|
| decreased follicular B cell number
|
J:138560
|
| decreased transitional stage B cell number
|
J:138560
|
Tnfsf13btm1Msc/Tnfsf13btm1Msc
Traf2tm1Rbr/Traf2tm1Rbr
(involves: 129S2/SvPas * C57BL/6)
|
absent follicular B cells
|
J:132877
|
| absent marginal zone B cells
|
J:132877
|
| decreased mature B cell number
|
J:132877
|
Tnfsf14tm1Kpf/Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:77250
|
Tnfsf14tm1Kpf/Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
Tnfsf14tm1Kpf/Tnfsf14tm1Kpf
(B6.129P2-Tnfsf14tm1Kpf)
|
abnormal osteoclast differentiation
|
J:294030
|
Tnfsf15tm1Hluo/Tnfsf15tm1Hluo
(D1LacJ.129(B6)-Tnfsf15tm1Hluo)
|
decreased B cell number
|
J:207029
|
| decreased germinal center B cell number
|
J:207029
|
| decreased plasma cell number
|
J:207029
|
| decreased T cell number
|
J:207029
|
| decreased T follicular helper cell number
|
J:207029
|
Tnfsf15tm1Lex/Tnfsf15tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased NK cell number
|
J:82809
|
Tnip1m1Btlr/Tnip1m1Btlr
(C57BL/6J-Tnip1m1Btlr)
|
decreased B cell number
|
J:265175
|
| decreased B-2 B cell number
|
J:265175
|
| increased B-1a cell number
|
J:265175
|
| increased B-1b cell number
|
J:265175
|
| increased macrophage cell number
|
J:265175
|
Tnip1tm1.1Pcoh/Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal effector T cell morphology
|
J:176826
|
| abnormal plasma cell morphology
|
J:176826
|
| increased B cell number
|
J:176826
|
| increased germinal center B cell number
|
J:176826
|
| increased monocyte cell number
|
J:176826
|
| increased plasma cell number
|
J:176826
|
| increased T follicular helper cell number
|
J:176826
|
Tnip1tm1.2Ama/Tnip1tm1.2Ama
Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
increased memory T cell number
|
J:205446
|
Tnip1tm1b(EUCOMM)Hmgu/Tnip1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tnip1tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Tob2tm1Tya/Tob2tm1Tya
(involves: 129S4/SvJae * C57BL/6)
|
abnormal osteoclast differentiation
|
J:134287
|
| increased osteoclast cell number
|
J:134287
|
Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased B cell number
|
J:133892
|
| increased CD4-positive, alpha-beta T cell number
|
J:133892
|
| increased CD8-positive, alpha-beta T cell number
|
J:133892
|
| increased T cell number
|
J:133892
|
Toxtm1.1Kay/Toxtm1.1Kay
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive T cell differentiation
|
J:131287
|
| abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:131287
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:131287
|
| decreased CD4-positive, alpha-beta T cell number
|
J:131287
|
| decreased NK T cell number
|
J:131287
|
Toxtm1.1Kay/Toxtm1.1Kay
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal positive T cell selection
|
J:164687
|
| decreased NK cell number
|
J:164687
|
Toxtm1Kay/Toxtm1Kay
Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:164687
|
Tpp2tm1.1Gnie/Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:133572
|
| decreased double-positive T cell number
|
J:133572
|
| decreased T cell number
|
J:133572
|
| increased double-negative T cell number
|
J:133572
|
| increased single-positive T cell number
|
J:133572
|
| increased T cell number
|
J:133572
|
Tpp2tm1.1Gnie/Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive T cell differentiation
|
J:221205
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221205
|
| increased B cell number
|
J:221205
|
| increased memory T cell number
|
J:221205
|
Tppp3em1(IMPC)Ccpcz/Tppp3+
(C57BL/6NCrl-Tppp3em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive NK T cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
Traf1tm1Tsi/Traf1tm1Tsi
(involves: 129S4/SvJae * C57BL/6)
|
increased lymphocyte cell number
|
J:72327
|
Traf2tm1a(EUCOMM)Wtsi/Traf2+
(C57BL/6N-Traf2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
Traf2tm1Mak/Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
decreased double-positive T cell number
|
J:44360
|
| decreased immature B cell number
|
J:44360
|
| decreased lymphocyte cell number
|
J:44360
|
| decreased thymocyte number
|
J:44360
|
Traf3m1Btlr/Traf3m1Btlr
(C57BL/6J-Traf3m1Btlr)
|
decreased mature B cell number
|
J:212064
|
Traf3tm1Bal/Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal B cell differentiation
|
J:37065
|
| decreased double-positive T cell number
|
J:37065
|
| decreased thymocyte number
|
J:37065
|
Traf3tm1Bshp/Traf3tm1Bshp
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased T cell number
|
J:124329
|
| increased B cell number
|
J:124329
|
| increased follicular B cell number
|
J:124329
|
| increased marginal zone B cell number
|
J:124329
|
| increased transitional stage B cell number
|
J:124329
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(involves: 129/Sv * BALB/c)
|
increased B cell number
|
J:93923
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(C.129-Traf3ip2tm1.1Lix)
|
increased follicular B cell number
|
J:138560
|
| increased marginal zone B cell number
|
J:138560
|
| increased transitional stage B cell number
|
J:138560
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(B6.129-Traf3ip2tm1.1Lix)
|
abnormal transitional stage B cell morphology
|
J:187766
|
| increased B cell number
|
J:187766
|
| increased immature B cell number
|
J:187766
|
| increased marginal zone B cell number
|
J:187766
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129 * 129S2/SvPas * BALB/c)
|
decreased B cell number
|
J:138560
|
| decreased follicular B cell number
|
J:138560
|
| decreased mature B cell number
|
J:138560
|
| decreased transitional stage B cell number
|
J:138560
|
Traf3ip2tm1Lix/Traf3ip2tm1.1Lix
Tg(CD19-cre/ERT2)1Cgn/0
(involves: 129/Sv * BALB/c)
|
increased B cell number
|
J:93923
|
Traf3ip3tm1b(KOMP)Wtsi/Traf3ip3tm1b(KOMP)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
abnormal T cell differentiation
|
J:226431
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:226431
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:226431
|
| decreased regulatory T cell number
|
J:226431
|
| decreased T cell number
|
J:226431
|
| decreased thymocyte number
|
J:226431
|
| increased double-positive T cell number
|
J:226431
|
| increased gamma-delta T cell number
|
J:226431
|
Traf6tm1Jino/Traf6tm1Jino
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:77453
|
| decreased immature B cell number
|
J:77453
|
Traf6tm1Mak/Traf6tm1Mak
(involves: 129P3/J)
|
abnormal osteoclast morphology
|
J:54467
|
Traf6tm2Ywc/Traf6tm2Ywc
Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:130882
|
| increased memory T cell number
|
J:130882
|
Traj18em1Hwata/Traj18em1Hwata
(C57BL/6-Traj18em1Hwata)
|
absent NK T cells
|
J:256533
|
Traj18em1Hwata/Traj18em1Hwata
(C.B6-Traj18em1Hwata)
|
absent NK T cells
|
J:256533
|
Traj18tm1.1Kro/Traj18tm1.1Kro
(involves: C57BL/6NTac)
|
absent NK T cells
|
J:232957
|
Traj33em#Dig/Traj33em#Dig
(involves: C57BL/6)
|
decreased T cell number
|
J:276912
|
Trap1em1(IMPC)Mbp/Trap1em1(IMPC)Mbp
(C57BL/6N-Trap1em1(IMPC)Mbp/MbpMmucd)
|
decreased monocyte cell number
|
J:211773
|
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased gamma-delta T cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| increased Ly6C high monocyte number
|
J:211773
|
| increased Ly6C low monocyte number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Trbv13-2tm1(CD2)Zhu/Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:121608
|
Trbv13-2tm1(CD2)Zhu/Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:121608
|
Trbv14tm1Che/Trbv14tm1Che
(involves: 129S4/SvJae)
|
decreased T cell number
|
J:92288
|
Trbv14tm2Che/Trbv14tm2Che
(involves: 129S4/SvJae)
|
decreased T cell number
|
J:92288
|
Trdmt1Gt(OST19279)Lex/Trdmt1Gt(OST19279)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased NK cell number
|
J:103485
|
Trem1tm1.1Ahoru/Trem1tm1.1Ahoru
(C57BL/6-Trem1tm1.1Ahoru)
|
decreased monocyte cell number
|
J:191035
|
Trem2em2Bwef/Trem2+
(involves: C57BL/6J * DBA/2J * FVB/N)
|
decreased macrophage cell number
|
J:242126
|
Trem2em2Bwef/Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N)
|
decreased macrophage cell number
|
J:242126
|
Trex1tm1.1Fwpe/Trex1+
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)
|
increased CD4-positive, alpha-beta T cell number
|
J:220965
|
Trex1tm1.1Fwpe/Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)
|
increased B cell number
|
J:220965
|
| increased CD4-positive, alpha-beta T cell number
|
J:220965
|
| increased plasma cell number
|
J:220965
|
| increased regulatory T cell number
|
J:220965
|
Trgc1tm1.2Dhr/Trgc1tm1.2Dhr
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))
|
decreased gamma-delta T cell number
|
J:91304
|
Trib1tm1Aki/Trib1tm1Aki
(involves: 129P2/OlaHsd)
|
decreased macrophage cell number
|
J:196449
|
Trib2Tg(Thy1-Trh/APP*)2.1Ingm/Trib2+
Tg(Thy1-APP*)2.2Ingm/0
(involves: C57BL/6 * DBA/1)
|
microgliosis
|
J:176575
|
Trib2Tg(Thy1-Trh/APP*)2.1Ingm/Trib2Tg(Thy1-Trh/APP*)2.1Ingm
(involves: C57BL/6 * DBA/1)
|
microgliosis
|
J:176575
|
Trib2tm1Lex/Trib2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:82809
|
| increased CD8-positive, alpha-beta T cell number
|
J:82809
|
Trim9em1(IMPC)Ccpcz/Trim9em1(IMPC)Ccpcz
(C57BL/6N-Trim9em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
Trim30atm1Yjk/Trim30atm1Yjk
(B6.129P2-Trim30atm1Yjk)
|
abnormal T cell subpopulation ratio
|
J:215171
|
| increased CD4-positive, alpha-beta T cell number
|
J:215171
|
Trim31em1Cya/Trim31em1Cya
(involves: C57BL/6)
|
increased Ly6C high monocyte number
|
J:243237
|
Trim39tm1b(EUCOMM)Hmgu/Trim39tm1b(EUCOMM)Hmgu
(C57BL/6N-Trim39tm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Trim56tm1a(EUCOMM)Wtsi/Trim56tm1a(EUCOMM)Wtsi
(C57BL/6N-Trim56tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased regulatory T cell number
|
J:211773
|
Trmq1C57BL/6J/Trmq1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:77603
|
Trmq1DBA/2J/Trmq1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:77603
|
Trmq2C57BL/6J/Trmq2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:77603
|
Trmq2C57BL/6J/Trmq2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:77603
|
Trmq3DBA/1J/Trmq3FVB/N
(involves: DBA/1J * FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:116665
|
Trmq3FVB/N/?
(involves: DBA/1J * FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:94347
|
Trmq3FVB/N/Trmq3FVB/N
(involves: DBA/1J * FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:116665
|
Trmq4RIIIS/J/Trmq4RIIIS/J
Trmq5RIIIS/J/Trmq5RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:95848
|
Trp53tm1.1Awbr/Trp53tm1.1Awbr
(involves: C57BL/6)
|
increased pro-B cell number
|
J:169434
|
Trp53tm1.2Awbr/Trp53+
(involves: C57BL/6)
|
abnormal lymphocyte morphology
|
J:173271
|
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6)
|
abnormal lymphocyte morphology
|
J:173271
|
Trp53tm1b(EUCOMM)Hmgu/Trp53tm1b(EUCOMM)Hmgu
(C57BL/6N-Trp53tm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc4tm1Fwa/Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal lymphopoiesis
|
J:61973
|
Trp53bp1Gt(OST94324)Lex/Trp53bp1Gt(OST94324)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell differentiation
|
J:83164
|
| decreased mature B cell number
|
J:83164
|
| decreased T cell number
|
J:83164
|
Trp53bp1m2Btlr/Trp53bp1m2Btlr
(C57BL/6J-Trp53bp1m2Btlr)
|
decreased B cell number
|
J:254841
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254841
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254841
|
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:82512
|
| increased double-negative T cell number
|
J:82512
|
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129)
|
abnormal class switch recombination
|
J:194603,
J:231089,
J:307190
|
Trpm2tm1Lhj/Trpm2tm1Lhj
(Not Specified)
|
abnormal macrophage morphology
|
J:202791
|
Trpm7tm1Clph/Trpm7tm1.1Clph
Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:140630
|
| decreased T cell number
|
J:140630
|
| decreased thymocyte number
|
J:140630
|
Trpv5tm1Bind/Trpv5tm1Bind
(involves: 129 * C57BL/6)
|
increased osteoclast cell number
|
J:86949
|
Tsc22d3tm1.2Efmd/Y
(Not Specified)
|
abnormal T cell subpopulation ratio
|
J:201728
|
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ)
|
decreased DN3 thymocyte number
|
J:223992
|
| increased DN4 thymocyte number
|
J:223992
|
Tshrhyt/Tshrhyt
(CBy.RF-Tshrhyt/J)
|
decreased B cell number
|
J:111014
|
| increased pro-B cell number
|
J:111014
|
TsilTg(Myc)12ALvn/TsilTg(Myc)12ALvn
(involves: C57BL/6 * SJL/J)
|
increased double-positive T cell number
|
J:33857
|
Tslptm1(KOMP)Vlcg/Tslptm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal T-helper 2 cell differentiation
|
J:187770
|
Tslptm1.1Pcn/Tslptm1.1Pcn
Tg(KRT14-cre)1Ipc/0
(involves: 129 * C57BL/6 * SJL)
|
decreased lymphocyte cell number
|
J:146511
|
Tspan2tm1Hbw/Tspan2tm1Hbw
(C57BL/6-Tspan2tm1Hbw)
|
microgliosis
|
J:201143
|
Tspan9em1Tshu/Tspan9em1Tshu
(C57BL/6-Tspan9em1Tshu)
|
abnormal macrophage morphology
|
J:307067
|
Tspan33tm1Stsa/Tspan33tm1Stsa
(involves: 129S1/Sv * 129X1/SvJ)
|
increased monocyte cell number
|
J:143158
|
Tspotm1.1Guwu/Tspotm1.1Guwu
(involves: C57BL/6)
|
increased NK cell number
|
J:219189
|
Tsttm1(KOMP)Vlcg/Tsttm1(KOMP)Vlcg
(C57BL/6N-Tsttm1(KOMP)Vlcg/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
Ttc7fsn/Ttc7fsn
(involves: A/J * BALB/cByJ)
|
increased dendritic epidermal T cell number
|
J:14506
|
| increased Langerhans cell number
|
J:14506
|
Ttc28tm1b(EUCOMM)Hmgu/Ttc28tm1b(EUCOMM)Hmgu
(C57BL/6N-Ttc28tm1b(EUCOMM)Hmgu/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Tti2tm1b(KOMP)Wtsi/Tti2+
(C57BL/6N-Tti2tm1b(KOMP)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J)
|
abnormal NK cell differentiation
|
J:119985
|
| decreased NK cell number
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv)
|
decreased thymocyte number
|
J:309768
|
| increased macrophage cell number
|
J:309768
|
| increased monocyte cell number
|
J:309768
|
Twsg1tm1Nosa/Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:82738
|
| decreased double-positive T cell number
|
J:82738
|
| decreased immature B cell number
|
J:82738
|
| decreased lymphocyte cell number
|
J:82738
|
| decreased pre-B cell number
|
J:82738
|
| decreased pro-B cell number
|
J:82738
|
| decreased thymocyte number
|
J:82738
|
| increased monocyte cell number
|
J:82738
|
| increased single-positive T cell number
|
J:82738
|
Txlnatm1b(EUCOMM)Hmgu/Txlna+
(C57BL/6N-Txlnatm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
Txlnatm1b(EUCOMM)Hmgu/Txlnatm1b(EUCOMM)Hmgu
(C57BL/6N-Txlnatm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Txniptm1Yu/Txniptm1Yu
(involves: 129)
|
abnormal NK cell morphology
|
J:96677
|
| decreased CD8-positive, alpha-beta T cell number
|
J:96677
|
| decreased NK cell number
|
J:96677
|
| decreased NK T cell number
|
J:96677
|
| increased lymphocyte cell number
|
J:96677
|
| increased regulatory T cell number
|
J:96677
|
Txnl1em1(IMPC)Tcp/Txnl1em1(IMPC)Tcp
(C57BL/6NCrl-Txnl1em1(IMPC)Tcp/Tcp)
|
increased monocyte cell number
|
J:211773
|
Tyk2tm1Shmd/Tyk2tm1Shmd
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:65409
|
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased uterine NK cell number
|
J:100668
|
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(B6.129P2-Tyrobptm1.1Viv)
|
abnormal microglial cell morphology
|
J:95232
|
Tyrobptm1Lll/Tyrobptm1Lll
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast differentiation
|
J:89583
|
Tyrobptm1Ttk/Tyrobptm1Ttk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast morphology
|
J:81823
|
Tyrobptm1Ttk/Tyrobptm1Ttk
(B6.129P2-Tyrobptm1Ttk)
|
increased germinal center B cell number
|
J:177613
|
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy)
|
abnormal Kupffer cell morphology
|
J:157049
|
Ubash3btm1Jni/Ubash3btm1Jni
Ubash3atm1Jni/Ubash3atm1Jni
(Not Specified)
|
increased mature B cell number
|
J:89761
|
Ubdtm1b(EUCOMM)Wtsi/Ubdtm1b(EUCOMM)Wtsi
(C57BL/6N-Ubdtm1b(EUCOMM)Wtsi/Ccpcz)
|
decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive NK T cell number
|
J:211773
|
Ube2btm1b(EUCOMM)Wtsi/Ube2b+
(C57BL/6N-Ube2btm1b(EUCOMM)Wtsi/Ics)
|
increased lymphocyte cell number
|
J:211773
|
Ube2j2em1(IMPC)Rbrc/Ube2j2em1(IMPC)Rbrc
(C57BL/6NJcl-Ube2j2em1(IMPC)Rbrc/Rbrc)
|
decreased lymphocyte cell number
|
J:211773
|
Ube3ctm1b(EUCOMM)Hmgu/Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6N-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
increased lymphocyte cell number
|
J:211773
|
Ube3ctm1b(EUCOMM)Hmgu/Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6NCrl-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
decreased CD4-negative NK T cell number
|
J:211773
|
| decreased CD5-positive Ly6C-positive T cell number
|
J:211773
|
| decreased Ly6C-positive immature NK cell number
|
J:211773
|
| decreased Ly6C-positive NK T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
Ufl1tm1c(EUCOMM)Wtsi/Ufl1tm1c(EUCOMM)Wtsi
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)
|
decreased lymphocyte cell number
|
J:238253
|
| decreased monocyte cell number
|
J:238253
|
Ugcgem1(IMPC)H/Ugcg+
(C57BL/6NTac-Ugcgem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
Uhrf1tm1a(EUCOMM)Wtsi/Uhrf1+
(Not Specified)
|
increased NK cell number
|
J:165965
|
Uhrf2tm1b(EUCOMM)Wtsi/Uhrf2tm1b(EUCOMM)Wtsi
(C57BL/6N-Uhrf2tm1b(EUCOMM)Wtsi/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Unc13dJinx/Unc13dJinx
(C57BL/6J-Unc13dJinx/Mmucd)
|
increased CD8-positive, alpha-beta T cell number
|
J:119974
|
| increased monocyte cell number
|
J:119974
|
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:174308
|
| abnormal T-helper 17 cell differentiation
|
J:174308
|
| decreased marginal zone B cell number
|
J:174308
|
| increased B cell number
|
J:174308
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:174308
|
| increased memory T cell number
|
J:174308
|
| increased T-helper 1 cell number
|
J:174308
|
| increased T-helper 17 cell number
|
J:174308
|
Ungtm1Tld/Ungtm1Tld
(Not Specified)
|
abnormal class switch recombination
|
J:79590
|
Ungtm1Tld/Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:306598
|
| abnormal somatic hypermutation frequency
|
J:155454
|
Upf2tm1Btp/Upf2tm1Btp
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell number
|
J:134765
|
Upf3bem1(IMPC)Tcp/Y
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Upf3bem1(IMPC)Tcp/Upf3bem1(IMPC)Tcp
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Urahplt2/Urahplt2
(C57BL/6-Urahplt2)
|
abnormal NK cell morphology
|
J:267227
|
| decreased CD8-positive, alpha-beta T cell number
|
J:267227
|
Usp12tm1a(EUCOMM)Hmgu/Usp12tm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
Usp17lctm1Khb/Usp17lc+
(either: 129-Usp17lctm1Khb or (involves: 129S/SvEv * C57BL/6J))
|
decreased regulatory T cell number
|
J:191761
|
| increased B cell number
|
J:191761
|
| increased CD4-positive, alpha-beta T cell number
|
J:191761
|
| increased CD8-positive, alpha-beta T cell number
|
J:191761
|
Usp18ity9/Usp18ity9
(involves: 129S1/SvImJ * C57BL/6)
|
abnormal lymphocyte morphology
|
J:163843
|
Usp21tm1.1Jhy/Usp21tm1.1Jhy
(B6.129S7(Cg)-Usp21tm1.1Jhy)
|
increased macrophage cell number
|
J:208320
|
Usp22tm1b(KOMP)Wtsi/Usp22+
(C57BL/6N-Usp22tm1b(KOMP)Wtsi/Wtsi)
|
increased monocyte cell number
|
J:211773
|
Usp32em1(IMPC)Mhzh/Usp32+
(C57BL/6N-Usp32em1(IMPC)Mhzh/Mhzh)
|
increased lymphocyte cell number
|
J:211773
|
Usp42tm2a(EUCOMM)Wtsi/Usp42tm2a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased CD4-positive, alpha-beta T cell number
|
J:213427
|
| increased T cell number
|
J:213427
|
Usp54tm1b(KOMP)Wtsi/Usp54tm1b(KOMP)Wtsi
(C57BL/6N-Usp54tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
Vav1m1Anu/Vav1m1Anu
(C57BL/6JAnu-Vav1m1Anu)
|
increased T cell number
|
J:104190
|
Vav1m1Btlr/Vav1m1Btlr
(C57BL/6J-Vav1m1Btlr)
|
decreased B-1 B cell number
|
J:265128
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265128
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265128
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265128
|
| decreased single-positive T cell number
|
J:265128
|
| decreased T cell number
|
J:265128
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265128
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265128
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265128
|
Vav1m2Btlr/Vav1m2Btlr
(C57BL/6J-Vav1m2Btlr)
|
decreased B-1 B cell number
|
J:265130
|
Vav1M4Btlr/Vav1M4Btlr
(C57BL/6J-Vav1M4Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272528
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272528
|
| abnormal T cell differentiation
|
J:272528
|
| decreased B-1 B cell number
|
J:272528
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272528
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272528
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272528
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272528
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272528
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272528
|
Vav1M5Btlr/Vav1M5Btlr
(C57BL/6J-Vav1M5Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272529
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas * 129S8/SvEv)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113270
|
| decreased double-negative T cell number
|
J:113270
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:113270
|
| abnormal negative T cell selection
|
J:113270
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas)
|
abnormal double-negative T cell morphology
|
J:79323
|
| decreased double-positive T cell number
|
J:79323
|
| decreased mature B cell number
|
J:86654
|
| decreased single-positive T cell number
|
J:79323
|
| decreased thymocyte number
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb
(C.129S2-Vav1tm1Tyb)
|
abnormal negative T cell selection
|
J:79323
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:79323
|
Vav1tm1Tyb/Vav1tm1Tyb
(either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
abnormal lymphocyte cell number
|
J:190087
|
| abnormal T cell number
|
J:190087
|
| decreased double-positive T cell number
|
J:190087
|
| increased DN2 thymocyte number
|
J:190087
|
| increased DN3 thymocyte number
|
J:190087
|
| increased double-negative T cell number
|
J:190087
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased double-negative T cell number
|
J:86654
|
| decreased double-positive T cell number
|
J:86654
|
| decreased mature B cell number
|
J:86654
|
| decreased single-positive T cell number
|
J:86654
|
| decreased T cell number
|
J:86654
|
| decreased thymocyte number
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Kdf/Vav2tm1Kdf
Vav3tm1Swat/Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:86654
|
| arrested T cell differentiation
|
J:86654
|
| decreased double-positive T cell number
|
J:86654
|
| decreased follicular B cell number
|
J:86654
|
| decreased marginal zone B cell number
|
J:86654
|
| decreased mature B cell number
|
J:86654
|
| decreased single-positive T cell number
|
J:86654
|
| decreased T cell number
|
J:86654
|
| decreased thymocyte number
|
J:86654
|
| decreased transitional stage T2 B cell number
|
J:86654
|
| increased immature B cell number
|
J:86654
|
| increased transitional stage T1 B cell number
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased B cell number
|
J:69807
|
| decreased CD4-positive, alpha-beta T cell number
|
J:69807
|
| decreased CD8-positive, alpha-beta T cell number
|
J:69807
|
| decreased follicular B cell number
|
J:69807
|
| decreased immature B cell number
|
J:69807
|
| decreased mature B cell number
|
J:69807
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav3tm1Swat/Vav3tm1Swat
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
decreased double-negative T cell number
|
J:86654
|
| decreased double-positive T cell number
|
J:86654
|
| decreased mature B cell number
|
J:86654
|
| decreased single-positive T cell number
|
J:86654
|
| decreased T cell number
|
J:86654
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal T cell differentiation
|
J:47596
|
| decreased B-1 B cell number
|
J:47596
|
| decreased CD4-positive, alpha-beta T cell number
|
J:47596
|
| decreased CD8-positive, alpha-beta T cell number
|
J:47596
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell number
|
J:55647
|
| abnormal T cell differentiation
|
J:47596
|
| abnormal T cell number
|
J:47596
|
| decreased B-1 B cell number
|
J:55647
|
| decreased CD4-positive, alpha-beta T cell number
|
J:47596
|
| decreased CD8-positive, alpha-beta T cell number
|
J:47596
|
| increased double-negative T cell number
|
J:47596
|
| increased transitional stage B cell number
|
J:69806
|
Vav1tm2Bbd/Vav1tm2Bbd
(B6.129-Vav1tm2Bbd)
|
abnormal CD4-positive T cell differentiation
|
J:141390
|
| abnormal positive T cell selection
|
J:141390
|
| decreased double-positive T cell number
|
J:141390
|
| decreased NK T cell number
|
J:71161
|
| decreased T cell number
|
J:141390
|
Vav1tm2Bbd/Vav1tm2Bbd
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:69806
|
| abnormal T cell differentiation
|
J:69806
|
| decreased B cell number
|
J:69806
|
| decreased B-1 B cell number
|
J:69806
|
| decreased CD8-positive, alpha-beta T cell number
|
J:69806
|
| decreased mature B cell number
|
J:69806
|
| decreased T cell number
|
J:69806
|
Vav1tm2Tyb/Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113270
|
| decreased double-negative T cell number
|
J:113270
|
Vav1tm2Tyb/Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:113270
|
| abnormal negative T cell selection
|
J:113270
|
Vav1tm4Tyb/Vav1tm4Tyb
(either: 129S8.129S4-Vav1tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
abnormal lymphocyte cell number
|
J:190087
|
| abnormal T cell number
|
J:190087
|
| increased DN2 thymocyte number
|
J:190087
|
| increased DN3 thymocyte number
|
J:190087
|
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * C57BL/6)
|
decreased mature B cell number
|
J:69806
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:69807
|
| decreased B cell number
|
J:69807
|
Vcam1tm1Dmil/Vcam1tm1Dmil
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
increased monocyte cell number
|
J:69597
|
Vcam1tm1Dmil/Vcam1tm1Dmil
(C.129S4-Vcam1tm1Dmil)
|
increased B cell number
|
J:69597
|
| increased monocyte cell number
|
J:69597
|
| increased T cell number
|
J:69597
|
Vcam1tm2Flv/Vcam1tm3Flv
Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C3H * C57BL/6)
|
decreased B cell number
|
J:68147
|
| decreased CD4-positive, alpha-beta T cell number
|
J:68147
|
| decreased CD8-positive, alpha-beta T cell number
|
J:68147
|
| decreased immature B cell number
|
J:68147
|
| increased immature B cell number
|
J:68147
|
Vcam1tm2Roml/Vcam1tm2Roml
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased B cell number
|
J:68148
|
| decreased mature B cell number
|
J:68148
|
| decreased transitional stage B cell number
|
J:68148
|
| increased B cell number
|
J:68148
|
| increased immature B cell number
|
J:68148
|
| increased mature B cell number
|
J:68148
|
| increased transitional stage B cell number
|
J:68148
|
Vcptm1Itl/Vcp+
(B6.129S-Vcptm1Itl)
|
abnormal osteoclast differentiation
|
J:166230
|
| increased osteoclast cell number
|
J:166230
|
Vdac2tm1.1Ehyc/Vdac2tm1.1Ehyc
Baxtm2Sjk/Baxtm2Sjk
Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:220951
|
Vdac2tm1.1Ehyc/Vdac2tm1.1Ehyc
Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:220951
|
Vdrtm1Gcm/Vdrtm1Gcm
Tg(Col2a1-cre)1Bhr/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased osteoclast cell number
|
J:117377
|
Vdrtm1Ska/Vdrtm1Ska
(NOD.Cg-Vdrtm1Ska/CmatJ)
|
abnormal T cell number
|
J:127787
|
| decreased regulatory T cell number
|
J:127787
|
Vegfatm1Pec/Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased lymphocyte cell number
|
J:81698
|
Vhltm1Jae/Vhltm1Jae
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * CD-1)
|
decreased lymphocyte cell number
|
J:186085
|
Vpreb1atm1Ilm/Vpreb1atm1Ilm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pre-B cell morphology
|
J:53512
|
| arrested B cell differentiation
|
J:53512
|
Vpreb1atm1Ilm/Vpreb1atm1Ilm
(B6.129P2-Vpreb1atm1Ilm)
|
decreased pre-B cell number
|
J:104211
|
| increased pre-B cell number
|
J:104211
|
Vpreb1atm1Ilm/Vpreb1atm1Ilm
Vpreb1btm1Ilm/Vpreb1b+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:104211
|
| decreased pre-B cell number
|
J:104211
|
| increased pre-B cell number
|
J:104211
|
Vpreb1atm1Ilm/Vpreb1atm1Ilm
Vpreb1btm1Ilm/Vpreb1btm1Ilm
(B6.129P2-Vpreb1atm1Ilm Vpreb1btm1Ilm)
|
abnormal B cell differentiation
|
J:67609
|
| abnormal immature B cell morphology
|
J:67609
|
| decreased B-1a cell number
|
J:67609
|
| decreased mature B cell number
|
J:67609
|
| decreased pre-B cell number
|
J:67609
|
| increased pre-B cell number
|
J:67609
|
Vps13atm1b(EUCOMM)Wtsi/Vps13atm1b(EUCOMM)Wtsi
(C57BL/6N-Vps13atm1b(EUCOMM)Wtsi/Wtsi)
|
decreased T-helper cell number
|
J:211773
|
Vps13bem1(IMPC)Tcp/Vps13bem1(IMPC)Tcp
(C57BL/6N-Vps13bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Vps33aem2(IMPC)Tcp/Vps33a+
(C57BL/6NCrl-Vps33aem2(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Vps33btm1.1Arte/Vps33btm1.1Arte
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6J)
|
decreased lymphocyte cell number
|
J:222766
|
| increased macrophage cell number
|
J:222766
|
| increased monocyte cell number
|
J:222766
|
Vps35tm1.1Mjff/Vps35tm1.1Mjff
(B6.Cg-Vps35tm1.1Mjff)
|
microgliosis
|
J:303283
|
Vsig4tm1Gne/Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne)
|
increased T-helper 1 cell number
|
J:281762
|
| increased T-helper 17 cell number
|
J:281762
|
Vtcn1tm1Xxz/Vtcn1tm1Xxz
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:177612
|
| increased T-helper 1 cell number
|
J:177612
|
| increased T-helper 17 cell number
|
J:177612
|
Wactm2b(EUCOMM)Wtsi/Wac+
(C57BL/6N-Wactm2b(EUCOMM)Wtsi/Wtsi)
|
increased Ly6C low monocyte number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Wastm1Itl/Y
(Not Specified)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
Wastm1Itl/Wastm1Itl
(Not Specified)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
Wastm1Kas/Wastm1Kas
(involves: 129/Sv * C57BL/6)
|
decreased B cell number
|
J:87875
|
| decreased double-positive T cell number
|
J:87875
|
| decreased lymphocyte cell number
|
J:87875
|
| decreased T cell number
|
J:87875
|
Wastm1Sbs/Y
(involves: 129S6/SvEvTac)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
| increased monocyte cell number
|
J:153247
|
Wastm1Sbs/Y
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased marginal zone B cell number
|
J:182528
|
| decreased mature B cell number
|
J:182528
|
| increased germinal center B cell number
|
J:182528
|
| increased plasma cell number
|
J:182528
|
Wastm1Sbs/Wastm1Sbs
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
decreased B cell number
|
J:48836
|
| decreased lymphocyte cell number
|
J:48836
|
| decreased T cell number
|
J:48836
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S/SvEv)
|
abnormal osteoclast differentiation
|
J:90542
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac)
|
abnormal double-negative T cell morphology
|
J:125309
|
| abnormal double-positive T cell morphology
|
J:125309
|
| abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
| increased monocyte cell number
|
J:153247
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased marginal zone B cell number
|
J:182528
|
| decreased mature B cell number
|
J:182528
|
| increased germinal center B cell number
|
J:182528
|
| increased plasma cell number
|
J:182528
|
Wastm1Sbs/Wastm1Sbs
Wasltm2Sbs/Wasltm2Sbs
Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:125309
|
| abnormal double-positive T cell morphology
|
J:125309
|
| decreased regulatory T cell number
|
J:125309
|
| decreased single-positive T cell number
|
J:125309
|
| decreased T cell number
|
J:125309
|
| decreased thymocyte number
|
J:125309
|
| increased single-positive T cell number
|
J:125309
|
Wastm2Itl/Y
(Not Specified)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
Wastm2Itl/Wastm2Itl
(Not Specified)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
Wbp1ltm2a(EUCOMM)Hmgu/Wbp1ltm2a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal pre-B cell morphology
|
J:284781
|
| decreased B cell number
|
J:284781
|
| decreased B-1 B cell number
|
J:284781
|
| decreased pre-B cell number
|
J:284781
|
| decreased pro-B cell number
|
J:284781
|
| increased marginal zone B cell number
|
J:284781
|
Wdr1rede/Wdr1rede
(C57BL/6-Wdr1rede)
|
increased osteoclast cell number
|
J:134092
|
Wdr41m1Btlr/Wdr41m1Btlr
(C57BL/6J-Wdr41m1Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:268243
|
| increased CD8-positive, alpha-beta T cell number
|
J:268243
|
Wdr41m2Btlr/Wdr41m2Btlr
(C57BL/6J-Wdr41m2Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:268243
|
| increased CD8-positive, alpha-beta T cell number
|
J:268243
|
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac)
|
decreased thymocyte number
|
J:74719
|
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal alpha-beta T cell morphology
|
J:116168
|
| abnormal lymphopoiesis
|
J:116168
|
| decreased B cell number
|
J:116168
|
| decreased follicular B cell number
|
J:116168
|
| decreased lymphocyte cell number
|
J:116168
|
| decreased marginal zone B cell number
|
J:116168
|
| increased monocyte cell number
|
J:116168
|
Wlstm1.1Arte/Wlstm1.1Arte
Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:202499
|
| abnormal T cell subpopulation ratio
|
J:202499
|
| decreased double-positive T cell number
|
J:202499
|
| decreased gamma-delta T cell number
|
J:202499
|
| decreased T cell number
|
J:202499
|
| increased double-negative T cell number
|
J:202499
|
| increased macrophage cell number
|
J:202499
|
Wnt1tm1Brd/Wnt1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte number
|
J:75999
|
Wnt1tm1Brd/Wnt1tm1Brd
Wnt4tm1Amc/Wnt4tm1Amc
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte number
|
J:75999
|
Wnt4tm1Amc/Wnt4tm1Amc
(involves: 129S1/Sv)
|
decreased thymocyte number
|
J:75999
|
Wrntm1Lgu/Wrntm1Lgu
(B6J.Cg-Wrntm1Lgu)
|
increased osteoclast cell number
|
J:213181
|
Wrnip1tm1a(EUCOMM)Wtsi/Wrnip1tm1a(EUCOMM)Wtsi
(C57BL/6N-Wrnip1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased T cell number
|
J:165965
|
Wwoxem1Mald/Wwoxem1Mald
(FVB/N-Wwoxem1Mald)
|
microgliosis
|
J:339564
|
Xbp1tm1a(EUCOMM)Wtsi/Xbp1+
(C57BL/6N-Xbp1tm1a(EUCOMM)Wtsi/Ics)
|
decreased T cell number
|
J:165965
|
Xbp1tm1b(EUCOMM)Wtsi/Xbp1+
(C57BL/6N-Xbp1tm1b(EUCOMM)Wtsi/Ics)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
Xcl1tm1.1Dnax/Xcl1tm1.1Dnax
(either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6))
|
decreased regulatory T cell number
|
J:176844
|
Xcl1tm1Rakr/Xcl1tm1Rakr
Tg(TcraTcrb)1100Mjb/0
(involves: 129/Sv * C57BL/6)
|
decreased T cell number
|
J:155297
|
Xpatm1Tnka/Xpatm1Tnka
(involves: C57BL/6 * CBA)
|
increased NK cell number
|
J:55739
|
Xpnpep1tm1a(KOMP)Wtsi/Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi)
|
increased gamma-delta T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
Xrcc5m1Btlr/Xrcc5m1Btlr
(C57BL/6J-Xrcc5m1Btlr)
|
abnormal B cell differentiation
|
J:274736
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274736
|
| abnormal T cell differentiation
|
J:274736
|
| decreased B-2 B cell number
|
J:274736
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274736
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274736
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274736
|
| decreased T cell number
|
J:274736
|
| increased B-1a cell number
|
J:274736
|
| increased B-1b cell number
|
J:274736
|
| increased CD4-positive, alpha-beta T cell number
|
J:274736
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274736
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274736
|
Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:34834
|
| absent T cells
|
J:34834
|
| arrested B cell differentiation
|
J:34834
|
| arrested T cell differentiation
|
J:34834
|
| increased double-negative T cell number
|
J:34834
|
Xrcc5tm1Dbr/Xrcc5tm1Dbr
Lig4tm1Fwa/Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal lymphocyte morphology
|
J:80467
|
Xrcc5tm1Nus/Xrcc5tm1Nus
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal class switch recombination
|
J:120658
|
Xrcc6avon/Xrcc6avon
(involves: C57BL/6JAnu)
|
decreased B cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:44361
|
| abnormal B cell morphology
|
J:44361
|
| abnormal T cell differentiation
|
J:44361
|
| abnormal T cell morphology
|
J:44361
|
| absent immature B cells
|
J:44361
|
| absent mature B cells
|
J:44361
|
| absent pre-B cells
|
J:44361
|
| arrested B cell differentiation
|
J:44361
|
| decreased single-positive T cell number
|
J:44361
|
| decreased thymocyte number
|
J:44361
|
| increased double-positive T cell number
|
J:44361
|
Xrcc6tm1Gcl/Xrcc6tm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:108657
|
| absent mature B cells
|
J:108657
|
Xylt1npo/Xylt1npo
(involves: C57BL/6J * FVB/NJ)
|
abnormal osteoclast differentiation
|
J:205339
|
X/Yaa
(BXSB/MpJ)
|
abnormal B cell differentiation
|
J:108760
|
| abnormal T cell subpopulation ratio
|
J:179430
|
| increased monocyte cell number
|
J:7308
|
| increased plasma cell number
|
J:108760
|
X/Yaa
(BXSB/MpJScr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:10973
|
| increased monocyte cell number
|
J:10973
|
X/Yaa
((NZB x B6.SB/Le-Yaa)F1)
|
increased monocyte cell number
|
J:129409
|
X/Yaa
(B6.SB-Yaa/J)
|
decreased marginal zone B cell number
|
J:127600
|
Ydjctm1(KOMP)Wtsi/Ydjctm1(KOMP)Wtsi
(C57BL/6N-Ydjctm1(KOMP)Wtsi/Wtsi)
|
increased effector memory T-helper cell number
|
J:211773
|
| increased germinal center B cell number
|
J:211773
|
Yeats4em1Zfa/Yeats4em1Zfa
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
| decreased lymphocyte cell number
|
J:282740
|
Yipf6em1(IMPC)Mbp/Yipf6em1(IMPC)Mbp
(C57BL/6N-Yipf6em1(IMPC)Mbp/MbpMmucd)
|
increased monocyte cell number
|
J:211773
|
Yod1tm1bNarl/Yod1tm1bNarl
(C57BL/6N-Yod1tm1bNarl/Narl)
|
decreased lymphocyte cell number
|
J:211773
|
Ywhaztm1b(EUCOMM)Hmgu/Ywhaz+
(C57BL/6N-Ywhaztm1b(EUCOMM)Hmgu/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
Zap70m1Btlr/Zap70m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| absent CD4-positive, alpha-beta T cells
|
J:167119
|
| absent CD8-positive, alpha-beta T cells
|
J:167119
|
| decreased T cell number
|
J:185495
|
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c)
|
abnormal positive T cell selection
|
J:154166,
J:86607
|
| abnormal T cell clonal deletion
|
J:154166
|
| abnormal T cell differentiation
|
J:86607
|
| abnormal T cell selection
|
J:86607
|
| decreased CD4-positive, alpha-beta T cell number
|
J:154166,
J:86607
|
| decreased CD8-positive, alpha-beta T cell number
|
J:154166,
J:86607
|
| decreased regulatory T cell number
|
J:154166
|
| increased activated T cell number
|
J:154166
|
| increased B cell number
|
J:86607
|
| increased memory T cell number
|
J:154166
|
Zap70m1Saka/Zap70m1Saka
Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
decreased T cell number
|
J:86607
|
Zap70m1Saka/Zap70m1Saka
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: BALB/c * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:86607
|
Zap70m1Saka/Zap70tm2.1Weis
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell clonal deletion
|
J:154166
|
Zap70m2Btlr/Zap70m2Btlr
(involves: C57BL/6J)
|
decreased T cell number
|
J:174837
|
Zap70m4Btlr/Zap70m4Btlr
(C57BL/6J-Zap70m4Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:236698
|
| decreased CD8-positive, alpha-beta T cell number
|
J:236698
|
| decreased T cell number
|
J:236698
|
Zap70m5Btlr/Zap70m5Btlr
(C57BL/6J-Zap70m5Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254830
|
| decreased CD8-positive, alpha-beta T cell number
|
J:254830
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254830
|
| increased B cell number
|
J:254830
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254830
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254830
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254830
|
Zap70m6Btlr/Zap70m6Btlr
(C57BL/6J-Zap70m6Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254831
|
| decreased CD8-positive, alpha-beta T cell number
|
J:254831
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254831
|
| increased B cell number
|
J:254831
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254831
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254831
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254831
|
Zap70m6Hefl/Zap70m6Hefl
(C3HeB/FeJ-Zap70m6Hefl)
|
abnormal T cell differentiation
|
J:137446
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137446
|
| decreased T cell number
|
J:137446
|
Zap70m6Hefl/Zap70tm1Weis
(involves: 129X1/SvJ * C3HeB/FeJ * C57BL/10 * DBA/2)
|
decreased T cell number
|
J:137446
|
Zap70m7Btlr/Zap70m7Btlr
(C57BL/6J-Zap70m7Btlr)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254832
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254832
|
Zap70m8Btlr/Zap70m8Btlr
(C57BL/6J-Zap70m8Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:272864
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272864
|
Zap70mrtle/Zap70mrtle
(C57BL/6JSfdAnu-Zap70mrtle/Apb)
|
abnormal positive T cell selection
|
J:104190
|
| abnormal T cell subpopulation ratio
|
J:104190
|
| absent T cells
|
J:104190
|
| arrested T cell differentiation
|
J:104190
|
| decreased T cell number
|
J:104190
|
Zap70mrtle/Zap70mrtle
(involves: C57BL/6JSfdAnu)
|
abnormal double-positive T cell morphology
|
J:211510
|
| abnormal regulatory T cell number
|
J:211510
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211510
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211510
|
| increased double-positive T cell number
|
J:211510
|
Zap70mrtle/Zap70rps
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:211510
|
| abnormal double-positive T cell morphology
|
J:211510
|
| abnormal regulatory T cell number
|
J:211510
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211510
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211510
|
| increased double-positive T cell number
|
J:211510
|
Zap70mur/Zap70mur
(C57BL/6Apb-Zap70mur/ApbH)
|
decreased T cell number
|
J:104190
|
Zap70st/Zap70st
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:41170
|
| decreased T cell number
|
J:41170
|
Zap70st/Zap70tm1Dlo
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:41170
|
Zap70tm1Dlo/Zap70tm1Dlo
(involves: 129P2/OlaHsd)
|
increased double-positive T cell number
|
J:97610
|
Zap70tm1Weis/Zap70tm1Weis
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:74974
|
| arrested T cell differentiation
|
J:74974
|
Zap70tm2.1Mmal/Zap70tm2.1Mmal
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J * DBA/2J)
|
abnormal T cell morphology
|
J:71099
|
Zap70tm2.1Mmal/Zap70tm2.1Mmal
Tg(TcrLCMV)327Sdz/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * DBA/2)
|
abnormal T cell morphology
|
J:71099
|
Zap70tm2.1Weis/Zap70tm2.1Weis
(B6.129S4-Zap70tm2.1Weis)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:154166
|
| decreased CD4-positive, alpha-beta T cell number
|
J:154166
|
| decreased CD8-positive, alpha-beta T cell number
|
J:154166
|
Zap70tm2.1Weis/Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis)
|
abnormal positive T cell selection
|
J:154166
|
| abnormal T cell clonal deletion
|
J:154166
|
| decreased CD4-positive, alpha-beta T cell number
|
J:154166
|
| decreased CD8-positive, alpha-beta T cell number
|
J:154166
|
| decreased regulatory T cell number
|
J:154166
|
| increased activated T cell number
|
J:154166
|
| increased memory T cell number
|
J:154166
|
Zap70tm2.1Weis/Zap70tm2.1Weis
Tg(DO11.10)10Dlo/?
(involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:154166
|
Zap70tm2.1Weis/Zap70tm2.1Weis
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S4/SvJae * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:154166
|
| abnormal T cell clonal deletion
|
J:154166
|
Zbtb1m1Btlr/Zbtb1m1Btlr
(involves: C3H/HeN * C57BL/6J)
|
abnormal B cell differentiation
|
J:178820
|
| abnormal T cell differentiation
|
J:178820
|
| decreased B cell number
|
J:178820
|
| decreased CD4-positive, alpha-beta T cell number
|
J:178820
|
| decreased CD8-positive, alpha-beta T cell number
|
J:178820
|
| decreased DN2 thymocyte number
|
J:178820
|
| decreased DN3 thymocyte number
|
J:178820
|
| decreased DN4 thymocyte number
|
J:178820
|
| decreased double-positive T cell number
|
J:178820
|
| decreased follicular B cell number
|
J:178820
|
| decreased NK cell number
|
J:178820
|
| decreased T cell number
|
J:178820
|
| decreased transitional stage B cell number
|
J:178820
|
| increased B cell number
|
J:178820
|
Zbtb1m2Btlr/Zbtb1m2Btlr
(C57BL/6J-Zbtb1m2Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272845
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272845
|
Zbtb7atm1Ppp/Zbtb7atm1Ppp
(B6.129S1-Zbtb7atm1Ppp)
|
abnormal lymphopoiesis
|
J:121576
|
| decreased B cell number
|
J:121576
|
| decreased pro-B cell number
|
J:121576
|
Zbtb7atm1Ppp/Zbtb7atm2Ppp
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:121576
|
| abnormal double-positive T cell morphology
|
J:121576
|
| decreased B cell number
|
J:121576
|
Zbtb7bhd/Zbtb7bhd
(involves: 129/Sv * BALB/c * C3H * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:48734
|
| absent CD4-positive, alpha-beta T cells
|
J:48734
|
| increased CD8-positive, alpha-beta T cell number
|
J:48734
|
Zbtb7bhpls/Zbtb7bhpls
(involves: C57BL/6JAnu)
|
decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
Zbtb7btm1.1Rbo/Zbtb7btm1.1Rbo
(Not Specified)
|
abnormal CD8-positive, alpha-beta T cell number
|
J:141145
|
| abnormal T cell differentiation
|
J:141145
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141145
|
Zbtb7btm1.1Skok/Zbtb7btm1.1Skok
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:169841
|
Zbtb7btm1Itan/Zbtb7btm1Tani
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:141142
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141142
|
| increased CD8-positive, alpha-beta T cell number
|
J:141142
|
| increased double-negative T cell number
|
J:141142
|
Zbtb7btm1Itan/Zbtb7btm2Itan
(involves: 129 * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:141142
|
| increased CD8-positive, alpha-beta T cell number
|
J:141142
|
| increased double-negative T cell number
|
J:141142
|
Zbtb7btm1Litt/Zbtb7btm1.2Litt
(involves: C57BL/6)
|
abnormal double-positive T cell morphology
|
J:141144
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
| increased CD8-positive, alpha-beta T cell number
|
J:141144
|
Zbtb7btm1Tani/Zbtb7btm1Tani
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
Zbtb7btm2Litt/Zbtb7btm1.2Litt
(involves: 129P2/OlaHsd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
Zbtb7btm2Litt/Zbtb7btm1.2Litt
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
Zbtb7btm2Litt/Zbtb7btm2Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
absent CD4-positive, alpha-beta T cells
|
J:141519
|
Zbtb7btm2Tani/Zbtb7b+
(Not Specified)
|
decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
Zbtb7btm4.1Itan/Zbtb7btm4.1Itan
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:193321
|
| increased CD8-positive, alpha-beta T cell number
|
J:193321
|
Zbtb7btm6.1Itan/Zbtb7btm6.1Itan
Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:195348
|
Zbtb7btm7Itan/Zbtb7btm7Itan
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:195348
|
Zbtb16lu/Zbtb16lu
(B6.C3-Zbtb16lu/J)
|
decreased NK T cell number
|
J:139690
|
Zbtb17tm1Cksn/Zbtb17tm1Cksn
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Zbtb17tm1Cksn Commd10Tg(Vav1-icre)A2Kio)
|
arrested T cell differentiation
|
J:170508
|
| decreased DN1 thymic pro-T cell number
|
J:170508
|
| decreased DN2 thymocyte number
|
J:170508
|
| decreased DN3 thymocyte number
|
J:170508
|
| decreased double-negative T cell number
|
J:170508
|
| decreased gamma-delta T cell number
|
J:170508
|
| decreased T cell number
|
J:170508
|
| decreased thymocyte number
|
J:170508
|
Zbtb46tm1(HBEGF)Mnz/Zbtb46+
(C57BL/6-Zbtb46tm1(HBEGF)Mnz)
|
increased monocyte cell number
|
J:189122
|
Zc3h8em1(IMPC)Ccpcz/Zc3h8+
(C57BL/6N-Zc3h8em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
Zc3h12atm1Aki/Zc3h12atm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147868
|
| increased memory T cell number
|
J:147868
|
| increased plasma cell number
|
J:147868
|
Zc3h12cem1(IMPC)Tcp/Zc3h12cem1(IMPC)Tcp
(C57BL/6NCrl-Zc3h12cem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Zc3h12ctm2c(EUCOMM)Hmgu/Zc3h12ctm2c(EUCOMM)Hmgu
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
increased B cell number
|
J:277714
|
| increased CD4-positive, alpha-beta T cell number
|
J:277714
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:277714
|
| increased immature B cell number
|
J:277714
|
| increased marginal zone B cell number
|
J:277714
|
Zc3h12ctm2d(EUCOMM)Hmgu/Zc3h12ctm2d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:277714
|
| decreased germinal center B cell number
|
J:277714
|
| decreased macrophage cell number
|
J:277714
|
| increased B cell number
|
J:277714
|
| increased CD4-positive, alpha-beta T cell number
|
J:277714
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:277714
|
| increased immature B cell number
|
J:277714
|
| increased marginal zone B cell number
|
J:277714
|
| increased T cell number
|
J:277714
|
Zc3h12dtm1b(EUCOMM)Hmgu/Zc3h12dtm1b(EUCOMM)Hmgu
(C57BL/6N-Zc3h12dtm1b(EUCOMM)Hmgu/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Zc3h12dtm1Tom/Zc3h12dtm1Tom
(B6.Cg-Zc3h12dtm1Tom)
|
increased T-helper 17 cell number
|
J:209383
|
Zdhhc2em1Eko/Zdhhc2em1Eko
(C57BL/6-Zdhhc2em1Eko)
|
decreased dendritic epidermal T cell number
|
J:303593
|
| increased alpha-beta T cell number
|
J:303593
|
| increased gamma-delta T cell number
|
J:303593
|
Zdhhc13skc4/Zdhhc13skc4
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
abnormal Kupffer cell morphology
|
J:161519
|
Zeb1m1Btlr/Zeb1m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
| abnormal class switch recombination
|
J:185495
|
| absent marginal zone B cells
|
J:185495
|
| decreased B-1 B cell number
|
J:185495
|
| decreased B-1a cell number
|
J:185495
|
| decreased B-1b cell number
|
J:185495
|
| decreased double-positive T cell number
|
J:185495
|
| decreased germinal center B cell number
|
J:185495
|
| decreased NK cell number
|
J:185495
|
| increased single-positive T cell number
|
J:185495
|
| increased thymocyte number
|
J:185495
|
Zeb1tm1Yhi/Zeb1tm1Yhi
(B6.129P2-Zeb1tm1Yhi)
|
abnormal T cell differentiation
|
J:39865
|
| abnormal T cell subpopulation ratio
|
J:39865
|
| decreased CD8-positive, alpha-beta T cell number
|
J:39865
|
| decreased double-positive T cell number
|
J:39865
|
| decreased lymphocyte cell number
|
J:39865
|
| decreased T cell number
|
J:39865
|
| decreased thymocyte number
|
J:39865
|
Zeb1tm2Yhi/Zeb1tm2Yhi
(B6.129-Zeb1tm2Yhi)
|
decreased thymocyte number
|
J:45575
|
Zeb1Tw/Zeb1+
(B6.Cg-Zeb1Tw)
|
decreased lymphocyte cell number
|
J:177274
|
Zfand2btm1Otin/Zfand2btm1Otin
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased lymphocyte cell number
|
J:233169
|
| increased lymphocyte cell number
|
J:233169
|
Zfattm2.1Sawa/Zfattm2.1Sawa
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:187164
|
| decreased CD4-positive, alpha-beta T cell number
|
J:187164
|
| decreased CD8-positive, alpha-beta T cell number
|
J:187164
|
Zfp35tm1Naka/Zfp35tm1Naka
(either: B6.Cg-Zfp35tm1Naka or C.Cg-Zfp35tm1Naka)
|
abnormal T-helper 2 cell differentiation
|
J:153828
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb)
|
decreased lymphocyte cell number
|
J:214114
|
| increased monocyte cell number
|
J:214114
|
Zfp106tm1a(KOMP)Wtsi/Zfp106tm1a(KOMP)Wtsi
(involves: C57BL/6Brd * C57BL/6Dnk * C57BL/6N)
|
microgliosis
|
J:229162
|
Zfp131tm1.1Mytk/Zfp131tm1.1Mytk
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal T cell subpopulation ratio
|
J:271921
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271921
|
| decreased CD8-positive, alpha-beta T cell number
|
J:271921
|
| decreased T cell number
|
J:271921
|
Zfp131tm1.1Mytk/Zfp131tm1.2Mytk
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N)
|
abnormal double-negative T cell morphology
|
J:271921
|
| abnormal T cell differentiation
|
J:271921
|
| arrested T cell differentiation
|
J:271921
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271921
|
| decreased CD8-positive, alpha-beta T cell number
|
J:271921
|
| decreased DN2 thymocyte number
|
J:271921
|
| decreased DN3 thymocyte number
|
J:271921
|
| decreased DN4 thymocyte number
|
J:271921
|
| decreased double-negative T cell number
|
J:271921
|
| decreased double-positive T cell number
|
J:271921
|
| decreased thymocyte number
|
J:271921
|
Zfp207tm1b(EUCOMM)Hmgu/Zfp207+
(C57BL/6N-Zfp207tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
Zfp260tm1b(NCOM)Mfgc/Zfp260+
(C57BL/6N-Zfp260tm1b(NCOM)Mfgc/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
Zfp318m1Anu/Zfp318m1Anu
(C57BL/6JAnu-Zfp318m1Anu)
|
abnormal B cell number
|
J:104190
|
| increased mature B cell number
|
J:207375
|
Zfp318tm1.1Jhws/Zfp318tm1.1Jhws
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Zfp318tm1.1Jhws TgVav1-creA2Kio)
|
decreased transitional stage T2 B cell number
|
J:215815
|
Zfp335blt/Zfp335blt
(involves: C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:214793
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:214793
|
| abnormal T cell differentiation
|
J:214793
|
| decreased B cell number
|
J:214793
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:214793
|
| decreased CD4-positive, alpha-beta T cell number
|
J:214793
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:214793
|
| decreased CD8-positive, alpha-beta T cell number
|
J:214793
|
| decreased NK T cell number
|
J:214793
|
| decreased regulatory T cell number
|
J:214793
|
| decreased single-positive T cell number
|
J:214793
|
Zfp467tm1.1(KOMP)Vlcg/Zfp467tm1.1(KOMP)Vlcg
(B6(Cg)-Zfp467tm1.1(KOMP)Vlcg)
|
increased osteoclast cell number
|
J:302865
|
Zfp469em1(IMPC)Mbp/Zfp469em1(IMPC)Mbp
(C57BL/6N-Zfp469em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
Zfp474em1(IMPC)Ccpcz/Zfp474em1(IMPC)Ccpcz
(C57BL/6N-Zfp474em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
Zfp595tm1b(KOMP)Wtsi/Zfp595tm1b(KOMP)Wtsi
(C57BL/6N-Zfp595tm1b(KOMP)Wtsi/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
Zfp616tm1b(KOMP)Wtsi/Zfp616tm1b(KOMP)Wtsi
(C57BL/6N-Zfp616tm1b(KOMP)Wtsi/Wtsi)
|
increased KLRG1-positive T-helper cell number
|
J:211773
|
Zfp683Gt(OST314703)Lex/Zfp683Gt(OST314703)Lex
(B6.129S5-Zfp683Gt(OST314703)Lex)
|
abnormal NK T cell morphology
|
J:187727
|
| decreased NK T cell number
|
J:187727
|
Zfpm1tm1.1Geab/Zfpm1tm1.1Geab
(Not Specified)
|
increased monocyte cell number
|
J:156393
|
Zfxtm1.1Reiz/Y
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:149654
|
Zfxtm1.1Reiz/Y
Tg(Tek-cre)12Flv/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
decreased mature B cell number
|
J:149654
|
| decreased T cell number
|
J:149654
|
Zfyve16tm2a(KOMP)Wtsi/Zfyve16tm2a(KOMP)Wtsi
(C57BL/6N-Zfyve16tm2a(KOMP)Wtsi)
|
decreased B cell number
|
J:302014
|
| increased T cell number
|
J:302014
|
Zranb1tm1c(EUCOMM)Hmgu/Zranb1tm1c(EUCOMM)Hmgu
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S4/SvJaeSor * C57BL/6N * CBA)
|
decreased T helper 1 cell number
|
J:235701
|
| decreased T-helper 17 cell number
|
J:235701
|
Zranb1tm1d(EUCOMM)Hmgu/Zranb1tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:235701
|
| decreased T helper 1 cell number
|
J:235701
|
| decreased T-helper 17 cell number
|
J:235701
|
Zrsr2em1(IMPC)Mbp/Y
(C57BL/6N-Zrsr2em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
Zscan10Gt(285B6)1.1Cmhd/Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal T cell subpopulation ratio
|
J:221010
|
| decreased T cell number
|
J:221010
|
| increased B cell number
|
J:221010
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:221010
|
| increased mature NK cell number
|
J:221010
|
Zswim1tm1b(KOMP)Mbp/Zswim1tm1b(KOMP)Mbp
(C57BL/6N-Zswim1tm1b(KOMP)Mbp/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
| decreased monocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
| increased monocyte cell number
|
J:211773
|
Analysis Tools